data_2jwk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jwk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo . . . . . 0 C--O 1.237 0.465 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.23 121.28 65.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.94 127.28 69.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.406 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 tt -114.88 120.68 40.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -109.59 127.72 54.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.418 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 t -85.0 119.93 34.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.207 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.1 -23.07 14.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.48 -119.34 0.6 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.861 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 mm -113.56 99.46 8.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.79 -2.21 86.71 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.808 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.98 129.08 53.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -138.72 156.49 47.34 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.152 0.977 . . . . 0.0 112.951 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 142.06 51.7 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.31 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 pt -132.47 134.81 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.52 115.11 28.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.369 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.67 109.6 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.219 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.82 44.86 24.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.917 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.81 21.52 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.855 -0.688 . . . . 0.0 114.031 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.53 126.77 35.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.276 1.038 . . . . 0.0 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -105.41 133.15 50.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.948 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.98 126.65 52.72 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.41 158.38 24.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.101 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 26.83 56.35 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.903 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.13 149.14 24.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.281 0.562 . . . . 0.0 112.074 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -90.51 169.02 11.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.21 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.34 -43.62 90.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.61 -40.56 95.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.6 ttp -70.77 -38.18 73.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 p -64.44 -32.8 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -63.94 -49.26 73.28 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.35 -51.83 42.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.77 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.04 -47.83 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.665 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -59.29 -42.88 92.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.611 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.97 -43.94 81.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.391 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.41 -40.97 98.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.997 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -38.09 77.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.14 -29.45 65.25 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.66 -28.44 45.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.761 0.255 . . . . 0.0 111.433 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.79 -33.78 24.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.212 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -132.47 104.5 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.61 5.52 15.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -123.64 17.87 9.56 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.509 0.595 . . . . 0.0 111.688 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 121.7 18.04 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.499 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.12 125.17 25.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -113.14 134.39 54.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.264 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.91 142.01 42.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -123.51 126.81 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.4 146.34 18.36 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.53 154.46 16.94 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.88 165.74 23.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 110.911 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.88 -32.77 68.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.27 -6.49 57.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.61 133.54 35.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 156.42 32.44 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.274 1.316 . . . . 0.0 110.306 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.406 ' CE1' ' HB3' ' B' ' 83' ' ' LEU . 4.9 t80 -64.26 -33.9 76.89 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.762 -0.586 . . . . 0.0 110.266 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -57.18 -37.33 71.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -35.24 71.76 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.846 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.12 -38.41 80.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.393 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 HD12 ' CE1' ' A' ' 76' ' ' TYR . 43.0 mm -59.93 -48.39 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.444 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -54.15 -45.38 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.469 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.05 -49.18 78.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 10.8 mt -61.58 -36.17 79.89 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.444 0.64 . . . . 0.0 109.46 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.95 -41.96 98.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.74 -38.86 92.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 110.614 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.57 -41.85 98.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.952 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -63.58 -41.0 98.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.51 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -38.92 78.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.449 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.05 11.82 21.81 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.87 44.32 97.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.266 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--O 1.238 0.475 0 N-CA-C 115.43 1.281 . . . . 0.0 115.43 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.409 HG13 ' CE2' ' B' ' 66' ' ' PHE . 39.7 t -113.25 121.38 65.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.81 127.24 69.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.515 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 tt -114.86 120.47 40.08 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.07 128.25 54.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.457 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.45 119.79 34.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.147 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 -23.2 14.61 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.47 -123.51 0.83 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.565 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -108.45 99.76 9.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.011 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.87 85.75 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.968 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.61 129.44 52.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.0 156.55 47.13 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.156 0.979 . . . . 0.0 113.034 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.96 51.76 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.261 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -132.56 134.94 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 112.599 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.73 115.01 28.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -114.74 109.54 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.192 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.71 45.05 24.18 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.976 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -26.34 18.99 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.931 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.15 126.86 35.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.211 1.005 . . . . 0.0 110.391 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -105.63 132.35 51.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.074 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.24 126.84 53.4 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.7 158.8 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 112.092 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 26.49 57.43 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.932 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.92 149.15 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.36 0.6 . . . . 0.0 112.325 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.39 169.21 11.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.446 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.63 -43.27 90.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.72 -40.05 94.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.99 -0.444 . . . . 0.0 111.233 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -71.35 -38.17 71.64 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.43 -32.86 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -63.96 -48.85 74.85 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -50.84 -51.92 46.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.7 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -64.76 -47.95 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.669 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -59.21 -42.95 92.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -43.89 82.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.36 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.33 -40.97 98.77 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -37.9 76.75 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -71.18 -29.53 65.3 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.77 -28.42 44.73 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.856 0.298 . . . . 0.0 111.432 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.89 -33.56 24.74 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -132.43 104.42 6.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.84 5.54 15.72 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -123.6 17.53 9.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.517 0.598 . . . . 0.0 111.772 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 122.06 18.44 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.22 125.38 25.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG13 ' B' ' 23' ' ' VAL . 16.4 m-85 -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.32 141.75 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 127.27 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.75 146.3 18.3 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.55 154.57 16.95 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.83 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -32.73 68.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.418 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.16 -6.85 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.4 133.38 36.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 156.49 33.33 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.409 1.406 . . . . 0.0 110.336 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.412 ' CE1' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -64.64 -33.66 76.46 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.832 -0.543 . . . . 0.0 110.264 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -57.29 -37.44 72.44 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -35.46 72.23 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.786 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.68 -38.65 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.395 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.412 HD11 ' CE1' ' B' ' 76' ' ' TYR . 43.3 mm -60.02 -48.01 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.524 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -54.38 -45.13 72.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.398 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 111.283 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 10.7 mt -62.05 -36.04 80.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.457 0.646 . . . . 0.0 109.419 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.88 -42.0 98.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.793 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.74 -39.01 92.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -41.92 98.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.978 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -63.52 -41.01 98.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.458 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -38.73 77.79 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.444 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.12 11.86 21.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 44.02 98.14 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.07 -39.53 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.759 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.476 0.488 0 N-CA-C 114.454 0.905 . . . . 0.0 114.454 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.7 115.02 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.404 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.5 mp -111.9 127.45 69.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -115.39 121.52 43.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.59 127.14 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.59 111.41 20.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.96 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.17 -119.38 0.64 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.68 -1.248 . . . . 0.0 114.16 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.38 99.91 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.069 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.92 -3.31 84.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.956 -0.566 . . . . 0.0 114.175 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 131.26 54.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.581 0.69 . . . . 0.0 109.766 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.9 m-85 -137.89 157.48 46.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 122.096 0.95 . . . . 0.0 112.746 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.2 51.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.878 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 pt -132.95 134.37 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.396 0.543 . . . . 0.0 112.341 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 115.05 28.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.247 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.2 mt -111.59 108.83 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.715 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.99 46.16 26.22 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.664 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.53 24.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.658 -0.782 . . . . 0.0 114.221 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -91.74 128.96 37.78 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.57 1.185 . . . . 0.0 110.201 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.52 135.01 47.69 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.84 127.71 53.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -117.47 156.1 28.56 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.156 0.503 . . . . 0.0 112.245 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.47 45.01 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.428 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.75 151.17 22.57 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.278 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -93.14 173.32 7.79 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.586 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -67.92 -43.83 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.86 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.6 -38.7 92.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.809 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -70.35 -44.91 67.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.57 -35.27 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.744 0.307 . . . . 0.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.2 m -63.55 -51.77 64.01 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.882 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -50.86 -51.18 53.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.683 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.31 -48.0 74.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.806 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -58.35 -42.86 87.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.082 0.467 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -66.48 -43.87 84.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.152 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -64.44 -39.23 93.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.015 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -38.2 70.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.57 -30.83 67.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.587 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.07 -28.75 54.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.916 0.325 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -37.45 27.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -127.38 105.4 8.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.88 1.04 24.88 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.27 20.01 8.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.242 0.474 . . . . 0.0 111.928 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.76 115.61 8.31 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.431 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.9 123.13 16.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -110.78 129.18 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.237 0.541 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.7 pp -136.91 140.53 42.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.586 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.96 134.63 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.42 146.53 18.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 154.76 16.64 Favored Glycine 0 C--N 1.33 0.238 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.66 166.25 23.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.826 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -58.93 -31.8 68.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.261 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -81.12 -5.23 57.43 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.2 t -86.48 132.27 43.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.36 154.4 31.87 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.55 1.5 . . . . 0.0 110.495 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CE1' HD13 ' A' ' 80' ' ' ILE . 5.7 t80 -64.2 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.887 -0.508 . . . . 0.0 111.04 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.93 -37.64 69.23 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.536 0.208 . . . . 0.0 110.744 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -71.54 -34.22 69.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.188 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.43 -38.32 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.372 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 80' ' ' ILE . 41.9 mm -60.69 -47.61 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.45 0.643 . . . . 0.0 109.621 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -55.14 -44.35 75.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.929 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.99 87.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -61.47 -37.69 84.51 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.532 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.66 -41.49 90.72 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.825 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.76 -39.34 90.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 110.764 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -42.95 99.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.909 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -63.1 -42.54 99.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.44 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.22 -37.78 72.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.598 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.22 10.59 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.24 44.59 96.8 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.177 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.475 0.436 0 N-CA-C 114.431 0.897 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.37 114.79 46.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.407 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.5 mp -111.86 127.79 68.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.522 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -115.43 121.78 43.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -110.81 126.89 55.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.397 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.34 111.28 20.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.97 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.52 -122.8 0.83 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 119.964 -1.113 . . . . 0.0 114.064 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.72 100.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.15 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.74 -3.57 82.67 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.446 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 131.62 53.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.552 0.676 . . . . 0.0 109.764 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -137.94 157.16 46.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.253 1.025 . . . . 0.0 112.721 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.57 142.63 51.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.769 -1.56 . . . . 0.0 109.046 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.44 134.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.317 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 115.49 29.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.262 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 34.3 mt -112.07 109.03 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.769 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.44 46.45 22.78 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.621 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 -25.59 24.38 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.914 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -91.75 128.78 37.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.516 1.158 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.44 135.06 47.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.75 127.84 53.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.46 156.49 27.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 112.169 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.54 46.01 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.43 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 34.2 mt -89.0 150.95 22.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 112.151 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -92.68 173.13 7.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.749 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.57 -44.28 78.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.844 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.2 -38.96 93.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mtm -70.22 -44.47 68.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.01 -35.09 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -63.82 -51.13 66.11 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.869 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.35 -51.3 55.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.67 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.17 -48.12 74.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.718 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -58.14 -43.07 87.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.478 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -66.22 -44.02 85.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.297 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -64.22 -39.36 93.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.018 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -38.34 71.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -70.47 -30.59 67.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.593 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.37 -28.52 52.9 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.932 0.333 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -37.09 27.56 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -127.93 105.27 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.87 1.0 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -124.99 19.81 8.36 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.276 0.489 . . . . 0.0 111.906 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.7 115.94 8.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.405 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.18 122.74 15.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.78 129.13 55.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.407 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -136.59 140.21 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.747 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.55 134.46 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.02 146.55 18.49 Favored Glycine 0 C--O 1.226 -0.346 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.99 154.78 16.75 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.11 166.53 23.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -59.19 -31.63 69.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.281 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -81.1 -5.46 57.69 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.25 132.12 44.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.35 154.06 31.69 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.583 1.522 . . . . 0.0 110.669 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.9 t80 -64.06 -37.83 88.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.911 -0.493 . . . . 0.0 111.046 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.47 -37.63 70.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.514 0.197 . . . . 0.0 110.629 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.44 -34.42 70.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.285 0.564 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.25 -38.3 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.425 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 43.7 mm -60.94 -47.29 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.453 0.644 . . . . 0.0 109.625 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -55.33 -43.99 75.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.957 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.31 86.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.346 0.594 . . . . 0.0 110.833 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -60.87 -38.05 84.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.38 -41.51 89.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.903 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.85 -39.23 90.58 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.481 . . . . 0.0 110.707 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -42.58 98.79 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.939 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -63.22 -42.77 99.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -37.58 72.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.683 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.48 10.81 23.81 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.12 44.5 97.12 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.234 0.853 . . . . 0.0 115.234 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -99.25 -36.69 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 114.658 0.984 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.36 110.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.62 126.38 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.287 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.54 123.48 48.61 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -111.95 127.16 55.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.306 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.86 108.25 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.537 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -22.71 24.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -119.24 0.61 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.939 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.81 98.84 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.63 -3.5 86.54 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.944 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.49 130.58 54.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.544 0.672 . . . . 0.0 109.447 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -139.12 157.25 46.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 113.115 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.77 51.06 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.954 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.3 134.13 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.368 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.64 114.01 26.78 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.389 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.71 108.68 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.89 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 47.37 21.18 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.735 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.64 23.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.267 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -92.14 128.3 37.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.478 1.139 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.17 135.49 47.55 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.41 127.47 53.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -116.53 155.76 28.09 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.7 46.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.396 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -87.76 149.01 24.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 112.361 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -91.89 173.06 8.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.554 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -67.53 -45.01 76.99 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.948 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -37.98 89.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.234 0.47 . . . . 0.0 110.845 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mtp -70.26 -44.87 67.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.53 -35.46 54.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.14 -51.76 62.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -50.2 -51.79 41.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.762 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.74 -48.12 75.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.021 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.638 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -66.83 -43.46 83.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.209 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -39.41 92.91 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.043 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.13 -37.57 72.31 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.695 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.77 -30.99 67.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.442 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.23 -27.97 53.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.913 0.324 . . . . 0.0 111.148 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.05 -38.81 24.4 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.86 119.18 25.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -91.26 -19.88 22.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.37 20.53 11.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.202 0.456 . . . . 0.0 111.579 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 115.64 9.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.724 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.06 125.92 26.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -110.0 126.78 54.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.211 0.529 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.12 139.85 46.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 p -127.39 135.71 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.37 144.74 16.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.647 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.47 152.79 17.06 Favored Glycine 0 C--N 1.33 0.204 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.1 164.71 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.085 0.469 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 -32.58 68.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.502 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -81.96 -6.84 59.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.81 127.79 61.08 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.08 154.41 62.42 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 110.394 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 3.9 t80 -63.12 -36.66 84.33 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.816 -0.552 . . . . 0.0 110.73 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 110.422 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -36.89 74.89 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 109.781 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.62 -39.55 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.687 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 80' ' ' ILE . 43.1 mm -59.85 -48.11 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.409 0.623 . . . . 0.0 109.806 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -54.96 -44.06 74.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.96 83.68 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.599 . . . . 0.0 110.873 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.32 -37.3 80.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.572 0.701 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.2 -40.88 95.62 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.985 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.01 -40.19 94.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.45 -42.47 98.65 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.017 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 t60 -63.24 -41.44 99.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -38.99 76.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.35 10.33 25.4 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.45 44.1 98.46 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 N--CA 1.478 0.614 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.36 110.72 32.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.83 126.76 65.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.371 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.05 123.68 48.54 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -112.35 127.23 55.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.225 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.5 t -85.06 108.21 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.591 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.6 -22.47 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.57 -123.54 0.85 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.459 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 28.9 mm -108.12 99.08 7.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.191 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -3.43 86.6 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.032 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 130.79 54.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.623 0.712 . . . . 0.0 109.6 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -139.13 157.89 45.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.515 1.15 . . . . 0.0 113.134 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 142.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.835 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.24 134.1 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.25 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -111.14 114.1 27.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.417 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.36 108.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.751 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.44 20.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.883 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.16 -25.82 22.24 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.71 -0.757 . . . . 0.0 114.04 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -91.77 128.76 37.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.656 1.228 . . . . 0.0 110.329 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.85 135.39 48.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.36 128.15 53.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -117.28 155.8 28.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.141 0.496 . . . . 0.0 112.325 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.48 27.73 46.59 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.198 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.68 148.87 24.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.387 0.613 . . . . 0.0 112.298 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -92.05 173.18 7.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -67.75 -44.8 76.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.025 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.49 91.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.161 0.505 . . . . 0.0 110.974 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mtp -69.96 -44.87 68.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.369 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.57 -35.31 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.728 0.299 . . . . 0.0 110.352 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.26 -51.53 63.11 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.888 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.39 -51.56 45.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.7 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.12 -48.17 74.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.732 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 18.1 m -57.52 -43.45 84.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 111.753 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -66.65 -43.7 83.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.139 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -39.95 94.52 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.76 -37.3 73.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -70.94 -31.17 67.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.299 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.91 -28.1 55.17 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.11 -0.369 . . . . 0.0 111.131 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.13 -38.52 24.63 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -128.15 119.44 25.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -91.28 -20.0 22.38 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 20.58 11.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.067 0.394 . . . . 0.0 111.543 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 115.91 9.51 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.51 125.98 27.42 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.76 127.0 54.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.213 0.53 . . . . 0.0 111.694 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.26 139.77 45.97 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.518 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.39 135.89 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.34 145.18 17.25 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.649 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.71 152.32 17.16 Favored Glycine 0 N--CA 1.454 -0.161 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.34 165.14 24.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -59.14 -32.27 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -81.71 -7.13 59.56 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.43 127.8 61.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.2 154.18 61.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.222 1.282 . . . . 0.0 110.264 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 3.9 t80 -62.96 -36.48 83.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.747 -0.596 . . . . 0.0 110.69 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.48 -36.27 68.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -36.9 74.58 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.306 0.574 . . . . 0.0 109.662 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.9 -39.24 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.642 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.407 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 46.0 mm -59.99 -48.03 89.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-O 121.476 0.655 . . . . 0.0 109.713 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -55.12 -44.12 74.72 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.99 83.48 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -37.2 80.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.611 0.72 . . . . 0.0 109.591 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.25 -40.83 95.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.883 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 mt -65.2 -39.9 93.46 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.855 0.36 . . . . 0.0 110.829 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.41 -42.6 98.76 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -63.26 -41.27 99.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.424 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -39.08 76.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.598 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.3 10.19 25.82 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.78 43.89 98.62 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.15 -31.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.241 0.626 0 N-CA-C 115.676 1.375 . . . . 0.0 115.676 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.49 120.13 61.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.7 mp -112.47 127.71 69.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -117.07 127.25 53.96 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -115.84 127.68 55.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.299 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.52 99.53 8.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.941 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.82 -21.64 51.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.974 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -113.93 92.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 -5.53 79.24 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.705 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.59 128.94 52.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.576 0.688 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.69 156.9 47.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.376 1.084 . . . . 0.0 113.133 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.98 142.29 51.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.842 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.83 135.14 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.18 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.69 116.11 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.938 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.05 108.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.183 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 48.52 18.35 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.523 -0.846 . . . . 0.0 114.39 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.99 -27.11 15.74 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.373 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.81 130.0 37.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.412 1.106 . . . . 0.0 110.197 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.29 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.13 125.57 51.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.52 157.02 25.9 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.25 50.99 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.042 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.44 149.15 24.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.971 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 p -92.09 173.16 7.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.47 -43.79 80.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.948 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.22 -38.25 90.38 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 122.043 -0.411 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mtp -70.93 -43.6 67.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.625 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.32 -35.8 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -63.24 -51.2 67.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.681 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.32 -52.5 36.27 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.93 -47.57 77.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.728 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -58.07 -43.15 86.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.099 0.476 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -44.66 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.046 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.91 -40.42 96.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.161 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -39.23 74.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.236 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.55 -27.73 64.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.41 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.86 -26.95 40.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.928 0.331 . . . . 0.0 111.385 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -33.96 25.05 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -134.52 97.45 3.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -70.86 -6.21 36.4 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -109.04 17.65 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.586 0.63 . . . . 0.0 111.826 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.61 115.61 8.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.519 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.2 tp -65.11 124.69 22.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.09 127.79 54.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.359 0.599 . . . . 0.0 111.514 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.7 pp -133.95 139.24 45.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.505 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.78 137.34 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.96 145.49 17.32 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.88 153.68 16.69 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.17 163.63 24.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.154 0.502 . . . . 0.0 111.285 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -31.76 68.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.415 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -81.73 -5.96 58.61 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -89.48 127.05 56.22 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.93 156.17 63.56 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.094 1.196 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -64.46 -34.7 78.8 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.768 -0.583 . . . . 0.0 110.46 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.23 -36.42 70.89 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -36.85 75.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.334 0.587 . . . . 0.0 109.688 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.61 -39.01 81.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.788 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 80' ' ' ILE . 48.9 mm -60.39 -48.52 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.359 0.6 . . . . 0.0 109.726 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -54.15 -44.8 71.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.47 85.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.509 0.671 . . . . 0.0 110.827 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.0 mt -61.0 -36.8 80.46 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 109.378 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.73 -42.38 97.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.851 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.12 -39.92 95.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.065 0.459 . . . . 0.0 110.837 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.03 -42.38 97.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.063 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.7 -42.32 99.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.511 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.5 -38.66 74.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.83 11.41 20.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.49 44.23 98.27 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.277 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo . . . . . 0 N--CA 1.478 0.615 0 N-CA-C 115.745 1.402 . . . . 0.0 115.745 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.1 t -111.52 120.49 62.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.407 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -112.7 127.65 69.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.74 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -117.1 127.09 53.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -115.72 127.68 55.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.165 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.58 98.99 7.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.033 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.27 -21.86 52.98 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.09 -124.55 0.88 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.704 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.12 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.105 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.33 79.35 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.814 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 129.13 53.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -138.16 156.65 47.53 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.337 1.065 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 142.06 51.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.95 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.64 135.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.406 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.89 115.89 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.892 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.0 108.73 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.149 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.99 15.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.462 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.74 -26.85 16.33 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.176 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.85 129.95 37.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.487 1.144 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.88 136.03 48.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.269 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.83 126.06 52.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.79 157.08 26.14 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 26.57 53.11 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.057 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.89 148.94 25.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.388 0.613 . . . . 0.0 112.109 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -91.74 172.97 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.7 -43.62 79.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -63.94 -38.61 91.72 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 110.996 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.53 -43.91 68.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.425 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.13 -35.77 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.948 0.404 . . . . 0.0 110.228 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 19.6 m -63.27 -51.3 66.71 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.745 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.26 -52.49 35.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.79 -47.35 78.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.796 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -58.4 -42.9 88.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.488 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.39 83.29 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.196 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.07 -40.58 96.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.992 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.34 75.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.225 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.35 -27.8 64.63 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.524 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -79.63 -27.43 40.96 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.84 0.291 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -83.25 -33.75 25.98 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -134.96 97.72 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -71.02 -6.15 36.75 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.86 17.4 21.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.7 0.682 . . . . 0.0 111.754 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.3 115.9 8.27 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.32 125.13 24.12 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -109.44 127.38 54.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 0.0 111.556 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.407 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -126.52 137.5 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.12 145.43 17.21 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.522 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.76 153.29 16.83 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.84 164.21 24.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -31.51 69.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.176 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.67 -6.59 59.16 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -88.98 127.0 57.41 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.99 156.33 63.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.962 1.108 . . . . 0.0 110.298 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CE1' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.51 -34.9 79.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.996 -0.44 . . . . 0.0 110.419 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.66 -36.02 71.33 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.672 0.273 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -36.96 75.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.502 0.668 . . . . 0.0 109.539 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -61.56 -39.04 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.687 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.428 HG23 HD12 ' B' ' 80' ' ' ILE . 50.6 mm -60.31 -48.24 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.429 0.633 . . . . 0.0 109.702 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -54.59 -44.68 73.24 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.219 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.34 85.8 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 110.846 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.31 -36.56 80.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.666 0.746 . . . . 0.0 109.377 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.99 -41.83 97.25 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.949 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.97 -39.41 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.31 -41.96 96.59 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.85 -42.23 99.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.556 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.47 -38.9 75.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.618 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 11.67 18.94 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.13 44.27 98.36 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -98.07 -30.53 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.939 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 C--O 1.24 0.595 0 N-CA-C 115.296 1.229 . . . . 0.0 115.296 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.27 117.23 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.51 127.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.409 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -116.02 121.72 43.06 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -106.97 125.59 51.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.9 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.32 116.26 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.657 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.31 -23.79 15.49 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -122.89 0.76 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.105 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.1 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 122.666 0.387 . . . . 0.0 110.112 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 -3.41 87.24 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.964 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.89 53.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -137.48 157.09 47.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.202 1.001 . . . . 0.0 113.335 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 141.99 51.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.708 -1.587 . . . . 0.0 108.638 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.73 134.81 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -112.3 114.41 27.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.54 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.45 109.99 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.32 45.45 21.72 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.962 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.98 -26.89 14.55 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.827 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -85.32 125.14 32.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.927 0.863 . . . . 0.0 110.517 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.87 133.27 50.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.94 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.78 127.36 52.73 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.71 155.66 28.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 112.058 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 26.27 51.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.339 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 mt -86.62 148.92 25.26 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.513 0.673 . . . . 0.0 112.042 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.8 p -90.77 172.69 8.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.535 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -67.9 -44.29 77.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.675 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.88 -38.79 92.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.099 0.476 . . . . 0.0 110.951 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.39 -46.15 67.56 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.03 -34.42 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -63.31 -50.42 70.1 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.789 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.42 -52.46 37.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.714 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.64 -47.7 77.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.693 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.6 -43.55 89.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.214 0.531 . . . . 0.0 111.701 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.58 -43.34 85.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.374 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.27 -40.63 96.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.76 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.56 -37.33 76.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.88 -30.91 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.63 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.19 -27.75 57.01 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.247 -0.283 . . . . 0.0 111.038 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.35 -36.48 26.81 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.19 107.59 8.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.81 4.38 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.8 19.24 9.4 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.381 0.537 . . . . 0.0 111.864 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.1 116.14 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.08 123.78 19.05 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.48 127.93 55.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.097 0.475 . . . . 0.0 111.441 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -133.46 140.27 47.18 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.818 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.33 136.34 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 147.13 19.02 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.15 155.76 17.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.1 23.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.068 0.461 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -57.63 -33.38 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -79.89 -5.63 55.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.79 132.98 49.83 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.6 153.19 23.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.541 1.494 . . . . 0.0 110.573 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 5.8 t80 -63.53 -38.45 91.18 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.658 -0.651 . . . . 0.0 110.987 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -56.28 -37.33 69.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.599 0.238 . . . . 0.0 110.641 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -71.34 -35.62 71.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.857 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.24 -38.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.407 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 50.5 mm -60.05 -47.92 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.42 0.629 . . . . 0.0 109.612 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -44.37 70.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.154 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.69 80.69 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.693 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.3 -36.35 77.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -61.92 -42.58 99.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.149 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.43 -39.04 93.07 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 110.985 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -41.84 96.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.139 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -63.47 -40.13 96.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -38.14 76.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.483 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.29 9.77 27.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.42 44.15 95.72 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.28 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo . . . . . 0 C--O 1.24 0.59 0 N-CA-C 115.407 1.272 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -112.17 117.57 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.92 127.27 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.398 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.59 121.85 43.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.8 125.9 51.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.921 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -84.59 116.06 27.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.587 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.9 -24.34 15.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -126.35 0.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.964 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.1 mm -108.03 100.88 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.421 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.16 -2.97 87.95 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.144 -0.55 . . . . 0.0 114.0 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 127.85 53.54 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -137.34 157.22 47.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.237 1.018 . . . . 0.0 113.379 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 141.72 51.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.754 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 pt -131.49 134.57 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.736 0.698 . . . . 0.0 112.816 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.98 114.25 27.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.517 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.29 109.77 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.36 45.7 22.1 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.831 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.88 -27.31 13.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.849 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -84.96 125.43 32.68 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.061 0.931 . . . . 0.0 110.522 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.34 133.09 51.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.823 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.3 127.57 53.33 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -117.18 155.59 29.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.51 50.87 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.137 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 41.4 mt -87.05 149.23 24.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.528 0.68 . . . . 0.0 111.998 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -90.98 172.84 8.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.759 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.92 -44.11 77.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.8 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.41 -38.38 90.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.043 0.449 . . . . 0.0 110.809 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.2 mtp -69.23 -46.71 66.68 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.66 -34.37 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -63.47 -50.23 70.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.719 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.8 -52.07 44.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.733 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.61 -48.22 75.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.621 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -43.84 88.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 111.739 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.52 -42.98 86.45 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.486 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.61 -40.65 95.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.745 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -69.55 -37.35 77.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.996 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.98 -30.81 67.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.18 -27.65 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.947 0.34 . . . . 0.0 111.039 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -82.33 -36.54 26.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.38 107.34 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.58 4.54 18.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -123.75 19.18 9.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.465 0.575 . . . . 0.0 111.845 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 116.49 8.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.4 123.83 19.31 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.38 127.66 55.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -133.45 139.96 47.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.609 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.2 p -127.05 136.5 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.51 147.05 18.96 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.03 155.83 17.32 Favored Glycine 0 N--CA 1.46 0.29 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.989 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 166.55 23.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -58.42 -33.14 69.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.461 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.99 -5.97 56.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -82.41 132.69 51.88 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.55 153.1 23.36 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.683 1.589 . . . . 0.0 110.316 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.9 t80 -63.38 -38.8 92.55 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.767 -0.583 . . . . 0.0 110.921 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.96 -37.37 68.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.492 0.187 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -71.3 -35.85 71.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.18 -38.26 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.416 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 50.4 mm -59.92 -47.63 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.51 0.671 . . . . 0.0 109.719 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -54.28 -44.29 71.77 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.46 81.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.148 0.499 . . . . 0.0 110.716 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 mt -60.68 -36.2 78.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.604 0.716 . . . . 0.0 109.238 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -61.93 -42.24 98.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.0 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.86 -38.92 92.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.96 0.41 . . . . 0.0 110.948 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.19 -42.05 96.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.288 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.36 -40.34 97.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -38.14 76.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.389 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.21 9.6 27.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.39 44.3 95.54 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 115.704 1.041 . . . . 0.0 115.704 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.65 -37.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.67 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--O 1.239 0.541 0 N-CA-C 115.692 1.381 . . . . 0.0 115.692 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.58 116.62 53.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.55 127.16 65.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.604 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -115.14 122.04 44.86 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.24 128.07 55.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.131 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.31 116.62 29.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.508 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.16 -22.15 16.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.8 -122.08 0.72 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.741 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -115.59 87.52 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.32 27.72 19.57 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.388 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 93.08 2.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.517 0.675 . . . . 0.0 109.487 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.26 157.39 17.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.263 1.03 . . . . 0.0 113.231 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 142.0 51.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 pt -131.54 133.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 118.529 0.604 . . . . 0.0 112.422 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.51 114.33 27.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.473 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.27 110.08 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.208 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.42 45.03 22.26 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.93 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 -26.86 17.04 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.086 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.88 126.25 34.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.225 1.013 . . . . 0.0 110.525 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.36 131.94 52.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.921 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.75 127.2 53.32 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -117.56 158.67 24.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.49 27.39 54.87 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.949 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.38 149.15 24.67 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.697 0.76 . . . . 0.0 112.191 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 p -91.36 171.53 9.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.419 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.42 -43.61 80.8 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.0 -38.8 92.42 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.027 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mtp -70.35 -44.11 68.82 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.48 -34.91 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -63.55 -50.46 69.43 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.855 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -50.67 -51.47 48.97 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.807 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.08 -48.09 74.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.279 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -43.84 83.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 111.622 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.76 -44.5 81.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.193 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.92 -40.58 96.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -69.41 -38.48 77.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.24 -31.27 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.23 -27.3 53.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.26 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -84.87 -36.62 21.42 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.994 0.426 . . . . 0.0 109.953 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -128.84 97.38 4.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.28 -6.11 37.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -114.16 19.19 16.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.573 0.624 . . . . 0.0 111.955 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.95 113.38 5.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.446 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.45 125.07 23.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -111.19 128.99 56.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.795 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -133.89 139.36 46.14 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.51 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.72 135.91 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.78 145.38 16.98 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.14 153.13 16.67 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.771 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.75 24.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -32.26 65.98 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.75 -5.71 59.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.38 133.25 53.67 Favored Pre-proline 0 CA--C 1.537 0.462 0 O-C-N 122.221 -0.299 . . . . 0.0 110.442 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.34 148.96 27.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.729 1.619 . . . . 0.0 110.729 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 4.7 t80 -63.04 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.748 -0.595 . . . . 0.0 111.251 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.56 -37.0 67.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.605 0.24 . . . . 0.0 110.832 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.6 -34.75 67.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.913 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.2 t -62.67 -38.83 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.381 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 80' ' ' ILE . 43.3 mm -60.24 -47.48 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.474 0.654 . . . . 0.0 109.407 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.12 -43.99 70.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.2 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -49.05 79.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.123 0.487 . . . . 0.0 110.792 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.33 -37.9 82.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.381 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.09 -42.0 97.7 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.696 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.22 -39.61 92.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.98 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -42.26 98.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.65 -42.05 98.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.394 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.392 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.99 10.83 20.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.65 97.73 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.669 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo . . . . . 0 C--O 1.24 0.587 0 N-CA-C 115.663 1.37 . . . . 0.0 115.663 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.5 116.81 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.74 127.11 65.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.632 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -115.04 122.16 45.32 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -111.21 127.58 55.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.254 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.71 116.89 30.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.323 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.4 -22.61 16.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.34 -125.71 0.94 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.649 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -111.06 87.84 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.192 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.62 27.93 20.68 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.485 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.86 93.3 2.69 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.514 0.673 . . . . 0.0 109.281 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -105.56 157.03 17.67 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.356 1.074 . . . . 0.0 113.336 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.78 141.99 51.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.992 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 pt -131.48 133.94 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.527 0.603 . . . . 0.0 112.271 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.05 114.45 27.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.396 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 72.3 mt -114.46 110.1 30.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.192 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.17 45.38 20.74 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.044 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.84 -26.8 16.8 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.102 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.94 126.3 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.322 1.061 . . . . 0.0 110.436 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.52 131.93 52.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.962 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 127.19 53.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -117.33 158.58 24.15 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.242 0.544 . . . . 0.0 112.445 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.21 27.74 54.96 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.2 149.1 24.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.57 0.7 . . . . 0.0 112.193 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.8 p -91.49 171.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.428 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -67.21 -44.08 80.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.78 -38.69 92.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mtp -70.3 -44.36 68.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.304 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.42 -34.47 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.3 m -64.29 -50.24 68.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.873 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -50.73 -51.55 48.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.604 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.95 -48.32 74.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.11 -43.92 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.058 0.456 . . . . 0.0 111.781 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.81 -44.24 81.72 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.195 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -64.16 -40.09 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.904 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -69.68 -39.01 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.188 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -69.81 -31.2 68.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.09 -27.84 54.3 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.894 0.315 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -84.31 -36.15 22.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.11 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -70.93 -5.96 34.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -114.15 18.51 17.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.616 0.644 . . . . 0.0 112.053 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.27 113.71 5.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.79 124.39 21.36 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -110.62 128.78 55.83 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.372 0.606 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -133.61 139.26 46.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.558 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -125.94 135.68 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.55 145.27 16.91 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.13 153.2 16.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.92 24.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.045 0.45 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -32.35 66.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.78 -5.51 58.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -81.49 133.39 53.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.59 149.12 26.7 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.725 1.617 . . . . 0.0 110.708 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 4.7 t80 -63.27 -39.08 93.58 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.709 -0.619 . . . . 0.0 111.157 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.51 -37.12 67.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.694 0.283 . . . . 0.0 110.728 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.4 -34.81 68.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.873 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -38.82 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 41.7 mm -60.58 -46.7 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.437 0.636 . . . . 0.0 109.447 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.84 -43.77 73.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.073 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.39 78.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.345 0.593 . . . . 0.0 110.792 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.08 -38.12 81.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 109.484 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.81 -42.27 97.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.817 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.76 -39.86 94.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.938 0.399 . . . . 0.0 111.079 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.42 -42.39 98.74 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.56 -41.88 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -38.32 74.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.497 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.01 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 44.67 97.56 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.05 -35.15 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo . . . . . 0 C--O 1.239 0.57 0 N-CA-C 115.414 1.275 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.52 119.19 60.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.58 127.57 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.305 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tt -113.88 119.99 39.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.31 128.32 54.99 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.113 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -87.2 116.38 29.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.391 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.95 -22.75 16.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.17 -119.26 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.348 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.66 101.46 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.221 -0.489 . . . . 0.0 109.708 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.72 1.65 72.88 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.884 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -107.12 92.73 4.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.423 0.612 . . . . 0.0 109.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -104.14 156.22 18.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.174 0.988 . . . . 0.0 112.926 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.22 141.41 52.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.981 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 pt -131.73 134.69 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.654 0.661 . . . . 0.0 112.702 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -112.1 115.77 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.884 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.94 110.56 32.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.084 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.3 44.58 27.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.992 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -26.25 18.77 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.744 -0.741 . . . . 0.0 114.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -88.71 127.95 35.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.58 1.19 . . . . 0.0 110.46 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -106.48 134.35 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.0 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.74 126.64 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -116.7 157.7 25.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.241 0.543 . . . . 0.0 112.366 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.05 27.76 51.9 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.052 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -88.12 150.14 23.52 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 112.293 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.5 p -91.11 171.33 9.33 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.228 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.14 -43.89 81.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.78 -38.57 91.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.171 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 mtp -69.87 -44.94 68.8 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.03 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -58.8 -34.14 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.8 m -64.11 -49.91 70.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.587 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.37 -52.68 35.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.696 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.42 -48.01 76.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t -58.01 -43.88 86.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.074 0.464 . . . . 0.0 111.738 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -44.62 83.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.249 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.99 95.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.096 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -69.92 -38.56 76.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.634 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.83 -29.41 65.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -78.85 -26.87 44.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.822 0.283 . . . . 0.0 111.393 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -85.63 -34.18 21.44 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.61 95.78 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.74 -13.36 62.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -106.0 19.28 20.79 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.604 0.638 . . . . 0.0 111.897 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -68.28 111.41 4.56 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 tp -66.42 127.21 31.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -114.3 131.25 56.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.021 0.439 . . . . 0.0 111.486 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.85 140.94 46.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.672 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -127.07 136.72 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.15 146.03 17.51 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.81 154.81 16.68 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.093 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 165.13 24.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.134 0.467 . . . . 0.0 111.14 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.29 -32.35 66.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.59 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -81.28 -5.74 58.12 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.29 132.21 48.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.03 151.72 35.32 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.57 1.513 . . . . 0.0 110.193 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 5.2 t80 -63.38 -36.6 84.24 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.719 -0.613 . . . . 0.0 110.753 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.6 -36.44 69.4 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.81 -34.89 69.73 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.91 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.88 -38.42 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.299 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.402 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 49.7 mm -61.2 -47.34 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.426 0.631 . . . . 0.0 109.482 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.9 -44.35 74.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.931 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -48.17 82.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.257 0.551 . . . . 0.0 111.055 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -60.63 -37.15 80.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.384 0.611 . . . . 0.0 109.659 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.92 -41.26 95.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.818 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.5 -39.68 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.578 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.86 -42.29 99.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.119 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -63.79 -42.09 97.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.369 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -37.86 75.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.478 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 10.51 25.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.65 97.16 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.716 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo . . . . . 0 C--O 1.24 0.601 0 N-CA-C 115.53 1.319 . . . . 0.0 115.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.34 119.07 60.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.48 127.81 67.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.302 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tt -114.23 119.83 38.38 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.06 128.14 54.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.262 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.02 116.0 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.364 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.98 -22.48 16.81 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.12 -123.53 0.82 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.117 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.51 101.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.894 -0.653 . . . . 0.0 110.279 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.48 1.78 72.03 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.047 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -107.05 92.79 4.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.473 0.637 . . . . 0.0 109.747 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -103.89 155.89 18.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.26 1.029 . . . . 0.0 113.031 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 142.12 51.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.928 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 pt -132.24 134.8 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 118.671 0.669 . . . . 0.0 112.41 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -112.4 115.89 29.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -115.93 110.64 32.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.018 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.31 44.27 27.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.219 -0.991 . . . . 0.0 114.19 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.7 -25.78 21.55 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.061 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -89.01 127.97 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.256 1.028 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.75 134.46 49.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.8 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 127.0 53.17 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -117.45 157.94 25.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 112.08 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.79 27.77 52.8 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.896 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 16.3 mt -88.35 149.87 23.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.749 0.785 . . . . 0.0 112.35 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.88 171.18 9.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.443 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.11 -43.92 81.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.95 -38.83 92.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.021 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.7 mtp -69.55 -44.78 70.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.114 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -34.36 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -63.83 -49.92 70.95 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.708 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.18 -52.69 33.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.82 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.45 -48.38 75.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.723 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -57.9 -43.3 86.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.052 0.453 . . . . 0.0 111.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.86 81.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.305 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -40.37 96.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.62 -38.63 77.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -70.46 -29.72 66.36 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -78.85 -27.08 44.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.876 0.307 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -85.59 -33.71 21.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.718 0.294 . . . . 0.0 110.544 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -131.01 95.99 3.94 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.1 -13.42 62.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -105.91 19.48 20.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.722 0.692 . . . . 0.0 111.809 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.9 m -68.13 111.25 4.38 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.41 126.94 30.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -113.99 131.26 56.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 111.567 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.98 141.14 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.47 137.21 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.47 146.14 17.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.69 155.11 16.62 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.43 24.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.893 0.378 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.66 -32.75 67.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.294 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -80.99 -5.83 58.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.24 132.04 48.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.81 151.82 36.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.557 1.505 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.41 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.2 t80 -63.51 -36.66 84.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 110.692 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.65 -36.57 69.69 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -71.49 -34.64 70.32 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.26 -38.17 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.461 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.422 HG21 HD12 ' B' ' 80' ' ' ILE . 49.1 mm -61.27 -47.13 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -55.0 -44.62 74.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.971 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.96 83.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 111.086 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.78 -37.31 81.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.698 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.59 -41.56 94.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.751 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.37 -39.41 92.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.031 0.444 . . . . 0.0 110.565 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.96 -42.59 99.87 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.994 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -63.26 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.515 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -38.13 75.93 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.509 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.28 10.17 25.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.25 44.87 97.02 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mt -103.36 -37.15 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 0.0 109.768 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--O 1.24 0.584 0 N-CA-C 115.575 1.336 . . . . 0.0 115.575 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.77 119.24 59.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.14 127.27 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.309 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.66 122.12 44.61 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -111.0 127.15 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.411 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -84.73 112.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.69 -22.52 20.18 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -119.87 0.65 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.775 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -111.87 99.4 8.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 122.905 0.482 . . . . 0.0 109.899 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.08 -2.47 87.62 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.228 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 131.29 54.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.866 0.833 . . . . 0.0 109.431 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.29 158.26 44.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.11 0.957 . . . . 0.0 112.942 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 142.64 51.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.192 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.4 pt -130.09 132.9 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.146 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.02 114.63 27.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.1 mt -114.99 110.39 31.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.473 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.39 46.0 28.78 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.21 -0.995 . . . . 0.0 114.141 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.13 -24.53 24.45 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.68 -0.771 . . . . 0.0 114.308 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 127.76 36.0 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.512 1.156 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.77 133.13 50.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.956 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.86 127.22 53.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -117.45 157.65 25.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.919 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.64 26.43 56.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.918 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.38 147.58 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.276 0.538 . . . . 0.0 111.941 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -92.03 172.06 8.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.547 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.14 -45.45 80.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.884 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.13 -39.42 93.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.14 -0.35 . . . . 0.0 111.059 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.3 ttp -70.61 -40.94 72.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.82 -34.8 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -63.61 -49.95 71.29 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.47 -52.58 36.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.642 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.95 -47.69 76.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.51 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -43.47 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 111.54 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -66.25 -44.24 84.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -41.75 99.17 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.106 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.63 -39.66 73.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.89 -28.05 65.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.682 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.41 -27.03 38.15 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.223 -0.298 . . . . 0.0 111.301 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -85.73 -35.41 20.82 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -130.88 105.33 7.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.86 9.23 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -126.52 16.25 7.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 111.901 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.01 113.77 5.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.46 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.44 124.3 19.11 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -113.1 131.56 55.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.819 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.22 140.17 45.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.591 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -126.65 136.94 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -140.38 147.9 19.55 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.623 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.32 154.55 16.52 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.08 23.38 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.934 0.367 . . . . 0.0 111.437 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.54 -32.73 67.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.42 -7.0 58.95 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -87.71 128.1 55.72 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.47 156.54 54.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.075 1.183 . . . . 0.0 110.08 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 4.8 t80 -63.65 -36.23 83.13 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.925 -0.485 . . . . 0.0 110.514 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -56.58 -36.33 69.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -37.16 74.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.509 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 t -61.36 -39.34 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.897 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 48.2 mm -60.76 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.327 0.584 . . . . 0.0 109.577 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -44.84 75.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.164 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.07 86.97 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.288 0.566 . . . . 0.0 111.049 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.13 -36.77 80.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.586 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.52 -41.15 96.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -39.99 94.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.865 0.365 . . . . 0.0 110.729 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.49 -42.4 98.54 Favored 'General case' 0 C--N 1.335 -0.037 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.859 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -63.31 -42.14 99.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.421 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.66 -38.73 78.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.384 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.6 10.71 24.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.785 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 C--O 1.241 0.651 0 N-CA-C 115.533 1.32 . . . . 0.0 115.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.55 119.15 59.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.36 127.49 67.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.263 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -115.98 122.43 45.22 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -110.95 127.77 55.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.486 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.04 112.1 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.59 -22.63 20.21 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.65 -123.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.522 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.64 99.56 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.842 -0.679 . . . . 0.0 110.121 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.05 -2.54 87.52 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 114.407 0.523 . . . . 0.0 114.407 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 131.22 54.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.644 0.722 . . . . 0.0 109.556 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -139.17 158.12 44.74 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.143 0.973 . . . . 0.0 112.954 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 142.73 51.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.069 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.33 133.11 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.974 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.98 114.93 28.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.463 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 81.7 mt -115.27 110.1 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.391 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.39 45.67 28.74 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.256 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.81 -24.94 23.93 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.025 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.82 127.31 35.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.683 1.241 . . . . 0.0 110.393 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.2 133.2 50.37 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.115 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.74 127.14 53.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -117.43 157.39 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.969 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.83 26.37 56.23 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.18 147.3 26.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.238 0.519 . . . . 0.0 111.778 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -91.83 172.14 8.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.441 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.57 -45.08 80.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.18 -39.23 93.57 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.002 -0.436 . . . . 0.0 111.053 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttp -70.71 -40.91 72.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.81 -35.07 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -63.3 -50.23 70.87 Favored 'General case' 0 CA--C 1.523 -0.066 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.926 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.23 -52.83 32.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.624 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 30.4 mt -64.75 -47.72 77.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.85 -43.33 90.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.279 0.561 . . . . 0.0 111.661 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -66.23 -44.06 84.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.284 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -42.0 99.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.59 -39.41 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.987 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.06 -28.47 65.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.716 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.78 -27.48 40.4 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.948 0.34 . . . . 0.0 111.43 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.72 -34.85 21.14 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.949 0.404 . . . . 0.0 110.337 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -131.16 105.74 7.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.33 9.48 10.8 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -126.58 16.15 7.58 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 111.854 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.06 114.27 6.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.375 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -58.85 124.48 19.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.608 0.242 . . . . 0.0 110.534 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -113.51 131.36 56.09 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.799 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.34 140.18 44.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.881 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.3 p -126.76 136.03 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.42 147.68 19.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.806 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.98 154.3 16.46 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.95 165.67 23.22 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.956 0.408 . . . . 0.0 111.286 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -58.42 -32.72 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.324 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.21 -7.5 59.0 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.98 128.03 57.4 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.42 156.4 54.48 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.139 1.226 . . . . 0.0 110.165 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.412 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.0 t80 -63.39 -36.44 83.74 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.866 -0.521 . . . . 0.0 110.683 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.18 -36.39 68.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -37.15 74.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.674 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.19 -39.59 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.674 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.449 HG22 HD11 ' B' ' 80' ' ' ILE . 47.9 mm -60.59 -47.3 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 109.64 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.06 74.36 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.216 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.63 84.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.382 0.61 . . . . 0.0 110.907 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.53 -36.72 79.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.78 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -61.72 -41.32 97.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.837 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -39.94 94.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.002 0.429 . . . . 0.0 110.684 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.59 -42.54 98.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.304 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.73 76.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.74 10.84 24.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.41 98.11 Favored Glycine 0 C--N 1.33 0.25 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.0 mt -101.9 -37.05 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.75 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo . . . . . 0 C--O 1.239 0.565 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.82 118.82 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.22 127.87 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -116.01 123.27 47.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -112.01 128.98 56.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.156 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 t -88.68 96.67 6.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.181 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -22.06 54.69 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.52 -120.65 0.65 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -112.57 101.12 12.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.019 0.527 . . . . 0.0 109.706 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.48 73.5 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.93 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 95.95 5.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.732 0.777 . . . . 0.0 110.285 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -104.83 156.65 17.82 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.294 1.045 . . . . 0.0 113.025 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.09 142.25 51.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.666 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 pt -132.77 134.24 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.49 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.15 115.15 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.679 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.8 mt -114.56 109.51 28.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.252 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 45.38 27.61 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.13 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.11 -25.73 22.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.071 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.47 128.07 36.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.327 1.064 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.89 136.05 47.4 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.023 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.44 127.48 53.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.35 157.7 25.69 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 112.228 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.53 52.55 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.12 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -87.94 147.7 24.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 112.221 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -89.71 169.88 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.629 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -65.55 -45.36 83.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -64.39 -38.77 92.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.1 ttp -72.11 -37.76 69.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.977 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.97 -33.36 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m -62.94 -50.3 71.35 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.448 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.13 -52.49 34.73 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.866 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -65.21 -47.36 77.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.773 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -58.7 -43.11 89.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.482 . . . . 0.0 111.592 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -65.95 -44.34 85.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.284 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.37 -41.58 98.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -69.57 -38.97 77.61 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.95 -29.75 66.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.575 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -76.91 -27.71 55.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.94 0.336 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -83.44 -35.94 24.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.846 0.355 . . . . 0.0 110.065 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.68 105.25 7.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -78.17 -15.61 58.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -105.13 19.06 21.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.359 0.527 . . . . 0.0 111.858 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -68.79 116.18 8.99 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 125.27 23.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -111.63 130.04 55.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.198 0.523 . . . . 0.0 111.627 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.52 139.93 44.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.67 138.65 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.32 142.81 14.08 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.5 154.0 16.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.722 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.0 23.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -31.43 69.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.515 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.12 -7.07 59.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.66 131.8 38.74 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.34 155.91 55.31 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.013 1.142 . . . . 0.0 110.246 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' A' ' 80' ' ' ILE . 6.1 t80 -63.71 -35.46 80.63 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.842 -0.536 . . . . 0.0 110.437 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -56.6 -36.94 69.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.649 0.261 . . . . 0.0 110.402 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -36.58 75.22 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.734 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.03 -39.26 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.483 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' CE1' ' A' ' 76' ' ' TYR . 45.6 mm -60.6 -46.56 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.41 0.624 . . . . 0.0 109.404 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -45.11 73.77 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.182 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.386 0.613 . . . . 0.0 110.657 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.65 -37.11 80.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.486 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.32 -41.77 97.56 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.787 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.55 -42.89 98.35 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -62.45 -43.13 99.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.567 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -37.57 79.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.53 10.48 25.25 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.24 98.22 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.392 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo . . . . . 0 C--O 1.24 0.6 0 N-CA-C 115.829 1.434 . . . . 0.0 115.829 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.08 118.43 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.2 127.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.316 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -115.97 123.44 48.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -112.03 129.34 56.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.215 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.91 96.48 6.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.185 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.92 -21.38 54.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.356 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.22 -125.3 0.91 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.651 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -107.65 101.9 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.016 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.45 70.55 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.006 -0.543 . . . . 0.0 114.099 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.58 95.57 5.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.823 0.821 . . . . 0.0 110.361 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -104.24 156.49 17.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.279 1.037 . . . . 0.0 113.093 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.0 142.14 51.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.479 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.6 pt -132.76 134.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.452 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.3 115.1 28.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.595 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mt -114.51 109.71 29.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.89 45.76 25.51 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.408 -0.901 . . . . 0.0 114.179 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -25.77 21.71 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.144 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.39 128.09 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.33 1.065 . . . . 0.0 110.396 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.82 136.02 47.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.899 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.4 127.52 53.19 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.43 157.02 26.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 27.97 49.01 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.119 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.93 148.23 24.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.653 0.74 . . . . 0.0 112.305 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -90.53 169.59 10.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.411 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.27 -45.36 84.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.37 -38.81 92.33 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.948 -0.47 . . . . 0.0 111.069 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 10.2 ttp -71.75 -37.98 70.46 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.75 -33.42 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.1 m -62.99 -50.29 71.33 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.506 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.09 -52.39 35.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.797 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 mt -65.25 -47.73 75.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.683 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -58.38 -43.37 88.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.077 0.465 . . . . 0.0 111.527 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -65.84 -44.4 85.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.28 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.27 -41.58 99.04 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.184 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.56 -38.84 77.59 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -69.93 -29.71 66.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.692 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -77.0 -27.78 54.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.851 0.296 . . . . 0.0 111.26 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -83.29 -35.52 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.838 0.351 . . . . 0.0 110.102 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -130.15 105.0 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.84 -15.54 58.98 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -105.38 19.57 20.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.362 0.528 . . . . 0.0 111.899 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 116.05 9.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.6 125.35 23.99 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -111.74 130.58 55.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.559 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.91 140.06 43.78 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.85 138.77 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 142.86 14.09 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.25 153.94 16.82 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 163.28 24.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.057 0.455 . . . . 0.0 111.322 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -31.44 69.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.307 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -7.15 59.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.55 132.1 38.05 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.5 155.78 54.72 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.052 1.168 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 6.0 t80 -63.74 -35.38 80.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.863 -0.523 . . . . 0.0 110.363 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.73 -36.78 70.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.565 0.221 . . . . 0.0 110.423 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.0 -36.5 75.19 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.713 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.19 -39.2 83.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.579 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.419 HG22 HD12 ' B' ' 80' ' ' ILE . 45.8 mm -60.53 -46.61 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.364 0.602 . . . . 0.0 109.435 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -44.88 73.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.085 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.64 80.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.278 0.561 . . . . 0.0 110.767 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -60.21 -37.03 79.05 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.566 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.13 -41.93 97.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.981 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -39.36 91.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.592 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.42 -42.55 98.73 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -62.75 -43.23 99.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.589 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.77 79.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.491 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 10.54 24.17 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.42 44.63 97.43 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.071 0.788 . . . . 0.0 115.071 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.84 -34.21 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.873 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo . . . . . 0 C--O 1.239 0.526 0 N-CA-C 115.663 1.37 . . . . 0.0 115.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.8 118.89 58.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.2 127.61 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.652 0.263 . . . . 0.0 111.607 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -115.88 122.65 45.99 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.59 127.29 55.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.207 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.7 105.27 14.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.723 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.63 -22.3 28.02 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.99 -121.55 0.72 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.956 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.15 97.97 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 122.869 0.467 . . . . 0.0 109.94 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.05 -5.3 85.02 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.956 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.04 128.55 53.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.562 0.681 . . . . 0.0 109.482 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -134.84 156.03 49.61 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.231 1.015 . . . . 0.0 112.759 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 141.53 52.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.796 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 pt -132.48 133.85 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.263 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -111.36 115.52 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.561 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.9 mt -113.69 108.92 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.281 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.69 46.74 24.46 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.65 -0.786 . . . . 0.0 114.079 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.99 15.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.082 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.3 129.24 36.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.527 1.163 . . . . 0.0 110.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -107.96 135.95 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.027 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.53 125.58 51.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.84 156.21 26.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.064 0.459 . . . . 0.0 111.885 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 26.95 52.81 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.959 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.96 148.7 25.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.344 0.572 . . . . 0.0 111.743 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.2 p -89.6 171.73 9.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.183 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -66.86 -44.92 79.7 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.646 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.234 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 mtp -70.22 -43.43 70.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -34.73 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.899 0.38 . . . . 0.0 110.08 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -63.98 -50.48 68.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.824 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -50.71 -52.07 43.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.657 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.84 -47.95 76.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.46 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -57.32 -43.88 83.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 111.618 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -66.66 -44.33 82.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.243 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -64.53 -40.02 94.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.99 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -69.94 -38.69 76.26 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.43 -31.33 69.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.9 -28.73 55.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.887 0.312 . . . . 0.0 111.239 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -82.24 -36.82 26.78 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -128.59 112.16 13.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -84.58 -10.07 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -112.45 19.67 17.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.376 0.535 . . . . 0.0 111.952 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 113.36 5.55 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.32 125.51 24.15 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -112.54 128.31 56.31 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 111.737 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -132.16 139.27 48.34 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -127.24 137.89 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 144.62 15.84 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.6 156.61 16.01 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.833 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.51 163.21 24.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.138 0.495 . . . . 0.0 111.276 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -57.47 -31.85 66.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.649 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.01 -6.01 58.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.27 129.72 57.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.31 151.81 49.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.22 1.28 . . . . 0.0 110.426 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.41 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 5.9 t80 -62.94 -39.46 94.7 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.493 -0.754 . . . . 0.0 111.271 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.73 -35.58 66.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.82 -35.96 70.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.204 0.526 . . . . 0.0 109.744 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -62.44 -38.82 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.439 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 76' ' ' TYR . 47.7 mm -61.04 -47.6 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -44.74 68.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.16 78.93 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.454 0.645 . . . . 0.0 110.358 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.35 -37.08 79.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.864 0.84 . . . . 0.0 109.353 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -61.32 -42.92 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.6 -39.73 95.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 110.657 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -41.97 99.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.85 -41.23 97.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.7 -38.68 78.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.442 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.43 11.02 22.9 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.32 44.13 98.1 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 C--O 1.239 0.537 0 N-CA-C 115.652 1.366 . . . . 0.0 115.652 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.63 118.67 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.98 127.43 68.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 120.698 0.285 . . . . 0.0 111.675 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -115.65 122.59 46.03 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.6 126.85 54.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.314 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.43 105.3 14.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.788 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.31 28.5 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.88 -124.71 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.778 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -109.04 97.58 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.406 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.33 -5.19 85.05 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.106 -0.569 . . . . 0.0 114.049 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 128.79 54.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -135.15 156.07 49.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.334 1.064 . . . . 0.0 112.804 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.52 141.48 52.06 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.828 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 pt -132.31 134.14 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.265 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -111.58 115.72 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.566 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -113.98 108.8 26.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.276 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.85 46.47 25.42 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.015 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.91 16.53 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.046 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -90.39 129.27 36.61 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.453 1.127 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -108.37 135.96 48.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.923 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.43 126.14 52.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -116.25 156.21 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.175 0.512 . . . . 0.0 111.864 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.35 51.74 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.065 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.27 148.89 24.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.281 0.562 . . . . 0.0 111.741 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.5 p -89.51 171.88 9.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.183 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.05 -44.85 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.508 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.19 -37.99 89.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.101 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 23.6 mtp -70.14 -43.68 70.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.13 -34.65 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -64.27 -50.24 68.7 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.834 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -50.65 -51.94 44.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.02 -48.02 75.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.377 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.12 -44.05 82.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 111.561 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -66.65 -44.27 82.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.5 -40.25 95.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.929 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -69.91 -38.26 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.195 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -69.91 -31.3 69.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.6 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.81 -28.98 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 122.213 -0.305 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -82.06 -36.56 27.54 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -128.71 112.39 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -84.66 -10.43 57.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -112.21 19.63 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.322 0.51 . . . . 0.0 111.945 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 113.11 5.17 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.39 125.31 23.46 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -112.3 128.01 56.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 111.672 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.21 139.45 48.33 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.344 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 p -127.53 137.91 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.55 145.12 16.42 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.81 156.86 16.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.039 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 163.18 24.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 111.396 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -57.59 -31.82 66.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.485 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.17 -6.37 59.15 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.6 t -83.77 129.43 59.42 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.98 151.57 50.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.545 1.496 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.408 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -62.86 -39.62 94.96 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.757 -0.589 . . . . 0.0 111.23 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.42 -35.55 65.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.685 0.279 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -72.07 -35.74 69.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -62.65 -38.85 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.421 HG21 HD13 ' B' ' 80' ' ' ILE . 45.7 mm -60.98 -47.45 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -44.63 68.08 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.982 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.85 80.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 110.459 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.59 -37.2 80.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.789 0.804 . . . . 0.0 109.221 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.19 -42.77 99.17 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.677 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.96 -39.57 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.239 0.542 . . . . 0.0 110.831 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.32 -41.72 98.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.894 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -63.9 -41.38 97.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.59 -38.69 78.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.366 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.35 11.0 22.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.37 44.28 97.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt -99.16 -36.16 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.893 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo . . . . . 0 C--O 1.239 0.564 0 N-CA-C 115.094 1.152 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.59 118.07 57.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.44 127.69 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.141 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tt -113.96 120.35 40.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -111.12 128.77 56.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.177 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.29 120.84 36.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.743 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.11 -23.12 14.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.37 -121.16 0.65 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.983 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -113.55 100.56 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.98 -0.77 86.64 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.881 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.24 93.93 4.82 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.42 0.61 . . . . 0.0 110.009 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -103.37 156.01 18.06 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.11 0.957 . . . . 0.0 112.717 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.92 141.44 51.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.989 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.06 133.8 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 114.24 27.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.645 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.3 mt -116.09 110.09 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.883 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.61 42.76 28.0 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.717 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.78 -26.39 18.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.996 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.72 124.93 31.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.184 0.992 . . . . 0.0 110.526 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 130.98 52.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.632 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 127.12 52.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.69 157.87 25.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.021 0.439 . . . . 0.0 111.901 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.91 27.3 50.74 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.07 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.48 150.32 23.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.8 0.81 . . . . 0.0 112.698 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -91.32 171.59 9.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.143 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -66.49 -45.02 80.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.789 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -63.53 -39.28 94.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 mtm -69.92 -44.6 69.32 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.171 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.87 -33.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 m -63.89 -50.68 67.79 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.628 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -49.8 -53.23 26.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.659 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.8 mt -64.78 -48.1 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.477 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 t -58.14 -43.12 87.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 111.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -44.1 84.62 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.499 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.66 -39.96 94.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -37.81 76.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.898 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.49 -31.15 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.641 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.01 -28.17 54.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.811 0.278 . . . . 0.0 111.249 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -83.27 -37.77 23.05 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.03 101.79 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -76.9 -1.54 29.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -121.38 19.76 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.164 0.438 . . . . 0.0 111.913 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 118.23 12.15 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.486 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -64.36 127.32 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -114.36 131.53 56.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 111.515 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -135.55 141.3 45.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.023 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.39 127.36 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.4 142.48 13.99 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.47 155.5 16.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.219 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.2 164.81 23.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.042 0.449 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -58.81 -32.79 69.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.51 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -80.72 -6.23 58.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.3 t -85.64 136.82 36.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.75 152.24 25.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.542 1.495 . . . . 0.0 110.457 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -64.08 -38.51 91.33 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.24 -36.48 66.07 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.664 0.269 . . . . 0.0 110.538 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.09 -34.26 66.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.783 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.28 -39.98 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.444 HG21 HD12 ' A' ' 80' ' ' ILE . 46.4 mm -59.01 -48.81 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.609 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.002 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.22 70.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.62 -36.88 79.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.624 0.726 . . . . 0.0 109.255 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.75 -41.97 96.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.81 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mt -65.49 -38.57 90.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.487 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.08 -42.38 99.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.009 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.5 -41.54 98.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.593 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.51 -38.3 77.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.536 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.29 11.67 25.06 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.18 44.59 97.24 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 114.869 0.708 . . . . 0.0 114.869 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 109.877 178.877 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo . . . . . 0 C--O 1.239 0.562 0 N-CA-C 115.104 1.155 . . . . 0.0 115.104 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' B' ' 66' ' ' PHE . 47.0 t -113.09 117.88 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.21 127.97 65.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.202 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tt -114.31 120.58 40.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -111.31 128.93 56.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.137 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.51 120.91 36.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.679 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 -23.18 13.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.13 -125.19 0.88 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.779 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.76 100.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.109 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.76 -0.53 86.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.119 -0.491 . . . . 0.0 114.013 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 94.5 5.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.466 0.633 . . . . 0.0 109.902 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.63 156.01 18.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.219 1.009 . . . . 0.0 112.765 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.76 141.91 51.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.038 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.28 133.8 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 113.9 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.79 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 99.0 mt -115.63 110.35 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.926 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.28 42.78 25.59 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.769 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -26.17 19.75 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.899 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.58 124.86 31.21 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.302 1.051 . . . . 0.0 110.561 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 131.01 52.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.644 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 126.7 52.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.51 158.05 25.22 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.063 0.459 . . . . 0.0 111.9 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 27.23 51.44 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.273 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.5 150.59 23.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.822 0.82 . . . . 0.0 112.681 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -91.68 171.5 9.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.1 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -66.19 -45.18 81.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.801 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.57 -39.35 94.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.892 0.314 . . . . 0.0 111.325 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mtm -69.84 -44.65 69.46 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.351 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.67 -33.49 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.8 m -64.21 -50.4 68.2 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.736 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.09 -53.01 30.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.523 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.98 -47.88 75.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.729 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.41 -43.43 88.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -43.88 87.04 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.581 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -64.81 -40.07 94.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.75 76.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -70.39 -31.17 68.28 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.652 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -28.38 55.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.971 0.35 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -83.07 -37.74 23.45 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.17 101.22 6.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -76.23 -1.67 27.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -121.48 19.74 11.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.281 0.491 . . . . 0.0 111.824 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 118.0 11.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.421 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.8 127.03 29.55 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.401 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 40.0 m-85 -114.22 131.51 56.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -135.55 141.4 45.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.264 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 87.0 t -122.53 127.07 74.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.13 142.44 13.96 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.42 155.15 16.27 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.117 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.02 165.2 23.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.968 0.414 . . . . 0.0 111.229 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -59.42 -32.21 69.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.429 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -80.94 -6.93 59.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.4 t -85.07 136.58 38.17 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.55 151.98 25.88 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.773 1.649 . . . . 0.0 110.385 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -63.88 -38.43 91.07 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.43 -0.794 . . . . 0.0 111.108 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -55.31 -36.5 66.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.68 0.276 . . . . 0.0 110.425 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.01 -34.31 66.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 109.868 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -62.59 -39.1 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.08 -48.26 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.507 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -43.01 68.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.076 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -51.07 71.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 110.884 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.55 -37.51 81.48 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.702 0.763 . . . . 0.0 109.116 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.798 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.49 -38.46 89.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.559 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.27 -42.21 99.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.094 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.68 -41.63 98.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.424 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.38 -38.37 77.15 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.429 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.07 11.49 25.18 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.37 44.8 97.2 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.95 -35.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.986 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 C--O 1.239 0.562 0 N-CA-C 115.933 1.474 . . . . 0.0 115.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.71 119.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.9 127.65 68.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.291 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -114.73 121.23 42.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.17 127.18 53.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.286 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.17 118.7 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.69 -23.06 15.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.95 -120.27 0.65 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.01 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mm -112.26 99.3 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 123.061 0.544 . . . . 0.0 109.793 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.75 -3.91 85.92 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.239 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 131.22 53.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 117.754 0.777 . . . . 0.0 109.897 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -138.03 157.24 46.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.134 0.969 . . . . 0.0 112.917 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 141.95 51.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.328 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.15 134.86 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.502 0.592 . . . . 0.0 112.406 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.28 115.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.488 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.29 110.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.343 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.66 45.52 24.0 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.446 -0.883 . . . . 0.0 114.076 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -26.5 18.31 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.205 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.59 128.72 36.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.41 1.105 . . . . 0.0 110.356 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.31 135.95 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.007 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.86 52.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.45 156.81 27.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.103 0.477 . . . . 0.0 112.238 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.25 45.71 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.322 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.27 151.99 21.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.45 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 p -92.58 171.54 8.95 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.187 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -42.31 84.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -64.32 -39.46 93.96 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.073 0.463 . . . . 0.0 111.142 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.17 -43.9 69.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.288 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.31 -34.41 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -64.09 -49.58 71.7 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.62 -51.93 44.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.746 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.49 -48.03 76.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.527 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t -58.23 -43.73 87.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.422 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.4 85.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.314 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.47 -41.58 98.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.154 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.99 -38.06 75.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.018 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.22 -30.21 67.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.95 -27.96 49.43 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.186 -0.321 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -82.68 -36.87 25.55 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -131.55 105.68 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.38 -8.03 58.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.69 19.42 18.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.421 0.555 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.96 117.84 11.13 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tp -64.29 124.17 21.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -112.52 132.81 54.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.958 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.06 140.44 43.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.416 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.3 t -122.99 129.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.25 146.82 18.81 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.79 155.04 17.08 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.939 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.8 163.6 25.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.99 0.424 . . . . 0.0 111.248 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.73 -32.53 65.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.567 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -80.77 -5.56 57.33 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -89.79 131.07 40.66 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.46 155.69 50.37 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.152 1.235 . . . . 0.0 110.339 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 80' ' ' ILE . 3.8 t80 -64.21 -34.89 79.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.787 -0.57 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.75 70.91 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.79 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.57 -39.24 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.408 HD12 ' CE1' ' A' ' 76' ' ' TYR . 42.1 mm -59.92 -48.88 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.518 0.675 . . . . 0.0 109.415 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -53.98 -44.6 70.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.51 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.05 79.01 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.353 0.597 . . . . 0.0 111.009 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 11.4 mt -61.89 -36.0 80.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 108.989 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -61.8 -42.56 99.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.039 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.87 -38.74 92.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.535 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.81 -42.15 97.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.987 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -62.86 -42.39 99.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.668 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.47 -38.45 74.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.616 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.49 11.02 20.6 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.52 44.22 98.28 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.332 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo . . . . . 0 C--O 1.239 0.552 0 N-CA-C 115.732 1.397 . . . . 0.0 115.732 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.51 119.68 61.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -111.87 127.93 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.316 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.21 120.93 41.36 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.86 127.4 54.0 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.24 118.96 33.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.14 -22.78 15.05 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.8 -124.18 0.87 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.629 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.8 99.55 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.979 -0.611 . . . . 0.0 110.247 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.5 -3.62 86.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 114.391 0.516 . . . . 0.0 114.391 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.53 131.22 53.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.617 0.709 . . . . 0.0 109.698 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -137.86 156.9 47.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.048 0.927 . . . . 0.0 113.007 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.24 51.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.253 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 pt -132.32 134.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.499 0.591 . . . . 0.0 112.581 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.82 114.95 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.58 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.51 109.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.347 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.11 45.17 26.87 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.996 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.26 19.31 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 119.277 -0.735 . . . . 0.0 114.254 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.45 129.02 36.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.46 1.13 . . . . 0.0 110.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.49 135.83 48.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.88 -178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.17 127.07 52.97 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -117.89 156.69 28.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 112.183 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.45 27.8 46.42 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.33 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mt -90.14 151.98 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.557 0.694 . . . . 0.0 112.495 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.1 p -92.42 171.94 8.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.31 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -41.59 83.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.136 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.1 -39.91 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.897 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.5 mtm -69.82 -43.7 71.5 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.52 -34.6 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -63.75 -50.08 70.49 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.56 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.667 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.51 -47.96 76.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.658 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -58.44 -42.9 88.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.421 0.629 . . . . 0.0 111.473 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -43.74 82.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.361 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -63.99 -41.5 97.49 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.877 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.09 -37.69 75.48 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.6 -30.13 66.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.594 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -78.08 -28.03 48.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.833 0.288 . . . . 0.0 111.214 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -82.63 -36.51 26.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -131.74 105.99 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.5 -8.42 59.13 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.41 19.58 18.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.899 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.14 117.72 11.13 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tp -64.34 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.28 132.97 54.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 111.151 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.95 140.53 44.06 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.291 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.01 129.46 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.34 146.97 18.96 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.16 155.46 17.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.13 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.94 163.66 25.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.989 0.423 . . . . 0.0 111.259 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -56.98 -32.88 66.54 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.59 -5.62 57.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.54 131.1 41.09 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.36 155.97 50.71 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.197 1.265 . . . . 0.0 110.242 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.407 ' CE1' HD13 ' B' ' 80' ' ' ILE . 3.9 t80 -64.73 -34.61 78.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.676 -0.64 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.38 -37.4 70.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -35.71 71.73 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.803 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.4 t -61.87 -39.23 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.509 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.407 HD13 ' CE1' ' B' ' 76' ' ' TYR . 39.9 mm -59.75 -48.87 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.404 0.621 . . . . 0.0 109.41 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.5 ttmm -53.84 -44.94 70.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.492 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.03 79.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.451 0.643 . . . . 0.0 110.929 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -36.0 79.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.741 0.782 . . . . 0.0 109.273 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.75 -42.71 99.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.073 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.0 mt -64.15 -38.47 91.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.111 0.481 . . . . 0.0 110.499 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.06 -42.07 97.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.889 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -62.81 -42.46 99.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.568 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.29 -38.77 74.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.657 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.44 11.23 19.9 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.38 44.46 98.01 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 115.129 0.811 . . . . 0.0 115.129 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.68 -38.07 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.659 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.479 0.621 0 N-CA-C 114.927 1.087 . . . . 0.0 114.927 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -106.72 110.09 30.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.71 126.64 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.194 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.65 120.69 40.98 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 126.9 54.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.323 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.8 t -85.14 109.34 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.894 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.78 -22.51 22.1 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -120.71 0.67 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.547 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.14 100.27 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.66 -4.65 84.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.972 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 131.11 54.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.439 0.62 . . . . 0.0 109.354 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -139.79 157.96 44.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.218 1.009 . . . . 0.0 113.077 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.886 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt -131.35 133.96 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.354 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -112.12 115.12 28.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.571 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -111.99 108.56 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.573 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.77 47.23 18.82 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.956 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.93 -27.0 18.04 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.69 -0.767 . . . . 0.0 114.002 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -90.38 128.4 36.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.464 1.132 . . . . 0.0 110.749 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -106.55 133.0 51.9 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.25 128.02 54.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.61 157.38 26.49 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 27.61 52.04 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.934 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -86.94 147.86 25.58 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.213 0.506 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -91.92 171.99 8.75 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.588 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.08 -46.16 78.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.065 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.902 0.319 . . . . 0.0 111.283 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -39.22 70.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 -34.93 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.52 -50.77 68.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.773 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -52.84 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.032 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.08 -47.25 77.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.685 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -59.18 -42.83 91.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.705 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -44.03 85.14 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.236 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -40.63 96.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.43 -28.2 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.673 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.23 -26.44 39.09 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.883 0.31 . . . . 0.0 111.277 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -85.19 -34.93 21.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.777 0.322 . . . . 0.0 110.446 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -132.87 94.78 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.96 -4.01 26.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -114.9 17.25 17.05 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.771 0.714 . . . . 0.0 111.858 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -69.28 126.42 29.73 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.2 tp -69.55 127.08 31.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.34 131.43 56.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.254 0.549 . . . . 0.0 111.464 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.44 140.34 44.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.662 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.36 135.35 64.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.22 145.66 17.21 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.45 154.59 16.4 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.986 -0.625 . . . . 0.0 111.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.15 164.07 25.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.113 0.482 . . . . 0.0 111.234 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -31.84 68.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.343 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -80.9 -6.09 58.21 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.15 132.06 44.6 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.9 152.81 41.77 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.554 1.502 . . . . 0.0 110.172 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.48 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.541 0.61 . . . . 0.0 111.023 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -56.21 -35.71 67.62 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.02 -36.56 72.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.03 -39.11 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.813 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.89 -45.41 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 109.508 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -44.92 80.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.858 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.71 87.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.517 0.675 . . . . 0.0 110.737 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.37 -37.63 84.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.716 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.52 -41.55 94.64 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.838 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -39.2 91.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.432 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -42.94 98.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.015 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -63.17 -41.94 99.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -37.94 76.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.351 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 10.08 28.05 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.21 45.11 97.19 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.554 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 N--CA 1.477 0.55 0 N-CA-C 114.935 1.09 . . . . 0.0 114.935 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.82 110.2 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.0 126.86 64.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.5 120.74 41.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.01 127.1 54.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.189 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -85.3 108.85 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.983 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.37 -22.55 22.54 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.41 -124.67 0.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.253 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.73 100.99 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.16 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.69 82.64 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.208 -0.52 . . . . 0.0 114.055 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.3 130.83 54.07 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.576 0.688 . . . . 0.0 109.488 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -139.2 158.07 44.82 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.336 1.065 . . . . 0.0 113.219 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.17 142.21 51.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.803 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.54 133.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.491 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.8 114.7 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.826 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.77 109.0 26.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.517 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.44 47.79 16.8 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.962 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -26.88 17.57 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.272 -0.738 . . . . 0.0 114.197 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -90.5 128.79 36.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.603 1.202 . . . . 0.0 110.473 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -107.04 133.3 51.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.205 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.53 127.94 54.48 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -117.45 157.81 25.59 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.76 52.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.553 -0.748 . . . . 0.0 113.052 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt -87.07 148.1 25.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 112.029 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.9 p -92.19 171.76 8.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.499 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -66.01 -46.22 78.71 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.023 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.23 -39.13 93.75 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.991 -0.443 . . . . 0.0 111.134 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.66 71.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.852 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.31 -34.83 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.53 -50.83 68.02 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.16 -52.97 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.808 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.95 -47.37 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.796 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.64 -43.26 89.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.097 0.475 . . . . 0.0 111.638 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -44.03 85.28 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.312 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.45 95.98 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -70.42 -40.06 74.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.084 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -69.23 -28.12 66.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.25 -26.8 38.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.956 0.344 . . . . 0.0 111.314 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.05 -34.56 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 110.527 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -132.95 94.73 3.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -72.11 -3.85 25.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -114.93 16.79 17.16 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.71 0.686 . . . . 0.0 111.828 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -68.87 126.45 29.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.386 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.6 tp -70.28 126.91 31.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.68 131.1 56.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 111.674 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.08 140.22 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.679 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.25 135.64 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.41 145.57 17.05 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.22 154.36 16.46 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.825 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 164.51 25.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -31.33 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.37 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -81.32 -6.25 58.7 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.82 132.06 45.26 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.17 153.0 40.68 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.416 1.411 . . . . 0.0 110.159 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -63.53 -38.28 90.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.652 0.66 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.78 -36.14 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.85 -36.58 72.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.92 -39.2 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.681 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.449 HG22 HD13 ' B' ' 80' ' ' ILE . 46.2 mm -61.8 -45.75 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.466 0.65 . . . . 0.0 109.604 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.05 78.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.978 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.2 -46.84 87.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 110.682 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.19 -37.97 84.86 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.758 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.23 -41.56 93.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.808 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -39.17 91.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -42.94 99.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.059 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -63.42 -41.82 98.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.99 76.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.34 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.06 10.47 26.63 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 45.12 97.12 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -103.1 -38.31 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.931 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 N--CA 1.477 0.504 0 N-CA-C 114.945 1.094 . . . . 0.0 114.945 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.3 124.89 73.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.4 mp -116.15 127.98 73.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.606 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.2 tt -115.5 125.72 53.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.03 128.84 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.811 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.01 122.91 38.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.707 -1.133 . . . . 0.0 107.999 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.87 -22.78 14.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.91 -118.84 0.6 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.018 -1.086 . . . . 0.0 113.843 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mm -113.38 95.76 4.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 122.961 0.504 . . . . 0.0 109.722 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.25 -3.25 86.79 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.157 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.01 51.15 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.648 0.724 . . . . 0.0 109.443 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.44 157.92 44.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.155 0.978 . . . . 0.0 112.934 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.87 142.06 51.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.315 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.64 135.46 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.04 113.88 26.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.93 106.85 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.151 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 49.31 16.62 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.082 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.35 -26.68 18.36 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.982 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.72 127.84 37.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.439 1.12 . . . . 0.0 110.315 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -105.52 136.04 45.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.157 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.14 127.83 53.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -117.84 156.97 27.47 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.14 26.93 54.24 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.087 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.87 149.95 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 112.412 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -92.0 169.52 10.59 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.09 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.37 -44.89 86.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.256 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.08 -39.1 93.32 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.119 -0.363 . . . . 0.0 111.279 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -71.69 -37.75 70.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.936 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.57 -34.05 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -63.27 -49.73 72.95 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.96 -51.63 50.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.769 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.17 -46.8 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.703 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.4 m -59.11 -43.63 91.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.271 0.558 . . . . 0.0 111.532 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -65.61 -44.18 87.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.349 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -63.45 -41.65 98.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.198 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.71 -38.17 76.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.26 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.805 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -77.44 -27.66 52.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 117.959 0.345 . . . . 0.0 111.345 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -35.0 25.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 110.179 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -130.94 99.32 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -72.89 -20.78 61.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.3 20.0 13.33 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.215 0.461 . . . . 0.0 111.775 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.34 119.11 14.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.91 126.72 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.37 135.64 53.86 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.8 pp -138.67 141.28 39.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.54 128.53 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.02 -178.89 15.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.52 156.54 27.86 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.528 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.73 164.39 23.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.051 0.453 . . . . 0.0 111.38 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.45 -32.49 68.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.48 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.05 -7.13 59.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.81 130.15 51.76 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.89 155.81 43.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.129 1.219 . . . . 0.0 110.516 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.41 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 5.4 t80 -65.03 -34.46 78.49 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.594 -0.691 . . . . 0.0 110.27 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.43 -36.85 69.45 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -36.92 73.91 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.299 0.571 . . . . 0.0 109.716 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.17 -39.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.758 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 80' ' ' ILE . 44.3 mm -59.5 -49.52 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.452 0.644 . . . . 0.0 109.711 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -43.6 73.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.378 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.44 77.75 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.753 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.12 -35.91 78.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.642 0.734 . . . . 0.0 109.095 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.28 -43.77 98.33 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.887 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.67 -37.65 88.3 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -41.85 96.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.374 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -63.87 -39.59 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.82 -38.95 79.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.51 11.4 24.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.62 44.68 97.63 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.821 0.688 . . . . 0.0 114.821 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.316 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo . . . . . 0 C--O 1.236 0.405 0 N-CA-C 115.03 1.127 . . . . 0.0 115.03 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -116.4 124.52 72.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.8 mp -115.76 128.11 73.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.735 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 tt -115.57 125.54 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.88 128.46 55.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.816 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.1 t -82.74 122.67 37.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.6 -23.08 14.33 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.32 -122.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.75 96.11 4.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.273 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 -3.14 87.08 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.187 -0.53 . . . . 0.0 114.116 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.34 50.67 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.708 0.754 . . . . 0.0 109.494 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.62 157.96 44.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.03 0.919 . . . . 0.0 112.944 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.96 141.66 51.87 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.383 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.45 135.33 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.449 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.95 113.74 26.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 55.8 mt -109.94 106.93 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.182 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.18 49.31 19.1 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.96 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -26.57 17.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.01 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -91.36 127.63 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.489 1.144 . . . . 0.0 110.34 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -105.51 135.71 46.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.86 127.47 53.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -117.45 157.02 26.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.84 27.16 54.43 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.178 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.72 150.12 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -92.49 169.92 10.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.128 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.46 -44.98 85.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.171 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.18 -39.0 93.08 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.916 -0.49 . . . . 0.0 111.283 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.71 -37.95 70.57 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.913 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.37 -34.1 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 45.9 m -63.12 -49.65 73.59 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.815 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.89 -52.11 45.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.62 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.61 -46.95 80.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.789 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 42.4 m -58.9 -43.58 91.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -65.85 -43.78 87.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.359 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -63.86 -41.86 97.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.081 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -69.56 -38.31 77.36 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.34 -30.08 66.94 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.27 -27.82 53.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.881 0.31 . . . . 0.0 111.316 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -34.67 25.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -131.32 98.98 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -72.56 -20.77 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.2 19.97 13.26 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.324 0.511 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -70.43 118.54 13.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.26 126.71 29.59 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.68 135.65 53.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.143 0.497 . . . . 0.0 111.634 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.8 pp -138.73 141.65 38.9 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.73 128.17 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.61 -178.86 15.57 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.04 27.28 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.644 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.63 164.57 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.01 0.433 . . . . 0.0 111.464 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -58.67 -32.49 69.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.419 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.89 -7.57 59.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.3 t -85.38 129.88 53.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.72 155.68 44.31 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.257 1.305 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.4 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -64.88 -34.32 78.12 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.578 -0.701 . . . . 0.0 110.238 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.6 -36.87 69.9 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -36.48 73.19 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.247 0.546 . . . . 0.0 109.595 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.63 -39.38 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.6 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.447 HG22 HD13 ' B' ' 80' ' ' ILE . 44.9 mm -59.58 -49.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.425 0.631 . . . . 0.0 109.685 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 ttmm -55.33 -43.52 75.04 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.324 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.4 77.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.308 0.575 . . . . 0.0 110.757 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.6 mt -61.22 -35.82 78.24 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.687 0.755 . . . . 0.0 109.196 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.29 -43.66 98.51 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.966 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.1 mt -64.76 -38.04 89.66 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.061 0.457 . . . . 0.0 110.776 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -41.71 97.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.489 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -64.22 -39.19 93.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.499 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.25 -38.7 80.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.58 44.37 98.05 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 114.708 0.643 . . . . 0.0 114.708 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.64 -35.01 4.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo . . . . . 0 C--O 1.239 0.572 0 N-CA-C 115.428 1.28 . . . . 0.0 115.428 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.32 120.54 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.43 127.9 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.344 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.48 121.13 41.77 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -110.15 127.35 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.403 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -84.55 119.67 33.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.126 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.92 -23.26 14.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.67 -122.07 0.72 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.554 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.88 98.78 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 122.812 0.445 . . . . 0.0 109.937 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -3.36 87.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 114.041 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.31 54.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.54 0.67 . . . . 0.0 109.313 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -138.83 156.79 47.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.228 1.013 . . . . 0.0 113.08 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 141.87 51.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.895 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -133.71 135.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.45 117.21 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.959 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.83 110.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.284 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.93 44.34 31.75 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.133 -1.032 . . . . 0.0 114.087 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.08 -24.88 24.76 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.982 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.5 128.48 36.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.371 1.085 . . . . 0.0 109.959 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -106.81 135.05 49.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.04 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.16 126.08 52.23 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.03 156.65 27.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.11 0.481 . . . . 0.0 111.925 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 26.91 53.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.952 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.42 149.21 24.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.278 0.561 . . . . 0.0 112.077 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.7 p -90.52 171.53 9.34 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.12 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.58 -44.26 82.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -63.6 -38.87 92.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.5 mtp -69.89 -43.66 71.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.315 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.58 -34.73 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -63.81 -50.23 69.74 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.685 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.31 -52.49 36.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.747 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.7 mt -64.78 -48.33 74.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.604 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -59.27 -42.68 91.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.209 0.528 . . . . 0.0 111.605 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.74 -44.15 82.26 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.165 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.34 -39.66 94.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.884 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -70.82 -38.34 73.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.241 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -69.91 -31.84 69.83 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.32 -27.81 47.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.817 0.281 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -85.1 -35.16 21.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.237 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -130.95 96.98 4.19 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -75.51 -0.8 21.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.91 16.86 13.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.66 0.664 . . . . 0.0 111.841 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.55 119.18 13.41 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.42 125.51 24.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -114.19 133.17 55.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.74 142.29 44.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.429 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.1 t -123.43 126.12 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.85 145.7 17.69 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.44 154.53 16.91 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 165.1 25.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.0 110.871 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.01 -32.58 64.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -81.2 -5.63 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -84.74 131.24 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.23 152.78 40.12 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.503 1.469 . . . . 0.0 109.99 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -64.15 -36.94 85.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.855 0.752 . . . . 0.0 110.981 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -56.3 -36.65 68.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.79 -36.25 70.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.5 t -61.55 -39.0 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.402 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.2 mm -59.53 -50.69 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.386 0.613 . . . . 0.0 109.452 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -44.18 70.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.442 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.49 80.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.387 0.613 . . . . 0.0 110.659 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 10.2 mt -62.23 -36.08 80.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.69 0.757 . . . . 0.0 109.189 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -61.78 -41.9 98.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.812 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.34 -38.71 92.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.028 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -63.56 -43.09 98.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.575 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.1 -39.12 74.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.25 12.79 19.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.6 44.86 95.32 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.583 0.593 . . . . 0.0 114.583 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 109.969 179.283 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo . . . . . 0 C--O 1.24 0.588 0 N-CA-C 115.544 1.325 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -115.43 120.47 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.39 127.72 68.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.15 121.12 42.04 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.94 127.14 54.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.303 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.3 119.67 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.387 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.88 -23.61 14.53 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.15 -125.75 0.94 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.399 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -108.37 98.87 7.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.117 -0.542 . . . . 0.0 110.236 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.37 -3.51 86.99 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 121.123 -0.561 . . . . 0.0 114.088 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 130.52 54.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.552 0.676 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -138.99 157.11 46.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.282 1.039 . . . . 0.0 113.166 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.94 141.96 51.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.863 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -133.85 135.14 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.422 0.555 . . . . 0.0 112.438 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.19 117.36 32.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 91.4 mt -116.27 110.54 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.086 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.62 44.59 29.88 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.213 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.99 -24.97 24.17 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.026 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.34 128.41 36.44 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.414 1.107 . . . . 0.0 110.108 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -106.73 134.56 49.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.022 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.73 125.77 52.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -116.55 156.8 26.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.097 0.475 . . . . 0.0 112.127 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.22 26.79 54.32 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.042 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -87.4 149.61 24.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.261 0.553 . . . . 0.0 111.997 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -90.69 171.61 9.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.064 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.0 -44.13 81.13 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.52 -39.06 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.145 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.7 mtp -69.95 -43.46 71.52 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.68 -34.58 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 -50.18 69.54 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.532 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -50.19 -52.59 34.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.732 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.69 -48.73 73.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.573 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -58.95 -42.43 89.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 111.71 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -67.1 -44.09 80.86 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.072 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -64.24 -39.87 94.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -70.61 -38.64 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.67 -31.7 69.9 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.56 -27.61 45.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.9 0.318 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -85.16 -35.14 21.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -130.88 97.24 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -75.73 -0.79 22.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -118.83 16.39 13.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.703 0.683 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.15 119.26 13.16 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.56 125.12 23.2 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -113.76 133.49 55.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 111.416 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.02 142.45 44.46 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.41 126.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.02 145.55 17.51 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.51 154.58 16.94 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.634 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 165.58 24.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.65 -32.39 65.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.524 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.06 -6.12 58.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.41 130.9 52.05 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 152.54 40.29 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.571 1.514 . . . . 0.0 110.003 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 83' ' ' LEU . 4.1 t80 -63.92 -37.05 85.98 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.649 -0.657 . . . . 0.0 110.983 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -56.41 -36.27 68.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.0 -36.06 69.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.184 0.516 . . . . 0.0 109.637 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.9 t -61.71 -39.18 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.488 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.401 HD13 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -59.42 -50.56 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.319 0.58 . . . . 0.0 109.469 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.19 -43.89 71.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.439 178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.57 -48.85 79.53 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.456 0.646 . . . . 0.0 110.494 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.74 -36.16 80.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.191 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.83 -41.7 98.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.938 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -64.51 -38.56 91.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 110.439 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.1 -41.72 97.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -63.48 -42.98 98.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -57.37 -38.72 74.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.514 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.48 12.55 20.37 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.93 44.81 95.88 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.26 -44.92 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.303 0.573 . . . . 0.0 109.682 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.963 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 C--O 1.241 0.633 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 66' ' ' PHE . 39.7 t -113.33 120.23 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.84 129.01 69.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.491 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -117.58 124.9 49.79 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -112.91 129.62 56.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.521 -178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.94 109.62 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.729 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.3 22.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.34 -119.39 0.62 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.45 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 mm -112.28 95.22 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.6 89.5 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.202 -0.523 . . . . 0.0 114.158 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.89 91.95 3.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.698 0.749 . . . . 0.0 110.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.34 154.32 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.184 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.36 143.61 50.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.417 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.86 135.85 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -112.85 115.97 29.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.312 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.49 111.68 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.891 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.02 44.63 32.65 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.142 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.11 -23.87 27.45 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.859 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.57 126.54 35.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.348 1.074 . . . . 0.0 109.869 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 133.43 49.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.588 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.99 123.85 49.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.84 149.49 30.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.54 78.54 0.65 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -137.78 148.06 45.2 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.282 0.563 . . . . 0.0 111.629 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 p -89.64 169.33 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.513 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.98 -41.12 82.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.945 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.86 -38.72 91.91 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.143 -0.348 . . . . 0.0 110.95 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mtp -69.81 -45.06 68.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.75 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.46 -35.76 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.889 0.376 . . . . 0.0 110.233 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -63.77 -49.99 70.8 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.853 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -53.08 27.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.21 -48.38 73.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.558 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -58.63 -43.03 89.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.577 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.68 -43.82 83.45 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.229 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -63.51 -41.42 98.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.877 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -37.73 76.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -70.83 -29.94 66.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.477 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.88 -27.62 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.844 0.293 . . . . 0.0 110.867 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -82.12 -38.25 25.07 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -129.2 110.46 12.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -82.51 7.29 14.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -127.09 20.32 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.145 0.43 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 113.23 5.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -61.36 123.54 18.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 23' ' ' VAL . 43.6 m-85 -114.26 133.09 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pp -132.96 141.42 48.32 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.258 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.55 124.79 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.42 142.3 13.57 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.9 154.99 16.23 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.687 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.88 163.38 24.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.357 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -31.44 69.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.98 -6.61 58.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.1 t -89.93 135.34 30.39 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.42 154.99 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.021 1.147 . . . . 0.0 110.373 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -63.79 -35.5 80.81 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.399 -0.813 . . . . 0.0 110.48 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.36 -36.75 66.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.415 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -34.53 67.27 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.835 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.41 -38.98 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 50.3 mm -59.19 -49.48 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -53.31 -44.35 68.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.283 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -51.95 67.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.24 -36.73 78.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 109.291 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -62.24 -41.53 98.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.541 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.13 -39.25 93.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.115 0.483 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.87 -41.8 97.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.12 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.35 -41.18 98.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.359 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.26 -38.37 76.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.61 24.19 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.22 44.69 97.79 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.5 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo . . . . . 0 C--O 1.239 0.56 0 N-CA-C 115.258 1.215 . . . . 0.0 115.258 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.5 120.09 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.7 129.3 68.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.392 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.64 124.97 49.87 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -113.09 129.36 56.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.63 109.38 18.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.664 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.14 -23.52 22.44 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.72 -123.53 0.84 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.24 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.25 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.17 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.97 0.46 89.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.085 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.79 92.12 3.96 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.705 0.752 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.13 154.26 18.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.265 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.18 143.86 50.73 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.8 135.86 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.3 t -112.93 116.11 29.47 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.291 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 61.1 mt -116.71 111.42 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.957 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.23 44.49 34.45 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.12 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.15 -23.71 28.29 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.781 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.64 126.61 35.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.334 1.067 . . . . 0.0 109.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 133.69 49.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.483 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.23 123.97 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -110.94 149.41 30.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.51 78.97 0.63 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.11 148.33 44.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.453 0.644 . . . . 0.0 111.475 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.6 p -89.9 169.39 11.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.0 -41.39 82.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.017 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.39 -38.83 92.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 33.7 mtp -69.88 -44.97 68.68 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.831 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -35.43 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.916 0.388 . . . . 0.0 110.143 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 26.6 m -64.1 -49.69 71.23 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.045 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -53.32 27.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.646 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.439 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.48 -43.59 89.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.11 0.481 . . . . 0.0 111.53 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.38 -43.52 85.69 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.02 -40.71 96.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 -37.91 75.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.66 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -70.55 -29.93 66.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.747 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.03 -27.98 54.74 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.234 -0.291 . . . . 0.0 110.868 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.99 -37.93 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -129.61 110.19 11.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.07 6.98 14.58 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -127.07 20.45 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.22 0.464 . . . . 0.0 111.895 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.89 113.66 5.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.461 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.66 123.48 18.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -114.05 133.09 55.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.546 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.02 141.33 48.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.144 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.46 124.61 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.44 141.95 13.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.33 155.51 16.06 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 163.87 23.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 111.259 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -31.25 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.335 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -81.17 -6.81 59.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.79 135.01 31.01 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.27 155.27 41.69 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.071 1.181 . . . . 0.0 110.153 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.407 ' CE1' HD12 ' B' ' 80' ' ' ILE . 8.5 t80 -64.02 -35.52 80.99 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.467 -0.771 . . . . 0.0 110.377 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.42 -37.12 67.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.94 -35.18 69.54 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.067 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -61.84 -39.22 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.349 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.428 HG23 HD13 ' B' ' 80' ' ' ILE . 50.3 mm -59.04 -48.91 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.485 0.659 . . . . 0.0 109.42 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -53.85 -44.2 70.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.68 68.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.292 0.568 . . . . 0.0 110.96 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.56 -36.55 78.73 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.781 0.801 . . . . 0.0 109.196 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.37 -41.6 98.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.62 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.02 -38.92 92.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.666 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.93 -41.99 97.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.999 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -63.48 -40.95 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.581 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.36 -38.67 77.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.32 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.22 10.64 23.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.23 -35.25 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 C--O 1.238 0.523 0 N-CA-C 115.725 1.394 . . . . 0.0 115.725 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.75 122.18 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.48 127.95 69.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.439 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 tt -115.08 121.85 44.32 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -110.11 126.46 54.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.323 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.7 119.71 34.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.56 -22.75 15.33 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.54 -117.84 0.56 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.842 -1.171 . . . . 0.0 114.009 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.36 101.11 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 109.788 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.14 82.46 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.702 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 129.52 53.99 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.553 0.676 . . . . 0.0 109.384 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -138.13 156.11 48.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.79 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.77 144.12 50.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.195 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 pt -133.72 135.72 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.853 0.752 . . . . 0.0 113.027 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -113.19 116.87 30.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.35 111.64 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.814 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.7 46.18 30.78 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.357 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.73 -25.24 19.98 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.662 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.6 127.34 35.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.126 0.963 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 134.57 48.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.472 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.87 123.35 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -110.4 148.48 31.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 78.81 0.69 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mt -136.96 148.66 47.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.139 0.495 . . . . 0.0 111.127 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 p -91.26 171.3 9.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.638 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.06 -42.13 80.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.44 -38.8 92.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.004 0.431 . . . . 0.0 110.711 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -70.04 -46.61 64.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.349 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -58.09 -35.63 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.775 0.321 . . . . 0.0 110.328 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -64.12 -49.34 72.55 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.76 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.51 -52.49 38.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.706 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.94 -47.69 76.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.624 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -58.93 -43.31 91.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.117 0.484 . . . . 0.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.49 -44.09 83.59 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.363 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -63.46 -40.58 97.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.913 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.75 -38.88 76.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.196 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -69.66 -30.65 68.38 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -78.14 -28.08 48.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.859 0.299 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -84.36 -34.94 23.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.92 0.391 . . . . 0.0 110.018 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -130.19 95.68 3.98 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -68.9 -7.87 38.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -113.78 19.46 16.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.547 0.612 . . . . 0.0 112.096 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -69.04 117.0 10.14 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 125.24 23.59 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -114.37 133.88 55.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.27 141.99 43.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.598 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -123.57 129.13 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.23 146.57 18.38 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.47 16.76 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.925 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.09 165.18 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.469 . . . . 0.0 110.999 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -57.11 -32.64 66.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.341 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.23 -5.84 58.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.81 135.21 30.73 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.39 156.92 29.17 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.131 1.221 . . . . 0.0 110.631 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -65.15 -33.88 77.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.614 -0.679 . . . . 0.0 110.506 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -57.07 -37.55 72.02 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.256 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.52 70.77 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.85 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -62.66 -39.02 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.323 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.4 mm -59.32 -48.91 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 109.591 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -44.8 69.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.385 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.64 76.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.327 0.584 . . . . 0.0 110.99 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.38 -36.58 82.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.545 0.688 . . . . 0.0 109.234 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.7 -43.28 97.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.814 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.29 -38.06 89.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 110.706 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -42.04 97.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.149 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -62.93 -41.98 99.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.47 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.66 -38.58 78.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 10.97 23.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.77 97.62 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.559 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 C--O 1.24 0.607 0 N-CA-C 115.736 1.399 . . . . 0.0 115.736 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.65 122.31 67.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.83 127.99 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.312 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.2 121.83 44.16 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -109.96 126.44 53.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.362 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.54 119.7 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.76 -22.32 15.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.33 -122.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.717 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -108.12 101.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.04 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.26 80.29 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.897 -0.592 . . . . 0.0 114.017 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 129.57 53.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 117.426 0.613 . . . . 0.0 109.429 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.16 156.09 48.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.599 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 144.18 50.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.164 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 pt -133.69 135.8 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -113.46 116.93 30.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.052 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.43 111.53 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.99 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.68 46.08 30.69 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.251 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.82 -25.17 20.6 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.669 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.54 126.97 35.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.242 1.021 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 134.73 48.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.457 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.96 123.11 48.28 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.14 148.47 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 78.71 0.71 Allowed Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mt -137.03 148.32 46.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.081 0.467 . . . . 0.0 111.149 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -90.99 171.43 9.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.65 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.86 -42.17 81.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.874 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.55 -39.01 92.96 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.078 -0.389 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mtm -69.99 -46.55 64.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.09 -36.08 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 51.6 m -63.72 -49.42 73.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.764 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.58 -52.03 42.94 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.738 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.28 -47.67 75.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.631 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -59.13 -43.04 91.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 111.518 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -66.65 -43.96 83.19 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.343 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.56 -40.52 97.19 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.76 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -38.66 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -69.79 -30.93 68.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -78.27 -28.05 47.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.852 0.296 . . . . 0.0 111.459 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -84.42 -34.94 23.41 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -130.12 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -69.18 -7.6 37.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -113.96 19.28 16.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.565 0.62 . . . . 0.0 111.958 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -68.87 116.86 9.84 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.58 125.16 23.34 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -114.39 134.04 55.27 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.974 0.416 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.57 141.73 43.33 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -123.31 129.62 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.49 18.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.05 154.47 16.78 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.03 165.37 24.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 0.0 111.061 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -57.25 -32.76 66.9 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.361 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.0 -6.38 58.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.18 135.49 31.39 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.9 156.82 27.19 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.227 1.285 . . . . 0.0 110.558 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' B' ' 80' ' ' ILE . 5.9 t80 -65.06 -33.89 77.13 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.792 -0.567 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.27 -37.59 72.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.53 70.78 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.882 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.4 t -62.66 -38.93 82.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.405 HD12 ' CE1' ' B' ' 76' ' ' TYR . 42.1 mm -59.52 -48.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.334 0.588 . . . . 0.0 109.602 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -44.76 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.277 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.38 77.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.321 0.581 . . . . 0.0 111.039 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 8.0 mt -62.66 -36.29 82.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.58 0.705 . . . . 0.0 109.34 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -60.83 -43.55 98.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.871 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.02 -38.14 89.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 110.598 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -41.91 98.18 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.195 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -63.08 -41.97 99.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -58.62 -38.46 78.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.399 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.57 10.75 24.25 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.23 44.71 97.75 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.9 mt -101.34 -36.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.854 -179.651 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo . . . . . 0 C--O 1.239 0.555 0 N-CA-C 115.405 1.271 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -110.67 120.7 62.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.3 128.97 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.766 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.75 122.48 45.62 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.39 128.28 56.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.13 119.16 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.2 -22.16 15.77 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -119.85 0.64 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.945 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -112.84 100.64 11.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -2.84 83.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.755 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.14 53.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.539 0.669 . . . . 0.0 109.301 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -137.15 156.37 48.43 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.068 0.937 . . . . 0.0 112.576 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.23 142.34 51.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.138 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.6 134.89 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.459 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.97 113.89 26.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.545 0.688 . . . . 0.0 110.263 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.15 110.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.422 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 42.94 49.37 6.23 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.298 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.12 -37.35 3.44 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.799 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.4 119.12 14.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.846 0.323 . . . . 0.0 111.113 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -105.37 128.39 53.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.85 126.57 52.64 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.86 157.25 26.99 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 25.58 56.49 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.176 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.98 149.97 24.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.307 0.575 . . . . 0.0 111.929 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.75 171.7 8.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.269 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.68 -42.91 81.34 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.09 -39.22 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -69.76 -45.9 67.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.395 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.51 -34.85 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 m -62.95 -50.22 71.64 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.27 -52.76 33.64 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.828 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.94 -47.84 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.7 m -59.52 -42.67 92.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -66.2 -44.78 82.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.32 99.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.47 -39.8 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -69.91 -29.8 67.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.65 -28.44 45.42 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.723 0.238 . . . . 0.0 111.515 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -83.57 -35.76 24.49 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.08 106.21 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.7 6.21 13.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -125.53 17.97 8.15 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.613 0.642 . . . . 0.0 111.908 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.08 114.57 5.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.863 -0.153 . . . . 0.0 111.212 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.45 122.67 14.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -113.34 134.39 54.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.072 0.463 . . . . 0.0 111.294 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.15 141.34 40.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.405 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.99 127.67 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.12 146.79 18.78 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.5 155.0 16.96 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.021 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.51 164.5 24.66 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 120.922 0.391 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -56.97 -33.24 66.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.512 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.25 -5.64 56.54 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.69 134.58 31.99 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.26 156.72 33.33 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.28 1.32 . . . . 0.0 110.006 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.411 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 3.4 t80 -64.86 -35.62 81.73 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.666 -0.646 . . . . 0.0 110.683 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.57 -37.36 70.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.712 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.9 t -62.54 -39.28 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.442 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 45.7 mm -60.17 -47.4 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.26 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.92 79.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.589 . . . . 0.0 110.863 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 10.0 mt -60.56 -37.1 80.18 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.527 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -61.23 -41.67 97.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.975 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.12 -38.31 87.87 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 110.553 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.89 -42.12 97.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.86 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -63.15 -43.3 98.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.12 -38.77 73.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.3 12.16 19.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.42 44.87 96.31 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.892 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo . . . . . 0 C--O 1.241 0.63 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.54 120.72 61.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.25 128.58 71.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.5 122.64 46.32 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -112.45 128.07 56.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.709 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.72 119.22 33.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.64 -21.88 15.66 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.75 -124.17 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.565 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.78 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.27 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -2.8 82.28 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.01 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.18 53.76 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.18 156.59 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.128 0.966 . . . . 0.0 112.592 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.46 142.4 51.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.117 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -131.95 134.91 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.345 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.2 114.21 26.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.601 0.715 . . . . 0.0 110.119 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.32 110.17 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.458 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 42.71 49.71 5.96 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.24 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -37.37 3.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.863 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.13 118.58 13.14 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.855 0.328 . . . . 0.0 111.158 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -104.72 128.84 52.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.41 126.58 52.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.9 157.45 26.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 25.38 57.1 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.118 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -86.84 149.92 24.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.382 0.591 . . . . 0.0 112.078 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.68 171.53 9.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.504 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.52 -42.82 82.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.947 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.34 -39.47 92.43 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 34.5 mtp -69.42 -45.83 68.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.472 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.74 -34.39 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 110.166 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -63.23 -50.12 71.47 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.922 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.55 -52.78 35.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -64.86 -47.5 77.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.331 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -60.01 -42.42 94.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.145 0.498 . . . . 0.0 111.614 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.26 -44.72 82.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.243 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.03 99.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.908 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -70.03 -39.51 75.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.102 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -70.0 -29.75 66.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.665 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.69 -28.79 45.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.754 0.252 . . . . 0.0 111.535 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.16 -35.73 25.29 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.04 106.06 8.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.46 6.06 13.39 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -125.37 17.85 8.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.622 0.646 . . . . 0.0 111.918 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 114.84 6.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.893 -0.14 . . . . 0.0 111.22 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tp -59.64 122.89 15.24 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -113.58 133.94 54.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.173 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.9 141.34 40.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.417 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.2 127.91 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.05 146.71 18.7 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.13 154.97 16.8 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 121.127 -0.558 . . . . 0.0 111.959 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.44 165.25 23.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -57.95 -32.88 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.513 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.2 -6.18 57.36 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -89.35 134.53 32.64 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.47 156.83 32.6 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.201 1.268 . . . . 0.0 110.256 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 83' ' ' LEU . 3.3 t80 -64.85 -35.92 82.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.713 -0.617 . . . . 0.0 110.592 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -56.46 -37.36 70.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -35.61 73.34 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.772 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.6 t -62.31 -39.26 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.596 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.21 -47.08 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.408 0.623 . . . . 0.0 109.469 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.93 73.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.276 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.79 80.31 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.322 0.582 . . . . 0.0 110.809 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.8 -36.76 79.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.392 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -61.33 -41.92 97.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.039 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.77 -38.58 89.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.69 -42.15 98.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.2 -43.35 98.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.437 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -39.1 74.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.707 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.83 12.02 18.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.65 44.75 96.6 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.03 -35.77 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.499 . . . . 0.0 109.943 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.051 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.479 0.635 0 N-CA-C 114.542 0.939 . . . . 0.0 114.542 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.0 118.11 52.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.8 128.27 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.71 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.3 121.42 43.61 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -110.46 127.14 55.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.29 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.85 123.43 39.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.457 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.52 -22.49 13.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.3 -120.75 0.68 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.64 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.44 95.97 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.762 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.87 -3.52 85.94 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.949 -0.569 . . . . 0.0 114.406 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 132.28 52.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.488 0.644 . . . . 0.0 109.375 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -139.93 158.03 44.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.172 0.986 . . . . 0.0 112.985 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.64 141.85 51.81 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.748 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 pt -134.19 135.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.704 0.684 . . . . 0.0 112.706 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.35 115.52 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.694 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.89 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.245 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.45 48.31 16.58 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.848 -0.691 . . . . 0.0 114.215 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.29 -25.83 22.41 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.814 -0.708 . . . . 0.0 114.135 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.72 129.63 38.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.501 1.15 . . . . 0.0 110.501 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.1 135.69 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.11 127.96 54.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -118.13 156.09 29.3 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.94 26.88 47.79 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.304 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.46 150.15 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.344 0.572 . . . . 0.0 112.303 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.3 p -91.72 170.6 9.77 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.545 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.02 -47.25 78.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.9 -38.75 92.17 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.133 -0.355 . . . . 0.0 111.38 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.3 ttp -71.57 -39.04 70.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.668 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.78 -32.8 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 m -63.79 -50.21 69.88 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.539 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.11 -52.3 36.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.88 -48.08 75.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.462 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.6 m -58.65 -42.56 88.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.086 0.469 . . . . 0.0 111.548 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.72 -40.98 98.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.912 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.64 -38.4 80.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.598 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -70.82 -30.89 67.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.849 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.15 -28.09 54.05 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -83.65 -33.82 25.17 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.296 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -129.65 109.12 10.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.97 5.26 19.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -125.91 17.45 7.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.458 0.572 . . . . 0.0 111.893 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.05 113.94 5.43 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.083 0.153 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tp -61.38 123.05 16.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -111.11 130.39 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.393 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.63 141.24 41.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.325 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.83 131.3 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.73 146.88 18.75 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.34 152.85 16.74 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.9 165.15 25.07 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -33.06 67.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.398 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -81.54 -5.82 58.37 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.6 t -89.77 131.56 39.27 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.95 155.47 53.02 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.337 1.358 . . . . 0.0 110.403 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' B' ' 83' ' ' LEU . 6.2 t80 -65.11 -34.24 77.93 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.493 -0.754 . . . . 0.0 110.577 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.74 -37.1 70.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.72 0.295 . . . . 0.0 110.254 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -36.08 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.847 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.26 -39.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.573 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 80' ' ' ILE . 44.7 mm -60.39 -46.96 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.503 0.668 . . . . 0.0 109.436 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.63 -45.5 70.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.312 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.12 78.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.346 0.593 . . . . 0.0 111.19 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.407 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 7.7 mt -61.57 -36.78 81.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.6 0.714 . . . . 0.0 109.505 177.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -60.84 -42.95 98.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.904 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.37 -38.95 91.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.059 0.457 . . . . 0.0 110.58 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -41.89 98.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.159 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -63.17 -43.68 97.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.9 -38.5 72.9 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.76 12.08 20.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.2 44.71 97.14 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.575 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo . . . . . 0 N--CA 1.477 0.533 0 N-CA-C 114.668 0.988 . . . . 0.0 114.668 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.83 117.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.78 128.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.788 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -114.6 121.45 43.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -110.42 127.09 54.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.437 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 123.11 38.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.484 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.29 -22.46 13.7 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.85 -124.37 0.89 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.712 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -107.66 95.99 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 114.916 -0.642 . . . . 0.0 110.202 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -3.25 86.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.133 -0.556 . . . . 0.0 114.375 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 132.31 52.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.547 0.674 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -139.69 158.12 44.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.2 1.0 . . . . 0.0 113.042 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 141.77 51.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.682 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 pt -134.33 136.51 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 115.23 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.565 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.76 108.7 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.381 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.41 47.98 16.53 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.037 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.45 20.14 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -92.34 129.61 38.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.456 1.128 . . . . 0.0 110.498 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.01 136.01 47.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.87 127.33 53.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -117.89 156.36 28.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 112.418 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.76 26.83 48.77 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.428 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.44 150.23 23.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.465 0.65 . . . . 0.0 112.206 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 16.9 p -91.72 170.03 10.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.529 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.68 -47.25 79.07 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.273 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.96 -38.8 92.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.1 ttp -71.6 -39.08 70.76 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.614 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.61 -33.19 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 m -63.59 -49.89 71.57 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.638 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.67 -51.66 47.19 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.823 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.26 -48.09 74.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -58.4 -43.16 88.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.705 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -66.19 -44.16 84.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.296 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.03 -40.8 97.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -68.57 -38.81 81.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.356 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.54 -31.09 68.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -77.07 -27.8 54.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.833 0.288 . . . . 0.0 111.528 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -84.05 -33.68 24.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -129.81 108.85 10.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -81.69 5.18 19.17 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.17 17.98 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.248 0.476 . . . . 0.0 111.939 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.42 113.64 5.46 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.135 0.174 . . . . 0.0 111.221 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tp -61.12 122.8 15.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -110.9 130.89 55.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.237 0.542 . . . . 0.0 111.47 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.16 141.26 40.09 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.098 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.92 131.71 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.84 18.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.91 153.06 16.68 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.636 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.3 165.3 24.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -33.3 67.29 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -81.18 -6.17 58.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -89.44 131.51 40.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.22 155.33 51.78 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.276 1.317 . . . . 0.0 110.451 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 6.0 t80 -64.82 -34.33 78.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.514 -0.741 . . . . 0.0 110.656 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.92 -36.71 70.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.758 0.314 . . . . 0.0 110.239 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 -35.69 72.43 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.606 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.8 -38.77 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.439 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.431 HG23 HD12 ' B' ' 80' ' ' ILE . 44.3 mm -60.58 -47.15 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.546 0.689 . . . . 0.0 109.372 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.38 -45.73 69.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.05 79.01 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.296 0.57 . . . . 0.0 111.181 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 8.0 mt -61.95 -35.95 79.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.356 0.598 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.68 -42.79 99.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.633 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.2 -38.96 92.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.68 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -42.01 98.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.965 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -62.94 -43.91 97.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.44 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.79 -38.22 72.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.615 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.95 11.94 21.2 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.95 96.98 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -101.66 -35.09 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.935 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 114.186 0.802 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.67 110.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.33 127.78 67.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 tt -115.69 120.67 40.13 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -110.1 127.19 54.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.577 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.39 114.89 25.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.269 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.13 -22.63 17.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -120.35 0.65 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.436 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -114.35 96.79 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 122.892 0.477 . . . . 0.0 109.767 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 -4.5 85.89 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.713 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 129.67 51.74 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -137.61 156.12 48.42 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.15 0.976 . . . . 0.0 112.805 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.88 51.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.296 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 pt -131.16 134.61 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.322 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.1 114.74 27.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.675 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.9 mt -112.18 108.78 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.951 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 48.02 20.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.892 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.01 20.55 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.137 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -92.41 130.03 38.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.505 1.152 . . . . 0.0 110.482 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -108.44 136.95 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.157 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.79 127.74 53.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -117.48 156.03 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.104 0.478 . . . . 0.0 112.217 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 25.91 53.11 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.552 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -86.93 149.21 24.95 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.542 0.687 . . . . 0.0 112.208 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 p -91.88 171.44 9.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.419 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.62 -44.29 82.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.79 -39.26 93.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 ttp -71.17 -41.45 70.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.973 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.66 -34.43 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.55 -50.23 70.32 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.857 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.57 -52.03 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.759 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.84 -47.96 76.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.6 -43.6 84.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.218 0.532 . . . . 0.0 111.672 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -44.46 83.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.281 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.93 -40.13 95.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.178 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.58 -38.83 77.51 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.401 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.28 -30.38 67.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.65 -27.43 45.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 117.885 0.311 . . . . 0.0 111.249 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -84.77 -35.64 22.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.916 0.388 . . . . 0.0 110.029 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -130.94 101.28 5.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.12 1.12 16.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -116.78 18.34 14.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.614 0.643 . . . . 0.0 111.955 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.68 115.21 7.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.47 126.44 27.84 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.61 129.67 56.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.171 0.51 . . . . 0.0 111.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.24 140.84 45.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.981 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.3 t -122.54 127.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.97 145.8 17.66 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 155.35 16.73 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.084 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.68 166.86 22.91 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.086 0.469 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -57.88 -34.16 69.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.323 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -80.95 -5.11 57.08 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.9 133.45 41.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.81 152.86 32.94 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.495 1.463 . . . . 0.0 110.34 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -63.41 -37.4 87.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.73 0.696 . . . . 0.0 110.722 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.82 -35.74 66.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.49 -34.82 67.92 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.705 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.0 -38.63 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.76 -47.52 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.329 0.585 . . . . 0.0 109.564 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -54.46 -44.27 72.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.22 78.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.342 0.592 . . . . 0.0 111.242 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.87 -36.97 80.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.79 -41.85 96.38 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.825 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.3 -39.17 92.17 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.514 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.34 -42.27 98.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.074 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -63.72 -41.81 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -38.64 77.34 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.08 11.41 23.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.89 44.62 97.87 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.02 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo . . . . . 0 N--CA 1.481 0.749 0 N-CA-C 114.436 0.898 . . . . 0.0 114.436 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.64 109.79 28.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.04 127.3 67.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.192 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 tt -115.06 120.59 40.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -110.04 127.31 54.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.435 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.67 114.79 25.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.038 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 -22.89 17.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.86 -124.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.299 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -109.7 97.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.04 -0.58 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -4.17 86.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.916 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 129.92 52.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.75 155.98 48.47 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.115 0.96 . . . . 0.0 112.795 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.06 141.66 51.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.322 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 pt -130.84 134.8 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.301 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.36 114.89 27.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.439 0.638 . . . . 0.0 109.624 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.27 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.775 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.82 48.56 18.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.944 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.46 -25.68 21.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.225 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.449 1.124 . . . . 0.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -108.08 136.94 46.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.295 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.01 127.63 53.62 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -117.19 156.36 27.81 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.87 26.49 53.34 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.413 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.4 149.12 24.68 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.485 0.659 . . . . 0.0 112.076 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.1 p -91.62 171.07 9.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.373 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.42 -44.25 83.45 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.269 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.83 -39.29 93.88 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.044 -0.41 . . . . 0.0 111.185 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 6.3 ttp -71.5 -40.98 69.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.953 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.85 -34.27 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.78 -49.96 70.9 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.846 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.74 -51.9 45.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.789 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.05 -47.67 76.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -57.64 -43.78 85.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.207 0.527 . . . . 0.0 111.764 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -44.66 84.85 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.314 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.82 -39.87 95.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.165 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.297 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.4 -30.75 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.57 -27.5 45.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.83 0.286 . . . . 0.0 111.268 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -84.72 -35.87 22.21 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.073 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -130.64 101.6 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.42 1.71 15.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -117.28 18.32 14.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.705 0.684 . . . . 0.0 111.91 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 115.41 7.91 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.7 126.27 27.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -113.4 129.49 56.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.244 0.545 . . . . 0.0 111.748 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.3 140.97 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.1 t -122.62 127.42 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.79 145.89 17.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.29 155.68 16.91 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.915 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.75 167.63 21.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -58.43 -34.74 71.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.036 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -80.35 -6.04 57.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.89 133.43 43.44 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.1 152.97 31.78 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.561 1.507 . . . . 0.0 110.251 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.55 -37.25 86.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.739 0.7 . . . . 0.0 110.572 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -55.78 -35.83 66.71 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.32 -35.07 68.53 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.844 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.75 -38.91 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 42.7 mm -60.37 -47.53 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.435 0.636 . . . . 0.0 109.784 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -54.4 -44.35 72.25 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.984 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -49.23 78.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.275 0.559 . . . . 0.0 111.146 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.63 -36.96 79.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 109.448 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.05 -41.67 97.04 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.832 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.22 -39.29 92.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.17 -42.63 99.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.93 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -63.64 -41.73 98.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -38.57 77.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.518 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.11 11.04 24.45 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.32 44.6 97.86 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 114.752 0.661 . . . . 0.0 114.752 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.65 -36.03 4.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.776 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -65.91 -40.78 91.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 46.7 t -115.78 118.48 38.74 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.837 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.95 175.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.871 2.38 . . . . 0.0 115.404 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.23 121.28 65.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.94 127.28 69.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.406 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 tt -114.88 120.68 40.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -109.59 127.72 54.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.418 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 t -85.0 119.93 34.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.207 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.1 -23.07 14.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.48 -119.34 0.6 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.861 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 mm -113.56 99.46 8.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.79 -2.21 86.71 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.808 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.98 129.08 53.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -138.72 156.49 47.34 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.152 0.977 . . . . 0.0 112.951 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 142.06 51.7 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.31 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 pt -132.47 134.81 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.52 115.11 28.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.369 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.67 109.6 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.219 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.82 44.86 24.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.917 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.81 21.52 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.855 -0.688 . . . . 0.0 114.031 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.53 126.77 35.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.276 1.038 . . . . 0.0 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -105.41 133.15 50.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.948 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.98 126.65 52.72 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.41 158.38 24.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.101 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 26.83 56.35 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.903 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.13 149.14 24.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.281 0.562 . . . . 0.0 112.074 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -90.51 169.02 11.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.21 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.34 -43.62 90.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.61 -40.56 95.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.6 ttp -70.77 -38.18 73.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 p -64.44 -32.8 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -63.94 -49.26 73.28 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.35 -51.83 42.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.77 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.04 -47.83 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.665 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -59.29 -42.88 92.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.611 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.97 -43.94 81.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.391 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.41 -40.97 98.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.997 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -38.09 77.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.14 -29.45 65.25 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.66 -28.44 45.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.761 0.255 . . . . 0.0 111.433 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.79 -33.78 24.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.212 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -132.47 104.5 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.61 5.52 15.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -123.64 17.87 9.56 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.509 0.595 . . . . 0.0 111.688 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 121.7 18.04 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.499 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.12 125.17 25.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -113.14 134.39 54.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.264 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.91 142.01 42.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.3 t -123.51 126.81 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.4 146.34 18.36 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.53 154.46 16.94 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.88 165.74 23.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 110.911 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.88 -32.77 68.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.27 -6.49 57.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.61 133.54 35.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 156.42 32.44 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.274 1.316 . . . . 0.0 110.306 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.406 ' CE1' ' HB3' ' B' ' 83' ' ' LEU . 4.9 t80 -64.26 -33.9 76.89 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.762 -0.586 . . . . 0.0 110.266 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -57.18 -37.33 71.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -35.24 71.76 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.846 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.12 -38.41 80.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.393 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 HD12 ' CE1' ' A' ' 76' ' ' TYR . 43.0 mm -59.93 -48.39 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.444 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -54.15 -45.38 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.469 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.05 -49.18 78.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 10.8 mt -61.58 -36.17 79.89 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.444 0.64 . . . . 0.0 109.46 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.95 -41.96 98.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.74 -38.86 92.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 110.614 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.57 -41.85 98.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.952 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -63.58 -41.0 98.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.51 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -38.92 78.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.449 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.05 11.82 21.81 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.87 44.32 97.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.34 -39.35 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.716 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.569 -0.213 . . . . 0.0 112.569 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -65.83 -40.99 92.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.963 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.431 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 45.8 t -115.95 118.44 38.42 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.803 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.77 175.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.86 2.373 . . . . 0.0 115.43 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.409 HG13 ' CE2' ' B' ' 66' ' ' PHE . 39.7 t -113.25 121.38 65.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.81 127.24 69.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.515 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 tt -114.86 120.47 40.08 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.07 128.25 54.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.457 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.45 119.79 34.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.147 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 -23.2 14.61 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.47 -123.51 0.83 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.565 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -108.45 99.76 9.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.011 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.87 85.75 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.968 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.61 129.44 52.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.0 156.55 47.13 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.156 0.979 . . . . 0.0 113.034 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.96 51.76 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.261 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -132.56 134.94 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 112.599 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.73 115.01 28.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -114.74 109.54 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.192 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.431 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.71 45.05 24.18 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.976 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -26.34 18.99 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.931 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.15 126.86 35.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.211 1.005 . . . . 0.0 110.391 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -105.63 132.35 51.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.074 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.24 126.84 53.4 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.7 158.8 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 112.092 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 26.49 57.43 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.932 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.92 149.15 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.36 0.6 . . . . 0.0 112.325 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.39 169.21 11.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.446 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -65.63 -43.27 90.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.72 -40.05 94.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.99 -0.444 . . . . 0.0 111.233 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -71.35 -38.17 71.64 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.43 -32.86 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -63.96 -48.85 74.85 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -50.84 -51.92 46.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.7 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -64.76 -47.95 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.669 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -59.21 -42.95 92.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -43.89 82.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.36 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.33 -40.97 98.77 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -37.9 76.75 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -71.18 -29.53 65.3 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.77 -28.42 44.73 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.856 0.298 . . . . 0.0 111.432 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.89 -33.56 24.74 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -132.43 104.42 6.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.84 5.54 15.72 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -123.6 17.53 9.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.517 0.598 . . . . 0.0 111.772 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 122.06 18.44 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.22 125.38 25.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG13 ' B' ' 23' ' ' VAL . 16.4 m-85 -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.32 141.75 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 127.27 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.75 146.3 18.3 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.55 154.57 16.95 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.83 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -32.73 68.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.418 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.16 -6.85 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.4 133.38 36.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 156.49 33.33 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.409 1.406 . . . . 0.0 110.336 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.412 ' CE1' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -64.64 -33.66 76.46 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.832 -0.543 . . . . 0.0 110.264 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -57.29 -37.44 72.44 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -35.46 72.23 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.786 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.68 -38.65 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.395 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.412 HD11 ' CE1' ' B' ' 76' ' ' TYR . 43.3 mm -60.02 -48.01 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.524 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -54.38 -45.13 72.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.398 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 111.283 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 10.7 mt -62.05 -36.04 80.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.457 0.646 . . . . 0.0 109.419 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.88 -42.0 98.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.793 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.74 -39.01 92.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -41.92 98.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.978 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -63.52 -41.01 98.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.458 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -38.73 77.79 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.444 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.12 11.86 21.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 44.02 98.14 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.07 -39.53 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.759 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -52.22 19.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.672 0.273 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.09 128.55 17.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.434 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.2 -173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.158 2.572 . . . . 0.0 114.454 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.7 115.02 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.404 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.5 mp -111.9 127.45 69.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -115.39 121.52 43.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.59 127.14 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.59 111.41 20.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.96 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.17 -119.38 0.64 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.68 -1.248 . . . . 0.0 114.16 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.38 99.91 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.069 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.92 -3.31 84.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.956 -0.566 . . . . 0.0 114.175 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 131.26 54.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.581 0.69 . . . . 0.0 109.766 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.9 m-85 -137.89 157.48 46.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 122.096 0.95 . . . . 0.0 112.746 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.2 51.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.878 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 pt -132.95 134.37 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.396 0.543 . . . . 0.0 112.341 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 115.05 28.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.247 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.2 mt -111.59 108.83 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.715 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.99 46.16 26.22 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.664 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.53 24.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.658 -0.782 . . . . 0.0 114.221 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -91.74 128.96 37.78 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.57 1.185 . . . . 0.0 110.201 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.52 135.01 47.69 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.84 127.71 53.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -117.47 156.1 28.56 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.156 0.503 . . . . 0.0 112.245 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.47 45.01 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.428 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.75 151.17 22.57 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.278 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -93.14 173.32 7.79 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.586 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -67.92 -43.83 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.86 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.6 -38.7 92.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.809 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -70.35 -44.91 67.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.2 p -58.57 -35.27 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.744 0.307 . . . . 0.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.2 m -63.55 -51.77 64.01 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.882 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -50.86 -51.18 53.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.683 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.31 -48.0 74.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.806 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -58.35 -42.86 87.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.082 0.467 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -66.48 -43.87 84.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.152 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -64.44 -39.23 93.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.015 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -38.2 70.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.57 -30.83 67.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.587 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.07 -28.75 54.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.916 0.325 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -37.45 27.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -127.38 105.4 8.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.88 1.04 24.88 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.27 20.01 8.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.242 0.474 . . . . 0.0 111.928 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.76 115.61 8.31 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.431 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.9 123.13 16.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -110.78 129.18 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.237 0.541 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.7 pp -136.91 140.53 42.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.586 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.96 134.63 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.42 146.53 18.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 154.76 16.64 Favored Glycine 0 C--N 1.33 0.238 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.66 166.25 23.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.826 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -58.93 -31.8 68.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.261 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -81.12 -5.23 57.43 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.2 t -86.48 132.27 43.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.36 154.4 31.87 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.55 1.5 . . . . 0.0 110.495 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CE1' HD13 ' A' ' 80' ' ' ILE . 5.7 t80 -64.2 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.887 -0.508 . . . . 0.0 111.04 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.93 -37.64 69.23 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.536 0.208 . . . . 0.0 110.744 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -71.54 -34.22 69.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.188 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.43 -38.32 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.372 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 80' ' ' ILE . 41.9 mm -60.69 -47.61 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.45 0.643 . . . . 0.0 109.621 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -55.14 -44.35 75.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.929 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.99 87.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -61.47 -37.69 84.51 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.532 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.66 -41.49 90.72 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.825 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.76 -39.34 90.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 110.764 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -42.95 99.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.909 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -63.1 -42.54 99.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.44 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.22 -37.78 72.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.598 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.22 10.59 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.24 44.59 96.8 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mt -99.02 -36.57 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.71 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -71.59 -52.28 18.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.14 128.66 17.6 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.29 -173.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 123.119 2.546 . . . . 0.0 114.431 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.37 114.79 46.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.407 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.5 mp -111.86 127.79 68.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.522 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -115.43 121.78 43.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -110.81 126.89 55.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.397 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.34 111.28 20.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.97 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.52 -122.8 0.83 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 119.964 -1.113 . . . . 0.0 114.064 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.72 100.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.15 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.74 -3.57 82.67 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.446 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 131.62 53.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.552 0.676 . . . . 0.0 109.764 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -137.94 157.16 46.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.253 1.025 . . . . 0.0 112.721 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.57 142.63 51.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.769 -1.56 . . . . 0.0 109.046 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.44 134.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.317 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 115.49 29.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.262 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 34.3 mt -112.07 109.03 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.769 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.44 46.45 22.78 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.621 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 -25.59 24.38 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.914 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -91.75 128.78 37.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.516 1.158 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.44 135.06 47.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.75 127.84 53.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.46 156.49 27.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 112.169 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.54 46.01 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.43 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 34.2 mt -89.0 150.95 22.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 112.151 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -92.68 173.13 7.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.749 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.57 -44.28 78.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.844 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.2 -38.96 93.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mtm -70.22 -44.47 68.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.01 -35.09 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -63.82 -51.13 66.11 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.869 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.35 -51.3 55.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.67 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.17 -48.12 74.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.718 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -58.14 -43.07 87.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.478 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -66.22 -44.02 85.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.297 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -64.22 -39.36 93.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.018 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -38.34 71.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -70.47 -30.59 67.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.593 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.37 -28.52 52.9 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.932 0.333 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -37.09 27.56 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -127.93 105.27 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.87 1.0 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -124.99 19.81 8.36 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.276 0.489 . . . . 0.0 111.906 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.7 115.94 8.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.405 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.18 122.74 15.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.78 129.13 55.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.407 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -136.59 140.21 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.747 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.55 134.46 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.02 146.55 18.49 Favored Glycine 0 C--O 1.226 -0.346 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.99 154.78 16.75 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.11 166.53 23.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -59.19 -31.63 69.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.281 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -81.1 -5.46 57.69 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.25 132.12 44.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.35 154.06 31.69 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.583 1.522 . . . . 0.0 110.669 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.9 t80 -64.06 -37.83 88.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.911 -0.493 . . . . 0.0 111.046 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.47 -37.63 70.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.514 0.197 . . . . 0.0 110.629 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.44 -34.42 70.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.285 0.564 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.25 -38.3 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.425 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 43.7 mm -60.94 -47.29 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.453 0.644 . . . . 0.0 109.625 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -55.33 -43.99 75.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.957 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.31 86.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.346 0.594 . . . . 0.0 110.833 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -60.87 -38.05 84.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.38 -41.51 89.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.903 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.85 -39.23 90.58 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.481 . . . . 0.0 110.707 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -42.58 98.79 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.939 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -63.22 -42.77 99.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -37.58 72.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.683 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.48 10.81 23.81 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.12 44.5 97.12 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.234 0.853 . . . . 0.0 115.234 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -99.25 -36.69 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.033 0 N-CA-C 112.361 -0.296 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 t -65.9 -43.47 88.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.76 131.39 13.56 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.89 -169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.224 2.616 . . . . 0.0 114.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.36 110.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.62 126.38 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.287 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.54 123.48 48.61 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -111.95 127.16 55.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.306 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.86 108.25 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.537 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -22.71 24.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -119.24 0.61 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.939 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.81 98.84 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.63 -3.5 86.54 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.944 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.49 130.58 54.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.544 0.672 . . . . 0.0 109.447 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -139.12 157.25 46.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 113.115 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.77 51.06 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.954 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.3 134.13 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.368 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.64 114.01 26.78 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.389 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.71 108.68 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.89 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 47.37 21.18 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.735 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.64 23.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.267 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -92.14 128.3 37.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.478 1.139 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.17 135.49 47.55 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.41 127.47 53.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -116.53 155.76 28.09 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.7 46.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.396 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.5 mt -87.76 149.01 24.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 112.361 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -91.89 173.06 8.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.554 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -67.53 -45.01 76.99 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.948 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -37.98 89.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.234 0.47 . . . . 0.0 110.845 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mtp -70.26 -44.87 67.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.53 -35.46 54.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.14 -51.76 62.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -50.2 -51.79 41.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.762 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.74 -48.12 75.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.021 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.638 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -66.83 -43.46 83.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.209 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -39.41 92.91 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.043 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.13 -37.57 72.31 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.695 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.77 -30.99 67.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.442 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.23 -27.97 53.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.913 0.324 . . . . 0.0 111.148 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.05 -38.81 24.4 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.86 119.18 25.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -91.26 -19.88 22.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.37 20.53 11.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.202 0.456 . . . . 0.0 111.579 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.96 115.64 9.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.724 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.06 125.92 26.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -110.0 126.78 54.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.211 0.529 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.12 139.85 46.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 p -127.39 135.71 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.37 144.74 16.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.647 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.47 152.79 17.06 Favored Glycine 0 C--N 1.33 0.204 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.1 164.71 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.085 0.469 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 -32.58 68.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.502 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -81.96 -6.84 59.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.81 127.79 61.08 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.08 154.41 62.42 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 110.394 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 3.9 t80 -63.12 -36.66 84.33 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.816 -0.552 . . . . 0.0 110.73 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 110.422 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -36.89 74.89 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 109.781 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.62 -39.55 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.687 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 80' ' ' ILE . 43.1 mm -59.85 -48.11 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.409 0.623 . . . . 0.0 109.806 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -54.96 -44.06 74.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.96 83.68 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.599 . . . . 0.0 110.873 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.32 -37.3 80.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.572 0.701 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.2 -40.88 95.62 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.985 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.01 -40.19 94.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.45 -42.47 98.65 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.017 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 t60 -63.24 -41.44 99.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -38.99 76.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.35 10.33 25.4 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.45 44.1 98.46 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.09 -31.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.053 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -66.08 -43.75 86.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.581 0.229 . . . . 0.0 110.866 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -140.35 131.62 14.12 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.652 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -49.11 -169.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.178 2.585 . . . . 0.0 114.48 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.36 110.72 32.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.83 126.76 65.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.371 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.05 123.68 48.54 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -112.35 127.23 55.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.225 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.5 t -85.06 108.21 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.591 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.6 -22.47 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.57 -123.54 0.85 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.459 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 28.9 mm -108.12 99.08 7.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.191 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -3.43 86.6 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.032 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 130.79 54.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.623 0.712 . . . . 0.0 109.6 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -139.13 157.89 45.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.515 1.15 . . . . 0.0 113.134 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 142.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.835 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.24 134.1 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.25 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -111.14 114.1 27.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.417 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.36 108.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.751 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.44 20.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.883 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.16 -25.82 22.24 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.71 -0.757 . . . . 0.0 114.04 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -91.77 128.76 37.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.656 1.228 . . . . 0.0 110.329 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.85 135.39 48.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.36 128.15 53.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -117.28 155.8 28.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.141 0.496 . . . . 0.0 112.325 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.48 27.73 46.59 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.198 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.68 148.87 24.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.387 0.613 . . . . 0.0 112.298 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -92.05 173.18 7.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -67.75 -44.8 76.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.025 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.49 91.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.161 0.505 . . . . 0.0 110.974 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mtp -69.96 -44.87 68.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.369 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.57 -35.31 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.728 0.299 . . . . 0.0 110.352 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.26 -51.53 63.11 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.888 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.39 -51.56 45.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.7 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.12 -48.17 74.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.732 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 18.1 m -57.52 -43.45 84.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 111.753 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -66.65 -43.7 83.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.139 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -39.95 94.52 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.76 -37.3 73.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -70.94 -31.17 67.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.299 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.91 -28.1 55.17 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.11 -0.369 . . . . 0.0 111.131 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.13 -38.52 24.63 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -128.15 119.44 25.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -91.28 -20.0 22.38 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 20.58 11.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.067 0.394 . . . . 0.0 111.543 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 115.91 9.51 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.51 125.98 27.42 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.76 127.0 54.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.213 0.53 . . . . 0.0 111.694 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.26 139.77 45.97 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.518 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.39 135.89 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.34 145.18 17.25 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.649 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.71 152.32 17.16 Favored Glycine 0 N--CA 1.454 -0.161 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.34 165.14 24.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -59.14 -32.27 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -81.71 -7.13 59.56 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.43 127.8 61.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.2 154.18 61.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.222 1.282 . . . . 0.0 110.264 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 3.9 t80 -62.96 -36.48 83.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.747 -0.596 . . . . 0.0 110.69 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.48 -36.27 68.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -36.9 74.58 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.306 0.574 . . . . 0.0 109.662 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.9 -39.24 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.642 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.407 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 46.0 mm -59.99 -48.03 89.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-O 121.476 0.655 . . . . 0.0 109.713 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -55.12 -44.12 74.72 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.99 83.48 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.46 -37.2 80.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.611 0.72 . . . . 0.0 109.591 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.25 -40.83 95.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.883 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 mt -65.2 -39.9 93.46 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.855 0.36 . . . . 0.0 110.829 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.41 -42.6 98.76 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -63.26 -41.27 99.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.424 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -39.08 76.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.598 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.3 10.19 25.82 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.78 43.89 98.62 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.15 -31.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 t -88.11 -43.06 11.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 62.0 t -118.01 120.46 32.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.48 177.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.283 2.655 . . . . 0.0 115.676 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.49 120.13 61.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.7 mp -112.47 127.71 69.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -117.07 127.25 53.96 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -115.84 127.68 55.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.299 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.52 99.53 8.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.941 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.82 -21.64 51.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.974 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -113.93 92.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 -5.53 79.24 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.705 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.59 128.94 52.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.576 0.688 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.69 156.9 47.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.376 1.084 . . . . 0.0 113.133 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.98 142.29 51.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.842 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.83 135.14 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.18 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.69 116.11 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.938 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.05 108.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.183 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 46.85 48.52 18.35 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.523 -0.846 . . . . 0.0 114.39 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.99 -27.11 15.74 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.373 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.81 130.0 37.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.412 1.106 . . . . 0.0 110.197 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.29 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.13 125.57 51.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.52 157.02 25.9 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.25 50.99 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.042 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.44 149.15 24.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.971 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 p -92.09 173.16 7.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.47 -43.79 80.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.948 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.22 -38.25 90.38 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 122.043 -0.411 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mtp -70.93 -43.6 67.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.625 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.32 -35.8 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -63.24 -51.2 67.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.681 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.32 -52.5 36.27 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.93 -47.57 77.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.728 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -58.07 -43.15 86.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.099 0.476 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -44.66 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.046 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.91 -40.42 96.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.161 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -39.23 74.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.236 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.55 -27.73 64.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.41 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.86 -26.95 40.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.928 0.331 . . . . 0.0 111.385 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -33.96 25.05 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -134.52 97.45 3.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -70.86 -6.21 36.4 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -109.04 17.65 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.586 0.63 . . . . 0.0 111.826 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.61 115.61 8.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.519 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.2 tp -65.11 124.69 22.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.09 127.79 54.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.359 0.599 . . . . 0.0 111.514 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.7 pp -133.95 139.24 45.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.505 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.78 137.34 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.96 145.49 17.32 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.88 153.68 16.69 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.17 163.63 24.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.154 0.502 . . . . 0.0 111.285 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -31.76 68.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.415 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -81.73 -5.96 58.61 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -89.48 127.05 56.22 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.93 156.17 63.56 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.094 1.196 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -64.46 -34.7 78.8 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.768 -0.583 . . . . 0.0 110.46 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.23 -36.42 70.89 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -36.85 75.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.334 0.587 . . . . 0.0 109.688 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.61 -39.01 81.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.788 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 80' ' ' ILE . 48.9 mm -60.39 -48.52 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.359 0.6 . . . . 0.0 109.726 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -54.15 -44.8 71.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.47 85.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.509 0.671 . . . . 0.0 110.827 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.0 mt -61.0 -36.8 80.46 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 109.378 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.73 -42.38 97.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.851 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.12 -39.92 95.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.065 0.459 . . . . 0.0 110.837 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.03 -42.38 97.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.063 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.7 -42.32 99.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.511 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.5 -38.66 74.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.83 11.41 20.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.49 44.23 98.27 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -98.06 -30.95 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 N-CA-C 112.895 -0.082 . . . . 0.0 112.895 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -88.27 -43.21 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.757 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 62.8 t -118.03 120.5 32.44 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.59 177.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.176 2.584 . . . . 0.0 115.745 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.1 t -111.52 120.49 62.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.407 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -112.7 127.65 69.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.74 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -117.1 127.09 53.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -115.72 127.68 55.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.165 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.58 98.99 7.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.033 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.27 -21.86 52.98 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.09 -124.55 0.88 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.704 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.12 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.105 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.33 79.35 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.814 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 129.13 53.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -138.16 156.65 47.53 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.337 1.065 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 142.06 51.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.95 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.64 135.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.406 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.89 115.89 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.892 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.0 108.73 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.149 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 46.31 48.99 15.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.462 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.74 -26.85 16.33 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.176 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.85 129.95 37.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.487 1.144 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.88 136.03 48.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.269 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.83 126.06 52.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.79 157.08 26.14 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 26.57 53.11 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.057 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.89 148.94 25.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.388 0.613 . . . . 0.0 112.109 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -91.74 172.97 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.7 -43.62 79.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -63.94 -38.61 91.72 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 110.996 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.53 -43.91 68.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.425 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.13 -35.77 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.948 0.404 . . . . 0.0 110.228 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 19.6 m -63.27 -51.3 66.71 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.745 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.26 -52.49 35.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.79 -47.35 78.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.796 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -58.4 -42.9 88.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.488 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.39 83.29 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.196 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.07 -40.58 96.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.992 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.34 75.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.225 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.35 -27.8 64.63 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.524 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -79.63 -27.43 40.96 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.84 0.291 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -83.25 -33.75 25.98 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -134.96 97.72 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -71.02 -6.15 36.75 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.86 17.4 21.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.7 0.682 . . . . 0.0 111.754 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.3 115.9 8.27 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.32 125.13 24.12 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -109.44 127.38 54.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 0.0 111.556 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.407 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -126.52 137.5 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.12 145.43 17.21 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.522 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.76 153.29 16.83 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.84 164.21 24.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -31.51 69.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.176 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.67 -6.59 59.16 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -88.98 127.0 57.41 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.99 156.33 63.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.962 1.108 . . . . 0.0 110.298 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CE1' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.51 -34.9 79.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.996 -0.44 . . . . 0.0 110.419 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.66 -36.02 71.33 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.672 0.273 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -36.96 75.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.502 0.668 . . . . 0.0 109.539 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -61.56 -39.04 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.687 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.428 HG23 HD12 ' B' ' 80' ' ' ILE . 50.6 mm -60.31 -48.24 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.429 0.633 . . . . 0.0 109.702 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -54.59 -44.68 73.24 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.219 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.34 85.8 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 110.846 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.31 -36.56 80.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.666 0.746 . . . . 0.0 109.377 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.99 -41.83 97.25 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.949 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.97 -39.41 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.31 -41.96 96.59 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.85 -42.23 99.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.556 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.47 -38.9 75.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.618 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 11.67 18.94 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.13 44.27 98.36 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -98.07 -30.53 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.939 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 t -98.19 -58.21 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 28.9 t -125.85 126.24 24.87 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.114 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -54.11 174.09 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.892 2.395 . . . . 0.0 115.296 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.27 117.23 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.51 127.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.409 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -116.02 121.72 43.06 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -106.97 125.59 51.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.9 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.32 116.26 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.657 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.31 -23.79 15.49 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -122.89 0.76 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.105 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.1 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 122.666 0.387 . . . . 0.0 110.112 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 -3.41 87.24 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.964 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.89 53.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -137.48 157.09 47.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.202 1.001 . . . . 0.0 113.335 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 141.99 51.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.708 -1.587 . . . . 0.0 108.638 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.73 134.81 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -112.3 114.41 27.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.54 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mt -114.45 109.99 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.221 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.32 45.45 21.72 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.962 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.98 -26.89 14.55 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.827 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -85.32 125.14 32.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.927 0.863 . . . . 0.0 110.517 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.87 133.27 50.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.94 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.78 127.36 52.73 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.71 155.66 28.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 112.058 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 26.27 51.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.339 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 mt -86.62 148.92 25.26 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.513 0.673 . . . . 0.0 112.042 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.8 p -90.77 172.69 8.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.535 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -67.9 -44.29 77.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.675 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.88 -38.79 92.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.099 0.476 . . . . 0.0 110.951 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.39 -46.15 67.56 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.03 -34.42 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -63.31 -50.42 70.1 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.789 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.42 -52.46 37.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.714 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.64 -47.7 77.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.693 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.6 -43.55 89.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.214 0.531 . . . . 0.0 111.701 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.58 -43.34 85.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.374 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.27 -40.63 96.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.76 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.56 -37.33 76.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.88 -30.91 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.63 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.19 -27.75 57.01 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.247 -0.283 . . . . 0.0 111.038 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.35 -36.48 26.81 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.19 107.59 8.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.81 4.38 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.8 19.24 9.4 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.381 0.537 . . . . 0.0 111.864 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.1 116.14 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.08 123.78 19.05 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.48 127.93 55.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.097 0.475 . . . . 0.0 111.441 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -133.46 140.27 47.18 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.818 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.33 136.34 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 147.13 19.02 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.15 155.76 17.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.1 23.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.068 0.461 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -57.63 -33.38 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -79.89 -5.63 55.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.79 132.98 49.83 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.6 153.19 23.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.541 1.494 . . . . 0.0 110.573 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 5.8 t80 -63.53 -38.45 91.18 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.658 -0.651 . . . . 0.0 110.987 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -56.28 -37.33 69.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.599 0.238 . . . . 0.0 110.641 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -71.34 -35.62 71.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.857 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.24 -38.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.407 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 50.5 mm -60.05 -47.92 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.42 0.629 . . . . 0.0 109.612 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -44.37 70.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.154 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.69 80.69 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.693 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.3 -36.35 77.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -61.92 -42.58 99.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.149 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.43 -39.04 93.07 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 110.985 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -41.84 96.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.139 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -63.47 -40.13 96.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -38.14 76.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.483 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.29 9.77 27.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.42 44.15 95.72 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.9 -36.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.627 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 33.3 t -98.72 -58.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.419 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 26.2 t -125.7 126.16 24.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.129 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -54.3 174.21 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.79 2.327 . . . . 0.0 115.407 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -112.17 117.57 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.92 127.27 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.398 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.59 121.85 43.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.8 125.9 51.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.921 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -84.59 116.06 27.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.587 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.9 -24.34 15.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -126.35 0.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.964 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.1 mm -108.03 100.88 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.421 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.16 -2.97 87.95 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.144 -0.55 . . . . 0.0 114.0 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 127.85 53.54 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -137.34 157.22 47.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.237 1.018 . . . . 0.0 113.379 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 141.72 51.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.754 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 pt -131.49 134.57 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.736 0.698 . . . . 0.0 112.816 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.98 114.25 27.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.517 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.29 109.77 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.419 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.36 45.7 22.1 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.831 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.88 -27.31 13.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.849 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -84.96 125.43 32.68 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.061 0.931 . . . . 0.0 110.522 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.34 133.09 51.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.823 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.3 127.57 53.33 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -117.18 155.59 29.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.51 50.87 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.137 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 41.4 mt -87.05 149.23 24.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.528 0.68 . . . . 0.0 111.998 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -90.98 172.84 8.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.759 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.92 -44.11 77.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.8 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.41 -38.38 90.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.043 0.449 . . . . 0.0 110.809 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.2 mtp -69.23 -46.71 66.68 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.66 -34.37 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -63.47 -50.23 70.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.719 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.8 -52.07 44.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.733 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.61 -48.22 75.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.621 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -43.84 88.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 111.739 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.52 -42.98 86.45 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.486 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.61 -40.65 95.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.745 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -69.55 -37.35 77.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.996 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.98 -30.81 67.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.18 -27.65 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.947 0.34 . . . . 0.0 111.039 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -82.33 -36.54 26.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.38 107.34 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.58 4.54 18.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -123.75 19.18 9.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.465 0.575 . . . . 0.0 111.845 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 116.49 8.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.4 123.83 19.31 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.38 127.66 55.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -133.45 139.96 47.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.609 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.2 p -127.05 136.5 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.51 147.05 18.96 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.03 155.83 17.32 Favored Glycine 0 N--CA 1.46 0.29 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.989 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 166.55 23.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -58.42 -33.14 69.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.461 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.99 -5.97 56.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -82.41 132.69 51.88 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.55 153.1 23.36 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.683 1.589 . . . . 0.0 110.316 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.9 t80 -63.38 -38.8 92.55 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.767 -0.583 . . . . 0.0 110.921 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.96 -37.37 68.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.492 0.187 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -71.3 -35.85 71.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.18 -38.26 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.416 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 50.4 mm -59.92 -47.63 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.51 0.671 . . . . 0.0 109.719 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -54.28 -44.29 71.77 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.46 81.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.148 0.499 . . . . 0.0 110.716 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 mt -60.68 -36.2 78.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.604 0.716 . . . . 0.0 109.238 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -61.93 -42.24 98.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.0 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.86 -38.92 92.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.96 0.41 . . . . 0.0 110.948 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.19 -42.05 96.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.288 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.36 -40.34 97.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -38.14 76.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.389 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.21 9.6 27.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.39 44.3 95.54 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 115.704 1.041 . . . . 0.0 115.704 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.65 -37.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.67 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 p -169.42 -64.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.441 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 44.4 t -127.94 121.29 21.82 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.51 176.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.842 2.361 . . . . 0.0 115.692 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.58 116.62 53.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.55 127.16 65.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.604 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -115.14 122.04 44.86 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.24 128.07 55.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.131 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.31 116.62 29.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.508 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.16 -22.15 16.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.8 -122.08 0.72 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.741 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -115.59 87.52 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.32 27.72 19.57 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.388 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 93.08 2.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.517 0.675 . . . . 0.0 109.487 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.26 157.39 17.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.263 1.03 . . . . 0.0 113.231 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 142.0 51.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 pt -131.54 133.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 118.529 0.604 . . . . 0.0 112.422 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.51 114.33 27.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.473 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.27 110.08 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.208 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.42 45.03 22.26 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.93 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 -26.86 17.04 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.086 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.88 126.25 34.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.225 1.013 . . . . 0.0 110.525 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.36 131.94 52.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.921 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.75 127.2 53.32 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -117.56 158.67 24.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.49 27.39 54.87 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.949 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.38 149.15 24.67 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.697 0.76 . . . . 0.0 112.191 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 p -91.36 171.53 9.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.419 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.42 -43.61 80.8 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.0 -38.8 92.42 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.027 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mtp -70.35 -44.11 68.82 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.48 -34.91 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -63.55 -50.46 69.43 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.855 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -50.67 -51.47 48.97 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.807 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.08 -48.09 74.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.279 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -43.84 83.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 111.622 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.76 -44.5 81.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.193 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.92 -40.58 96.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -69.41 -38.48 77.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.24 -31.27 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.23 -27.3 53.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.26 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -84.87 -36.62 21.42 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.994 0.426 . . . . 0.0 109.953 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -128.84 97.38 4.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.28 -6.11 37.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -114.16 19.19 16.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.573 0.624 . . . . 0.0 111.955 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.95 113.38 5.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.446 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.45 125.07 23.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -111.19 128.99 56.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.795 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -133.89 139.36 46.14 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.51 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -125.72 135.91 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.78 145.38 16.98 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.14 153.13 16.67 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.771 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.75 24.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -32.26 65.98 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.75 -5.71 59.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.38 133.25 53.67 Favored Pre-proline 0 CA--C 1.537 0.462 0 O-C-N 122.221 -0.299 . . . . 0.0 110.442 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.34 148.96 27.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.729 1.619 . . . . 0.0 110.729 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 4.7 t80 -63.04 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.748 -0.595 . . . . 0.0 111.251 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.56 -37.0 67.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.605 0.24 . . . . 0.0 110.832 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.6 -34.75 67.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.913 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.2 t -62.67 -38.83 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.381 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 80' ' ' ILE . 43.3 mm -60.24 -47.48 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.474 0.654 . . . . 0.0 109.407 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.12 -43.99 70.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.2 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -49.05 79.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.123 0.487 . . . . 0.0 110.792 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.33 -37.9 82.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.381 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.09 -42.0 97.7 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.696 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.22 -39.61 92.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.98 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -42.26 98.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.65 -42.05 98.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.394 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.392 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.99 10.83 20.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.65 97.73 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mt -101.15 -34.92 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.666 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 8.9 p -169.69 -64.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.449 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 44.4 t -127.55 121.34 22.26 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -51.8 176.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.851 2.367 . . . . 0.0 115.663 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.5 116.81 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.74 127.11 65.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.632 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -115.04 122.16 45.32 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -111.21 127.58 55.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.254 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.71 116.89 30.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.323 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.4 -22.61 16.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.34 -125.71 0.94 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.649 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -111.06 87.84 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.192 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.62 27.93 20.68 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.485 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.86 93.3 2.69 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.514 0.673 . . . . 0.0 109.281 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -105.56 157.03 17.67 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.356 1.074 . . . . 0.0 113.336 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.78 141.99 51.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.992 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 pt -131.48 133.94 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.527 0.603 . . . . 0.0 112.271 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.05 114.45 27.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.396 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 72.3 mt -114.46 110.1 30.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.192 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.17 45.38 20.74 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.044 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.84 -26.8 16.8 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.102 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.94 126.3 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.322 1.061 . . . . 0.0 110.436 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.52 131.93 52.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.962 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 127.19 53.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -117.33 158.58 24.15 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.242 0.544 . . . . 0.0 112.445 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.21 27.74 54.96 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.2 149.1 24.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.57 0.7 . . . . 0.0 112.193 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.8 p -91.49 171.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.428 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -67.21 -44.08 80.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.748 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.78 -38.69 92.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mtp -70.3 -44.36 68.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.304 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.42 -34.47 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.3 m -64.29 -50.24 68.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.873 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -50.73 -51.55 48.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.604 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.95 -48.32 74.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.11 -43.92 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.058 0.456 . . . . 0.0 111.781 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.81 -44.24 81.72 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.195 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -64.16 -40.09 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.904 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -69.68 -39.01 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.188 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -69.81 -31.2 68.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.09 -27.84 54.3 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.894 0.315 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -84.31 -36.15 22.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.11 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -70.93 -5.96 34.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -114.15 18.51 17.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.616 0.644 . . . . 0.0 112.053 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.27 113.71 5.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.79 124.39 21.36 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -110.62 128.78 55.83 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.372 0.606 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -133.61 139.26 46.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.558 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -125.94 135.68 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.55 145.27 16.91 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.13 153.2 16.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.92 24.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.045 0.45 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -32.35 66.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.78 -5.51 58.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -81.49 133.39 53.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.59 149.12 26.7 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.725 1.617 . . . . 0.0 110.708 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 4.7 t80 -63.27 -39.08 93.58 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.709 -0.619 . . . . 0.0 111.157 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.51 -37.12 67.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.694 0.283 . . . . 0.0 110.728 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.4 -34.81 68.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.873 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -38.82 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 76' ' ' TYR . 41.7 mm -60.58 -46.7 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.437 0.636 . . . . 0.0 109.447 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.84 -43.77 73.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.073 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.39 78.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.345 0.593 . . . . 0.0 110.792 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.08 -38.12 81.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 109.484 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.81 -42.27 97.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.817 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.76 -39.86 94.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.938 0.399 . . . . 0.0 111.079 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.42 -42.39 98.74 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.56 -41.88 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -38.32 74.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.497 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.01 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 44.67 97.56 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.05 -35.15 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 112.724 -0.15 . . . . 0.0 112.724 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -108.5 -63.57 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 34.3 t -124.36 123.58 25.87 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.67 174.52 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.903 2.402 . . . . 0.0 115.414 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.52 119.19 60.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.58 127.57 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.305 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tt -113.88 119.99 39.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.31 128.32 54.99 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.113 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -87.2 116.38 29.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.391 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.95 -22.75 16.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.17 -119.26 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.348 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.66 101.46 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.221 -0.489 . . . . 0.0 109.708 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.72 1.65 72.88 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.884 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -107.12 92.73 4.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.423 0.612 . . . . 0.0 109.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -104.14 156.22 18.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.174 0.988 . . . . 0.0 112.926 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.22 141.41 52.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.981 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 pt -131.73 134.69 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.654 0.661 . . . . 0.0 112.702 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -112.1 115.77 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.884 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.0 mt -115.94 110.56 32.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.084 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.3 44.58 27.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.992 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -26.25 18.77 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.744 -0.741 . . . . 0.0 114.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -88.71 127.95 35.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.58 1.19 . . . . 0.0 110.46 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -106.48 134.35 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.0 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.74 126.64 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -116.7 157.7 25.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.241 0.543 . . . . 0.0 112.366 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.05 27.76 51.9 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.052 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -88.12 150.14 23.52 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 112.293 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.5 p -91.11 171.33 9.33 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.228 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.14 -43.89 81.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.78 -38.57 91.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.171 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 mtp -69.87 -44.94 68.8 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.03 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -58.8 -34.14 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.8 m -64.11 -49.91 70.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.587 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.37 -52.68 35.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.696 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.42 -48.01 76.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t -58.01 -43.88 86.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.074 0.464 . . . . 0.0 111.738 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -44.62 83.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.249 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.99 95.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.096 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -69.92 -38.56 76.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.634 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.83 -29.41 65.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -78.85 -26.87 44.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.822 0.283 . . . . 0.0 111.393 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -85.63 -34.18 21.44 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.61 95.78 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.74 -13.36 62.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -106.0 19.28 20.79 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.604 0.638 . . . . 0.0 111.897 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -68.28 111.41 4.56 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 tp -66.42 127.21 31.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -114.3 131.25 56.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.021 0.439 . . . . 0.0 111.486 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -134.85 140.94 46.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.672 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 p -127.07 136.72 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.15 146.03 17.51 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.81 154.81 16.68 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.093 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 165.13 24.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.134 0.467 . . . . 0.0 111.14 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.29 -32.35 66.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.59 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -81.28 -5.74 58.12 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.29 132.21 48.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.03 151.72 35.32 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.57 1.513 . . . . 0.0 110.193 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 5.2 t80 -63.38 -36.6 84.24 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.719 -0.613 . . . . 0.0 110.753 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.6 -36.44 69.4 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.81 -34.89 69.73 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.91 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.88 -38.42 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.299 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.402 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 49.7 mm -61.2 -47.34 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.426 0.631 . . . . 0.0 109.482 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.9 -44.35 74.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.931 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -48.17 82.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.257 0.551 . . . . 0.0 111.055 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -60.63 -37.15 80.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.384 0.611 . . . . 0.0 109.659 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.92 -41.26 95.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.818 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.5 -39.68 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.578 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.86 -42.29 99.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.119 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -63.79 -42.09 97.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.369 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -37.86 75.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.478 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 10.51 25.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.65 97.16 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -103.39 -37.02 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.017 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -109.07 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.784 0.326 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.408 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 34.2 t -124.4 123.67 25.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.155 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.41 174.06 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.963 2.442 . . . . 0.0 115.53 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.34 119.07 60.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.48 127.81 67.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.302 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tt -114.23 119.83 38.38 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.06 128.14 54.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.262 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.02 116.0 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.364 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.98 -22.48 16.81 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.12 -123.53 0.82 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.117 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.51 101.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.894 -0.653 . . . . 0.0 110.279 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.48 1.78 72.03 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.047 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -107.05 92.79 4.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.473 0.637 . . . . 0.0 109.747 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -103.89 155.89 18.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.26 1.029 . . . . 0.0 113.031 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 142.12 51.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.928 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 pt -132.24 134.8 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 118.671 0.669 . . . . 0.0 112.41 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -112.4 115.89 29.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -115.93 110.64 32.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.018 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.31 44.27 27.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.219 -0.991 . . . . 0.0 114.19 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.7 -25.78 21.55 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.061 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -89.01 127.97 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.256 1.028 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.75 134.46 49.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.8 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 127.0 53.17 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -117.45 157.94 25.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 112.08 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.79 27.77 52.8 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.896 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 16.3 mt -88.35 149.87 23.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.749 0.785 . . . . 0.0 112.35 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.88 171.18 9.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.443 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.11 -43.92 81.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.95 -38.83 92.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.021 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.7 mtp -69.55 -44.78 70.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.114 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -34.36 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -63.83 -49.92 70.95 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.708 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.18 -52.69 33.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.82 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.45 -48.38 75.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.723 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -57.9 -43.3 86.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.052 0.453 . . . . 0.0 111.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.86 81.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.305 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -40.37 96.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.62 -38.63 77.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -70.46 -29.72 66.36 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -78.85 -27.08 44.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.876 0.307 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -85.59 -33.71 21.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.718 0.294 . . . . 0.0 110.544 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -131.01 95.99 3.94 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.1 -13.42 62.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -105.91 19.48 20.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.722 0.692 . . . . 0.0 111.809 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.9 m -68.13 111.25 4.38 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.41 126.94 30.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -113.99 131.26 56.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 111.567 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.98 141.14 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.47 137.21 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.47 146.14 17.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.69 155.11 16.62 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.43 24.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.893 0.378 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.66 -32.75 67.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.294 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -80.99 -5.83 58.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.24 132.04 48.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.81 151.82 36.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.557 1.505 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.41 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.2 t80 -63.51 -36.66 84.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 110.692 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.65 -36.57 69.69 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -71.49 -34.64 70.32 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.26 -38.17 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.461 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.422 HG21 HD12 ' B' ' 80' ' ' ILE . 49.1 mm -61.27 -47.13 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -55.0 -44.62 74.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.971 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.96 83.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 111.086 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.78 -37.31 81.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.698 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.59 -41.56 94.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.751 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.37 -39.41 92.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.031 0.444 . . . . 0.0 110.565 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.96 -42.59 99.87 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.994 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -63.26 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.515 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -38.13 75.93 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.509 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.28 10.17 25.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.25 44.87 97.02 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mt -103.36 -37.15 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 0.0 109.768 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 t -96.52 -47.94 5.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.331 . . . . 0.0 110.984 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 36.3 t -125.49 127.09 24.99 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.49 173.9 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.664 2.243 . . . . 0.0 115.575 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.77 119.24 59.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.14 127.27 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.309 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.66 122.12 44.61 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -111.0 127.15 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.411 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -84.73 112.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.69 -22.52 20.18 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -119.87 0.65 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.775 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -111.87 99.4 8.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 122.905 0.482 . . . . 0.0 109.899 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.08 -2.47 87.62 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.228 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 131.29 54.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.866 0.833 . . . . 0.0 109.431 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.29 158.26 44.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.11 0.957 . . . . 0.0 112.942 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 142.64 51.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.192 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.4 pt -130.09 132.9 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.146 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.02 114.63 27.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.1 mt -114.99 110.39 31.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.473 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.39 46.0 28.78 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.21 -0.995 . . . . 0.0 114.141 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.13 -24.53 24.45 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.68 -0.771 . . . . 0.0 114.308 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 127.76 36.0 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.512 1.156 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.77 133.13 50.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.956 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.86 127.22 53.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -117.45 157.65 25.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.919 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.64 26.43 56.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.918 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.38 147.58 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.276 0.538 . . . . 0.0 111.941 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -92.03 172.06 8.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.547 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.14 -45.45 80.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.884 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.13 -39.42 93.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.14 -0.35 . . . . 0.0 111.059 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.3 ttp -70.61 -40.94 72.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.82 -34.8 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -63.61 -49.95 71.29 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.47 -52.58 36.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.642 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.95 -47.69 76.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.51 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -43.47 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 111.54 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -66.25 -44.24 84.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -41.75 99.17 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.106 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.63 -39.66 73.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.89 -28.05 65.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.682 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.41 -27.03 38.15 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.223 -0.298 . . . . 0.0 111.301 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -85.73 -35.41 20.82 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -130.88 105.33 7.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.86 9.23 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -126.52 16.25 7.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 111.901 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.01 113.77 5.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.46 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.44 124.3 19.11 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -113.1 131.56 55.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.819 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.22 140.17 45.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.591 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -126.65 136.94 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -140.38 147.9 19.55 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.623 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.32 154.55 16.52 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.08 23.38 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.934 0.367 . . . . 0.0 111.437 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.54 -32.73 67.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.42 -7.0 58.95 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -87.71 128.1 55.72 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.47 156.54 54.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.075 1.183 . . . . 0.0 110.08 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 4.8 t80 -63.65 -36.23 83.13 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.925 -0.485 . . . . 0.0 110.514 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -56.58 -36.33 69.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -37.16 74.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.509 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 t -61.36 -39.34 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.897 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 48.2 mm -60.76 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.327 0.584 . . . . 0.0 109.577 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -44.84 75.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.164 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.07 86.97 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.288 0.566 . . . . 0.0 111.049 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.13 -36.77 80.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.586 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.52 -41.15 96.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -39.99 94.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.865 0.365 . . . . 0.0 110.729 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.49 -42.4 98.54 Favored 'General case' 0 C--N 1.335 -0.037 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.859 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -63.31 -42.14 99.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.421 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.66 -38.73 78.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.384 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.6 10.71 24.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 mt -102.18 -37.68 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.812 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.694 -0.163 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -96.85 -47.93 5.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 33.5 t -125.53 127.28 24.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.38 173.59 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.755 2.303 . . . . 0.0 115.533 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.55 119.15 59.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.36 127.49 67.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.263 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -115.98 122.43 45.22 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -110.95 127.77 55.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.486 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.04 112.1 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.59 -22.63 20.21 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.65 -123.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.522 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.64 99.56 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.842 -0.679 . . . . 0.0 110.121 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.05 -2.54 87.52 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 114.407 0.523 . . . . 0.0 114.407 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 131.22 54.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.644 0.722 . . . . 0.0 109.556 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -139.17 158.12 44.74 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.143 0.973 . . . . 0.0 112.954 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 142.73 51.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.069 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.33 133.11 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.974 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.98 114.93 28.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.463 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 81.7 mt -115.27 110.1 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.391 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.39 45.67 28.74 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.256 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.81 -24.94 23.93 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.025 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.82 127.31 35.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.683 1.241 . . . . 0.0 110.393 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.2 133.2 50.37 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.115 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.74 127.14 53.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -117.43 157.39 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.969 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.83 26.37 56.23 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.18 147.3 26.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.238 0.519 . . . . 0.0 111.778 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -91.83 172.14 8.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.441 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -66.57 -45.08 80.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.18 -39.23 93.57 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.002 -0.436 . . . . 0.0 111.053 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttp -70.71 -40.91 72.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.81 -35.07 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -63.3 -50.23 70.87 Favored 'General case' 0 CA--C 1.523 -0.066 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.926 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.23 -52.83 32.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.624 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 30.4 mt -64.75 -47.72 77.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.85 -43.33 90.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.279 0.561 . . . . 0.0 111.661 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -66.23 -44.06 84.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.284 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -42.0 99.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.59 -39.41 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.987 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.06 -28.47 65.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.716 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.78 -27.48 40.4 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.948 0.34 . . . . 0.0 111.43 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.72 -34.85 21.14 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.949 0.404 . . . . 0.0 110.337 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -131.16 105.74 7.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.33 9.48 10.8 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -126.58 16.15 7.58 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 111.854 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.06 114.27 6.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.375 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -58.85 124.48 19.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.608 0.242 . . . . 0.0 110.534 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -113.51 131.36 56.09 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.799 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.34 140.18 44.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.881 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.3 p -126.76 136.03 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.42 147.68 19.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.806 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.98 154.3 16.46 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.95 165.67 23.22 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.956 0.408 . . . . 0.0 111.286 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -58.42 -32.72 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.324 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.21 -7.5 59.0 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.98 128.03 57.4 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.42 156.4 54.48 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.139 1.226 . . . . 0.0 110.165 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.412 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 5.0 t80 -63.39 -36.44 83.74 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.866 -0.521 . . . . 0.0 110.683 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.18 -36.39 68.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -37.15 74.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.674 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.19 -39.59 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.674 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.449 HG22 HD11 ' B' ' 80' ' ' ILE . 47.9 mm -60.59 -47.3 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 109.64 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.06 74.36 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.216 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.63 84.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.382 0.61 . . . . 0.0 110.907 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.53 -36.72 79.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.78 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -61.72 -41.32 97.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.837 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -39.94 94.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.002 0.429 . . . . 0.0 110.684 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.59 -42.54 98.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.304 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.73 76.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.74 10.84 24.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.41 98.11 Favored Glycine 0 C--N 1.33 0.25 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.0 mt -101.9 -37.05 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.75 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 m -163.03 -61.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 42.9 t -127.02 123.19 23.46 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -52.37 175.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.017 2.478 . . . . 0.0 115.775 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.82 118.82 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.22 127.87 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -116.01 123.27 47.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -112.01 128.98 56.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.156 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 t -88.68 96.67 6.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.181 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -22.06 54.69 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.52 -120.65 0.65 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -112.57 101.12 12.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.019 0.527 . . . . 0.0 109.706 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.48 73.5 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.93 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 95.95 5.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.732 0.777 . . . . 0.0 110.285 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -104.83 156.65 17.82 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.294 1.045 . . . . 0.0 113.025 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.09 142.25 51.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.666 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 pt -132.77 134.24 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.49 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.15 115.15 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.679 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.8 mt -114.56 109.51 28.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.252 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.22 45.38 27.61 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.13 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.11 -25.73 22.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.071 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.47 128.07 36.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.327 1.064 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.89 136.05 47.4 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.023 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.44 127.48 53.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.35 157.7 25.69 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 112.228 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.53 52.55 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.12 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -87.94 147.7 24.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 112.221 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -89.71 169.88 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.629 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -65.55 -45.36 83.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -64.39 -38.77 92.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.1 ttp -72.11 -37.76 69.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.977 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.97 -33.36 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m -62.94 -50.3 71.35 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.448 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.13 -52.49 34.73 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.866 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -65.21 -47.36 77.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.773 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -58.7 -43.11 89.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.482 . . . . 0.0 111.592 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -65.95 -44.34 85.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.284 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.37 -41.58 98.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -69.57 -38.97 77.61 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.95 -29.75 66.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.575 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -76.91 -27.71 55.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.94 0.336 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -83.44 -35.94 24.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.846 0.355 . . . . 0.0 110.065 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.68 105.25 7.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -78.17 -15.61 58.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -105.13 19.06 21.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.359 0.527 . . . . 0.0 111.858 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -68.79 116.18 8.99 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 125.27 23.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -111.63 130.04 55.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.198 0.523 . . . . 0.0 111.627 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.52 139.93 44.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.67 138.65 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.32 142.81 14.08 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.5 154.0 16.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.722 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.0 23.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -31.43 69.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.515 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.12 -7.07 59.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -89.66 131.8 38.74 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.34 155.91 55.31 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.013 1.142 . . . . 0.0 110.246 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' A' ' 80' ' ' ILE . 6.1 t80 -63.71 -35.46 80.63 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.842 -0.536 . . . . 0.0 110.437 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -56.6 -36.94 69.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.649 0.261 . . . . 0.0 110.402 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -36.58 75.22 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.734 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.03 -39.26 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.483 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' CE1' ' A' ' 76' ' ' TYR . 45.6 mm -60.6 -46.56 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.41 0.624 . . . . 0.0 109.404 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -45.11 73.77 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.182 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.386 0.613 . . . . 0.0 110.657 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.65 -37.11 80.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.486 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.32 -41.77 97.56 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.787 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.55 -42.89 98.35 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -62.45 -43.13 99.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.567 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -37.57 79.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.53 10.48 25.25 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.24 98.22 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mt -101.55 -33.78 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.975 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -162.48 -61.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.45 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 44.8 t -126.93 123.44 23.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.197 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -52.42 175.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.987 2.458 . . . . 0.0 115.829 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.08 118.43 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.2 127.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.316 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tt -115.97 123.44 48.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -112.03 129.34 56.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.215 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.91 96.48 6.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.185 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.92 -21.38 54.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.356 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.22 -125.3 0.91 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.651 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -107.65 101.9 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.016 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.45 70.55 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.006 -0.543 . . . . 0.0 114.099 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.58 95.57 5.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.823 0.821 . . . . 0.0 110.361 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -104.24 156.49 17.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.279 1.037 . . . . 0.0 113.093 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.0 142.14 51.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.479 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.6 pt -132.76 134.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.452 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.3 115.1 28.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.595 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mt -114.51 109.71 29.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.89 45.76 25.51 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.408 -0.901 . . . . 0.0 114.179 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -25.77 21.71 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.144 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.39 128.09 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.33 1.065 . . . . 0.0 110.396 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.82 136.02 47.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.899 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.4 127.52 53.19 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.43 157.02 26.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 27.97 49.01 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.119 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.93 148.23 24.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.653 0.74 . . . . 0.0 112.305 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -90.53 169.59 10.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.411 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.27 -45.36 84.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.37 -38.81 92.33 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.948 -0.47 . . . . 0.0 111.069 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 10.2 ttp -71.75 -37.98 70.46 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.75 -33.42 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.1 m -62.99 -50.29 71.33 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.506 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.09 -52.39 35.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.797 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 38.6 mt -65.25 -47.73 75.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.683 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -58.38 -43.37 88.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.077 0.465 . . . . 0.0 111.527 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -65.84 -44.4 85.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.28 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.27 -41.58 99.04 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.184 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.56 -38.84 77.59 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -69.93 -29.71 66.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.692 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -77.0 -27.78 54.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.851 0.296 . . . . 0.0 111.26 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -83.29 -35.52 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.838 0.351 . . . . 0.0 110.102 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -130.15 105.0 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.84 -15.54 58.98 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -105.38 19.57 20.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.362 0.528 . . . . 0.0 111.899 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 116.05 9.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.6 125.35 23.99 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -111.74 130.58 55.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.559 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -135.91 140.06 43.78 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.85 138.77 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 142.86 14.09 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.25 153.94 16.82 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 163.28 24.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.057 0.455 . . . . 0.0 111.322 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -31.44 69.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.307 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -7.15 59.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.55 132.1 38.05 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.5 155.78 54.72 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.052 1.168 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 6.0 t80 -63.74 -35.38 80.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.863 -0.523 . . . . 0.0 110.363 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.73 -36.78 70.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.565 0.221 . . . . 0.0 110.423 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.0 -36.5 75.19 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.713 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.19 -39.2 83.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.579 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.419 HG22 HD12 ' B' ' 80' ' ' ILE . 45.8 mm -60.53 -46.61 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.364 0.602 . . . . 0.0 109.435 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -44.88 73.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.085 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.64 80.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.278 0.561 . . . . 0.0 110.767 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -60.21 -37.03 79.05 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.566 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.13 -41.93 97.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.981 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.69 -39.36 91.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.592 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.42 -42.55 98.73 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -62.75 -43.23 99.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.589 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.77 79.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.491 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 10.54 24.17 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.42 44.63 97.43 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.071 0.788 . . . . 0.0 115.071 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.84 -34.21 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.873 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -68.43 -42.45 78.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.997 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 48.0 t -114.57 119.11 40.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.712 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.27 174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.0 2.467 . . . . 0.0 115.663 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.8 118.89 58.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.2 127.61 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.652 0.263 . . . . 0.0 111.607 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -115.88 122.65 45.99 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.59 127.29 55.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.207 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.7 105.27 14.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.723 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.63 -22.3 28.02 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.99 -121.55 0.72 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.956 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.15 97.97 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 122.869 0.467 . . . . 0.0 109.94 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.05 -5.3 85.02 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.956 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.04 128.55 53.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.562 0.681 . . . . 0.0 109.482 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -134.84 156.03 49.61 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.231 1.015 . . . . 0.0 112.759 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 141.53 52.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.796 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 pt -132.48 133.85 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.263 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -111.36 115.52 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.561 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.9 mt -113.69 108.92 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.281 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.69 46.74 24.46 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.65 -0.786 . . . . 0.0 114.079 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.99 15.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.082 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.3 129.24 36.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.527 1.163 . . . . 0.0 110.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -107.96 135.95 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.027 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.53 125.58 51.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.84 156.21 26.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.064 0.459 . . . . 0.0 111.885 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 26.95 52.81 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.959 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.96 148.7 25.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.344 0.572 . . . . 0.0 111.743 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.2 p -89.6 171.73 9.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.183 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -66.86 -44.92 79.7 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.646 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.234 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 mtp -70.22 -43.43 70.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -34.73 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.899 0.38 . . . . 0.0 110.08 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -63.98 -50.48 68.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.824 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -50.71 -52.07 43.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.657 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.84 -47.95 76.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.46 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -57.32 -43.88 83.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 111.618 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -66.66 -44.33 82.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.243 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -64.53 -40.02 94.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.99 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -69.94 -38.69 76.26 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.43 -31.33 69.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.9 -28.73 55.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.887 0.312 . . . . 0.0 111.239 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -82.24 -36.82 26.78 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -128.59 112.16 13.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -84.58 -10.07 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -112.45 19.67 17.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.376 0.535 . . . . 0.0 111.952 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 113.36 5.55 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.32 125.51 24.15 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -112.54 128.31 56.31 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 111.737 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -132.16 139.27 48.34 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -127.24 137.89 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 144.62 15.84 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.6 156.61 16.01 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.833 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.51 163.21 24.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.138 0.495 . . . . 0.0 111.276 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -57.47 -31.85 66.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.649 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.01 -6.01 58.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.27 129.72 57.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.31 151.81 49.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.22 1.28 . . . . 0.0 110.426 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.41 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 5.9 t80 -62.94 -39.46 94.7 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.493 -0.754 . . . . 0.0 111.271 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.73 -35.58 66.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.82 -35.96 70.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.204 0.526 . . . . 0.0 109.744 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -62.44 -38.82 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.439 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 76' ' ' TYR . 47.7 mm -61.04 -47.6 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -44.74 68.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.16 78.93 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.454 0.645 . . . . 0.0 110.358 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.35 -37.08 79.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.864 0.84 . . . . 0.0 109.353 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -61.32 -42.92 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.6 -39.73 95.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 110.657 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -41.97 99.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.85 -41.23 97.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.7 -38.68 78.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.442 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.43 11.02 22.9 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.32 44.13 98.1 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt -99.11 -36.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.671 -179.525 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 112.731 -0.147 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -67.94 -42.53 80.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 110.775 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.434 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 48.3 t -114.29 119.57 40.01 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.11 175.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.932 2.421 . . . . 0.0 115.652 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.63 118.67 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.98 127.43 68.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 120.698 0.285 . . . . 0.0 111.675 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -115.65 122.59 46.03 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.6 126.85 54.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.314 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.43 105.3 14.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.788 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.31 28.5 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.88 -124.71 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.778 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -109.04 97.58 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.406 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.33 -5.19 85.05 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.106 -0.569 . . . . 0.0 114.049 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 128.79 54.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -135.15 156.07 49.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.334 1.064 . . . . 0.0 112.804 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.52 141.48 52.06 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.828 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 pt -132.31 134.14 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.265 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -111.58 115.72 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.566 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -113.98 108.8 26.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.276 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.85 46.47 25.42 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.015 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.91 16.53 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.046 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -90.39 129.27 36.61 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.453 1.127 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -108.37 135.96 48.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.923 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.43 126.14 52.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -116.25 156.21 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.175 0.512 . . . . 0.0 111.864 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.35 51.74 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.065 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.27 148.89 24.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.281 0.562 . . . . 0.0 111.741 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.5 p -89.51 171.88 9.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.183 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.05 -44.85 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.508 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.19 -37.99 89.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.101 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 23.6 mtp -70.14 -43.68 70.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.13 -34.65 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -64.27 -50.24 68.7 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.834 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -50.65 -51.94 44.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.02 -48.02 75.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.377 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.12 -44.05 82.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 111.561 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -66.65 -44.27 82.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.5 -40.25 95.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.929 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -69.91 -38.26 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.195 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -69.91 -31.3 69.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.6 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.81 -28.98 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 122.213 -0.305 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -82.06 -36.56 27.54 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -128.71 112.39 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -84.66 -10.43 57.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -112.21 19.63 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.322 0.51 . . . . 0.0 111.945 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 113.11 5.17 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.39 125.31 23.46 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -112.3 128.01 56.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 111.672 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.21 139.45 48.33 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.344 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 p -127.53 137.91 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.55 145.12 16.42 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.81 156.86 16.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.039 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 163.18 24.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 111.396 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -57.59 -31.82 66.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.485 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.17 -6.37 59.15 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.6 t -83.77 129.43 59.42 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.98 151.57 50.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.545 1.496 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.408 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -62.86 -39.62 94.96 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.757 -0.589 . . . . 0.0 111.23 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.42 -35.55 65.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.685 0.279 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -72.07 -35.74 69.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -62.65 -38.85 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.421 HG21 HD13 ' B' ' 80' ' ' ILE . 45.7 mm -60.98 -47.45 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -44.63 68.08 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.982 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.85 80.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 110.459 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.59 -37.2 80.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.789 0.804 . . . . 0.0 109.221 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.19 -42.77 99.17 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.677 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.96 -39.57 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.239 0.542 . . . . 0.0 110.831 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.32 -41.72 98.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.894 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -63.9 -41.38 97.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.59 -38.69 78.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.366 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.35 11.0 22.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.37 44.28 97.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mt -99.16 -36.16 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.893 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -51.45 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.3 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.405 ' CG1' ' HA2' ' A' ' 38' ' ' GLY . 17.7 t -121.82 125.45 26.71 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.63 173.24 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.677 2.251 . . . . 0.0 115.094 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.59 118.07 57.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.44 127.69 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.141 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 tt -113.96 120.35 40.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -111.12 128.77 56.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.177 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.29 120.84 36.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.743 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.11 -23.12 14.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.37 -121.16 0.65 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.983 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -113.55 100.56 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.98 -0.77 86.64 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.881 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.24 93.93 4.82 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.42 0.61 . . . . 0.0 110.009 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -103.37 156.01 18.06 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.11 0.957 . . . . 0.0 112.717 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.92 141.44 51.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.989 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.7 pt -131.06 133.8 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 114.24 27.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.645 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.3 mt -116.09 110.09 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.883 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' CG1' ' A' ' 21' ' ' VAL . . . 48.61 42.76 28.0 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.717 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.78 -26.39 18.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.996 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.72 124.93 31.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.184 0.992 . . . . 0.0 110.526 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 130.98 52.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.632 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 127.12 52.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.69 157.87 25.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.021 0.439 . . . . 0.0 111.901 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.91 27.3 50.74 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.07 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.48 150.32 23.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.8 0.81 . . . . 0.0 112.698 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -91.32 171.59 9.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.143 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -66.49 -45.02 80.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.789 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -63.53 -39.28 94.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 mtm -69.92 -44.6 69.32 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.171 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.87 -33.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 m -63.89 -50.68 67.79 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.628 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -49.8 -53.23 26.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.659 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.8 mt -64.78 -48.1 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.477 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 t -58.14 -43.12 87.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 111.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -44.1 84.62 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.499 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.66 -39.96 94.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -37.81 76.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.898 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.49 -31.15 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.641 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.01 -28.17 54.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.811 0.278 . . . . 0.0 111.249 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -83.27 -37.77 23.05 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.03 101.79 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -76.9 -1.54 29.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -121.38 19.76 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.164 0.438 . . . . 0.0 111.913 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 118.23 12.15 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.486 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -64.36 127.32 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -114.36 131.53 56.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 111.515 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -135.55 141.3 45.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.023 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.39 127.36 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.4 142.48 13.99 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.47 155.5 16.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.219 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.2 164.81 23.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.042 0.449 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -58.81 -32.79 69.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.51 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -80.72 -6.23 58.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.3 t -85.64 136.82 36.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.75 152.24 25.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.542 1.495 . . . . 0.0 110.457 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -64.08 -38.51 91.33 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.24 -36.48 66.07 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.664 0.269 . . . . 0.0 110.538 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.09 -34.26 66.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.783 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.28 -39.98 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.444 HG21 HD12 ' A' ' 80' ' ' ILE . 46.4 mm -59.01 -48.81 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.609 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.002 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.22 70.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.62 -36.88 79.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.624 0.726 . . . . 0.0 109.255 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.75 -41.97 96.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.81 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mt -65.49 -38.57 90.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.487 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.08 -42.38 99.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.009 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.5 -41.54 98.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.593 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.51 -38.3 77.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.536 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.29 11.67 25.06 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.18 44.59 97.24 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 114.869 0.708 . . . . 0.0 114.869 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.67 -35.3 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 109.877 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.026 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -51.03 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.632 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.409 ' CG1' ' HA2' ' B' ' 38' ' ' GLY . 17.4 t -122.06 125.26 26.69 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.422 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.44 172.55 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.871 2.38 . . . . 0.0 115.104 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' B' ' 66' ' ' PHE . 47.0 t -113.09 117.88 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.21 127.97 65.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.202 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tt -114.31 120.58 40.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -111.31 128.93 56.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.137 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.51 120.91 36.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.679 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 -23.18 13.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.13 -125.19 0.88 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.779 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.76 100.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.109 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.76 -0.53 86.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.119 -0.491 . . . . 0.0 114.013 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 94.5 5.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.466 0.633 . . . . 0.0 109.902 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.63 156.01 18.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.219 1.009 . . . . 0.0 112.765 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.76 141.91 51.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.038 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.28 133.8 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 113.9 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.79 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 99.0 mt -115.63 110.35 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.926 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' CG1' ' B' ' 21' ' ' VAL . . . 48.28 42.78 25.59 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.769 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -26.17 19.75 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.899 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.58 124.86 31.21 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.302 1.051 . . . . 0.0 110.561 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 131.01 52.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.644 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -119.36 126.7 52.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.51 158.05 25.22 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.063 0.459 . . . . 0.0 111.9 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 27.23 51.44 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.273 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.5 150.59 23.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.822 0.82 . . . . 0.0 112.681 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -91.68 171.5 9.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.1 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -66.19 -45.18 81.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.801 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.57 -39.35 94.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.892 0.314 . . . . 0.0 111.325 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mtm -69.84 -44.65 69.46 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.351 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.67 -33.49 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.8 m -64.21 -50.4 68.2 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.736 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.09 -53.01 30.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.523 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.98 -47.88 75.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.729 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.41 -43.43 88.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -43.88 87.04 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.581 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -64.81 -40.07 94.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.75 76.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -70.39 -31.17 68.28 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.652 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -28.38 55.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.971 0.35 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -83.07 -37.74 23.45 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.17 101.22 6.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -76.23 -1.67 27.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -121.48 19.74 11.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.281 0.491 . . . . 0.0 111.824 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 118.0 11.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.421 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.8 127.03 29.55 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.401 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 40.0 m-85 -114.22 131.51 56.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -135.55 141.4 45.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.264 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 87.0 t -122.53 127.07 74.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.13 142.44 13.96 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.42 155.15 16.27 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.117 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.02 165.2 23.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.968 0.414 . . . . 0.0 111.229 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -59.42 -32.21 69.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.429 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -80.94 -6.93 59.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.4 t -85.07 136.58 38.17 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.55 151.98 25.88 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.773 1.649 . . . . 0.0 110.385 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -63.88 -38.43 91.07 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.43 -0.794 . . . . 0.0 111.108 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -55.31 -36.5 66.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.68 0.276 . . . . 0.0 110.425 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.01 -34.31 66.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 109.868 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -62.59 -39.1 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.08 -48.26 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.507 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -43.01 68.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.076 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -51.07 71.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 110.884 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.55 -37.51 81.48 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.702 0.763 . . . . 0.0 109.116 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.798 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.49 -38.46 89.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.559 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.27 -42.21 99.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.094 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.68 -41.63 98.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.424 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.38 -38.37 77.15 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.429 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.07 11.49 25.18 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.37 44.8 97.2 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.95 -35.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.986 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -136.06 -48.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.994 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 49.0 t -115.5 123.08 31.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.764 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.9 176.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.876 2.384 . . . . 0.0 115.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.71 119.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.9 127.65 68.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.291 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -114.73 121.23 42.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.17 127.18 53.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.286 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.17 118.7 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.69 -23.06 15.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.95 -120.27 0.65 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.01 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mm -112.26 99.3 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 123.061 0.544 . . . . 0.0 109.793 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.75 -3.91 85.92 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.239 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 131.22 53.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 117.754 0.777 . . . . 0.0 109.897 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -138.03 157.24 46.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.134 0.969 . . . . 0.0 112.917 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 141.95 51.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.328 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.15 134.86 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.502 0.592 . . . . 0.0 112.406 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.28 115.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.488 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.29 110.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.343 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.66 45.52 24.0 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.446 -0.883 . . . . 0.0 114.076 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -26.5 18.31 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.205 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.59 128.72 36.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.41 1.105 . . . . 0.0 110.356 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.31 135.95 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.007 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.07 126.86 52.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.45 156.81 27.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.103 0.477 . . . . 0.0 112.238 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.25 45.71 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.322 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.27 151.99 21.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.45 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 p -92.58 171.54 8.95 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.187 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -42.31 84.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -64.32 -39.46 93.96 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.073 0.463 . . . . 0.0 111.142 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.17 -43.9 69.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.288 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.31 -34.41 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -64.09 -49.58 71.7 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.62 -51.93 44.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.746 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.49 -48.03 76.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.527 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t -58.23 -43.73 87.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.422 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.4 85.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.314 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.47 -41.58 98.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.154 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.99 -38.06 75.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.018 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.22 -30.21 67.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.95 -27.96 49.43 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.186 -0.321 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -82.68 -36.87 25.55 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -131.55 105.68 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.38 -8.03 58.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.69 19.42 18.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.421 0.555 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.96 117.84 11.13 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tp -64.29 124.17 21.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -112.52 132.81 54.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.958 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.06 140.44 43.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.416 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.3 t -122.99 129.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.25 146.82 18.81 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.79 155.04 17.08 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.939 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.8 163.6 25.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.99 0.424 . . . . 0.0 111.248 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.73 -32.53 65.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.567 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -80.77 -5.56 57.33 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -89.79 131.07 40.66 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.46 155.69 50.37 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.152 1.235 . . . . 0.0 110.339 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 80' ' ' ILE . 3.8 t80 -64.21 -34.89 79.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.787 -0.57 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.75 70.91 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.79 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.57 -39.24 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.408 HD12 ' CE1' ' A' ' 76' ' ' TYR . 42.1 mm -59.92 -48.88 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.518 0.675 . . . . 0.0 109.415 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -53.98 -44.6 70.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.51 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.05 79.01 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.353 0.597 . . . . 0.0 111.009 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 11.4 mt -61.89 -36.0 80.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 108.989 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -61.8 -42.56 99.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.039 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.87 -38.74 92.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.535 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.81 -42.15 97.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.987 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -62.86 -42.39 99.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.668 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.47 -38.45 74.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.616 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.49 11.02 20.6 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.52 44.22 98.28 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.57 -38.72 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.782 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 29.4 t -135.62 -48.14 0.69 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 111.008 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.457 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 49.8 t -115.74 123.09 31.7 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.55 176.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.07 2.513 . . . . 0.0 115.732 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.51 119.68 61.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -111.87 127.93 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.316 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.0 tt -115.21 120.93 41.36 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.86 127.4 54.0 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.24 118.96 33.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.14 -22.78 15.05 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.8 -124.18 0.87 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.629 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.8 99.55 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.979 -0.611 . . . . 0.0 110.247 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.5 -3.62 86.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 114.391 0.516 . . . . 0.0 114.391 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.53 131.22 53.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.617 0.709 . . . . 0.0 109.698 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -137.86 156.9 47.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.048 0.927 . . . . 0.0 113.007 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.24 51.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.253 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 8.0 pt -132.32 134.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.499 0.591 . . . . 0.0 112.581 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.82 114.95 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.58 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.51 109.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.347 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.11 45.17 26.87 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.996 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.26 19.31 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 119.277 -0.735 . . . . 0.0 114.254 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.45 129.02 36.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.46 1.13 . . . . 0.0 110.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.49 135.83 48.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.88 -178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.17 127.07 52.97 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -117.89 156.69 28.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 112.183 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.45 27.8 46.42 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.33 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mt -90.14 151.98 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.557 0.694 . . . . 0.0 112.495 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.1 p -92.42 171.94 8.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.31 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -41.59 83.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.136 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.1 -39.91 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.897 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.5 mtm -69.82 -43.7 71.5 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.52 -34.6 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -63.75 -50.08 70.49 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.56 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.667 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.51 -47.96 76.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.658 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -58.44 -42.9 88.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.421 0.629 . . . . 0.0 111.473 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -43.74 82.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.361 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -63.99 -41.5 97.49 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.877 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.09 -37.69 75.48 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.6 -30.13 66.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.594 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -78.08 -28.03 48.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.833 0.288 . . . . 0.0 111.214 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -82.63 -36.51 26.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -131.74 105.99 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.5 -8.42 59.13 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.41 19.58 18.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.899 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.14 117.72 11.13 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tp -64.34 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.28 132.97 54.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 111.151 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.95 140.53 44.06 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.291 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.01 129.46 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.34 146.97 18.96 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.16 155.46 17.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.13 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.94 163.66 25.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.989 0.423 . . . . 0.0 111.259 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -56.98 -32.88 66.54 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.59 -5.62 57.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.54 131.1 41.09 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.36 155.97 50.71 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.197 1.265 . . . . 0.0 110.242 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.407 ' CE1' HD13 ' B' ' 80' ' ' ILE . 3.9 t80 -64.73 -34.61 78.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.676 -0.64 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.38 -37.4 70.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -35.71 71.73 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.803 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.4 t -61.87 -39.23 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.509 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.407 HD13 ' CE1' ' B' ' 76' ' ' TYR . 39.9 mm -59.75 -48.87 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.404 0.621 . . . . 0.0 109.41 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.5 ttmm -53.84 -44.94 70.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.492 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.03 79.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.451 0.643 . . . . 0.0 110.929 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -36.0 79.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.741 0.782 . . . . 0.0 109.273 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.75 -42.71 99.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.073 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.0 mt -64.15 -38.47 91.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.111 0.481 . . . . 0.0 110.499 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.06 -42.07 97.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.889 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -62.81 -42.46 99.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.568 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.29 -38.77 74.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.657 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.44 11.23 19.9 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.38 44.46 98.01 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 115.129 0.811 . . . . 0.0 115.129 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.68 -38.07 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.659 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.2 m -75.84 163.0 27.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.568 0.223 . . . . 0.0 110.855 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.1 t -35.06 140.23 0.31 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.879 0.872 . . . . 0.0 113.161 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -46.47 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.351 2.701 . . . . 0.0 114.927 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -106.72 110.09 30.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.71 126.64 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.194 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.65 120.69 40.98 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 126.9 54.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.323 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.8 t -85.14 109.34 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.894 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.78 -22.51 22.1 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -120.71 0.67 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.547 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.14 100.27 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.66 -4.65 84.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.972 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 131.11 54.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.439 0.62 . . . . 0.0 109.354 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -139.79 157.96 44.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.218 1.009 . . . . 0.0 113.077 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.886 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt -131.35 133.96 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.354 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -112.12 115.12 28.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.571 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -111.99 108.56 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.573 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.77 47.23 18.82 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.956 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.93 -27.0 18.04 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.69 -0.767 . . . . 0.0 114.002 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -90.38 128.4 36.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.464 1.132 . . . . 0.0 110.749 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -106.55 133.0 51.9 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.25 128.02 54.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.61 157.38 26.49 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 27.61 52.04 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.934 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -86.94 147.86 25.58 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.213 0.506 . . . . 0.0 112.063 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -91.92 171.99 8.75 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.588 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -66.08 -46.16 78.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.065 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.902 0.319 . . . . 0.0 111.283 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -39.22 70.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 -34.93 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.52 -50.77 68.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.773 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -52.84 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.032 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.08 -47.25 77.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.685 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -59.18 -42.83 91.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.705 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -44.03 85.14 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.236 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -40.63 96.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.43 -28.2 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.673 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.23 -26.44 39.09 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.883 0.31 . . . . 0.0 111.277 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -85.19 -34.93 21.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.777 0.322 . . . . 0.0 110.446 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -132.87 94.78 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.96 -4.01 26.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -114.9 17.25 17.05 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.771 0.714 . . . . 0.0 111.858 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -69.28 126.42 29.73 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.2 tp -69.55 127.08 31.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.34 131.43 56.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.254 0.549 . . . . 0.0 111.464 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.44 140.34 44.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.662 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.36 135.35 64.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.22 145.66 17.21 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.45 154.59 16.4 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.986 -0.625 . . . . 0.0 111.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.15 164.07 25.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.113 0.482 . . . . 0.0 111.234 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -31.84 68.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.343 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -80.9 -6.09 58.21 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.15 132.06 44.6 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.9 152.81 41.77 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.554 1.502 . . . . 0.0 110.172 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.48 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.541 0.61 . . . . 0.0 111.023 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -56.21 -35.71 67.62 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.02 -36.56 72.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.03 -39.11 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.813 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.89 -45.41 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 109.508 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -44.92 80.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.858 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.71 87.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.517 0.675 . . . . 0.0 110.737 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.37 -37.63 84.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.716 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.52 -41.55 94.64 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.838 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -39.2 91.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.432 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -42.94 98.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.015 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -63.17 -41.94 99.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -37.94 76.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.351 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 10.08 28.05 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.21 45.11 97.19 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -102.68 -38.14 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.775 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -75.6 162.79 27.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.59 0.233 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 40.8 t -34.93 140.47 0.29 Allowed Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.0 0.92 . . . . 0.0 113.174 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -46.25 -171.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.507 2.805 . . . . 0.0 114.935 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.82 110.2 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.0 126.86 64.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.5 120.74 41.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.01 127.1 54.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.189 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 t -85.3 108.85 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.983 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.37 -22.55 22.54 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.41 -124.67 0.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.253 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.73 100.99 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.16 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.69 82.64 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.208 -0.52 . . . . 0.0 114.055 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.3 130.83 54.07 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.576 0.688 . . . . 0.0 109.488 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -139.2 158.07 44.82 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.336 1.065 . . . . 0.0 113.219 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.17 142.21 51.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.803 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.54 133.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.491 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.8 114.7 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.826 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.77 109.0 26.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.517 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.44 47.79 16.8 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.962 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -26.88 17.57 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.272 -0.738 . . . . 0.0 114.197 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -90.5 128.79 36.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.603 1.202 . . . . 0.0 110.473 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -107.04 133.3 51.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.205 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.53 127.94 54.48 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -117.45 157.81 25.59 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.76 52.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.553 -0.748 . . . . 0.0 113.052 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt -87.07 148.1 25.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 112.029 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.9 p -92.19 171.76 8.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.499 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -66.01 -46.22 78.71 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.023 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.23 -39.13 93.75 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.991 -0.443 . . . . 0.0 111.134 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.66 71.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.852 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.31 -34.83 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.53 -50.83 68.02 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.16 -52.97 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.808 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.95 -47.37 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.796 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.64 -43.26 89.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.097 0.475 . . . . 0.0 111.638 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -44.03 85.28 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.312 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.45 95.98 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -70.42 -40.06 74.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.084 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -69.23 -28.12 66.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.25 -26.8 38.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.956 0.344 . . . . 0.0 111.314 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.05 -34.56 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 110.527 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -132.95 94.73 3.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -72.11 -3.85 25.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -114.93 16.79 17.16 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.71 0.686 . . . . 0.0 111.828 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -68.87 126.45 29.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.386 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.6 tp -70.28 126.91 31.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.68 131.1 56.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 111.674 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.08 140.22 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.679 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.25 135.64 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.41 145.57 17.05 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.22 154.36 16.46 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.825 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 164.51 25.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -31.33 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.37 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -81.32 -6.25 58.7 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.82 132.06 45.26 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.17 153.0 40.68 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.416 1.411 . . . . 0.0 110.159 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -63.53 -38.28 90.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.652 0.66 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.78 -36.14 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.85 -36.58 72.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.92 -39.2 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.681 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.449 HG22 HD13 ' B' ' 80' ' ' ILE . 46.2 mm -61.8 -45.75 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.466 0.65 . . . . 0.0 109.604 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.05 78.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.978 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.2 -46.84 87.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 110.682 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.19 -37.97 84.86 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.758 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.23 -41.56 93.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.808 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -39.17 91.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -42.94 99.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.059 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -63.42 -41.82 98.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.99 76.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.34 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.06 10.47 26.63 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 45.12 97.12 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -103.1 -38.31 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.931 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -65.69 -53.34 42.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 0.0 111.075 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 61.9 t -94.32 112.45 57.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -47.85 -176.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.283 2.655 . . . . 0.0 114.945 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.3 t -116.3 124.89 73.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.4 mp -116.15 127.98 73.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.606 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.2 tt -115.5 125.72 53.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.03 128.84 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.811 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -83.01 122.91 38.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.707 -1.133 . . . . 0.0 107.999 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.87 -22.78 14.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.91 -118.84 0.6 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.018 -1.086 . . . . 0.0 113.843 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mm -113.38 95.76 4.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 122.961 0.504 . . . . 0.0 109.722 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.25 -3.25 86.79 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.157 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.01 51.15 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.648 0.724 . . . . 0.0 109.443 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.44 157.92 44.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.155 0.978 . . . . 0.0 112.934 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.87 142.06 51.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.315 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.64 135.46 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.04 113.88 26.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.93 106.85 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.151 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 46.68 49.31 16.62 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.082 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.35 -26.68 18.36 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.982 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.72 127.84 37.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.439 1.12 . . . . 0.0 110.315 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -105.52 136.04 45.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.157 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.14 127.83 53.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -117.84 156.97 27.47 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.14 26.93 54.24 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.087 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.87 149.95 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 112.412 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -92.0 169.52 10.59 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.09 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.37 -44.89 86.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.256 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.08 -39.1 93.32 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.119 -0.363 . . . . 0.0 111.279 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -71.69 -37.75 70.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.936 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.57 -34.05 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -63.27 -49.73 72.95 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.96 -51.63 50.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.769 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.17 -46.8 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.703 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.4 m -59.11 -43.63 91.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.271 0.558 . . . . 0.0 111.532 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -65.61 -44.18 87.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.349 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -63.45 -41.65 98.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.198 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.71 -38.17 76.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.26 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.805 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -77.44 -27.66 52.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 117.959 0.345 . . . . 0.0 111.345 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -35.0 25.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 110.179 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -130.94 99.32 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -72.89 -20.78 61.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.3 20.0 13.33 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.215 0.461 . . . . 0.0 111.775 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.34 119.11 14.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.91 126.72 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.37 135.64 53.86 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.8 pp -138.67 141.28 39.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.54 128.53 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.02 -178.89 15.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.52 156.54 27.86 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.528 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.73 164.39 23.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.051 0.453 . . . . 0.0 111.38 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.45 -32.49 68.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.48 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.05 -7.13 59.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.81 130.15 51.76 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.89 155.81 43.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.129 1.219 . . . . 0.0 110.516 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.41 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 5.4 t80 -65.03 -34.46 78.49 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.594 -0.691 . . . . 0.0 110.27 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.43 -36.85 69.45 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -36.92 73.91 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.299 0.571 . . . . 0.0 109.716 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.17 -39.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.758 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 80' ' ' ILE . 44.3 mm -59.5 -49.52 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.452 0.644 . . . . 0.0 109.711 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -43.6 73.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.378 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.44 77.75 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.753 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.12 -35.91 78.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.642 0.734 . . . . 0.0 109.095 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.28 -43.77 98.33 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.887 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.67 -37.65 88.3 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -41.85 96.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.374 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -63.87 -39.59 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.82 -38.95 79.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.51 11.4 24.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.62 44.68 97.63 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.821 0.688 . . . . 0.0 114.821 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.0 -34.35 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.957 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -65.6 -53.48 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.291 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.42 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 61.5 t -94.45 112.34 57.29 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.135 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -47.52 -176.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.352 2.701 . . . . 0.0 115.03 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -116.4 124.52 72.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.8 mp -115.76 128.11 73.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.735 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 tt -115.57 125.54 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.88 128.46 55.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.816 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.1 t -82.74 122.67 37.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.6 -23.08 14.33 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.32 -122.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.75 96.11 4.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.273 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 -3.14 87.08 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.187 -0.53 . . . . 0.0 114.116 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.34 50.67 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.708 0.754 . . . . 0.0 109.494 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.62 157.96 44.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.03 0.919 . . . . 0.0 112.944 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.96 141.66 51.87 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.383 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.45 135.33 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.449 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.95 113.74 26.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 55.8 mt -109.94 106.93 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.182 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.42 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.18 49.31 19.1 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.96 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -26.57 17.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.01 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -91.36 127.63 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.489 1.144 . . . . 0.0 110.34 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -105.51 135.71 46.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.86 127.47 53.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -117.45 157.02 26.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.84 27.16 54.43 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.178 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.72 150.12 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -92.49 169.92 10.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.128 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.46 -44.98 85.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.171 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.18 -39.0 93.08 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.916 -0.49 . . . . 0.0 111.283 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.71 -37.95 70.57 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.913 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.37 -34.1 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 45.9 m -63.12 -49.65 73.59 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.815 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.89 -52.11 45.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.62 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.61 -46.95 80.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.789 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 42.4 m -58.9 -43.58 91.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -65.85 -43.78 87.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.359 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -63.86 -41.86 97.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.081 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -69.56 -38.31 77.36 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.34 -30.08 66.94 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.27 -27.82 53.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.881 0.31 . . . . 0.0 111.316 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -34.67 25.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -131.32 98.98 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -72.56 -20.77 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.2 19.97 13.26 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.324 0.511 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -70.43 118.54 13.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.26 126.71 29.59 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.68 135.65 53.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.143 0.497 . . . . 0.0 111.634 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.8 pp -138.73 141.65 38.9 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.73 128.17 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.61 -178.86 15.57 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.04 27.28 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.644 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.63 164.57 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.01 0.433 . . . . 0.0 111.464 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -58.67 -32.49 69.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.419 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.89 -7.57 59.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.3 t -85.38 129.88 53.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.72 155.68 44.31 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.257 1.305 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.4 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -64.88 -34.32 78.12 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.578 -0.701 . . . . 0.0 110.238 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.6 -36.87 69.9 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -36.48 73.19 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.247 0.546 . . . . 0.0 109.595 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.63 -39.38 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.6 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.447 HG22 HD13 ' B' ' 80' ' ' ILE . 44.9 mm -59.58 -49.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.425 0.631 . . . . 0.0 109.685 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 ttmm -55.33 -43.52 75.04 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.324 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.4 77.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.308 0.575 . . . . 0.0 110.757 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.6 mt -61.22 -35.82 78.24 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.687 0.755 . . . . 0.0 109.196 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.29 -43.66 98.51 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.966 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.1 mt -64.76 -38.04 89.66 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.061 0.457 . . . . 0.0 110.776 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -41.71 97.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.489 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -64.22 -39.19 93.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.499 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.25 -38.7 80.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.58 44.37 98.05 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 114.708 0.643 . . . . 0.0 114.708 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -99.64 -35.01 4.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -63.43 -33.46 75.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.599 0.237 . . . . 0.0 110.876 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.427 ' CG1' ' HA2' ' A' ' 38' ' ' GLY . 21.0 t -118.91 120.99 30.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -51.64 173.3 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.72 2.28 . . . . 0.0 115.428 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.32 120.54 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.43 127.9 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.344 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.48 121.13 41.77 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -110.15 127.35 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.403 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -84.55 119.67 33.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.126 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.92 -23.26 14.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.67 -122.07 0.72 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.554 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.88 98.78 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 122.812 0.445 . . . . 0.0 109.937 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -3.36 87.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 114.041 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.31 54.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.54 0.67 . . . . 0.0 109.313 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -138.83 156.79 47.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.228 1.013 . . . . 0.0 113.08 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 141.87 51.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.895 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -133.71 135.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.45 117.21 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.959 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.83 110.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.284 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' CG1' ' A' ' 21' ' ' VAL . . . 48.93 44.34 31.75 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.133 -1.032 . . . . 0.0 114.087 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.08 -24.88 24.76 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.982 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.5 128.48 36.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.371 1.085 . . . . 0.0 109.959 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -106.81 135.05 49.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.04 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.16 126.08 52.23 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.03 156.65 27.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.11 0.481 . . . . 0.0 111.925 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 26.91 53.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.952 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.42 149.21 24.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.278 0.561 . . . . 0.0 112.077 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.7 p -90.52 171.53 9.34 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.12 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.58 -44.26 82.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -63.6 -38.87 92.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.5 mtp -69.89 -43.66 71.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.315 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.58 -34.73 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -63.81 -50.23 69.74 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.685 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.31 -52.49 36.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.747 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.7 mt -64.78 -48.33 74.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.604 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -59.27 -42.68 91.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.209 0.528 . . . . 0.0 111.605 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.74 -44.15 82.26 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.165 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.34 -39.66 94.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.884 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -70.82 -38.34 73.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.241 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -69.91 -31.84 69.83 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.32 -27.81 47.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.817 0.281 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -85.1 -35.16 21.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.237 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -130.95 96.98 4.19 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -75.51 -0.8 21.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.91 16.86 13.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.66 0.664 . . . . 0.0 111.841 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.55 119.18 13.41 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.42 125.51 24.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -114.19 133.17 55.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.74 142.29 44.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.429 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.1 t -123.43 126.12 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.85 145.7 17.69 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.44 154.53 16.91 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 165.1 25.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.0 110.871 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.01 -32.58 64.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -81.2 -5.63 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -84.74 131.24 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.23 152.78 40.12 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.503 1.469 . . . . 0.0 109.99 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -64.15 -36.94 85.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.855 0.752 . . . . 0.0 110.981 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -56.3 -36.65 68.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.79 -36.25 70.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.5 t -61.55 -39.0 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.402 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.2 mm -59.53 -50.69 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.386 0.613 . . . . 0.0 109.452 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -44.18 70.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.442 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.49 80.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.387 0.613 . . . . 0.0 110.659 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 10.2 mt -62.23 -36.08 80.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.69 0.757 . . . . 0.0 109.189 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -61.78 -41.9 98.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.812 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.34 -38.71 92.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.028 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -63.56 -43.09 98.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.575 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.1 -39.12 74.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.25 12.79 19.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.6 44.86 95.32 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.583 0.593 . . . . 0.0 114.583 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt -106.1 -43.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 109.969 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.65 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 71.1 m -63.16 -33.89 76.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.016 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.416 ' CG1' ' HA2' ' B' ' 38' ' ' GLY . 21.5 t -118.79 121.08 30.95 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -51.79 173.49 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.777 2.318 . . . . 0.0 115.544 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -115.43 120.47 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.39 127.72 68.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.15 121.12 42.04 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.94 127.14 54.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.303 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.3 119.67 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.387 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.88 -23.61 14.53 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.15 -125.75 0.94 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.399 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -108.37 98.87 7.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.117 -0.542 . . . . 0.0 110.236 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.37 -3.51 86.99 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 121.123 -0.561 . . . . 0.0 114.088 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 130.52 54.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.552 0.676 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -138.99 157.11 46.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.282 1.039 . . . . 0.0 113.166 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.94 141.96 51.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.863 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -133.85 135.14 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.422 0.555 . . . . 0.0 112.438 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.19 117.36 32.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 91.4 mt -116.27 110.54 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.086 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' CG1' ' B' ' 21' ' ' VAL . . . 48.62 44.59 29.88 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.213 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.99 -24.97 24.17 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.026 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.34 128.41 36.44 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.414 1.107 . . . . 0.0 110.108 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -106.73 134.56 49.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.022 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.73 125.77 52.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -116.55 156.8 26.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.097 0.475 . . . . 0.0 112.127 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.22 26.79 54.32 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.042 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -87.4 149.61 24.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.261 0.553 . . . . 0.0 111.997 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -90.69 171.61 9.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.064 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.0 -44.13 81.13 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.52 -39.06 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.145 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.7 mtp -69.95 -43.46 71.52 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.68 -34.58 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 -50.18 69.54 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.532 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -50.19 -52.59 34.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.732 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.69 -48.73 73.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.573 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -58.95 -42.43 89.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 111.71 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -67.1 -44.09 80.86 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.072 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -64.24 -39.87 94.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -70.61 -38.64 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.67 -31.7 69.9 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.56 -27.61 45.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.9 0.318 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -85.16 -35.14 21.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -130.88 97.24 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -75.73 -0.79 22.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -118.83 16.39 13.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.703 0.683 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.15 119.26 13.16 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.56 125.12 23.2 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -113.76 133.49 55.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 111.416 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.02 142.45 44.46 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.41 126.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.02 145.55 17.51 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.51 154.58 16.94 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.634 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 165.58 24.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.65 -32.39 65.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.524 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.06 -6.12 58.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.41 130.9 52.05 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 152.54 40.29 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.571 1.514 . . . . 0.0 110.003 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 83' ' ' LEU . 4.1 t80 -63.92 -37.05 85.98 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.649 -0.657 . . . . 0.0 110.983 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -56.41 -36.27 68.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.0 -36.06 69.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.184 0.516 . . . . 0.0 109.637 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.9 t -61.71 -39.18 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.488 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.401 HD13 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -59.42 -50.56 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.319 0.58 . . . . 0.0 109.469 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.19 -43.89 71.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.439 178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.57 -48.85 79.53 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.456 0.646 . . . . 0.0 110.494 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.74 -36.16 80.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.191 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.83 -41.7 98.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.938 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -64.51 -38.56 91.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 110.439 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.1 -41.72 97.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -63.48 -42.98 98.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -57.37 -38.72 74.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.514 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.48 12.55 20.37 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.93 44.81 95.88 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.26 -44.92 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.303 0.573 . . . . 0.0 109.682 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.963 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 m -97.38 -31.26 12.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 32.4 t -124.25 125.66 25.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.067 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.86 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.888 2.392 . . . . 0.0 115.235 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 66' ' ' PHE . 39.7 t -113.33 120.23 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.84 129.01 69.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.491 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -117.58 124.9 49.79 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -112.91 129.62 56.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.521 -178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.94 109.62 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.729 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.3 22.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.34 -119.39 0.62 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.45 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 mm -112.28 95.22 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.6 89.5 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.202 -0.523 . . . . 0.0 114.158 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.89 91.95 3.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.698 0.749 . . . . 0.0 110.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.34 154.32 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.184 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.36 143.61 50.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.417 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.86 135.85 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -112.85 115.97 29.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.312 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.49 111.68 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.891 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 49.02 44.63 32.65 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.142 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.11 -23.87 27.45 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.859 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.57 126.54 35.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.348 1.074 . . . . 0.0 109.869 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 133.43 49.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.588 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.99 123.85 49.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.84 149.49 30.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.54 78.54 0.65 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -137.78 148.06 45.2 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.282 0.563 . . . . 0.0 111.629 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 p -89.64 169.33 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.513 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.98 -41.12 82.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.945 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.86 -38.72 91.91 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.143 -0.348 . . . . 0.0 110.95 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mtp -69.81 -45.06 68.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.75 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.46 -35.76 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.889 0.376 . . . . 0.0 110.233 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -63.77 -49.99 70.8 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.853 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -53.08 27.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.7 mt -65.21 -48.38 73.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.558 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -58.63 -43.03 89.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.577 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.68 -43.82 83.45 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.229 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -63.51 -41.42 98.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.877 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -37.73 76.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -70.83 -29.94 66.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.477 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.88 -27.62 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.844 0.293 . . . . 0.0 110.867 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -82.12 -38.25 25.07 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -129.2 110.46 12.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -82.51 7.29 14.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -127.09 20.32 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.145 0.43 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 113.23 5.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -61.36 123.54 18.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 23' ' ' VAL . 43.6 m-85 -114.26 133.09 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pp -132.96 141.42 48.32 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.258 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.55 124.79 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.42 142.3 13.57 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.9 154.99 16.23 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.687 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.88 163.38 24.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.357 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -31.44 69.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.98 -6.61 58.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.1 t -89.93 135.34 30.39 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.42 154.99 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.021 1.147 . . . . 0.0 110.373 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -63.79 -35.5 80.81 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.399 -0.813 . . . . 0.0 110.48 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.36 -36.75 66.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.415 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -34.53 67.27 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.835 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.41 -38.98 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 50.3 mm -59.19 -49.48 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -53.31 -44.35 68.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.283 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -51.95 67.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.24 -36.73 78.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 109.291 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -62.24 -41.53 98.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.541 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.13 -39.25 93.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.115 0.483 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.87 -41.8 97.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.12 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.35 -41.18 98.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.359 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.26 -38.37 76.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.61 24.19 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.22 44.69 97.79 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.13 -34.78 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.116 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.873 -0.091 . . . . 0.0 112.873 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.7 m -96.91 -32.23 12.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.318 . . . . 0.0 111.094 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 36.0 t -123.63 125.85 25.9 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.83 173.29 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.804 2.336 . . . . 0.0 115.258 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.5 120.09 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.7 129.3 68.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.392 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.64 124.97 49.87 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -113.09 129.36 56.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.63 109.38 18.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.664 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.14 -23.52 22.44 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.72 -123.53 0.84 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.24 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.25 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.17 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.97 0.46 89.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.085 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.79 92.12 3.96 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.705 0.752 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.13 154.26 18.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.265 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.18 143.86 50.73 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.8 135.86 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.3 t -112.93 116.11 29.47 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.291 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 61.1 mt -116.71 111.42 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.957 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 49.23 44.49 34.45 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.12 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.15 -23.71 28.29 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.781 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.64 126.61 35.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.334 1.067 . . . . 0.0 109.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 133.69 49.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.483 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.23 123.97 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -110.94 149.41 30.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.51 78.97 0.63 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.11 148.33 44.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.453 0.644 . . . . 0.0 111.475 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.6 p -89.9 169.39 11.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.0 -41.39 82.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.017 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.39 -38.83 92.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 33.7 mtp -69.88 -44.97 68.68 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.831 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -35.43 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.916 0.388 . . . . 0.0 110.143 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 26.6 m -64.1 -49.69 71.23 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.045 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -53.32 27.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.646 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.439 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.48 -43.59 89.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.11 0.481 . . . . 0.0 111.53 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.38 -43.52 85.69 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.02 -40.71 96.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 -37.91 75.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.66 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -70.55 -29.93 66.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.747 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.03 -27.98 54.74 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.234 -0.291 . . . . 0.0 110.868 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.99 -37.93 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -129.61 110.19 11.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.07 6.98 14.58 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -127.07 20.45 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.22 0.464 . . . . 0.0 111.895 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.89 113.66 5.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.461 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.66 123.48 18.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -114.05 133.09 55.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.546 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.02 141.33 48.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.144 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.46 124.61 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.44 141.95 13.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.33 155.51 16.06 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 163.87 23.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 111.259 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -31.25 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.335 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -81.17 -6.81 59.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.79 135.01 31.01 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.27 155.27 41.69 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.071 1.181 . . . . 0.0 110.153 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.407 ' CE1' HD12 ' B' ' 80' ' ' ILE . 8.5 t80 -64.02 -35.52 80.99 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.467 -0.771 . . . . 0.0 110.377 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.42 -37.12 67.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.94 -35.18 69.54 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.067 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -61.84 -39.22 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.349 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.428 HG23 HD13 ' B' ' 80' ' ' ILE . 50.3 mm -59.04 -48.91 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.485 0.659 . . . . 0.0 109.42 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -53.85 -44.2 70.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.68 68.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.292 0.568 . . . . 0.0 110.96 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.56 -36.55 78.73 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.781 0.801 . . . . 0.0 109.196 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.37 -41.6 98.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.62 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.02 -38.92 92.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.666 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.93 -41.99 97.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.999 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -63.48 -40.95 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.581 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.36 -38.67 77.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.32 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.22 10.64 23.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 mt -101.23 -35.25 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -70.98 -56.56 5.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.981 0.419 . . . . 0.0 110.602 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 43.4 t -128.37 124.64 22.97 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.14 174.89 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.876 2.384 . . . . 0.0 115.725 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.75 122.18 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.48 127.95 69.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.439 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 tt -115.08 121.85 44.32 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -110.11 126.46 54.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.323 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.7 119.71 34.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.56 -22.75 15.33 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.54 -117.84 0.56 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.842 -1.171 . . . . 0.0 114.009 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.36 101.11 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 109.788 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.14 82.46 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.702 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 129.52 53.99 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.553 0.676 . . . . 0.0 109.384 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -138.13 156.11 48.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.79 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.77 144.12 50.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.195 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 pt -133.72 135.72 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.853 0.752 . . . . 0.0 113.027 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -113.19 116.87 30.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.35 111.64 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.814 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.7 46.18 30.78 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.357 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.73 -25.24 19.98 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.662 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.6 127.34 35.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.126 0.963 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 134.57 48.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.472 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.87 123.35 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -110.4 148.48 31.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 78.81 0.69 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mt -136.96 148.66 47.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.139 0.495 . . . . 0.0 111.127 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 p -91.26 171.3 9.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.638 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.06 -42.13 80.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.44 -38.8 92.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.004 0.431 . . . . 0.0 110.711 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -70.04 -46.61 64.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.349 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 p -58.09 -35.63 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.775 0.321 . . . . 0.0 110.328 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -64.12 -49.34 72.55 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.76 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.51 -52.49 38.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.706 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.94 -47.69 76.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.624 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -58.93 -43.31 91.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.117 0.484 . . . . 0.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.49 -44.09 83.59 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.363 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -63.46 -40.58 97.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.913 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.75 -38.88 76.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.196 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -69.66 -30.65 68.38 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -78.14 -28.08 48.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.859 0.299 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -84.36 -34.94 23.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.92 0.391 . . . . 0.0 110.018 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -130.19 95.68 3.98 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -68.9 -7.87 38.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -113.78 19.46 16.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.547 0.612 . . . . 0.0 112.096 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -69.04 117.0 10.14 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 125.24 23.59 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -114.37 133.88 55.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.27 141.99 43.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.598 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -123.57 129.13 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.23 146.57 18.38 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.47 16.76 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.925 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.09 165.18 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.469 . . . . 0.0 110.999 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -57.11 -32.64 66.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.341 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.23 -5.84 58.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.81 135.21 30.73 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.39 156.92 29.17 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.131 1.221 . . . . 0.0 110.631 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -65.15 -33.88 77.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.614 -0.679 . . . . 0.0 110.506 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -57.07 -37.55 72.02 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.256 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.52 70.77 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.85 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -62.66 -39.02 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.323 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.4 mm -59.32 -48.91 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 109.591 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -44.8 69.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.385 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.64 76.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.327 0.584 . . . . 0.0 110.99 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.38 -36.58 82.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.545 0.688 . . . . 0.0 109.234 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.7 -43.28 97.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.814 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.29 -38.06 89.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 110.706 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -42.04 97.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.149 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -62.93 -41.98 99.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.47 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.66 -38.58 78.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 10.97 23.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.77 97.62 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 mt -101.67 -36.61 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.851 -179.616 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -70.25 -56.49 6.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.446 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 43.8 t -128.44 124.68 22.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.184 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.14 174.72 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 115.736 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.65 122.31 67.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.83 127.99 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.312 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.2 121.83 44.16 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -109.96 126.44 53.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.362 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.54 119.7 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.76 -22.32 15.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.33 -122.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.717 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -108.12 101.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.04 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.26 80.29 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.897 -0.592 . . . . 0.0 114.017 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 129.57 53.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 117.426 0.613 . . . . 0.0 109.429 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.16 156.09 48.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.599 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 144.18 50.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.164 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 pt -133.69 135.8 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -113.46 116.93 30.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.052 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.43 111.53 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.99 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.446 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.68 46.08 30.69 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.251 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.82 -25.17 20.6 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.669 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.54 126.97 35.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.242 1.021 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 134.73 48.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.457 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.96 123.11 48.28 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.14 148.47 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 78.71 0.71 Allowed Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mt -137.03 148.32 46.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.081 0.467 . . . . 0.0 111.149 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -90.99 171.43 9.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.65 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -67.86 -42.17 81.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.874 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.55 -39.01 92.96 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.078 -0.389 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mtm -69.99 -46.55 64.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.09 -36.08 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 51.6 m -63.72 -49.42 73.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.764 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.58 -52.03 42.94 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.738 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.28 -47.67 75.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.631 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -59.13 -43.04 91.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 111.518 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -66.65 -43.96 83.19 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.343 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.56 -40.52 97.19 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.76 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -38.66 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -69.79 -30.93 68.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -78.27 -28.05 47.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.852 0.296 . . . . 0.0 111.459 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -84.42 -34.94 23.41 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -130.12 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -69.18 -7.6 37.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -113.96 19.28 16.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.565 0.62 . . . . 0.0 111.958 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -68.87 116.86 9.84 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.58 125.16 23.34 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -114.39 134.04 55.27 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.974 0.416 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.57 141.73 43.33 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -123.31 129.62 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.49 18.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.05 154.47 16.78 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.03 165.37 24.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 0.0 111.061 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -57.25 -32.76 66.9 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.361 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.0 -6.38 58.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.18 135.49 31.39 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.9 156.82 27.19 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.227 1.285 . . . . 0.0 110.558 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CE1' HD12 ' B' ' 80' ' ' ILE . 5.9 t80 -65.06 -33.89 77.13 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.792 -0.567 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.27 -37.59 72.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.53 70.78 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.882 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.4 t -62.66 -38.93 82.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.405 HD12 ' CE1' ' B' ' 76' ' ' TYR . 42.1 mm -59.52 -48.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.334 0.588 . . . . 0.0 109.602 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -44.76 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.277 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.38 77.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.321 0.581 . . . . 0.0 111.039 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 8.0 mt -62.66 -36.29 82.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.58 0.705 . . . . 0.0 109.34 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -60.83 -43.55 98.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.871 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.02 -38.14 89.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 110.598 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -41.91 98.18 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.195 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -63.08 -41.97 99.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -58.62 -38.46 78.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.399 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.57 10.75 24.25 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.23 44.71 97.75 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.9 mt -101.34 -36.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.854 -179.651 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.989 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -153.5 -57.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 40.1 t -135.35 129.04 18.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.501 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.45 176.64 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.106 2.537 . . . . 0.0 115.405 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -110.67 120.7 62.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.3 128.97 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.766 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.75 122.48 45.62 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.39 128.28 56.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.13 119.16 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.2 -22.16 15.77 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -119.85 0.64 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.945 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -112.84 100.64 11.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -2.84 83.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.755 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.14 53.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.539 0.669 . . . . 0.0 109.301 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -137.15 156.37 48.43 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.068 0.937 . . . . 0.0 112.576 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.23 142.34 51.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.138 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.6 134.89 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.459 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.97 113.89 26.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.545 0.688 . . . . 0.0 110.263 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.15 110.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.422 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 42.94 49.37 6.23 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.298 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.12 -37.35 3.44 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.799 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.4 119.12 14.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.846 0.323 . . . . 0.0 111.113 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -105.37 128.39 53.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.85 126.57 52.64 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.86 157.25 26.99 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 25.58 56.49 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.176 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.98 149.97 24.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.307 0.575 . . . . 0.0 111.929 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.75 171.7 8.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.269 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.68 -42.91 81.34 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.09 -39.22 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -69.76 -45.9 67.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.395 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.51 -34.85 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 m -62.95 -50.22 71.64 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.27 -52.76 33.64 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.828 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.94 -47.84 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.7 m -59.52 -42.67 92.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -66.2 -44.78 82.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.32 99.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.47 -39.8 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -69.91 -29.8 67.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.65 -28.44 45.42 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.723 0.238 . . . . 0.0 111.515 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -83.57 -35.76 24.49 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.08 106.21 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.7 6.21 13.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -125.53 17.97 8.15 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.613 0.642 . . . . 0.0 111.908 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.08 114.57 5.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.863 -0.153 . . . . 0.0 111.212 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.45 122.67 14.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -113.34 134.39 54.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.072 0.463 . . . . 0.0 111.294 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.15 141.34 40.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.405 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.99 127.67 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.12 146.79 18.78 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.5 155.0 16.96 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.021 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.51 164.5 24.66 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 120.922 0.391 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -56.97 -33.24 66.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.512 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.25 -5.64 56.54 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.69 134.58 31.99 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.26 156.72 33.33 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.28 1.32 . . . . 0.0 110.006 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.411 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 3.4 t80 -64.86 -35.62 81.73 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.666 -0.646 . . . . 0.0 110.683 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.57 -37.36 70.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.712 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.9 t -62.54 -39.28 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.442 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 45.7 mm -60.17 -47.4 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.26 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.92 79.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.589 . . . . 0.0 110.863 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 10.0 mt -60.56 -37.1 80.18 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.527 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -61.23 -41.67 97.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.975 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.12 -38.31 87.87 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 110.553 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.89 -42.12 97.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.86 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -63.15 -43.3 98.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.12 -38.77 73.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.3 12.16 19.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.42 44.87 96.31 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mt -103.0 -36.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.023 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -153.1 -57.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 40.6 t -135.55 128.88 18.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.664 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.18 176.52 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.91 2.406 . . . . 0.0 115.486 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.54 120.72 61.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.25 128.58 71.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.5 122.64 46.32 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -112.45 128.07 56.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.709 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.72 119.22 33.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.64 -21.88 15.66 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.75 -124.17 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.565 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.78 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.27 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -2.8 82.28 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.01 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.18 53.76 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.18 156.59 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.128 0.966 . . . . 0.0 112.592 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.46 142.4 51.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.117 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.0 pt -131.95 134.91 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.345 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.2 114.21 26.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.601 0.715 . . . . 0.0 110.119 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.32 110.17 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.458 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 42.71 49.71 5.96 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.24 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -37.37 3.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.863 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.13 118.58 13.14 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.855 0.328 . . . . 0.0 111.158 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -104.72 128.84 52.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.41 126.58 52.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.9 157.45 26.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 25.38 57.1 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.118 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -86.84 149.92 24.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.382 0.591 . . . . 0.0 112.078 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.68 171.53 9.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.504 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.52 -42.82 82.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.947 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.34 -39.47 92.43 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 34.5 mtp -69.42 -45.83 68.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.472 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.74 -34.39 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 110.166 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -63.23 -50.12 71.47 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.922 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.55 -52.78 35.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -64.86 -47.5 77.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.331 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -60.01 -42.42 94.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.145 0.498 . . . . 0.0 111.614 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.26 -44.72 82.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.243 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.03 99.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.908 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -70.03 -39.51 75.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.102 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -70.0 -29.75 66.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.665 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.69 -28.79 45.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.754 0.252 . . . . 0.0 111.535 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.16 -35.73 25.29 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.04 106.06 8.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.46 6.06 13.39 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -125.37 17.85 8.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.622 0.646 . . . . 0.0 111.918 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 114.84 6.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.893 -0.14 . . . . 0.0 111.22 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tp -59.64 122.89 15.24 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -113.58 133.94 54.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.173 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.9 141.34 40.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.417 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.2 127.91 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.05 146.71 18.7 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.13 154.97 16.8 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 121.127 -0.558 . . . . 0.0 111.959 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.44 165.25 23.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -57.95 -32.88 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.513 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.2 -6.18 57.36 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -89.35 134.53 32.64 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.47 156.83 32.6 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.201 1.268 . . . . 0.0 110.256 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 83' ' ' LEU . 3.3 t80 -64.85 -35.92 82.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.713 -0.617 . . . . 0.0 110.592 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -56.46 -37.36 70.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -35.61 73.34 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.772 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.6 t -62.31 -39.26 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.596 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.21 -47.08 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.408 0.623 . . . . 0.0 109.469 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -44.93 73.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.276 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.79 80.31 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.322 0.582 . . . . 0.0 110.809 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.8 -36.76 79.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.392 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -61.33 -41.92 97.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.039 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.77 -38.58 89.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.69 -42.15 98.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.2 -43.35 98.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.437 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -39.1 74.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.707 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.83 12.02 18.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.65 44.75 96.6 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.03 -35.77 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.499 . . . . 0.0 109.943 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.051 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 m -82.21 -40.33 21.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.631 0.253 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.14 125.94 17.28 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.972 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.39 -171.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.022 2.482 . . . . 0.0 114.542 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.0 118.11 52.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.8 128.27 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.71 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.3 121.42 43.61 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -110.46 127.14 55.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.29 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.85 123.43 39.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.457 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.52 -22.49 13.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.3 -120.75 0.68 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.64 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.44 95.97 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.762 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.87 -3.52 85.94 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.949 -0.569 . . . . 0.0 114.406 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 132.28 52.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.488 0.644 . . . . 0.0 109.375 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -139.93 158.03 44.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.172 0.986 . . . . 0.0 112.985 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.64 141.85 51.81 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.748 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 pt -134.19 135.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.704 0.684 . . . . 0.0 112.706 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.35 115.52 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.694 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.89 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.245 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.45 48.31 16.58 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.848 -0.691 . . . . 0.0 114.215 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.29 -25.83 22.41 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.814 -0.708 . . . . 0.0 114.135 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.72 129.63 38.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.501 1.15 . . . . 0.0 110.501 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.1 135.69 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.11 127.96 54.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -118.13 156.09 29.3 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.94 26.88 47.79 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.304 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.46 150.15 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.344 0.572 . . . . 0.0 112.303 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.3 p -91.72 170.6 9.77 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.545 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.02 -47.25 78.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.9 -38.75 92.17 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.133 -0.355 . . . . 0.0 111.38 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.3 ttp -71.57 -39.04 70.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.668 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.78 -32.8 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 m -63.79 -50.21 69.88 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.539 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.11 -52.3 36.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.88 -48.08 75.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.462 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.6 m -58.65 -42.56 88.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.086 0.469 . . . . 0.0 111.548 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.284 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.72 -40.98 98.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.912 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.64 -38.4 80.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.598 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -70.82 -30.89 67.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.849 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.15 -28.09 54.05 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -83.65 -33.82 25.17 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.296 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -129.65 109.12 10.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.97 5.26 19.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -125.91 17.45 7.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.458 0.572 . . . . 0.0 111.893 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.05 113.94 5.43 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.083 0.153 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tp -61.38 123.05 16.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -111.11 130.39 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.393 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.63 141.24 41.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.325 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.2 t -123.83 131.3 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.73 146.88 18.75 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.34 152.85 16.74 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.9 165.15 25.07 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -33.06 67.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.398 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -81.54 -5.82 58.37 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.6 t -89.77 131.56 39.27 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.95 155.47 53.02 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.337 1.358 . . . . 0.0 110.403 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' B' ' 83' ' ' LEU . 6.2 t80 -65.11 -34.24 77.93 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.493 -0.754 . . . . 0.0 110.577 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.74 -37.1 70.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.72 0.295 . . . . 0.0 110.254 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -36.08 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.847 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.26 -39.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.573 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 80' ' ' ILE . 44.7 mm -60.39 -46.96 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.503 0.668 . . . . 0.0 109.436 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.63 -45.5 70.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.312 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.12 78.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.346 0.593 . . . . 0.0 111.19 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.407 ' HB3' ' CE1' ' B' ' 76' ' ' TYR . 7.7 mt -61.57 -36.78 81.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.6 0.714 . . . . 0.0 109.505 177.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -60.84 -42.95 98.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.904 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.37 -38.95 91.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.059 0.457 . . . . 0.0 110.58 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -41.89 98.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.159 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -63.17 -43.68 97.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.9 -38.5 72.9 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.76 12.08 20.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.2 44.71 97.14 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mt -101.33 -35.07 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.838 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 112.957 -0.057 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -82.38 -40.21 21.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.617 0.246 . . . . 0.0 110.97 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.03 125.38 17.09 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -48.28 -171.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.992 2.461 . . . . 0.0 114.668 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.83 117.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.78 128.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.788 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 tt -114.6 121.45 43.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -110.42 127.09 54.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.437 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 123.11 38.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.484 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.29 -22.46 13.7 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.85 -124.37 0.89 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.712 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -107.66 95.99 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 114.916 -0.642 . . . . 0.0 110.202 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -3.25 86.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.133 -0.556 . . . . 0.0 114.375 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 132.31 52.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.547 0.674 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -139.69 158.12 44.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.2 1.0 . . . . 0.0 113.042 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.07 141.77 51.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.682 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 pt -134.33 136.51 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 115.23 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.565 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.76 108.7 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.381 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.41 47.98 16.53 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.037 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.45 20.14 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -92.34 129.61 38.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.456 1.128 . . . . 0.0 110.498 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.01 136.01 47.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.87 127.33 53.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -117.89 156.36 28.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 112.418 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.76 26.83 48.77 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.428 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.44 150.23 23.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.465 0.65 . . . . 0.0 112.206 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 16.9 p -91.72 170.03 10.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.529 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -64.68 -47.25 79.07 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.273 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.96 -38.8 92.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.1 ttp -71.6 -39.08 70.76 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.614 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.61 -33.19 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 m -63.59 -49.89 71.57 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.638 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.67 -51.66 47.19 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.823 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.26 -48.09 74.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -58.4 -43.16 88.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.705 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -66.19 -44.16 84.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.296 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.03 -40.8 97.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -68.57 -38.81 81.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.356 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.54 -31.09 68.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -77.07 -27.8 54.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.833 0.288 . . . . 0.0 111.528 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -84.05 -33.68 24.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -129.81 108.85 10.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -81.69 5.18 19.17 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.17 17.98 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.248 0.476 . . . . 0.0 111.939 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.42 113.64 5.46 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.135 0.174 . . . . 0.0 111.221 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tp -61.12 122.8 15.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -110.9 130.89 55.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.237 0.542 . . . . 0.0 111.47 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.16 141.26 40.09 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.098 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.92 131.71 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.84 18.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.91 153.06 16.68 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.636 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.3 165.3 24.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -33.3 67.29 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -81.18 -6.17 58.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -89.44 131.51 40.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.22 155.33 51.78 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.276 1.317 . . . . 0.0 110.451 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.409 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 6.0 t80 -64.82 -34.33 78.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.514 -0.741 . . . . 0.0 110.656 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.92 -36.71 70.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.758 0.314 . . . . 0.0 110.239 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 -35.69 72.43 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.606 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.8 -38.77 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.439 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.431 HG23 HD12 ' B' ' 80' ' ' ILE . 44.3 mm -60.58 -47.15 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.546 0.689 . . . . 0.0 109.372 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.38 -45.73 69.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.05 79.01 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.296 0.57 . . . . 0.0 111.181 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 8.0 mt -61.95 -35.95 79.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.356 0.598 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.68 -42.79 99.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.633 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.2 -38.96 92.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.68 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -42.01 98.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.965 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -62.94 -43.91 97.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.44 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.79 -38.22 72.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.615 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.95 11.94 21.2 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.95 96.98 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -101.66 -35.09 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.935 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.455 0 N-CA-C 112.763 -0.135 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 t -69.33 -54.27 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.68 126.59 27.05 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.97 -164.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.052 2.501 . . . . 0.0 114.186 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.67 110.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.33 127.78 67.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 tt -115.69 120.67 40.13 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -110.1 127.19 54.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.577 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.39 114.89 25.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.269 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.13 -22.63 17.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -120.35 0.65 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.436 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -114.35 96.79 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 122.892 0.477 . . . . 0.0 109.767 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 -4.5 85.89 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.713 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 129.67 51.74 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -137.61 156.12 48.42 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.15 0.976 . . . . 0.0 112.805 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.1 141.88 51.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.296 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 pt -131.16 134.61 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.322 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.1 114.74 27.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.675 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 80.9 mt -112.18 108.78 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.951 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 48.02 20.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.892 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.01 20.55 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.137 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -92.41 130.03 38.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.505 1.152 . . . . 0.0 110.482 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -108.44 136.95 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.157 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.79 127.74 53.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -117.48 156.03 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.104 0.478 . . . . 0.0 112.217 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 25.91 53.11 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.552 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -86.93 149.21 24.95 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.542 0.687 . . . . 0.0 112.208 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 p -91.88 171.44 9.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.419 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.62 -44.29 82.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.79 -39.26 93.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.8 ttp -71.17 -41.45 70.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.973 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.66 -34.43 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.55 -50.23 70.32 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.857 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.57 -52.03 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.759 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.84 -47.96 76.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.6 -43.6 84.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.218 0.532 . . . . 0.0 111.672 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -44.46 83.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.281 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.93 -40.13 95.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.178 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.58 -38.83 77.51 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.401 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.28 -30.38 67.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.65 -27.43 45.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 117.885 0.311 . . . . 0.0 111.249 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -84.77 -35.64 22.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.916 0.388 . . . . 0.0 110.029 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -130.94 101.28 5.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.12 1.12 16.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -116.78 18.34 14.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.614 0.643 . . . . 0.0 111.955 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.68 115.21 7.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.47 126.44 27.84 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.61 129.67 56.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.171 0.51 . . . . 0.0 111.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.24 140.84 45.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.981 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.3 t -122.54 127.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.97 145.8 17.66 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 155.35 16.73 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.084 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.68 166.86 22.91 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.086 0.469 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -57.88 -34.16 69.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.323 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -80.95 -5.11 57.08 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.9 133.45 41.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.81 152.86 32.94 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.495 1.463 . . . . 0.0 110.34 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -63.41 -37.4 87.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.73 0.696 . . . . 0.0 110.722 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.82 -35.74 66.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.49 -34.82 67.92 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.705 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.0 -38.63 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.76 -47.52 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.329 0.585 . . . . 0.0 109.564 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -54.46 -44.27 72.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.22 78.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.342 0.592 . . . . 0.0 111.242 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.87 -36.97 80.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.79 -41.85 96.38 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.825 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.3 -39.17 92.17 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.514 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.34 -42.27 98.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.074 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -63.72 -41.81 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -38.64 77.34 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.08 11.41 23.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.89 44.62 97.87 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mt -102.61 -36.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.705 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -69.74 -54.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 111.087 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 22.2 t -118.92 126.53 27.05 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.672 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -50.64 -164.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.132 2.555 . . . . 0.0 114.436 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.64 109.79 28.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.04 127.3 67.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.192 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 tt -115.06 120.59 40.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -110.04 127.31 54.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.435 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.67 114.79 25.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.038 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 -22.89 17.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.86 -124.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.299 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -109.7 97.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.04 -0.58 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -4.17 86.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.916 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 129.92 52.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.75 155.98 48.47 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.115 0.96 . . . . 0.0 112.795 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.06 141.66 51.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.322 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 pt -130.84 134.8 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.301 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.36 114.89 27.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.439 0.638 . . . . 0.0 109.624 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.27 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.775 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.82 48.56 18.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.944 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.46 -25.68 21.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.225 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.449 1.124 . . . . 0.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -108.08 136.94 46.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.295 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.01 127.63 53.62 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -117.19 156.36 27.81 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.87 26.49 53.34 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.413 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.4 149.12 24.68 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.485 0.659 . . . . 0.0 112.076 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.1 p -91.62 171.07 9.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.373 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.42 -44.25 83.45 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.269 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.83 -39.29 93.88 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.044 -0.41 . . . . 0.0 111.185 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 6.3 ttp -71.5 -40.98 69.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.953 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.85 -34.27 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.78 -49.96 70.9 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.846 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.74 -51.9 45.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.789 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.05 -47.67 76.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -57.64 -43.78 85.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.207 0.527 . . . . 0.0 111.764 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -44.66 84.85 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.314 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.82 -39.87 95.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.165 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.297 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.4 -30.75 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.57 -27.5 45.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.83 0.286 . . . . 0.0 111.268 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -84.72 -35.87 22.21 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.073 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -130.64 101.6 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.42 1.71 15.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -117.28 18.32 14.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.705 0.684 . . . . 0.0 111.91 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 115.41 7.91 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.7 126.27 27.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -113.4 129.49 56.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.244 0.545 . . . . 0.0 111.748 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.3 140.97 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.953 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.1 t -122.62 127.42 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.79 145.89 17.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.29 155.68 16.91 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.915 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.75 167.63 21.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -58.43 -34.74 71.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.036 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -80.35 -6.04 57.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.89 133.43 43.44 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.1 152.97 31.78 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.561 1.507 . . . . 0.0 110.251 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.55 -37.25 86.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.739 0.7 . . . . 0.0 110.572 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -55.78 -35.83 66.71 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.32 -35.07 68.53 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.844 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.75 -38.91 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 42.7 mm -60.37 -47.53 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.435 0.636 . . . . 0.0 109.784 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -54.4 -44.35 72.25 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.984 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -49.23 78.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.275 0.559 . . . . 0.0 111.146 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.63 -36.96 79.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 109.448 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.05 -41.67 97.04 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.832 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.22 -39.29 92.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.17 -42.63 99.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.93 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -63.64 -41.73 98.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -38.57 77.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.518 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.11 11.04 24.45 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.32 44.6 97.86 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 114.752 0.661 . . . . 0.0 114.752 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.65 -36.03 4.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.776 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo . . . . . 0 C--O 1.237 0.465 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.23 121.28 65.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.003 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -111.94 127.28 69.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.406 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 25' ' ' LEU . 9.4 tt -114.88 120.68 40.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -109.59 127.72 54.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.418 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 t -85.0 119.93 34.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.207 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.1 -23.07 14.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.48 -119.34 0.6 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.861 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 78' ' ' GLU . 29.5 mm -113.56 99.46 8.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.79 -2.21 86.71 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.808 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.98 129.08 53.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -138.72 156.49 47.34 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.152 0.977 . . . . 0.0 112.951 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 142.06 51.7 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.31 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.642 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.2 pt -132.47 134.81 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.52 115.11 28.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.369 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.642 HD11 ' CD1' ' A' ' 35' ' ' ILE . 68.1 mt -114.67 109.6 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.219 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.82 44.86 24.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.917 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.81 21.52 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.855 -0.688 . . . . 0.0 114.031 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.53 126.77 35.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.276 1.038 . . . . 0.0 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -105.41 133.15 50.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.948 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.98 126.65 52.72 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.41 158.38 24.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.101 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 26.83 56.35 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.903 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 35' ' ' ILE . 9.6 mt -88.13 149.14 24.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.281 0.562 . . . . 0.0 112.074 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -90.51 169.02 11.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.21 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.4 pt-20 -65.34 -43.62 90.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.61 -40.56 95.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.418 ' CE ' HD22 ' A' ' 45' ' ' LEU . 7.6 ttp -70.77 -38.18 73.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -64.44 -32.8 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -63.94 -49.26 73.28 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -50.35 -51.83 42.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.77 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.04 -47.83 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.665 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -59.29 -42.88 92.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.611 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -66.97 -43.94 81.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.391 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.41 -40.97 98.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.997 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -38.09 77.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.14 -29.45 65.25 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.66 -28.44 45.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.761 0.255 . . . . 0.0 111.433 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.79 -33.78 24.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.212 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -132.47 104.5 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.61 5.52 15.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -123.64 17.87 9.56 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.509 0.595 . . . . 0.0 111.688 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 121.7 18.04 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.499 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.12 125.17 25.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -113.14 134.39 54.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.264 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.91 142.01 42.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 83' ' ' LEU . 69.3 t -123.51 126.81 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.4 146.34 18.36 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.53 154.46 16.94 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.88 165.74 23.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 110.911 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.88 -32.77 68.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.27 -6.49 57.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.61 133.54 35.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 156.42 32.44 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.274 1.316 . . . . 0.0 110.306 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.743 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -64.26 -33.9 76.89 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.762 -0.586 . . . . 0.0 110.266 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -57.18 -37.33 71.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -71.09 -35.24 71.76 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.846 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.12 -38.41 80.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.393 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.0 mm -59.93 -48.39 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.444 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -54.15 -45.38 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.469 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.05 -49.18 78.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' B' ' 83' ' ' LEU . 10.8 mt -61.58 -36.17 79.89 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.444 0.64 . . . . 0.0 109.46 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.95 -41.96 98.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.74 -38.86 92.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 110.614 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 91' ' ' ILE . 1.1 mm? -63.57 -41.85 98.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.952 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -63.58 -41.0 98.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.51 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -38.92 78.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.449 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.05 11.82 21.81 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.87 44.32 97.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.638 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--O 1.238 0.475 0 N-CA-C 115.43 1.281 . . . . 0.0 115.43 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.25 121.38 65.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.979 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.81 127.24 69.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.515 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.453 ' C ' HD23 ' B' ' 25' ' ' LEU . 9.4 tt -114.86 120.47 40.08 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.07 128.25 54.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.457 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.45 119.79 34.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.147 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 -23.2 14.61 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.47 -123.51 0.83 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.565 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' B' ' 78' ' ' GLU . 27.1 mm -108.45 99.76 9.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.011 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.87 85.75 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.968 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.61 129.44 52.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.0 156.55 47.13 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.156 0.979 . . . . 0.0 113.034 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.96 51.76 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.261 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.645 ' CD1' HD11 ' B' ' 37' ' ' ILE . 5.8 pt -132.56 134.94 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 112.599 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.73 115.01 28.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 68.4 mt -114.74 109.54 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.192 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.71 45.05 24.18 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.976 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -26.34 18.99 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.931 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.15 126.86 35.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.211 1.005 . . . . 0.0 110.391 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -105.63 132.35 51.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.074 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.545 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -117.24 126.84 53.4 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.7 158.8 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 112.092 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 26.49 57.43 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.932 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 35' ' ' ILE . 9.5 mt -87.92 149.15 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.36 0.6 . . . . 0.0 112.325 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.39 169.21 11.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.446 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 16.8 pt-20 -65.63 -43.27 90.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.72 -40.05 94.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.99 -0.444 . . . . 0.0 111.233 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.431 ' CE ' HD22 ' B' ' 45' ' ' LEU . 7.1 ttp -71.35 -38.17 71.64 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -64.43 -32.86 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -63.96 -48.85 74.85 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -50.84 -51.92 46.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.7 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -64.76 -47.95 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.669 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -59.21 -42.95 92.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -66.91 -43.89 82.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.36 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.33 -40.97 98.77 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -37.9 76.75 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -71.18 -29.53 65.3 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.77 -28.42 44.73 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.856 0.298 . . . . 0.0 111.432 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.89 -33.56 24.74 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -132.43 104.42 6.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.84 5.54 15.72 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -123.6 17.53 9.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.517 0.598 . . . . 0.0 111.772 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 122.06 18.44 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.22 125.38 25.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.979 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -137.32 141.75 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' B' ' 83' ' ' LEU . 70.4 t -123.46 127.27 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.75 146.3 18.3 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.55 154.57 16.95 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.83 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -32.73 68.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.418 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.16 -6.85 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.4 133.38 36.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 156.49 33.33 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.409 1.406 . . . . 0.0 110.336 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.745 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -64.64 -33.66 76.46 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.832 -0.543 . . . . 0.0 110.264 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -57.29 -37.44 72.44 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.467 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.93 -35.46 72.23 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.786 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.68 -38.65 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.395 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.745 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.02 -48.01 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.524 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.6 mttm -54.38 -45.13 72.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.398 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.425 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.43 -48.78 80.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 111.283 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' A' ' 83' ' ' LEU . 10.7 mt -62.05 -36.04 80.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.457 0.646 . . . . 0.0 109.419 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.88 -42.0 98.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.793 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.5 mt -64.74 -39.01 92.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.625 HD13 HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -63.5 -41.92 98.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.978 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -63.52 -41.01 98.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.458 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -38.73 77.79 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.444 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.12 11.86 21.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 44.02 98.14 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.625 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -100.07 -39.53 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.759 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.476 0.488 0 N-CA-C 114.454 0.905 . . . . 0.0 114.454 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 64' ' ' THR . 41.3 t -106.7 115.02 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.894 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.9 127.45 69.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.2 tt -115.39 121.52 43.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' N ' HD23 ' A' ' 25' ' ' LEU . 30.1 mt-10 -110.59 127.14 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.59 111.41 20.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.96 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.17 -119.38 0.64 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.68 -1.248 . . . . 0.0 114.16 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.38 99.91 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.069 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.92 -3.31 84.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.956 -0.566 . . . . 0.0 114.175 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 131.26 54.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.581 0.69 . . . . 0.0 109.766 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.9 m-85 -137.89 157.48 46.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 122.096 0.95 . . . . 0.0 112.746 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.84 142.2 51.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.878 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.4 pt -132.95 134.37 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.396 0.543 . . . . 0.0 112.341 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 115.05 28.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.247 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 35' ' ' ILE . 33.2 mt -111.59 108.83 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.715 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.99 46.16 26.22 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.664 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.53 24.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.658 -0.782 . . . . 0.0 114.221 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -91.74 128.96 37.78 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.57 1.185 . . . . 0.0 110.201 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.52 135.01 47.69 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.84 127.71 53.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -117.47 156.1 28.56 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.156 0.503 . . . . 0.0 112.245 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.47 45.01 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.428 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.55 HD12 HG23 ' A' ' 35' ' ' ILE . 35.9 mt -88.75 151.17 22.57 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.278 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -93.14 173.32 7.79 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.586 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.7 mt-10 -67.92 -43.83 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.86 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.6 -38.7 92.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.809 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -70.35 -44.91 67.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.2 p -58.57 -35.27 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.744 0.307 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.2 m -63.55 -51.77 64.01 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.882 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -50.86 -51.18 53.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.683 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.31 -48.0 74.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.806 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -58.35 -42.86 87.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.082 0.467 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -66.48 -43.87 84.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.152 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -64.44 -39.23 93.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.015 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -38.2 70.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.57 -30.83 67.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.587 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.07 -28.75 54.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.916 0.325 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -37.45 27.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -127.38 105.4 8.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.88 1.04 24.88 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.27 20.01 8.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.242 0.474 . . . . 0.0 111.928 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.76 115.61 8.31 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.431 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.9 123.13 16.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -110.78 129.18 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.237 0.541 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.91 140.53 42.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.586 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.1 p -126.96 134.63 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.42 146.53 18.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 154.76 16.64 Favored Glycine 0 C--N 1.33 0.238 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.66 166.25 23.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.826 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -58.93 -31.8 68.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.261 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -81.12 -5.23 57.43 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.2 t -86.48 132.27 43.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.465 ' O ' HG23 ' A' ' 79' ' ' VAL . 71.8 Cg_endo -77.36 154.4 31.87 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.55 1.5 . . . . 0.0 110.495 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.7 t80 -64.2 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.887 -0.508 . . . . 0.0 111.04 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.93 -37.64 69.23 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.536 0.208 . . . . 0.0 110.744 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -71.54 -34.22 69.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.188 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 75' ' ' PRO . 11.1 t -63.43 -38.32 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.372 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.9 mm -60.69 -47.61 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.45 0.643 . . . . 0.0 109.621 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -55.14 -44.35 75.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.929 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.99 87.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -61.47 -37.69 84.51 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.532 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.66 -41.49 90.72 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.825 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.76 -39.34 90.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 110.764 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.699 HD13 HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -63.24 -42.95 99.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.909 179.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -63.1 -42.54 99.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.44 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.22 -37.78 72.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.598 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.22 10.59 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.24 44.59 96.8 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.699 HD13 HD13 ' A' ' 86' ' ' LEU . 4.7 mt . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.475 0.436 0 N-CA-C 114.431 0.897 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.625 HG23 HG22 ' B' ' 64' ' ' THR . 41.3 t -106.37 114.79 46.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.886 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.86 127.79 68.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.522 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt -115.43 121.78 43.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.447 ' N ' HD23 ' B' ' 25' ' ' LEU . 27.9 mt-10 -110.81 126.89 55.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.397 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.34 111.28 20.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.97 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.52 -122.8 0.83 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 119.964 -1.113 . . . . 0.0 114.064 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.72 100.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.15 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.74 -3.57 82.67 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.446 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 131.62 53.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.552 0.676 . . . . 0.0 109.764 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -137.94 157.16 46.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.253 1.025 . . . . 0.0 112.721 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.57 142.63 51.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.769 -1.56 . . . . 0.0 109.046 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.6 pt -133.44 134.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.317 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 115.49 29.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.262 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.3 mt -112.07 109.03 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.769 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.44 46.45 22.78 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.621 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 -25.59 24.38 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.914 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -91.75 128.78 37.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.516 1.158 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.44 135.06 47.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.75 127.84 53.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.46 156.49 27.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 112.169 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.54 46.01 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.43 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' B' ' 42' ' ' GLN . 34.2 mt -89.0 150.95 22.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 112.151 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -92.68 173.13 7.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.749 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.0 mt-10 -67.57 -44.28 78.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.844 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.2 -38.96 93.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mtm -70.22 -44.47 68.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.2 p -59.01 -35.09 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -63.82 -51.13 66.11 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.869 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.35 -51.3 55.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.67 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.17 -48.12 74.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.718 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -58.14 -43.07 87.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.478 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -66.22 -44.02 85.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.297 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -64.22 -39.36 93.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.018 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -38.34 71.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -70.47 -30.59 67.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.593 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.37 -28.52 52.9 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.932 0.333 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -37.09 27.56 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -127.93 105.27 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.87 1.0 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -124.99 19.81 8.36 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.276 0.489 . . . . 0.0 111.906 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.625 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.7 115.94 8.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.405 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.18 122.74 15.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.78 129.13 55.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.59 140.21 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.747 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.6 p -126.55 134.46 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.02 146.55 18.49 Favored Glycine 0 C--O 1.226 -0.346 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.99 154.78 16.75 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.11 166.53 23.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -59.19 -31.63 69.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.281 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -81.1 -5.46 57.69 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.25 132.12 44.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.471 ' O ' HG23 ' B' ' 79' ' ' VAL . 75.1 Cg_endo -77.35 154.06 31.69 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.583 1.522 . . . . 0.0 110.669 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -64.06 -37.83 88.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.911 -0.493 . . . . 0.0 111.046 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.47 -37.63 70.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.514 0.197 . . . . 0.0 110.629 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' B' ' 75' ' ' PRO . 1.4 tp10 -71.44 -34.42 70.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.285 0.564 . . . . 0.0 110.199 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 75' ' ' PRO . 11.4 t -63.25 -38.3 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.425 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.94 -47.29 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.453 0.644 . . . . 0.0 109.625 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' B' ' 85' ' ' LEU . 12.1 mmmt -55.33 -43.99 75.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.957 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.31 86.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.346 0.594 . . . . 0.0 110.833 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 83' ' ' LEU . 6.3 mt -60.87 -38.05 84.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.38 -41.51 89.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.903 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' B' ' 81' ' ' LYS . 1.6 mt -65.85 -39.23 90.58 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.481 . . . . 0.0 110.707 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 91' ' ' ILE . 0.5 OUTLIER -63.4 -42.58 98.79 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.939 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -63.22 -42.77 99.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -37.58 72.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.683 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.48 10.81 23.81 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.12 44.5 97.12 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.234 0.853 . . . . 0.0 115.234 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.719 HD13 HD13 ' B' ' 86' ' ' LEU . 4.5 mt -99.25 -36.69 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 114.658 0.984 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 64' ' ' THR . 38.3 t -106.36 110.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.881 HG23 HD11 ' A' ' 67' ' ' LEU . 3.1 mp -108.62 126.38 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.287 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.0 tt -115.54 123.48 48.61 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' HD23 ' A' ' 25' ' ' LEU . 11.3 mt-10 -111.95 127.16 55.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.306 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 74' ' ' VAL . 34.7 t -84.86 108.25 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.537 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -22.71 24.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -119.24 0.61 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.939 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.81 98.84 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.63 -3.5 86.54 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.944 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.49 130.58 54.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.544 0.672 . . . . 0.0 109.447 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -139.12 157.25 46.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 113.115 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.77 51.06 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.954 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.694 HG23 HD12 ' A' ' 45' ' ' LEU . 3.7 pt -132.3 134.13 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.368 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.64 114.01 26.78 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.389 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 35' ' ' ILE . 63.0 mt -110.71 108.68 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.89 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 47.37 21.18 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.735 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.64 23.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.267 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -92.14 128.3 37.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.478 1.139 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.17 135.49 47.55 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.41 127.47 53.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -116.53 155.76 28.09 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.7 46.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.396 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 35' ' ' ILE . 17.5 mt -87.76 149.01 24.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 112.361 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -91.89 173.06 8.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.554 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.1 mt-10 -67.53 -45.01 76.99 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.948 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -37.98 89.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.234 0.47 . . . . 0.0 110.845 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mtp -70.26 -44.87 67.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -58.53 -35.46 54.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.14 -51.76 62.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -50.2 -51.79 41.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.762 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.74 -48.12 75.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.021 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.638 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -66.83 -43.46 83.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.209 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -39.41 92.91 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.043 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.13 -37.57 72.31 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.695 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.77 -30.99 67.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.442 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.23 -27.97 53.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.913 0.324 . . . . 0.0 111.148 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.05 -38.81 24.4 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.86 119.18 25.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -91.26 -19.88 22.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.37 20.53 11.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.202 0.456 . . . . 0.0 111.579 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.96 115.64 9.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.724 -178.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.06 125.92 26.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -110.0 126.78 54.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.211 0.529 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -134.12 139.85 46.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.491 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.3 p -127.39 135.71 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.37 144.74 16.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.647 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.47 152.79 17.06 Favored Glycine 0 C--N 1.33 0.204 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.1 164.71 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.085 0.469 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 -32.58 68.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.502 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -81.96 -6.84 59.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 27' ' ' VAL . 79.2 t -85.81 127.79 61.08 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.08 154.41 62.42 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 110.394 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.9 t80 -63.12 -36.66 84.33 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.816 -0.552 . . . . 0.0 110.73 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 110.422 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -36.89 74.89 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 109.781 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.62 -39.55 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.687 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.1 mm -59.85 -48.11 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.409 0.623 . . . . 0.0 109.806 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 4.3 mmmt -54.96 -44.06 74.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.96 83.68 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.599 . . . . 0.0 110.873 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' B' ' 83' ' ' LEU . 7.1 mt -60.32 -37.3 80.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.572 0.701 . . . . 0.0 109.541 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.2 -40.88 95.62 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.985 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.3 mt -65.01 -40.19 94.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.673 HD13 HD13 ' A' ' 91' ' ' ILE . 2.5 mm? -63.45 -42.47 98.65 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 t60 -63.24 -41.44 99.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -38.99 76.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.35 10.33 25.4 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.45 44.1 98.46 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.673 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 N--CA 1.478 0.614 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.493 HG23 HG22 ' B' ' 64' ' ' THR . 38.3 t -106.36 110.72 32.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.893 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.83 126.76 65.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.371 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.0 tt -116.05 123.68 48.54 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.502 ' N ' HD23 ' B' ' 25' ' ' LEU . 11.8 mt-10 -112.35 127.23 55.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.225 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 37.5 t -85.06 108.21 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.591 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.6 -22.47 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.57 -123.54 0.85 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.459 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 28.9 mm -108.12 99.08 7.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.191 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -3.43 86.6 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.032 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 130.79 54.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.623 0.712 . . . . 0.0 109.6 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -139.13 157.89 45.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.515 1.15 . . . . 0.0 113.134 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 142.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.835 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.71 HG23 HD12 ' B' ' 45' ' ' LEU . 3.5 pt -132.24 134.1 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.25 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -111.14 114.1 27.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.417 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 59.7 mt -111.36 108.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.751 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.44 20.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.883 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.16 -25.82 22.24 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.71 -0.757 . . . . 0.0 114.04 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -91.77 128.76 37.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.656 1.228 . . . . 0.0 110.329 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.85 135.39 48.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.36 128.15 53.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -117.28 155.8 28.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.141 0.496 . . . . 0.0 112.325 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.48 27.73 46.59 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.198 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.71 HD12 HG23 ' B' ' 35' ' ' ILE . 17.6 mt -87.68 148.87 24.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.387 0.613 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -92.05 173.18 7.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.7 mt-10 -67.75 -44.8 76.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.025 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.49 91.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.161 0.505 . . . . 0.0 110.974 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mtp -69.96 -44.87 68.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.369 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -58.57 -35.31 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.728 0.299 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.26 -51.53 63.11 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.888 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.39 -51.56 45.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.7 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.12 -48.17 74.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.732 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 18.1 m -57.52 -43.45 84.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 111.753 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -66.65 -43.7 83.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.139 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -39.95 94.52 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.76 -37.3 73.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -70.94 -31.17 67.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.299 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.91 -28.1 55.17 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.11 -0.369 . . . . 0.0 111.131 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.13 -38.52 24.63 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -128.15 119.44 25.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -91.28 -20.0 22.38 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 20.58 11.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.067 0.394 . . . . 0.0 111.543 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.493 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.72 115.91 9.51 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.51 125.98 27.42 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.76 127.0 54.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.213 0.53 . . . . 0.0 111.694 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.26 139.77 45.97 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.518 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.788 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.9 p -127.39 135.89 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.34 145.18 17.25 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.649 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.71 152.32 17.16 Favored Glycine 0 N--CA 1.454 -0.161 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.34 165.14 24.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -59.14 -32.27 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -81.71 -7.13 59.56 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 75.3 t -85.43 127.8 61.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.2 154.18 61.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.222 1.282 . . . . 0.0 110.264 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.687 ' CE1' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -62.96 -36.48 83.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.747 -0.596 . . . . 0.0 110.69 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.48 -36.27 68.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -36.9 74.58 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.306 0.574 . . . . 0.0 109.662 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.9 -39.24 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.642 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.687 HD11 ' CE1' ' B' ' 76' ' ' TYR . 46.0 mm -59.99 -48.03 89.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-O 121.476 0.655 . . . . 0.0 109.713 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.4 mmmt -55.12 -44.12 74.72 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.014 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.99 83.48 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 7.4 mt -60.46 -37.2 80.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.611 0.72 . . . . 0.0 109.591 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.25 -40.83 95.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.883 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.4 mt -65.2 -39.9 93.46 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.855 0.36 . . . . 0.0 110.829 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.679 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -63.41 -42.6 98.76 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -63.26 -41.27 99.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.424 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -39.08 76.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.598 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.3 10.19 25.82 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.78 43.89 98.62 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.679 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -99.15 -31.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.241 0.626 0 N-CA-C 115.676 1.375 . . . . 0.0 115.676 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.49 120.13 61.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -112.47 127.71 69.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -117.07 127.25 53.96 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.4 mt-10 -115.84 127.68 55.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.299 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 74' ' ' VAL . 26.4 t -87.52 99.53 8.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.941 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.82 -21.64 51.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.974 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -113.93 92.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 -5.53 79.24 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.705 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.59 128.94 52.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.576 0.688 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.69 156.9 47.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.376 1.084 . . . . 0.0 113.133 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.98 142.29 51.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.842 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -132.83 135.14 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.18 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.69 116.11 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.938 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.05 108.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.183 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 48.52 18.35 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.523 -0.846 . . . . 0.0 114.39 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.99 -27.11 15.74 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.373 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.81 130.0 37.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.412 1.106 . . . . 0.0 110.197 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.29 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.13 125.57 51.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.52 157.02 25.9 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.25 50.99 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.042 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 HG23 ' A' ' 35' ' ' ILE . 13.6 mt -87.44 149.15 24.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.971 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 p -92.09 173.16 7.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.2 mt-10 -67.47 -43.79 80.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.22 -38.25 90.38 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 122.043 -0.411 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mtp -70.93 -43.6 67.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.625 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.32 -35.8 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -63.24 -51.2 67.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.681 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.32 -52.5 36.27 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.93 -47.57 77.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.728 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -58.07 -43.15 86.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.099 0.476 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -44.66 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.046 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.91 -40.42 96.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.161 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -70.31 -39.23 74.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.236 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.55 -27.73 64.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.41 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.86 -26.95 40.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.928 0.331 . . . . 0.0 111.385 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -33.96 25.05 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.741 ' HB3' HG23 ' A' ' 64' ' ' THR . 4.4 t70 -134.52 97.45 3.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -70.86 -6.21 36.4 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -109.04 17.65 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.586 0.63 . . . . 0.0 111.826 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -68.61 115.61 8.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.519 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 66' ' ' PHE . 6.2 tp -65.11 124.69 22.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.449 ' N ' HD12 ' A' ' 65' ' ' LEU . 11.8 m-85 -109.09 127.79 54.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.359 0.599 . . . . 0.0 111.514 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -133.95 139.24 45.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.505 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -126.78 137.34 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.96 145.49 17.32 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.88 153.68 16.69 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.17 163.63 24.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.154 0.502 . . . . 0.0 111.285 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -31.76 68.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.415 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -81.73 -5.96 58.61 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 27' ' ' VAL . 74.5 t -89.48 127.05 56.22 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.93 156.17 63.56 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.094 1.196 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.4 t80 -64.46 -34.7 78.8 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.768 -0.583 . . . . 0.0 110.46 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.23 -36.42 70.89 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -36.85 75.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.334 0.587 . . . . 0.0 109.688 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.61 -39.01 81.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.788 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.9 mm -60.39 -48.52 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.359 0.6 . . . . 0.0 109.726 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -54.15 -44.8 71.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.47 85.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.509 0.671 . . . . 0.0 110.827 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.0 mt -61.0 -36.8 80.46 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 109.378 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.73 -42.38 97.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.851 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.12 -39.92 95.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.065 0.459 . . . . 0.0 110.837 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 91' ' ' ILE . 2.1 mm? -64.03 -42.38 97.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.063 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.7 -42.32 99.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.511 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.5 -38.66 74.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.83 11.41 20.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.49 44.23 98.27 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 86' ' ' LEU . 4.1 mt . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo . . . . . 0 N--CA 1.478 0.615 0 N-CA-C 115.745 1.402 . . . . 0.0 115.745 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.1 t -111.52 120.49 62.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 127.65 69.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.74 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.521 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -117.1 127.09 53.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.492 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.0 mt-10 -115.72 127.68 55.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.165 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.425 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.4 t -87.58 98.99 7.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.033 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.27 -21.86 52.98 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.09 -124.55 0.88 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.704 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.12 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.105 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.33 79.35 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.814 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 129.13 53.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -138.16 156.65 47.53 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.337 1.065 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.03 142.06 51.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.95 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.621 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -132.64 135.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.406 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.89 115.89 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.892 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.0 108.73 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.149 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.99 15.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.462 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.74 -26.85 16.33 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.176 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.85 129.95 37.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.487 1.144 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.88 136.03 48.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.269 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.55 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -116.83 126.06 52.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.79 157.08 26.14 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 26.57 53.11 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.057 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.621 HD12 HG23 ' B' ' 35' ' ' ILE . 13.8 mt -86.89 148.94 25.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.388 0.613 . . . . 0.0 112.109 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -91.74 172.97 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.45 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.7 -43.62 79.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -63.94 -38.61 91.72 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 110.996 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.53 -43.91 68.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.425 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.45 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.13 -35.77 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.948 0.404 . . . . 0.0 110.228 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 19.6 m -63.27 -51.3 66.71 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.745 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.26 -52.49 35.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.79 -47.35 78.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.796 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -58.4 -42.9 88.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.488 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.39 83.29 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.196 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.07 -40.58 96.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.992 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.609 ' OE2' HG21 ' B' ' 64' ' ' THR . 0.0 OUTLIER -70.23 -39.34 75.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.225 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.35 -27.8 64.63 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.524 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -79.63 -27.43 40.96 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.84 0.291 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -83.25 -33.75 25.98 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.732 ' HB3' HG23 ' B' ' 64' ' ' THR . 4.4 t70 -134.96 97.72 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -71.02 -6.15 36.75 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.86 17.4 21.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.7 0.682 . . . . 0.0 111.754 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.732 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -68.3 115.9 8.27 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.471 HD12 ' N ' ' B' ' 66' ' ' PHE . 5.6 tp -65.32 125.13 24.12 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.471 ' N ' HD12 ' B' ' 65' ' ' LEU . 11.6 m-85 -109.44 127.38 54.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 0.0 111.556 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.785 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.52 137.5 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.12 145.43 17.21 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.522 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.76 153.29 16.83 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.84 164.21 24.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -31.51 69.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.176 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.67 -6.59 59.16 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.425 HG21 ' O ' ' B' ' 27' ' ' VAL . 73.9 t -88.98 127.0 57.41 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.99 156.33 63.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.962 1.108 . . . . 0.0 110.298 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.51 -34.9 79.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.996 -0.44 . . . . 0.0 110.419 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.66 -36.02 71.33 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.672 0.273 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -36.96 75.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.502 0.668 . . . . 0.0 109.539 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -61.56 -39.04 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.687 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.6 mm -60.31 -48.24 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.429 0.633 . . . . 0.0 109.702 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -54.59 -44.68 73.24 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.219 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.34 85.8 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 110.846 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -61.31 -36.56 80.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.666 0.746 . . . . 0.0 109.377 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.99 -41.83 97.25 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.949 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.97 -39.41 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.754 HD13 HD13 ' B' ' 91' ' ' ILE . 2.2 mm? -64.31 -41.96 96.59 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.85 -42.23 99.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.556 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.47 -38.9 75.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.618 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.58 11.67 18.94 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.13 44.27 98.36 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -98.07 -30.53 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.939 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 C--O 1.24 0.595 0 N-CA-C 115.296 1.229 . . . . 0.0 115.296 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 64' ' ' THR . 46.9 t -112.27 117.23 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.868 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -109.51 127.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.409 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.4 tt -116.02 121.72 43.06 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 tt0 -106.97 125.59 51.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.9 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.32 116.26 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.657 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.31 -23.79 15.49 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -122.89 0.76 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.105 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.1 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 122.666 0.387 . . . . 0.0 110.112 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 -3.41 87.24 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.964 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.89 53.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -137.48 157.09 47.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.202 1.001 . . . . 0.0 113.335 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 141.99 51.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.708 -1.587 . . . . 0.0 108.638 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 37' ' ' ILE . 5.8 pt -131.73 134.81 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -112.3 114.41 27.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.54 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 35' ' ' ILE . 47.7 mt -114.45 109.99 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.221 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.32 45.45 21.72 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.962 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.98 -26.89 14.55 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.827 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -85.32 125.14 32.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.927 0.863 . . . . 0.0 110.517 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.87 133.27 50.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.94 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.78 127.36 52.73 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.71 155.66 28.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 112.058 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 26.27 51.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.339 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 42' ' ' GLN . 40.7 mt -86.62 148.92 25.26 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.513 0.673 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.8 p -90.77 172.69 8.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.535 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 50' ' ' VAL . 6.2 mt-10 -67.9 -44.29 77.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.675 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.88 -38.79 92.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.099 0.476 . . . . 0.0 110.951 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.39 -46.15 67.56 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.03 -34.42 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -63.31 -50.42 70.1 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.789 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.42 -52.46 37.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.714 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.64 -47.7 77.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.693 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.6 -43.55 89.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.214 0.531 . . . . 0.0 111.701 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.58 -43.34 85.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.374 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.27 -40.63 96.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.76 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.56 -37.33 76.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.88 -30.91 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.63 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.19 -27.75 57.01 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.247 -0.283 . . . . 0.0 111.038 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.35 -36.48 26.81 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.19 107.59 8.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.81 4.38 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.8 19.24 9.4 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.381 0.537 . . . . 0.0 111.864 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.475 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.1 116.14 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.08 123.78 19.05 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.48 127.93 55.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.097 0.475 . . . . 0.0 111.441 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -133.46 140.27 47.18 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.818 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.7 p -127.33 136.34 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 147.13 19.02 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.15 155.76 17.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.1 23.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.068 0.461 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -57.63 -33.38 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -79.89 -5.63 55.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.79 132.98 49.83 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 87.3 Cg_endo -79.6 153.19 23.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.541 1.494 . . . . 0.0 110.573 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.8 t80 -63.53 -38.45 91.18 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.658 -0.651 . . . . 0.0 110.987 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -56.28 -37.33 69.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.599 0.238 . . . . 0.0 110.641 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -71.34 -35.62 71.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.857 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' PRO . 12.7 t -62.24 -38.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.715 HD11 ' CE1' ' A' ' 76' ' ' TYR . 50.5 mm -60.05 -47.92 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.42 0.629 . . . . 0.0 109.612 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -53.79 -44.37 70.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.154 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.69 80.69 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.693 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' B' ' 83' ' ' LEU . 7.4 mt -60.3 -36.35 77.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -61.92 -42.58 99.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.149 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.0 mt -64.43 -39.04 93.07 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 110.985 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 91' ' ' ILE . 2.1 mm? -64.24 -41.84 96.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.139 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -63.47 -40.13 96.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -38.14 76.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.483 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.29 9.77 27.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.42 44.15 95.72 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.709 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo . . . . . 0 C--O 1.24 0.59 0 N-CA-C 115.407 1.272 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.433 HG23 HG22 ' B' ' 64' ' ' THR . 45.9 t -112.17 117.57 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.92 127.27 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.398 -178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.491 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.5 tt -115.59 121.85 43.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.491 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.5 tt0 -106.8 125.9 51.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.921 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -84.59 116.06 27.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.587 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.9 -24.34 15.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -126.35 0.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.964 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.1 mm -108.03 100.88 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.421 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.16 -2.97 87.95 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.144 -0.55 . . . . 0.0 114.0 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 127.85 53.54 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -137.34 157.22 47.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.237 1.018 . . . . 0.0 113.379 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.44 141.72 51.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.754 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.703 HD12 HD11 ' B' ' 37' ' ' ILE . 6.1 pt -131.49 134.57 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.736 0.698 . . . . 0.0 112.816 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.98 114.25 27.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.517 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.703 HD11 HD12 ' B' ' 35' ' ' ILE . 45.1 mt -114.29 109.77 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.36 45.7 22.1 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.831 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.88 -27.31 13.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.849 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -84.96 125.43 32.68 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.061 0.931 . . . . 0.0 110.522 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.34 133.09 51.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.823 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.3 127.57 53.33 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -117.18 155.59 29.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.51 50.87 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.137 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' B' ' 42' ' ' GLN . 41.4 mt -87.05 149.23 24.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.528 0.68 . . . . 0.0 111.998 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -90.98 172.84 8.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.759 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.431 ' O ' HG12 ' B' ' 50' ' ' VAL . 6.1 mt-10 -67.92 -44.11 77.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.8 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.41 -38.38 90.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.043 0.449 . . . . 0.0 110.809 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.2 mtp -69.23 -46.71 66.68 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.66 -34.37 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -63.47 -50.23 70.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.719 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.8 -52.07 44.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.733 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.61 -48.22 75.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.621 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -43.84 88.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 111.739 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.52 -42.98 86.45 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.486 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.61 -40.65 95.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.745 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -69.55 -37.35 77.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.996 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.98 -30.81 67.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.18 -27.65 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.947 0.34 . . . . 0.0 111.039 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -82.33 -36.54 26.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.38 107.34 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.58 4.54 18.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -123.75 19.18 9.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.465 0.575 . . . . 0.0 111.845 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.433 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.23 116.49 8.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.4 123.83 19.31 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.38 127.66 55.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.45 139.96 47.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.609 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.2 p -127.05 136.5 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.51 147.05 18.96 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.03 155.83 17.32 Favored Glycine 0 N--CA 1.46 0.29 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.989 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 166.55 23.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -58.42 -33.14 69.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.461 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.99 -5.97 56.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -82.41 132.69 51.88 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.464 ' O ' HG23 ' B' ' 79' ' ' VAL . 93.0 Cg_endo -79.55 153.1 23.36 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.683 1.589 . . . . 0.0 110.316 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.717 ' CE1' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -63.38 -38.8 92.55 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.767 -0.583 . . . . 0.0 110.921 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.96 -37.37 68.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.492 0.187 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -71.3 -35.85 71.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 75' ' ' PRO . 12.5 t -62.18 -38.26 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.717 HD11 ' CE1' ' B' ' 76' ' ' TYR . 50.4 mm -59.92 -47.63 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.51 0.671 . . . . 0.0 109.719 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 tttp -54.28 -44.29 71.77 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.46 81.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.148 0.499 . . . . 0.0 110.716 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' A' ' 83' ' ' LEU . 7.2 mt -60.68 -36.2 78.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.604 0.716 . . . . 0.0 109.238 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -61.93 -42.24 98.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.0 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 1.8 mt -64.86 -38.92 92.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.96 0.41 . . . . 0.0 110.948 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.435 HD12 HG21 ' B' ' 91' ' ' ILE . 2.0 mm? -64.19 -42.05 96.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.288 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.36 -40.34 97.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -38.14 76.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.389 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.727 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.21 9.6 27.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.39 44.3 95.54 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 115.704 1.041 . . . . 0.0 115.704 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.727 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.3 mp -97.65 -37.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.67 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--O 1.239 0.541 0 N-CA-C 115.692 1.381 . . . . 0.0 115.692 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.58 116.62 53.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.883 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -108.55 127.16 65.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.604 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -115.14 122.04 44.86 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.544 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.2 tm-20 -111.24 128.07 55.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.131 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.31 116.62 29.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.508 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -97.16 -22.15 16.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.8 -122.08 0.72 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.741 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -115.59 87.52 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.32 27.72 19.57 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.388 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -139.13 93.08 2.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.517 0.675 . . . . 0.0 109.487 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.26 157.39 17.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.263 1.03 . . . . 0.0 113.231 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 142.0 51.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.709 HG23 HD12 ' A' ' 45' ' ' LEU . 4.8 pt -131.54 133.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 118.529 0.604 . . . . 0.0 112.422 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.51 114.33 27.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.473 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 35' ' ' ILE . 67.0 mt -114.27 110.08 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.208 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.42 45.03 22.26 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.93 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 -26.86 17.04 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.086 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.88 126.25 34.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.225 1.013 . . . . 0.0 110.525 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.36 131.94 52.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.921 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.75 127.2 53.32 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -117.56 158.67 24.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.49 27.39 54.87 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.949 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.709 HD12 HG23 ' A' ' 35' ' ' ILE . 10.0 mt -87.38 149.15 24.67 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.697 0.76 . . . . 0.0 112.191 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 p -91.36 171.53 9.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.419 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.42 -43.61 80.8 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.0 -38.8 92.42 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.027 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mtp -70.35 -44.11 68.82 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.48 -34.91 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -63.55 -50.46 69.43 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.855 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -50.67 -51.47 48.97 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.807 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.08 -48.09 74.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.279 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -43.84 83.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 111.622 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -66.76 -44.5 81.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.193 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.92 -40.58 96.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -69.41 -38.48 77.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.24 -31.27 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.23 -27.3 53.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.26 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -84.87 -36.62 21.42 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.994 0.426 . . . . 0.0 109.953 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.646 ' HB3' HG23 ' A' ' 64' ' ' THR . 10.4 m-20 -128.84 97.38 4.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.28 -6.11 37.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -114.16 19.19 16.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.573 0.624 . . . . 0.0 111.955 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -67.95 113.38 5.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.446 -179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.45 125.07 23.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -111.19 128.99 56.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.795 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.898 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.89 139.36 46.14 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.51 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.761 HG11 ' CD2' ' A' ' 83' ' ' LEU . 11.9 p -125.72 135.91 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.78 145.38 16.98 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.14 153.13 16.67 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.771 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.75 24.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -32.26 65.98 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.75 -5.71 59.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.38 133.25 53.67 Favored Pre-proline 0 CA--C 1.537 0.462 0 O-C-N 122.221 -0.299 . . . . 0.0 110.442 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 Cg_endo -77.34 148.96 27.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.729 1.619 . . . . 0.0 110.729 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 80' ' ' ILE . 4.7 t80 -63.04 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.748 -0.595 . . . . 0.0 111.251 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.56 -37.0 67.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.605 0.24 . . . . 0.0 110.832 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.6 -34.75 67.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.913 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 75' ' ' PRO . 13.2 t -62.67 -38.83 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.381 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.3 mm -60.24 -47.48 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.474 0.654 . . . . 0.0 109.407 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.12 -43.99 70.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.2 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -49.05 79.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.123 0.487 . . . . 0.0 110.792 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.33 -37.9 82.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.381 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.09 -42.0 97.7 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.696 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.22 -39.61 92.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.98 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -63.51 -42.26 98.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.65 -42.05 98.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.394 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.392 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.99 10.83 20.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.65 97.73 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.595 HD13 HD13 ' A' ' 86' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo . . . . . 0 C--O 1.24 0.587 0 N-CA-C 115.663 1.37 . . . . 0.0 115.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.5 116.81 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.902 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.74 127.11 65.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.632 -177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.524 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.04 122.16 45.32 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.524 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.3 tm-20 -111.21 127.58 55.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.254 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.71 116.89 30.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.323 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -97.4 -22.61 16.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.34 -125.71 0.94 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.649 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -111.06 87.84 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.192 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.62 27.93 20.68 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.485 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -138.86 93.3 2.69 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.514 0.673 . . . . 0.0 109.281 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -105.56 157.03 17.67 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.356 1.074 . . . . 0.0 113.336 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.78 141.99 51.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.992 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.724 HG23 HD12 ' B' ' 45' ' ' LEU . 4.8 pt -131.48 133.94 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.527 0.603 . . . . 0.0 112.271 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.05 114.45 27.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.396 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.652 HD11 HD12 ' B' ' 35' ' ' ILE . 72.3 mt -114.46 110.1 30.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.192 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.17 45.38 20.74 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.044 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.84 -26.8 16.8 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.102 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.94 126.3 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.322 1.061 . . . . 0.0 110.436 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.52 131.93 52.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.962 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.04 127.19 53.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -117.33 158.58 24.15 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.242 0.544 . . . . 0.0 112.445 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.21 27.74 54.96 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.724 HD12 HG23 ' B' ' 35' ' ' ILE . 10.4 mt -87.2 149.1 24.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.57 0.7 . . . . 0.0 112.193 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.8 p -91.49 171.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.428 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.9 mt-10 -67.21 -44.08 80.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.748 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.78 -38.69 92.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mtp -70.3 -44.36 68.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.304 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -34.47 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.3 m -64.29 -50.24 68.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.873 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -50.73 -51.55 48.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.604 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.95 -48.32 74.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.11 -43.92 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.058 0.456 . . . . 0.0 111.781 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.458 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -66.81 -44.24 81.72 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.195 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -64.16 -40.09 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.904 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -69.68 -39.01 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.188 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -69.81 -31.2 68.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.09 -27.84 54.3 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.894 0.315 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -84.31 -36.15 22.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.11 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.662 ' HB3' HG23 ' B' ' 64' ' ' THR . 10.4 m-20 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -70.93 -5.96 34.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -114.15 18.51 17.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.616 0.644 . . . . 0.0 112.053 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.662 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -67.27 113.71 5.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.79 124.39 21.36 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -110.62 128.78 55.83 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.372 0.606 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.902 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -133.61 139.26 46.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.558 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.745 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.4 p -125.94 135.68 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.55 145.27 16.91 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.13 153.2 16.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.92 24.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.045 0.45 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -32.35 66.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.78 -5.51 58.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -81.49 133.39 53.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.481 ' O ' HG23 ' B' ' 79' ' ' VAL . 95.7 Cg_endo -77.59 149.12 26.7 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.725 1.617 . . . . 0.0 110.708 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.7 t80 -63.27 -39.08 93.58 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.709 -0.619 . . . . 0.0 111.157 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.51 -37.12 67.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.694 0.283 . . . . 0.0 110.728 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.4 -34.81 68.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.873 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.481 HG23 ' O ' ' B' ' 75' ' ' PRO . 13.9 t -62.67 -38.82 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.7 mm -60.58 -46.7 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.437 0.636 . . . . 0.0 109.447 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.4 mttp -54.84 -43.77 73.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.073 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.39 78.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.345 0.593 . . . . 0.0 110.792 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 83' ' ' LEU . 7.6 mt -60.08 -38.12 81.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 109.484 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.81 -42.27 97.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.817 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 9.4 mt -64.76 -39.86 94.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.938 0.399 . . . . 0.0 111.079 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.42 -42.39 98.74 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.56 -41.88 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -38.32 74.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.497 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.492 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.35 11.01 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 44.67 97.56 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.598 HD13 HD13 ' B' ' 86' ' ' LEU . 4.2 mt -101.05 -35.15 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo . . . . . 0 C--O 1.239 0.57 0 N-CA-C 115.414 1.275 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.0 t -114.52 119.19 60.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.834 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.58 127.57 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.305 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.7 tt -113.88 119.99 39.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 3.1 tt0 -109.31 128.32 54.99 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.113 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -87.2 116.38 29.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.391 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -96.95 -22.75 16.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.17 -119.26 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.348 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.66 101.46 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.221 -0.489 . . . . 0.0 109.708 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.72 1.65 72.88 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.884 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.6 mttt -107.12 92.73 4.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.423 0.612 . . . . 0.0 109.831 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -104.14 156.22 18.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.174 0.988 . . . . 0.0 112.926 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.22 141.41 52.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.981 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CD1' HD13 ' A' ' 53' ' ' LEU . 6.5 pt -131.73 134.69 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.654 0.661 . . . . 0.0 112.702 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -112.1 115.77 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.884 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 35' ' ' ILE . 79.0 mt -115.94 110.56 32.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.084 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.3 44.58 27.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.992 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -26.25 18.77 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.744 -0.741 . . . . 0.0 114.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -88.71 127.95 35.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.58 1.19 . . . . 0.0 110.46 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -106.48 134.35 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.0 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.74 126.64 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -116.7 157.7 25.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.241 0.543 . . . . 0.0 112.366 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.05 27.76 51.9 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.052 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' A' ' 42' ' ' GLN . 16.7 mt -88.12 150.14 23.52 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 112.293 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.5 p -91.11 171.33 9.33 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.228 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.14 -43.89 81.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.826 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.78 -38.57 91.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.171 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 mtp -69.87 -44.94 68.8 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.03 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.8 -34.14 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.8 m -64.11 -49.91 70.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.587 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.37 -52.68 35.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.696 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 35' ' ' ILE . 18.6 mt -64.42 -48.01 76.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.713 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t -58.01 -43.88 86.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.074 0.464 . . . . 0.0 111.738 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -44.62 83.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.249 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.99 95.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.096 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -69.92 -38.56 76.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.634 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.83 -29.41 65.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -78.85 -26.87 44.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.822 0.283 . . . . 0.0 111.393 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -85.63 -34.18 21.44 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.61 95.78 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.74 -13.36 62.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -106.0 19.28 20.79 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.604 0.638 . . . . 0.0 111.897 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' A' ' 23' ' ' VAL . 27.1 m -68.28 111.41 4.56 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.0 tp -66.42 127.21 31.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 65' ' ' LEU . 61.2 m-85 -114.3 131.25 56.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.021 0.439 . . . . 0.0 111.486 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' B' ' 67' ' ' LEU . 3.3 pp -134.85 140.94 46.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 83' ' ' LEU . 14.5 p -127.07 136.72 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.15 146.03 17.51 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.81 154.81 16.68 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.093 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 165.13 24.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.134 0.467 . . . . 0.0 111.14 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.29 -32.35 66.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.59 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -81.28 -5.74 58.12 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.29 132.21 48.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.03 151.72 35.32 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.57 1.513 . . . . 0.0 110.193 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.2 t80 -63.38 -36.6 84.24 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.719 -0.613 . . . . 0.0 110.753 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.6 -36.44 69.4 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.81 -34.89 69.73 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.91 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.88 -38.42 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.299 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 49.7 mm -61.2 -47.34 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.426 0.631 . . . . 0.0 109.482 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 3.1 mmtp -54.9 -44.35 74.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.931 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -48.17 82.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.257 0.551 . . . . 0.0 111.055 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.63 -37.15 80.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.384 0.611 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.92 -41.26 95.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.818 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.6 mt -65.5 -39.68 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.578 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 91' ' ' ILE . 2.2 mm? -62.86 -42.29 99.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.119 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -63.79 -42.09 97.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.369 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -37.86 75.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.478 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.66 10.51 25.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.65 97.16 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.5 mt . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo . . . . . 0 C--O 1.24 0.601 0 N-CA-C 115.53 1.319 . . . . 0.0 115.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.55 HG23 ' CG2' ' B' ' 64' ' ' THR . 58.8 t -114.34 119.07 60.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.831 HG23 HD11 ' B' ' 67' ' ' LEU . 3.3 mp -110.48 127.81 67.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.302 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.7 tt -114.23 119.83 38.38 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 2.9 tt0 -109.06 128.14 54.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.262 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.02 116.0 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.364 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.98 -22.48 16.81 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.12 -123.53 0.82 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.117 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.51 101.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.894 -0.653 . . . . 0.0 110.279 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.48 1.78 72.03 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.047 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -107.05 92.79 4.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.473 0.637 . . . . 0.0 109.747 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -103.89 155.89 18.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.26 1.029 . . . . 0.0 113.031 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -123.89 142.12 51.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.928 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.596 HD11 HD13 ' B' ' 53' ' ' LEU . 6.6 pt -132.24 134.8 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 118.671 0.669 . . . . 0.0 112.41 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -112.4 115.89 29.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.543 HD11 HD12 ' B' ' 35' ' ' ILE . 78.2 mt -115.93 110.64 32.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.018 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.31 44.27 27.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.219 -0.991 . . . . 0.0 114.19 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.7 -25.78 21.55 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.061 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -89.01 127.97 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.256 1.028 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.75 134.46 49.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.8 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.62 127.0 53.17 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -117.45 157.94 25.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 112.08 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.79 27.77 52.8 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.896 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 42' ' ' GLN . 16.3 mt -88.35 149.87 23.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.749 0.785 . . . . 0.0 112.35 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.88 171.18 9.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.443 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.8 mt-10 -67.11 -43.92 81.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.804 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.95 -38.83 92.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.021 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.7 mtp -69.55 -44.78 70.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.114 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.81 -34.36 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -63.83 -49.92 70.95 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.708 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.18 -52.69 33.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.82 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.596 HD13 HD11 ' B' ' 35' ' ' ILE . 18.4 mt -64.45 -48.38 75.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.723 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -57.9 -43.3 86.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.052 0.453 . . . . 0.0 111.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.86 81.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.305 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -40.37 96.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.62 -38.63 77.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -70.46 -29.72 66.36 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -78.85 -27.08 44.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.876 0.307 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -85.59 -33.71 21.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.718 0.294 . . . . 0.0 110.544 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -131.01 95.99 3.94 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.1 -13.42 62.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -105.91 19.48 20.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.722 0.692 . . . . 0.0 111.809 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.55 ' CG2' HG23 ' B' ' 23' ' ' VAL . 27.9 m -68.13 111.25 4.38 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.687 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.1 tp -66.41 126.94 30.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.687 ' N ' HD12 ' B' ' 65' ' ' LEU . 61.8 m-85 -113.99 131.26 56.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 111.567 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.98 141.14 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.623 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.732 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.8 p -127.47 137.21 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.47 146.14 17.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.69 155.11 16.62 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.43 24.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.893 0.378 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.66 -32.75 67.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.294 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -80.99 -5.83 58.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.24 132.04 48.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.81 151.82 36.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.557 1.505 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.724 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -63.51 -36.66 84.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 110.692 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.65 -36.57 69.69 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -71.49 -34.64 70.32 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.26 -38.17 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.461 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.724 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 49.1 mm -61.27 -47.13 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 3.2 mmtp -55.0 -44.62 74.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.971 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.96 83.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 111.086 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.78 -37.31 81.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.698 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.59 -41.56 94.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.751 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.1 mt -65.37 -39.41 92.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.031 0.444 . . . . 0.0 110.565 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.49 HD13 HD13 ' B' ' 91' ' ' ILE . 2.4 mm? -62.96 -42.59 99.87 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -63.26 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.515 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -38.13 75.93 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.509 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.607 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.28 10.17 25.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.25 44.87 97.02 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.7 mt -103.36 -37.15 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 0.0 109.768 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--O 1.24 0.584 0 N-CA-C 115.575 1.336 . . . . 0.0 115.575 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 64' ' ' THR . 49.2 t -112.77 119.24 59.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.14 127.27 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.309 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.5 tt -115.66 122.12 44.61 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.0 tt0 -111.0 127.15 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.411 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -84.73 112.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.69 -22.52 20.18 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -119.87 0.65 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.775 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' OE2' ' A' ' 78' ' ' GLU . 27.0 mm -111.87 99.4 8.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 122.905 0.482 . . . . 0.0 109.899 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.08 -2.47 87.62 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.228 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 131.29 54.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.866 0.833 . . . . 0.0 109.431 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.29 158.26 44.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.11 0.957 . . . . 0.0 112.942 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 142.64 51.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.192 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.856 HG23 HD12 ' A' ' 45' ' ' LEU . 5.4 pt -130.09 132.9 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.146 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.02 114.63 27.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 35' ' ' ILE . 81.1 mt -114.99 110.39 31.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.473 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.39 46.0 28.78 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.21 -0.995 . . . . 0.0 114.141 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.13 -24.53 24.45 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.68 -0.771 . . . . 0.0 114.308 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 127.76 36.0 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.512 1.156 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.77 133.13 50.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.956 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.86 127.22 53.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -117.45 157.65 25.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.919 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.64 26.43 56.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.918 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 35' ' ' ILE . 9.2 mt -85.38 147.58 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.276 0.538 . . . . 0.0 111.941 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -92.03 172.06 8.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.547 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.2 mt-10 -66.14 -45.45 80.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.13 -39.42 93.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.14 -0.35 . . . . 0.0 111.059 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.413 ' CE ' HD22 ' A' ' 45' ' ' LEU . 10.3 ttp -70.61 -40.94 72.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -62.82 -34.8 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -63.61 -49.95 71.29 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.47 -52.58 36.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.642 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 35' ' ' ILE . 27.2 mt -64.95 -47.69 76.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.51 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -43.47 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 111.54 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -66.25 -44.24 84.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -41.75 99.17 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.106 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.63 -39.66 73.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.89 -28.05 65.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.682 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.41 -27.03 38.15 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.223 -0.298 . . . . 0.0 111.301 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -85.73 -35.41 20.82 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -130.88 105.33 7.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.86 9.23 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -126.52 16.25 7.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 111.901 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.497 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.01 113.77 5.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.46 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 66' ' ' PHE . 8.1 tp -58.44 124.3 19.11 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.5 m-85 -113.1 131.56 55.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.819 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -135.22 140.17 45.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.744 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.65 136.94 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -140.38 147.9 19.55 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.623 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.32 154.55 16.52 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.08 23.38 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.934 0.367 . . . . 0.0 111.437 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.54 -32.73 67.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.42 -7.0 58.95 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -87.71 128.1 55.72 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.47 156.54 54.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.075 1.183 . . . . 0.0 110.08 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.8 t80 -63.65 -36.23 83.13 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.925 -0.485 . . . . 0.0 110.514 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -56.58 -36.33 69.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' OE2' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.24 -37.16 74.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.509 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 t -61.36 -39.34 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.897 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.2 mm -60.76 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.327 0.584 . . . . 0.0 109.577 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -44.84 75.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.164 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.07 86.97 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.288 0.566 . . . . 0.0 111.049 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -61.13 -36.77 80.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.586 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.52 -41.15 96.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -39.99 94.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.865 0.365 . . . . 0.0 110.729 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' A' ' 91' ' ' ILE . 1.5 mm? -63.49 -42.4 98.54 Favored 'General case' 0 C--N 1.335 -0.037 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -63.31 -42.14 99.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.421 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.66 -38.73 78.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.384 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.6 10.71 24.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' A' ' 86' ' ' LEU . 5.3 mt . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 C--O 1.241 0.651 0 N-CA-C 115.533 1.32 . . . . 0.0 115.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.48 HG23 HG22 ' B' ' 64' ' ' THR . 47.1 t -112.55 119.15 59.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.961 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -110.36 127.49 67.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.263 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.513 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.4 tt -115.98 122.43 45.22 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.513 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt0 -110.95 127.77 55.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.486 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.04 112.1 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.59 -22.63 20.21 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.65 -123.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.522 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.432 HD12 ' OE2' ' B' ' 78' ' ' GLU . 27.3 mm -107.64 99.56 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.842 -0.679 . . . . 0.0 110.121 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.05 -2.54 87.52 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 114.407 0.523 . . . . 0.0 114.407 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 131.22 54.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.644 0.722 . . . . 0.0 109.556 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -139.17 158.12 44.74 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.143 0.973 . . . . 0.0 112.954 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 142.73 51.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.069 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.845 HG23 HD12 ' B' ' 45' ' ' LEU . 5.5 pt -130.33 133.11 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.974 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.98 114.93 28.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.463 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.567 HD11 HD12 ' B' ' 35' ' ' ILE . 81.7 mt -115.27 110.1 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.391 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.39 45.67 28.74 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.256 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.81 -24.94 23.93 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.025 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.82 127.31 35.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.683 1.241 . . . . 0.0 110.393 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.2 133.2 50.37 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.115 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.74 127.14 53.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -117.43 157.39 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.969 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.83 26.37 56.23 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.845 HD12 HG23 ' B' ' 35' ' ' ILE . 9.0 mt -85.18 147.3 26.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.238 0.519 . . . . 0.0 111.778 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -91.83 172.14 8.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.441 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.441 ' O ' HG12 ' B' ' 50' ' ' VAL . 3.2 mt-10 -66.57 -45.08 80.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.18 -39.23 93.57 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.002 -0.436 . . . . 0.0 111.053 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.406 ' CE ' HD22 ' B' ' 45' ' ' LEU . 9.6 ttp -70.71 -40.91 72.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.441 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -62.81 -35.07 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -63.3 -50.23 70.87 Favored 'General case' 0 CA--C 1.523 -0.066 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.926 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.23 -52.83 32.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.624 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.451 HD13 HD11 ' B' ' 35' ' ' ILE . 30.4 mt -64.75 -47.72 77.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.85 -43.33 90.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.279 0.561 . . . . 0.0 111.661 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -66.23 -44.06 84.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.284 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -42.0 99.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.59 -39.41 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.987 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.06 -28.47 65.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.716 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.78 -27.48 40.4 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.948 0.34 . . . . 0.0 111.43 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.72 -34.85 21.14 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.949 0.404 . . . . 0.0 110.337 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -131.16 105.74 7.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.33 9.48 10.8 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -126.58 16.15 7.58 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 111.854 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.48 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.06 114.27 6.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.375 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.439 HD12 ' N ' ' B' ' 66' ' ' PHE . 7.8 tp -58.85 124.48 19.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.608 0.242 . . . . 0.0 110.534 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.439 ' N ' HD12 ' B' ' 65' ' ' LEU . 31.8 m-85 -113.51 131.36 56.09 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.799 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.34 140.18 44.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.881 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.762 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.3 p -126.76 136.03 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.42 147.68 19.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.806 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.98 154.3 16.46 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.95 165.67 23.22 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.956 0.408 . . . . 0.0 111.286 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -58.42 -32.72 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.324 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.21 -7.5 59.0 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.98 128.03 57.4 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.42 156.4 54.48 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.139 1.226 . . . . 0.0 110.165 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.39 -36.44 83.74 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.866 -0.521 . . . . 0.0 110.683 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.18 -36.39 68.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.432 ' OE2' HD12 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.38 -37.15 74.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.674 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.19 -39.59 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.674 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 47.9 mm -60.59 -47.3 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 109.64 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.06 74.36 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.216 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.63 84.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.382 0.61 . . . . 0.0 110.907 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.53 -36.72 79.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.78 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -61.72 -41.32 97.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.837 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -39.94 94.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.002 0.429 . . . . 0.0 110.684 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -63.59 -42.54 98.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.304 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.73 76.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.74 10.84 24.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.41 98.11 Favored Glycine 0 C--N 1.33 0.25 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' B' ' 86' ' ' LEU . 5.0 mt -101.9 -37.05 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.75 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo . . . . . 0 C--O 1.239 0.565 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 58.5 t -112.82 118.82 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.22 127.87 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -116.01 123.27 47.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.9 tm-20 -112.01 128.98 56.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.156 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 74' ' ' VAL . 29.3 t -88.68 96.67 6.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.181 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB3' ' HG3' ' A' ' 32' ' ' LYS . . . -76.61 -22.06 54.69 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.52 -120.65 0.65 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -112.57 101.12 12.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.019 0.527 . . . . 0.0 109.706 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.48 73.5 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.93 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -109.66 95.95 5.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.732 0.777 . . . . 0.0 110.285 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -104.83 156.65 17.82 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.294 1.045 . . . . 0.0 113.025 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.09 142.25 51.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.666 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 37' ' ' ILE . 5.3 pt -132.77 134.24 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.15 115.15 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.679 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' ILE . 48.8 mt -114.56 109.51 28.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.252 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 45.38 27.61 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.13 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.11 -25.73 22.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.071 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.47 128.07 36.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.327 1.064 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.89 136.05 47.4 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.023 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 127.48 53.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.35 157.7 25.69 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 112.228 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.53 52.55 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.12 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.614 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -87.94 147.7 24.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 112.221 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -89.71 169.88 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.629 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -65.55 -45.36 83.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.861 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -64.39 -38.77 92.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.562 ' CE ' HD22 ' A' ' 45' ' ' LEU . 11.1 ttp -72.11 -37.76 69.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.977 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.6 p -64.97 -33.36 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m -62.94 -50.3 71.35 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.448 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.13 -52.49 34.73 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.866 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -65.21 -47.36 77.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.773 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -58.7 -43.11 89.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.482 . . . . 0.0 111.592 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -65.95 -44.34 85.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.284 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.37 -41.58 98.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -69.57 -38.97 77.61 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.95 -29.75 66.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.575 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -76.91 -27.71 55.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.94 0.336 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -83.44 -35.94 24.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.846 0.355 . . . . 0.0 110.065 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.68 105.25 7.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -78.17 -15.61 58.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -105.13 19.06 21.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.359 0.527 . . . . 0.0 111.858 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 1.9 m -68.79 116.18 8.99 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -63.83 125.27 23.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.664 ' N ' HD12 ' A' ' 65' ' ' LEU . 55.6 m-85 -111.63 130.04 55.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.198 0.523 . . . . 0.0 111.627 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -135.52 139.93 44.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.67 138.65 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.32 142.81 14.08 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.5 154.0 16.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.722 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.0 23.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -31.43 69.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.515 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.12 -7.07 59.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 27' ' ' VAL . 59.8 t -89.66 131.8 38.74 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.34 155.91 55.31 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.013 1.142 . . . . 0.0 110.246 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.71 -35.46 80.63 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.842 -0.536 . . . . 0.0 110.437 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -56.6 -36.94 69.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.649 0.261 . . . . 0.0 110.402 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -36.58 75.22 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.734 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.03 -39.26 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.483 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.6 mm -60.6 -46.56 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.41 0.624 . . . . 0.0 109.404 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.65 -45.11 73.77 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.182 178.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.386 0.613 . . . . 0.0 110.657 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.6 mt -60.65 -37.11 80.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.486 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.32 -41.77 97.56 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.787 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.55 -42.89 98.35 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -62.45 -43.13 99.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.567 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -37.57 79.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.53 10.48 25.25 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.24 98.22 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.3 mt . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo . . . . . 0 C--O 1.24 0.6 0 N-CA-C 115.829 1.434 . . . . 0.0 115.829 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.564 HG23 ' CG2' ' B' ' 64' ' ' THR . 60.3 t -113.08 118.43 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.813 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.2 127.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.316 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.97 123.44 48.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.55 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.9 tm-20 -112.03 129.34 56.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.215 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 74' ' ' VAL . 28.4 t -88.91 96.48 6.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.185 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.409 ' HB3' ' HG3' ' B' ' 32' ' ' LYS . . . -76.92 -21.38 54.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.22 -125.3 0.91 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.651 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -107.65 101.9 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.016 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.45 70.55 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.006 -0.543 . . . . 0.0 114.099 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -109.58 95.57 5.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.823 0.821 . . . . 0.0 110.361 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -104.24 156.49 17.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.279 1.037 . . . . 0.0 113.093 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.0 142.14 51.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.479 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.668 HD12 HD11 ' B' ' 37' ' ' ILE . 5.6 pt -132.76 134.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.452 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.3 115.1 28.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.595 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.668 HD11 HD12 ' B' ' 35' ' ' ILE . 45.6 mt -114.51 109.71 29.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.301 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.89 45.76 25.51 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.408 -0.901 . . . . 0.0 114.179 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -25.77 21.71 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.144 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.39 128.09 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.33 1.065 . . . . 0.0 110.396 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.82 136.02 47.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.899 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.555 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.4 127.52 53.19 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.43 157.02 26.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 27.97 49.01 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.119 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.616 HD12 HG23 ' B' ' 35' ' ' ILE . 9.2 mt -87.93 148.23 24.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.653 0.74 . . . . 0.0 112.305 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -90.53 169.59 10.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.411 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.469 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.7 mt-10 -65.27 -45.36 84.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.37 -38.81 92.33 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.948 -0.47 . . . . 0.0 111.069 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.566 ' CE ' HD22 ' B' ' 45' ' ' LEU . 10.2 ttp -71.75 -37.98 70.46 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.5 p -64.75 -33.42 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.1 m -62.99 -50.29 71.33 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.506 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.09 -52.39 35.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.797 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.416 HD13 HD11 ' B' ' 35' ' ' ILE . 38.6 mt -65.25 -47.73 75.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.683 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -58.38 -43.37 88.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.077 0.465 . . . . 0.0 111.527 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -65.84 -44.4 85.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.28 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.27 -41.58 99.04 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.184 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.56 -38.84 77.59 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -69.93 -29.71 66.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.692 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -77.0 -27.78 54.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.851 0.296 . . . . 0.0 111.26 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -83.29 -35.52 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.838 0.351 . . . . 0.0 110.102 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -130.15 105.0 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.84 -15.54 58.98 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -105.38 19.57 20.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.362 0.528 . . . . 0.0 111.899 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.564 ' CG2' HG23 ' B' ' 23' ' ' VAL . 1.8 m -69.26 116.05 9.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.647 HD12 ' N ' ' B' ' 66' ' ' PHE . 0.8 OUTLIER -63.6 125.35 23.99 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.647 ' N ' HD12 ' B' ' 65' ' ' LEU . 55.4 m-85 -111.74 130.58 55.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.559 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -135.91 140.06 43.78 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.915 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.722 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -126.85 138.77 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 142.86 14.09 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.25 153.94 16.82 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 163.28 24.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.057 0.455 . . . . 0.0 111.322 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -31.44 69.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.307 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -7.15 59.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 27' ' ' VAL . 66.9 t -89.55 132.1 38.05 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.5 155.78 54.72 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.052 1.168 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.754 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.74 -35.38 80.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.863 -0.523 . . . . 0.0 110.363 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.73 -36.78 70.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.565 0.221 . . . . 0.0 110.423 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.0 -36.5 75.19 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.713 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.19 -39.2 83.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.579 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.754 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.8 mm -60.53 -46.61 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.364 0.602 . . . . 0.0 109.435 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -44.88 73.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.085 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.64 80.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.278 0.561 . . . . 0.0 110.767 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.8 mt -60.21 -37.03 79.05 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.566 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.13 -41.93 97.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.981 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.41 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.9 OUTLIER -65.69 -39.36 91.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.592 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.567 HD13 HD13 ' B' ' 91' ' ' ILE . 1.5 mm? -63.42 -42.55 98.73 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -62.75 -43.23 99.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.589 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.77 79.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.491 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.19 10.54 24.17 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.42 44.63 97.43 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.071 0.788 . . . . 0.0 115.071 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -101.84 -34.21 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.873 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo . . . . . 0 C--O 1.239 0.526 0 N-CA-C 115.663 1.37 . . . . 0.0 115.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.8 118.89 58.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.2 127.61 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.652 0.263 . . . . 0.0 111.607 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -115.88 122.65 45.99 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -110.59 127.29 55.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.207 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.7 105.27 14.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.723 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.63 -22.3 28.02 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.99 -121.55 0.72 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.956 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.15 97.97 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 122.869 0.467 . . . . 0.0 109.94 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.05 -5.3 85.02 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.956 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.04 128.55 53.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.562 0.681 . . . . 0.0 109.482 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -134.84 156.03 49.61 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.231 1.015 . . . . 0.0 112.759 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 141.53 52.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.796 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 45' ' ' LEU . 5.1 pt -132.48 133.85 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.263 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -111.36 115.52 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.561 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 35' ' ' ILE . 89.9 mt -113.69 108.92 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.281 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.69 46.74 24.46 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.65 -0.786 . . . . 0.0 114.079 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.99 15.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.082 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.3 129.24 36.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.527 1.163 . . . . 0.0 110.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -107.96 135.95 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.027 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -117.53 125.58 51.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.84 156.21 26.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.064 0.459 . . . . 0.0 111.885 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 26.95 52.81 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.959 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 42' ' ' GLN . 20.5 mt -86.96 148.7 25.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.344 0.572 . . . . 0.0 111.743 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.2 p -89.6 171.73 9.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.183 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.1 mt-10 -66.86 -44.92 79.7 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.234 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 mtp -70.22 -43.43 70.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -59.27 -34.73 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.899 0.38 . . . . 0.0 110.08 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -63.98 -50.48 68.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.824 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -50.71 -52.07 43.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.657 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.84 -47.95 76.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.46 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -57.32 -43.88 83.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 111.618 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mmt180 -66.66 -44.33 82.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.243 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -64.53 -40.02 94.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.99 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -69.94 -38.69 76.26 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.43 -31.33 69.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.9 -28.73 55.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.887 0.312 . . . . 0.0 111.239 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -82.24 -36.82 26.78 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -128.59 112.16 13.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -84.58 -10.07 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -112.45 19.67 17.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.376 0.535 . . . . 0.0 111.952 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 113.36 5.55 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.32 125.51 24.15 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -112.54 128.31 56.31 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 111.737 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' B' ' 67' ' ' LEU . 3.1 pp -132.16 139.27 48.34 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.461 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 15.0 p -127.24 137.89 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 144.62 15.84 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.6 156.61 16.01 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.833 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.51 163.21 24.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.138 0.495 . . . . 0.0 111.276 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -57.47 -31.85 66.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.649 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.01 -6.01 58.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.27 129.72 57.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' VAL . 67.9 Cg_endo -73.31 151.81 49.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.22 1.28 . . . . 0.0 110.426 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -62.94 -39.46 94.7 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.493 -0.754 . . . . 0.0 111.271 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.73 -35.58 66.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.82 -35.96 70.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.204 0.526 . . . . 0.0 109.744 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' PRO . 6.5 t -62.44 -38.82 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.439 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 76' ' ' TYR . 47.7 mm -61.04 -47.6 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -44.74 68.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.16 78.93 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.454 0.645 . . . . 0.0 110.358 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.35 -37.08 79.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.864 0.84 . . . . 0.0 109.353 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -61.32 -42.92 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 47' ' ' GLU . 7.6 mt -63.6 -39.73 95.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 110.657 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.08 -41.97 99.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.85 -41.23 97.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.7 -38.68 78.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.442 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.43 11.02 22.9 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.32 44.13 98.1 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.668 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 C--O 1.239 0.537 0 N-CA-C 115.652 1.366 . . . . 0.0 115.652 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.63 118.67 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -110.98 127.43 68.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 120.698 0.285 . . . . 0.0 111.675 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.8 tt -115.65 122.59 46.03 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -110.6 126.85 54.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.314 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.43 105.3 14.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.788 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.31 28.5 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.88 -124.71 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.778 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -109.04 97.58 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.406 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.33 -5.19 85.05 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.106 -0.569 . . . . 0.0 114.049 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 128.79 54.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -135.15 156.07 49.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.334 1.064 . . . . 0.0 112.804 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.52 141.48 52.06 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.828 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.543 HG23 HD12 ' B' ' 45' ' ' LEU . 5.1 pt -132.31 134.14 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.265 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -111.58 115.72 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.566 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.48 HD11 HD12 ' B' ' 35' ' ' ILE . 93.0 mt -113.98 108.8 26.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.276 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.85 46.47 25.42 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.015 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.91 16.53 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.046 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -90.39 129.27 36.61 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.453 1.127 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -108.37 135.96 48.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.923 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.43 126.14 52.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -116.25 156.21 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.175 0.512 . . . . 0.0 111.864 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.35 51.74 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.065 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' B' ' 42' ' ' GLN . 20.9 mt -87.27 148.89 24.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.281 0.562 . . . . 0.0 111.741 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.5 p -89.51 171.88 9.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.183 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.51 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.05 -44.85 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.508 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.19 -37.99 89.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.101 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 23.6 mtp -70.14 -43.68 70.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.51 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.8 OUTLIER -59.13 -34.65 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -64.27 -50.24 68.7 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.834 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -50.65 -51.94 44.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.02 -48.02 75.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.377 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.12 -44.05 82.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 111.561 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 2.4 mmt180 -66.65 -44.27 82.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.147 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.5 -40.25 95.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.929 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -69.91 -38.26 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.195 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -69.91 -31.3 69.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.6 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.81 -28.98 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 122.213 -0.305 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -82.06 -36.56 27.54 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -128.71 112.39 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -84.66 -10.43 57.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -112.21 19.63 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.322 0.51 . . . . 0.0 111.945 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 113.11 5.17 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.39 125.31 23.46 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -112.3 128.01 56.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 111.672 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 67' ' ' LEU . 3.3 pp -132.21 139.45 48.33 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.344 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.772 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.3 p -127.53 137.91 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.55 145.12 16.42 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.81 156.86 16.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.039 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 163.18 24.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 111.396 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -57.59 -31.82 66.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.485 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.17 -6.37 59.15 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.6 t -83.77 129.43 59.42 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.98 151.57 50.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.545 1.496 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -62.86 -39.62 94.96 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.757 -0.589 . . . . 0.0 111.23 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.42 -35.55 65.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.685 0.279 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -72.07 -35.74 69.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -62.65 -38.85 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.7 mm -60.98 -47.45 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -44.63 68.08 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.982 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.407 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.33 -48.85 80.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 110.459 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.59 -37.2 80.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.789 0.804 . . . . 0.0 109.221 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.19 -42.77 99.17 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.677 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.411 HD11 ' OE1' ' B' ' 47' ' ' GLU . 8.3 mt -63.96 -39.57 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.239 0.542 . . . . 0.0 110.831 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.67 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.32 -41.72 98.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.894 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -63.9 -41.38 97.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.59 -38.69 78.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.366 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.606 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.35 11.0 22.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.37 44.28 97.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.67 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -99.16 -36.16 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.893 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo . . . . . 0 C--O 1.239 0.564 0 N-CA-C 115.094 1.152 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 64' ' ' THR . 47.6 t -113.59 118.07 57.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' A' ' 67' ' ' LEU . 3.3 mp -109.44 127.69 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.141 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.6 tt -113.96 120.35 40.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' N ' HD23 ' A' ' 25' ' ' LEU . 8.8 tt0 -111.12 128.77 56.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.177 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 74' ' ' VAL . 38.8 t -85.29 120.84 36.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.743 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.11 -23.12 14.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.37 -121.16 0.65 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.983 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -113.55 100.56 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.98 -0.77 86.64 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.881 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.24 93.93 4.82 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.42 0.61 . . . . 0.0 110.009 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -103.37 156.01 18.06 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.11 0.957 . . . . 0.0 112.717 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -122.92 141.44 51.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.989 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.611 HD11 HD13 ' A' ' 53' ' ' LEU . 8.7 pt -131.06 133.8 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 114.24 27.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.645 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 35' ' ' ILE . 98.3 mt -116.09 110.09 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.883 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.61 42.76 28.0 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.717 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.78 -26.39 18.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.996 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.72 124.93 31.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.184 0.992 . . . . 0.0 110.526 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 130.98 52.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.632 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -119.37 127.12 52.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.69 157.87 25.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.021 0.439 . . . . 0.0 111.901 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.91 27.3 50.74 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.07 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 42' ' ' GLN . 15.4 mt -88.48 150.32 23.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.8 0.81 . . . . 0.0 112.698 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -91.32 171.59 9.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.143 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.4 mt-10 -66.49 -45.02 80.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.789 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -63.53 -39.28 94.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 mtm -69.92 -44.6 69.32 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.171 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -58.87 -33.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 m -63.89 -50.68 67.79 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.628 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -49.8 -53.23 26.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.659 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 35' ' ' ILE . 27.8 mt -64.78 -48.1 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.477 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 t -58.14 -43.12 87.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 111.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -44.1 84.62 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.499 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.66 -39.96 94.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -37.81 76.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.898 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.49 -31.15 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.641 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.01 -28.17 54.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.811 0.278 . . . . 0.0 111.249 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -83.27 -37.77 23.05 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.03 101.79 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -76.9 -1.54 29.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -121.38 19.76 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.164 0.438 . . . . 0.0 111.913 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.589 ' CG2' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.54 118.23 12.15 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.486 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -64.36 127.32 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -114.36 131.53 56.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 111.515 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.921 HD11 HG23 ' A' ' 24' ' ' ILE . 3.0 pp -135.55 141.3 45.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.023 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 83' ' ' LEU . 86.9 t -122.39 127.36 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.4 142.48 13.99 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.47 155.5 16.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.219 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.2 164.81 23.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.042 0.449 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -58.81 -32.79 69.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.51 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -80.72 -6.23 58.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 27' ' ' VAL . 77.3 t -85.64 136.82 36.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . 98.2 Cg_endo -78.75 152.24 25.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.542 1.495 . . . . 0.0 110.457 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -64.08 -38.51 91.33 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.24 -36.48 66.07 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.664 0.269 . . . . 0.0 110.538 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.09 -34.26 66.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.783 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.2 t -62.28 -39.98 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.4 mm -59.01 -48.81 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.609 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.002 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.22 70.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -60.62 -36.88 79.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.624 0.726 . . . . 0.0 109.255 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.75 -41.97 96.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.81 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 3.4 mt -65.49 -38.57 90.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.487 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.43 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.08 -42.38 99.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.009 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.5 -41.54 98.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.593 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.51 -38.3 77.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.536 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -92.29 11.67 25.06 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.18 44.59 97.24 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 114.869 0.708 . . . . 0.0 114.869 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.2 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 109.877 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo . . . . . 0 C--O 1.239 0.562 0 N-CA-C 115.104 1.155 . . . . 0.0 115.104 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.576 HG23 HG22 ' B' ' 64' ' ' THR . 47.0 t -113.09 117.88 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.938 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.21 127.97 65.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.47 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.7 tt -114.31 120.58 40.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 8.5 tt0 -111.31 128.93 56.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.137 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 74' ' ' VAL . 35.8 t -85.51 120.91 36.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.679 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 -23.18 13.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.13 -125.19 0.88 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.779 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.76 100.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.109 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.76 -0.53 86.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.119 -0.491 . . . . 0.0 114.013 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 94.5 5.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.466 0.633 . . . . 0.0 109.902 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.63 156.01 18.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.219 1.009 . . . . 0.0 112.765 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -122.76 141.91 51.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.038 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 53' ' ' LEU . 8.5 pt -131.28 133.8 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 113.9 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.79 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.536 HD11 HD12 ' B' ' 35' ' ' ILE . 99.0 mt -115.63 110.35 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.926 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.28 42.78 25.59 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.769 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -26.17 19.75 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.899 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.58 124.86 31.21 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.302 1.051 . . . . 0.0 110.561 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 131.01 52.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.644 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -119.36 126.7 52.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.51 158.05 25.22 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.063 0.459 . . . . 0.0 111.9 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 27.23 51.44 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.273 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 42' ' ' GLN . 14.7 mt -88.5 150.59 23.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.822 0.82 . . . . 0.0 112.681 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -91.68 171.5 9.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.1 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.492 ' O ' HG12 ' B' ' 50' ' ' VAL . 24.9 mt-10 -66.19 -45.18 81.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.57 -39.35 94.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.892 0.314 . . . . 0.0 111.325 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mtm -69.84 -44.65 69.46 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.351 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.492 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.67 -33.49 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.8 m -64.21 -50.4 68.2 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.736 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.09 -53.01 30.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.523 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.591 HD13 HD11 ' B' ' 35' ' ' ILE . 22.6 mt -64.98 -47.88 75.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.729 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.41 -43.43 88.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -43.88 87.04 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.581 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -64.81 -40.07 94.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.75 76.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -70.39 -31.17 68.28 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.652 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -28.38 55.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.971 0.35 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -83.07 -37.74 23.45 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.17 101.22 6.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -76.23 -1.67 27.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -121.48 19.74 11.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.281 0.491 . . . . 0.0 111.824 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.576 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.56 118.0 11.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.421 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.8 127.03 29.55 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 40.0 m-85 -114.22 131.51 56.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.938 HD11 HG23 ' B' ' 24' ' ' ILE . 3.0 pp -135.55 141.4 45.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.264 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 87.0 t -122.53 127.07 74.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.13 142.44 13.96 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.42 155.15 16.27 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.117 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.02 165.2 23.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.968 0.414 . . . . 0.0 111.229 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -59.42 -32.21 69.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.429 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -80.94 -6.93 59.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 27' ' ' VAL . 72.4 t -85.07 136.58 38.17 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.454 ' O ' HG23 ' B' ' 79' ' ' VAL . 96.1 Cg_endo -78.55 151.98 25.88 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.773 1.649 . . . . 0.0 110.385 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.5 t80 -63.88 -38.43 91.07 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.43 -0.794 . . . . 0.0 111.108 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -55.31 -36.5 66.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.68 0.276 . . . . 0.0 110.425 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.01 -34.31 66.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 109.868 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' B' ' 75' ' ' PRO . 20.1 t -62.59 -39.1 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.6 mm -60.08 -48.26 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.507 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -53.68 -43.01 68.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.076 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -51.07 71.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 110.884 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 83' ' ' LEU . 8.5 mt -60.55 -37.51 81.48 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.702 0.763 . . . . 0.0 109.116 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.798 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.6 mt -65.49 -38.46 89.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.559 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.436 HD13 HD13 ' B' ' 91' ' ' ILE . 1.2 mm? -63.27 -42.21 99.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.094 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.68 -41.63 98.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.424 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.38 -38.37 77.15 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.429 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -92.07 11.49 25.18 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.37 44.8 97.2 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -102.95 -35.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.986 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 C--O 1.239 0.562 0 N-CA-C 115.933 1.474 . . . . 0.0 115.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 HG22 ' A' ' 64' ' ' THR . 48.9 t -113.71 119.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.9 127.65 68.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.291 -178.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.481 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -114.73 121.23 42.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.17 127.18 53.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.286 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.17 118.7 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.69 -23.06 15.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.95 -120.27 0.65 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.01 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.525 HD13 ' HG2' ' A' ' 78' ' ' GLU . 28.4 mm -112.26 99.3 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 123.061 0.544 . . . . 0.0 109.793 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.75 -3.91 85.92 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.239 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 131.22 53.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 117.754 0.777 . . . . 0.0 109.897 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -138.03 157.24 46.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.134 0.969 . . . . 0.0 112.917 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 141.95 51.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.328 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 53' ' ' LEU . 8.2 pt -132.15 134.86 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.502 0.592 . . . . 0.0 112.406 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.28 115.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.488 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 HD12 ' A' ' 35' ' ' ILE . 80.7 mt -114.29 110.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.343 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.66 45.52 24.0 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.446 -0.883 . . . . 0.0 114.076 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -26.5 18.31 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.205 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.59 128.72 36.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.41 1.105 . . . . 0.0 110.356 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.31 135.95 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.007 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.565 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.07 126.86 52.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.45 156.81 27.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.103 0.477 . . . . 0.0 112.238 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.25 45.71 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.322 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.6 mt -90.27 151.99 21.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.45 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 p -92.58 171.54 8.95 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.187 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.24 -42.31 84.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.081 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -64.32 -39.46 93.96 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.073 0.463 . . . . 0.0 111.142 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.17 -43.9 69.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.288 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -59.31 -34.41 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -64.09 -49.58 71.7 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.62 -51.93 44.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.746 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 35' ' ' ILE . 31.4 mt -64.49 -48.03 76.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.527 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t -58.23 -43.73 87.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.422 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.4 85.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.314 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.47 -41.58 98.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.154 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.99 -38.06 75.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.018 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.22 -30.21 67.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.95 -27.96 49.43 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.186 -0.321 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -82.68 -36.87 25.55 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -131.55 105.68 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.38 -8.03 58.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.69 19.42 18.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.421 0.555 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.532 HG22 HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -68.96 117.84 11.13 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.2 tp -64.29 124.17 21.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.609 ' N ' HD12 ' A' ' 65' ' ' LEU . 56.2 m-85 -112.52 132.81 54.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.958 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.06 140.44 43.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.416 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.3 t -122.99 129.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.25 146.82 18.81 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.79 155.04 17.08 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.939 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.8 163.6 25.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.99 0.424 . . . . 0.0 111.248 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.73 -32.53 65.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.567 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -80.77 -5.56 57.33 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -89.79 131.07 40.66 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.46 155.69 50.37 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.152 1.235 . . . . 0.0 110.339 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.8 t80 -64.21 -34.89 79.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.787 -0.57 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -71.48 -35.75 70.91 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.79 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.57 -39.24 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.1 mm -59.92 -48.88 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.518 0.675 . . . . 0.0 109.415 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.8 ttmm -53.98 -44.6 70.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.51 178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.69 -49.05 79.01 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.353 0.597 . . . . 0.0 111.009 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' B' ' 83' ' ' LEU . 11.4 mt -61.89 -36.0 80.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 108.989 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -61.8 -42.56 99.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.039 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.2 mt -63.87 -38.74 92.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.535 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 91' ' ' ILE . 1.8 mm? -63.81 -42.15 97.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.987 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -62.86 -42.39 99.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.668 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.47 -38.45 74.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.616 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.49 11.02 20.6 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.52 44.22 98.28 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.649 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo . . . . . 0 C--O 1.239 0.552 0 N-CA-C 115.732 1.397 . . . . 0.0 115.732 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.544 HG23 HG22 ' B' ' 64' ' ' THR . 47.4 t -113.51 119.68 61.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.946 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -111.87 127.93 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.316 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.459 HD13 HD21 ' B' ' 86' ' ' LEU . 8.0 tt -115.21 120.93 41.36 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.86 127.4 54.0 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.24 118.96 33.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.14 -22.78 15.05 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.8 -124.18 0.87 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.629 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.531 HD13 ' HG2' ' B' ' 78' ' ' GLU . 29.1 mm -107.8 99.55 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.979 -0.611 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.5 -3.62 86.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 114.391 0.516 . . . . 0.0 114.391 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.53 131.22 53.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.617 0.709 . . . . 0.0 109.698 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -137.86 156.9 47.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.048 0.927 . . . . 0.0 113.007 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.24 51.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.253 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.645 HD12 HD11 ' B' ' 37' ' ' ILE . 8.0 pt -132.32 134.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.499 0.591 . . . . 0.0 112.581 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.82 114.95 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.58 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 HD12 ' B' ' 35' ' ' ILE . 74.6 mt -114.51 109.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.347 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.11 45.17 26.87 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.996 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.26 19.31 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 119.277 -0.735 . . . . 0.0 114.254 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.45 129.02 36.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.46 1.13 . . . . 0.0 110.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.49 135.83 48.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.88 -178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.568 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.17 127.07 52.97 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -117.89 156.69 28.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 112.183 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.45 27.8 46.42 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.33 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' B' ' 42' ' ' GLN . 2.7 mt -90.14 151.98 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.557 0.694 . . . . 0.0 112.495 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.1 p -92.42 171.94 8.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.31 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.448 ' O ' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER -67.67 -41.59 83.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.136 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.1 -39.91 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.897 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.5 mtm -69.82 -43.7 71.5 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.448 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.1 p -59.52 -34.6 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -63.75 -50.08 70.49 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.56 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.667 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.632 HD13 HD11 ' B' ' 35' ' ' ILE . 28.9 mt -64.51 -47.96 76.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.658 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -58.44 -42.9 88.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.421 0.629 . . . . 0.0 111.473 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -43.74 82.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.361 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -63.99 -41.5 97.49 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.877 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.09 -37.69 75.48 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.6 -30.13 66.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.594 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -78.08 -28.03 48.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.833 0.288 . . . . 0.0 111.214 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -82.63 -36.51 26.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -131.74 105.99 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.5 -8.42 59.13 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.41 19.58 18.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.899 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.544 HG22 HG23 ' B' ' 23' ' ' VAL . 0.6 OUTLIER -69.14 117.72 11.13 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.591 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.0 tp -64.34 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.591 ' N ' HD12 ' B' ' 65' ' ' LEU . 56.7 m-85 -112.28 132.97 54.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 111.151 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.946 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.95 140.53 44.06 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.291 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.01 129.46 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.34 146.97 18.96 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.16 155.46 17.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.13 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.94 163.66 25.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.989 0.423 . . . . 0.0 111.259 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -56.98 -32.88 66.54 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.59 -5.62 57.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.54 131.1 41.09 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.36 155.97 50.71 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.197 1.265 . . . . 0.0 110.242 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -64.73 -34.61 78.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.676 -0.64 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.38 -37.4 70.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.531 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.2 OUTLIER -71.17 -35.71 71.73 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.803 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.4 t -61.87 -39.23 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.509 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.9 mm -59.75 -48.87 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.404 0.621 . . . . 0.0 109.41 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.5 ttmm -53.84 -44.94 70.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.492 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.429 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.64 -49.03 79.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.451 0.643 . . . . 0.0 110.929 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.68 -36.0 79.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.741 0.782 . . . . 0.0 109.273 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.75 -42.71 99.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.073 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.0 mt -64.15 -38.47 91.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.111 0.481 . . . . 0.0 110.499 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.632 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -64.06 -42.07 97.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.889 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -62.81 -42.46 99.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.568 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.29 -38.77 74.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.657 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.44 11.23 19.9 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.38 44.46 98.01 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 115.129 0.811 . . . . 0.0 115.129 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.632 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.68 -38.07 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.659 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.479 0.621 0 N-CA-C 114.927 1.087 . . . . 0.0 114.927 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 64' ' ' THR . 45.5 t -106.72 110.09 30.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 67' ' ' LEU . 3.2 mp -107.71 126.64 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.194 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -114.65 120.69 40.98 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -109.93 126.9 54.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.323 -178.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 74' ' ' VAL . 28.8 t -85.14 109.34 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.894 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.78 -22.51 22.1 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -120.71 0.67 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.547 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.14 100.27 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.66 -4.65 84.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.972 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 131.11 54.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.439 0.62 . . . . 0.0 109.354 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -139.79 157.96 44.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.218 1.009 . . . . 0.0 113.077 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.886 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.842 HG23 HD12 ' A' ' 45' ' ' LEU . 4.3 pt -131.35 133.96 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.354 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -112.12 115.12 28.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.571 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -111.99 108.56 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.573 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.77 47.23 18.82 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.956 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.93 -27.0 18.04 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.69 -0.767 . . . . 0.0 114.002 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -90.38 128.4 36.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.464 1.132 . . . . 0.0 110.749 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -106.55 133.0 51.9 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -117.25 128.02 54.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.61 157.38 26.49 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 27.61 52.04 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.934 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 35' ' ' ILE . 9.4 mt -86.94 147.86 25.58 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.213 0.506 . . . . 0.0 112.063 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -91.92 171.99 8.75 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.588 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.8 mt-10 -66.08 -46.16 78.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.065 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.902 0.319 . . . . 0.0 111.283 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.426 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -71.53 -39.22 70.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -62.39 -34.93 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.52 -50.77 68.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.773 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -52.84 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.032 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.08 -47.25 77.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.685 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -59.18 -42.83 91.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.705 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -44.03 85.14 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.236 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -40.63 96.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.43 -28.2 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.673 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.23 -26.44 39.09 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.883 0.31 . . . . 0.0 111.277 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -85.19 -34.93 21.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.777 0.322 . . . . 0.0 110.446 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -132.87 94.78 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.96 -4.01 26.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -114.9 17.25 17.05 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.771 0.714 . . . . 0.0 111.858 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.542 ' CG2' HG23 ' A' ' 23' ' ' VAL . 2.2 m -69.28 126.42 29.73 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.2 tp -69.55 127.08 31.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 23' ' ' VAL . 8.3 m-85 -114.34 131.43 56.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.254 0.549 . . . . 0.0 111.464 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.44 140.34 44.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.662 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.759 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.2 p -126.36 135.35 64.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.22 145.66 17.21 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.45 154.59 16.4 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.986 -0.625 . . . . 0.0 111.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.15 164.07 25.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.113 0.482 . . . . 0.0 111.234 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -31.84 68.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.343 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -80.9 -6.09 58.21 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 27' ' ' VAL . 69.9 t -86.15 132.06 44.6 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.9 152.81 41.77 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.554 1.502 . . . . 0.0 110.172 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.48 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.541 0.61 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -56.21 -35.71 67.62 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.02 -36.56 72.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.03 -39.11 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.813 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.5 mm -61.89 -45.41 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 109.508 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -44.92 80.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.858 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.28 -46.71 87.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.517 0.675 . . . . 0.0 110.737 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' B' ' 83' ' ' LEU . 4.8 mt -61.37 -37.63 84.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.716 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.52 -41.55 94.64 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.838 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -39.2 91.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.432 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.529 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.41 -42.94 98.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.015 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -63.17 -41.94 99.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -37.94 76.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.351 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.99 10.08 28.05 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.21 45.11 97.19 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.6 mt . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 N--CA 1.477 0.55 0 N-CA-C 114.935 1.09 . . . . 0.0 114.935 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' B' ' 64' ' ' THR . 47.5 t -106.82 110.2 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -108.0 126.86 64.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.9 tt -114.5 120.74 41.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.456 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -110.01 127.1 54.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.189 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 31.7 t -85.3 108.85 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.37 -22.55 22.54 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.41 -124.67 0.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.253 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.73 100.99 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.16 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.69 82.64 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.208 -0.52 . . . . 0.0 114.055 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.3 130.83 54.07 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.576 0.688 . . . . 0.0 109.488 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -139.2 158.07 44.82 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.336 1.065 . . . . 0.0 113.219 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.17 142.21 51.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.803 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.862 HG23 HD12 ' B' ' 45' ' ' LEU . 4.2 pt -131.54 133.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.491 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.8 114.7 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.826 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.77 109.0 26.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.517 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.44 47.79 16.8 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.962 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -26.88 17.57 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.272 -0.738 . . . . 0.0 114.197 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -90.5 128.79 36.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.603 1.202 . . . . 0.0 110.473 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -107.04 133.3 51.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.205 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.461 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -117.53 127.94 54.48 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.388 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -117.45 157.81 25.59 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.76 52.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.553 -0.748 . . . . 0.0 113.052 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.862 HD12 HG23 ' B' ' 35' ' ' ILE . 9.3 mt -87.07 148.1 25.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 112.029 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.9 p -92.19 171.76 8.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.499 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.502 ' O ' HG12 ' B' ' 50' ' ' VAL . 29.7 mt-10 -66.01 -46.22 78.71 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.023 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.23 -39.13 93.75 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.991 -0.443 . . . . 0.0 111.134 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.421 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -71.37 -39.66 71.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.852 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.502 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -62.31 -34.83 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.53 -50.83 68.02 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.16 -52.97 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.808 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.95 -47.37 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.796 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.64 -43.26 89.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.097 0.475 . . . . 0.0 111.638 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -44.03 85.28 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.312 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.45 95.98 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -70.42 -40.06 74.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.084 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -69.23 -28.12 66.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.25 -26.8 38.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.956 0.344 . . . . 0.0 111.314 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.05 -34.56 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 110.527 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -132.95 94.73 3.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -72.11 -3.85 25.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -114.93 16.79 17.16 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.71 0.686 . . . . 0.0 111.828 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' B' ' 23' ' ' VAL . 2.0 m -68.87 126.45 29.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.386 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 66' ' ' PHE . 11.6 tp -70.28 126.91 31.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.495 ' CE2' HG11 ' B' ' 23' ' ' VAL . 8.4 m-85 -113.68 131.1 56.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.08 140.22 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.776 HG11 HD21 ' B' ' 83' ' ' LEU . 14.8 p -126.25 135.64 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.41 145.57 17.05 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.22 154.36 16.46 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.825 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 164.51 25.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -31.33 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.37 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -81.32 -6.25 58.7 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 70.7 t -85.82 132.06 45.26 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.17 153.0 40.68 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.416 1.411 . . . . 0.0 110.159 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.53 -38.28 90.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.652 0.66 . . . . 0.0 111.084 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.78 -36.14 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.85 -36.58 72.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.92 -39.2 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.681 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 46.2 mm -61.8 -45.75 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.466 0.65 . . . . 0.0 109.604 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.05 78.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.978 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.2 -46.84 87.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 110.682 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' A' ' 83' ' ' LEU . 4.9 mt -61.19 -37.97 84.86 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.758 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.23 -41.56 93.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.808 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -39.17 91.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.53 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.3 -42.94 99.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.059 179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -63.42 -41.82 98.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.99 76.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.34 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.06 10.47 26.63 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 45.12 97.12 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.6 mt -103.1 -38.31 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.931 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 N--CA 1.477 0.504 0 N-CA-C 114.945 1.094 . . . . 0.0 114.945 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.594 HG23 ' CG2' ' A' ' 64' ' ' THR . 66.3 t -116.3 124.89 73.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -116.15 127.98 73.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.606 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HD21 ' A' ' 86' ' ' LEU . 9.2 tt -115.5 125.72 53.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.03 128.84 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.811 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 74' ' ' VAL . 25.9 t -83.01 122.91 38.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.707 -1.133 . . . . 0.0 107.999 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.87 -22.78 14.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.91 -118.84 0.6 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.018 -1.086 . . . . 0.0 113.843 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mm -113.38 95.76 4.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 122.961 0.504 . . . . 0.0 109.722 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.25 -3.25 86.79 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.157 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.01 51.15 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.648 0.724 . . . . 0.0 109.443 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.44 157.92 44.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.155 0.978 . . . . 0.0 112.934 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.87 142.06 51.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.315 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.68 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.1 pt -132.64 135.46 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.04 113.88 26.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 35' ' ' ILE . 55.2 mt -109.93 106.85 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.151 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 49.31 16.62 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.082 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.35 -26.68 18.36 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.982 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.72 127.84 37.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.439 1.12 . . . . 0.0 110.315 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -105.52 136.04 45.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.157 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.14 127.83 53.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -117.84 156.97 27.47 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.14 26.93 54.24 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.087 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD22 ' CE ' ' A' ' 49' ' ' MET . 7.5 mt -87.87 149.95 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 112.412 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -92.0 169.52 10.59 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.09 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.6 pt-20 -65.37 -44.89 86.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.256 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.08 -39.1 93.32 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.119 -0.363 . . . . 0.0 111.279 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.639 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.69 -37.75 70.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.936 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -64.57 -34.05 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -63.27 -49.73 72.95 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -50.96 -51.63 50.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.769 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.17 -46.8 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.703 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.4 m -59.11 -43.63 91.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.271 0.558 . . . . 0.0 111.532 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -65.61 -44.18 87.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.349 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -63.45 -41.65 98.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.198 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.71 -38.17 76.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.26 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.805 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -77.44 -27.66 52.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 117.959 0.345 . . . . 0.0 111.345 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -35.0 25.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 110.179 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -130.94 99.32 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -72.89 -20.78 61.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.3 20.0 13.33 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.215 0.461 . . . . 0.0 111.775 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.594 ' CG2' HG23 ' A' ' 23' ' ' VAL . 19.4 m -70.34 119.11 14.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.91 126.72 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.37 135.64 53.86 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 24' ' ' ILE . 3.8 pp -138.67 141.28 39.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 83' ' ' LEU . 54.5 t -123.54 128.53 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.02 -178.89 15.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.52 156.54 27.86 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.528 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.73 164.39 23.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.051 0.453 . . . . 0.0 111.38 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.45 -32.49 68.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.48 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.05 -7.13 59.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 27' ' ' VAL . 69.9 t -85.81 130.15 51.76 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.89 155.81 43.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.129 1.219 . . . . 0.0 110.516 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.4 t80 -65.03 -34.46 78.49 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.594 -0.691 . . . . 0.0 110.27 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.43 -36.85 69.45 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -36.92 73.91 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.299 0.571 . . . . 0.0 109.716 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.17 -39.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.758 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.3 mm -59.5 -49.52 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.452 0.644 . . . . 0.0 109.711 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -55.02 -43.6 73.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.378 178.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.44 77.75 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.753 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 7.9 mt -61.12 -35.91 78.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.642 0.734 . . . . 0.0 109.095 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.28 -43.77 98.33 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.887 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.6 mt -64.67 -37.65 88.3 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.3 -41.85 96.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.374 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -63.87 -39.59 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.82 -38.95 79.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.51 11.4 24.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.62 44.68 97.63 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.821 0.688 . . . . 0.0 114.821 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.63 HD13 HD13 ' A' ' 86' ' ' LEU . 4.0 mt . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo . . . . . 0 C--O 1.236 0.405 0 N-CA-C 115.03 1.127 . . . . 0.0 115.03 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' B' ' 64' ' ' THR . 65.9 t -116.4 124.52 72.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -115.76 128.11 73.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.735 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 86' ' ' LEU . 9.4 tt -115.57 125.54 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.88 128.46 55.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.816 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.482 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.1 t -82.74 122.67 37.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.6 -23.08 14.33 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.32 -122.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.75 96.11 4.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.273 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 -3.14 87.08 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.187 -0.53 . . . . 0.0 114.116 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.34 50.67 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.708 0.754 . . . . 0.0 109.494 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.62 157.96 44.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.03 0.919 . . . . 0.0 112.944 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.96 141.66 51.87 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.383 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.678 ' CD1' HD11 ' B' ' 37' ' ' ILE . 6.1 pt -132.45 135.33 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.449 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.95 113.74 26.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD1' ' B' ' 35' ' ' ILE . 55.8 mt -109.94 106.93 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.182 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.18 49.31 19.1 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.96 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -26.57 17.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.01 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -91.36 127.63 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.489 1.144 . . . . 0.0 110.34 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -105.51 135.71 46.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.86 127.47 53.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -117.45 157.02 26.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.84 27.16 54.43 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.178 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' CE ' ' B' ' 49' ' ' MET . 7.5 mt -87.72 150.12 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -92.49 169.92 10.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.128 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.505 ' O ' HG12 ' B' ' 50' ' ' VAL . 5.6 pt-20 -65.46 -44.98 85.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.18 -39.0 93.08 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.916 -0.49 . . . . 0.0 111.283 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.629 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.71 -37.95 70.57 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.913 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -64.37 -34.1 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 45.9 m -63.12 -49.65 73.59 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.815 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -50.89 -52.11 45.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.62 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.61 -46.95 80.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.789 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 42.4 m -58.9 -43.58 91.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -65.85 -43.78 87.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.359 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -63.86 -41.86 97.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.081 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -69.56 -38.31 77.36 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.34 -30.08 66.94 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.27 -27.82 53.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.881 0.31 . . . . 0.0 111.316 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -34.67 25.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -131.32 98.98 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -72.56 -20.77 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.2 19.97 13.26 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.324 0.511 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.588 ' CG2' HG23 ' B' ' 23' ' ' VAL . 21.5 m -70.43 118.54 13.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.26 126.71 29.59 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.68 135.65 53.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.143 0.497 . . . . 0.0 111.634 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.934 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -138.73 141.65 38.9 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 83' ' ' LEU . 56.0 t -123.73 128.17 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.61 -178.86 15.57 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.04 27.28 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.644 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.63 164.57 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.01 0.433 . . . . 0.0 111.464 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -58.67 -32.49 69.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.419 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.89 -7.57 59.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 27' ' ' VAL . 77.3 t -85.38 129.88 53.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.72 155.68 44.31 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.257 1.305 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -64.88 -34.32 78.12 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.578 -0.701 . . . . 0.0 110.238 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.6 -36.87 69.9 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -36.48 73.19 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.247 0.546 . . . . 0.0 109.595 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.63 -39.38 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.6 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.9 mm -59.58 -49.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.425 0.631 . . . . 0.0 109.685 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 ttmm -55.33 -43.52 75.04 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.324 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.4 77.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.308 0.575 . . . . 0.0 110.757 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 8.6 mt -61.22 -35.82 78.24 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.687 0.755 . . . . 0.0 109.196 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.29 -43.66 98.51 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.966 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.1 mt -64.76 -38.04 89.66 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.061 0.457 . . . . 0.0 110.776 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.613 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.76 -41.71 97.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.489 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -64.22 -39.19 93.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.499 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.25 -38.7 80.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.572 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.58 44.37 98.05 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 114.708 0.643 . . . . 0.0 114.708 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -99.64 -35.01 4.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo . . . . . 0 C--O 1.239 0.572 0 N-CA-C 115.428 1.28 . . . . 0.0 115.428 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.647 HG23 HG22 ' A' ' 64' ' ' THR . 55.7 t -115.32 120.54 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.075 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -111.43 127.9 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.344 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.48 121.13 41.77 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.3 mt-10 -110.15 127.35 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.403 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -84.55 119.67 33.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.126 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.92 -23.26 14.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.67 -122.07 0.72 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.554 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.88 98.78 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 122.812 0.445 . . . . 0.0 109.937 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -3.36 87.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 114.041 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.31 54.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.54 0.67 . . . . 0.0 109.313 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -138.83 156.79 47.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.228 1.013 . . . . 0.0 113.08 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.72 141.87 51.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.895 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -133.71 135.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.514 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.45 117.21 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.959 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' OE2' ' A' ' 57' ' ' GLU . 89.9 mt -115.83 110.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.284 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.93 44.34 31.75 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.133 -1.032 . . . . 0.0 114.087 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.08 -24.88 24.76 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.982 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.5 128.48 36.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.371 1.085 . . . . 0.0 109.959 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -106.81 135.05 49.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.04 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.16 126.08 52.23 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.03 156.65 27.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.11 0.481 . . . . 0.0 111.925 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 26.91 53.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.952 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.4 mt -87.42 149.21 24.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.278 0.561 . . . . 0.0 112.077 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.7 p -90.52 171.53 9.34 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.12 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.9 pt-20 -66.58 -44.26 82.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -63.6 -38.87 92.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.5 mtp -69.89 -43.66 71.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.315 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.58 -34.73 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -63.81 -50.23 69.74 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.685 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -50.31 -52.49 36.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.747 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.7 mt -64.78 -48.33 74.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.604 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -59.27 -42.68 91.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.209 0.528 . . . . 0.0 111.605 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.74 -44.15 82.26 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.165 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.34 -39.66 94.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.884 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' A' ' 37' ' ' ILE . 8.3 mm-40 -70.82 -38.34 73.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.241 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -69.91 -31.84 69.83 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.32 -27.81 47.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.817 0.281 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -85.1 -35.16 21.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.237 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -130.95 96.98 4.19 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -75.51 -0.8 21.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.91 16.86 13.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.66 0.664 . . . . 0.0 111.841 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.647 HG22 HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -69.55 119.18 13.41 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.235 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.42 125.51 24.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -114.19 133.17 55.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.075 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.74 142.29 44.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.429 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 83' ' ' LEU . 73.1 t -123.43 126.12 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.85 145.7 17.69 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.44 154.53 16.91 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 165.1 25.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.0 110.871 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.01 -32.58 64.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -81.2 -5.63 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -84.74 131.24 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 79' ' ' VAL . 72.7 Cg_endo -75.23 152.78 40.12 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.503 1.469 . . . . 0.0 109.99 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.4 t80 -64.15 -36.94 85.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.855 0.752 . . . . 0.0 110.981 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -56.3 -36.65 68.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.79 -36.25 70.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 75' ' ' PRO . 16.5 t -61.55 -39.0 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.402 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.2 mm -59.53 -50.69 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.386 0.613 . . . . 0.0 109.452 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -44.18 70.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.442 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.37 -48.49 80.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.387 0.613 . . . . 0.0 110.659 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' B' ' 83' ' ' LEU . 10.2 mt -62.23 -36.08 80.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.69 0.757 . . . . 0.0 109.189 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -61.78 -41.9 98.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.812 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.34 -38.71 92.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 HD13 ' A' ' 91' ' ' ILE . 2.7 mm? -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.028 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -63.56 -43.09 98.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.575 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.1 -39.12 74.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.555 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.25 12.79 19.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.6 44.86 95.32 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.583 0.593 . . . . 0.0 114.583 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 89' ' ' ALA . 5.1 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 109.969 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo . . . . . 0 C--O 1.24 0.588 0 N-CA-C 115.544 1.325 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.622 HG23 HG22 ' B' ' 64' ' ' THR . 56.3 t -115.43 120.47 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.049 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.39 127.72 68.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.467 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.15 121.12 42.04 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 3.1 mt-10 -109.94 127.14 54.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.303 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.3 119.67 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.387 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.88 -23.61 14.53 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.15 -125.75 0.94 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.399 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -108.37 98.87 7.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.117 -0.542 . . . . 0.0 110.236 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.37 -3.51 86.99 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 121.123 -0.561 . . . . 0.0 114.088 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 130.52 54.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.552 0.676 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -138.99 157.11 46.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.282 1.039 . . . . 0.0 113.166 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.94 141.96 51.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.863 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.531 HG23 HD12 ' B' ' 45' ' ' LEU . 5.8 pt -133.85 135.14 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.422 0.555 . . . . 0.0 112.438 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.19 117.36 32.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.474 HG21 ' OE2' ' B' ' 57' ' ' GLU . 91.4 mt -116.27 110.54 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.086 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.62 44.59 29.88 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.213 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.99 -24.97 24.17 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.026 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.34 128.41 36.44 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.414 1.107 . . . . 0.0 110.108 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -106.73 134.56 49.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.022 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -116.73 125.77 52.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -116.55 156.8 26.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.097 0.475 . . . . 0.0 112.127 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.22 26.79 54.32 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.042 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' B' ' 42' ' ' GLN . 10.9 mt -87.4 149.61 24.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.261 0.553 . . . . 0.0 111.997 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -90.69 171.61 9.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.064 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.0 pt-20 -67.0 -44.13 81.13 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.52 -39.06 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.145 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.7 mtp -69.95 -43.46 71.52 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.68 -34.58 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 -50.18 69.54 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.532 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -50.19 -52.59 34.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.732 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.69 -48.73 73.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.573 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -58.95 -42.43 89.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 111.71 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -67.1 -44.09 80.86 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.072 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -64.24 -39.87 94.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.474 ' OE2' HG21 ' B' ' 37' ' ' ILE . 8.3 mm-40 -70.61 -38.64 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.67 -31.7 69.9 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.56 -27.61 45.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.9 0.318 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -85.16 -35.14 21.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -130.88 97.24 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -75.73 -0.79 22.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -118.83 16.39 13.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.703 0.683 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.622 HG22 HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -69.15 119.26 13.16 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.56 125.12 23.2 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -113.76 133.49 55.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 111.416 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.049 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -136.02 142.45 44.46 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' B' ' 83' ' ' LEU . 73.8 t -123.41 126.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.02 145.55 17.51 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.51 154.58 16.94 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.634 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 165.58 24.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.65 -32.39 65.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.524 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.06 -6.12 58.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.41 130.9 52.05 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.417 ' O ' HG23 ' B' ' 79' ' ' VAL . 71.8 Cg_endo -75.13 152.54 40.29 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.571 1.514 . . . . 0.0 110.003 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.1 t80 -63.92 -37.05 85.98 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.649 -0.657 . . . . 0.0 110.983 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -56.41 -36.27 68.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.0 -36.06 69.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.184 0.516 . . . . 0.0 109.637 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 75' ' ' PRO . 16.9 t -61.71 -39.18 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.488 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -59.42 -50.56 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.319 0.58 . . . . 0.0 109.469 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.19 -43.89 71.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.439 178.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.57 -48.85 79.53 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.456 0.646 . . . . 0.0 110.494 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.74 -36.16 80.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.191 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.83 -41.7 98.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.938 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -64.51 -38.56 91.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 110.439 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.428 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -64.1 -41.72 97.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -63.48 -42.98 98.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -57.37 -38.72 74.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.514 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.537 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.48 12.55 20.37 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.93 44.81 95.88 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.2 mt -106.26 -44.92 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.303 0.573 . . . . 0.0 109.682 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.963 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 C--O 1.241 0.633 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 66' ' ' PHE . 39.7 t -113.33 120.23 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.068 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -112.84 129.01 69.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.491 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.9 tt -117.58 124.9 49.79 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HD23 ' A' ' 25' ' ' LEU . 9.2 tt0 -112.91 129.62 56.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.521 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.94 109.62 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.729 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -89.38 -23.3 22.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.34 -119.39 0.62 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.45 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 mm -112.28 95.22 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.6 89.5 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.202 -0.523 . . . . 0.0 114.158 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -106.89 91.95 3.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.698 0.749 . . . . 0.0 110.061 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.34 154.32 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.184 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.36 143.61 50.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.417 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 37' ' ' ILE . 7.4 pt -133.86 135.85 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -112.85 115.97 29.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.312 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.811 HD11 HD12 ' A' ' 35' ' ' ILE . 59.6 mt -116.49 111.68 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.891 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.02 44.63 32.65 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.142 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.11 -23.87 27.45 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.859 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.57 126.54 35.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.348 1.074 . . . . 0.0 109.869 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 133.43 49.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.588 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.99 123.85 49.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.84 149.49 30.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.54 78.54 0.65 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mt -137.78 148.06 45.2 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.282 0.563 . . . . 0.0 111.629 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 p -89.64 169.33 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.513 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.3 pt-20 -67.98 -41.12 82.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.945 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.86 -38.72 91.91 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.143 -0.348 . . . . 0.0 110.95 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mtp -69.81 -45.06 68.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.75 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -57.46 -35.76 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.889 0.376 . . . . 0.0 110.233 179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -63.77 -49.99 70.8 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.853 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -53.08 27.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 35' ' ' ILE . 3.7 mt -65.21 -48.38 73.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.558 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -58.63 -43.03 89.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.577 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.68 -43.82 83.45 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.229 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -63.51 -41.42 98.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.877 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -37.73 76.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -70.83 -29.94 66.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.477 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.88 -27.62 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.844 0.293 . . . . 0.0 110.867 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -82.12 -38.25 25.07 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -129.2 110.46 12.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -82.51 7.29 14.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -127.09 20.32 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.145 0.43 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 113.23 5.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -61.36 123.54 18.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 23' ' ' VAL . 43.6 m-85 -114.26 133.09 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.068 HD11 HG23 ' A' ' 24' ' ' ILE . 2.1 pp -132.96 141.42 48.32 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.258 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 83' ' ' LEU . 53.4 t -123.55 124.79 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.42 142.3 13.57 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.9 154.99 16.23 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.687 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.88 163.38 24.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.357 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -31.44 69.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.98 -6.61 58.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.1 t -89.93 135.34 30.39 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.42 154.99 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.021 1.147 . . . . 0.0 110.373 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.767 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -63.79 -35.5 80.81 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.399 -0.813 . . . . 0.0 110.48 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.36 -36.75 66.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.415 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -34.53 67.27 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.835 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.41 -38.98 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 50.3 mm -59.19 -49.48 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.0 mttp -53.31 -44.35 68.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.283 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -51.95 67.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' B' ' 83' ' ' LEU . 9.9 mt -60.24 -36.73 78.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -62.24 -41.53 98.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.541 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 6.9 mt -64.13 -39.25 93.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.115 0.483 . . . . 0.0 110.675 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.87 -41.8 97.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.12 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.35 -41.18 98.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.359 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.26 -38.37 76.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.31 10.61 24.19 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.22 44.69 97.79 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.587 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo . . . . . 0 C--O 1.239 0.56 0 N-CA-C 115.258 1.215 . . . . 0.0 115.258 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' B' ' 66' ' ' PHE . 40.0 t -113.5 120.09 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 129.3 68.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.392 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.451 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -117.64 124.97 49.87 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.43 ' N ' HD23 ' B' ' 25' ' ' LEU . 9.8 tt0 -113.09 129.36 56.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.63 109.38 18.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.664 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -89.14 -23.52 22.44 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.72 -123.53 0.84 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.24 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.25 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.17 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.97 0.46 89.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.085 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -106.79 92.12 3.96 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.705 0.752 . . . . 0.0 110.156 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.13 154.26 18.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.265 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.18 143.86 50.73 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 37' ' ' ILE . 7.3 pt -133.8 135.86 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.3 t -112.93 116.11 29.47 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.291 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.808 HD11 HD12 ' B' ' 35' ' ' ILE . 61.1 mt -116.71 111.42 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.957 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.23 44.49 34.45 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.12 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.15 -23.71 28.29 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.781 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.64 126.61 35.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.334 1.067 . . . . 0.0 109.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 133.69 49.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.483 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.23 123.97 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -110.94 149.41 30.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.51 78.97 0.63 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.11 148.33 44.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.453 0.644 . . . . 0.0 111.475 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.6 p -89.9 169.39 11.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.499 ' O ' HG12 ' B' ' 50' ' ' VAL . 8.4 pt-20 -68.0 -41.39 82.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.39 -38.83 92.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 33.7 mtp -69.88 -44.97 68.68 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.831 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.5 OUTLIER -57.62 -35.43 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.916 0.388 . . . . 0.0 110.143 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 26.6 m -64.1 -49.69 71.23 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.045 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -53.32 27.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.646 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.487 HD13 ' CD1' ' B' ' 35' ' ' ILE . 4.3 mt -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.439 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.48 -43.59 89.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.11 0.481 . . . . 0.0 111.53 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.38 -43.52 85.69 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.02 -40.71 96.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 -37.91 75.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.66 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -70.55 -29.93 66.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.747 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.03 -27.98 54.74 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.234 -0.291 . . . . 0.0 110.868 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.99 -37.93 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -129.61 110.19 11.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.07 6.98 14.58 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -127.07 20.45 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.22 0.464 . . . . 0.0 111.895 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.89 113.66 5.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.461 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.66 123.48 18.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.403 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 44.9 m-85 -114.05 133.09 55.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.546 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 2.1 pp -133.02 141.33 48.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.144 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.611 HG11 HD23 ' B' ' 83' ' ' LEU . 54.8 t -123.46 124.61 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.44 141.95 13.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.33 155.51 16.06 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 163.87 23.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 111.259 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -31.25 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.335 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -81.17 -6.81 59.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.79 135.01 31.01 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.27 155.27 41.69 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.071 1.181 . . . . 0.0 110.153 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.5 t80 -64.02 -35.52 80.99 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.467 -0.771 . . . . 0.0 110.377 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.42 -37.12 67.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.94 -35.18 69.54 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.067 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -61.84 -39.22 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.349 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.3 mm -59.04 -48.91 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.485 0.659 . . . . 0.0 109.42 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 13.1 mttp -53.85 -44.2 70.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.401 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.11 -51.68 68.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.292 0.568 . . . . 0.0 110.96 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 83' ' ' LEU . 9.9 mt -60.56 -36.55 78.73 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.781 0.801 . . . . 0.0 109.196 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.37 -41.6 98.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.62 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.7 mt -64.02 -38.92 92.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.666 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.6 HD13 HD13 ' B' ' 91' ' ' ILE . 1.3 mm? -63.93 -41.99 97.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -63.48 -40.95 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.581 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.36 -38.67 77.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.32 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.22 10.64 23.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.6 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.23 -35.25 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 C--O 1.238 0.523 0 N-CA-C 115.725 1.394 . . . . 0.0 115.725 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.8 t -113.75 122.18 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -112.48 127.95 69.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.439 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.7 tt -115.08 121.85 44.32 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 8.4 mt-10 -110.11 126.46 54.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.323 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.7 119.71 34.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.56 -22.75 15.33 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.54 -117.84 0.56 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.842 -1.171 . . . . 0.0 114.009 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.36 101.11 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 109.788 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.14 82.46 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.702 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 129.52 53.99 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.553 0.676 . . . . 0.0 109.384 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -138.13 156.11 48.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.79 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -125.77 144.12 50.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.195 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 53' ' ' LEU . 8.4 pt -133.72 135.72 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.853 0.752 . . . . 0.0 113.027 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -113.19 116.87 30.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 35' ' ' ILE . 89.4 mt -116.35 111.64 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.814 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.7 46.18 30.78 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.357 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.73 -25.24 19.98 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.662 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.6 127.34 35.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.126 0.963 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 134.57 48.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.472 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -114.87 123.35 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -110.4 148.48 31.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 78.81 0.69 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mt -136.96 148.66 47.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.139 0.495 . . . . 0.0 111.127 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 p -91.26 171.3 9.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.638 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.06 -42.13 80.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.44 -38.8 92.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.004 0.431 . . . . 0.0 110.711 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -70.04 -46.61 64.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.349 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.09 -35.63 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.775 0.321 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -64.12 -49.34 72.55 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.76 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.51 -52.49 38.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.706 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 35' ' ' ILE . 15.6 mt -64.94 -47.69 76.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.624 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -58.93 -43.31 91.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.117 0.484 . . . . 0.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.49 -44.09 83.59 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.363 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -63.46 -40.58 97.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.913 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.75 -38.88 76.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.196 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -69.66 -30.65 68.38 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -78.14 -28.08 48.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.859 0.299 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -84.36 -34.94 23.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.92 0.391 . . . . 0.0 110.018 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -130.19 95.68 3.98 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -68.9 -7.87 38.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -113.78 19.46 16.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.547 0.612 . . . . 0.0 112.096 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 4.0 m -69.04 117.0 10.14 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 125.24 23.59 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -114.37 133.88 55.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.27 141.99 43.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 83' ' ' LEU . 79.6 t -123.57 129.13 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.23 146.57 18.38 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.47 16.76 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.925 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.09 165.18 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.469 . . . . 0.0 110.999 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -57.11 -32.64 66.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.341 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.23 -5.84 58.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.81 135.21 30.73 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.39 156.92 29.17 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.131 1.221 . . . . 0.0 110.631 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.759 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -65.15 -33.88 77.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.614 -0.679 . . . . 0.0 110.506 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -57.07 -37.55 72.02 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.256 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.52 70.77 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.85 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -62.66 -39.02 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.323 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.4 mm -59.32 -48.91 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 109.591 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.67 -44.8 69.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.385 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.05 -49.64 76.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.327 0.584 . . . . 0.0 110.99 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -62.38 -36.58 82.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.545 0.688 . . . . 0.0 109.234 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.7 -43.28 97.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.814 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 8.8 mt -65.29 -38.06 89.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 110.706 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -63.77 -42.04 97.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.149 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -62.93 -41.98 99.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.47 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.66 -38.58 78.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.68 10.97 23.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.77 97.62 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.8 mt . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 C--O 1.24 0.607 0 N-CA-C 115.736 1.399 . . . . 0.0 115.736 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.546 HG23 ' CG2' ' B' ' 64' ' ' THR . 56.8 t -113.65 122.31 67.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.006 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -112.83 127.99 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.312 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.492 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -115.2 121.83 44.16 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 8.7 mt-10 -109.96 126.44 53.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.362 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.54 119.7 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.76 -22.32 15.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.33 -122.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.717 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -108.12 101.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.04 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.26 80.29 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.897 -0.592 . . . . 0.0 114.017 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 129.57 53.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 117.426 0.613 . . . . 0.0 109.429 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.16 156.09 48.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.599 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.62 144.18 50.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.164 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.561 HD11 HD13 ' B' ' 53' ' ' LEU . 8.4 pt -133.69 135.8 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -113.46 116.93 30.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.052 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.538 HD11 HD12 ' B' ' 35' ' ' ILE . 91.3 mt -116.43 111.53 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.99 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.68 46.08 30.69 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.251 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.82 -25.17 20.6 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.669 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.54 126.97 35.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.242 1.021 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 134.73 48.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.457 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.417 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.96 123.11 48.28 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.14 148.47 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 78.71 0.71 Allowed Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' B' ' 42' ' ' GLN . 4.1 mt -137.03 148.32 46.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.081 0.467 . . . . 0.0 111.149 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -90.99 171.43 9.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.65 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.427 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.1 pt-20 -67.86 -42.17 81.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.874 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.55 -39.01 92.96 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.078 -0.389 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mtm -69.99 -46.55 64.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.09 -36.08 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 51.6 m -63.72 -49.42 73.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.764 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.58 -52.03 42.94 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.738 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.561 HD13 HD11 ' B' ' 35' ' ' ILE . 15.2 mt -65.28 -47.67 75.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.631 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -59.13 -43.04 91.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 111.518 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -66.65 -43.96 83.19 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.343 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.56 -40.52 97.19 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.76 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -38.66 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -69.79 -30.93 68.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -78.27 -28.05 47.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.852 0.296 . . . . 0.0 111.459 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -84.42 -34.94 23.41 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -130.12 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -69.18 -7.6 37.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -113.96 19.28 16.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.565 0.62 . . . . 0.0 111.958 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.546 ' CG2' HG23 ' B' ' 23' ' ' VAL . 3.9 m -68.87 116.86 9.84 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.58 125.16 23.34 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -114.39 134.04 55.27 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.974 0.416 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.006 HD11 HG23 ' B' ' 24' ' ' ILE . 3.3 pp -136.57 141.73 43.33 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.409 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.518 HG11 ' CD2' ' B' ' 83' ' ' LEU . 78.8 t -123.31 129.62 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.49 18.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.05 154.47 16.78 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.03 165.37 24.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 0.0 111.061 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -57.25 -32.76 66.9 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.361 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.0 -6.38 58.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.18 135.49 31.39 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.9 156.82 27.19 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.227 1.285 . . . . 0.0 110.558 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -65.06 -33.89 77.13 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.792 -0.567 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.27 -37.59 72.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.53 70.78 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.882 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.4 t -62.66 -38.93 82.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -59.52 -48.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.334 0.588 . . . . 0.0 109.602 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -44.76 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.277 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.15 -49.38 77.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.321 0.581 . . . . 0.0 111.039 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -62.66 -36.29 82.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.58 0.705 . . . . 0.0 109.34 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -60.83 -43.55 98.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.871 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.02 -38.14 89.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 110.598 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -63.65 -41.91 98.18 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.195 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -63.08 -41.97 99.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -58.62 -38.46 78.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.399 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.57 10.75 24.25 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.23 44.71 97.75 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.9 mt -101.34 -36.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.854 -179.651 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo . . . . . 0 C--O 1.239 0.555 0 N-CA-C 115.405 1.271 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 66' ' ' PHE . 22.1 t -110.67 120.7 62.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -114.3 128.97 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -115.75 122.48 45.62 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.39 128.28 56.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.13 119.16 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.2 -22.16 15.77 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -119.85 0.64 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.945 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -112.84 100.64 11.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -2.84 83.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.755 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.14 53.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.539 0.669 . . . . 0.0 109.301 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -137.15 156.37 48.43 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.068 0.937 . . . . 0.0 112.576 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.23 142.34 51.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.138 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.558 HG23 HD12 ' A' ' 45' ' ' LEU . 5.8 pt -131.6 134.89 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.459 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.97 113.89 26.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.545 0.688 . . . . 0.0 110.263 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.15 110.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.422 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 42.94 49.37 6.23 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.298 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.12 -37.35 3.44 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.799 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.4 119.12 14.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.846 0.323 . . . . 0.0 111.113 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -105.37 128.39 53.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.85 126.57 52.64 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.86 157.25 26.99 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 25.58 56.49 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.176 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 42' ' ' GLN . 12.7 mt -86.98 149.97 24.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.307 0.575 . . . . 0.0 111.929 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.75 171.7 8.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.269 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.1 pt-20 -67.68 -42.91 81.34 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.143 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.09 -39.22 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -69.76 -45.9 67.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.395 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 35' ' ' ILE . 2.0 p -58.51 -34.85 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 m -62.95 -50.22 71.64 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.27 -52.76 33.64 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.828 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.94 -47.84 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.7 m -59.52 -42.67 92.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -66.2 -44.78 82.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.32 99.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.47 -39.8 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -69.91 -29.8 67.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.65 -28.44 45.42 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.723 0.238 . . . . 0.0 111.515 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -83.57 -35.76 24.49 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.08 106.21 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.7 6.21 13.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -125.53 17.97 8.15 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.613 0.642 . . . . 0.0 111.908 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.08 114.57 5.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.863 -0.153 . . . . 0.0 111.212 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.45 122.67 14.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 23' ' ' VAL . 12.9 m-85 -113.34 134.39 54.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.072 0.463 . . . . 0.0 111.294 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -138.15 141.34 40.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.405 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 96.7 t -122.99 127.67 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.12 146.79 18.78 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.5 155.0 16.96 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.021 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.51 164.5 24.66 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 120.922 0.391 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -56.97 -33.24 66.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.512 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.25 -5.64 56.54 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.69 134.58 31.99 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 79' ' ' VAL . 73.8 Cg_endo -77.26 156.72 33.33 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.28 1.32 . . . . 0.0 110.006 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.705 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.4 t80 -64.86 -35.62 81.73 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.666 -0.646 . . . . 0.0 110.683 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.57 -37.36 70.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.712 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.9 t -62.54 -39.28 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.442 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.705 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.7 mm -60.17 -47.4 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.26 178.595 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.2 -48.92 79.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.589 . . . . 0.0 110.863 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' B' ' 83' ' ' LEU . 10.0 mt -60.56 -37.1 80.18 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.527 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -61.23 -41.67 97.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.975 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.8 mt -66.12 -38.31 87.87 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 110.553 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 25' ' ' LEU . 1.2 mm? -63.89 -42.12 97.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -63.15 -43.3 98.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.12 -38.77 73.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.3 12.16 19.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.42 44.87 96.31 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 4.4 mt . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo . . . . . 0 C--O 1.241 0.63 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' B' ' 66' ' ' PHE . 21.9 t -110.54 120.72 61.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.999 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -114.25 128.58 71.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.573 HD13 HD21 ' B' ' 86' ' ' LEU . 7.9 tt -115.5 122.64 46.32 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -112.45 128.07 56.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.709 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.72 119.22 33.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.64 -21.88 15.66 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.75 -124.17 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.565 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.78 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.27 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -2.8 82.28 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.01 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.18 53.76 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.18 156.59 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.128 0.966 . . . . 0.0 112.592 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.46 142.4 51.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.117 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.571 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -131.95 134.91 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.345 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.2 114.21 26.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.601 0.715 . . . . 0.0 110.119 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.32 110.17 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.458 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 42.71 49.71 5.96 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.24 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -37.37 3.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.863 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.13 118.58 13.14 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.855 0.328 . . . . 0.0 111.158 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -104.72 128.84 52.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.573 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.41 126.58 52.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.9 157.45 26.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 25.38 57.1 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.118 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 42' ' ' GLN . 13.0 mt -86.84 149.92 24.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.382 0.591 . . . . 0.0 112.078 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.68 171.53 9.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.504 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.423 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 pt-20 -67.52 -42.82 82.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.34 -39.47 92.43 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 34.5 mtp -69.42 -45.83 68.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.472 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.447 HG23 HG21 ' B' ' 35' ' ' ILE . 2.0 p -58.74 -34.39 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 110.166 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -63.23 -50.12 71.47 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.922 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.55 -52.78 35.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -64.86 -47.5 77.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.331 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -60.01 -42.42 94.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.145 0.498 . . . . 0.0 111.614 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.26 -44.72 82.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.243 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.03 99.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.908 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -70.03 -39.51 75.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.102 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -70.0 -29.75 66.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.665 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.69 -28.79 45.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.754 0.252 . . . . 0.0 111.535 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.16 -35.73 25.29 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.04 106.06 8.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.46 6.06 13.39 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -125.37 17.85 8.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.622 0.646 . . . . 0.0 111.918 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.402 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -67.09 114.84 6.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.893 -0.14 . . . . 0.0 111.22 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tp -59.64 122.89 15.24 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' B' ' 23' ' ' VAL . 13.3 m-85 -113.58 133.94 54.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.173 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.999 HD11 HG23 ' B' ' 24' ' ' ILE . 3.6 pp -137.9 141.34 40.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.417 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.498 ' HB ' HD21 ' B' ' 83' ' ' LEU . 98.6 t -123.2 127.91 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.05 146.71 18.7 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.13 154.97 16.8 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 121.127 -0.558 . . . . 0.0 111.959 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.44 165.25 23.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -57.95 -32.88 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.513 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.2 -6.18 57.36 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -89.35 134.53 32.64 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.402 ' O ' HG23 ' B' ' 79' ' ' VAL . 70.0 Cg_endo -77.47 156.83 32.6 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.201 1.268 . . . . 0.0 110.256 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.3 t80 -64.85 -35.92 82.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.713 -0.617 . . . . 0.0 110.592 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -56.46 -37.36 70.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -35.61 73.34 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.772 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 75' ' ' PRO . 18.6 t -62.31 -39.26 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.596 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.21 -47.08 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.408 0.623 . . . . 0.0 109.469 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.2 OUTLIER -54.59 -44.93 73.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.276 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.451 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.48 -48.79 80.31 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.322 0.582 . . . . 0.0 110.809 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 83' ' ' LEU . 10.0 mt -60.8 -36.76 79.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.392 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -61.33 -41.92 97.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.039 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.7 mt -65.77 -38.58 89.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.573 HD21 HD13 ' B' ' 25' ' ' LEU . 1.2 mm? -63.69 -42.15 98.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.2 -43.35 98.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.437 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -39.1 74.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.707 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 12.02 18.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.65 44.75 96.6 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 4.3 mt -103.03 -35.77 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.499 . . . . 0.0 109.943 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.051 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.479 0.635 0 N-CA-C 114.542 0.939 . . . . 0.0 114.542 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.0 118.11 52.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.8 128.27 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.71 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -114.3 121.42 43.61 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.4 tm-20 -110.46 127.14 55.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.29 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.85 123.43 39.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.457 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.52 -22.49 13.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.3 -120.75 0.68 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.64 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.44 95.97 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.762 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.87 -3.52 85.94 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.949 -0.569 . . . . 0.0 114.406 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 132.28 52.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.488 0.644 . . . . 0.0 109.375 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -139.93 158.03 44.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.172 0.986 . . . . 0.0 112.985 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -125.64 141.85 51.81 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.748 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 45' ' ' LEU . 4.5 pt -134.19 135.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.704 0.684 . . . . 0.0 112.706 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.35 115.52 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.694 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.89 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.245 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.45 48.31 16.58 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.848 -0.691 . . . . 0.0 114.215 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.29 -25.83 22.41 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.814 -0.708 . . . . 0.0 114.135 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.72 129.63 38.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.501 1.15 . . . . 0.0 110.501 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.1 135.69 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.11 127.96 54.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -118.13 156.09 29.3 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.94 26.88 47.79 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.304 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.7 mt -88.46 150.15 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.344 0.572 . . . . 0.0 112.303 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.3 p -91.72 170.6 9.77 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.545 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' O ' HG12 ' A' ' 50' ' ' VAL . 13.7 pt-20 -65.02 -47.25 78.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.9 -38.75 92.17 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.133 -0.355 . . . . 0.0 111.38 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.3 ttp -71.57 -39.04 70.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.668 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -62.78 -32.8 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 m -63.79 -50.21 69.88 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.539 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.11 -52.3 36.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.88 -48.08 75.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.462 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.6 m -58.65 -42.56 88.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.086 0.469 . . . . 0.0 111.548 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 9.2 mmm180 -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.284 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.72 -40.98 98.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.912 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.64 -38.4 80.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.598 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -70.82 -30.89 67.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.849 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.15 -28.09 54.05 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -83.65 -33.82 25.17 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.296 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -129.65 109.12 10.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.97 5.26 19.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -125.91 17.45 7.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.458 0.572 . . . . 0.0 111.893 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.05 113.94 5.43 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.083 0.153 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 66' ' ' PHE . 3.3 tp -61.38 123.05 16.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.557 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.9 m-85 -111.11 130.39 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.393 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -137.63 141.24 41.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.325 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 83' ' ' LEU . 69.2 t -123.83 131.3 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.73 146.88 18.75 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.34 152.85 16.74 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.9 165.15 25.07 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -33.06 67.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.398 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -81.54 -5.82 58.37 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.6 t -89.77 131.56 39.27 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.95 155.47 53.02 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.337 1.358 . . . . 0.0 110.403 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.2 t80 -65.11 -34.24 77.93 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.493 -0.754 . . . . 0.0 110.577 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.74 -37.1 70.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.72 0.295 . . . . 0.0 110.254 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -36.08 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.847 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.26 -39.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.573 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.7 mm -60.39 -46.96 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.503 0.668 . . . . 0.0 109.436 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.63 -45.5 70.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.312 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.12 78.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.346 0.593 . . . . 0.0 111.19 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' B' ' 83' ' ' LEU . 7.7 mt -61.57 -36.78 81.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.6 0.714 . . . . 0.0 109.505 177.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -60.84 -42.95 98.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.904 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.37 -38.95 91.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.059 0.457 . . . . 0.0 110.58 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.517 HD13 HD13 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.38 -41.89 98.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.159 179.264 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -63.17 -43.68 97.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.9 -38.5 72.9 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.76 12.08 20.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.2 44.71 97.14 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.0 mt . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo . . . . . 0 N--CA 1.477 0.533 0 N-CA-C 114.668 0.988 . . . . 0.0 114.668 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.83 117.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.78 128.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.788 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -114.6 121.45 43.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 9.4 tm-20 -110.42 127.09 54.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.437 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 123.11 38.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.484 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.29 -22.46 13.7 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.85 -124.37 0.89 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.712 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -107.66 95.99 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 114.916 -0.642 . . . . 0.0 110.202 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -3.25 86.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.133 -0.556 . . . . 0.0 114.375 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 132.31 52.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.547 0.674 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -139.69 158.12 44.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.2 1.0 . . . . 0.0 113.042 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.07 141.77 51.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.682 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 45' ' ' LEU . 4.9 pt -134.33 136.51 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.536 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 115.23 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.565 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.76 108.7 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.381 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.41 47.98 16.53 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.037 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.45 20.14 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -92.34 129.61 38.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.456 1.128 . . . . 0.0 110.498 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.01 136.01 47.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.87 127.33 53.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.035 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -117.89 156.36 28.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 112.418 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.76 26.83 48.77 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.428 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' B' ' 42' ' ' GLN . 11.9 mt -88.44 150.23 23.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.465 0.65 . . . . 0.0 112.206 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 16.9 p -91.72 170.03 10.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.529 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.562 ' O ' HG12 ' B' ' 50' ' ' VAL . 13.7 pt-20 -64.68 -47.25 79.07 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.273 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.96 -38.8 92.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.1 ttp -71.6 -39.08 70.76 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.614 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.562 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -62.61 -33.19 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 m -63.59 -49.89 71.57 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.638 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.67 -51.66 47.19 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.823 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.26 -48.09 74.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -58.4 -43.16 88.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.705 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.401 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 9.3 mmm180 -66.19 -44.16 84.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.296 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.03 -40.8 97.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -68.57 -38.81 81.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.356 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.54 -31.09 68.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -77.07 -27.8 54.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.833 0.288 . . . . 0.0 111.528 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -84.05 -33.68 24.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -129.81 108.85 10.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -81.69 5.18 19.17 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.17 17.98 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.248 0.476 . . . . 0.0 111.939 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.42 113.64 5.46 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.135 0.174 . . . . 0.0 111.221 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.54 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.3 tp -61.12 122.8 15.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.54 ' N ' HD12 ' B' ' 65' ' ' LEU . 32.5 m-85 -110.9 130.89 55.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.237 0.542 . . . . 0.0 111.47 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.918 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -138.16 141.26 40.09 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.098 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.416 HG11 HD23 ' B' ' 83' ' ' LEU . 71.4 t -123.92 131.71 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.84 18.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.91 153.06 16.68 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.636 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.3 165.3 24.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -33.3 67.29 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -81.18 -6.17 58.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -89.44 131.51 40.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.22 155.33 51.78 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.276 1.317 . . . . 0.0 110.451 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.82 -34.33 78.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.514 -0.741 . . . . 0.0 110.656 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.92 -36.71 70.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.758 0.314 . . . . 0.0 110.239 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 -35.69 72.43 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.606 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.8 -38.77 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.439 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.764 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.3 mm -60.58 -47.15 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.546 0.689 . . . . 0.0 109.372 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.38 -45.73 69.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.05 79.01 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.296 0.57 . . . . 0.0 111.181 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -61.95 -35.95 79.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.356 0.598 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.68 -42.79 99.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.633 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.2 -38.96 92.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.68 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.494 HD13 HD13 ' B' ' 91' ' ' ILE . 0.6 OUTLIER -63.72 -42.01 98.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.965 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -62.94 -43.91 97.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.44 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.79 -38.22 72.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.615 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.95 11.94 21.2 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.95 96.98 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.1 mt -101.66 -35.09 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.935 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 114.186 0.802 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG11 ' CE1' ' A' ' 66' ' ' PHE . 18.5 t -103.67 110.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -110.33 127.78 67.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD21 ' A' ' 86' ' ' LEU . 7.7 tt -115.69 120.67 40.13 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 14.3 tt0 -110.1 127.19 54.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.577 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.39 114.89 25.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.269 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.13 -22.63 17.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -120.35 0.65 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.436 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -114.35 96.79 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 122.892 0.477 . . . . 0.0 109.767 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 -4.5 85.89 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.713 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 129.67 51.74 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -137.61 156.12 48.42 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.15 0.976 . . . . 0.0 112.805 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -126.1 141.88 51.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.296 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 HD12 ' A' ' 45' ' ' LEU . 4.7 pt -131.16 134.61 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.322 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.1 114.74 27.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.675 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' CD1' ' A' ' 35' ' ' ILE . 80.9 mt -112.18 108.78 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.951 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 48.02 20.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.892 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.01 20.55 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.137 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -92.41 130.03 38.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.505 1.152 . . . . 0.0 110.482 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -108.44 136.95 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.157 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -118.79 127.74 53.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -117.48 156.03 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.104 0.478 . . . . 0.0 112.217 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 25.91 53.11 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.552 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 42' ' ' GLN . 17.1 mt -86.93 149.21 24.95 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.542 0.687 . . . . 0.0 112.208 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 p -91.88 171.44 9.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.419 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' VAL . 11.6 pt-20 -66.62 -44.29 82.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.244 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.79 -39.26 93.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.498 ' HE2' HD22 ' A' ' 45' ' ' LEU . 5.8 ttp -71.17 -41.45 70.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.973 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.2 p -61.66 -34.43 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.55 -50.23 70.32 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.857 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.57 -52.03 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.759 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.84 -47.96 76.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.6 -43.6 84.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.218 0.532 . . . . 0.0 111.672 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.48 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -66.35 -44.46 83.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.281 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.93 -40.13 95.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.178 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' OE2' HG22 ' A' ' 23' ' ' VAL . 4.4 tt0 -69.58 -38.83 77.51 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.401 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.28 -30.38 67.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.65 -27.43 45.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 117.885 0.311 . . . . 0.0 111.249 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -84.77 -35.64 22.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.916 0.388 . . . . 0.0 110.029 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -130.94 101.28 5.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.12 1.12 16.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -116.78 18.34 14.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.614 0.643 . . . . 0.0 111.955 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.68 115.21 7.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.47 126.44 27.84 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE1' HG11 ' A' ' 23' ' ' VAL . 58.9 m-85 -113.61 129.67 56.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.171 0.51 . . . . 0.0 111.592 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -135.24 140.84 45.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG11 HD23 ' A' ' 83' ' ' LEU . 81.3 t -122.54 127.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.97 145.8 17.66 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 155.35 16.73 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.084 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.68 166.86 22.91 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.086 0.469 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -57.88 -34.16 69.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.323 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -80.95 -5.11 57.08 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.9 133.45 41.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.81 152.86 32.94 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.495 1.463 . . . . 0.0 110.34 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -63.41 -37.4 87.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.73 0.696 . . . . 0.0 110.722 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.82 -35.74 66.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.49 -34.82 67.92 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.705 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.0 -38.63 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.76 -47.52 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.329 0.585 . . . . 0.0 109.564 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -54.46 -44.27 72.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.22 78.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.342 0.592 . . . . 0.0 111.242 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 5.9 mt -60.87 -36.97 80.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.79 -41.85 96.38 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.825 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.3 -39.17 92.17 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.514 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.34 -42.27 98.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.074 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -63.72 -41.81 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -38.64 77.34 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.08 11.41 23.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.89 44.62 97.87 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.7 mt . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo . . . . . 0 N--CA 1.481 0.749 0 N-CA-C 114.436 0.898 . . . . 0.0 114.436 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.528 HG11 ' CE1' ' B' ' 66' ' ' PHE . 16.2 t -103.64 109.79 28.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.02 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -110.04 127.3 67.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.192 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.49 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.7 tt -115.06 120.59 40.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 14.4 tt0 -110.04 127.31 54.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.435 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.67 114.79 25.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.038 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 -22.89 17.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.86 -124.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.299 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -109.7 97.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.04 -0.58 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -4.17 86.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.916 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 129.92 52.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.75 155.98 48.47 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.115 0.96 . . . . 0.0 112.795 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.06 141.66 51.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.322 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.593 HG23 HD12 ' B' ' 45' ' ' LEU . 4.5 pt -130.84 134.8 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.301 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.36 114.89 27.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.439 0.638 . . . . 0.0 109.624 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.541 HD11 ' CD1' ' B' ' 35' ' ' ILE . 78.1 mt -112.27 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.775 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.82 48.56 18.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.944 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.46 -25.68 21.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.225 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.449 1.124 . . . . 0.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -108.08 136.94 46.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.295 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.01 127.63 53.62 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.062 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -117.19 156.36 27.81 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.87 26.49 53.34 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.413 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.593 HD12 HG23 ' B' ' 35' ' ' ILE . 16.5 mt -87.4 149.12 24.68 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.485 0.659 . . . . 0.0 112.076 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.1 p -91.62 171.07 9.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.373 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 11.4 pt-20 -66.42 -44.25 83.45 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.269 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.83 -39.29 93.88 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.044 -0.41 . . . . 0.0 111.185 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.447 ' HE2' HD22 ' B' ' 45' ' ' LEU . 6.3 ttp -71.5 -40.98 69.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.953 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -61.85 -34.27 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.78 -49.96 70.9 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.846 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.74 -51.9 45.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.789 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.05 -47.67 76.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -57.64 -43.78 85.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.207 0.527 . . . . 0.0 111.764 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.84 -44.66 84.85 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.314 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.82 -39.87 95.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.165 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.297 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.4 -30.75 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.57 -27.5 45.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.83 0.286 . . . . 0.0 111.268 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -84.72 -35.87 22.21 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.073 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -130.64 101.6 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.42 1.71 15.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -117.28 18.32 14.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.705 0.684 . . . . 0.0 111.91 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 115.41 7.91 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.7 126.27 27.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.528 ' CE1' HG11 ' B' ' 23' ' ' VAL . 60.9 m-85 -113.4 129.49 56.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.244 0.545 . . . . 0.0 111.748 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.02 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.3 140.97 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.953 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.599 HG11 HD23 ' B' ' 83' ' ' LEU . 78.1 t -122.62 127.42 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.79 145.89 17.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.29 155.68 16.91 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.915 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.75 167.63 21.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -58.43 -34.74 71.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.036 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -80.35 -6.04 57.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.89 133.43 43.44 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.1 152.97 31.78 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.561 1.507 . . . . 0.0 110.251 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.729 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.55 -37.25 86.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.739 0.7 . . . . 0.0 110.572 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -55.78 -35.83 66.71 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.32 -35.07 68.53 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.844 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.75 -38.91 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.729 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.7 mm -60.37 -47.53 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.435 0.636 . . . . 0.0 109.784 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.2 mttm -54.4 -44.35 72.25 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.984 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -49.23 78.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.275 0.559 . . . . 0.0 111.146 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 5.8 mt -60.63 -36.96 79.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 109.448 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.05 -41.67 97.04 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.832 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 8.5 mt -65.22 -39.29 92.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.521 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.524 HD13 HD13 ' B' ' 91' ' ' ILE . 1.4 mm? -63.17 -42.63 99.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.93 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -63.64 -41.73 98.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -38.57 77.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.518 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.11 11.04 24.45 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.32 44.6 97.86 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 114.752 0.661 . . . . 0.0 114.752 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.6 mt -102.65 -36.03 4.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.776 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -65.91 -40.78 91.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 46.7 t -115.78 118.48 38.74 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.837 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.95 175.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.871 2.38 . . . . 0.0 115.404 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.23 121.28 65.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.003 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -111.94 127.28 69.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.406 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 25' ' ' LEU . 9.4 tt -114.88 120.68 40.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -109.59 127.72 54.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.418 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 t -85.0 119.93 34.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.207 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.1 -23.07 14.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.48 -119.34 0.6 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.861 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 78' ' ' GLU . 29.5 mm -113.56 99.46 8.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.79 -2.21 86.71 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.808 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.98 129.08 53.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -138.72 156.49 47.34 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.152 0.977 . . . . 0.0 112.951 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 142.06 51.7 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.31 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.642 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.2 pt -132.47 134.81 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.52 115.11 28.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.369 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.642 HD11 ' CD1' ' A' ' 35' ' ' ILE . 68.1 mt -114.67 109.6 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.219 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.82 44.86 24.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.917 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.81 21.52 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.855 -0.688 . . . . 0.0 114.031 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.53 126.77 35.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.276 1.038 . . . . 0.0 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -105.41 133.15 50.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.948 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.98 126.65 52.72 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.41 158.38 24.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.101 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 26.83 56.35 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.903 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 35' ' ' ILE . 9.6 mt -88.13 149.14 24.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.281 0.562 . . . . 0.0 112.074 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -90.51 169.02 11.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.21 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.4 pt-20 -65.34 -43.62 90.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.61 -40.56 95.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.418 ' CE ' HD22 ' A' ' 45' ' ' LEU . 7.6 ttp -70.77 -38.18 73.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -64.44 -32.8 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -63.94 -49.26 73.28 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -50.35 -51.83 42.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.77 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.04 -47.83 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.665 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -59.29 -42.88 92.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.611 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -66.97 -43.94 81.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.391 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.41 -40.97 98.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.997 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -38.09 77.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.14 -29.45 65.25 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.66 -28.44 45.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.761 0.255 . . . . 0.0 111.433 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.79 -33.78 24.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.212 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -132.47 104.5 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.61 5.52 15.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -123.64 17.87 9.56 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.509 0.595 . . . . 0.0 111.688 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 121.7 18.04 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.499 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.12 125.17 25.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -113.14 134.39 54.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.264 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.91 142.01 42.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 83' ' ' LEU . 69.3 t -123.51 126.81 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.4 146.34 18.36 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.53 154.46 16.94 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.88 165.74 23.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 110.911 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.88 -32.77 68.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.27 -6.49 57.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.61 133.54 35.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 156.42 32.44 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.274 1.316 . . . . 0.0 110.306 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.743 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -64.26 -33.9 76.89 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.762 -0.586 . . . . 0.0 110.266 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -57.18 -37.33 71.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -71.09 -35.24 71.76 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.846 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.12 -38.41 80.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.393 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.0 mm -59.93 -48.39 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.444 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -54.15 -45.38 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.469 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.05 -49.18 78.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' B' ' 83' ' ' LEU . 10.8 mt -61.58 -36.17 79.89 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.444 0.64 . . . . 0.0 109.46 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.95 -41.96 98.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.74 -38.86 92.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 110.614 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 91' ' ' ILE . 1.1 mm? -63.57 -41.85 98.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.952 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -63.58 -41.0 98.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.51 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -38.92 78.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.449 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.05 11.82 21.81 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.87 44.32 97.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.638 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt -100.34 -39.35 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.716 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.569 -0.213 . . . . 0.0 112.569 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -65.83 -40.99 92.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.963 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 45.8 t -115.95 118.44 38.42 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.803 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.77 175.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.86 2.373 . . . . 0.0 115.43 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.25 121.38 65.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.979 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.81 127.24 69.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.515 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.453 ' C ' HD23 ' B' ' 25' ' ' LEU . 9.4 tt -114.86 120.47 40.08 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.07 128.25 54.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.457 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.45 119.79 34.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.147 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 -23.2 14.61 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.47 -123.51 0.83 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.565 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' B' ' 78' ' ' GLU . 27.1 mm -108.45 99.76 9.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.011 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.87 85.75 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.968 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.61 129.44 52.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.0 156.55 47.13 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.156 0.979 . . . . 0.0 113.034 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.96 51.76 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.261 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.645 ' CD1' HD11 ' B' ' 37' ' ' ILE . 5.8 pt -132.56 134.94 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 112.599 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.73 115.01 28.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 68.4 mt -114.74 109.54 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.192 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.71 45.05 24.18 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.976 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -26.34 18.99 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.931 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.15 126.86 35.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.211 1.005 . . . . 0.0 110.391 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -105.63 132.35 51.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.074 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.545 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -117.24 126.84 53.4 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.7 158.8 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 112.092 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 26.49 57.43 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.932 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 35' ' ' ILE . 9.5 mt -87.92 149.15 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.36 0.6 . . . . 0.0 112.325 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.39 169.21 11.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.446 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 16.8 pt-20 -65.63 -43.27 90.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.72 -40.05 94.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.99 -0.444 . . . . 0.0 111.233 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.431 ' CE ' HD22 ' B' ' 45' ' ' LEU . 7.1 ttp -71.35 -38.17 71.64 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -64.43 -32.86 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -63.96 -48.85 74.85 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -50.84 -51.92 46.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.7 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -64.76 -47.95 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.669 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -59.21 -42.95 92.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -66.91 -43.89 82.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.36 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.33 -40.97 98.77 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -37.9 76.75 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -71.18 -29.53 65.3 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.77 -28.42 44.73 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.856 0.298 . . . . 0.0 111.432 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.89 -33.56 24.74 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -132.43 104.42 6.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.84 5.54 15.72 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -123.6 17.53 9.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.517 0.598 . . . . 0.0 111.772 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 122.06 18.44 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.22 125.38 25.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.979 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -137.32 141.75 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' B' ' 83' ' ' LEU . 70.4 t -123.46 127.27 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.75 146.3 18.3 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.55 154.57 16.95 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.83 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -32.73 68.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.418 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.16 -6.85 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.4 133.38 36.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 156.49 33.33 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.409 1.406 . . . . 0.0 110.336 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.745 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -64.64 -33.66 76.46 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.832 -0.543 . . . . 0.0 110.264 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -57.29 -37.44 72.44 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.467 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.93 -35.46 72.23 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.786 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.68 -38.65 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.395 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.745 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.02 -48.01 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.524 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.6 mttm -54.38 -45.13 72.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.398 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.425 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.43 -48.78 80.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 111.283 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' A' ' 83' ' ' LEU . 10.7 mt -62.05 -36.04 80.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.457 0.646 . . . . 0.0 109.419 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.88 -42.0 98.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.793 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.5 mt -64.74 -39.01 92.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.625 HD13 HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -63.5 -41.92 98.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.978 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -63.52 -41.01 98.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.458 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -38.73 77.79 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.444 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.12 11.86 21.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 44.02 98.14 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.625 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -100.07 -39.53 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.759 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -52.22 19.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.672 0.273 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.09 128.55 17.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.434 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.2 -173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.158 2.572 . . . . 0.0 114.454 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 64' ' ' THR . 41.3 t -106.7 115.02 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.894 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.9 127.45 69.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.2 tt -115.39 121.52 43.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' N ' HD23 ' A' ' 25' ' ' LEU . 30.1 mt-10 -110.59 127.14 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.59 111.41 20.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.96 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.17 -119.38 0.64 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.68 -1.248 . . . . 0.0 114.16 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.38 99.91 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.069 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.92 -3.31 84.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.956 -0.566 . . . . 0.0 114.175 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 131.26 54.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.581 0.69 . . . . 0.0 109.766 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.9 m-85 -137.89 157.48 46.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 122.096 0.95 . . . . 0.0 112.746 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.84 142.2 51.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.878 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.4 pt -132.95 134.37 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.396 0.543 . . . . 0.0 112.341 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 115.05 28.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.247 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 35' ' ' ILE . 33.2 mt -111.59 108.83 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.715 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.99 46.16 26.22 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.664 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.53 24.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.658 -0.782 . . . . 0.0 114.221 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -91.74 128.96 37.78 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.57 1.185 . . . . 0.0 110.201 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.52 135.01 47.69 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.84 127.71 53.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -117.47 156.1 28.56 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.156 0.503 . . . . 0.0 112.245 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.47 45.01 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.428 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.55 HD12 HG23 ' A' ' 35' ' ' ILE . 35.9 mt -88.75 151.17 22.57 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.278 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -93.14 173.32 7.79 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.586 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.7 mt-10 -67.92 -43.83 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.86 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.6 -38.7 92.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.809 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -70.35 -44.91 67.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.2 p -58.57 -35.27 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.744 0.307 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.2 m -63.55 -51.77 64.01 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.882 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -50.86 -51.18 53.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.683 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.31 -48.0 74.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.806 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -58.35 -42.86 87.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.082 0.467 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -66.48 -43.87 84.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.152 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -64.44 -39.23 93.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.015 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -38.2 70.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.57 -30.83 67.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.587 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.07 -28.75 54.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.916 0.325 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -37.45 27.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -127.38 105.4 8.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.88 1.04 24.88 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.27 20.01 8.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.242 0.474 . . . . 0.0 111.928 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.76 115.61 8.31 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.431 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.9 123.13 16.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -110.78 129.18 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.237 0.541 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.91 140.53 42.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.586 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.1 p -126.96 134.63 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.42 146.53 18.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 154.76 16.64 Favored Glycine 0 C--N 1.33 0.238 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.66 166.25 23.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.826 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -58.93 -31.8 68.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.261 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -81.12 -5.23 57.43 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.2 t -86.48 132.27 43.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.465 ' O ' HG23 ' A' ' 79' ' ' VAL . 71.8 Cg_endo -77.36 154.4 31.87 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.55 1.5 . . . . 0.0 110.495 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.7 t80 -64.2 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.887 -0.508 . . . . 0.0 111.04 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.93 -37.64 69.23 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.536 0.208 . . . . 0.0 110.744 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -71.54 -34.22 69.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.188 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 75' ' ' PRO . 11.1 t -63.43 -38.32 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.372 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.9 mm -60.69 -47.61 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.45 0.643 . . . . 0.0 109.621 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -55.14 -44.35 75.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.929 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.99 87.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -61.47 -37.69 84.51 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.532 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.66 -41.49 90.72 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.825 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.76 -39.34 90.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 110.764 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.699 HD13 HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -63.24 -42.95 99.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.909 179.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -63.1 -42.54 99.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.44 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.22 -37.78 72.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.598 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.22 10.59 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.24 44.59 96.8 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.699 HD13 HD13 ' A' ' 86' ' ' LEU . 4.7 mt -99.02 -36.57 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.71 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -71.59 -52.28 18.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.14 128.66 17.6 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.29 -173.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 123.119 2.546 . . . . 0.0 114.431 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.625 HG23 HG22 ' B' ' 64' ' ' THR . 41.3 t -106.37 114.79 46.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.886 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.86 127.79 68.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.522 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt -115.43 121.78 43.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.447 ' N ' HD23 ' B' ' 25' ' ' LEU . 27.9 mt-10 -110.81 126.89 55.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.397 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.34 111.28 20.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.97 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.52 -122.8 0.83 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 119.964 -1.113 . . . . 0.0 114.064 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.72 100.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.15 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.74 -3.57 82.67 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.446 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 131.62 53.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.552 0.676 . . . . 0.0 109.764 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -137.94 157.16 46.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.253 1.025 . . . . 0.0 112.721 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.57 142.63 51.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.769 -1.56 . . . . 0.0 109.046 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.6 pt -133.44 134.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.317 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 115.49 29.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.262 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.3 mt -112.07 109.03 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.769 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.44 46.45 22.78 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.621 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 -25.59 24.38 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.914 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -91.75 128.78 37.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.516 1.158 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.44 135.06 47.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.75 127.84 53.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.46 156.49 27.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 112.169 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.54 46.01 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.43 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' B' ' 42' ' ' GLN . 34.2 mt -89.0 150.95 22.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 112.151 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -92.68 173.13 7.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.749 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.0 mt-10 -67.57 -44.28 78.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.844 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.2 -38.96 93.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mtm -70.22 -44.47 68.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.2 p -59.01 -35.09 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -63.82 -51.13 66.11 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.869 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.35 -51.3 55.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.67 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.17 -48.12 74.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.718 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -58.14 -43.07 87.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.478 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -66.22 -44.02 85.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.297 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -64.22 -39.36 93.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.018 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -38.34 71.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -70.47 -30.59 67.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.593 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.37 -28.52 52.9 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.932 0.333 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -37.09 27.56 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -127.93 105.27 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.87 1.0 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -124.99 19.81 8.36 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.276 0.489 . . . . 0.0 111.906 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.625 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.7 115.94 8.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.405 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.18 122.74 15.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.78 129.13 55.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.59 140.21 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.747 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.6 p -126.55 134.46 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.02 146.55 18.49 Favored Glycine 0 C--O 1.226 -0.346 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.99 154.78 16.75 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.11 166.53 23.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -59.19 -31.63 69.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.281 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -81.1 -5.46 57.69 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.25 132.12 44.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.471 ' O ' HG23 ' B' ' 79' ' ' VAL . 75.1 Cg_endo -77.35 154.06 31.69 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.583 1.522 . . . . 0.0 110.669 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -64.06 -37.83 88.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.911 -0.493 . . . . 0.0 111.046 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.47 -37.63 70.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.514 0.197 . . . . 0.0 110.629 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' B' ' 75' ' ' PRO . 1.4 tp10 -71.44 -34.42 70.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.285 0.564 . . . . 0.0 110.199 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 75' ' ' PRO . 11.4 t -63.25 -38.3 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.425 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.94 -47.29 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.453 0.644 . . . . 0.0 109.625 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' B' ' 85' ' ' LEU . 12.1 mmmt -55.33 -43.99 75.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.957 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.31 86.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.346 0.594 . . . . 0.0 110.833 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 83' ' ' LEU . 6.3 mt -60.87 -38.05 84.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.38 -41.51 89.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.903 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' B' ' 81' ' ' LYS . 1.6 mt -65.85 -39.23 90.58 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.481 . . . . 0.0 110.707 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 91' ' ' ILE . 0.5 OUTLIER -63.4 -42.58 98.79 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.939 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -63.22 -42.77 99.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -37.58 72.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.683 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.48 10.81 23.81 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.12 44.5 97.12 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.234 0.853 . . . . 0.0 115.234 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.719 HD13 HD13 ' B' ' 86' ' ' LEU . 4.5 mt -99.25 -36.69 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.033 0 N-CA-C 112.361 -0.296 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 t -65.9 -43.47 88.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.76 131.39 13.56 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.89 -169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.224 2.616 . . . . 0.0 114.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 64' ' ' THR . 38.3 t -106.36 110.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.881 HG23 HD11 ' A' ' 67' ' ' LEU . 3.1 mp -108.62 126.38 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.287 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.0 tt -115.54 123.48 48.61 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' HD23 ' A' ' 25' ' ' LEU . 11.3 mt-10 -111.95 127.16 55.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.306 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 74' ' ' VAL . 34.7 t -84.86 108.25 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.537 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -22.71 24.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -119.24 0.61 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.939 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.81 98.84 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.63 -3.5 86.54 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.944 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.49 130.58 54.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.544 0.672 . . . . 0.0 109.447 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -139.12 157.25 46.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 113.115 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.77 51.06 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.954 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.694 HG23 HD12 ' A' ' 45' ' ' LEU . 3.7 pt -132.3 134.13 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.368 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.64 114.01 26.78 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.389 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 35' ' ' ILE . 63.0 mt -110.71 108.68 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.89 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 47.37 21.18 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.735 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.64 23.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.267 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -92.14 128.3 37.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.478 1.139 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.17 135.49 47.55 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.41 127.47 53.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -116.53 155.76 28.09 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.7 46.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.396 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 35' ' ' ILE . 17.5 mt -87.76 149.01 24.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 112.361 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -91.89 173.06 8.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.554 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.1 mt-10 -67.53 -45.01 76.99 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.948 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -37.98 89.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.234 0.47 . . . . 0.0 110.845 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mtp -70.26 -44.87 67.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -58.53 -35.46 54.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.14 -51.76 62.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -50.2 -51.79 41.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.762 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.74 -48.12 75.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.021 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.638 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -66.83 -43.46 83.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.209 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -39.41 92.91 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.043 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.13 -37.57 72.31 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.695 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.77 -30.99 67.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.442 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.23 -27.97 53.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.913 0.324 . . . . 0.0 111.148 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.05 -38.81 24.4 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.86 119.18 25.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -91.26 -19.88 22.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.37 20.53 11.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.202 0.456 . . . . 0.0 111.579 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.96 115.64 9.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.724 -178.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.06 125.92 26.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -110.0 126.78 54.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.211 0.529 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -134.12 139.85 46.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.491 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.3 p -127.39 135.71 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.37 144.74 16.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.647 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.47 152.79 17.06 Favored Glycine 0 C--N 1.33 0.204 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.1 164.71 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.085 0.469 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 -32.58 68.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.502 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -81.96 -6.84 59.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 27' ' ' VAL . 79.2 t -85.81 127.79 61.08 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.08 154.41 62.42 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 110.394 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.9 t80 -63.12 -36.66 84.33 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.816 -0.552 . . . . 0.0 110.73 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 110.422 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -36.89 74.89 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 109.781 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.62 -39.55 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.687 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.1 mm -59.85 -48.11 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.409 0.623 . . . . 0.0 109.806 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 4.3 mmmt -54.96 -44.06 74.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.96 83.68 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.599 . . . . 0.0 110.873 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' B' ' 83' ' ' LEU . 7.1 mt -60.32 -37.3 80.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.572 0.701 . . . . 0.0 109.541 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.2 -40.88 95.62 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.985 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.3 mt -65.01 -40.19 94.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.673 HD13 HD13 ' A' ' 91' ' ' ILE . 2.5 mm? -63.45 -42.47 98.65 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 t60 -63.24 -41.44 99.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -38.99 76.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.35 10.33 25.4 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.45 44.1 98.46 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.673 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt -99.09 -31.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.053 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -66.08 -43.75 86.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.581 0.229 . . . . 0.0 110.866 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -140.35 131.62 14.12 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.652 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -49.11 -169.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.178 2.585 . . . . 0.0 114.48 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.493 HG23 HG22 ' B' ' 64' ' ' THR . 38.3 t -106.36 110.72 32.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.893 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.83 126.76 65.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.371 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.0 tt -116.05 123.68 48.54 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.502 ' N ' HD23 ' B' ' 25' ' ' LEU . 11.8 mt-10 -112.35 127.23 55.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.225 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 37.5 t -85.06 108.21 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.591 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.6 -22.47 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.57 -123.54 0.85 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.459 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 28.9 mm -108.12 99.08 7.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.191 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -3.43 86.6 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.032 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 130.79 54.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.623 0.712 . . . . 0.0 109.6 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -139.13 157.89 45.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.515 1.15 . . . . 0.0 113.134 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 142.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.835 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.71 HG23 HD12 ' B' ' 45' ' ' LEU . 3.5 pt -132.24 134.1 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.25 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -111.14 114.1 27.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.417 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 59.7 mt -111.36 108.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.751 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.44 20.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.883 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.16 -25.82 22.24 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.71 -0.757 . . . . 0.0 114.04 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -91.77 128.76 37.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.656 1.228 . . . . 0.0 110.329 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.85 135.39 48.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.36 128.15 53.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -117.28 155.8 28.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.141 0.496 . . . . 0.0 112.325 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.48 27.73 46.59 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.198 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.71 HD12 HG23 ' B' ' 35' ' ' ILE . 17.6 mt -87.68 148.87 24.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.387 0.613 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -92.05 173.18 7.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.7 mt-10 -67.75 -44.8 76.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.025 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.49 91.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.161 0.505 . . . . 0.0 110.974 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mtp -69.96 -44.87 68.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.369 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -58.57 -35.31 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.728 0.299 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.26 -51.53 63.11 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.888 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.39 -51.56 45.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.7 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.12 -48.17 74.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.732 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 18.1 m -57.52 -43.45 84.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 111.753 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -66.65 -43.7 83.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.139 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -39.95 94.52 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.76 -37.3 73.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -70.94 -31.17 67.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.299 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.91 -28.1 55.17 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.11 -0.369 . . . . 0.0 111.131 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.13 -38.52 24.63 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -128.15 119.44 25.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -91.28 -20.0 22.38 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 20.58 11.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.067 0.394 . . . . 0.0 111.543 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.493 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.72 115.91 9.51 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.51 125.98 27.42 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.76 127.0 54.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.213 0.53 . . . . 0.0 111.694 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.26 139.77 45.97 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.518 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.788 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.9 p -127.39 135.89 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.34 145.18 17.25 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.649 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.71 152.32 17.16 Favored Glycine 0 N--CA 1.454 -0.161 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.34 165.14 24.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -59.14 -32.27 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -81.71 -7.13 59.56 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 75.3 t -85.43 127.8 61.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.2 154.18 61.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.222 1.282 . . . . 0.0 110.264 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.687 ' CE1' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -62.96 -36.48 83.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.747 -0.596 . . . . 0.0 110.69 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.48 -36.27 68.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -36.9 74.58 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.306 0.574 . . . . 0.0 109.662 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.9 -39.24 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.642 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.687 HD11 ' CE1' ' B' ' 76' ' ' TYR . 46.0 mm -59.99 -48.03 89.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-O 121.476 0.655 . . . . 0.0 109.713 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.4 mmmt -55.12 -44.12 74.72 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.014 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.99 83.48 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 7.4 mt -60.46 -37.2 80.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.611 0.72 . . . . 0.0 109.591 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.25 -40.83 95.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.883 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.4 mt -65.2 -39.9 93.46 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.855 0.36 . . . . 0.0 110.829 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.679 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -63.41 -42.6 98.76 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -63.26 -41.27 99.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.424 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -39.08 76.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.598 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.3 10.19 25.82 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.78 43.89 98.62 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.679 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -99.15 -31.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 t -88.11 -43.06 11.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 62.0 t -118.01 120.46 32.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.48 177.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.283 2.655 . . . . 0.0 115.676 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.49 120.13 61.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -112.47 127.71 69.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -117.07 127.25 53.96 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.4 mt-10 -115.84 127.68 55.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.299 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 74' ' ' VAL . 26.4 t -87.52 99.53 8.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.941 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.82 -21.64 51.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.974 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -113.93 92.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 -5.53 79.24 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.705 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.59 128.94 52.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.576 0.688 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.69 156.9 47.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.376 1.084 . . . . 0.0 113.133 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.98 142.29 51.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.842 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -132.83 135.14 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.18 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.69 116.11 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.938 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.05 108.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.183 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 46.85 48.52 18.35 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.523 -0.846 . . . . 0.0 114.39 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.99 -27.11 15.74 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.373 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.81 130.0 37.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.412 1.106 . . . . 0.0 110.197 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.29 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.13 125.57 51.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.52 157.02 25.9 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.25 50.99 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.042 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 HG23 ' A' ' 35' ' ' ILE . 13.6 mt -87.44 149.15 24.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.971 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 p -92.09 173.16 7.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.2 mt-10 -67.47 -43.79 80.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.22 -38.25 90.38 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 122.043 -0.411 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mtp -70.93 -43.6 67.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.625 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.32 -35.8 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -63.24 -51.2 67.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.681 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.32 -52.5 36.27 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.93 -47.57 77.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.728 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -58.07 -43.15 86.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.099 0.476 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -44.66 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.046 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.91 -40.42 96.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.161 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -70.31 -39.23 74.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.236 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.55 -27.73 64.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.41 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.86 -26.95 40.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.928 0.331 . . . . 0.0 111.385 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -33.96 25.05 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.741 ' HB3' HG23 ' A' ' 64' ' ' THR . 4.4 t70 -134.52 97.45 3.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -70.86 -6.21 36.4 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -109.04 17.65 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.586 0.63 . . . . 0.0 111.826 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -68.61 115.61 8.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.519 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 66' ' ' PHE . 6.2 tp -65.11 124.69 22.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.449 ' N ' HD12 ' A' ' 65' ' ' LEU . 11.8 m-85 -109.09 127.79 54.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.359 0.599 . . . . 0.0 111.514 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -133.95 139.24 45.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.505 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -126.78 137.34 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.96 145.49 17.32 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.88 153.68 16.69 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.17 163.63 24.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.154 0.502 . . . . 0.0 111.285 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -31.76 68.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.415 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -81.73 -5.96 58.61 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 27' ' ' VAL . 74.5 t -89.48 127.05 56.22 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.93 156.17 63.56 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.094 1.196 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.4 t80 -64.46 -34.7 78.8 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.768 -0.583 . . . . 0.0 110.46 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.23 -36.42 70.89 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -36.85 75.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.334 0.587 . . . . 0.0 109.688 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.61 -39.01 81.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.788 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.9 mm -60.39 -48.52 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.359 0.6 . . . . 0.0 109.726 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -54.15 -44.8 71.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.47 85.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.509 0.671 . . . . 0.0 110.827 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.0 mt -61.0 -36.8 80.46 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 109.378 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.73 -42.38 97.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.851 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.12 -39.92 95.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.065 0.459 . . . . 0.0 110.837 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 91' ' ' ILE . 2.1 mm? -64.03 -42.38 97.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.063 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.7 -42.32 99.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.511 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.5 -38.66 74.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.83 11.41 20.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.49 44.23 98.27 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 86' ' ' LEU . 4.1 mt -98.06 -30.95 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 N-CA-C 112.895 -0.082 . . . . 0.0 112.895 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -88.27 -43.21 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.757 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.478 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 62.8 t -118.03 120.5 32.44 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.59 177.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.176 2.584 . . . . 0.0 115.745 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.1 t -111.52 120.49 62.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 127.65 69.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.74 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.521 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -117.1 127.09 53.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.492 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.0 mt-10 -115.72 127.68 55.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.165 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.425 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.4 t -87.58 98.99 7.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.033 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.27 -21.86 52.98 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.09 -124.55 0.88 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.704 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.12 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.105 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.33 79.35 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.814 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 129.13 53.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -138.16 156.65 47.53 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.337 1.065 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.03 142.06 51.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.95 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.621 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -132.64 135.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.406 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.89 115.89 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.892 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.0 108.73 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.149 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.478 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 46.31 48.99 15.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.462 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.74 -26.85 16.33 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.176 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.85 129.95 37.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.487 1.144 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.88 136.03 48.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.269 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.55 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -116.83 126.06 52.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.79 157.08 26.14 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 26.57 53.11 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.057 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.621 HD12 HG23 ' B' ' 35' ' ' ILE . 13.8 mt -86.89 148.94 25.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.388 0.613 . . . . 0.0 112.109 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -91.74 172.97 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.45 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.7 -43.62 79.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -63.94 -38.61 91.72 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 110.996 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.53 -43.91 68.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.425 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.45 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.13 -35.77 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.948 0.404 . . . . 0.0 110.228 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 19.6 m -63.27 -51.3 66.71 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.745 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.26 -52.49 35.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.79 -47.35 78.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.796 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -58.4 -42.9 88.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.488 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.39 83.29 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.196 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.07 -40.58 96.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.992 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.609 ' OE2' HG21 ' B' ' 64' ' ' THR . 0.0 OUTLIER -70.23 -39.34 75.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.225 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.35 -27.8 64.63 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.524 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -79.63 -27.43 40.96 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.84 0.291 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -83.25 -33.75 25.98 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.732 ' HB3' HG23 ' B' ' 64' ' ' THR . 4.4 t70 -134.96 97.72 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -71.02 -6.15 36.75 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.86 17.4 21.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.7 0.682 . . . . 0.0 111.754 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.732 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -68.3 115.9 8.27 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.471 HD12 ' N ' ' B' ' 66' ' ' PHE . 5.6 tp -65.32 125.13 24.12 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.471 ' N ' HD12 ' B' ' 65' ' ' LEU . 11.6 m-85 -109.44 127.38 54.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 0.0 111.556 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.785 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.52 137.5 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.12 145.43 17.21 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.522 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.76 153.29 16.83 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.84 164.21 24.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -31.51 69.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.176 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.67 -6.59 59.16 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.425 HG21 ' O ' ' B' ' 27' ' ' VAL . 73.9 t -88.98 127.0 57.41 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.99 156.33 63.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.962 1.108 . . . . 0.0 110.298 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.51 -34.9 79.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.996 -0.44 . . . . 0.0 110.419 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.66 -36.02 71.33 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.672 0.273 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -36.96 75.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.502 0.668 . . . . 0.0 109.539 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -61.56 -39.04 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.687 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.6 mm -60.31 -48.24 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.429 0.633 . . . . 0.0 109.702 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -54.59 -44.68 73.24 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.219 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.34 85.8 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 110.846 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -61.31 -36.56 80.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.666 0.746 . . . . 0.0 109.377 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.99 -41.83 97.25 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.949 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.97 -39.41 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.754 HD13 HD13 ' B' ' 91' ' ' ILE . 2.2 mm? -64.31 -41.96 96.59 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.85 -42.23 99.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.556 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.47 -38.9 75.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.618 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.58 11.67 18.94 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.13 44.27 98.36 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -98.07 -30.53 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.939 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 t -98.19 -58.21 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.448 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 28.9 t -125.85 126.24 24.87 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.114 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -54.11 174.09 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.892 2.395 . . . . 0.0 115.296 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 64' ' ' THR . 46.9 t -112.27 117.23 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.868 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -109.51 127.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.409 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.4 tt -116.02 121.72 43.06 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 tt0 -106.97 125.59 51.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.9 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.32 116.26 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.657 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.31 -23.79 15.49 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -122.89 0.76 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.105 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.1 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 122.666 0.387 . . . . 0.0 110.112 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 -3.41 87.24 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.964 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.89 53.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -137.48 157.09 47.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.202 1.001 . . . . 0.0 113.335 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 141.99 51.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.708 -1.587 . . . . 0.0 108.638 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 37' ' ' ILE . 5.8 pt -131.73 134.81 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -112.3 114.41 27.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.54 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 35' ' ' ILE . 47.7 mt -114.45 109.99 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.221 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.32 45.45 21.72 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.962 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.98 -26.89 14.55 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.827 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -85.32 125.14 32.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.927 0.863 . . . . 0.0 110.517 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.87 133.27 50.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.94 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.78 127.36 52.73 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.71 155.66 28.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 112.058 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 26.27 51.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.339 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 42' ' ' GLN . 40.7 mt -86.62 148.92 25.26 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.513 0.673 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.8 p -90.77 172.69 8.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.535 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 50' ' ' VAL . 6.2 mt-10 -67.9 -44.29 77.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.675 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.88 -38.79 92.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.099 0.476 . . . . 0.0 110.951 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.39 -46.15 67.56 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.03 -34.42 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -63.31 -50.42 70.1 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.789 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.42 -52.46 37.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.714 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.64 -47.7 77.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.693 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.6 -43.55 89.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.214 0.531 . . . . 0.0 111.701 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.58 -43.34 85.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.374 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.27 -40.63 96.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.76 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.56 -37.33 76.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.88 -30.91 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.63 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.19 -27.75 57.01 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.247 -0.283 . . . . 0.0 111.038 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.35 -36.48 26.81 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.19 107.59 8.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.81 4.38 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.8 19.24 9.4 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.381 0.537 . . . . 0.0 111.864 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.475 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.1 116.14 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.08 123.78 19.05 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.48 127.93 55.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.097 0.475 . . . . 0.0 111.441 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -133.46 140.27 47.18 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.818 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.7 p -127.33 136.34 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 147.13 19.02 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.15 155.76 17.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.1 23.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.068 0.461 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -57.63 -33.38 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -79.89 -5.63 55.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.79 132.98 49.83 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 87.3 Cg_endo -79.6 153.19 23.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.541 1.494 . . . . 0.0 110.573 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.8 t80 -63.53 -38.45 91.18 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.658 -0.651 . . . . 0.0 110.987 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -56.28 -37.33 69.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.599 0.238 . . . . 0.0 110.641 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -71.34 -35.62 71.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.857 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' PRO . 12.7 t -62.24 -38.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.715 HD11 ' CE1' ' A' ' 76' ' ' TYR . 50.5 mm -60.05 -47.92 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.42 0.629 . . . . 0.0 109.612 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -53.79 -44.37 70.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.154 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.69 80.69 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.693 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' B' ' 83' ' ' LEU . 7.4 mt -60.3 -36.35 77.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -61.92 -42.58 99.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.149 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.0 mt -64.43 -39.04 93.07 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 110.985 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 91' ' ' ILE . 2.1 mm? -64.24 -41.84 96.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.139 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -63.47 -40.13 96.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -38.14 76.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.483 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.29 9.77 27.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.42 44.15 95.72 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.709 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp -97.9 -36.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.627 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 33.3 t -98.72 -58.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 26.2 t -125.7 126.16 24.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.129 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -54.3 174.21 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.79 2.327 . . . . 0.0 115.407 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.433 HG23 HG22 ' B' ' 64' ' ' THR . 45.9 t -112.17 117.57 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.92 127.27 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.398 -178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.491 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.5 tt -115.59 121.85 43.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.491 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.5 tt0 -106.8 125.9 51.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.921 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -84.59 116.06 27.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.587 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.9 -24.34 15.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -126.35 0.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.964 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.1 mm -108.03 100.88 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.421 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.16 -2.97 87.95 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.144 -0.55 . . . . 0.0 114.0 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 127.85 53.54 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -137.34 157.22 47.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.237 1.018 . . . . 0.0 113.379 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.44 141.72 51.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.754 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.703 HD12 HD11 ' B' ' 37' ' ' ILE . 6.1 pt -131.49 134.57 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.736 0.698 . . . . 0.0 112.816 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.98 114.25 27.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.517 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.703 HD11 HD12 ' B' ' 35' ' ' ILE . 45.1 mt -114.29 109.77 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.36 45.7 22.1 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.831 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.88 -27.31 13.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.849 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -84.96 125.43 32.68 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.061 0.931 . . . . 0.0 110.522 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.34 133.09 51.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.823 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.3 127.57 53.33 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -117.18 155.59 29.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.51 50.87 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.137 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' B' ' 42' ' ' GLN . 41.4 mt -87.05 149.23 24.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.528 0.68 . . . . 0.0 111.998 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -90.98 172.84 8.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.759 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.431 ' O ' HG12 ' B' ' 50' ' ' VAL . 6.1 mt-10 -67.92 -44.11 77.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.8 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.41 -38.38 90.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.043 0.449 . . . . 0.0 110.809 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.2 mtp -69.23 -46.71 66.68 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.66 -34.37 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -63.47 -50.23 70.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.719 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.8 -52.07 44.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.733 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.61 -48.22 75.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.621 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -43.84 88.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 111.739 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.52 -42.98 86.45 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.486 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.61 -40.65 95.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.745 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -69.55 -37.35 77.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.996 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.98 -30.81 67.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.18 -27.65 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.947 0.34 . . . . 0.0 111.039 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -82.33 -36.54 26.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.38 107.34 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.58 4.54 18.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -123.75 19.18 9.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.465 0.575 . . . . 0.0 111.845 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.433 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.23 116.49 8.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.4 123.83 19.31 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.38 127.66 55.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.45 139.96 47.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.609 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.2 p -127.05 136.5 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.51 147.05 18.96 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.03 155.83 17.32 Favored Glycine 0 N--CA 1.46 0.29 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.989 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 166.55 23.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -58.42 -33.14 69.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.461 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.99 -5.97 56.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -82.41 132.69 51.88 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.464 ' O ' HG23 ' B' ' 79' ' ' VAL . 93.0 Cg_endo -79.55 153.1 23.36 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.683 1.589 . . . . 0.0 110.316 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.717 ' CE1' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -63.38 -38.8 92.55 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.767 -0.583 . . . . 0.0 110.921 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.96 -37.37 68.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.492 0.187 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -71.3 -35.85 71.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 75' ' ' PRO . 12.5 t -62.18 -38.26 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.717 HD11 ' CE1' ' B' ' 76' ' ' TYR . 50.4 mm -59.92 -47.63 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.51 0.671 . . . . 0.0 109.719 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 tttp -54.28 -44.29 71.77 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.46 81.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.148 0.499 . . . . 0.0 110.716 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' A' ' 83' ' ' LEU . 7.2 mt -60.68 -36.2 78.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.604 0.716 . . . . 0.0 109.238 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -61.93 -42.24 98.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.0 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 1.8 mt -64.86 -38.92 92.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.96 0.41 . . . . 0.0 110.948 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.435 HD12 HG21 ' B' ' 91' ' ' ILE . 2.0 mm? -64.19 -42.05 96.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.288 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.36 -40.34 97.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -38.14 76.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.389 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.727 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.21 9.6 27.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.39 44.3 95.54 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 115.704 1.041 . . . . 0.0 115.704 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.727 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.3 mp -97.65 -37.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.67 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 p -169.42 -64.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 44.4 t -127.94 121.29 21.82 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.51 176.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.842 2.361 . . . . 0.0 115.692 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.58 116.62 53.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.883 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -108.55 127.16 65.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.604 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -115.14 122.04 44.86 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.544 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.2 tm-20 -111.24 128.07 55.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.131 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.31 116.62 29.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.508 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -97.16 -22.15 16.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.8 -122.08 0.72 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.741 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -115.59 87.52 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.32 27.72 19.57 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.388 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -139.13 93.08 2.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.517 0.675 . . . . 0.0 109.487 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.26 157.39 17.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.263 1.03 . . . . 0.0 113.231 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 142.0 51.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.709 HG23 HD12 ' A' ' 45' ' ' LEU . 4.8 pt -131.54 133.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 118.529 0.604 . . . . 0.0 112.422 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.51 114.33 27.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.473 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 35' ' ' ILE . 67.0 mt -114.27 110.08 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.208 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.42 45.03 22.26 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.93 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 -26.86 17.04 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.086 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.88 126.25 34.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.225 1.013 . . . . 0.0 110.525 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.36 131.94 52.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.921 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.75 127.2 53.32 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -117.56 158.67 24.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.49 27.39 54.87 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.949 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.709 HD12 HG23 ' A' ' 35' ' ' ILE . 10.0 mt -87.38 149.15 24.67 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.697 0.76 . . . . 0.0 112.191 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 p -91.36 171.53 9.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.419 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.42 -43.61 80.8 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.0 -38.8 92.42 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.027 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mtp -70.35 -44.11 68.82 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.48 -34.91 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -63.55 -50.46 69.43 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.855 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -50.67 -51.47 48.97 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.807 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.08 -48.09 74.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.279 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -43.84 83.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 111.622 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -66.76 -44.5 81.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.193 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.92 -40.58 96.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -69.41 -38.48 77.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.24 -31.27 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.23 -27.3 53.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.26 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -84.87 -36.62 21.42 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.994 0.426 . . . . 0.0 109.953 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.646 ' HB3' HG23 ' A' ' 64' ' ' THR . 10.4 m-20 -128.84 97.38 4.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.28 -6.11 37.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -114.16 19.19 16.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.573 0.624 . . . . 0.0 111.955 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -67.95 113.38 5.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.446 -179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.45 125.07 23.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -111.19 128.99 56.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.795 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.898 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.89 139.36 46.14 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.51 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.761 HG11 ' CD2' ' A' ' 83' ' ' LEU . 11.9 p -125.72 135.91 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.78 145.38 16.98 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.14 153.13 16.67 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.771 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.75 24.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -32.26 65.98 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.75 -5.71 59.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.38 133.25 53.67 Favored Pre-proline 0 CA--C 1.537 0.462 0 O-C-N 122.221 -0.299 . . . . 0.0 110.442 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 Cg_endo -77.34 148.96 27.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.729 1.619 . . . . 0.0 110.729 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 80' ' ' ILE . 4.7 t80 -63.04 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.748 -0.595 . . . . 0.0 111.251 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.56 -37.0 67.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.605 0.24 . . . . 0.0 110.832 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.6 -34.75 67.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.913 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 75' ' ' PRO . 13.2 t -62.67 -38.83 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.381 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.3 mm -60.24 -47.48 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.474 0.654 . . . . 0.0 109.407 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.12 -43.99 70.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.2 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -49.05 79.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.123 0.487 . . . . 0.0 110.792 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.33 -37.9 82.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.381 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.09 -42.0 97.7 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.696 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.22 -39.61 92.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.98 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -63.51 -42.26 98.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.65 -42.05 98.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.394 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.392 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.99 10.83 20.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.65 97.73 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.595 HD13 HD13 ' A' ' 86' ' ' LEU . 4.4 mt -101.15 -34.92 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.666 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 8.9 p -169.69 -64.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.494 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 44.4 t -127.55 121.34 22.26 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -51.8 176.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.851 2.367 . . . . 0.0 115.663 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.5 116.81 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.902 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.74 127.11 65.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.632 -177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.524 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.04 122.16 45.32 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.524 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.3 tm-20 -111.21 127.58 55.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.254 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.71 116.89 30.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.323 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -97.4 -22.61 16.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.34 -125.71 0.94 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.649 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -111.06 87.84 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.192 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.62 27.93 20.68 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.485 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -138.86 93.3 2.69 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.514 0.673 . . . . 0.0 109.281 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -105.56 157.03 17.67 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.356 1.074 . . . . 0.0 113.336 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.78 141.99 51.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.992 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.724 HG23 HD12 ' B' ' 45' ' ' LEU . 4.8 pt -131.48 133.94 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.527 0.603 . . . . 0.0 112.271 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.05 114.45 27.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.396 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.652 HD11 HD12 ' B' ' 35' ' ' ILE . 72.3 mt -114.46 110.1 30.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.192 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.494 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.17 45.38 20.74 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.044 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.84 -26.8 16.8 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.102 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.94 126.3 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.322 1.061 . . . . 0.0 110.436 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.52 131.93 52.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.962 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.04 127.19 53.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -117.33 158.58 24.15 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.242 0.544 . . . . 0.0 112.445 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.21 27.74 54.96 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.724 HD12 HG23 ' B' ' 35' ' ' ILE . 10.4 mt -87.2 149.1 24.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.57 0.7 . . . . 0.0 112.193 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.8 p -91.49 171.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.428 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.9 mt-10 -67.21 -44.08 80.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.748 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.78 -38.69 92.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mtp -70.3 -44.36 68.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.304 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -34.47 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.3 m -64.29 -50.24 68.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.873 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -50.73 -51.55 48.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.604 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.95 -48.32 74.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.11 -43.92 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.058 0.456 . . . . 0.0 111.781 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.458 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -66.81 -44.24 81.72 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.195 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -64.16 -40.09 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.904 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -69.68 -39.01 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.188 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -69.81 -31.2 68.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.09 -27.84 54.3 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.894 0.315 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -84.31 -36.15 22.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.11 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.662 ' HB3' HG23 ' B' ' 64' ' ' THR . 10.4 m-20 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -70.93 -5.96 34.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -114.15 18.51 17.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.616 0.644 . . . . 0.0 112.053 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.662 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -67.27 113.71 5.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.79 124.39 21.36 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -110.62 128.78 55.83 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.372 0.606 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.902 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -133.61 139.26 46.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.558 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.745 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.4 p -125.94 135.68 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.55 145.27 16.91 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.13 153.2 16.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.92 24.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.045 0.45 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -32.35 66.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.78 -5.51 58.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -81.49 133.39 53.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.481 ' O ' HG23 ' B' ' 79' ' ' VAL . 95.7 Cg_endo -77.59 149.12 26.7 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.725 1.617 . . . . 0.0 110.708 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.7 t80 -63.27 -39.08 93.58 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.709 -0.619 . . . . 0.0 111.157 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.51 -37.12 67.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.694 0.283 . . . . 0.0 110.728 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.4 -34.81 68.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.873 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.481 HG23 ' O ' ' B' ' 75' ' ' PRO . 13.9 t -62.67 -38.82 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.7 mm -60.58 -46.7 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.437 0.636 . . . . 0.0 109.447 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.4 mttp -54.84 -43.77 73.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.073 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.39 78.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.345 0.593 . . . . 0.0 110.792 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 83' ' ' LEU . 7.6 mt -60.08 -38.12 81.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 109.484 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.81 -42.27 97.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.817 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 9.4 mt -64.76 -39.86 94.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.938 0.399 . . . . 0.0 111.079 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.42 -42.39 98.74 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.56 -41.88 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -38.32 74.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.497 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.492 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.35 11.01 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 44.67 97.56 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.598 HD13 HD13 ' B' ' 86' ' ' LEU . 4.2 mt -101.05 -35.15 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 112.724 -0.15 . . . . 0.0 112.724 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -108.5 -63.57 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 34.3 t -124.36 123.58 25.87 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.67 174.52 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.903 2.402 . . . . 0.0 115.414 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.0 t -114.52 119.19 60.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.834 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.58 127.57 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.305 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.7 tt -113.88 119.99 39.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 3.1 tt0 -109.31 128.32 54.99 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.113 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -87.2 116.38 29.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.391 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -96.95 -22.75 16.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.17 -119.26 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.348 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.66 101.46 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.221 -0.489 . . . . 0.0 109.708 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.72 1.65 72.88 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.884 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.6 mttt -107.12 92.73 4.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.423 0.612 . . . . 0.0 109.831 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -104.14 156.22 18.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.174 0.988 . . . . 0.0 112.926 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.22 141.41 52.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.981 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CD1' HD13 ' A' ' 53' ' ' LEU . 6.5 pt -131.73 134.69 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.654 0.661 . . . . 0.0 112.702 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -112.1 115.77 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.884 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 35' ' ' ILE . 79.0 mt -115.94 110.56 32.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.084 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.3 44.58 27.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.992 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -26.25 18.77 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.744 -0.741 . . . . 0.0 114.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -88.71 127.95 35.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.58 1.19 . . . . 0.0 110.46 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -106.48 134.35 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.0 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.74 126.64 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -116.7 157.7 25.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.241 0.543 . . . . 0.0 112.366 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.05 27.76 51.9 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.052 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' A' ' 42' ' ' GLN . 16.7 mt -88.12 150.14 23.52 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 112.293 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.5 p -91.11 171.33 9.33 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.228 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.14 -43.89 81.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.826 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.78 -38.57 91.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.171 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 mtp -69.87 -44.94 68.8 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.03 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.8 -34.14 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.8 m -64.11 -49.91 70.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.587 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.37 -52.68 35.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.696 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 35' ' ' ILE . 18.6 mt -64.42 -48.01 76.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.713 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t -58.01 -43.88 86.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.074 0.464 . . . . 0.0 111.738 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -44.62 83.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.249 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.99 95.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.096 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -69.92 -38.56 76.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.634 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.83 -29.41 65.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -78.85 -26.87 44.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.822 0.283 . . . . 0.0 111.393 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -85.63 -34.18 21.44 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.61 95.78 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.74 -13.36 62.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -106.0 19.28 20.79 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.604 0.638 . . . . 0.0 111.897 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' A' ' 23' ' ' VAL . 27.1 m -68.28 111.41 4.56 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.0 tp -66.42 127.21 31.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 65' ' ' LEU . 61.2 m-85 -114.3 131.25 56.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.021 0.439 . . . . 0.0 111.486 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' B' ' 67' ' ' LEU . 3.3 pp -134.85 140.94 46.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 83' ' ' LEU . 14.5 p -127.07 136.72 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.15 146.03 17.51 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.81 154.81 16.68 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.093 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 165.13 24.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.134 0.467 . . . . 0.0 111.14 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.29 -32.35 66.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.59 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -81.28 -5.74 58.12 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.29 132.21 48.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.03 151.72 35.32 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.57 1.513 . . . . 0.0 110.193 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.2 t80 -63.38 -36.6 84.24 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.719 -0.613 . . . . 0.0 110.753 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.6 -36.44 69.4 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.81 -34.89 69.73 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.91 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.88 -38.42 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.299 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 49.7 mm -61.2 -47.34 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.426 0.631 . . . . 0.0 109.482 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 3.1 mmtp -54.9 -44.35 74.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.931 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -48.17 82.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.257 0.551 . . . . 0.0 111.055 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.63 -37.15 80.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.384 0.611 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.92 -41.26 95.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.818 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.6 mt -65.5 -39.68 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.578 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 91' ' ' ILE . 2.2 mm? -62.86 -42.29 99.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.119 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -63.79 -42.09 97.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.369 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -37.86 75.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.478 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.66 10.51 25.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.65 97.16 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.5 mt -103.39 -37.02 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.017 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -109.07 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.784 0.326 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 34.2 t -124.4 123.67 25.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.155 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.41 174.06 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.963 2.442 . . . . 0.0 115.53 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.55 HG23 ' CG2' ' B' ' 64' ' ' THR . 58.8 t -114.34 119.07 60.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.831 HG23 HD11 ' B' ' 67' ' ' LEU . 3.3 mp -110.48 127.81 67.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.302 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.7 tt -114.23 119.83 38.38 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 2.9 tt0 -109.06 128.14 54.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.262 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.02 116.0 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.364 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.98 -22.48 16.81 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.12 -123.53 0.82 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.117 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.51 101.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.894 -0.653 . . . . 0.0 110.279 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.48 1.78 72.03 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.047 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -107.05 92.79 4.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.473 0.637 . . . . 0.0 109.747 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -103.89 155.89 18.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.26 1.029 . . . . 0.0 113.031 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -123.89 142.12 51.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.928 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.596 HD11 HD13 ' B' ' 53' ' ' LEU . 6.6 pt -132.24 134.8 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 118.671 0.669 . . . . 0.0 112.41 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -112.4 115.89 29.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.543 HD11 HD12 ' B' ' 35' ' ' ILE . 78.2 mt -115.93 110.64 32.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.018 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.31 44.27 27.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.219 -0.991 . . . . 0.0 114.19 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.7 -25.78 21.55 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.061 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -89.01 127.97 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.256 1.028 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.75 134.46 49.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.8 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.62 127.0 53.17 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -117.45 157.94 25.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 112.08 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.79 27.77 52.8 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.896 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 42' ' ' GLN . 16.3 mt -88.35 149.87 23.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.749 0.785 . . . . 0.0 112.35 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.88 171.18 9.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.443 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.8 mt-10 -67.11 -43.92 81.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.804 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.95 -38.83 92.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.021 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.7 mtp -69.55 -44.78 70.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.114 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.81 -34.36 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -63.83 -49.92 70.95 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.708 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.18 -52.69 33.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.82 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.596 HD13 HD11 ' B' ' 35' ' ' ILE . 18.4 mt -64.45 -48.38 75.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.723 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -57.9 -43.3 86.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.052 0.453 . . . . 0.0 111.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.86 81.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.305 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -40.37 96.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.62 -38.63 77.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -70.46 -29.72 66.36 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -78.85 -27.08 44.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.876 0.307 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -85.59 -33.71 21.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.718 0.294 . . . . 0.0 110.544 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -131.01 95.99 3.94 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.1 -13.42 62.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -105.91 19.48 20.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.722 0.692 . . . . 0.0 111.809 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.55 ' CG2' HG23 ' B' ' 23' ' ' VAL . 27.9 m -68.13 111.25 4.38 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.687 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.1 tp -66.41 126.94 30.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.687 ' N ' HD12 ' B' ' 65' ' ' LEU . 61.8 m-85 -113.99 131.26 56.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 111.567 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.98 141.14 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.623 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.732 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.8 p -127.47 137.21 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.47 146.14 17.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.69 155.11 16.62 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.43 24.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.893 0.378 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.66 -32.75 67.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.294 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -80.99 -5.83 58.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.24 132.04 48.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.81 151.82 36.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.557 1.505 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.724 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -63.51 -36.66 84.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 110.692 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.65 -36.57 69.69 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -71.49 -34.64 70.32 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.26 -38.17 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.461 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.724 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 49.1 mm -61.27 -47.13 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 3.2 mmtp -55.0 -44.62 74.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.971 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.96 83.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 111.086 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.78 -37.31 81.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.698 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.59 -41.56 94.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.751 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.1 mt -65.37 -39.41 92.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.031 0.444 . . . . 0.0 110.565 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.49 HD13 HD13 ' B' ' 91' ' ' ILE . 2.4 mm? -62.96 -42.59 99.87 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -63.26 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.515 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -38.13 75.93 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.509 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.607 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.28 10.17 25.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.25 44.87 97.02 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.7 mt -103.36 -37.15 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 0.0 109.768 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 t -96.52 -47.94 5.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.331 . . . . 0.0 110.984 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 36.3 t -125.49 127.09 24.99 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.49 173.9 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.664 2.243 . . . . 0.0 115.575 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 64' ' ' THR . 49.2 t -112.77 119.24 59.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.14 127.27 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.309 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.5 tt -115.66 122.12 44.61 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.0 tt0 -111.0 127.15 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.411 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -84.73 112.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.69 -22.52 20.18 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -119.87 0.65 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.775 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' OE2' ' A' ' 78' ' ' GLU . 27.0 mm -111.87 99.4 8.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 122.905 0.482 . . . . 0.0 109.899 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.08 -2.47 87.62 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.228 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 131.29 54.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.866 0.833 . . . . 0.0 109.431 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.29 158.26 44.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.11 0.957 . . . . 0.0 112.942 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 142.64 51.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.192 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.856 HG23 HD12 ' A' ' 45' ' ' LEU . 5.4 pt -130.09 132.9 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.146 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.02 114.63 27.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 35' ' ' ILE . 81.1 mt -114.99 110.39 31.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.473 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.39 46.0 28.78 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.21 -0.995 . . . . 0.0 114.141 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.13 -24.53 24.45 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.68 -0.771 . . . . 0.0 114.308 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 127.76 36.0 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.512 1.156 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.77 133.13 50.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.956 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.86 127.22 53.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -117.45 157.65 25.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.919 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.64 26.43 56.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.918 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 35' ' ' ILE . 9.2 mt -85.38 147.58 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.276 0.538 . . . . 0.0 111.941 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -92.03 172.06 8.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.547 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.2 mt-10 -66.14 -45.45 80.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.13 -39.42 93.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.14 -0.35 . . . . 0.0 111.059 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.413 ' CE ' HD22 ' A' ' 45' ' ' LEU . 10.3 ttp -70.61 -40.94 72.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -62.82 -34.8 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -63.61 -49.95 71.29 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.47 -52.58 36.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.642 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 35' ' ' ILE . 27.2 mt -64.95 -47.69 76.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.51 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -43.47 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 111.54 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -66.25 -44.24 84.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -41.75 99.17 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.106 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.63 -39.66 73.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.89 -28.05 65.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.682 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.41 -27.03 38.15 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.223 -0.298 . . . . 0.0 111.301 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -85.73 -35.41 20.82 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -130.88 105.33 7.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.86 9.23 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -126.52 16.25 7.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 111.901 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.497 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.01 113.77 5.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.46 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 66' ' ' PHE . 8.1 tp -58.44 124.3 19.11 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.5 m-85 -113.1 131.56 55.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.819 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -135.22 140.17 45.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.744 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.65 136.94 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -140.38 147.9 19.55 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.623 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.32 154.55 16.52 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.08 23.38 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.934 0.367 . . . . 0.0 111.437 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.54 -32.73 67.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.42 -7.0 58.95 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -87.71 128.1 55.72 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.47 156.54 54.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.075 1.183 . . . . 0.0 110.08 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.8 t80 -63.65 -36.23 83.13 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.925 -0.485 . . . . 0.0 110.514 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -56.58 -36.33 69.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' OE2' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.24 -37.16 74.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.509 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 t -61.36 -39.34 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.897 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.2 mm -60.76 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.327 0.584 . . . . 0.0 109.577 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -44.84 75.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.164 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.07 86.97 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.288 0.566 . . . . 0.0 111.049 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -61.13 -36.77 80.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.586 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.52 -41.15 96.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -39.99 94.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.865 0.365 . . . . 0.0 110.729 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' A' ' 91' ' ' ILE . 1.5 mm? -63.49 -42.4 98.54 Favored 'General case' 0 C--N 1.335 -0.037 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -63.31 -42.14 99.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.421 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.66 -38.73 78.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.384 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.6 10.71 24.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' A' ' 86' ' ' LEU . 5.3 mt -102.18 -37.68 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.812 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.694 -0.163 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -96.85 -47.93 5.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.452 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 33.5 t -125.53 127.28 24.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.38 173.59 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.755 2.303 . . . . 0.0 115.533 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.48 HG23 HG22 ' B' ' 64' ' ' THR . 47.1 t -112.55 119.15 59.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.961 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -110.36 127.49 67.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.263 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.513 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.4 tt -115.98 122.43 45.22 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.513 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt0 -110.95 127.77 55.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.486 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.04 112.1 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.59 -22.63 20.21 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.65 -123.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.522 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.432 HD12 ' OE2' ' B' ' 78' ' ' GLU . 27.3 mm -107.64 99.56 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.842 -0.679 . . . . 0.0 110.121 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.05 -2.54 87.52 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 114.407 0.523 . . . . 0.0 114.407 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 131.22 54.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.644 0.722 . . . . 0.0 109.556 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -139.17 158.12 44.74 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.143 0.973 . . . . 0.0 112.954 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 142.73 51.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.069 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.845 HG23 HD12 ' B' ' 45' ' ' LEU . 5.5 pt -130.33 133.11 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.974 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.98 114.93 28.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.463 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.567 HD11 HD12 ' B' ' 35' ' ' ILE . 81.7 mt -115.27 110.1 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.391 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.39 45.67 28.74 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.256 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.81 -24.94 23.93 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.025 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.82 127.31 35.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.683 1.241 . . . . 0.0 110.393 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.2 133.2 50.37 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.115 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.74 127.14 53.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -117.43 157.39 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.969 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.83 26.37 56.23 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.845 HD12 HG23 ' B' ' 35' ' ' ILE . 9.0 mt -85.18 147.3 26.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.238 0.519 . . . . 0.0 111.778 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -91.83 172.14 8.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.441 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.441 ' O ' HG12 ' B' ' 50' ' ' VAL . 3.2 mt-10 -66.57 -45.08 80.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.18 -39.23 93.57 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.002 -0.436 . . . . 0.0 111.053 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.406 ' CE ' HD22 ' B' ' 45' ' ' LEU . 9.6 ttp -70.71 -40.91 72.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.441 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -62.81 -35.07 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -63.3 -50.23 70.87 Favored 'General case' 0 CA--C 1.523 -0.066 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.926 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.23 -52.83 32.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.624 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.451 HD13 HD11 ' B' ' 35' ' ' ILE . 30.4 mt -64.75 -47.72 77.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.85 -43.33 90.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.279 0.561 . . . . 0.0 111.661 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -66.23 -44.06 84.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.284 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -42.0 99.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.59 -39.41 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.987 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.06 -28.47 65.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.716 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.78 -27.48 40.4 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.948 0.34 . . . . 0.0 111.43 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.72 -34.85 21.14 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.949 0.404 . . . . 0.0 110.337 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -131.16 105.74 7.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.33 9.48 10.8 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -126.58 16.15 7.58 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 111.854 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.48 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.06 114.27 6.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.375 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.439 HD12 ' N ' ' B' ' 66' ' ' PHE . 7.8 tp -58.85 124.48 19.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.608 0.242 . . . . 0.0 110.534 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.439 ' N ' HD12 ' B' ' 65' ' ' LEU . 31.8 m-85 -113.51 131.36 56.09 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.799 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.34 140.18 44.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.881 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.762 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.3 p -126.76 136.03 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.42 147.68 19.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.806 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.98 154.3 16.46 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.95 165.67 23.22 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.956 0.408 . . . . 0.0 111.286 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -58.42 -32.72 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.324 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.21 -7.5 59.0 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.98 128.03 57.4 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.42 156.4 54.48 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.139 1.226 . . . . 0.0 110.165 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.39 -36.44 83.74 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.866 -0.521 . . . . 0.0 110.683 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.18 -36.39 68.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.432 ' OE2' HD12 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.38 -37.15 74.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.674 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.19 -39.59 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.674 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 47.9 mm -60.59 -47.3 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 109.64 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.06 74.36 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.216 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.63 84.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.382 0.61 . . . . 0.0 110.907 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.53 -36.72 79.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.78 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -61.72 -41.32 97.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.837 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -39.94 94.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.002 0.429 . . . . 0.0 110.684 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -63.59 -42.54 98.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.304 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.73 76.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.74 10.84 24.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.41 98.11 Favored Glycine 0 C--N 1.33 0.25 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' B' ' 86' ' ' LEU . 5.0 mt -101.9 -37.05 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.75 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 m -163.03 -61.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 42.9 t -127.02 123.19 23.46 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -52.37 175.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.017 2.478 . . . . 0.0 115.775 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 58.5 t -112.82 118.82 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.22 127.87 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -116.01 123.27 47.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.9 tm-20 -112.01 128.98 56.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.156 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 74' ' ' VAL . 29.3 t -88.68 96.67 6.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.181 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB3' ' HG3' ' A' ' 32' ' ' LYS . . . -76.61 -22.06 54.69 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.52 -120.65 0.65 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -112.57 101.12 12.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.019 0.527 . . . . 0.0 109.706 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.48 73.5 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.93 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -109.66 95.95 5.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.732 0.777 . . . . 0.0 110.285 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -104.83 156.65 17.82 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.294 1.045 . . . . 0.0 113.025 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.09 142.25 51.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.666 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 37' ' ' ILE . 5.3 pt -132.77 134.24 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.15 115.15 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.679 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' ILE . 48.8 mt -114.56 109.51 28.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.252 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.22 45.38 27.61 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.13 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.11 -25.73 22.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.071 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.47 128.07 36.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.327 1.064 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.89 136.05 47.4 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.023 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 127.48 53.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.35 157.7 25.69 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 112.228 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.53 52.55 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.12 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.614 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -87.94 147.7 24.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 112.221 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -89.71 169.88 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.629 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -65.55 -45.36 83.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.861 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -64.39 -38.77 92.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.562 ' CE ' HD22 ' A' ' 45' ' ' LEU . 11.1 ttp -72.11 -37.76 69.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.977 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.6 p -64.97 -33.36 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m -62.94 -50.3 71.35 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.448 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.13 -52.49 34.73 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.866 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -65.21 -47.36 77.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.773 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -58.7 -43.11 89.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.482 . . . . 0.0 111.592 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -65.95 -44.34 85.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.284 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.37 -41.58 98.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -69.57 -38.97 77.61 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.95 -29.75 66.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.575 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -76.91 -27.71 55.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.94 0.336 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -83.44 -35.94 24.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.846 0.355 . . . . 0.0 110.065 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.68 105.25 7.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -78.17 -15.61 58.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -105.13 19.06 21.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.359 0.527 . . . . 0.0 111.858 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 1.9 m -68.79 116.18 8.99 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -63.83 125.27 23.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.664 ' N ' HD12 ' A' ' 65' ' ' LEU . 55.6 m-85 -111.63 130.04 55.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.198 0.523 . . . . 0.0 111.627 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -135.52 139.93 44.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.67 138.65 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.32 142.81 14.08 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.5 154.0 16.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.722 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.0 23.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -31.43 69.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.515 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.12 -7.07 59.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 27' ' ' VAL . 59.8 t -89.66 131.8 38.74 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.34 155.91 55.31 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.013 1.142 . . . . 0.0 110.246 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.71 -35.46 80.63 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.842 -0.536 . . . . 0.0 110.437 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -56.6 -36.94 69.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.649 0.261 . . . . 0.0 110.402 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -36.58 75.22 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.734 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.03 -39.26 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.483 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.6 mm -60.6 -46.56 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.41 0.624 . . . . 0.0 109.404 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.65 -45.11 73.77 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.182 178.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.386 0.613 . . . . 0.0 110.657 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.6 mt -60.65 -37.11 80.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.486 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.32 -41.77 97.56 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.787 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.55 -42.89 98.35 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -62.45 -43.13 99.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.567 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -37.57 79.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.53 10.48 25.25 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.24 98.22 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.3 mt -101.55 -33.78 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.975 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -162.48 -61.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 44.8 t -126.93 123.44 23.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.197 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -52.42 175.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.987 2.458 . . . . 0.0 115.829 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.564 HG23 ' CG2' ' B' ' 64' ' ' THR . 60.3 t -113.08 118.43 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.813 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.2 127.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.316 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.97 123.44 48.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.55 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.9 tm-20 -112.03 129.34 56.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.215 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 74' ' ' VAL . 28.4 t -88.91 96.48 6.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.185 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.409 ' HB3' ' HG3' ' B' ' 32' ' ' LYS . . . -76.92 -21.38 54.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.22 -125.3 0.91 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.651 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -107.65 101.9 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.016 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.45 70.55 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.006 -0.543 . . . . 0.0 114.099 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -109.58 95.57 5.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.823 0.821 . . . . 0.0 110.361 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -104.24 156.49 17.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.279 1.037 . . . . 0.0 113.093 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.0 142.14 51.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.479 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.668 HD12 HD11 ' B' ' 37' ' ' ILE . 5.6 pt -132.76 134.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.452 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.3 115.1 28.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.595 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.668 HD11 HD12 ' B' ' 35' ' ' ILE . 45.6 mt -114.51 109.71 29.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.301 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.89 45.76 25.51 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.408 -0.901 . . . . 0.0 114.179 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -25.77 21.71 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.144 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.39 128.09 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.33 1.065 . . . . 0.0 110.396 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.82 136.02 47.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.899 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.555 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.4 127.52 53.19 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.43 157.02 26.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 27.97 49.01 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.119 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.616 HD12 HG23 ' B' ' 35' ' ' ILE . 9.2 mt -87.93 148.23 24.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.653 0.74 . . . . 0.0 112.305 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -90.53 169.59 10.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.411 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.469 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.7 mt-10 -65.27 -45.36 84.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.37 -38.81 92.33 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.948 -0.47 . . . . 0.0 111.069 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.566 ' CE ' HD22 ' B' ' 45' ' ' LEU . 10.2 ttp -71.75 -37.98 70.46 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.5 p -64.75 -33.42 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.1 m -62.99 -50.29 71.33 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.506 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.09 -52.39 35.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.797 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.416 HD13 HD11 ' B' ' 35' ' ' ILE . 38.6 mt -65.25 -47.73 75.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.683 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -58.38 -43.37 88.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.077 0.465 . . . . 0.0 111.527 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -65.84 -44.4 85.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.28 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.27 -41.58 99.04 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.184 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.56 -38.84 77.59 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -69.93 -29.71 66.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.692 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -77.0 -27.78 54.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.851 0.296 . . . . 0.0 111.26 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -83.29 -35.52 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.838 0.351 . . . . 0.0 110.102 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -130.15 105.0 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.84 -15.54 58.98 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -105.38 19.57 20.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.362 0.528 . . . . 0.0 111.899 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.564 ' CG2' HG23 ' B' ' 23' ' ' VAL . 1.8 m -69.26 116.05 9.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.647 HD12 ' N ' ' B' ' 66' ' ' PHE . 0.8 OUTLIER -63.6 125.35 23.99 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.647 ' N ' HD12 ' B' ' 65' ' ' LEU . 55.4 m-85 -111.74 130.58 55.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.559 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -135.91 140.06 43.78 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.915 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.722 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -126.85 138.77 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 142.86 14.09 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.25 153.94 16.82 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 163.28 24.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.057 0.455 . . . . 0.0 111.322 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -31.44 69.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.307 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -7.15 59.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 27' ' ' VAL . 66.9 t -89.55 132.1 38.05 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.5 155.78 54.72 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.052 1.168 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.754 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.74 -35.38 80.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.863 -0.523 . . . . 0.0 110.363 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.73 -36.78 70.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.565 0.221 . . . . 0.0 110.423 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.0 -36.5 75.19 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.713 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.19 -39.2 83.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.579 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.754 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.8 mm -60.53 -46.61 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.364 0.602 . . . . 0.0 109.435 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -44.88 73.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.085 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.64 80.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.278 0.561 . . . . 0.0 110.767 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.8 mt -60.21 -37.03 79.05 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.566 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.13 -41.93 97.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.981 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.41 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.9 OUTLIER -65.69 -39.36 91.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.592 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.567 HD13 HD13 ' B' ' 91' ' ' ILE . 1.5 mm? -63.42 -42.55 98.73 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -62.75 -43.23 99.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.589 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.77 79.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.491 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.19 10.54 24.17 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.42 44.63 97.43 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.071 0.788 . . . . 0.0 115.071 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -101.84 -34.21 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.873 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -68.43 -42.45 78.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.997 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 48.0 t -114.57 119.11 40.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.712 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.27 174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.0 2.467 . . . . 0.0 115.663 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.8 118.89 58.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.2 127.61 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.652 0.263 . . . . 0.0 111.607 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -115.88 122.65 45.99 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -110.59 127.29 55.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.207 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.7 105.27 14.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.723 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.63 -22.3 28.02 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.99 -121.55 0.72 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.956 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.15 97.97 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 122.869 0.467 . . . . 0.0 109.94 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.05 -5.3 85.02 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.956 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.04 128.55 53.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.562 0.681 . . . . 0.0 109.482 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -134.84 156.03 49.61 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.231 1.015 . . . . 0.0 112.759 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 141.53 52.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.796 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 45' ' ' LEU . 5.1 pt -132.48 133.85 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.263 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -111.36 115.52 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.561 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 35' ' ' ILE . 89.9 mt -113.69 108.92 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.281 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.69 46.74 24.46 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.65 -0.786 . . . . 0.0 114.079 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.99 15.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.082 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.3 129.24 36.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.527 1.163 . . . . 0.0 110.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -107.96 135.95 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.027 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -117.53 125.58 51.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.84 156.21 26.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.064 0.459 . . . . 0.0 111.885 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 26.95 52.81 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.959 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 42' ' ' GLN . 20.5 mt -86.96 148.7 25.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.344 0.572 . . . . 0.0 111.743 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.2 p -89.6 171.73 9.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.183 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.1 mt-10 -66.86 -44.92 79.7 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.234 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 mtp -70.22 -43.43 70.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -59.27 -34.73 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.899 0.38 . . . . 0.0 110.08 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -63.98 -50.48 68.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.824 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -50.71 -52.07 43.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.657 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.84 -47.95 76.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.46 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -57.32 -43.88 83.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 111.618 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mmt180 -66.66 -44.33 82.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.243 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -64.53 -40.02 94.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.99 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -69.94 -38.69 76.26 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.43 -31.33 69.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.9 -28.73 55.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.887 0.312 . . . . 0.0 111.239 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -82.24 -36.82 26.78 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -128.59 112.16 13.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -84.58 -10.07 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -112.45 19.67 17.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.376 0.535 . . . . 0.0 111.952 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 113.36 5.55 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.32 125.51 24.15 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -112.54 128.31 56.31 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 111.737 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' B' ' 67' ' ' LEU . 3.1 pp -132.16 139.27 48.34 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.461 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 15.0 p -127.24 137.89 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 144.62 15.84 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.6 156.61 16.01 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.833 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.51 163.21 24.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.138 0.495 . . . . 0.0 111.276 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -57.47 -31.85 66.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.649 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.01 -6.01 58.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.27 129.72 57.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' VAL . 67.9 Cg_endo -73.31 151.81 49.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.22 1.28 . . . . 0.0 110.426 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -62.94 -39.46 94.7 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.493 -0.754 . . . . 0.0 111.271 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.73 -35.58 66.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.82 -35.96 70.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.204 0.526 . . . . 0.0 109.744 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' PRO . 6.5 t -62.44 -38.82 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.439 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 76' ' ' TYR . 47.7 mm -61.04 -47.6 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -44.74 68.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.16 78.93 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.454 0.645 . . . . 0.0 110.358 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.35 -37.08 79.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.864 0.84 . . . . 0.0 109.353 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -61.32 -42.92 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 47' ' ' GLU . 7.6 mt -63.6 -39.73 95.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 110.657 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.08 -41.97 99.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.85 -41.23 97.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.7 -38.68 78.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.442 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.43 11.02 22.9 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.32 44.13 98.1 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.668 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt -99.11 -36.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.671 -179.525 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 112.731 -0.147 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -67.94 -42.53 80.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 110.775 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 48.3 t -114.29 119.57 40.01 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.11 175.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.932 2.421 . . . . 0.0 115.652 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.63 118.67 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -110.98 127.43 68.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 120.698 0.285 . . . . 0.0 111.675 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.8 tt -115.65 122.59 46.03 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -110.6 126.85 54.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.314 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.43 105.3 14.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.788 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.31 28.5 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.88 -124.71 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.778 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -109.04 97.58 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.406 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.33 -5.19 85.05 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.106 -0.569 . . . . 0.0 114.049 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 128.79 54.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -135.15 156.07 49.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.334 1.064 . . . . 0.0 112.804 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.52 141.48 52.06 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.828 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.543 HG23 HD12 ' B' ' 45' ' ' LEU . 5.1 pt -132.31 134.14 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.265 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -111.58 115.72 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.566 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.48 HD11 HD12 ' B' ' 35' ' ' ILE . 93.0 mt -113.98 108.8 26.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.276 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.85 46.47 25.42 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.015 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.91 16.53 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.046 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -90.39 129.27 36.61 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.453 1.127 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -108.37 135.96 48.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.923 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.43 126.14 52.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -116.25 156.21 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.175 0.512 . . . . 0.0 111.864 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.35 51.74 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.065 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' B' ' 42' ' ' GLN . 20.9 mt -87.27 148.89 24.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.281 0.562 . . . . 0.0 111.741 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.5 p -89.51 171.88 9.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.183 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.51 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.05 -44.85 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.508 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.19 -37.99 89.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.101 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 23.6 mtp -70.14 -43.68 70.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.51 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.8 OUTLIER -59.13 -34.65 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -64.27 -50.24 68.7 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.834 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -50.65 -51.94 44.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.02 -48.02 75.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.377 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.12 -44.05 82.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 111.561 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 2.4 mmt180 -66.65 -44.27 82.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.147 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.5 -40.25 95.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.929 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -69.91 -38.26 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.195 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -69.91 -31.3 69.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.6 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.81 -28.98 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 122.213 -0.305 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -82.06 -36.56 27.54 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -128.71 112.39 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -84.66 -10.43 57.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -112.21 19.63 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.322 0.51 . . . . 0.0 111.945 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 113.11 5.17 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.39 125.31 23.46 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -112.3 128.01 56.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 111.672 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 67' ' ' LEU . 3.3 pp -132.21 139.45 48.33 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.344 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.772 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.3 p -127.53 137.91 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.55 145.12 16.42 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.81 156.86 16.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.039 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 163.18 24.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 111.396 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -57.59 -31.82 66.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.485 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.17 -6.37 59.15 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.6 t -83.77 129.43 59.42 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.98 151.57 50.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.545 1.496 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -62.86 -39.62 94.96 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.757 -0.589 . . . . 0.0 111.23 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.42 -35.55 65.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.685 0.279 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -72.07 -35.74 69.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -62.65 -38.85 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.7 mm -60.98 -47.45 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -44.63 68.08 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.982 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.407 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.33 -48.85 80.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 110.459 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.59 -37.2 80.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.789 0.804 . . . . 0.0 109.221 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.19 -42.77 99.17 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.677 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.411 HD11 ' OE1' ' B' ' 47' ' ' GLU . 8.3 mt -63.96 -39.57 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.239 0.542 . . . . 0.0 110.831 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.67 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.32 -41.72 98.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.894 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -63.9 -41.38 97.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.59 -38.69 78.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.366 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.606 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.35 11.0 22.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.37 44.28 97.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.67 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -99.16 -36.16 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.893 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -51.45 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.3 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 17.7 t -121.82 125.45 26.71 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.63 173.24 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.677 2.251 . . . . 0.0 115.094 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 64' ' ' THR . 47.6 t -113.59 118.07 57.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' A' ' 67' ' ' LEU . 3.3 mp -109.44 127.69 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.141 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.6 tt -113.96 120.35 40.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' N ' HD23 ' A' ' 25' ' ' LEU . 8.8 tt0 -111.12 128.77 56.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.177 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 74' ' ' VAL . 38.8 t -85.29 120.84 36.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.743 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.11 -23.12 14.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.37 -121.16 0.65 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.983 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -113.55 100.56 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.98 -0.77 86.64 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.881 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.24 93.93 4.82 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.42 0.61 . . . . 0.0 110.009 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -103.37 156.01 18.06 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.11 0.957 . . . . 0.0 112.717 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -122.92 141.44 51.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.989 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.611 HD11 HD13 ' A' ' 53' ' ' LEU . 8.7 pt -131.06 133.8 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 114.24 27.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.645 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 35' ' ' ILE . 98.3 mt -116.09 110.09 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.883 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.61 42.76 28.0 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.717 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.78 -26.39 18.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.996 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.72 124.93 31.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.184 0.992 . . . . 0.0 110.526 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 130.98 52.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.632 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -119.37 127.12 52.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.69 157.87 25.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.021 0.439 . . . . 0.0 111.901 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.91 27.3 50.74 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.07 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 42' ' ' GLN . 15.4 mt -88.48 150.32 23.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.8 0.81 . . . . 0.0 112.698 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -91.32 171.59 9.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.143 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.4 mt-10 -66.49 -45.02 80.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.789 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -63.53 -39.28 94.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 mtm -69.92 -44.6 69.32 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.171 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -58.87 -33.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 m -63.89 -50.68 67.79 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.628 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -49.8 -53.23 26.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.659 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 35' ' ' ILE . 27.8 mt -64.78 -48.1 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.477 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 t -58.14 -43.12 87.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 111.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -44.1 84.62 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.499 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.66 -39.96 94.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -37.81 76.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.898 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.49 -31.15 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.641 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.01 -28.17 54.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.811 0.278 . . . . 0.0 111.249 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -83.27 -37.77 23.05 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.03 101.79 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -76.9 -1.54 29.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -121.38 19.76 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.164 0.438 . . . . 0.0 111.913 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.589 ' CG2' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.54 118.23 12.15 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.486 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -64.36 127.32 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -114.36 131.53 56.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 111.515 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.921 HD11 HG23 ' A' ' 24' ' ' ILE . 3.0 pp -135.55 141.3 45.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.023 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 83' ' ' LEU . 86.9 t -122.39 127.36 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.4 142.48 13.99 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.47 155.5 16.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.219 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.2 164.81 23.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.042 0.449 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -58.81 -32.79 69.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.51 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -80.72 -6.23 58.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 27' ' ' VAL . 77.3 t -85.64 136.82 36.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . 98.2 Cg_endo -78.75 152.24 25.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.542 1.495 . . . . 0.0 110.457 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -64.08 -38.51 91.33 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.24 -36.48 66.07 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.664 0.269 . . . . 0.0 110.538 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.09 -34.26 66.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.783 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.2 t -62.28 -39.98 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.4 mm -59.01 -48.81 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.609 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.002 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.22 70.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -60.62 -36.88 79.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.624 0.726 . . . . 0.0 109.255 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.75 -41.97 96.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.81 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 3.4 mt -65.49 -38.57 90.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.487 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.43 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.08 -42.38 99.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.009 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.5 -41.54 98.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.593 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.51 -38.3 77.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.536 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -92.29 11.67 25.06 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.18 44.59 97.24 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 114.869 0.708 . . . . 0.0 114.869 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.2 mt -102.67 -35.3 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 109.877 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.026 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -51.03 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.632 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 17.4 t -122.06 125.26 26.69 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.422 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.44 172.55 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.871 2.38 . . . . 0.0 115.104 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.576 HG23 HG22 ' B' ' 64' ' ' THR . 47.0 t -113.09 117.88 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.938 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.21 127.97 65.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.47 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.7 tt -114.31 120.58 40.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 8.5 tt0 -111.31 128.93 56.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.137 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 74' ' ' VAL . 35.8 t -85.51 120.91 36.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.679 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 -23.18 13.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.13 -125.19 0.88 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.779 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.76 100.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.109 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.76 -0.53 86.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.119 -0.491 . . . . 0.0 114.013 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 94.5 5.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.466 0.633 . . . . 0.0 109.902 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.63 156.01 18.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.219 1.009 . . . . 0.0 112.765 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -122.76 141.91 51.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.038 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 53' ' ' LEU . 8.5 pt -131.28 133.8 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 113.9 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.79 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.536 HD11 HD12 ' B' ' 35' ' ' ILE . 99.0 mt -115.63 110.35 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.926 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.28 42.78 25.59 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.769 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -26.17 19.75 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.899 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.58 124.86 31.21 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.302 1.051 . . . . 0.0 110.561 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 131.01 52.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.644 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -119.36 126.7 52.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.51 158.05 25.22 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.063 0.459 . . . . 0.0 111.9 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 27.23 51.44 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.273 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 42' ' ' GLN . 14.7 mt -88.5 150.59 23.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.822 0.82 . . . . 0.0 112.681 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -91.68 171.5 9.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.1 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.492 ' O ' HG12 ' B' ' 50' ' ' VAL . 24.9 mt-10 -66.19 -45.18 81.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.57 -39.35 94.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.892 0.314 . . . . 0.0 111.325 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mtm -69.84 -44.65 69.46 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.351 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.492 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.67 -33.49 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.8 m -64.21 -50.4 68.2 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.736 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.09 -53.01 30.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.523 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.591 HD13 HD11 ' B' ' 35' ' ' ILE . 22.6 mt -64.98 -47.88 75.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.729 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.41 -43.43 88.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -43.88 87.04 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.581 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -64.81 -40.07 94.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.75 76.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -70.39 -31.17 68.28 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.652 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -28.38 55.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.971 0.35 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -83.07 -37.74 23.45 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.17 101.22 6.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -76.23 -1.67 27.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -121.48 19.74 11.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.281 0.491 . . . . 0.0 111.824 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.576 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.56 118.0 11.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.421 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.8 127.03 29.55 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 40.0 m-85 -114.22 131.51 56.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.938 HD11 HG23 ' B' ' 24' ' ' ILE . 3.0 pp -135.55 141.4 45.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.264 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 87.0 t -122.53 127.07 74.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.13 142.44 13.96 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.42 155.15 16.27 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.117 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.02 165.2 23.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.968 0.414 . . . . 0.0 111.229 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -59.42 -32.21 69.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.429 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -80.94 -6.93 59.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 27' ' ' VAL . 72.4 t -85.07 136.58 38.17 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.454 ' O ' HG23 ' B' ' 79' ' ' VAL . 96.1 Cg_endo -78.55 151.98 25.88 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.773 1.649 . . . . 0.0 110.385 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.5 t80 -63.88 -38.43 91.07 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.43 -0.794 . . . . 0.0 111.108 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -55.31 -36.5 66.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.68 0.276 . . . . 0.0 110.425 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.01 -34.31 66.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 109.868 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' B' ' 75' ' ' PRO . 20.1 t -62.59 -39.1 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.6 mm -60.08 -48.26 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.507 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -53.68 -43.01 68.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.076 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -51.07 71.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 110.884 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 83' ' ' LEU . 8.5 mt -60.55 -37.51 81.48 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.702 0.763 . . . . 0.0 109.116 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.798 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.6 mt -65.49 -38.46 89.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.559 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.436 HD13 HD13 ' B' ' 91' ' ' ILE . 1.2 mm? -63.27 -42.21 99.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.094 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.68 -41.63 98.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.424 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.38 -38.37 77.15 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.429 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -92.07 11.49 25.18 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.37 44.8 97.2 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -102.95 -35.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.986 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -136.06 -48.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.994 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 49.0 t -115.5 123.08 31.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.764 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.9 176.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.876 2.384 . . . . 0.0 115.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 HG22 ' A' ' 64' ' ' THR . 48.9 t -113.71 119.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.9 127.65 68.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.291 -178.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.481 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -114.73 121.23 42.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.17 127.18 53.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.286 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.17 118.7 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.69 -23.06 15.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.95 -120.27 0.65 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.01 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.525 HD13 ' HG2' ' A' ' 78' ' ' GLU . 28.4 mm -112.26 99.3 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 123.061 0.544 . . . . 0.0 109.793 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.75 -3.91 85.92 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.239 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 131.22 53.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 117.754 0.777 . . . . 0.0 109.897 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -138.03 157.24 46.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.134 0.969 . . . . 0.0 112.917 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 141.95 51.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.328 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 53' ' ' LEU . 8.2 pt -132.15 134.86 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.502 0.592 . . . . 0.0 112.406 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.28 115.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.488 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 HD12 ' A' ' 35' ' ' ILE . 80.7 mt -114.29 110.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.343 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.66 45.52 24.0 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.446 -0.883 . . . . 0.0 114.076 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -26.5 18.31 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.205 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.59 128.72 36.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.41 1.105 . . . . 0.0 110.356 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.31 135.95 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.007 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.565 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.07 126.86 52.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.45 156.81 27.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.103 0.477 . . . . 0.0 112.238 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.25 45.71 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.322 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.6 mt -90.27 151.99 21.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.45 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 p -92.58 171.54 8.95 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.187 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.24 -42.31 84.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.081 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -64.32 -39.46 93.96 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.073 0.463 . . . . 0.0 111.142 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.17 -43.9 69.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.288 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -59.31 -34.41 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -64.09 -49.58 71.7 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.62 -51.93 44.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.746 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 35' ' ' ILE . 31.4 mt -64.49 -48.03 76.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.527 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t -58.23 -43.73 87.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.422 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.4 85.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.314 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.47 -41.58 98.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.154 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.99 -38.06 75.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.018 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.22 -30.21 67.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.95 -27.96 49.43 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.186 -0.321 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -82.68 -36.87 25.55 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -131.55 105.68 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.38 -8.03 58.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.69 19.42 18.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.421 0.555 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.532 HG22 HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -68.96 117.84 11.13 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.2 tp -64.29 124.17 21.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.609 ' N ' HD12 ' A' ' 65' ' ' LEU . 56.2 m-85 -112.52 132.81 54.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.958 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.06 140.44 43.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.416 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.3 t -122.99 129.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.25 146.82 18.81 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.79 155.04 17.08 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.939 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.8 163.6 25.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.99 0.424 . . . . 0.0 111.248 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.73 -32.53 65.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.567 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -80.77 -5.56 57.33 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -89.79 131.07 40.66 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.46 155.69 50.37 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.152 1.235 . . . . 0.0 110.339 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.8 t80 -64.21 -34.89 79.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.787 -0.57 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -71.48 -35.75 70.91 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.79 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.57 -39.24 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.1 mm -59.92 -48.88 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.518 0.675 . . . . 0.0 109.415 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.8 ttmm -53.98 -44.6 70.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.51 178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.69 -49.05 79.01 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.353 0.597 . . . . 0.0 111.009 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' B' ' 83' ' ' LEU . 11.4 mt -61.89 -36.0 80.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 108.989 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -61.8 -42.56 99.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.039 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.2 mt -63.87 -38.74 92.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.535 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 91' ' ' ILE . 1.8 mm? -63.81 -42.15 97.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.987 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -62.86 -42.39 99.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.668 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.47 -38.45 74.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.616 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.49 11.02 20.6 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.52 44.22 98.28 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.649 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt -101.57 -38.72 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.782 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 29.4 t -135.62 -48.14 0.69 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 111.008 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.502 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 49.8 t -115.74 123.09 31.7 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.55 176.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.07 2.513 . . . . 0.0 115.732 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.544 HG23 HG22 ' B' ' 64' ' ' THR . 47.4 t -113.51 119.68 61.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.946 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -111.87 127.93 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.316 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.459 HD13 HD21 ' B' ' 86' ' ' LEU . 8.0 tt -115.21 120.93 41.36 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.86 127.4 54.0 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.24 118.96 33.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.14 -22.78 15.05 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.8 -124.18 0.87 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.629 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.531 HD13 ' HG2' ' B' ' 78' ' ' GLU . 29.1 mm -107.8 99.55 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.979 -0.611 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.5 -3.62 86.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 114.391 0.516 . . . . 0.0 114.391 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.53 131.22 53.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.617 0.709 . . . . 0.0 109.698 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -137.86 156.9 47.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.048 0.927 . . . . 0.0 113.007 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.24 51.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.253 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.645 HD12 HD11 ' B' ' 37' ' ' ILE . 8.0 pt -132.32 134.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.499 0.591 . . . . 0.0 112.581 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.82 114.95 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.58 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 HD12 ' B' ' 35' ' ' ILE . 74.6 mt -114.51 109.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.347 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.502 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.11 45.17 26.87 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.996 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.26 19.31 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 119.277 -0.735 . . . . 0.0 114.254 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.45 129.02 36.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.46 1.13 . . . . 0.0 110.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.49 135.83 48.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.88 -178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.568 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.17 127.07 52.97 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -117.89 156.69 28.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 112.183 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.45 27.8 46.42 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.33 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' B' ' 42' ' ' GLN . 2.7 mt -90.14 151.98 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.557 0.694 . . . . 0.0 112.495 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.1 p -92.42 171.94 8.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.31 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.448 ' O ' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER -67.67 -41.59 83.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.136 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.1 -39.91 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.897 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.5 mtm -69.82 -43.7 71.5 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.448 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.1 p -59.52 -34.6 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -63.75 -50.08 70.49 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.56 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.667 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.632 HD13 HD11 ' B' ' 35' ' ' ILE . 28.9 mt -64.51 -47.96 76.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.658 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -58.44 -42.9 88.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.421 0.629 . . . . 0.0 111.473 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -43.74 82.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.361 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -63.99 -41.5 97.49 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.877 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.09 -37.69 75.48 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.6 -30.13 66.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.594 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -78.08 -28.03 48.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.833 0.288 . . . . 0.0 111.214 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -82.63 -36.51 26.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -131.74 105.99 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.5 -8.42 59.13 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.41 19.58 18.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.899 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.544 HG22 HG23 ' B' ' 23' ' ' VAL . 0.6 OUTLIER -69.14 117.72 11.13 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.591 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.0 tp -64.34 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.591 ' N ' HD12 ' B' ' 65' ' ' LEU . 56.7 m-85 -112.28 132.97 54.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 111.151 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.946 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.95 140.53 44.06 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.291 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.01 129.46 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.34 146.97 18.96 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.16 155.46 17.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.13 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.94 163.66 25.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.989 0.423 . . . . 0.0 111.259 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -56.98 -32.88 66.54 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.59 -5.62 57.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.54 131.1 41.09 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.36 155.97 50.71 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.197 1.265 . . . . 0.0 110.242 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -64.73 -34.61 78.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.676 -0.64 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.38 -37.4 70.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.531 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.2 OUTLIER -71.17 -35.71 71.73 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.803 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.4 t -61.87 -39.23 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.509 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.9 mm -59.75 -48.87 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.404 0.621 . . . . 0.0 109.41 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.5 ttmm -53.84 -44.94 70.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.492 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.429 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.64 -49.03 79.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.451 0.643 . . . . 0.0 110.929 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.68 -36.0 79.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.741 0.782 . . . . 0.0 109.273 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.75 -42.71 99.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.073 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.0 mt -64.15 -38.47 91.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.111 0.481 . . . . 0.0 110.499 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.632 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -64.06 -42.07 97.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.889 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -62.81 -42.46 99.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.568 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.29 -38.77 74.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.657 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.44 11.23 19.9 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.38 44.46 98.01 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 115.129 0.811 . . . . 0.0 115.129 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.632 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.68 -38.07 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.659 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.2 m -75.84 163.0 27.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.568 0.223 . . . . 0.0 110.855 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 22' ' ' PRO . 41.1 t -35.06 140.23 0.31 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.879 0.872 . . . . 0.0 113.161 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 21' ' ' VAL . 26.3 Cg_exo -46.47 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.351 2.701 . . . . 0.0 114.927 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 64' ' ' THR . 45.5 t -106.72 110.09 30.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 67' ' ' LEU . 3.2 mp -107.71 126.64 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.194 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -114.65 120.69 40.98 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -109.93 126.9 54.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.323 -178.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 74' ' ' VAL . 28.8 t -85.14 109.34 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.894 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.78 -22.51 22.1 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -120.71 0.67 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.547 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.14 100.27 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.66 -4.65 84.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.972 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 131.11 54.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.439 0.62 . . . . 0.0 109.354 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -139.79 157.96 44.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.218 1.009 . . . . 0.0 113.077 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.886 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.842 HG23 HD12 ' A' ' 45' ' ' LEU . 4.3 pt -131.35 133.96 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.354 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -112.12 115.12 28.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.571 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -111.99 108.56 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.573 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.77 47.23 18.82 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.956 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.93 -27.0 18.04 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.69 -0.767 . . . . 0.0 114.002 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -90.38 128.4 36.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.464 1.132 . . . . 0.0 110.749 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -106.55 133.0 51.9 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -117.25 128.02 54.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.61 157.38 26.49 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 27.61 52.04 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.934 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 35' ' ' ILE . 9.4 mt -86.94 147.86 25.58 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.213 0.506 . . . . 0.0 112.063 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -91.92 171.99 8.75 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.588 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.8 mt-10 -66.08 -46.16 78.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.065 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.902 0.319 . . . . 0.0 111.283 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.426 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -71.53 -39.22 70.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -62.39 -34.93 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.52 -50.77 68.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.773 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -52.84 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.032 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.08 -47.25 77.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.685 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -59.18 -42.83 91.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.705 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -44.03 85.14 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.236 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -40.63 96.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.43 -28.2 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.673 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.23 -26.44 39.09 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.883 0.31 . . . . 0.0 111.277 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -85.19 -34.93 21.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.777 0.322 . . . . 0.0 110.446 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -132.87 94.78 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.96 -4.01 26.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -114.9 17.25 17.05 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.771 0.714 . . . . 0.0 111.858 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.542 ' CG2' HG23 ' A' ' 23' ' ' VAL . 2.2 m -69.28 126.42 29.73 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.2 tp -69.55 127.08 31.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 23' ' ' VAL . 8.3 m-85 -114.34 131.43 56.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.254 0.549 . . . . 0.0 111.464 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.44 140.34 44.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.662 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.759 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.2 p -126.36 135.35 64.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.22 145.66 17.21 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.45 154.59 16.4 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.986 -0.625 . . . . 0.0 111.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.15 164.07 25.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.113 0.482 . . . . 0.0 111.234 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -31.84 68.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.343 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -80.9 -6.09 58.21 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 27' ' ' VAL . 69.9 t -86.15 132.06 44.6 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.9 152.81 41.77 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.554 1.502 . . . . 0.0 110.172 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.48 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.541 0.61 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -56.21 -35.71 67.62 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.02 -36.56 72.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.03 -39.11 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.813 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.5 mm -61.89 -45.41 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 109.508 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -44.92 80.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.858 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.28 -46.71 87.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.517 0.675 . . . . 0.0 110.737 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' B' ' 83' ' ' LEU . 4.8 mt -61.37 -37.63 84.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.716 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.52 -41.55 94.64 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.838 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -39.2 91.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.432 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.529 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.41 -42.94 98.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.015 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -63.17 -41.94 99.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -37.94 76.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.351 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.99 10.08 28.05 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.21 45.11 97.19 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.6 mt -102.68 -38.14 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.775 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -75.6 162.79 27.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.59 0.233 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' B' ' 22' ' ' PRO . 40.8 t -34.93 140.47 0.29 Allowed Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.0 0.92 . . . . 0.0 113.174 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.434 ' HD2' HG13 ' B' ' 21' ' ' VAL . 25.8 Cg_exo -46.25 -171.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.507 2.805 . . . . 0.0 114.935 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' B' ' 64' ' ' THR . 47.5 t -106.82 110.2 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -108.0 126.86 64.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.9 tt -114.5 120.74 41.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.456 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -110.01 127.1 54.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.189 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 31.7 t -85.3 108.85 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.37 -22.55 22.54 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.41 -124.67 0.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.253 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.73 100.99 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.16 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.69 82.64 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.208 -0.52 . . . . 0.0 114.055 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.3 130.83 54.07 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.576 0.688 . . . . 0.0 109.488 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -139.2 158.07 44.82 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.336 1.065 . . . . 0.0 113.219 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.17 142.21 51.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.803 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.862 HG23 HD12 ' B' ' 45' ' ' LEU . 4.2 pt -131.54 133.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.491 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.8 114.7 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.826 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.77 109.0 26.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.517 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.44 47.79 16.8 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.962 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -26.88 17.57 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.272 -0.738 . . . . 0.0 114.197 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -90.5 128.79 36.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.603 1.202 . . . . 0.0 110.473 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -107.04 133.3 51.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.205 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.461 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -117.53 127.94 54.48 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -117.45 157.81 25.59 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.76 52.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.553 -0.748 . . . . 0.0 113.052 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.862 HD12 HG23 ' B' ' 35' ' ' ILE . 9.3 mt -87.07 148.1 25.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 112.029 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.9 p -92.19 171.76 8.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.499 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.502 ' O ' HG12 ' B' ' 50' ' ' VAL . 29.7 mt-10 -66.01 -46.22 78.71 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.023 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.23 -39.13 93.75 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.991 -0.443 . . . . 0.0 111.134 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.421 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -71.37 -39.66 71.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.852 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.502 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -62.31 -34.83 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.53 -50.83 68.02 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.16 -52.97 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.808 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.95 -47.37 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.796 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.64 -43.26 89.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.097 0.475 . . . . 0.0 111.638 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -44.03 85.28 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.312 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.45 95.98 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -70.42 -40.06 74.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.084 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -69.23 -28.12 66.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.25 -26.8 38.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.956 0.344 . . . . 0.0 111.314 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.05 -34.56 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 110.527 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -132.95 94.73 3.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -72.11 -3.85 25.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -114.93 16.79 17.16 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.71 0.686 . . . . 0.0 111.828 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' B' ' 23' ' ' VAL . 2.0 m -68.87 126.45 29.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.386 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 66' ' ' PHE . 11.6 tp -70.28 126.91 31.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.495 ' CE2' HG11 ' B' ' 23' ' ' VAL . 8.4 m-85 -113.68 131.1 56.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.08 140.22 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.776 HG11 HD21 ' B' ' 83' ' ' LEU . 14.8 p -126.25 135.64 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.41 145.57 17.05 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.22 154.36 16.46 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.825 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 164.51 25.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -31.33 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.37 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -81.32 -6.25 58.7 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 70.7 t -85.82 132.06 45.26 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.17 153.0 40.68 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.416 1.411 . . . . 0.0 110.159 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.53 -38.28 90.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.652 0.66 . . . . 0.0 111.084 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.78 -36.14 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.85 -36.58 72.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.92 -39.2 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.681 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 46.2 mm -61.8 -45.75 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.466 0.65 . . . . 0.0 109.604 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.05 78.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.978 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.2 -46.84 87.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 110.682 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' A' ' 83' ' ' LEU . 4.9 mt -61.19 -37.97 84.86 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.758 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.23 -41.56 93.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.808 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -39.17 91.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.53 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.3 -42.94 99.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.059 179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -63.42 -41.82 98.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.99 76.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.34 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.06 10.47 26.63 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 45.12 97.12 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.6 mt -103.1 -38.31 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.931 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -65.69 -53.34 42.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 0.0 111.075 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 61.9 t -94.32 112.45 57.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -47.85 -176.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.283 2.655 . . . . 0.0 114.945 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.594 HG23 ' CG2' ' A' ' 64' ' ' THR . 66.3 t -116.3 124.89 73.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -116.15 127.98 73.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.606 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HD21 ' A' ' 86' ' ' LEU . 9.2 tt -115.5 125.72 53.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.03 128.84 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.811 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 74' ' ' VAL . 25.9 t -83.01 122.91 38.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.707 -1.133 . . . . 0.0 107.999 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.87 -22.78 14.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.91 -118.84 0.6 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.018 -1.086 . . . . 0.0 113.843 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mm -113.38 95.76 4.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 122.961 0.504 . . . . 0.0 109.722 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.25 -3.25 86.79 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.157 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.01 51.15 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.648 0.724 . . . . 0.0 109.443 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.44 157.92 44.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.155 0.978 . . . . 0.0 112.934 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.87 142.06 51.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.315 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.68 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.1 pt -132.64 135.46 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.04 113.88 26.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 35' ' ' ILE . 55.2 mt -109.93 106.85 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.151 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 46.68 49.31 16.62 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.082 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.35 -26.68 18.36 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.982 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.72 127.84 37.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.439 1.12 . . . . 0.0 110.315 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -105.52 136.04 45.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.157 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.14 127.83 53.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -117.84 156.97 27.47 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.14 26.93 54.24 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.087 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD22 ' CE ' ' A' ' 49' ' ' MET . 7.5 mt -87.87 149.95 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 112.412 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -92.0 169.52 10.59 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.09 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.6 pt-20 -65.37 -44.89 86.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.256 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.08 -39.1 93.32 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.119 -0.363 . . . . 0.0 111.279 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.639 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.69 -37.75 70.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.936 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -64.57 -34.05 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -63.27 -49.73 72.95 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -50.96 -51.63 50.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.769 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.17 -46.8 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.703 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.4 m -59.11 -43.63 91.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.271 0.558 . . . . 0.0 111.532 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -65.61 -44.18 87.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.349 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -63.45 -41.65 98.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.198 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.71 -38.17 76.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.26 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.805 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -77.44 -27.66 52.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 117.959 0.345 . . . . 0.0 111.345 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -35.0 25.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 110.179 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -130.94 99.32 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -72.89 -20.78 61.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.3 20.0 13.33 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.215 0.461 . . . . 0.0 111.775 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.594 ' CG2' HG23 ' A' ' 23' ' ' VAL . 19.4 m -70.34 119.11 14.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.91 126.72 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.37 135.64 53.86 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 24' ' ' ILE . 3.8 pp -138.67 141.28 39.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 83' ' ' LEU . 54.5 t -123.54 128.53 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.02 -178.89 15.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.52 156.54 27.86 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.528 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.73 164.39 23.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.051 0.453 . . . . 0.0 111.38 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.45 -32.49 68.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.48 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.05 -7.13 59.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 27' ' ' VAL . 69.9 t -85.81 130.15 51.76 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.89 155.81 43.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.129 1.219 . . . . 0.0 110.516 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.4 t80 -65.03 -34.46 78.49 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.594 -0.691 . . . . 0.0 110.27 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.43 -36.85 69.45 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -36.92 73.91 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.299 0.571 . . . . 0.0 109.716 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.17 -39.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.758 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.3 mm -59.5 -49.52 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.452 0.644 . . . . 0.0 109.711 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -55.02 -43.6 73.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.378 178.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.44 77.75 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.753 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 7.9 mt -61.12 -35.91 78.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.642 0.734 . . . . 0.0 109.095 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.28 -43.77 98.33 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.887 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.6 mt -64.67 -37.65 88.3 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.3 -41.85 96.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.374 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -63.87 -39.59 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.82 -38.95 79.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.51 11.4 24.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.62 44.68 97.63 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.821 0.688 . . . . 0.0 114.821 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.63 HD13 HD13 ' A' ' 86' ' ' LEU . 4.0 mt -100.0 -34.35 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.957 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -65.6 -53.48 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.291 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 61.5 t -94.45 112.34 57.29 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.135 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -47.52 -176.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.352 2.701 . . . . 0.0 115.03 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' B' ' 64' ' ' THR . 65.9 t -116.4 124.52 72.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -115.76 128.11 73.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.735 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 86' ' ' LEU . 9.4 tt -115.57 125.54 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.88 128.46 55.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.816 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.482 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.1 t -82.74 122.67 37.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.6 -23.08 14.33 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.32 -122.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.75 96.11 4.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.273 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 -3.14 87.08 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.187 -0.53 . . . . 0.0 114.116 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.34 50.67 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.708 0.754 . . . . 0.0 109.494 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.62 157.96 44.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.03 0.919 . . . . 0.0 112.944 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.96 141.66 51.87 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.383 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.678 ' CD1' HD11 ' B' ' 37' ' ' ILE . 6.1 pt -132.45 135.33 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.449 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.95 113.74 26.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD1' ' B' ' 35' ' ' ILE . 55.8 mt -109.94 106.93 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.182 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.18 49.31 19.1 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.96 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -26.57 17.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.01 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -91.36 127.63 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.489 1.144 . . . . 0.0 110.34 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -105.51 135.71 46.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.86 127.47 53.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -117.45 157.02 26.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.84 27.16 54.43 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.178 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' CE ' ' B' ' 49' ' ' MET . 7.5 mt -87.72 150.12 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -92.49 169.92 10.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.128 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.505 ' O ' HG12 ' B' ' 50' ' ' VAL . 5.6 pt-20 -65.46 -44.98 85.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.18 -39.0 93.08 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.916 -0.49 . . . . 0.0 111.283 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.629 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.71 -37.95 70.57 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.913 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -64.37 -34.1 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 45.9 m -63.12 -49.65 73.59 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.815 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -50.89 -52.11 45.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.62 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.61 -46.95 80.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.789 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 42.4 m -58.9 -43.58 91.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -65.85 -43.78 87.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.359 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -63.86 -41.86 97.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.081 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -69.56 -38.31 77.36 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.34 -30.08 66.94 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.27 -27.82 53.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.881 0.31 . . . . 0.0 111.316 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -34.67 25.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -131.32 98.98 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -72.56 -20.77 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.2 19.97 13.26 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.324 0.511 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.588 ' CG2' HG23 ' B' ' 23' ' ' VAL . 21.5 m -70.43 118.54 13.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.26 126.71 29.59 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.68 135.65 53.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.143 0.497 . . . . 0.0 111.634 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.934 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -138.73 141.65 38.9 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 83' ' ' LEU . 56.0 t -123.73 128.17 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.61 -178.86 15.57 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.04 27.28 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.644 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.63 164.57 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.01 0.433 . . . . 0.0 111.464 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -58.67 -32.49 69.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.419 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.89 -7.57 59.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 27' ' ' VAL . 77.3 t -85.38 129.88 53.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.72 155.68 44.31 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.257 1.305 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -64.88 -34.32 78.12 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.578 -0.701 . . . . 0.0 110.238 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.6 -36.87 69.9 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -36.48 73.19 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.247 0.546 . . . . 0.0 109.595 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.63 -39.38 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.6 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.9 mm -59.58 -49.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.425 0.631 . . . . 0.0 109.685 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 ttmm -55.33 -43.52 75.04 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.324 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.4 77.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.308 0.575 . . . . 0.0 110.757 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 8.6 mt -61.22 -35.82 78.24 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.687 0.755 . . . . 0.0 109.196 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.29 -43.66 98.51 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.966 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.1 mt -64.76 -38.04 89.66 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.061 0.457 . . . . 0.0 110.776 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.613 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.76 -41.71 97.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.489 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -64.22 -39.19 93.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.499 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.25 -38.7 80.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.572 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.58 44.37 98.05 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 114.708 0.643 . . . . 0.0 114.708 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -99.64 -35.01 4.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -63.43 -33.46 75.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.599 0.237 . . . . 0.0 110.876 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 21.0 t -118.91 120.99 30.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -51.64 173.3 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.72 2.28 . . . . 0.0 115.428 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.647 HG23 HG22 ' A' ' 64' ' ' THR . 55.7 t -115.32 120.54 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.075 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -111.43 127.9 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.344 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.48 121.13 41.77 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.3 mt-10 -110.15 127.35 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.403 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -84.55 119.67 33.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.126 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.92 -23.26 14.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.67 -122.07 0.72 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.554 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.88 98.78 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 122.812 0.445 . . . . 0.0 109.937 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -3.36 87.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 114.041 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.31 54.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.54 0.67 . . . . 0.0 109.313 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -138.83 156.79 47.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.228 1.013 . . . . 0.0 113.08 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.72 141.87 51.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.895 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -133.71 135.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.514 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.45 117.21 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.959 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' OE2' ' A' ' 57' ' ' GLU . 89.9 mt -115.83 110.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.284 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.93 44.34 31.75 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.133 -1.032 . . . . 0.0 114.087 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.08 -24.88 24.76 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.982 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.5 128.48 36.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.371 1.085 . . . . 0.0 109.959 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -106.81 135.05 49.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.04 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.16 126.08 52.23 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.03 156.65 27.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.11 0.481 . . . . 0.0 111.925 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 26.91 53.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.952 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.4 mt -87.42 149.21 24.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.278 0.561 . . . . 0.0 112.077 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.7 p -90.52 171.53 9.34 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.12 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.9 pt-20 -66.58 -44.26 82.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -63.6 -38.87 92.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.5 mtp -69.89 -43.66 71.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.315 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.58 -34.73 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -63.81 -50.23 69.74 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.685 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -50.31 -52.49 36.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.747 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.7 mt -64.78 -48.33 74.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.604 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -59.27 -42.68 91.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.209 0.528 . . . . 0.0 111.605 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.74 -44.15 82.26 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.165 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.34 -39.66 94.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.884 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' A' ' 37' ' ' ILE . 8.3 mm-40 -70.82 -38.34 73.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.241 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -69.91 -31.84 69.83 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.32 -27.81 47.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.817 0.281 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -85.1 -35.16 21.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.237 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -130.95 96.98 4.19 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -75.51 -0.8 21.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.91 16.86 13.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.66 0.664 . . . . 0.0 111.841 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.647 HG22 HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -69.55 119.18 13.41 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.235 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.42 125.51 24.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -114.19 133.17 55.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.075 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.74 142.29 44.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.429 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 83' ' ' LEU . 73.1 t -123.43 126.12 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.85 145.7 17.69 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.44 154.53 16.91 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 165.1 25.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.0 110.871 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.01 -32.58 64.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -81.2 -5.63 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -84.74 131.24 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 79' ' ' VAL . 72.7 Cg_endo -75.23 152.78 40.12 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.503 1.469 . . . . 0.0 109.99 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.4 t80 -64.15 -36.94 85.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.855 0.752 . . . . 0.0 110.981 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -56.3 -36.65 68.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.79 -36.25 70.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 75' ' ' PRO . 16.5 t -61.55 -39.0 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.402 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.2 mm -59.53 -50.69 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.386 0.613 . . . . 0.0 109.452 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -44.18 70.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.442 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.37 -48.49 80.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.387 0.613 . . . . 0.0 110.659 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' B' ' 83' ' ' LEU . 10.2 mt -62.23 -36.08 80.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.69 0.757 . . . . 0.0 109.189 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -61.78 -41.9 98.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.812 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.34 -38.71 92.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 HD13 ' A' ' 91' ' ' ILE . 2.7 mm? -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.028 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -63.56 -43.09 98.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.575 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.1 -39.12 74.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.555 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.25 12.79 19.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.6 44.86 95.32 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.583 0.593 . . . . 0.0 114.583 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 89' ' ' ALA . 5.1 mt -106.1 -43.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 109.969 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.65 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 71.1 m -63.16 -33.89 76.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.016 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.431 ' CG1' ' HA2' ' B' ' 38' ' ' GLY . 21.5 t -118.79 121.08 30.95 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -51.79 173.49 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.777 2.318 . . . . 0.0 115.544 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.622 HG23 HG22 ' B' ' 64' ' ' THR . 56.3 t -115.43 120.47 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.049 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.39 127.72 68.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.467 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.15 121.12 42.04 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 3.1 mt-10 -109.94 127.14 54.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.303 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.3 119.67 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.387 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.88 -23.61 14.53 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.15 -125.75 0.94 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.399 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -108.37 98.87 7.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.117 -0.542 . . . . 0.0 110.236 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.37 -3.51 86.99 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 121.123 -0.561 . . . . 0.0 114.088 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 130.52 54.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.552 0.676 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -138.99 157.11 46.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.282 1.039 . . . . 0.0 113.166 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.94 141.96 51.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.863 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.531 HG23 HD12 ' B' ' 45' ' ' LEU . 5.8 pt -133.85 135.14 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.422 0.555 . . . . 0.0 112.438 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.19 117.36 32.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.474 HG21 ' OE2' ' B' ' 57' ' ' GLU . 91.4 mt -116.27 110.54 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.086 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.431 ' HA2' ' CG1' ' B' ' 21' ' ' VAL . . . 48.62 44.59 29.88 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.213 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.99 -24.97 24.17 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.026 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.34 128.41 36.44 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.414 1.107 . . . . 0.0 110.108 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -106.73 134.56 49.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.022 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -116.73 125.77 52.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -116.55 156.8 26.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.097 0.475 . . . . 0.0 112.127 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.22 26.79 54.32 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.042 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' B' ' 42' ' ' GLN . 10.9 mt -87.4 149.61 24.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.261 0.553 . . . . 0.0 111.997 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -90.69 171.61 9.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.064 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.0 pt-20 -67.0 -44.13 81.13 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.52 -39.06 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.145 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.7 mtp -69.95 -43.46 71.52 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.68 -34.58 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 -50.18 69.54 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.532 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -50.19 -52.59 34.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.732 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.69 -48.73 73.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.573 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -58.95 -42.43 89.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 111.71 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -67.1 -44.09 80.86 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.072 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -64.24 -39.87 94.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.474 ' OE2' HG21 ' B' ' 37' ' ' ILE . 8.3 mm-40 -70.61 -38.64 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.67 -31.7 69.9 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.56 -27.61 45.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.9 0.318 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -85.16 -35.14 21.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -130.88 97.24 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -75.73 -0.79 22.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -118.83 16.39 13.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.703 0.683 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.622 HG22 HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -69.15 119.26 13.16 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.56 125.12 23.2 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -113.76 133.49 55.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 111.416 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.049 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -136.02 142.45 44.46 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' B' ' 83' ' ' LEU . 73.8 t -123.41 126.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.02 145.55 17.51 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.51 154.58 16.94 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.634 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 165.58 24.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.65 -32.39 65.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.524 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.06 -6.12 58.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.41 130.9 52.05 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.417 ' O ' HG23 ' B' ' 79' ' ' VAL . 71.8 Cg_endo -75.13 152.54 40.29 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.571 1.514 . . . . 0.0 110.003 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.1 t80 -63.92 -37.05 85.98 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.649 -0.657 . . . . 0.0 110.983 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -56.41 -36.27 68.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.0 -36.06 69.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.184 0.516 . . . . 0.0 109.637 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 75' ' ' PRO . 16.9 t -61.71 -39.18 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.488 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -59.42 -50.56 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.319 0.58 . . . . 0.0 109.469 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.19 -43.89 71.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.439 178.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.57 -48.85 79.53 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.456 0.646 . . . . 0.0 110.494 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.74 -36.16 80.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.191 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.83 -41.7 98.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.938 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -64.51 -38.56 91.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 110.439 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.428 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -64.1 -41.72 97.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -63.48 -42.98 98.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -57.37 -38.72 74.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.514 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.537 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.48 12.55 20.37 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.93 44.81 95.88 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.2 mt -106.26 -44.92 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.303 0.573 . . . . 0.0 109.682 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.963 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 m -97.38 -31.26 12.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 32.4 t -124.25 125.66 25.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.067 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.86 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.888 2.392 . . . . 0.0 115.235 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 66' ' ' PHE . 39.7 t -113.33 120.23 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.068 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -112.84 129.01 69.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.491 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.9 tt -117.58 124.9 49.79 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HD23 ' A' ' 25' ' ' LEU . 9.2 tt0 -112.91 129.62 56.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.521 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.94 109.62 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.729 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -89.38 -23.3 22.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.34 -119.39 0.62 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.45 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 mm -112.28 95.22 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.6 89.5 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.202 -0.523 . . . . 0.0 114.158 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -106.89 91.95 3.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.698 0.749 . . . . 0.0 110.061 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.34 154.32 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.184 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.36 143.61 50.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.417 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 37' ' ' ILE . 7.4 pt -133.86 135.85 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -112.85 115.97 29.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.312 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.811 HD11 HD12 ' A' ' 35' ' ' ILE . 59.6 mt -116.49 111.68 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.891 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 49.02 44.63 32.65 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.142 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.11 -23.87 27.45 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.859 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.57 126.54 35.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.348 1.074 . . . . 0.0 109.869 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 133.43 49.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.588 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.99 123.85 49.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.84 149.49 30.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.54 78.54 0.65 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mt -137.78 148.06 45.2 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.282 0.563 . . . . 0.0 111.629 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 p -89.64 169.33 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.513 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.3 pt-20 -67.98 -41.12 82.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.945 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.86 -38.72 91.91 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.143 -0.348 . . . . 0.0 110.95 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mtp -69.81 -45.06 68.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.75 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -57.46 -35.76 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.889 0.376 . . . . 0.0 110.233 179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -63.77 -49.99 70.8 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.853 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -53.08 27.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 35' ' ' ILE . 3.7 mt -65.21 -48.38 73.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.558 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -58.63 -43.03 89.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.577 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.68 -43.82 83.45 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.229 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -63.51 -41.42 98.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.877 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -37.73 76.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -70.83 -29.94 66.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.477 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.88 -27.62 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.844 0.293 . . . . 0.0 110.867 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -82.12 -38.25 25.07 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -129.2 110.46 12.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -82.51 7.29 14.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -127.09 20.32 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.145 0.43 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 113.23 5.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -61.36 123.54 18.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 23' ' ' VAL . 43.6 m-85 -114.26 133.09 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.068 HD11 HG23 ' A' ' 24' ' ' ILE . 2.1 pp -132.96 141.42 48.32 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.258 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 83' ' ' LEU . 53.4 t -123.55 124.79 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.42 142.3 13.57 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.9 154.99 16.23 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.687 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.88 163.38 24.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.357 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -31.44 69.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.98 -6.61 58.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.1 t -89.93 135.34 30.39 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.42 154.99 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.021 1.147 . . . . 0.0 110.373 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.767 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -63.79 -35.5 80.81 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.399 -0.813 . . . . 0.0 110.48 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.36 -36.75 66.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.415 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -34.53 67.27 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.835 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.41 -38.98 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 50.3 mm -59.19 -49.48 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.0 mttp -53.31 -44.35 68.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.283 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -51.95 67.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' B' ' 83' ' ' LEU . 9.9 mt -60.24 -36.73 78.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -62.24 -41.53 98.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.541 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 6.9 mt -64.13 -39.25 93.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.115 0.483 . . . . 0.0 110.675 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.87 -41.8 97.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.12 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.35 -41.18 98.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.359 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.26 -38.37 76.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.31 10.61 24.19 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.22 44.69 97.79 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.587 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt -101.13 -34.78 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.116 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.873 -0.091 . . . . 0.0 112.873 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.7 m -96.91 -32.23 12.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.318 . . . . 0.0 111.094 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.466 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 36.0 t -123.63 125.85 25.9 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.83 173.29 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.804 2.336 . . . . 0.0 115.258 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' B' ' 66' ' ' PHE . 40.0 t -113.5 120.09 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 129.3 68.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.392 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.451 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -117.64 124.97 49.87 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.43 ' N ' HD23 ' B' ' 25' ' ' LEU . 9.8 tt0 -113.09 129.36 56.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.63 109.38 18.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.664 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -89.14 -23.52 22.44 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.72 -123.53 0.84 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.24 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.25 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.17 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.97 0.46 89.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.085 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -106.79 92.12 3.96 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.705 0.752 . . . . 0.0 110.156 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.13 154.26 18.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.265 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.18 143.86 50.73 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 37' ' ' ILE . 7.3 pt -133.8 135.86 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.3 t -112.93 116.11 29.47 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.291 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.808 HD11 HD12 ' B' ' 35' ' ' ILE . 61.1 mt -116.71 111.42 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.957 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 49.23 44.49 34.45 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.12 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.15 -23.71 28.29 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.781 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.64 126.61 35.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.334 1.067 . . . . 0.0 109.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 133.69 49.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.483 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.23 123.97 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -110.94 149.41 30.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.51 78.97 0.63 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.11 148.33 44.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.453 0.644 . . . . 0.0 111.475 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.6 p -89.9 169.39 11.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.499 ' O ' HG12 ' B' ' 50' ' ' VAL . 8.4 pt-20 -68.0 -41.39 82.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.39 -38.83 92.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 33.7 mtp -69.88 -44.97 68.68 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.831 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.5 OUTLIER -57.62 -35.43 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.916 0.388 . . . . 0.0 110.143 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 26.6 m -64.1 -49.69 71.23 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.045 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -53.32 27.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.646 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.487 HD13 ' CD1' ' B' ' 35' ' ' ILE . 4.3 mt -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.439 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.48 -43.59 89.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.11 0.481 . . . . 0.0 111.53 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.38 -43.52 85.69 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.02 -40.71 96.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 -37.91 75.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.66 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -70.55 -29.93 66.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.747 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.03 -27.98 54.74 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.234 -0.291 . . . . 0.0 110.868 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.99 -37.93 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -129.61 110.19 11.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.07 6.98 14.58 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -127.07 20.45 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.22 0.464 . . . . 0.0 111.895 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.89 113.66 5.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.461 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.66 123.48 18.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.403 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 44.9 m-85 -114.05 133.09 55.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.546 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 2.1 pp -133.02 141.33 48.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.144 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.611 HG11 HD23 ' B' ' 83' ' ' LEU . 54.8 t -123.46 124.61 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.44 141.95 13.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.33 155.51 16.06 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 163.87 23.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 111.259 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -31.25 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.335 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -81.17 -6.81 59.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.79 135.01 31.01 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.27 155.27 41.69 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.071 1.181 . . . . 0.0 110.153 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.5 t80 -64.02 -35.52 80.99 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.467 -0.771 . . . . 0.0 110.377 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.42 -37.12 67.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.94 -35.18 69.54 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.067 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -61.84 -39.22 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.349 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.3 mm -59.04 -48.91 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.485 0.659 . . . . 0.0 109.42 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 13.1 mttp -53.85 -44.2 70.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.401 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.11 -51.68 68.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.292 0.568 . . . . 0.0 110.96 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 83' ' ' LEU . 9.9 mt -60.56 -36.55 78.73 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.781 0.801 . . . . 0.0 109.196 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.37 -41.6 98.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.62 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.7 mt -64.02 -38.92 92.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.666 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.6 HD13 HD13 ' B' ' 91' ' ' ILE . 1.3 mm? -63.93 -41.99 97.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -63.48 -40.95 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.581 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.36 -38.67 77.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.32 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.22 10.64 23.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.6 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.23 -35.25 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -70.98 -56.56 5.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.981 0.419 . . . . 0.0 110.602 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 43.4 t -128.37 124.64 22.97 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.14 174.89 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.876 2.384 . . . . 0.0 115.725 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.8 t -113.75 122.18 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -112.48 127.95 69.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.439 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.7 tt -115.08 121.85 44.32 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 8.4 mt-10 -110.11 126.46 54.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.323 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.7 119.71 34.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.56 -22.75 15.33 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.54 -117.84 0.56 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.842 -1.171 . . . . 0.0 114.009 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.36 101.11 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 109.788 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.14 82.46 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.702 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 129.52 53.99 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.553 0.676 . . . . 0.0 109.384 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -138.13 156.11 48.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.79 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -125.77 144.12 50.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.195 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 53' ' ' LEU . 8.4 pt -133.72 135.72 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.853 0.752 . . . . 0.0 113.027 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -113.19 116.87 30.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 35' ' ' ILE . 89.4 mt -116.35 111.64 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.814 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.7 46.18 30.78 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.357 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.73 -25.24 19.98 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.662 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.6 127.34 35.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.126 0.963 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 134.57 48.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.472 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -114.87 123.35 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -110.4 148.48 31.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 78.81 0.69 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mt -136.96 148.66 47.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.139 0.495 . . . . 0.0 111.127 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 p -91.26 171.3 9.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.638 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.06 -42.13 80.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.44 -38.8 92.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.004 0.431 . . . . 0.0 110.711 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -70.04 -46.61 64.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.349 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.09 -35.63 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.775 0.321 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -64.12 -49.34 72.55 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.76 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.51 -52.49 38.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.706 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 35' ' ' ILE . 15.6 mt -64.94 -47.69 76.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.624 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -58.93 -43.31 91.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.117 0.484 . . . . 0.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.49 -44.09 83.59 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.363 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -63.46 -40.58 97.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.913 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.75 -38.88 76.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.196 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -69.66 -30.65 68.38 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -78.14 -28.08 48.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.859 0.299 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -84.36 -34.94 23.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.92 0.391 . . . . 0.0 110.018 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -130.19 95.68 3.98 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -68.9 -7.87 38.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -113.78 19.46 16.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.547 0.612 . . . . 0.0 112.096 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 4.0 m -69.04 117.0 10.14 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 125.24 23.59 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -114.37 133.88 55.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.27 141.99 43.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 83' ' ' LEU . 79.6 t -123.57 129.13 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.23 146.57 18.38 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.47 16.76 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.925 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.09 165.18 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.469 . . . . 0.0 110.999 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -57.11 -32.64 66.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.341 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.23 -5.84 58.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.81 135.21 30.73 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.39 156.92 29.17 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.131 1.221 . . . . 0.0 110.631 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.759 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -65.15 -33.88 77.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.614 -0.679 . . . . 0.0 110.506 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -57.07 -37.55 72.02 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.256 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.52 70.77 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.85 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -62.66 -39.02 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.323 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.4 mm -59.32 -48.91 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 109.591 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.67 -44.8 69.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.385 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.05 -49.64 76.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.327 0.584 . . . . 0.0 110.99 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -62.38 -36.58 82.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.545 0.688 . . . . 0.0 109.234 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.7 -43.28 97.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.814 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 8.8 mt -65.29 -38.06 89.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 110.706 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -63.77 -42.04 97.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.149 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -62.93 -41.98 99.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.47 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.66 -38.58 78.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.68 10.97 23.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.77 97.62 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.8 mt -101.67 -36.61 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.851 -179.616 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -70.25 -56.49 6.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.49 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 43.8 t -128.44 124.68 22.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.184 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.14 174.72 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 115.736 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.546 HG23 ' CG2' ' B' ' 64' ' ' THR . 56.8 t -113.65 122.31 67.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.006 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -112.83 127.99 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.312 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.492 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -115.2 121.83 44.16 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 8.7 mt-10 -109.96 126.44 53.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.362 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.54 119.7 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.76 -22.32 15.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.33 -122.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.717 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -108.12 101.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.04 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.26 80.29 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.897 -0.592 . . . . 0.0 114.017 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 129.57 53.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 117.426 0.613 . . . . 0.0 109.429 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.16 156.09 48.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.599 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.62 144.18 50.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.164 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.561 HD11 HD13 ' B' ' 53' ' ' LEU . 8.4 pt -133.69 135.8 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -113.46 116.93 30.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.052 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.538 HD11 HD12 ' B' ' 35' ' ' ILE . 91.3 mt -116.43 111.53 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.99 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.68 46.08 30.69 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.251 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.82 -25.17 20.6 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.669 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.54 126.97 35.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.242 1.021 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 134.73 48.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.457 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.417 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.96 123.11 48.28 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.14 148.47 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 78.71 0.71 Allowed Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' B' ' 42' ' ' GLN . 4.1 mt -137.03 148.32 46.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.081 0.467 . . . . 0.0 111.149 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -90.99 171.43 9.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.65 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.427 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.1 pt-20 -67.86 -42.17 81.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.874 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.55 -39.01 92.96 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.078 -0.389 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mtm -69.99 -46.55 64.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.09 -36.08 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 51.6 m -63.72 -49.42 73.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.764 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.58 -52.03 42.94 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.738 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.561 HD13 HD11 ' B' ' 35' ' ' ILE . 15.2 mt -65.28 -47.67 75.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.631 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -59.13 -43.04 91.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 111.518 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -66.65 -43.96 83.19 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.343 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.56 -40.52 97.19 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.76 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -38.66 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -69.79 -30.93 68.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -78.27 -28.05 47.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.852 0.296 . . . . 0.0 111.459 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -84.42 -34.94 23.41 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -130.12 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -69.18 -7.6 37.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -113.96 19.28 16.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.565 0.62 . . . . 0.0 111.958 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.546 ' CG2' HG23 ' B' ' 23' ' ' VAL . 3.9 m -68.87 116.86 9.84 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.58 125.16 23.34 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -114.39 134.04 55.27 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.974 0.416 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.006 HD11 HG23 ' B' ' 24' ' ' ILE . 3.3 pp -136.57 141.73 43.33 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.409 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.518 HG11 ' CD2' ' B' ' 83' ' ' LEU . 78.8 t -123.31 129.62 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.49 18.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.05 154.47 16.78 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.03 165.37 24.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 0.0 111.061 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -57.25 -32.76 66.9 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.361 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.0 -6.38 58.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.18 135.49 31.39 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.9 156.82 27.19 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.227 1.285 . . . . 0.0 110.558 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -65.06 -33.89 77.13 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.792 -0.567 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.27 -37.59 72.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.53 70.78 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.882 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.4 t -62.66 -38.93 82.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -59.52 -48.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.334 0.588 . . . . 0.0 109.602 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -44.76 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.277 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.15 -49.38 77.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.321 0.581 . . . . 0.0 111.039 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -62.66 -36.29 82.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.58 0.705 . . . . 0.0 109.34 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -60.83 -43.55 98.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.871 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.02 -38.14 89.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 110.598 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -63.65 -41.91 98.18 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.195 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -63.08 -41.97 99.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -58.62 -38.46 78.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.399 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.57 10.75 24.25 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.23 44.71 97.75 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.9 mt -101.34 -36.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.854 -179.651 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.989 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -153.5 -57.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 40.1 t -135.35 129.04 18.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.501 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.45 176.64 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.106 2.537 . . . . 0.0 115.405 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 66' ' ' PHE . 22.1 t -110.67 120.7 62.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -114.3 128.97 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -115.75 122.48 45.62 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.39 128.28 56.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.13 119.16 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.2 -22.16 15.77 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -119.85 0.64 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.945 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -112.84 100.64 11.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -2.84 83.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.755 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.14 53.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.539 0.669 . . . . 0.0 109.301 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -137.15 156.37 48.43 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.068 0.937 . . . . 0.0 112.576 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.23 142.34 51.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.138 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.558 HG23 HD12 ' A' ' 45' ' ' LEU . 5.8 pt -131.6 134.89 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.459 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.97 113.89 26.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.545 0.688 . . . . 0.0 110.263 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.15 110.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.422 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 42.94 49.37 6.23 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.298 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.12 -37.35 3.44 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.799 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.4 119.12 14.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.846 0.323 . . . . 0.0 111.113 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -105.37 128.39 53.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.85 126.57 52.64 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.86 157.25 26.99 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 25.58 56.49 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.176 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 42' ' ' GLN . 12.7 mt -86.98 149.97 24.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.307 0.575 . . . . 0.0 111.929 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.75 171.7 8.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.269 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.1 pt-20 -67.68 -42.91 81.34 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.143 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.09 -39.22 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -69.76 -45.9 67.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.395 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 35' ' ' ILE . 2.0 p -58.51 -34.85 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 m -62.95 -50.22 71.64 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.27 -52.76 33.64 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.828 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.94 -47.84 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.7 m -59.52 -42.67 92.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -66.2 -44.78 82.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.32 99.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.47 -39.8 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -69.91 -29.8 67.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.65 -28.44 45.42 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.723 0.238 . . . . 0.0 111.515 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -83.57 -35.76 24.49 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.08 106.21 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.7 6.21 13.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -125.53 17.97 8.15 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.613 0.642 . . . . 0.0 111.908 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.08 114.57 5.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.863 -0.153 . . . . 0.0 111.212 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.45 122.67 14.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 23' ' ' VAL . 12.9 m-85 -113.34 134.39 54.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.072 0.463 . . . . 0.0 111.294 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -138.15 141.34 40.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.405 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 96.7 t -122.99 127.67 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.12 146.79 18.78 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.5 155.0 16.96 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.021 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.51 164.5 24.66 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 120.922 0.391 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -56.97 -33.24 66.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.512 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.25 -5.64 56.54 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.69 134.58 31.99 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 79' ' ' VAL . 73.8 Cg_endo -77.26 156.72 33.33 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.28 1.32 . . . . 0.0 110.006 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.705 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.4 t80 -64.86 -35.62 81.73 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.666 -0.646 . . . . 0.0 110.683 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.57 -37.36 70.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.712 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.9 t -62.54 -39.28 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.442 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.705 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.7 mm -60.17 -47.4 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.26 178.595 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.2 -48.92 79.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.589 . . . . 0.0 110.863 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' B' ' 83' ' ' LEU . 10.0 mt -60.56 -37.1 80.18 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.527 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -61.23 -41.67 97.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.975 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.8 mt -66.12 -38.31 87.87 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 110.553 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 25' ' ' LEU . 1.2 mm? -63.89 -42.12 97.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -63.15 -43.3 98.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.12 -38.77 73.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.3 12.16 19.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.42 44.87 96.31 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 4.4 mt -103.0 -36.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.023 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -153.1 -57.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 40.6 t -135.55 128.88 18.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.664 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.18 176.52 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.91 2.406 . . . . 0.0 115.486 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' B' ' 66' ' ' PHE . 21.9 t -110.54 120.72 61.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.999 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -114.25 128.58 71.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.573 HD13 HD21 ' B' ' 86' ' ' LEU . 7.9 tt -115.5 122.64 46.32 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -112.45 128.07 56.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.709 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.72 119.22 33.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.64 -21.88 15.66 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.75 -124.17 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.565 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.78 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.27 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -2.8 82.28 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.01 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.18 53.76 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.18 156.59 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.128 0.966 . . . . 0.0 112.592 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.46 142.4 51.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.117 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.571 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -131.95 134.91 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.345 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.2 114.21 26.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.601 0.715 . . . . 0.0 110.119 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.32 110.17 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.458 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 42.71 49.71 5.96 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.24 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -37.37 3.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.863 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.13 118.58 13.14 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.855 0.328 . . . . 0.0 111.158 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -104.72 128.84 52.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.573 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.41 126.58 52.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.9 157.45 26.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 25.38 57.1 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.118 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 42' ' ' GLN . 13.0 mt -86.84 149.92 24.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.382 0.591 . . . . 0.0 112.078 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.68 171.53 9.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.504 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.423 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 pt-20 -67.52 -42.82 82.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.34 -39.47 92.43 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 34.5 mtp -69.42 -45.83 68.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.472 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.447 HG23 HG21 ' B' ' 35' ' ' ILE . 2.0 p -58.74 -34.39 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 110.166 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -63.23 -50.12 71.47 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.922 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.55 -52.78 35.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -64.86 -47.5 77.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.331 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -60.01 -42.42 94.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.145 0.498 . . . . 0.0 111.614 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.26 -44.72 82.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.243 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.03 99.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.908 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -70.03 -39.51 75.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.102 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -70.0 -29.75 66.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.665 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.69 -28.79 45.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.754 0.252 . . . . 0.0 111.535 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.16 -35.73 25.29 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.04 106.06 8.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.46 6.06 13.39 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -125.37 17.85 8.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.622 0.646 . . . . 0.0 111.918 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.402 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -67.09 114.84 6.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.893 -0.14 . . . . 0.0 111.22 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tp -59.64 122.89 15.24 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' B' ' 23' ' ' VAL . 13.3 m-85 -113.58 133.94 54.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.173 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.999 HD11 HG23 ' B' ' 24' ' ' ILE . 3.6 pp -137.9 141.34 40.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.417 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.498 ' HB ' HD21 ' B' ' 83' ' ' LEU . 98.6 t -123.2 127.91 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.05 146.71 18.7 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.13 154.97 16.8 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 121.127 -0.558 . . . . 0.0 111.959 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.44 165.25 23.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -57.95 -32.88 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.513 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.2 -6.18 57.36 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -89.35 134.53 32.64 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.402 ' O ' HG23 ' B' ' 79' ' ' VAL . 70.0 Cg_endo -77.47 156.83 32.6 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.201 1.268 . . . . 0.0 110.256 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.3 t80 -64.85 -35.92 82.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.713 -0.617 . . . . 0.0 110.592 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -56.46 -37.36 70.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -35.61 73.34 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.772 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 75' ' ' PRO . 18.6 t -62.31 -39.26 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.596 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.21 -47.08 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.408 0.623 . . . . 0.0 109.469 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.2 OUTLIER -54.59 -44.93 73.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.276 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.451 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.48 -48.79 80.31 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.322 0.582 . . . . 0.0 110.809 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 83' ' ' LEU . 10.0 mt -60.8 -36.76 79.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.392 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -61.33 -41.92 97.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.039 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.7 mt -65.77 -38.58 89.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.573 HD21 HD13 ' B' ' 25' ' ' LEU . 1.2 mm? -63.69 -42.15 98.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.2 -43.35 98.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.437 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -39.1 74.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.707 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 12.02 18.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.65 44.75 96.6 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 4.3 mt -103.03 -35.77 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.499 . . . . 0.0 109.943 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.051 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 m -82.21 -40.33 21.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.631 0.253 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.14 125.94 17.28 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.972 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.39 -171.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.022 2.482 . . . . 0.0 114.542 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.0 118.11 52.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.8 128.27 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.71 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -114.3 121.42 43.61 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.4 tm-20 -110.46 127.14 55.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.29 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.85 123.43 39.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.457 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.52 -22.49 13.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.3 -120.75 0.68 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.64 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.44 95.97 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.762 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.87 -3.52 85.94 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.949 -0.569 . . . . 0.0 114.406 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 132.28 52.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.488 0.644 . . . . 0.0 109.375 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -139.93 158.03 44.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.172 0.986 . . . . 0.0 112.985 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -125.64 141.85 51.81 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.748 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 45' ' ' LEU . 4.5 pt -134.19 135.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.704 0.684 . . . . 0.0 112.706 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.35 115.52 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.694 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.89 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.245 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.45 48.31 16.58 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.848 -0.691 . . . . 0.0 114.215 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.29 -25.83 22.41 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.814 -0.708 . . . . 0.0 114.135 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.72 129.63 38.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.501 1.15 . . . . 0.0 110.501 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.1 135.69 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.11 127.96 54.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -118.13 156.09 29.3 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.94 26.88 47.79 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.304 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.7 mt -88.46 150.15 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.344 0.572 . . . . 0.0 112.303 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.3 p -91.72 170.6 9.77 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.545 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' O ' HG12 ' A' ' 50' ' ' VAL . 13.7 pt-20 -65.02 -47.25 78.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.9 -38.75 92.17 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.133 -0.355 . . . . 0.0 111.38 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.3 ttp -71.57 -39.04 70.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.668 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -62.78 -32.8 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 m -63.79 -50.21 69.88 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.539 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.11 -52.3 36.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.88 -48.08 75.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.462 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.6 m -58.65 -42.56 88.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.086 0.469 . . . . 0.0 111.548 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 9.2 mmm180 -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.284 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.72 -40.98 98.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.912 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.64 -38.4 80.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.598 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -70.82 -30.89 67.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.849 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.15 -28.09 54.05 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -83.65 -33.82 25.17 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.296 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -129.65 109.12 10.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.97 5.26 19.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -125.91 17.45 7.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.458 0.572 . . . . 0.0 111.893 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.05 113.94 5.43 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.083 0.153 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 66' ' ' PHE . 3.3 tp -61.38 123.05 16.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.557 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.9 m-85 -111.11 130.39 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.393 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -137.63 141.24 41.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.325 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 83' ' ' LEU . 69.2 t -123.83 131.3 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.73 146.88 18.75 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.34 152.85 16.74 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.9 165.15 25.07 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -33.06 67.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.398 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -81.54 -5.82 58.37 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.6 t -89.77 131.56 39.27 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.95 155.47 53.02 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.337 1.358 . . . . 0.0 110.403 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.2 t80 -65.11 -34.24 77.93 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.493 -0.754 . . . . 0.0 110.577 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.74 -37.1 70.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.72 0.295 . . . . 0.0 110.254 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -36.08 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.847 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.26 -39.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.573 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.7 mm -60.39 -46.96 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.503 0.668 . . . . 0.0 109.436 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.63 -45.5 70.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.312 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.12 78.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.346 0.593 . . . . 0.0 111.19 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' B' ' 83' ' ' LEU . 7.7 mt -61.57 -36.78 81.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.6 0.714 . . . . 0.0 109.505 177.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -60.84 -42.95 98.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.904 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.37 -38.95 91.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.059 0.457 . . . . 0.0 110.58 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.517 HD13 HD13 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.38 -41.89 98.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.159 179.264 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -63.17 -43.68 97.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.9 -38.5 72.9 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.76 12.08 20.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.2 44.71 97.14 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.0 mt -101.33 -35.07 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.838 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 112.957 -0.057 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -82.38 -40.21 21.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.617 0.246 . . . . 0.0 110.97 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.03 125.38 17.09 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -48.28 -171.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.992 2.461 . . . . 0.0 114.668 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.83 117.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.78 128.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.788 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -114.6 121.45 43.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 9.4 tm-20 -110.42 127.09 54.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.437 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 123.11 38.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.484 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.29 -22.46 13.7 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.85 -124.37 0.89 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.712 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -107.66 95.99 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 114.916 -0.642 . . . . 0.0 110.202 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -3.25 86.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.133 -0.556 . . . . 0.0 114.375 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 132.31 52.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.547 0.674 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -139.69 158.12 44.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.2 1.0 . . . . 0.0 113.042 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.07 141.77 51.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.682 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 45' ' ' LEU . 4.9 pt -134.33 136.51 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.536 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 115.23 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.565 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.76 108.7 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.381 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.41 47.98 16.53 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.037 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.45 20.14 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -92.34 129.61 38.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.456 1.128 . . . . 0.0 110.498 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.01 136.01 47.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.87 127.33 53.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -117.89 156.36 28.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 112.418 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.76 26.83 48.77 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.428 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' B' ' 42' ' ' GLN . 11.9 mt -88.44 150.23 23.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.465 0.65 . . . . 0.0 112.206 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 16.9 p -91.72 170.03 10.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.529 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.562 ' O ' HG12 ' B' ' 50' ' ' VAL . 13.7 pt-20 -64.68 -47.25 79.07 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.273 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.96 -38.8 92.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.1 ttp -71.6 -39.08 70.76 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.614 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.562 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -62.61 -33.19 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 m -63.59 -49.89 71.57 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.638 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.67 -51.66 47.19 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.823 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.26 -48.09 74.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -58.4 -43.16 88.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.705 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.401 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 9.3 mmm180 -66.19 -44.16 84.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.296 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.03 -40.8 97.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -68.57 -38.81 81.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.356 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.54 -31.09 68.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -77.07 -27.8 54.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.833 0.288 . . . . 0.0 111.528 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -84.05 -33.68 24.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -129.81 108.85 10.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -81.69 5.18 19.17 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.17 17.98 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.248 0.476 . . . . 0.0 111.939 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.42 113.64 5.46 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.135 0.174 . . . . 0.0 111.221 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.54 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.3 tp -61.12 122.8 15.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.54 ' N ' HD12 ' B' ' 65' ' ' LEU . 32.5 m-85 -110.9 130.89 55.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.237 0.542 . . . . 0.0 111.47 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.918 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -138.16 141.26 40.09 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.098 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.416 HG11 HD23 ' B' ' 83' ' ' LEU . 71.4 t -123.92 131.71 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.84 18.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.91 153.06 16.68 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.636 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.3 165.3 24.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -33.3 67.29 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -81.18 -6.17 58.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -89.44 131.51 40.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.22 155.33 51.78 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.276 1.317 . . . . 0.0 110.451 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.82 -34.33 78.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.514 -0.741 . . . . 0.0 110.656 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.92 -36.71 70.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.758 0.314 . . . . 0.0 110.239 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 -35.69 72.43 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.606 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.8 -38.77 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.439 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.764 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.3 mm -60.58 -47.15 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.546 0.689 . . . . 0.0 109.372 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.38 -45.73 69.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.05 79.01 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.296 0.57 . . . . 0.0 111.181 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -61.95 -35.95 79.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.356 0.598 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.68 -42.79 99.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.633 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.2 -38.96 92.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.68 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.494 HD13 HD13 ' B' ' 91' ' ' ILE . 0.6 OUTLIER -63.72 -42.01 98.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.965 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -62.94 -43.91 97.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.44 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.79 -38.22 72.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.615 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.95 11.94 21.2 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.95 96.98 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.1 mt -101.66 -35.09 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.935 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.455 0 N-CA-C 112.763 -0.135 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 t -69.33 -54.27 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.68 126.59 27.05 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.97 -164.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.052 2.501 . . . . 0.0 114.186 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG11 ' CE1' ' A' ' 66' ' ' PHE . 18.5 t -103.67 110.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -110.33 127.78 67.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD21 ' A' ' 86' ' ' LEU . 7.7 tt -115.69 120.67 40.13 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 14.3 tt0 -110.1 127.19 54.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.577 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.39 114.89 25.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.269 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.13 -22.63 17.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -120.35 0.65 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.436 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -114.35 96.79 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 122.892 0.477 . . . . 0.0 109.767 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 -4.5 85.89 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.713 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 129.67 51.74 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -137.61 156.12 48.42 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.15 0.976 . . . . 0.0 112.805 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -126.1 141.88 51.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.296 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 HD12 ' A' ' 45' ' ' LEU . 4.7 pt -131.16 134.61 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.322 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.1 114.74 27.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.675 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' CD1' ' A' ' 35' ' ' ILE . 80.9 mt -112.18 108.78 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.951 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 48.02 20.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.892 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.01 20.55 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.137 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -92.41 130.03 38.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.505 1.152 . . . . 0.0 110.482 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -108.44 136.95 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.157 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -118.79 127.74 53.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -117.48 156.03 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.104 0.478 . . . . 0.0 112.217 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 25.91 53.11 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.552 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 42' ' ' GLN . 17.1 mt -86.93 149.21 24.95 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.542 0.687 . . . . 0.0 112.208 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 p -91.88 171.44 9.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.419 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' VAL . 11.6 pt-20 -66.62 -44.29 82.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.244 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.79 -39.26 93.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.498 ' HE2' HD22 ' A' ' 45' ' ' LEU . 5.8 ttp -71.17 -41.45 70.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.973 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.2 p -61.66 -34.43 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.55 -50.23 70.32 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.857 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.57 -52.03 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.759 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.84 -47.96 76.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.6 -43.6 84.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.218 0.532 . . . . 0.0 111.672 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -66.35 -44.46 83.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.281 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.93 -40.13 95.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.178 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' OE2' HG22 ' A' ' 23' ' ' VAL . 4.4 tt0 -69.58 -38.83 77.51 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.401 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.28 -30.38 67.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.65 -27.43 45.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 117.885 0.311 . . . . 0.0 111.249 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -84.77 -35.64 22.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.916 0.388 . . . . 0.0 110.029 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -130.94 101.28 5.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.12 1.12 16.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -116.78 18.34 14.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.614 0.643 . . . . 0.0 111.955 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.68 115.21 7.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.47 126.44 27.84 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE1' HG11 ' A' ' 23' ' ' VAL . 58.9 m-85 -113.61 129.67 56.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.171 0.51 . . . . 0.0 111.592 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -135.24 140.84 45.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG11 HD23 ' A' ' 83' ' ' LEU . 81.3 t -122.54 127.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.97 145.8 17.66 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 155.35 16.73 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.084 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.68 166.86 22.91 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.086 0.469 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -57.88 -34.16 69.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.323 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -80.95 -5.11 57.08 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.9 133.45 41.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.81 152.86 32.94 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.495 1.463 . . . . 0.0 110.34 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -63.41 -37.4 87.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.73 0.696 . . . . 0.0 110.722 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.82 -35.74 66.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.49 -34.82 67.92 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.705 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.0 -38.63 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.76 -47.52 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.329 0.585 . . . . 0.0 109.564 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -54.46 -44.27 72.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.22 78.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.342 0.592 . . . . 0.0 111.242 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 5.9 mt -60.87 -36.97 80.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.79 -41.85 96.38 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.825 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.3 -39.17 92.17 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.514 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.34 -42.27 98.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.074 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -63.72 -41.81 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -38.64 77.34 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.08 11.41 23.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.89 44.62 97.87 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.7 mt -102.61 -36.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.705 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -69.74 -54.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 111.087 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 22.2 t -118.92 126.53 27.05 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.672 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -50.64 -164.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.132 2.555 . . . . 0.0 114.436 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.528 HG11 ' CE1' ' B' ' 66' ' ' PHE . 16.2 t -103.64 109.79 28.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.02 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -110.04 127.3 67.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.192 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.49 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.7 tt -115.06 120.59 40.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 14.4 tt0 -110.04 127.31 54.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.435 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.67 114.79 25.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.038 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 -22.89 17.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.86 -124.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.299 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -109.7 97.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.04 -0.58 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -4.17 86.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.916 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 129.92 52.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.75 155.98 48.47 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.115 0.96 . . . . 0.0 112.795 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.06 141.66 51.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.322 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.593 HG23 HD12 ' B' ' 45' ' ' LEU . 4.5 pt -130.84 134.8 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.301 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.36 114.89 27.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.439 0.638 . . . . 0.0 109.624 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.541 HD11 ' CD1' ' B' ' 35' ' ' ILE . 78.1 mt -112.27 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.775 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.82 48.56 18.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.944 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.46 -25.68 21.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.225 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.449 1.124 . . . . 0.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -108.08 136.94 46.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.295 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.01 127.63 53.62 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.062 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -117.19 156.36 27.81 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.87 26.49 53.34 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.413 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.593 HD12 HG23 ' B' ' 35' ' ' ILE . 16.5 mt -87.4 149.12 24.68 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.485 0.659 . . . . 0.0 112.076 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.1 p -91.62 171.07 9.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.373 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 11.4 pt-20 -66.42 -44.25 83.45 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.269 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.83 -39.29 93.88 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.044 -0.41 . . . . 0.0 111.185 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.447 ' HE2' HD22 ' B' ' 45' ' ' LEU . 6.3 ttp -71.5 -40.98 69.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.953 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -61.85 -34.27 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.78 -49.96 70.9 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.846 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.74 -51.9 45.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.789 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.05 -47.67 76.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -57.64 -43.78 85.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.207 0.527 . . . . 0.0 111.764 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.84 -44.66 84.85 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.314 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.82 -39.87 95.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.165 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.297 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.4 -30.75 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.57 -27.5 45.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.83 0.286 . . . . 0.0 111.268 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -84.72 -35.87 22.21 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.073 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -130.64 101.6 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.42 1.71 15.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -117.28 18.32 14.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.705 0.684 . . . . 0.0 111.91 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 115.41 7.91 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.7 126.27 27.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.528 ' CE1' HG11 ' B' ' 23' ' ' VAL . 60.9 m-85 -113.4 129.49 56.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.244 0.545 . . . . 0.0 111.748 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.02 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.3 140.97 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.953 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.599 HG11 HD23 ' B' ' 83' ' ' LEU . 78.1 t -122.62 127.42 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.79 145.89 17.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.29 155.68 16.91 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.915 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.75 167.63 21.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -58.43 -34.74 71.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.036 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -80.35 -6.04 57.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.89 133.43 43.44 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.1 152.97 31.78 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.561 1.507 . . . . 0.0 110.251 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.729 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.55 -37.25 86.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.739 0.7 . . . . 0.0 110.572 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -55.78 -35.83 66.71 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.32 -35.07 68.53 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.844 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.75 -38.91 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.729 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.7 mm -60.37 -47.53 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.435 0.636 . . . . 0.0 109.784 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.2 mttm -54.4 -44.35 72.25 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.984 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -49.23 78.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.275 0.559 . . . . 0.0 111.146 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 5.8 mt -60.63 -36.96 79.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 109.448 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.05 -41.67 97.04 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.832 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 8.5 mt -65.22 -39.29 92.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.521 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.524 HD13 HD13 ' B' ' 91' ' ' ILE . 1.4 mm? -63.17 -42.63 99.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.93 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -63.64 -41.73 98.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -38.57 77.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.518 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.11 11.04 24.45 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.32 44.6 97.86 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 114.752 0.661 . . . . 0.0 114.752 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.6 mt -102.65 -36.03 4.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.776 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo . . . . . 0 C--O 1.237 0.465 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.23 121.28 65.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.003 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -111.94 127.28 69.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.406 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 25' ' ' LEU . 9.4 tt -114.88 120.68 40.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -109.59 127.72 54.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.418 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 t -85.0 119.93 34.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.207 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.1 -23.07 14.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.48 -119.34 0.6 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.861 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 78' ' ' GLU . 29.5 mm -113.56 99.46 8.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.79 -2.21 86.71 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.808 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.98 129.08 53.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -138.72 156.49 47.34 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.152 0.977 . . . . 0.0 112.951 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 142.06 51.7 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.31 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.642 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.2 pt -132.47 134.81 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.52 115.11 28.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.369 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.642 HD11 ' CD1' ' A' ' 35' ' ' ILE . 68.1 mt -114.67 109.6 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.219 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.82 44.86 24.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.917 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.81 21.52 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.855 -0.688 . . . . 0.0 114.031 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.53 126.77 35.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.276 1.038 . . . . 0.0 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -105.41 133.15 50.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.948 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.98 126.65 52.72 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.41 158.38 24.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.101 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 26.83 56.35 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.903 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 35' ' ' ILE . 9.6 mt -88.13 149.14 24.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.281 0.562 . . . . 0.0 112.074 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -90.51 169.02 11.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.21 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.4 pt-20 -65.34 -43.62 90.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.61 -40.56 95.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.418 ' CE ' HD22 ' A' ' 45' ' ' LEU . 7.6 ttp -70.77 -38.18 73.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -64.44 -32.8 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -63.94 -49.26 73.28 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.35 -51.83 42.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.77 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.04 -47.83 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.665 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -59.29 -42.88 92.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.611 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -66.97 -43.94 81.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.391 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.41 -40.97 98.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.997 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -38.09 77.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.14 -29.45 65.25 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.66 -28.44 45.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.761 0.255 . . . . 0.0 111.433 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.79 -33.78 24.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.212 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -132.47 104.5 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.61 5.52 15.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -123.64 17.87 9.56 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.509 0.595 . . . . 0.0 111.688 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 121.7 18.04 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.499 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.12 125.17 25.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -113.14 134.39 54.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.264 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.91 142.01 42.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 83' ' ' LEU . 69.3 t -123.51 126.81 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.4 146.34 18.36 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.53 154.46 16.94 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.88 165.74 23.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 110.911 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.88 -32.77 68.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.27 -6.49 57.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.61 133.54 35.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 156.42 32.44 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.274 1.316 . . . . 0.0 110.306 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.743 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -64.26 -33.9 76.89 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.762 -0.586 . . . . 0.0 110.266 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -57.18 -37.33 71.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -71.09 -35.24 71.76 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.846 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.12 -38.41 80.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.393 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.0 mm -59.93 -48.39 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.444 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -54.15 -45.38 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.469 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.05 -49.18 78.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' B' ' 83' ' ' LEU . 10.8 mt -61.58 -36.17 79.89 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.444 0.64 . . . . 0.0 109.46 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.95 -41.96 98.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.74 -38.86 92.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 110.614 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 91' ' ' ILE . 1.1 mm? -63.57 -41.85 98.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.952 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -63.58 -41.0 98.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.51 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -38.92 78.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.449 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.05 11.82 21.81 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.87 44.32 97.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.638 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--O 1.238 0.475 0 N-CA-C 115.43 1.281 . . . . 0.0 115.43 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.25 121.38 65.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.979 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.81 127.24 69.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.515 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.453 ' C ' HD23 ' B' ' 25' ' ' LEU . 9.4 tt -114.86 120.47 40.08 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.07 128.25 54.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.457 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.45 119.79 34.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.147 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 -23.2 14.61 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.47 -123.51 0.83 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.565 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' B' ' 78' ' ' GLU . 27.1 mm -108.45 99.76 9.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.011 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.87 85.75 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.968 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.61 129.44 52.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.0 156.55 47.13 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.156 0.979 . . . . 0.0 113.034 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.96 51.76 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.261 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.645 ' CD1' HD11 ' B' ' 37' ' ' ILE . 5.8 pt -132.56 134.94 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 112.599 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.73 115.01 28.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 68.4 mt -114.74 109.54 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.192 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.71 45.05 24.18 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.976 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -26.34 18.99 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.931 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.15 126.86 35.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.211 1.005 . . . . 0.0 110.391 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -105.63 132.35 51.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.074 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.545 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -117.24 126.84 53.4 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.7 158.8 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 112.092 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 26.49 57.43 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.932 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 35' ' ' ILE . 9.5 mt -87.92 149.15 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.36 0.6 . . . . 0.0 112.325 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.39 169.21 11.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.446 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 16.8 pt-20 -65.63 -43.27 90.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.72 -40.05 94.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.99 -0.444 . . . . 0.0 111.233 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.431 ' CE ' HD22 ' B' ' 45' ' ' LEU . 7.1 ttp -71.35 -38.17 71.64 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -64.43 -32.86 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -63.96 -48.85 74.85 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -50.84 -51.92 46.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.7 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -64.76 -47.95 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.669 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -59.21 -42.95 92.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -66.91 -43.89 82.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.36 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.33 -40.97 98.77 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -37.9 76.75 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -71.18 -29.53 65.3 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.77 -28.42 44.73 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.856 0.298 . . . . 0.0 111.432 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.89 -33.56 24.74 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -132.43 104.42 6.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.84 5.54 15.72 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -123.6 17.53 9.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.517 0.598 . . . . 0.0 111.772 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 122.06 18.44 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.22 125.38 25.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.979 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -137.32 141.75 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' B' ' 83' ' ' LEU . 70.4 t -123.46 127.27 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.75 146.3 18.3 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.55 154.57 16.95 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.83 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -32.73 68.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.418 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.16 -6.85 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.4 133.38 36.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 156.49 33.33 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.409 1.406 . . . . 0.0 110.336 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.745 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -64.64 -33.66 76.46 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.832 -0.543 . . . . 0.0 110.264 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -57.29 -37.44 72.44 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.467 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.93 -35.46 72.23 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.786 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.68 -38.65 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.395 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.745 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.02 -48.01 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.524 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.6 mttm -54.38 -45.13 72.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.398 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.425 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.43 -48.78 80.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 111.283 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' A' ' 83' ' ' LEU . 10.7 mt -62.05 -36.04 80.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.457 0.646 . . . . 0.0 109.419 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.88 -42.0 98.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.793 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.5 mt -64.74 -39.01 92.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.625 HD13 HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -63.5 -41.92 98.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.978 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -63.52 -41.01 98.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.458 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -38.73 77.79 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.444 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.12 11.86 21.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 44.02 98.14 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.625 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -100.07 -39.53 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.759 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.476 0.488 0 N-CA-C 114.454 0.905 . . . . 0.0 114.454 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 64' ' ' THR . 41.3 t -106.7 115.02 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.894 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.9 127.45 69.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.2 tt -115.39 121.52 43.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' N ' HD23 ' A' ' 25' ' ' LEU . 30.1 mt-10 -110.59 127.14 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.59 111.41 20.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.96 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.17 -119.38 0.64 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.68 -1.248 . . . . 0.0 114.16 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.38 99.91 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.069 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.92 -3.31 84.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.956 -0.566 . . . . 0.0 114.175 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 131.26 54.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.581 0.69 . . . . 0.0 109.766 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.9 m-85 -137.89 157.48 46.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 122.096 0.95 . . . . 0.0 112.746 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.84 142.2 51.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.878 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.4 pt -132.95 134.37 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.396 0.543 . . . . 0.0 112.341 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 115.05 28.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.247 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 35' ' ' ILE . 33.2 mt -111.59 108.83 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.715 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.99 46.16 26.22 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.664 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.53 24.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.658 -0.782 . . . . 0.0 114.221 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -91.74 128.96 37.78 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.57 1.185 . . . . 0.0 110.201 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.52 135.01 47.69 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.84 127.71 53.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -117.47 156.1 28.56 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.156 0.503 . . . . 0.0 112.245 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.47 45.01 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.428 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.55 HD12 HG23 ' A' ' 35' ' ' ILE . 35.9 mt -88.75 151.17 22.57 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.278 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -93.14 173.32 7.79 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.586 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.7 mt-10 -67.92 -43.83 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.86 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.6 -38.7 92.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.809 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -70.35 -44.91 67.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.2 p -58.57 -35.27 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.744 0.307 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.2 m -63.55 -51.77 64.01 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.882 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -50.86 -51.18 53.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.683 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.31 -48.0 74.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.806 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -58.35 -42.86 87.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.082 0.467 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -66.48 -43.87 84.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.152 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -64.44 -39.23 93.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.015 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -38.2 70.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.57 -30.83 67.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.587 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.07 -28.75 54.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.916 0.325 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -37.45 27.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -127.38 105.4 8.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.88 1.04 24.88 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.27 20.01 8.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.242 0.474 . . . . 0.0 111.928 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.76 115.61 8.31 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.431 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.9 123.13 16.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -110.78 129.18 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.237 0.541 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.91 140.53 42.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.586 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.1 p -126.96 134.63 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.42 146.53 18.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 154.76 16.64 Favored Glycine 0 C--N 1.33 0.238 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.66 166.25 23.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.826 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -58.93 -31.8 68.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.261 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -81.12 -5.23 57.43 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.2 t -86.48 132.27 43.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.465 ' O ' HG23 ' A' ' 79' ' ' VAL . 71.8 Cg_endo -77.36 154.4 31.87 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.55 1.5 . . . . 0.0 110.495 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.7 t80 -64.2 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.887 -0.508 . . . . 0.0 111.04 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.93 -37.64 69.23 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.536 0.208 . . . . 0.0 110.744 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -71.54 -34.22 69.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.188 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 75' ' ' PRO . 11.1 t -63.43 -38.32 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.372 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.9 mm -60.69 -47.61 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.45 0.643 . . . . 0.0 109.621 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -55.14 -44.35 75.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.929 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.99 87.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -61.47 -37.69 84.51 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.532 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.66 -41.49 90.72 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.825 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.76 -39.34 90.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 110.764 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.699 HD13 HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -63.24 -42.95 99.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.909 179.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -63.1 -42.54 99.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.44 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.22 -37.78 72.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.598 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.22 10.59 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.24 44.59 96.8 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.699 HD13 HD13 ' A' ' 86' ' ' LEU . 4.7 mt . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.475 0.436 0 N-CA-C 114.431 0.897 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.625 HG23 HG22 ' B' ' 64' ' ' THR . 41.3 t -106.37 114.79 46.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.886 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.86 127.79 68.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.522 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt -115.43 121.78 43.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.447 ' N ' HD23 ' B' ' 25' ' ' LEU . 27.9 mt-10 -110.81 126.89 55.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.397 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.34 111.28 20.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.97 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.52 -122.8 0.83 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 119.964 -1.113 . . . . 0.0 114.064 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.72 100.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.15 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.74 -3.57 82.67 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.446 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 131.62 53.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.552 0.676 . . . . 0.0 109.764 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -137.94 157.16 46.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.253 1.025 . . . . 0.0 112.721 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.57 142.63 51.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.769 -1.56 . . . . 0.0 109.046 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.6 pt -133.44 134.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.317 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 115.49 29.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.262 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.3 mt -112.07 109.03 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.769 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.44 46.45 22.78 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.621 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 -25.59 24.38 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.914 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -91.75 128.78 37.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.516 1.158 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.44 135.06 47.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.75 127.84 53.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.46 156.49 27.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 112.169 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.54 46.01 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.43 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' B' ' 42' ' ' GLN . 34.2 mt -89.0 150.95 22.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 112.151 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -92.68 173.13 7.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.749 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.0 mt-10 -67.57 -44.28 78.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.844 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.2 -38.96 93.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mtm -70.22 -44.47 68.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.2 p -59.01 -35.09 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -63.82 -51.13 66.11 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.869 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.35 -51.3 55.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.67 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.17 -48.12 74.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.718 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -58.14 -43.07 87.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.478 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -66.22 -44.02 85.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.297 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -64.22 -39.36 93.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.018 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -38.34 71.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -70.47 -30.59 67.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.593 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.37 -28.52 52.9 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.932 0.333 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -37.09 27.56 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -127.93 105.27 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.87 1.0 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -124.99 19.81 8.36 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.276 0.489 . . . . 0.0 111.906 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.625 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.7 115.94 8.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.405 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.18 122.74 15.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.78 129.13 55.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.59 140.21 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.747 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.6 p -126.55 134.46 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.02 146.55 18.49 Favored Glycine 0 C--O 1.226 -0.346 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.99 154.78 16.75 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.11 166.53 23.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -59.19 -31.63 69.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.281 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -81.1 -5.46 57.69 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.25 132.12 44.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.471 ' O ' HG23 ' B' ' 79' ' ' VAL . 75.1 Cg_endo -77.35 154.06 31.69 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.583 1.522 . . . . 0.0 110.669 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -64.06 -37.83 88.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.911 -0.493 . . . . 0.0 111.046 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.47 -37.63 70.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.514 0.197 . . . . 0.0 110.629 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' B' ' 75' ' ' PRO . 1.4 tp10 -71.44 -34.42 70.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.285 0.564 . . . . 0.0 110.199 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 75' ' ' PRO . 11.4 t -63.25 -38.3 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.425 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.94 -47.29 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.453 0.644 . . . . 0.0 109.625 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' B' ' 85' ' ' LEU . 12.1 mmmt -55.33 -43.99 75.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.957 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.31 86.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.346 0.594 . . . . 0.0 110.833 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 83' ' ' LEU . 6.3 mt -60.87 -38.05 84.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.38 -41.51 89.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.903 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' B' ' 81' ' ' LYS . 1.6 mt -65.85 -39.23 90.58 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.481 . . . . 0.0 110.707 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 91' ' ' ILE . 0.5 OUTLIER -63.4 -42.58 98.79 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.939 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -63.22 -42.77 99.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -37.58 72.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.683 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.48 10.81 23.81 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.12 44.5 97.12 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.234 0.853 . . . . 0.0 115.234 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.719 HD13 HD13 ' B' ' 86' ' ' LEU . 4.5 mt -99.25 -36.69 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 114.658 0.984 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 64' ' ' THR . 38.3 t -106.36 110.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.881 HG23 HD11 ' A' ' 67' ' ' LEU . 3.1 mp -108.62 126.38 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.287 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.0 tt -115.54 123.48 48.61 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' HD23 ' A' ' 25' ' ' LEU . 11.3 mt-10 -111.95 127.16 55.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.306 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 74' ' ' VAL . 34.7 t -84.86 108.25 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.537 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -22.71 24.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -119.24 0.61 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.939 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.81 98.84 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.63 -3.5 86.54 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.944 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.49 130.58 54.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.544 0.672 . . . . 0.0 109.447 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -139.12 157.25 46.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 113.115 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.77 51.06 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.954 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.694 HG23 HD12 ' A' ' 45' ' ' LEU . 3.7 pt -132.3 134.13 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.368 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.64 114.01 26.78 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.389 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 35' ' ' ILE . 63.0 mt -110.71 108.68 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.89 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 47.37 21.18 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.735 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.64 23.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.267 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -92.14 128.3 37.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.478 1.139 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.17 135.49 47.55 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.41 127.47 53.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -116.53 155.76 28.09 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.7 46.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.396 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 35' ' ' ILE . 17.5 mt -87.76 149.01 24.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 112.361 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -91.89 173.06 8.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.554 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.1 mt-10 -67.53 -45.01 76.99 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.948 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -37.98 89.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.234 0.47 . . . . 0.0 110.845 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mtp -70.26 -44.87 67.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -58.53 -35.46 54.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.14 -51.76 62.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -50.2 -51.79 41.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.762 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.74 -48.12 75.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.021 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.638 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -66.83 -43.46 83.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.209 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -39.41 92.91 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.043 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.13 -37.57 72.31 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.695 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.77 -30.99 67.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.442 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.23 -27.97 53.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.913 0.324 . . . . 0.0 111.148 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.05 -38.81 24.4 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.86 119.18 25.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -91.26 -19.88 22.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.37 20.53 11.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.202 0.456 . . . . 0.0 111.579 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.96 115.64 9.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.724 -178.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.06 125.92 26.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -110.0 126.78 54.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.211 0.529 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -134.12 139.85 46.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.491 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.3 p -127.39 135.71 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.37 144.74 16.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.647 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.47 152.79 17.06 Favored Glycine 0 C--N 1.33 0.204 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.1 164.71 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.085 0.469 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 -32.58 68.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.502 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -81.96 -6.84 59.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 27' ' ' VAL . 79.2 t -85.81 127.79 61.08 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.08 154.41 62.42 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 110.394 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.9 t80 -63.12 -36.66 84.33 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.816 -0.552 . . . . 0.0 110.73 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 110.422 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -36.89 74.89 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 109.781 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.62 -39.55 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.687 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.1 mm -59.85 -48.11 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.409 0.623 . . . . 0.0 109.806 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 4.3 mmmt -54.96 -44.06 74.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.96 83.68 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.599 . . . . 0.0 110.873 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' B' ' 83' ' ' LEU . 7.1 mt -60.32 -37.3 80.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.572 0.701 . . . . 0.0 109.541 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.2 -40.88 95.62 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.985 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.3 mt -65.01 -40.19 94.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.673 HD13 HD13 ' A' ' 91' ' ' ILE . 2.5 mm? -63.45 -42.47 98.65 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 t60 -63.24 -41.44 99.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -38.99 76.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.35 10.33 25.4 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.45 44.1 98.46 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.673 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 N--CA 1.478 0.614 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.493 HG23 HG22 ' B' ' 64' ' ' THR . 38.3 t -106.36 110.72 32.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.893 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.83 126.76 65.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.371 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.0 tt -116.05 123.68 48.54 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.502 ' N ' HD23 ' B' ' 25' ' ' LEU . 11.8 mt-10 -112.35 127.23 55.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.225 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 37.5 t -85.06 108.21 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.591 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.6 -22.47 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.57 -123.54 0.85 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.459 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 28.9 mm -108.12 99.08 7.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.191 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -3.43 86.6 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.032 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 130.79 54.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.623 0.712 . . . . 0.0 109.6 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -139.13 157.89 45.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.515 1.15 . . . . 0.0 113.134 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 142.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.835 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.71 HG23 HD12 ' B' ' 45' ' ' LEU . 3.5 pt -132.24 134.1 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.25 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -111.14 114.1 27.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.417 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 59.7 mt -111.36 108.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.751 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.44 20.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.883 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.16 -25.82 22.24 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.71 -0.757 . . . . 0.0 114.04 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -91.77 128.76 37.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.656 1.228 . . . . 0.0 110.329 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.85 135.39 48.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.36 128.15 53.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -117.28 155.8 28.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.141 0.496 . . . . 0.0 112.325 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.48 27.73 46.59 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.198 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.71 HD12 HG23 ' B' ' 35' ' ' ILE . 17.6 mt -87.68 148.87 24.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.387 0.613 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -92.05 173.18 7.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.7 mt-10 -67.75 -44.8 76.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.025 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.49 91.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.161 0.505 . . . . 0.0 110.974 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mtp -69.96 -44.87 68.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.369 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -58.57 -35.31 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.728 0.299 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.26 -51.53 63.11 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.888 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.39 -51.56 45.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.7 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.12 -48.17 74.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.732 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 18.1 m -57.52 -43.45 84.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 111.753 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -66.65 -43.7 83.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.139 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -39.95 94.52 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.76 -37.3 73.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -70.94 -31.17 67.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.299 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.91 -28.1 55.17 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.11 -0.369 . . . . 0.0 111.131 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.13 -38.52 24.63 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -128.15 119.44 25.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -91.28 -20.0 22.38 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 20.58 11.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.067 0.394 . . . . 0.0 111.543 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.493 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.72 115.91 9.51 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.51 125.98 27.42 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.76 127.0 54.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.213 0.53 . . . . 0.0 111.694 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.26 139.77 45.97 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.518 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.788 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.9 p -127.39 135.89 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.34 145.18 17.25 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.649 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.71 152.32 17.16 Favored Glycine 0 N--CA 1.454 -0.161 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.34 165.14 24.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -59.14 -32.27 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -81.71 -7.13 59.56 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 75.3 t -85.43 127.8 61.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.2 154.18 61.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.222 1.282 . . . . 0.0 110.264 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.687 ' CE1' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -62.96 -36.48 83.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.747 -0.596 . . . . 0.0 110.69 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.48 -36.27 68.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -36.9 74.58 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.306 0.574 . . . . 0.0 109.662 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.9 -39.24 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.642 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.687 HD11 ' CE1' ' B' ' 76' ' ' TYR . 46.0 mm -59.99 -48.03 89.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-O 121.476 0.655 . . . . 0.0 109.713 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.4 mmmt -55.12 -44.12 74.72 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.014 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.99 83.48 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 7.4 mt -60.46 -37.2 80.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.611 0.72 . . . . 0.0 109.591 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.25 -40.83 95.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.883 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.4 mt -65.2 -39.9 93.46 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.855 0.36 . . . . 0.0 110.829 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.679 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -63.41 -42.6 98.76 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -63.26 -41.27 99.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.424 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -39.08 76.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.598 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.3 10.19 25.82 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.78 43.89 98.62 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.679 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -99.15 -31.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.241 0.626 0 N-CA-C 115.676 1.375 . . . . 0.0 115.676 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.49 120.13 61.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -112.47 127.71 69.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -117.07 127.25 53.96 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.4 mt-10 -115.84 127.68 55.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.299 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 74' ' ' VAL . 26.4 t -87.52 99.53 8.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.941 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.82 -21.64 51.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.974 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -113.93 92.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 -5.53 79.24 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.705 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.59 128.94 52.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.576 0.688 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.69 156.9 47.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.376 1.084 . . . . 0.0 113.133 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.98 142.29 51.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.842 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -132.83 135.14 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.18 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.69 116.11 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.938 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.05 108.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.183 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 48.52 18.35 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.523 -0.846 . . . . 0.0 114.39 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.99 -27.11 15.74 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.373 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.81 130.0 37.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.412 1.106 . . . . 0.0 110.197 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.29 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.13 125.57 51.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.52 157.02 25.9 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.25 50.99 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.042 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 HG23 ' A' ' 35' ' ' ILE . 13.6 mt -87.44 149.15 24.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.971 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 p -92.09 173.16 7.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.2 mt-10 -67.47 -43.79 80.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.22 -38.25 90.38 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 122.043 -0.411 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mtp -70.93 -43.6 67.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.625 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.32 -35.8 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -63.24 -51.2 67.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.681 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.32 -52.5 36.27 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.93 -47.57 77.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.728 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -58.07 -43.15 86.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.099 0.476 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -44.66 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.046 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.91 -40.42 96.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.161 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -70.31 -39.23 74.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.236 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.55 -27.73 64.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.41 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.86 -26.95 40.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.928 0.331 . . . . 0.0 111.385 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -33.96 25.05 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.741 ' HB3' HG23 ' A' ' 64' ' ' THR . 4.4 t70 -134.52 97.45 3.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -70.86 -6.21 36.4 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -109.04 17.65 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.586 0.63 . . . . 0.0 111.826 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -68.61 115.61 8.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.519 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 66' ' ' PHE . 6.2 tp -65.11 124.69 22.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.449 ' N ' HD12 ' A' ' 65' ' ' LEU . 11.8 m-85 -109.09 127.79 54.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.359 0.599 . . . . 0.0 111.514 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -133.95 139.24 45.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.505 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -126.78 137.34 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.96 145.49 17.32 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.88 153.68 16.69 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.17 163.63 24.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.154 0.502 . . . . 0.0 111.285 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -31.76 68.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.415 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -81.73 -5.96 58.61 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 27' ' ' VAL . 74.5 t -89.48 127.05 56.22 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.93 156.17 63.56 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.094 1.196 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.4 t80 -64.46 -34.7 78.8 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.768 -0.583 . . . . 0.0 110.46 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.23 -36.42 70.89 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -36.85 75.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.334 0.587 . . . . 0.0 109.688 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.61 -39.01 81.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.788 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.9 mm -60.39 -48.52 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.359 0.6 . . . . 0.0 109.726 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -54.15 -44.8 71.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.47 85.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.509 0.671 . . . . 0.0 110.827 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.0 mt -61.0 -36.8 80.46 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 109.378 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.73 -42.38 97.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.851 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.12 -39.92 95.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.065 0.459 . . . . 0.0 110.837 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 91' ' ' ILE . 2.1 mm? -64.03 -42.38 97.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.063 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.7 -42.32 99.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.511 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.5 -38.66 74.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.83 11.41 20.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.49 44.23 98.27 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 86' ' ' LEU . 4.1 mt . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo . . . . . 0 N--CA 1.478 0.615 0 N-CA-C 115.745 1.402 . . . . 0.0 115.745 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.1 t -111.52 120.49 62.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 127.65 69.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.74 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.521 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -117.1 127.09 53.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.492 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.0 mt-10 -115.72 127.68 55.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.165 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.425 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.4 t -87.58 98.99 7.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.033 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.27 -21.86 52.98 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.09 -124.55 0.88 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.704 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.12 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.105 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.33 79.35 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.814 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 129.13 53.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -138.16 156.65 47.53 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.337 1.065 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.03 142.06 51.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.95 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.621 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -132.64 135.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.406 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.89 115.89 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.892 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.0 108.73 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.149 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.99 15.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.462 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.74 -26.85 16.33 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.176 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.85 129.95 37.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.487 1.144 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.88 136.03 48.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.269 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.55 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -116.83 126.06 52.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.79 157.08 26.14 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 26.57 53.11 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.057 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.621 HD12 HG23 ' B' ' 35' ' ' ILE . 13.8 mt -86.89 148.94 25.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.388 0.613 . . . . 0.0 112.109 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -91.74 172.97 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.45 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.7 -43.62 79.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -63.94 -38.61 91.72 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 110.996 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.53 -43.91 68.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.425 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.45 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.13 -35.77 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.948 0.404 . . . . 0.0 110.228 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 19.6 m -63.27 -51.3 66.71 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.745 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.26 -52.49 35.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.79 -47.35 78.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.796 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -58.4 -42.9 88.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.488 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.39 83.29 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.196 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.07 -40.58 96.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.992 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.609 ' OE2' HG21 ' B' ' 64' ' ' THR . 0.0 OUTLIER -70.23 -39.34 75.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.225 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.35 -27.8 64.63 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.524 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -79.63 -27.43 40.96 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.84 0.291 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -83.25 -33.75 25.98 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.732 ' HB3' HG23 ' B' ' 64' ' ' THR . 4.4 t70 -134.96 97.72 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -71.02 -6.15 36.75 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.86 17.4 21.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.7 0.682 . . . . 0.0 111.754 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.732 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -68.3 115.9 8.27 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.471 HD12 ' N ' ' B' ' 66' ' ' PHE . 5.6 tp -65.32 125.13 24.12 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.471 ' N ' HD12 ' B' ' 65' ' ' LEU . 11.6 m-85 -109.44 127.38 54.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 0.0 111.556 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.785 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.52 137.5 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.12 145.43 17.21 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.522 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.76 153.29 16.83 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.84 164.21 24.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -31.51 69.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.176 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.67 -6.59 59.16 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.425 HG21 ' O ' ' B' ' 27' ' ' VAL . 73.9 t -88.98 127.0 57.41 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.99 156.33 63.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.962 1.108 . . . . 0.0 110.298 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.51 -34.9 79.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.996 -0.44 . . . . 0.0 110.419 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.66 -36.02 71.33 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.672 0.273 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -36.96 75.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.502 0.668 . . . . 0.0 109.539 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -61.56 -39.04 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.687 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.6 mm -60.31 -48.24 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.429 0.633 . . . . 0.0 109.702 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -54.59 -44.68 73.24 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.219 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.34 85.8 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 110.846 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -61.31 -36.56 80.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.666 0.746 . . . . 0.0 109.377 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.99 -41.83 97.25 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.949 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.97 -39.41 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.754 HD13 HD13 ' B' ' 91' ' ' ILE . 2.2 mm? -64.31 -41.96 96.59 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.85 -42.23 99.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.556 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.47 -38.9 75.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.618 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.58 11.67 18.94 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.13 44.27 98.36 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -98.07 -30.53 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.939 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 C--O 1.24 0.595 0 N-CA-C 115.296 1.229 . . . . 0.0 115.296 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 64' ' ' THR . 46.9 t -112.27 117.23 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.868 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -109.51 127.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.409 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.4 tt -116.02 121.72 43.06 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 tt0 -106.97 125.59 51.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.9 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.32 116.26 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.657 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.31 -23.79 15.49 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -122.89 0.76 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.105 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.1 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 122.666 0.387 . . . . 0.0 110.112 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 -3.41 87.24 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.964 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.89 53.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -137.48 157.09 47.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.202 1.001 . . . . 0.0 113.335 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 141.99 51.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.708 -1.587 . . . . 0.0 108.638 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 37' ' ' ILE . 5.8 pt -131.73 134.81 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -112.3 114.41 27.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.54 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 35' ' ' ILE . 47.7 mt -114.45 109.99 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.221 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.32 45.45 21.72 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.962 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.98 -26.89 14.55 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.827 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -85.32 125.14 32.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.927 0.863 . . . . 0.0 110.517 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.87 133.27 50.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.94 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.78 127.36 52.73 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.71 155.66 28.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 112.058 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 26.27 51.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.339 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 42' ' ' GLN . 40.7 mt -86.62 148.92 25.26 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.513 0.673 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.8 p -90.77 172.69 8.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.535 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 50' ' ' VAL . 6.2 mt-10 -67.9 -44.29 77.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.675 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.88 -38.79 92.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.099 0.476 . . . . 0.0 110.951 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.39 -46.15 67.56 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.03 -34.42 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -63.31 -50.42 70.1 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.789 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.42 -52.46 37.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.714 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.64 -47.7 77.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.693 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.6 -43.55 89.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.214 0.531 . . . . 0.0 111.701 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.58 -43.34 85.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.374 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.27 -40.63 96.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.76 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.56 -37.33 76.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.88 -30.91 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.63 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.19 -27.75 57.01 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.247 -0.283 . . . . 0.0 111.038 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.35 -36.48 26.81 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.19 107.59 8.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.81 4.38 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.8 19.24 9.4 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.381 0.537 . . . . 0.0 111.864 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.475 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.1 116.14 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.08 123.78 19.05 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.48 127.93 55.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.097 0.475 . . . . 0.0 111.441 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -133.46 140.27 47.18 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.818 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.7 p -127.33 136.34 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 147.13 19.02 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.15 155.76 17.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.1 23.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.068 0.461 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -57.63 -33.38 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -79.89 -5.63 55.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.79 132.98 49.83 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 87.3 Cg_endo -79.6 153.19 23.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.541 1.494 . . . . 0.0 110.573 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.8 t80 -63.53 -38.45 91.18 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.658 -0.651 . . . . 0.0 110.987 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -56.28 -37.33 69.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.599 0.238 . . . . 0.0 110.641 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -71.34 -35.62 71.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.857 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' PRO . 12.7 t -62.24 -38.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.715 HD11 ' CE1' ' A' ' 76' ' ' TYR . 50.5 mm -60.05 -47.92 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.42 0.629 . . . . 0.0 109.612 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -53.79 -44.37 70.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.154 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.69 80.69 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.693 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' B' ' 83' ' ' LEU . 7.4 mt -60.3 -36.35 77.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -61.92 -42.58 99.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.149 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.0 mt -64.43 -39.04 93.07 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 110.985 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 91' ' ' ILE . 2.1 mm? -64.24 -41.84 96.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.139 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -63.47 -40.13 96.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -38.14 76.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.483 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.29 9.77 27.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.42 44.15 95.72 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.709 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo . . . . . 0 C--O 1.24 0.59 0 N-CA-C 115.407 1.272 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.433 HG23 HG22 ' B' ' 64' ' ' THR . 45.9 t -112.17 117.57 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.92 127.27 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.398 -178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.491 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.5 tt -115.59 121.85 43.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.491 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.5 tt0 -106.8 125.9 51.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.921 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -84.59 116.06 27.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.587 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.9 -24.34 15.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -126.35 0.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.964 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.1 mm -108.03 100.88 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.421 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.16 -2.97 87.95 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.144 -0.55 . . . . 0.0 114.0 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 127.85 53.54 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -137.34 157.22 47.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.237 1.018 . . . . 0.0 113.379 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.44 141.72 51.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.754 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.703 HD12 HD11 ' B' ' 37' ' ' ILE . 6.1 pt -131.49 134.57 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.736 0.698 . . . . 0.0 112.816 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.98 114.25 27.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.517 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.703 HD11 HD12 ' B' ' 35' ' ' ILE . 45.1 mt -114.29 109.77 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.36 45.7 22.1 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.831 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.88 -27.31 13.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.849 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -84.96 125.43 32.68 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.061 0.931 . . . . 0.0 110.522 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.34 133.09 51.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.823 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.3 127.57 53.33 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -117.18 155.59 29.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.51 50.87 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.137 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' B' ' 42' ' ' GLN . 41.4 mt -87.05 149.23 24.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.528 0.68 . . . . 0.0 111.998 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -90.98 172.84 8.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.759 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.431 ' O ' HG12 ' B' ' 50' ' ' VAL . 6.1 mt-10 -67.92 -44.11 77.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.8 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.41 -38.38 90.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.043 0.449 . . . . 0.0 110.809 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.2 mtp -69.23 -46.71 66.68 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.66 -34.37 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -63.47 -50.23 70.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.719 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.8 -52.07 44.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.733 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.61 -48.22 75.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.621 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -43.84 88.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 111.739 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.52 -42.98 86.45 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.486 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.61 -40.65 95.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.745 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -69.55 -37.35 77.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.996 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.98 -30.81 67.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.18 -27.65 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.947 0.34 . . . . 0.0 111.039 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -82.33 -36.54 26.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.38 107.34 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.58 4.54 18.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -123.75 19.18 9.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.465 0.575 . . . . 0.0 111.845 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.433 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.23 116.49 8.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.4 123.83 19.31 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.38 127.66 55.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.45 139.96 47.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.609 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.2 p -127.05 136.5 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.51 147.05 18.96 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.03 155.83 17.32 Favored Glycine 0 N--CA 1.46 0.29 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.989 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 166.55 23.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -58.42 -33.14 69.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.461 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.99 -5.97 56.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -82.41 132.69 51.88 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.464 ' O ' HG23 ' B' ' 79' ' ' VAL . 93.0 Cg_endo -79.55 153.1 23.36 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.683 1.589 . . . . 0.0 110.316 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.717 ' CE1' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -63.38 -38.8 92.55 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.767 -0.583 . . . . 0.0 110.921 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.96 -37.37 68.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.492 0.187 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -71.3 -35.85 71.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 75' ' ' PRO . 12.5 t -62.18 -38.26 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.717 HD11 ' CE1' ' B' ' 76' ' ' TYR . 50.4 mm -59.92 -47.63 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.51 0.671 . . . . 0.0 109.719 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 tttp -54.28 -44.29 71.77 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.46 81.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.148 0.499 . . . . 0.0 110.716 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' A' ' 83' ' ' LEU . 7.2 mt -60.68 -36.2 78.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.604 0.716 . . . . 0.0 109.238 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -61.93 -42.24 98.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.0 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 1.8 mt -64.86 -38.92 92.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.96 0.41 . . . . 0.0 110.948 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.435 HD12 HG21 ' B' ' 91' ' ' ILE . 2.0 mm? -64.19 -42.05 96.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.288 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.36 -40.34 97.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -38.14 76.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.389 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.727 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.21 9.6 27.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.39 44.3 95.54 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 115.704 1.041 . . . . 0.0 115.704 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.727 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.3 mp -97.65 -37.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.67 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--O 1.239 0.541 0 N-CA-C 115.692 1.381 . . . . 0.0 115.692 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.58 116.62 53.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.883 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -108.55 127.16 65.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.604 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -115.14 122.04 44.86 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.544 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.2 tm-20 -111.24 128.07 55.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.131 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.31 116.62 29.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.508 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -97.16 -22.15 16.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.8 -122.08 0.72 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.741 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -115.59 87.52 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.32 27.72 19.57 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.388 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -139.13 93.08 2.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.517 0.675 . . . . 0.0 109.487 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.26 157.39 17.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.263 1.03 . . . . 0.0 113.231 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 142.0 51.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.709 HG23 HD12 ' A' ' 45' ' ' LEU . 4.8 pt -131.54 133.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 118.529 0.604 . . . . 0.0 112.422 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.51 114.33 27.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.473 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 35' ' ' ILE . 67.0 mt -114.27 110.08 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.208 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.42 45.03 22.26 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.93 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 -26.86 17.04 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.086 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.88 126.25 34.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.225 1.013 . . . . 0.0 110.525 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.36 131.94 52.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.921 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.75 127.2 53.32 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -117.56 158.67 24.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.49 27.39 54.87 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.949 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.709 HD12 HG23 ' A' ' 35' ' ' ILE . 10.0 mt -87.38 149.15 24.67 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.697 0.76 . . . . 0.0 112.191 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 p -91.36 171.53 9.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.419 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.42 -43.61 80.8 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.0 -38.8 92.42 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.027 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mtp -70.35 -44.11 68.82 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.48 -34.91 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -63.55 -50.46 69.43 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.855 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -50.67 -51.47 48.97 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.807 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.08 -48.09 74.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.279 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -43.84 83.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 111.622 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -66.76 -44.5 81.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.193 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.92 -40.58 96.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -69.41 -38.48 77.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.24 -31.27 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.23 -27.3 53.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.26 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -84.87 -36.62 21.42 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.994 0.426 . . . . 0.0 109.953 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.646 ' HB3' HG23 ' A' ' 64' ' ' THR . 10.4 m-20 -128.84 97.38 4.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.28 -6.11 37.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -114.16 19.19 16.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.573 0.624 . . . . 0.0 111.955 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -67.95 113.38 5.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.446 -179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.45 125.07 23.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -111.19 128.99 56.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.795 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.898 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.89 139.36 46.14 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.51 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.761 HG11 ' CD2' ' A' ' 83' ' ' LEU . 11.9 p -125.72 135.91 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.78 145.38 16.98 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.14 153.13 16.67 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.771 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.75 24.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -32.26 65.98 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.75 -5.71 59.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.38 133.25 53.67 Favored Pre-proline 0 CA--C 1.537 0.462 0 O-C-N 122.221 -0.299 . . . . 0.0 110.442 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 Cg_endo -77.34 148.96 27.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.729 1.619 . . . . 0.0 110.729 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 80' ' ' ILE . 4.7 t80 -63.04 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.748 -0.595 . . . . 0.0 111.251 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.56 -37.0 67.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.605 0.24 . . . . 0.0 110.832 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.6 -34.75 67.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.913 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 75' ' ' PRO . 13.2 t -62.67 -38.83 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.381 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.3 mm -60.24 -47.48 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.474 0.654 . . . . 0.0 109.407 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.12 -43.99 70.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.2 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -49.05 79.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.123 0.487 . . . . 0.0 110.792 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.33 -37.9 82.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.381 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.09 -42.0 97.7 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.696 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.22 -39.61 92.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.98 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -63.51 -42.26 98.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.65 -42.05 98.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.394 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.392 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.99 10.83 20.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.65 97.73 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.595 HD13 HD13 ' A' ' 86' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo . . . . . 0 C--O 1.24 0.587 0 N-CA-C 115.663 1.37 . . . . 0.0 115.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.5 116.81 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.902 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.74 127.11 65.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.632 -177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.524 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.04 122.16 45.32 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.524 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.3 tm-20 -111.21 127.58 55.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.254 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.71 116.89 30.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.323 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -97.4 -22.61 16.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.34 -125.71 0.94 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.649 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -111.06 87.84 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.192 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.62 27.93 20.68 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.485 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -138.86 93.3 2.69 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.514 0.673 . . . . 0.0 109.281 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -105.56 157.03 17.67 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.356 1.074 . . . . 0.0 113.336 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.78 141.99 51.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.992 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.724 HG23 HD12 ' B' ' 45' ' ' LEU . 4.8 pt -131.48 133.94 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.527 0.603 . . . . 0.0 112.271 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.05 114.45 27.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.396 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.652 HD11 HD12 ' B' ' 35' ' ' ILE . 72.3 mt -114.46 110.1 30.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.192 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.17 45.38 20.74 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.044 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.84 -26.8 16.8 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.102 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.94 126.3 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.322 1.061 . . . . 0.0 110.436 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.52 131.93 52.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.962 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.04 127.19 53.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -117.33 158.58 24.15 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.242 0.544 . . . . 0.0 112.445 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.21 27.74 54.96 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.724 HD12 HG23 ' B' ' 35' ' ' ILE . 10.4 mt -87.2 149.1 24.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.57 0.7 . . . . 0.0 112.193 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.8 p -91.49 171.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.428 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.9 mt-10 -67.21 -44.08 80.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.748 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.78 -38.69 92.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mtp -70.3 -44.36 68.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.304 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -34.47 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.3 m -64.29 -50.24 68.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.873 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -50.73 -51.55 48.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.604 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.95 -48.32 74.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.11 -43.92 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.058 0.456 . . . . 0.0 111.781 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.458 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -66.81 -44.24 81.72 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.195 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -64.16 -40.09 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.904 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -69.68 -39.01 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.188 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -69.81 -31.2 68.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.09 -27.84 54.3 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.894 0.315 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -84.31 -36.15 22.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.11 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.662 ' HB3' HG23 ' B' ' 64' ' ' THR . 10.4 m-20 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -70.93 -5.96 34.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -114.15 18.51 17.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.616 0.644 . . . . 0.0 112.053 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.662 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -67.27 113.71 5.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.79 124.39 21.36 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -110.62 128.78 55.83 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.372 0.606 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.902 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -133.61 139.26 46.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.558 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.745 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.4 p -125.94 135.68 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.55 145.27 16.91 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.13 153.2 16.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.92 24.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.045 0.45 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -32.35 66.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.78 -5.51 58.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -81.49 133.39 53.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.481 ' O ' HG23 ' B' ' 79' ' ' VAL . 95.7 Cg_endo -77.59 149.12 26.7 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.725 1.617 . . . . 0.0 110.708 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.7 t80 -63.27 -39.08 93.58 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.709 -0.619 . . . . 0.0 111.157 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.51 -37.12 67.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.694 0.283 . . . . 0.0 110.728 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.4 -34.81 68.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.873 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.481 HG23 ' O ' ' B' ' 75' ' ' PRO . 13.9 t -62.67 -38.82 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.7 mm -60.58 -46.7 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.437 0.636 . . . . 0.0 109.447 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.4 mttp -54.84 -43.77 73.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.073 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.39 78.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.345 0.593 . . . . 0.0 110.792 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 83' ' ' LEU . 7.6 mt -60.08 -38.12 81.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 109.484 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.81 -42.27 97.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.817 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 9.4 mt -64.76 -39.86 94.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.938 0.399 . . . . 0.0 111.079 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.42 -42.39 98.74 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.56 -41.88 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -38.32 74.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.497 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.492 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.35 11.01 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 44.67 97.56 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.598 HD13 HD13 ' B' ' 86' ' ' LEU . 4.2 mt -101.05 -35.15 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo . . . . . 0 C--O 1.239 0.57 0 N-CA-C 115.414 1.275 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.0 t -114.52 119.19 60.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.834 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.58 127.57 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.305 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.7 tt -113.88 119.99 39.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 3.1 tt0 -109.31 128.32 54.99 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.113 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -87.2 116.38 29.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.391 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -96.95 -22.75 16.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.17 -119.26 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.348 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.66 101.46 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.221 -0.489 . . . . 0.0 109.708 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.72 1.65 72.88 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.884 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.6 mttt -107.12 92.73 4.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.423 0.612 . . . . 0.0 109.831 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -104.14 156.22 18.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.174 0.988 . . . . 0.0 112.926 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.22 141.41 52.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.981 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CD1' HD13 ' A' ' 53' ' ' LEU . 6.5 pt -131.73 134.69 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.654 0.661 . . . . 0.0 112.702 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -112.1 115.77 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.884 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 35' ' ' ILE . 79.0 mt -115.94 110.56 32.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.084 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.3 44.58 27.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.992 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -26.25 18.77 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.744 -0.741 . . . . 0.0 114.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -88.71 127.95 35.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.58 1.19 . . . . 0.0 110.46 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -106.48 134.35 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.0 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.74 126.64 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -116.7 157.7 25.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.241 0.543 . . . . 0.0 112.366 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.05 27.76 51.9 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.052 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' A' ' 42' ' ' GLN . 16.7 mt -88.12 150.14 23.52 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 112.293 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.5 p -91.11 171.33 9.33 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.228 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.14 -43.89 81.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.826 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.78 -38.57 91.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.171 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 mtp -69.87 -44.94 68.8 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.03 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.8 -34.14 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.8 m -64.11 -49.91 70.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.587 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.37 -52.68 35.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.696 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 35' ' ' ILE . 18.6 mt -64.42 -48.01 76.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.713 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t -58.01 -43.88 86.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.074 0.464 . . . . 0.0 111.738 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -44.62 83.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.249 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.99 95.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.096 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -69.92 -38.56 76.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.634 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.83 -29.41 65.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -78.85 -26.87 44.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.822 0.283 . . . . 0.0 111.393 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -85.63 -34.18 21.44 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.61 95.78 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.74 -13.36 62.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -106.0 19.28 20.79 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.604 0.638 . . . . 0.0 111.897 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' A' ' 23' ' ' VAL . 27.1 m -68.28 111.41 4.56 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.0 tp -66.42 127.21 31.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 65' ' ' LEU . 61.2 m-85 -114.3 131.25 56.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.021 0.439 . . . . 0.0 111.486 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' B' ' 67' ' ' LEU . 3.3 pp -134.85 140.94 46.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 83' ' ' LEU . 14.5 p -127.07 136.72 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.15 146.03 17.51 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.81 154.81 16.68 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.093 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 165.13 24.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.134 0.467 . . . . 0.0 111.14 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.29 -32.35 66.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.59 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -81.28 -5.74 58.12 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.29 132.21 48.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.03 151.72 35.32 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.57 1.513 . . . . 0.0 110.193 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.2 t80 -63.38 -36.6 84.24 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.719 -0.613 . . . . 0.0 110.753 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.6 -36.44 69.4 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.81 -34.89 69.73 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.91 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.88 -38.42 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.299 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 49.7 mm -61.2 -47.34 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.426 0.631 . . . . 0.0 109.482 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 3.1 mmtp -54.9 -44.35 74.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.931 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -48.17 82.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.257 0.551 . . . . 0.0 111.055 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.63 -37.15 80.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.384 0.611 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.92 -41.26 95.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.818 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.6 mt -65.5 -39.68 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.578 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 91' ' ' ILE . 2.2 mm? -62.86 -42.29 99.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.119 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -63.79 -42.09 97.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.369 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -37.86 75.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.478 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.66 10.51 25.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.65 97.16 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.5 mt . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo . . . . . 0 C--O 1.24 0.601 0 N-CA-C 115.53 1.319 . . . . 0.0 115.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.55 HG23 ' CG2' ' B' ' 64' ' ' THR . 58.8 t -114.34 119.07 60.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.831 HG23 HD11 ' B' ' 67' ' ' LEU . 3.3 mp -110.48 127.81 67.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.302 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.7 tt -114.23 119.83 38.38 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 2.9 tt0 -109.06 128.14 54.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.262 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.02 116.0 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.364 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.98 -22.48 16.81 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.12 -123.53 0.82 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.117 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.51 101.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.894 -0.653 . . . . 0.0 110.279 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.48 1.78 72.03 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.047 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -107.05 92.79 4.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.473 0.637 . . . . 0.0 109.747 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -103.89 155.89 18.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.26 1.029 . . . . 0.0 113.031 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -123.89 142.12 51.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.928 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.596 HD11 HD13 ' B' ' 53' ' ' LEU . 6.6 pt -132.24 134.8 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 118.671 0.669 . . . . 0.0 112.41 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -112.4 115.89 29.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.543 HD11 HD12 ' B' ' 35' ' ' ILE . 78.2 mt -115.93 110.64 32.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.018 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.31 44.27 27.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.219 -0.991 . . . . 0.0 114.19 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.7 -25.78 21.55 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.061 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -89.01 127.97 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.256 1.028 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.75 134.46 49.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.8 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.62 127.0 53.17 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -117.45 157.94 25.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 112.08 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.79 27.77 52.8 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.896 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 42' ' ' GLN . 16.3 mt -88.35 149.87 23.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.749 0.785 . . . . 0.0 112.35 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.88 171.18 9.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.443 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.8 mt-10 -67.11 -43.92 81.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.804 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.95 -38.83 92.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.021 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.7 mtp -69.55 -44.78 70.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.114 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.81 -34.36 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -63.83 -49.92 70.95 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.708 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.18 -52.69 33.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.82 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.596 HD13 HD11 ' B' ' 35' ' ' ILE . 18.4 mt -64.45 -48.38 75.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.723 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -57.9 -43.3 86.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.052 0.453 . . . . 0.0 111.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.86 81.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.305 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -40.37 96.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.62 -38.63 77.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -70.46 -29.72 66.36 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -78.85 -27.08 44.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.876 0.307 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -85.59 -33.71 21.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.718 0.294 . . . . 0.0 110.544 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -131.01 95.99 3.94 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.1 -13.42 62.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -105.91 19.48 20.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.722 0.692 . . . . 0.0 111.809 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.55 ' CG2' HG23 ' B' ' 23' ' ' VAL . 27.9 m -68.13 111.25 4.38 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.687 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.1 tp -66.41 126.94 30.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.687 ' N ' HD12 ' B' ' 65' ' ' LEU . 61.8 m-85 -113.99 131.26 56.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 111.567 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.98 141.14 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.623 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.732 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.8 p -127.47 137.21 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.47 146.14 17.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.69 155.11 16.62 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.43 24.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.893 0.378 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.66 -32.75 67.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.294 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -80.99 -5.83 58.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.24 132.04 48.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.81 151.82 36.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.557 1.505 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.724 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -63.51 -36.66 84.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 110.692 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.65 -36.57 69.69 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -71.49 -34.64 70.32 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.26 -38.17 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.461 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.724 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 49.1 mm -61.27 -47.13 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 3.2 mmtp -55.0 -44.62 74.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.971 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.96 83.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 111.086 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.78 -37.31 81.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.698 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.59 -41.56 94.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.751 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.1 mt -65.37 -39.41 92.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.031 0.444 . . . . 0.0 110.565 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.49 HD13 HD13 ' B' ' 91' ' ' ILE . 2.4 mm? -62.96 -42.59 99.87 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -63.26 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.515 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -38.13 75.93 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.509 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.607 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.28 10.17 25.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.25 44.87 97.02 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.7 mt -103.36 -37.15 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 0.0 109.768 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 C--O 1.24 0.584 0 N-CA-C 115.575 1.336 . . . . 0.0 115.575 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 64' ' ' THR . 49.2 t -112.77 119.24 59.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.14 127.27 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.309 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.5 tt -115.66 122.12 44.61 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.0 tt0 -111.0 127.15 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.411 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -84.73 112.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.69 -22.52 20.18 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -119.87 0.65 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.775 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' OE2' ' A' ' 78' ' ' GLU . 27.0 mm -111.87 99.4 8.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 122.905 0.482 . . . . 0.0 109.899 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.08 -2.47 87.62 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.228 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 131.29 54.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.866 0.833 . . . . 0.0 109.431 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.29 158.26 44.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.11 0.957 . . . . 0.0 112.942 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 142.64 51.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.192 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.856 HG23 HD12 ' A' ' 45' ' ' LEU . 5.4 pt -130.09 132.9 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.146 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.02 114.63 27.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 35' ' ' ILE . 81.1 mt -114.99 110.39 31.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.473 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.39 46.0 28.78 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.21 -0.995 . . . . 0.0 114.141 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.13 -24.53 24.45 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.68 -0.771 . . . . 0.0 114.308 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 127.76 36.0 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.512 1.156 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.77 133.13 50.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.956 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.86 127.22 53.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -117.45 157.65 25.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.919 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.64 26.43 56.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.918 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 35' ' ' ILE . 9.2 mt -85.38 147.58 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.276 0.538 . . . . 0.0 111.941 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -92.03 172.06 8.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.547 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.2 mt-10 -66.14 -45.45 80.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.13 -39.42 93.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.14 -0.35 . . . . 0.0 111.059 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.413 ' CE ' HD22 ' A' ' 45' ' ' LEU . 10.3 ttp -70.61 -40.94 72.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -62.82 -34.8 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -63.61 -49.95 71.29 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.47 -52.58 36.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.642 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 35' ' ' ILE . 27.2 mt -64.95 -47.69 76.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.51 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -43.47 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 111.54 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -66.25 -44.24 84.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -41.75 99.17 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.106 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.63 -39.66 73.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.89 -28.05 65.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.682 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.41 -27.03 38.15 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.223 -0.298 . . . . 0.0 111.301 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -85.73 -35.41 20.82 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -130.88 105.33 7.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.86 9.23 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -126.52 16.25 7.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 111.901 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.497 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.01 113.77 5.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.46 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 66' ' ' PHE . 8.1 tp -58.44 124.3 19.11 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.5 m-85 -113.1 131.56 55.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.819 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -135.22 140.17 45.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.744 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.65 136.94 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -140.38 147.9 19.55 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.623 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.32 154.55 16.52 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.08 23.38 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.934 0.367 . . . . 0.0 111.437 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.54 -32.73 67.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.42 -7.0 58.95 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -87.71 128.1 55.72 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.47 156.54 54.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.075 1.183 . . . . 0.0 110.08 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.8 t80 -63.65 -36.23 83.13 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.925 -0.485 . . . . 0.0 110.514 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -56.58 -36.33 69.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' OE2' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.24 -37.16 74.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.509 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 t -61.36 -39.34 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.897 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.2 mm -60.76 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.327 0.584 . . . . 0.0 109.577 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -44.84 75.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.164 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.07 86.97 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.288 0.566 . . . . 0.0 111.049 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -61.13 -36.77 80.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.586 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.52 -41.15 96.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -39.99 94.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.865 0.365 . . . . 0.0 110.729 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' A' ' 91' ' ' ILE . 1.5 mm? -63.49 -42.4 98.54 Favored 'General case' 0 C--N 1.335 -0.037 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -63.31 -42.14 99.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.421 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.66 -38.73 78.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.384 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.6 10.71 24.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' A' ' 86' ' ' LEU . 5.3 mt . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 C--O 1.241 0.651 0 N-CA-C 115.533 1.32 . . . . 0.0 115.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.48 HG23 HG22 ' B' ' 64' ' ' THR . 47.1 t -112.55 119.15 59.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.961 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -110.36 127.49 67.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.263 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.513 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.4 tt -115.98 122.43 45.22 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.513 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt0 -110.95 127.77 55.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.486 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.04 112.1 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.59 -22.63 20.21 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.65 -123.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.522 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.432 HD12 ' OE2' ' B' ' 78' ' ' GLU . 27.3 mm -107.64 99.56 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.842 -0.679 . . . . 0.0 110.121 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.05 -2.54 87.52 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 114.407 0.523 . . . . 0.0 114.407 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 131.22 54.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.644 0.722 . . . . 0.0 109.556 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -139.17 158.12 44.74 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.143 0.973 . . . . 0.0 112.954 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 142.73 51.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.069 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.845 HG23 HD12 ' B' ' 45' ' ' LEU . 5.5 pt -130.33 133.11 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.974 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.98 114.93 28.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.463 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.567 HD11 HD12 ' B' ' 35' ' ' ILE . 81.7 mt -115.27 110.1 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.391 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.39 45.67 28.74 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.256 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.81 -24.94 23.93 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.025 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.82 127.31 35.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.683 1.241 . . . . 0.0 110.393 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.2 133.2 50.37 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.115 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.74 127.14 53.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -117.43 157.39 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.969 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.83 26.37 56.23 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.845 HD12 HG23 ' B' ' 35' ' ' ILE . 9.0 mt -85.18 147.3 26.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.238 0.519 . . . . 0.0 111.778 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -91.83 172.14 8.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.441 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.441 ' O ' HG12 ' B' ' 50' ' ' VAL . 3.2 mt-10 -66.57 -45.08 80.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.18 -39.23 93.57 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.002 -0.436 . . . . 0.0 111.053 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.406 ' CE ' HD22 ' B' ' 45' ' ' LEU . 9.6 ttp -70.71 -40.91 72.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.441 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -62.81 -35.07 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -63.3 -50.23 70.87 Favored 'General case' 0 CA--C 1.523 -0.066 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.926 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.23 -52.83 32.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.624 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.451 HD13 HD11 ' B' ' 35' ' ' ILE . 30.4 mt -64.75 -47.72 77.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.85 -43.33 90.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.279 0.561 . . . . 0.0 111.661 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -66.23 -44.06 84.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.284 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -42.0 99.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.59 -39.41 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.987 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.06 -28.47 65.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.716 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.78 -27.48 40.4 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.948 0.34 . . . . 0.0 111.43 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.72 -34.85 21.14 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.949 0.404 . . . . 0.0 110.337 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -131.16 105.74 7.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.33 9.48 10.8 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -126.58 16.15 7.58 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 111.854 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.48 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.06 114.27 6.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.375 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.439 HD12 ' N ' ' B' ' 66' ' ' PHE . 7.8 tp -58.85 124.48 19.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.608 0.242 . . . . 0.0 110.534 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.439 ' N ' HD12 ' B' ' 65' ' ' LEU . 31.8 m-85 -113.51 131.36 56.09 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.799 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.34 140.18 44.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.881 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.762 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.3 p -126.76 136.03 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.42 147.68 19.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.806 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.98 154.3 16.46 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.95 165.67 23.22 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.956 0.408 . . . . 0.0 111.286 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -58.42 -32.72 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.324 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.21 -7.5 59.0 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.98 128.03 57.4 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.42 156.4 54.48 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.139 1.226 . . . . 0.0 110.165 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.39 -36.44 83.74 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.866 -0.521 . . . . 0.0 110.683 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.18 -36.39 68.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.432 ' OE2' HD12 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.38 -37.15 74.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.674 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.19 -39.59 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.674 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 47.9 mm -60.59 -47.3 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 109.64 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.06 74.36 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.216 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.63 84.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.382 0.61 . . . . 0.0 110.907 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.53 -36.72 79.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.78 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -61.72 -41.32 97.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.837 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -39.94 94.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.002 0.429 . . . . 0.0 110.684 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -63.59 -42.54 98.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.304 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.73 76.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.74 10.84 24.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.41 98.11 Favored Glycine 0 C--N 1.33 0.25 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' B' ' 86' ' ' LEU . 5.0 mt -101.9 -37.05 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.75 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo . . . . . 0 C--O 1.239 0.565 0 N-CA-C 115.775 1.413 . . . . 0.0 115.775 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 58.5 t -112.82 118.82 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.22 127.87 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -116.01 123.27 47.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.9 tm-20 -112.01 128.98 56.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.156 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 74' ' ' VAL . 29.3 t -88.68 96.67 6.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.181 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB3' ' HG3' ' A' ' 32' ' ' LYS . . . -76.61 -22.06 54.69 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.52 -120.65 0.65 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -112.57 101.12 12.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.019 0.527 . . . . 0.0 109.706 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.48 73.5 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.93 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -109.66 95.95 5.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.732 0.777 . . . . 0.0 110.285 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -104.83 156.65 17.82 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.294 1.045 . . . . 0.0 113.025 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.09 142.25 51.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.666 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 37' ' ' ILE . 5.3 pt -132.77 134.24 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.15 115.15 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.679 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' ILE . 48.8 mt -114.56 109.51 28.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.252 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 45.38 27.61 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.13 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.11 -25.73 22.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.071 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.47 128.07 36.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.327 1.064 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.89 136.05 47.4 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.023 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 127.48 53.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.35 157.7 25.69 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 112.228 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.53 52.55 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.12 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.614 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -87.94 147.7 24.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 112.221 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -89.71 169.88 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.629 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -65.55 -45.36 83.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.861 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -64.39 -38.77 92.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.562 ' CE ' HD22 ' A' ' 45' ' ' LEU . 11.1 ttp -72.11 -37.76 69.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.977 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.6 p -64.97 -33.36 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m -62.94 -50.3 71.35 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.448 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.13 -52.49 34.73 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.866 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -65.21 -47.36 77.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.773 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -58.7 -43.11 89.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.482 . . . . 0.0 111.592 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -65.95 -44.34 85.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.284 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.37 -41.58 98.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -69.57 -38.97 77.61 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.95 -29.75 66.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.575 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -76.91 -27.71 55.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.94 0.336 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -83.44 -35.94 24.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.846 0.355 . . . . 0.0 110.065 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.68 105.25 7.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -78.17 -15.61 58.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -105.13 19.06 21.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.359 0.527 . . . . 0.0 111.858 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 1.9 m -68.79 116.18 8.99 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -63.83 125.27 23.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.664 ' N ' HD12 ' A' ' 65' ' ' LEU . 55.6 m-85 -111.63 130.04 55.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.198 0.523 . . . . 0.0 111.627 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -135.52 139.93 44.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.67 138.65 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.32 142.81 14.08 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.5 154.0 16.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.722 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.0 23.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -31.43 69.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.515 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.12 -7.07 59.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 27' ' ' VAL . 59.8 t -89.66 131.8 38.74 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.34 155.91 55.31 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.013 1.142 . . . . 0.0 110.246 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.71 -35.46 80.63 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.842 -0.536 . . . . 0.0 110.437 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -56.6 -36.94 69.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.649 0.261 . . . . 0.0 110.402 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -36.58 75.22 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.734 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.03 -39.26 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.483 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.6 mm -60.6 -46.56 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.41 0.624 . . . . 0.0 109.404 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.65 -45.11 73.77 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.182 178.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.386 0.613 . . . . 0.0 110.657 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.6 mt -60.65 -37.11 80.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.486 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.32 -41.77 97.56 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.787 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.55 -42.89 98.35 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -62.45 -43.13 99.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.567 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -37.57 79.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.53 10.48 25.25 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.24 98.22 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.3 mt . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo . . . . . 0 C--O 1.24 0.6 0 N-CA-C 115.829 1.434 . . . . 0.0 115.829 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.564 HG23 ' CG2' ' B' ' 64' ' ' THR . 60.3 t -113.08 118.43 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.813 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.2 127.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.316 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.97 123.44 48.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.55 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.9 tm-20 -112.03 129.34 56.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.215 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 74' ' ' VAL . 28.4 t -88.91 96.48 6.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.185 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.409 ' HB3' ' HG3' ' B' ' 32' ' ' LYS . . . -76.92 -21.38 54.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.22 -125.3 0.91 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.651 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -107.65 101.9 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.016 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.45 70.55 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.006 -0.543 . . . . 0.0 114.099 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -109.58 95.57 5.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.823 0.821 . . . . 0.0 110.361 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -104.24 156.49 17.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.279 1.037 . . . . 0.0 113.093 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.0 142.14 51.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.479 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.668 HD12 HD11 ' B' ' 37' ' ' ILE . 5.6 pt -132.76 134.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.452 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.3 115.1 28.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.595 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.668 HD11 HD12 ' B' ' 35' ' ' ILE . 45.6 mt -114.51 109.71 29.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.301 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.89 45.76 25.51 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.408 -0.901 . . . . 0.0 114.179 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -25.77 21.71 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.144 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.39 128.09 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.33 1.065 . . . . 0.0 110.396 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.82 136.02 47.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.899 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.555 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.4 127.52 53.19 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.43 157.02 26.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 27.97 49.01 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.119 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.616 HD12 HG23 ' B' ' 35' ' ' ILE . 9.2 mt -87.93 148.23 24.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.653 0.74 . . . . 0.0 112.305 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -90.53 169.59 10.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.411 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.469 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.7 mt-10 -65.27 -45.36 84.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.37 -38.81 92.33 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.948 -0.47 . . . . 0.0 111.069 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.566 ' CE ' HD22 ' B' ' 45' ' ' LEU . 10.2 ttp -71.75 -37.98 70.46 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.5 p -64.75 -33.42 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.1 m -62.99 -50.29 71.33 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.506 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.09 -52.39 35.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.797 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.416 HD13 HD11 ' B' ' 35' ' ' ILE . 38.6 mt -65.25 -47.73 75.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.683 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -58.38 -43.37 88.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.077 0.465 . . . . 0.0 111.527 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -65.84 -44.4 85.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.28 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.27 -41.58 99.04 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.184 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.56 -38.84 77.59 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -69.93 -29.71 66.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.692 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -77.0 -27.78 54.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.851 0.296 . . . . 0.0 111.26 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -83.29 -35.52 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.838 0.351 . . . . 0.0 110.102 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -130.15 105.0 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.84 -15.54 58.98 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -105.38 19.57 20.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.362 0.528 . . . . 0.0 111.899 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.564 ' CG2' HG23 ' B' ' 23' ' ' VAL . 1.8 m -69.26 116.05 9.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.647 HD12 ' N ' ' B' ' 66' ' ' PHE . 0.8 OUTLIER -63.6 125.35 23.99 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.647 ' N ' HD12 ' B' ' 65' ' ' LEU . 55.4 m-85 -111.74 130.58 55.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.559 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -135.91 140.06 43.78 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.915 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.722 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -126.85 138.77 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 142.86 14.09 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.25 153.94 16.82 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 163.28 24.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.057 0.455 . . . . 0.0 111.322 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -31.44 69.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.307 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -7.15 59.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 27' ' ' VAL . 66.9 t -89.55 132.1 38.05 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.5 155.78 54.72 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.052 1.168 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.754 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.74 -35.38 80.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.863 -0.523 . . . . 0.0 110.363 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.73 -36.78 70.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.565 0.221 . . . . 0.0 110.423 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.0 -36.5 75.19 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.713 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.19 -39.2 83.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.579 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.754 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.8 mm -60.53 -46.61 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.364 0.602 . . . . 0.0 109.435 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -44.88 73.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.085 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.64 80.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.278 0.561 . . . . 0.0 110.767 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.8 mt -60.21 -37.03 79.05 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.566 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.13 -41.93 97.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.981 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.41 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.9 OUTLIER -65.69 -39.36 91.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.592 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.567 HD13 HD13 ' B' ' 91' ' ' ILE . 1.5 mm? -63.42 -42.55 98.73 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -62.75 -43.23 99.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.589 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.77 79.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.491 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.19 10.54 24.17 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.42 44.63 97.43 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.071 0.788 . . . . 0.0 115.071 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -101.84 -34.21 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.873 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo . . . . . 0 C--O 1.239 0.526 0 N-CA-C 115.663 1.37 . . . . 0.0 115.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.8 118.89 58.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.2 127.61 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.652 0.263 . . . . 0.0 111.607 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -115.88 122.65 45.99 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -110.59 127.29 55.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.207 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.7 105.27 14.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.723 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.63 -22.3 28.02 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.99 -121.55 0.72 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.956 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.15 97.97 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 122.869 0.467 . . . . 0.0 109.94 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.05 -5.3 85.02 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.956 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.04 128.55 53.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.562 0.681 . . . . 0.0 109.482 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -134.84 156.03 49.61 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.231 1.015 . . . . 0.0 112.759 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 141.53 52.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.796 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 45' ' ' LEU . 5.1 pt -132.48 133.85 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.263 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -111.36 115.52 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.561 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 35' ' ' ILE . 89.9 mt -113.69 108.92 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.281 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.69 46.74 24.46 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.65 -0.786 . . . . 0.0 114.079 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.99 15.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.082 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.3 129.24 36.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.527 1.163 . . . . 0.0 110.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -107.96 135.95 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.027 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -117.53 125.58 51.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.84 156.21 26.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.064 0.459 . . . . 0.0 111.885 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 26.95 52.81 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.959 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 42' ' ' GLN . 20.5 mt -86.96 148.7 25.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.344 0.572 . . . . 0.0 111.743 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.2 p -89.6 171.73 9.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.183 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.1 mt-10 -66.86 -44.92 79.7 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.234 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 mtp -70.22 -43.43 70.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -59.27 -34.73 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.899 0.38 . . . . 0.0 110.08 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -63.98 -50.48 68.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.824 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -50.71 -52.07 43.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.657 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.84 -47.95 76.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.46 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -57.32 -43.88 83.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 111.618 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mmt180 -66.66 -44.33 82.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.243 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -64.53 -40.02 94.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.99 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -69.94 -38.69 76.26 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.43 -31.33 69.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.9 -28.73 55.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.887 0.312 . . . . 0.0 111.239 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -82.24 -36.82 26.78 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -128.59 112.16 13.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -84.58 -10.07 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -112.45 19.67 17.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.376 0.535 . . . . 0.0 111.952 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 113.36 5.55 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.32 125.51 24.15 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -112.54 128.31 56.31 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 111.737 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' B' ' 67' ' ' LEU . 3.1 pp -132.16 139.27 48.34 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.461 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 15.0 p -127.24 137.89 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 144.62 15.84 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.6 156.61 16.01 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.833 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.51 163.21 24.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.138 0.495 . . . . 0.0 111.276 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -57.47 -31.85 66.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.649 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.01 -6.01 58.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.27 129.72 57.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' VAL . 67.9 Cg_endo -73.31 151.81 49.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.22 1.28 . . . . 0.0 110.426 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -62.94 -39.46 94.7 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.493 -0.754 . . . . 0.0 111.271 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.73 -35.58 66.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.82 -35.96 70.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.204 0.526 . . . . 0.0 109.744 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' PRO . 6.5 t -62.44 -38.82 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.439 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 76' ' ' TYR . 47.7 mm -61.04 -47.6 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -44.74 68.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.16 78.93 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.454 0.645 . . . . 0.0 110.358 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.35 -37.08 79.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.864 0.84 . . . . 0.0 109.353 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -61.32 -42.92 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 47' ' ' GLU . 7.6 mt -63.6 -39.73 95.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 110.657 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.08 -41.97 99.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.85 -41.23 97.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.7 -38.68 78.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.442 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.43 11.02 22.9 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.32 44.13 98.1 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.668 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 C--O 1.239 0.537 0 N-CA-C 115.652 1.366 . . . . 0.0 115.652 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.63 118.67 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -110.98 127.43 68.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 120.698 0.285 . . . . 0.0 111.675 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.8 tt -115.65 122.59 46.03 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -110.6 126.85 54.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.314 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.43 105.3 14.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.788 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.31 28.5 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.88 -124.71 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.778 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -109.04 97.58 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.406 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.33 -5.19 85.05 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.106 -0.569 . . . . 0.0 114.049 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 128.79 54.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -135.15 156.07 49.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.334 1.064 . . . . 0.0 112.804 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.52 141.48 52.06 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.828 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.543 HG23 HD12 ' B' ' 45' ' ' LEU . 5.1 pt -132.31 134.14 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.265 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -111.58 115.72 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.566 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.48 HD11 HD12 ' B' ' 35' ' ' ILE . 93.0 mt -113.98 108.8 26.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.276 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.85 46.47 25.42 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.015 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.91 16.53 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.046 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -90.39 129.27 36.61 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.453 1.127 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -108.37 135.96 48.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.923 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.43 126.14 52.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -116.25 156.21 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.175 0.512 . . . . 0.0 111.864 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.35 51.74 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.065 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' B' ' 42' ' ' GLN . 20.9 mt -87.27 148.89 24.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.281 0.562 . . . . 0.0 111.741 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.5 p -89.51 171.88 9.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.183 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.51 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.05 -44.85 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.508 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.19 -37.99 89.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.101 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 23.6 mtp -70.14 -43.68 70.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.51 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.8 OUTLIER -59.13 -34.65 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -64.27 -50.24 68.7 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.834 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -50.65 -51.94 44.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.02 -48.02 75.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.377 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.12 -44.05 82.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 111.561 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 2.4 mmt180 -66.65 -44.27 82.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.147 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.5 -40.25 95.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.929 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -69.91 -38.26 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.195 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -69.91 -31.3 69.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.6 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.81 -28.98 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 122.213 -0.305 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -82.06 -36.56 27.54 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -128.71 112.39 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -84.66 -10.43 57.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -112.21 19.63 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.322 0.51 . . . . 0.0 111.945 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 113.11 5.17 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.39 125.31 23.46 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -112.3 128.01 56.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 111.672 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 67' ' ' LEU . 3.3 pp -132.21 139.45 48.33 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.344 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.772 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.3 p -127.53 137.91 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.55 145.12 16.42 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.81 156.86 16.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.039 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 163.18 24.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 111.396 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -57.59 -31.82 66.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.485 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.17 -6.37 59.15 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.6 t -83.77 129.43 59.42 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.98 151.57 50.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.545 1.496 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -62.86 -39.62 94.96 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.757 -0.589 . . . . 0.0 111.23 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.42 -35.55 65.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.685 0.279 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -72.07 -35.74 69.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -62.65 -38.85 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.7 mm -60.98 -47.45 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -44.63 68.08 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.982 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.407 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.33 -48.85 80.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 110.459 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.59 -37.2 80.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.789 0.804 . . . . 0.0 109.221 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.19 -42.77 99.17 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.677 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.411 HD11 ' OE1' ' B' ' 47' ' ' GLU . 8.3 mt -63.96 -39.57 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.239 0.542 . . . . 0.0 110.831 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.67 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.32 -41.72 98.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.894 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -63.9 -41.38 97.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.59 -38.69 78.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.366 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.606 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.35 11.0 22.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.37 44.28 97.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.67 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -99.16 -36.16 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.893 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo . . . . . 0 C--O 1.239 0.564 0 N-CA-C 115.094 1.152 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 64' ' ' THR . 47.6 t -113.59 118.07 57.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' A' ' 67' ' ' LEU . 3.3 mp -109.44 127.69 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.141 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.6 tt -113.96 120.35 40.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' N ' HD23 ' A' ' 25' ' ' LEU . 8.8 tt0 -111.12 128.77 56.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.177 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 74' ' ' VAL . 38.8 t -85.29 120.84 36.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.743 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.11 -23.12 14.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.37 -121.16 0.65 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.983 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -113.55 100.56 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.98 -0.77 86.64 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.881 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.24 93.93 4.82 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.42 0.61 . . . . 0.0 110.009 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -103.37 156.01 18.06 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.11 0.957 . . . . 0.0 112.717 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -122.92 141.44 51.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.989 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.611 HD11 HD13 ' A' ' 53' ' ' LEU . 8.7 pt -131.06 133.8 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 114.24 27.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.645 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 35' ' ' ILE . 98.3 mt -116.09 110.09 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.883 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.61 42.76 28.0 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.717 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.78 -26.39 18.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.996 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.72 124.93 31.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.184 0.992 . . . . 0.0 110.526 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 130.98 52.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.632 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -119.37 127.12 52.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.69 157.87 25.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.021 0.439 . . . . 0.0 111.901 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.91 27.3 50.74 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.07 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 42' ' ' GLN . 15.4 mt -88.48 150.32 23.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.8 0.81 . . . . 0.0 112.698 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -91.32 171.59 9.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.143 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.4 mt-10 -66.49 -45.02 80.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.789 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -63.53 -39.28 94.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 mtm -69.92 -44.6 69.32 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.171 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -58.87 -33.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 m -63.89 -50.68 67.79 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.628 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -49.8 -53.23 26.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.659 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 35' ' ' ILE . 27.8 mt -64.78 -48.1 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.477 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 t -58.14 -43.12 87.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 111.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -44.1 84.62 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.499 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.66 -39.96 94.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -37.81 76.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.898 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.49 -31.15 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.641 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.01 -28.17 54.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.811 0.278 . . . . 0.0 111.249 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -83.27 -37.77 23.05 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.03 101.79 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -76.9 -1.54 29.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -121.38 19.76 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.164 0.438 . . . . 0.0 111.913 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.589 ' CG2' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.54 118.23 12.15 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.486 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -64.36 127.32 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -114.36 131.53 56.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 111.515 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.921 HD11 HG23 ' A' ' 24' ' ' ILE . 3.0 pp -135.55 141.3 45.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.023 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 83' ' ' LEU . 86.9 t -122.39 127.36 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.4 142.48 13.99 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.47 155.5 16.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.219 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.2 164.81 23.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.042 0.449 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -58.81 -32.79 69.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.51 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -80.72 -6.23 58.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 27' ' ' VAL . 77.3 t -85.64 136.82 36.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . 98.2 Cg_endo -78.75 152.24 25.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.542 1.495 . . . . 0.0 110.457 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -64.08 -38.51 91.33 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.24 -36.48 66.07 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.664 0.269 . . . . 0.0 110.538 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.09 -34.26 66.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.783 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.2 t -62.28 -39.98 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.4 mm -59.01 -48.81 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.609 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.002 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.22 70.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -60.62 -36.88 79.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.624 0.726 . . . . 0.0 109.255 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.75 -41.97 96.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.81 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 3.4 mt -65.49 -38.57 90.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.487 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.43 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.08 -42.38 99.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.009 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.5 -41.54 98.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.593 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.51 -38.3 77.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.536 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -92.29 11.67 25.06 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.18 44.59 97.24 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 114.869 0.708 . . . . 0.0 114.869 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.2 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 109.877 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo . . . . . 0 C--O 1.239 0.562 0 N-CA-C 115.104 1.155 . . . . 0.0 115.104 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.576 HG23 HG22 ' B' ' 64' ' ' THR . 47.0 t -113.09 117.88 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.938 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.21 127.97 65.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.47 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.7 tt -114.31 120.58 40.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 8.5 tt0 -111.31 128.93 56.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.137 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 74' ' ' VAL . 35.8 t -85.51 120.91 36.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.679 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 -23.18 13.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.13 -125.19 0.88 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.779 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.76 100.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.109 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.76 -0.53 86.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.119 -0.491 . . . . 0.0 114.013 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 94.5 5.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.466 0.633 . . . . 0.0 109.902 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.63 156.01 18.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.219 1.009 . . . . 0.0 112.765 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -122.76 141.91 51.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.038 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 53' ' ' LEU . 8.5 pt -131.28 133.8 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 113.9 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.79 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.536 HD11 HD12 ' B' ' 35' ' ' ILE . 99.0 mt -115.63 110.35 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.926 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.28 42.78 25.59 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.769 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -26.17 19.75 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.899 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.58 124.86 31.21 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.302 1.051 . . . . 0.0 110.561 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 131.01 52.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.644 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -119.36 126.7 52.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.51 158.05 25.22 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.063 0.459 . . . . 0.0 111.9 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 27.23 51.44 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.273 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 42' ' ' GLN . 14.7 mt -88.5 150.59 23.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.822 0.82 . . . . 0.0 112.681 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -91.68 171.5 9.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.1 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.492 ' O ' HG12 ' B' ' 50' ' ' VAL . 24.9 mt-10 -66.19 -45.18 81.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.57 -39.35 94.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.892 0.314 . . . . 0.0 111.325 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mtm -69.84 -44.65 69.46 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.351 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.492 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.67 -33.49 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.8 m -64.21 -50.4 68.2 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.736 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.09 -53.01 30.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.523 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.591 HD13 HD11 ' B' ' 35' ' ' ILE . 22.6 mt -64.98 -47.88 75.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.729 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.41 -43.43 88.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -43.88 87.04 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.581 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -64.81 -40.07 94.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.75 76.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -70.39 -31.17 68.28 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.652 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -28.38 55.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.971 0.35 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -83.07 -37.74 23.45 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.17 101.22 6.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -76.23 -1.67 27.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -121.48 19.74 11.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.281 0.491 . . . . 0.0 111.824 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.576 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.56 118.0 11.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.421 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.8 127.03 29.55 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 40.0 m-85 -114.22 131.51 56.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.938 HD11 HG23 ' B' ' 24' ' ' ILE . 3.0 pp -135.55 141.4 45.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.264 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 87.0 t -122.53 127.07 74.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.13 142.44 13.96 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.42 155.15 16.27 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.117 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.02 165.2 23.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.968 0.414 . . . . 0.0 111.229 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -59.42 -32.21 69.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.429 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -80.94 -6.93 59.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 27' ' ' VAL . 72.4 t -85.07 136.58 38.17 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.454 ' O ' HG23 ' B' ' 79' ' ' VAL . 96.1 Cg_endo -78.55 151.98 25.88 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.773 1.649 . . . . 0.0 110.385 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.5 t80 -63.88 -38.43 91.07 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.43 -0.794 . . . . 0.0 111.108 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -55.31 -36.5 66.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.68 0.276 . . . . 0.0 110.425 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.01 -34.31 66.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 109.868 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' B' ' 75' ' ' PRO . 20.1 t -62.59 -39.1 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.6 mm -60.08 -48.26 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.507 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -53.68 -43.01 68.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.076 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -51.07 71.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 110.884 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 83' ' ' LEU . 8.5 mt -60.55 -37.51 81.48 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.702 0.763 . . . . 0.0 109.116 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.798 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.6 mt -65.49 -38.46 89.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.559 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.436 HD13 HD13 ' B' ' 91' ' ' ILE . 1.2 mm? -63.27 -42.21 99.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.094 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.68 -41.63 98.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.424 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.38 -38.37 77.15 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.429 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -92.07 11.49 25.18 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.37 44.8 97.2 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -102.95 -35.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.986 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 C--O 1.239 0.562 0 N-CA-C 115.933 1.474 . . . . 0.0 115.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 HG22 ' A' ' 64' ' ' THR . 48.9 t -113.71 119.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.9 127.65 68.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.291 -178.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.481 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -114.73 121.23 42.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.17 127.18 53.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.286 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.17 118.7 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.69 -23.06 15.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.95 -120.27 0.65 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.01 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.525 HD13 ' HG2' ' A' ' 78' ' ' GLU . 28.4 mm -112.26 99.3 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 123.061 0.544 . . . . 0.0 109.793 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.75 -3.91 85.92 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.239 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 131.22 53.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 117.754 0.777 . . . . 0.0 109.897 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -138.03 157.24 46.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.134 0.969 . . . . 0.0 112.917 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 141.95 51.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.328 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 53' ' ' LEU . 8.2 pt -132.15 134.86 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.502 0.592 . . . . 0.0 112.406 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.28 115.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.488 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 HD12 ' A' ' 35' ' ' ILE . 80.7 mt -114.29 110.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.343 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.66 45.52 24.0 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.446 -0.883 . . . . 0.0 114.076 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -26.5 18.31 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.205 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.59 128.72 36.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.41 1.105 . . . . 0.0 110.356 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.31 135.95 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.007 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.565 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.07 126.86 52.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.45 156.81 27.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.103 0.477 . . . . 0.0 112.238 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.25 45.71 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.322 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.6 mt -90.27 151.99 21.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.45 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 p -92.58 171.54 8.95 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.187 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.24 -42.31 84.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.081 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -64.32 -39.46 93.96 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.073 0.463 . . . . 0.0 111.142 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.17 -43.9 69.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.288 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -59.31 -34.41 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -64.09 -49.58 71.7 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.62 -51.93 44.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.746 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 35' ' ' ILE . 31.4 mt -64.49 -48.03 76.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.527 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t -58.23 -43.73 87.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.422 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.4 85.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.314 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.47 -41.58 98.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.154 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.99 -38.06 75.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.018 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.22 -30.21 67.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.95 -27.96 49.43 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.186 -0.321 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -82.68 -36.87 25.55 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -131.55 105.68 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.38 -8.03 58.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.69 19.42 18.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.421 0.555 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.532 HG22 HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -68.96 117.84 11.13 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.2 tp -64.29 124.17 21.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.609 ' N ' HD12 ' A' ' 65' ' ' LEU . 56.2 m-85 -112.52 132.81 54.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.958 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.06 140.44 43.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.416 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.3 t -122.99 129.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.25 146.82 18.81 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.79 155.04 17.08 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.939 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.8 163.6 25.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.99 0.424 . . . . 0.0 111.248 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.73 -32.53 65.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.567 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -80.77 -5.56 57.33 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -89.79 131.07 40.66 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.46 155.69 50.37 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.152 1.235 . . . . 0.0 110.339 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.8 t80 -64.21 -34.89 79.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.787 -0.57 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -71.48 -35.75 70.91 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.79 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.57 -39.24 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.1 mm -59.92 -48.88 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.518 0.675 . . . . 0.0 109.415 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.8 ttmm -53.98 -44.6 70.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.51 178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.69 -49.05 79.01 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.353 0.597 . . . . 0.0 111.009 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' B' ' 83' ' ' LEU . 11.4 mt -61.89 -36.0 80.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 108.989 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -61.8 -42.56 99.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.039 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.2 mt -63.87 -38.74 92.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.535 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 91' ' ' ILE . 1.8 mm? -63.81 -42.15 97.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.987 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -62.86 -42.39 99.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.668 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.47 -38.45 74.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.616 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.49 11.02 20.6 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.52 44.22 98.28 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.649 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo . . . . . 0 C--O 1.239 0.552 0 N-CA-C 115.732 1.397 . . . . 0.0 115.732 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.544 HG23 HG22 ' B' ' 64' ' ' THR . 47.4 t -113.51 119.68 61.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.946 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -111.87 127.93 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.316 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.459 HD13 HD21 ' B' ' 86' ' ' LEU . 8.0 tt -115.21 120.93 41.36 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.86 127.4 54.0 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.24 118.96 33.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.14 -22.78 15.05 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.8 -124.18 0.87 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.629 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.531 HD13 ' HG2' ' B' ' 78' ' ' GLU . 29.1 mm -107.8 99.55 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.979 -0.611 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.5 -3.62 86.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 114.391 0.516 . . . . 0.0 114.391 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.53 131.22 53.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.617 0.709 . . . . 0.0 109.698 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -137.86 156.9 47.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.048 0.927 . . . . 0.0 113.007 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.24 51.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.253 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.645 HD12 HD11 ' B' ' 37' ' ' ILE . 8.0 pt -132.32 134.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.499 0.591 . . . . 0.0 112.581 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.82 114.95 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.58 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 HD12 ' B' ' 35' ' ' ILE . 74.6 mt -114.51 109.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.347 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.11 45.17 26.87 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.996 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.26 19.31 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 119.277 -0.735 . . . . 0.0 114.254 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.45 129.02 36.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.46 1.13 . . . . 0.0 110.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.49 135.83 48.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.88 -178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.568 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.17 127.07 52.97 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -117.89 156.69 28.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 112.183 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.45 27.8 46.42 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.33 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' B' ' 42' ' ' GLN . 2.7 mt -90.14 151.98 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.557 0.694 . . . . 0.0 112.495 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.1 p -92.42 171.94 8.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.31 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.448 ' O ' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER -67.67 -41.59 83.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.136 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.1 -39.91 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.897 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.5 mtm -69.82 -43.7 71.5 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.448 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.1 p -59.52 -34.6 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -63.75 -50.08 70.49 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.56 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.667 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.632 HD13 HD11 ' B' ' 35' ' ' ILE . 28.9 mt -64.51 -47.96 76.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.658 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -58.44 -42.9 88.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.421 0.629 . . . . 0.0 111.473 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -43.74 82.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.361 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -63.99 -41.5 97.49 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.877 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.09 -37.69 75.48 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.6 -30.13 66.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.594 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -78.08 -28.03 48.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.833 0.288 . . . . 0.0 111.214 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -82.63 -36.51 26.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -131.74 105.99 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.5 -8.42 59.13 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.41 19.58 18.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.899 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.544 HG22 HG23 ' B' ' 23' ' ' VAL . 0.6 OUTLIER -69.14 117.72 11.13 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.591 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.0 tp -64.34 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.591 ' N ' HD12 ' B' ' 65' ' ' LEU . 56.7 m-85 -112.28 132.97 54.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 111.151 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.946 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.95 140.53 44.06 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.291 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.01 129.46 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.34 146.97 18.96 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.16 155.46 17.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.13 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.94 163.66 25.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.989 0.423 . . . . 0.0 111.259 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -56.98 -32.88 66.54 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.59 -5.62 57.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.54 131.1 41.09 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.36 155.97 50.71 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.197 1.265 . . . . 0.0 110.242 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -64.73 -34.61 78.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.676 -0.64 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.38 -37.4 70.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.531 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.2 OUTLIER -71.17 -35.71 71.73 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.803 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.4 t -61.87 -39.23 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.509 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.9 mm -59.75 -48.87 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.404 0.621 . . . . 0.0 109.41 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.5 ttmm -53.84 -44.94 70.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.492 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.429 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.64 -49.03 79.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.451 0.643 . . . . 0.0 110.929 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.68 -36.0 79.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.741 0.782 . . . . 0.0 109.273 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.75 -42.71 99.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.073 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.0 mt -64.15 -38.47 91.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.111 0.481 . . . . 0.0 110.499 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.632 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -64.06 -42.07 97.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.889 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -62.81 -42.46 99.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.568 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.29 -38.77 74.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.657 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.44 11.23 19.9 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.38 44.46 98.01 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 115.129 0.811 . . . . 0.0 115.129 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.632 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.68 -38.07 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.659 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.479 0.621 0 N-CA-C 114.927 1.087 . . . . 0.0 114.927 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 64' ' ' THR . 45.5 t -106.72 110.09 30.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 67' ' ' LEU . 3.2 mp -107.71 126.64 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.194 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -114.65 120.69 40.98 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -109.93 126.9 54.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.323 -178.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 74' ' ' VAL . 28.8 t -85.14 109.34 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.894 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.78 -22.51 22.1 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -120.71 0.67 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.547 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.14 100.27 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.66 -4.65 84.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.972 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 131.11 54.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.439 0.62 . . . . 0.0 109.354 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -139.79 157.96 44.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.218 1.009 . . . . 0.0 113.077 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.886 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.842 HG23 HD12 ' A' ' 45' ' ' LEU . 4.3 pt -131.35 133.96 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.354 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -112.12 115.12 28.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.571 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -111.99 108.56 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.573 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.77 47.23 18.82 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.956 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.93 -27.0 18.04 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.69 -0.767 . . . . 0.0 114.002 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -90.38 128.4 36.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.464 1.132 . . . . 0.0 110.749 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -106.55 133.0 51.9 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -117.25 128.02 54.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.61 157.38 26.49 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 27.61 52.04 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.934 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 35' ' ' ILE . 9.4 mt -86.94 147.86 25.58 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.213 0.506 . . . . 0.0 112.063 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -91.92 171.99 8.75 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.588 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.8 mt-10 -66.08 -46.16 78.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.065 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.902 0.319 . . . . 0.0 111.283 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.426 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -71.53 -39.22 70.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -62.39 -34.93 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.52 -50.77 68.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.773 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -52.84 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.032 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.08 -47.25 77.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.685 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -59.18 -42.83 91.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.705 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -44.03 85.14 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.236 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -40.63 96.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.43 -28.2 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.673 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.23 -26.44 39.09 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.883 0.31 . . . . 0.0 111.277 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -85.19 -34.93 21.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.777 0.322 . . . . 0.0 110.446 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -132.87 94.78 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.96 -4.01 26.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -114.9 17.25 17.05 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.771 0.714 . . . . 0.0 111.858 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.542 ' CG2' HG23 ' A' ' 23' ' ' VAL . 2.2 m -69.28 126.42 29.73 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.2 tp -69.55 127.08 31.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 23' ' ' VAL . 8.3 m-85 -114.34 131.43 56.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.254 0.549 . . . . 0.0 111.464 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.44 140.34 44.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.662 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.759 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.2 p -126.36 135.35 64.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.22 145.66 17.21 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.45 154.59 16.4 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.986 -0.625 . . . . 0.0 111.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.15 164.07 25.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.113 0.482 . . . . 0.0 111.234 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -31.84 68.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.343 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -80.9 -6.09 58.21 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 27' ' ' VAL . 69.9 t -86.15 132.06 44.6 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.9 152.81 41.77 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.554 1.502 . . . . 0.0 110.172 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.48 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.541 0.61 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -56.21 -35.71 67.62 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.02 -36.56 72.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.03 -39.11 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.813 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.5 mm -61.89 -45.41 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 109.508 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -44.92 80.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.858 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.28 -46.71 87.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.517 0.675 . . . . 0.0 110.737 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' B' ' 83' ' ' LEU . 4.8 mt -61.37 -37.63 84.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.716 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.52 -41.55 94.64 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.838 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -39.2 91.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.432 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.529 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.41 -42.94 98.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.015 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -63.17 -41.94 99.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -37.94 76.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.351 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.99 10.08 28.05 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.21 45.11 97.19 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.6 mt . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 N--CA 1.477 0.55 0 N-CA-C 114.935 1.09 . . . . 0.0 114.935 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' B' ' 64' ' ' THR . 47.5 t -106.82 110.2 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -108.0 126.86 64.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.9 tt -114.5 120.74 41.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.456 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -110.01 127.1 54.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.189 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 31.7 t -85.3 108.85 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.37 -22.55 22.54 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.41 -124.67 0.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.253 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.73 100.99 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.16 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.69 82.64 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.208 -0.52 . . . . 0.0 114.055 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.3 130.83 54.07 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.576 0.688 . . . . 0.0 109.488 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -139.2 158.07 44.82 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.336 1.065 . . . . 0.0 113.219 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.17 142.21 51.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.803 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.862 HG23 HD12 ' B' ' 45' ' ' LEU . 4.2 pt -131.54 133.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.491 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.8 114.7 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.826 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.77 109.0 26.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.517 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.44 47.79 16.8 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.962 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -26.88 17.57 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.272 -0.738 . . . . 0.0 114.197 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -90.5 128.79 36.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.603 1.202 . . . . 0.0 110.473 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -107.04 133.3 51.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.205 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.461 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -117.53 127.94 54.48 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -117.45 157.81 25.59 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.76 52.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.553 -0.748 . . . . 0.0 113.052 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.862 HD12 HG23 ' B' ' 35' ' ' ILE . 9.3 mt -87.07 148.1 25.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 112.029 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.9 p -92.19 171.76 8.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.499 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.502 ' O ' HG12 ' B' ' 50' ' ' VAL . 29.7 mt-10 -66.01 -46.22 78.71 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.023 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.23 -39.13 93.75 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.991 -0.443 . . . . 0.0 111.134 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.421 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -71.37 -39.66 71.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.852 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.502 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -62.31 -34.83 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.53 -50.83 68.02 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.16 -52.97 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.808 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.95 -47.37 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.796 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.64 -43.26 89.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.097 0.475 . . . . 0.0 111.638 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -44.03 85.28 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.312 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.45 95.98 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -70.42 -40.06 74.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.084 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -69.23 -28.12 66.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.25 -26.8 38.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.956 0.344 . . . . 0.0 111.314 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.05 -34.56 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 110.527 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -132.95 94.73 3.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -72.11 -3.85 25.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -114.93 16.79 17.16 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.71 0.686 . . . . 0.0 111.828 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' B' ' 23' ' ' VAL . 2.0 m -68.87 126.45 29.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.386 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 66' ' ' PHE . 11.6 tp -70.28 126.91 31.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.495 ' CE2' HG11 ' B' ' 23' ' ' VAL . 8.4 m-85 -113.68 131.1 56.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.08 140.22 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.776 HG11 HD21 ' B' ' 83' ' ' LEU . 14.8 p -126.25 135.64 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.41 145.57 17.05 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.22 154.36 16.46 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.825 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 164.51 25.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -31.33 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.37 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -81.32 -6.25 58.7 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 70.7 t -85.82 132.06 45.26 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.17 153.0 40.68 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.416 1.411 . . . . 0.0 110.159 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.53 -38.28 90.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.652 0.66 . . . . 0.0 111.084 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.78 -36.14 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.85 -36.58 72.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.92 -39.2 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.681 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 46.2 mm -61.8 -45.75 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.466 0.65 . . . . 0.0 109.604 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.05 78.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.978 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.2 -46.84 87.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 110.682 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' A' ' 83' ' ' LEU . 4.9 mt -61.19 -37.97 84.86 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.758 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.23 -41.56 93.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.808 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -39.17 91.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.53 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.3 -42.94 99.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.059 179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -63.42 -41.82 98.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.99 76.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.34 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.06 10.47 26.63 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 45.12 97.12 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.6 mt -103.1 -38.31 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.931 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 N--CA 1.477 0.504 0 N-CA-C 114.945 1.094 . . . . 0.0 114.945 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.594 HG23 ' CG2' ' A' ' 64' ' ' THR . 66.3 t -116.3 124.89 73.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -116.15 127.98 73.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.606 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HD21 ' A' ' 86' ' ' LEU . 9.2 tt -115.5 125.72 53.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.03 128.84 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.811 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 74' ' ' VAL . 25.9 t -83.01 122.91 38.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.707 -1.133 . . . . 0.0 107.999 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.87 -22.78 14.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.91 -118.84 0.6 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.018 -1.086 . . . . 0.0 113.843 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mm -113.38 95.76 4.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 122.961 0.504 . . . . 0.0 109.722 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.25 -3.25 86.79 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.157 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.01 51.15 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.648 0.724 . . . . 0.0 109.443 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.44 157.92 44.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.155 0.978 . . . . 0.0 112.934 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.87 142.06 51.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.315 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.68 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.1 pt -132.64 135.46 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.04 113.88 26.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 35' ' ' ILE . 55.2 mt -109.93 106.85 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.151 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 49.31 16.62 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.082 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.35 -26.68 18.36 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.982 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.72 127.84 37.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.439 1.12 . . . . 0.0 110.315 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -105.52 136.04 45.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.157 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.14 127.83 53.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -117.84 156.97 27.47 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.14 26.93 54.24 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.087 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD22 ' CE ' ' A' ' 49' ' ' MET . 7.5 mt -87.87 149.95 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 112.412 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -92.0 169.52 10.59 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.09 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.6 pt-20 -65.37 -44.89 86.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.256 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.08 -39.1 93.32 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.119 -0.363 . . . . 0.0 111.279 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.639 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.69 -37.75 70.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.936 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -64.57 -34.05 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -63.27 -49.73 72.95 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.96 -51.63 50.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.769 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.17 -46.8 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.703 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.4 m -59.11 -43.63 91.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.271 0.558 . . . . 0.0 111.532 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -65.61 -44.18 87.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.349 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -63.45 -41.65 98.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.198 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.71 -38.17 76.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.26 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.805 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -77.44 -27.66 52.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 117.959 0.345 . . . . 0.0 111.345 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -35.0 25.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 110.179 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -130.94 99.32 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -72.89 -20.78 61.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.3 20.0 13.33 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.215 0.461 . . . . 0.0 111.775 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.594 ' CG2' HG23 ' A' ' 23' ' ' VAL . 19.4 m -70.34 119.11 14.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.91 126.72 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.37 135.64 53.86 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 24' ' ' ILE . 3.8 pp -138.67 141.28 39.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 83' ' ' LEU . 54.5 t -123.54 128.53 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.02 -178.89 15.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.52 156.54 27.86 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.528 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.73 164.39 23.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.051 0.453 . . . . 0.0 111.38 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.45 -32.49 68.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.48 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.05 -7.13 59.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 27' ' ' VAL . 69.9 t -85.81 130.15 51.76 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.89 155.81 43.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.129 1.219 . . . . 0.0 110.516 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.4 t80 -65.03 -34.46 78.49 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.594 -0.691 . . . . 0.0 110.27 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.43 -36.85 69.45 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -36.92 73.91 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.299 0.571 . . . . 0.0 109.716 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.17 -39.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.758 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.3 mm -59.5 -49.52 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.452 0.644 . . . . 0.0 109.711 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -55.02 -43.6 73.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.378 178.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.44 77.75 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.753 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 7.9 mt -61.12 -35.91 78.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.642 0.734 . . . . 0.0 109.095 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.28 -43.77 98.33 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.887 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.6 mt -64.67 -37.65 88.3 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.3 -41.85 96.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.374 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -63.87 -39.59 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.82 -38.95 79.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.51 11.4 24.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.62 44.68 97.63 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.821 0.688 . . . . 0.0 114.821 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.63 HD13 HD13 ' A' ' 86' ' ' LEU . 4.0 mt . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo . . . . . 0 C--O 1.236 0.405 0 N-CA-C 115.03 1.127 . . . . 0.0 115.03 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' B' ' 64' ' ' THR . 65.9 t -116.4 124.52 72.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -115.76 128.11 73.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.735 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 86' ' ' LEU . 9.4 tt -115.57 125.54 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.88 128.46 55.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.816 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.482 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.1 t -82.74 122.67 37.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.6 -23.08 14.33 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.32 -122.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.75 96.11 4.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.273 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 -3.14 87.08 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.187 -0.53 . . . . 0.0 114.116 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.34 50.67 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.708 0.754 . . . . 0.0 109.494 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.62 157.96 44.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.03 0.919 . . . . 0.0 112.944 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.96 141.66 51.87 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.383 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.678 ' CD1' HD11 ' B' ' 37' ' ' ILE . 6.1 pt -132.45 135.33 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.449 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.95 113.74 26.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD1' ' B' ' 35' ' ' ILE . 55.8 mt -109.94 106.93 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.182 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.18 49.31 19.1 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.96 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -26.57 17.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.01 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -91.36 127.63 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.489 1.144 . . . . 0.0 110.34 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -105.51 135.71 46.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.86 127.47 53.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -117.45 157.02 26.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.84 27.16 54.43 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.178 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' CE ' ' B' ' 49' ' ' MET . 7.5 mt -87.72 150.12 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -92.49 169.92 10.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.128 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.505 ' O ' HG12 ' B' ' 50' ' ' VAL . 5.6 pt-20 -65.46 -44.98 85.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.18 -39.0 93.08 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.916 -0.49 . . . . 0.0 111.283 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.629 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.71 -37.95 70.57 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.913 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -64.37 -34.1 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 45.9 m -63.12 -49.65 73.59 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.815 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.89 -52.11 45.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.62 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.61 -46.95 80.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.789 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 42.4 m -58.9 -43.58 91.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -65.85 -43.78 87.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.359 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -63.86 -41.86 97.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.081 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -69.56 -38.31 77.36 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.34 -30.08 66.94 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.27 -27.82 53.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.881 0.31 . . . . 0.0 111.316 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -34.67 25.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -131.32 98.98 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -72.56 -20.77 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.2 19.97 13.26 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.324 0.511 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.588 ' CG2' HG23 ' B' ' 23' ' ' VAL . 21.5 m -70.43 118.54 13.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.26 126.71 29.59 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.68 135.65 53.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.143 0.497 . . . . 0.0 111.634 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.934 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -138.73 141.65 38.9 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 83' ' ' LEU . 56.0 t -123.73 128.17 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.61 -178.86 15.57 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.04 27.28 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.644 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.63 164.57 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.01 0.433 . . . . 0.0 111.464 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -58.67 -32.49 69.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.419 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.89 -7.57 59.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 27' ' ' VAL . 77.3 t -85.38 129.88 53.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.72 155.68 44.31 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.257 1.305 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -64.88 -34.32 78.12 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.578 -0.701 . . . . 0.0 110.238 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.6 -36.87 69.9 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -36.48 73.19 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.247 0.546 . . . . 0.0 109.595 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.63 -39.38 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.6 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.9 mm -59.58 -49.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.425 0.631 . . . . 0.0 109.685 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 ttmm -55.33 -43.52 75.04 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.324 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.4 77.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.308 0.575 . . . . 0.0 110.757 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 8.6 mt -61.22 -35.82 78.24 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.687 0.755 . . . . 0.0 109.196 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.29 -43.66 98.51 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.966 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.1 mt -64.76 -38.04 89.66 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.061 0.457 . . . . 0.0 110.776 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.613 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.76 -41.71 97.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.489 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -64.22 -39.19 93.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.499 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.25 -38.7 80.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.572 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.58 44.37 98.05 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 114.708 0.643 . . . . 0.0 114.708 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -99.64 -35.01 4.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo . . . . . 0 C--O 1.239 0.572 0 N-CA-C 115.428 1.28 . . . . 0.0 115.428 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.647 HG23 HG22 ' A' ' 64' ' ' THR . 55.7 t -115.32 120.54 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.075 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -111.43 127.9 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.344 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.48 121.13 41.77 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.3 mt-10 -110.15 127.35 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.403 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -84.55 119.67 33.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.126 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.92 -23.26 14.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.67 -122.07 0.72 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.554 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.88 98.78 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 122.812 0.445 . . . . 0.0 109.937 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -3.36 87.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 114.041 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.31 54.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.54 0.67 . . . . 0.0 109.313 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -138.83 156.79 47.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.228 1.013 . . . . 0.0 113.08 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.72 141.87 51.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.895 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -133.71 135.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.514 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.45 117.21 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.959 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' OE2' ' A' ' 57' ' ' GLU . 89.9 mt -115.83 110.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.284 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.93 44.34 31.75 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.133 -1.032 . . . . 0.0 114.087 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.08 -24.88 24.76 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.982 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.5 128.48 36.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.371 1.085 . . . . 0.0 109.959 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -106.81 135.05 49.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.04 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.16 126.08 52.23 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.03 156.65 27.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.11 0.481 . . . . 0.0 111.925 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 26.91 53.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.952 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.4 mt -87.42 149.21 24.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.278 0.561 . . . . 0.0 112.077 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.7 p -90.52 171.53 9.34 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.12 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.9 pt-20 -66.58 -44.26 82.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -63.6 -38.87 92.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.5 mtp -69.89 -43.66 71.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.315 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.58 -34.73 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -63.81 -50.23 69.74 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.685 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.31 -52.49 36.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.747 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.7 mt -64.78 -48.33 74.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.604 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -59.27 -42.68 91.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.209 0.528 . . . . 0.0 111.605 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.74 -44.15 82.26 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.165 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.34 -39.66 94.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.884 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' A' ' 37' ' ' ILE . 8.3 mm-40 -70.82 -38.34 73.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.241 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -69.91 -31.84 69.83 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.32 -27.81 47.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.817 0.281 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -85.1 -35.16 21.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.237 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -130.95 96.98 4.19 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -75.51 -0.8 21.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.91 16.86 13.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.66 0.664 . . . . 0.0 111.841 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.647 HG22 HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -69.55 119.18 13.41 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.235 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.42 125.51 24.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -114.19 133.17 55.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.075 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.74 142.29 44.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.429 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 83' ' ' LEU . 73.1 t -123.43 126.12 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.85 145.7 17.69 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.44 154.53 16.91 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 165.1 25.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.0 110.871 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.01 -32.58 64.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -81.2 -5.63 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -84.74 131.24 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 79' ' ' VAL . 72.7 Cg_endo -75.23 152.78 40.12 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.503 1.469 . . . . 0.0 109.99 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.4 t80 -64.15 -36.94 85.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.855 0.752 . . . . 0.0 110.981 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -56.3 -36.65 68.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.79 -36.25 70.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 75' ' ' PRO . 16.5 t -61.55 -39.0 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.402 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.2 mm -59.53 -50.69 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.386 0.613 . . . . 0.0 109.452 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -44.18 70.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.442 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.37 -48.49 80.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.387 0.613 . . . . 0.0 110.659 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' B' ' 83' ' ' LEU . 10.2 mt -62.23 -36.08 80.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.69 0.757 . . . . 0.0 109.189 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -61.78 -41.9 98.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.812 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.34 -38.71 92.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 HD13 ' A' ' 91' ' ' ILE . 2.7 mm? -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.028 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -63.56 -43.09 98.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.575 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.1 -39.12 74.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.555 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.25 12.79 19.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.6 44.86 95.32 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.583 0.593 . . . . 0.0 114.583 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 89' ' ' ALA . 5.1 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 109.969 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo . . . . . 0 C--O 1.24 0.588 0 N-CA-C 115.544 1.325 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.622 HG23 HG22 ' B' ' 64' ' ' THR . 56.3 t -115.43 120.47 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.049 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.39 127.72 68.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.467 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.15 121.12 42.04 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 3.1 mt-10 -109.94 127.14 54.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.303 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.3 119.67 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.387 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.88 -23.61 14.53 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.15 -125.75 0.94 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.399 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -108.37 98.87 7.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.117 -0.542 . . . . 0.0 110.236 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.37 -3.51 86.99 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 121.123 -0.561 . . . . 0.0 114.088 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 130.52 54.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.552 0.676 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -138.99 157.11 46.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.282 1.039 . . . . 0.0 113.166 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.94 141.96 51.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.863 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.531 HG23 HD12 ' B' ' 45' ' ' LEU . 5.8 pt -133.85 135.14 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.422 0.555 . . . . 0.0 112.438 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.19 117.36 32.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.474 HG21 ' OE2' ' B' ' 57' ' ' GLU . 91.4 mt -116.27 110.54 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.086 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.62 44.59 29.88 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.213 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.99 -24.97 24.17 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.026 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.34 128.41 36.44 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.414 1.107 . . . . 0.0 110.108 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -106.73 134.56 49.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.022 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -116.73 125.77 52.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -116.55 156.8 26.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.097 0.475 . . . . 0.0 112.127 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.22 26.79 54.32 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.042 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' B' ' 42' ' ' GLN . 10.9 mt -87.4 149.61 24.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.261 0.553 . . . . 0.0 111.997 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -90.69 171.61 9.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.064 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.0 pt-20 -67.0 -44.13 81.13 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.52 -39.06 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.145 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.7 mtp -69.95 -43.46 71.52 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.68 -34.58 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 -50.18 69.54 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.532 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -50.19 -52.59 34.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.732 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.69 -48.73 73.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.573 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -58.95 -42.43 89.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 111.71 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -67.1 -44.09 80.86 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.072 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -64.24 -39.87 94.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.474 ' OE2' HG21 ' B' ' 37' ' ' ILE . 8.3 mm-40 -70.61 -38.64 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.67 -31.7 69.9 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.56 -27.61 45.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.9 0.318 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -85.16 -35.14 21.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -130.88 97.24 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -75.73 -0.79 22.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -118.83 16.39 13.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.703 0.683 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.622 HG22 HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -69.15 119.26 13.16 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.56 125.12 23.2 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -113.76 133.49 55.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 111.416 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.049 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -136.02 142.45 44.46 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' B' ' 83' ' ' LEU . 73.8 t -123.41 126.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.02 145.55 17.51 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.51 154.58 16.94 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.634 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 165.58 24.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.65 -32.39 65.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.524 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.06 -6.12 58.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.41 130.9 52.05 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.417 ' O ' HG23 ' B' ' 79' ' ' VAL . 71.8 Cg_endo -75.13 152.54 40.29 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.571 1.514 . . . . 0.0 110.003 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.1 t80 -63.92 -37.05 85.98 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.649 -0.657 . . . . 0.0 110.983 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -56.41 -36.27 68.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.0 -36.06 69.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.184 0.516 . . . . 0.0 109.637 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 75' ' ' PRO . 16.9 t -61.71 -39.18 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.488 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -59.42 -50.56 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.319 0.58 . . . . 0.0 109.469 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.19 -43.89 71.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.439 178.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.57 -48.85 79.53 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.456 0.646 . . . . 0.0 110.494 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.74 -36.16 80.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.191 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.83 -41.7 98.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.938 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -64.51 -38.56 91.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 110.439 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.428 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -64.1 -41.72 97.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -63.48 -42.98 98.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -57.37 -38.72 74.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.514 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.537 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.48 12.55 20.37 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.93 44.81 95.88 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.2 mt -106.26 -44.92 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.303 0.573 . . . . 0.0 109.682 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.963 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 C--O 1.241 0.633 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 66' ' ' PHE . 39.7 t -113.33 120.23 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.068 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -112.84 129.01 69.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.491 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.9 tt -117.58 124.9 49.79 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HD23 ' A' ' 25' ' ' LEU . 9.2 tt0 -112.91 129.62 56.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.521 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.94 109.62 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.729 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -89.38 -23.3 22.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.34 -119.39 0.62 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.45 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 mm -112.28 95.22 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.6 89.5 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.202 -0.523 . . . . 0.0 114.158 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -106.89 91.95 3.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.698 0.749 . . . . 0.0 110.061 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.34 154.32 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.184 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.36 143.61 50.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.417 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 37' ' ' ILE . 7.4 pt -133.86 135.85 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -112.85 115.97 29.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.312 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.811 HD11 HD12 ' A' ' 35' ' ' ILE . 59.6 mt -116.49 111.68 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.891 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.02 44.63 32.65 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.142 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.11 -23.87 27.45 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.859 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.57 126.54 35.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.348 1.074 . . . . 0.0 109.869 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 133.43 49.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.588 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.99 123.85 49.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.84 149.49 30.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.54 78.54 0.65 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mt -137.78 148.06 45.2 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.282 0.563 . . . . 0.0 111.629 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 p -89.64 169.33 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.513 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.3 pt-20 -67.98 -41.12 82.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.945 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.86 -38.72 91.91 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.143 -0.348 . . . . 0.0 110.95 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mtp -69.81 -45.06 68.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.75 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -57.46 -35.76 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.889 0.376 . . . . 0.0 110.233 179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -63.77 -49.99 70.8 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.853 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -53.08 27.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 35' ' ' ILE . 3.7 mt -65.21 -48.38 73.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.558 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -58.63 -43.03 89.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.577 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.68 -43.82 83.45 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.229 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -63.51 -41.42 98.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.877 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -37.73 76.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -70.83 -29.94 66.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.477 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.88 -27.62 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.844 0.293 . . . . 0.0 110.867 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -82.12 -38.25 25.07 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -129.2 110.46 12.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -82.51 7.29 14.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -127.09 20.32 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.145 0.43 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 113.23 5.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -61.36 123.54 18.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 23' ' ' VAL . 43.6 m-85 -114.26 133.09 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.068 HD11 HG23 ' A' ' 24' ' ' ILE . 2.1 pp -132.96 141.42 48.32 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.258 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 83' ' ' LEU . 53.4 t -123.55 124.79 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.42 142.3 13.57 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.9 154.99 16.23 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.687 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.88 163.38 24.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.357 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -31.44 69.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.98 -6.61 58.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.1 t -89.93 135.34 30.39 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.42 154.99 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.021 1.147 . . . . 0.0 110.373 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.767 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -63.79 -35.5 80.81 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.399 -0.813 . . . . 0.0 110.48 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.36 -36.75 66.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.415 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -34.53 67.27 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.835 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.41 -38.98 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 50.3 mm -59.19 -49.48 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.0 mttp -53.31 -44.35 68.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.283 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -51.95 67.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' B' ' 83' ' ' LEU . 9.9 mt -60.24 -36.73 78.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -62.24 -41.53 98.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.541 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 6.9 mt -64.13 -39.25 93.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.115 0.483 . . . . 0.0 110.675 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.87 -41.8 97.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.12 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.35 -41.18 98.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.359 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.26 -38.37 76.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.31 10.61 24.19 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.22 44.69 97.79 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.587 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo . . . . . 0 C--O 1.239 0.56 0 N-CA-C 115.258 1.215 . . . . 0.0 115.258 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' B' ' 66' ' ' PHE . 40.0 t -113.5 120.09 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 129.3 68.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.392 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.451 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -117.64 124.97 49.87 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.43 ' N ' HD23 ' B' ' 25' ' ' LEU . 9.8 tt0 -113.09 129.36 56.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.63 109.38 18.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.664 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -89.14 -23.52 22.44 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.72 -123.53 0.84 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.24 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.25 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.17 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.97 0.46 89.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.085 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -106.79 92.12 3.96 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.705 0.752 . . . . 0.0 110.156 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.13 154.26 18.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.265 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.18 143.86 50.73 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 37' ' ' ILE . 7.3 pt -133.8 135.86 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.3 t -112.93 116.11 29.47 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.291 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.808 HD11 HD12 ' B' ' 35' ' ' ILE . 61.1 mt -116.71 111.42 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.957 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.23 44.49 34.45 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.12 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.15 -23.71 28.29 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.781 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.64 126.61 35.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.334 1.067 . . . . 0.0 109.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 133.69 49.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.483 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.23 123.97 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -110.94 149.41 30.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.51 78.97 0.63 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.11 148.33 44.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.453 0.644 . . . . 0.0 111.475 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.6 p -89.9 169.39 11.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.499 ' O ' HG12 ' B' ' 50' ' ' VAL . 8.4 pt-20 -68.0 -41.39 82.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.39 -38.83 92.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 33.7 mtp -69.88 -44.97 68.68 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.831 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.5 OUTLIER -57.62 -35.43 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.916 0.388 . . . . 0.0 110.143 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 26.6 m -64.1 -49.69 71.23 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.045 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -53.32 27.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.646 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.487 HD13 ' CD1' ' B' ' 35' ' ' ILE . 4.3 mt -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.439 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.48 -43.59 89.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.11 0.481 . . . . 0.0 111.53 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.38 -43.52 85.69 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.02 -40.71 96.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 -37.91 75.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.66 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -70.55 -29.93 66.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.747 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.03 -27.98 54.74 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.234 -0.291 . . . . 0.0 110.868 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.99 -37.93 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -129.61 110.19 11.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.07 6.98 14.58 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -127.07 20.45 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.22 0.464 . . . . 0.0 111.895 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.89 113.66 5.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.461 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.66 123.48 18.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.403 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 44.9 m-85 -114.05 133.09 55.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.546 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 2.1 pp -133.02 141.33 48.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.144 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.611 HG11 HD23 ' B' ' 83' ' ' LEU . 54.8 t -123.46 124.61 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.44 141.95 13.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.33 155.51 16.06 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 163.87 23.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 111.259 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -31.25 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.335 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -81.17 -6.81 59.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.79 135.01 31.01 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.27 155.27 41.69 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.071 1.181 . . . . 0.0 110.153 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.5 t80 -64.02 -35.52 80.99 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.467 -0.771 . . . . 0.0 110.377 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.42 -37.12 67.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.94 -35.18 69.54 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.067 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -61.84 -39.22 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.349 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.3 mm -59.04 -48.91 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.485 0.659 . . . . 0.0 109.42 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 13.1 mttp -53.85 -44.2 70.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.401 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.11 -51.68 68.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.292 0.568 . . . . 0.0 110.96 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 83' ' ' LEU . 9.9 mt -60.56 -36.55 78.73 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.781 0.801 . . . . 0.0 109.196 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.37 -41.6 98.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.62 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.7 mt -64.02 -38.92 92.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.666 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.6 HD13 HD13 ' B' ' 91' ' ' ILE . 1.3 mm? -63.93 -41.99 97.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -63.48 -40.95 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.581 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.36 -38.67 77.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.32 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.22 10.64 23.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.6 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.23 -35.25 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 C--O 1.238 0.523 0 N-CA-C 115.725 1.394 . . . . 0.0 115.725 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.8 t -113.75 122.18 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -112.48 127.95 69.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.439 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.7 tt -115.08 121.85 44.32 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 8.4 mt-10 -110.11 126.46 54.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.323 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.7 119.71 34.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.56 -22.75 15.33 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.54 -117.84 0.56 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.842 -1.171 . . . . 0.0 114.009 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.36 101.11 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 109.788 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.14 82.46 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.702 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 129.52 53.99 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.553 0.676 . . . . 0.0 109.384 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -138.13 156.11 48.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.79 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -125.77 144.12 50.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.195 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 53' ' ' LEU . 8.4 pt -133.72 135.72 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.853 0.752 . . . . 0.0 113.027 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -113.19 116.87 30.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 35' ' ' ILE . 89.4 mt -116.35 111.64 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.814 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.7 46.18 30.78 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.357 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.73 -25.24 19.98 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.662 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.6 127.34 35.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.126 0.963 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 134.57 48.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.472 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -114.87 123.35 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -110.4 148.48 31.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 78.81 0.69 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mt -136.96 148.66 47.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.139 0.495 . . . . 0.0 111.127 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 p -91.26 171.3 9.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.638 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.06 -42.13 80.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.44 -38.8 92.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.004 0.431 . . . . 0.0 110.711 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -70.04 -46.61 64.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.349 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.09 -35.63 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.775 0.321 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -64.12 -49.34 72.55 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.76 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.51 -52.49 38.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.706 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 35' ' ' ILE . 15.6 mt -64.94 -47.69 76.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.624 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -58.93 -43.31 91.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.117 0.484 . . . . 0.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.49 -44.09 83.59 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.363 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -63.46 -40.58 97.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.913 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.75 -38.88 76.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.196 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -69.66 -30.65 68.38 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -78.14 -28.08 48.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.859 0.299 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -84.36 -34.94 23.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.92 0.391 . . . . 0.0 110.018 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -130.19 95.68 3.98 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -68.9 -7.87 38.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -113.78 19.46 16.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.547 0.612 . . . . 0.0 112.096 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 4.0 m -69.04 117.0 10.14 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 125.24 23.59 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -114.37 133.88 55.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.27 141.99 43.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 83' ' ' LEU . 79.6 t -123.57 129.13 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.23 146.57 18.38 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.47 16.76 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.925 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.09 165.18 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.469 . . . . 0.0 110.999 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -57.11 -32.64 66.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.341 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.23 -5.84 58.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.81 135.21 30.73 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.39 156.92 29.17 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.131 1.221 . . . . 0.0 110.631 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.759 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -65.15 -33.88 77.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.614 -0.679 . . . . 0.0 110.506 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -57.07 -37.55 72.02 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.256 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.52 70.77 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.85 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -62.66 -39.02 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.323 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.4 mm -59.32 -48.91 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 109.591 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.67 -44.8 69.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.385 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.05 -49.64 76.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.327 0.584 . . . . 0.0 110.99 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -62.38 -36.58 82.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.545 0.688 . . . . 0.0 109.234 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.7 -43.28 97.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.814 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 8.8 mt -65.29 -38.06 89.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 110.706 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -63.77 -42.04 97.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.149 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -62.93 -41.98 99.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.47 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.66 -38.58 78.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.68 10.97 23.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.77 97.62 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.8 mt . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 C--O 1.24 0.607 0 N-CA-C 115.736 1.399 . . . . 0.0 115.736 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.546 HG23 ' CG2' ' B' ' 64' ' ' THR . 56.8 t -113.65 122.31 67.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.006 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -112.83 127.99 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.312 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.492 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -115.2 121.83 44.16 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 8.7 mt-10 -109.96 126.44 53.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.362 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.54 119.7 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.76 -22.32 15.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.33 -122.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.717 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -108.12 101.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.04 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.26 80.29 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.897 -0.592 . . . . 0.0 114.017 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 129.57 53.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 117.426 0.613 . . . . 0.0 109.429 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.16 156.09 48.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.599 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.62 144.18 50.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.164 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.561 HD11 HD13 ' B' ' 53' ' ' LEU . 8.4 pt -133.69 135.8 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -113.46 116.93 30.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.052 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.538 HD11 HD12 ' B' ' 35' ' ' ILE . 91.3 mt -116.43 111.53 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.99 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.68 46.08 30.69 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.251 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.82 -25.17 20.6 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.669 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.54 126.97 35.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.242 1.021 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 134.73 48.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.457 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.417 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.96 123.11 48.28 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.14 148.47 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 78.71 0.71 Allowed Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' B' ' 42' ' ' GLN . 4.1 mt -137.03 148.32 46.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.081 0.467 . . . . 0.0 111.149 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -90.99 171.43 9.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.65 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.427 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.1 pt-20 -67.86 -42.17 81.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.874 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.55 -39.01 92.96 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.078 -0.389 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mtm -69.99 -46.55 64.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.09 -36.08 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 51.6 m -63.72 -49.42 73.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.764 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.58 -52.03 42.94 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.738 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.561 HD13 HD11 ' B' ' 35' ' ' ILE . 15.2 mt -65.28 -47.67 75.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.631 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -59.13 -43.04 91.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 111.518 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -66.65 -43.96 83.19 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.343 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.56 -40.52 97.19 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.76 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -38.66 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -69.79 -30.93 68.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -78.27 -28.05 47.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.852 0.296 . . . . 0.0 111.459 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -84.42 -34.94 23.41 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -130.12 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -69.18 -7.6 37.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -113.96 19.28 16.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.565 0.62 . . . . 0.0 111.958 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.546 ' CG2' HG23 ' B' ' 23' ' ' VAL . 3.9 m -68.87 116.86 9.84 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.58 125.16 23.34 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -114.39 134.04 55.27 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.974 0.416 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.006 HD11 HG23 ' B' ' 24' ' ' ILE . 3.3 pp -136.57 141.73 43.33 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.409 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.518 HG11 ' CD2' ' B' ' 83' ' ' LEU . 78.8 t -123.31 129.62 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.49 18.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.05 154.47 16.78 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.03 165.37 24.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 0.0 111.061 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -57.25 -32.76 66.9 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.361 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.0 -6.38 58.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.18 135.49 31.39 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.9 156.82 27.19 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.227 1.285 . . . . 0.0 110.558 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -65.06 -33.89 77.13 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.792 -0.567 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.27 -37.59 72.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.53 70.78 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.882 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.4 t -62.66 -38.93 82.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -59.52 -48.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.334 0.588 . . . . 0.0 109.602 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -44.76 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.277 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.15 -49.38 77.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.321 0.581 . . . . 0.0 111.039 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -62.66 -36.29 82.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.58 0.705 . . . . 0.0 109.34 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -60.83 -43.55 98.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.871 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.02 -38.14 89.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 110.598 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -63.65 -41.91 98.18 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.195 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -63.08 -41.97 99.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -58.62 -38.46 78.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.399 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.57 10.75 24.25 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.23 44.71 97.75 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.9 mt -101.34 -36.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.854 -179.651 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo . . . . . 0 C--O 1.239 0.555 0 N-CA-C 115.405 1.271 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 66' ' ' PHE . 22.1 t -110.67 120.7 62.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -114.3 128.97 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -115.75 122.48 45.62 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.39 128.28 56.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.13 119.16 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.2 -22.16 15.77 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -119.85 0.64 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.945 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -112.84 100.64 11.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -2.84 83.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.755 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.14 53.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.539 0.669 . . . . 0.0 109.301 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -137.15 156.37 48.43 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.068 0.937 . . . . 0.0 112.576 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.23 142.34 51.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.138 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.558 HG23 HD12 ' A' ' 45' ' ' LEU . 5.8 pt -131.6 134.89 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.459 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.97 113.89 26.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.545 0.688 . . . . 0.0 110.263 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.15 110.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.422 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 42.94 49.37 6.23 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.298 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.12 -37.35 3.44 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.799 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.4 119.12 14.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.846 0.323 . . . . 0.0 111.113 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -105.37 128.39 53.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.85 126.57 52.64 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.86 157.25 26.99 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 25.58 56.49 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.176 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 42' ' ' GLN . 12.7 mt -86.98 149.97 24.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.307 0.575 . . . . 0.0 111.929 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.75 171.7 8.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.269 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.1 pt-20 -67.68 -42.91 81.34 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.143 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.09 -39.22 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -69.76 -45.9 67.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.395 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 35' ' ' ILE . 2.0 p -58.51 -34.85 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 m -62.95 -50.22 71.64 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.27 -52.76 33.64 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.828 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.94 -47.84 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.7 m -59.52 -42.67 92.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -66.2 -44.78 82.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.32 99.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.47 -39.8 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -69.91 -29.8 67.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.65 -28.44 45.42 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.723 0.238 . . . . 0.0 111.515 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -83.57 -35.76 24.49 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.08 106.21 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.7 6.21 13.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -125.53 17.97 8.15 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.613 0.642 . . . . 0.0 111.908 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.08 114.57 5.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.863 -0.153 . . . . 0.0 111.212 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.45 122.67 14.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 23' ' ' VAL . 12.9 m-85 -113.34 134.39 54.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.072 0.463 . . . . 0.0 111.294 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -138.15 141.34 40.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.405 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 96.7 t -122.99 127.67 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.12 146.79 18.78 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.5 155.0 16.96 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.021 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.51 164.5 24.66 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 120.922 0.391 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -56.97 -33.24 66.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.512 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.25 -5.64 56.54 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.69 134.58 31.99 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 79' ' ' VAL . 73.8 Cg_endo -77.26 156.72 33.33 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.28 1.32 . . . . 0.0 110.006 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.705 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.4 t80 -64.86 -35.62 81.73 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.666 -0.646 . . . . 0.0 110.683 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.57 -37.36 70.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.712 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.9 t -62.54 -39.28 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.442 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.705 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.7 mm -60.17 -47.4 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.26 178.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.2 -48.92 79.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.589 . . . . 0.0 110.863 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' B' ' 83' ' ' LEU . 10.0 mt -60.56 -37.1 80.18 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.527 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -61.23 -41.67 97.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.975 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.8 mt -66.12 -38.31 87.87 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 110.553 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 25' ' ' LEU . 1.2 mm? -63.89 -42.12 97.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -63.15 -43.3 98.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.12 -38.77 73.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.3 12.16 19.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.42 44.87 96.31 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 4.4 mt . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo . . . . . 0 C--O 1.241 0.63 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' B' ' 66' ' ' PHE . 21.9 t -110.54 120.72 61.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.999 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -114.25 128.58 71.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.573 HD13 HD21 ' B' ' 86' ' ' LEU . 7.9 tt -115.5 122.64 46.32 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -112.45 128.07 56.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.709 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.72 119.22 33.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.64 -21.88 15.66 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.75 -124.17 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.565 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.78 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.27 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -2.8 82.28 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.01 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.18 53.76 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.18 156.59 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.128 0.966 . . . . 0.0 112.592 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.46 142.4 51.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.117 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.571 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -131.95 134.91 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.345 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.2 114.21 26.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.601 0.715 . . . . 0.0 110.119 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.32 110.17 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.458 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 42.71 49.71 5.96 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.24 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -37.37 3.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.863 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.13 118.58 13.14 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.855 0.328 . . . . 0.0 111.158 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -104.72 128.84 52.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.573 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.41 126.58 52.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.9 157.45 26.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 25.38 57.1 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.118 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 42' ' ' GLN . 13.0 mt -86.84 149.92 24.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.382 0.591 . . . . 0.0 112.078 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.68 171.53 9.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.504 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.423 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 pt-20 -67.52 -42.82 82.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.34 -39.47 92.43 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 34.5 mtp -69.42 -45.83 68.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.472 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.447 HG23 HG21 ' B' ' 35' ' ' ILE . 2.0 p -58.74 -34.39 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 110.166 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -63.23 -50.12 71.47 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.922 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.55 -52.78 35.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -64.86 -47.5 77.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.331 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -60.01 -42.42 94.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.145 0.498 . . . . 0.0 111.614 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.26 -44.72 82.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.243 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.03 99.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.908 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -70.03 -39.51 75.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.102 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -70.0 -29.75 66.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.665 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.69 -28.79 45.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.754 0.252 . . . . 0.0 111.535 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.16 -35.73 25.29 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.04 106.06 8.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.46 6.06 13.39 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -125.37 17.85 8.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.622 0.646 . . . . 0.0 111.918 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.402 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -67.09 114.84 6.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.893 -0.14 . . . . 0.0 111.22 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tp -59.64 122.89 15.24 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' B' ' 23' ' ' VAL . 13.3 m-85 -113.58 133.94 54.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.173 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.999 HD11 HG23 ' B' ' 24' ' ' ILE . 3.6 pp -137.9 141.34 40.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.417 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.498 ' HB ' HD21 ' B' ' 83' ' ' LEU . 98.6 t -123.2 127.91 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.05 146.71 18.7 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.13 154.97 16.8 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 121.127 -0.558 . . . . 0.0 111.959 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.44 165.25 23.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -57.95 -32.88 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.513 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.2 -6.18 57.36 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -89.35 134.53 32.64 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.402 ' O ' HG23 ' B' ' 79' ' ' VAL . 70.0 Cg_endo -77.47 156.83 32.6 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.201 1.268 . . . . 0.0 110.256 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.3 t80 -64.85 -35.92 82.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.713 -0.617 . . . . 0.0 110.592 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -56.46 -37.36 70.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -35.61 73.34 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.772 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 75' ' ' PRO . 18.6 t -62.31 -39.26 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.596 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.21 -47.08 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.408 0.623 . . . . 0.0 109.469 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.2 OUTLIER -54.59 -44.93 73.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.276 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.451 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.48 -48.79 80.31 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.322 0.582 . . . . 0.0 110.809 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 83' ' ' LEU . 10.0 mt -60.8 -36.76 79.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.392 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -61.33 -41.92 97.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.039 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.7 mt -65.77 -38.58 89.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.573 HD21 HD13 ' B' ' 25' ' ' LEU . 1.2 mm? -63.69 -42.15 98.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.2 -43.35 98.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.437 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -39.1 74.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.707 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 12.02 18.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.65 44.75 96.6 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 4.3 mt -103.03 -35.77 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.499 . . . . 0.0 109.943 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.051 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.479 0.635 0 N-CA-C 114.542 0.939 . . . . 0.0 114.542 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.0 118.11 52.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.8 128.27 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.71 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -114.3 121.42 43.61 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.4 tm-20 -110.46 127.14 55.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.29 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.85 123.43 39.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.457 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.52 -22.49 13.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.3 -120.75 0.68 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.64 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.44 95.97 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.762 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.87 -3.52 85.94 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.949 -0.569 . . . . 0.0 114.406 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 132.28 52.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.488 0.644 . . . . 0.0 109.375 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -139.93 158.03 44.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.172 0.986 . . . . 0.0 112.985 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -125.64 141.85 51.81 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.748 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 45' ' ' LEU . 4.5 pt -134.19 135.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.704 0.684 . . . . 0.0 112.706 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.35 115.52 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.694 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.89 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.245 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.45 48.31 16.58 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.848 -0.691 . . . . 0.0 114.215 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.29 -25.83 22.41 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.814 -0.708 . . . . 0.0 114.135 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.72 129.63 38.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.501 1.15 . . . . 0.0 110.501 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.1 135.69 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.11 127.96 54.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -118.13 156.09 29.3 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.94 26.88 47.79 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.304 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.7 mt -88.46 150.15 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.344 0.572 . . . . 0.0 112.303 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.3 p -91.72 170.6 9.77 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.545 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' O ' HG12 ' A' ' 50' ' ' VAL . 13.7 pt-20 -65.02 -47.25 78.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.9 -38.75 92.17 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.133 -0.355 . . . . 0.0 111.38 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.3 ttp -71.57 -39.04 70.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.668 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -62.78 -32.8 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 m -63.79 -50.21 69.88 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.539 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.11 -52.3 36.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.88 -48.08 75.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.462 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.6 m -58.65 -42.56 88.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.086 0.469 . . . . 0.0 111.548 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 9.2 mmm180 -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.284 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.72 -40.98 98.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.912 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.64 -38.4 80.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.598 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -70.82 -30.89 67.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.849 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.15 -28.09 54.05 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -83.65 -33.82 25.17 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.296 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -129.65 109.12 10.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.97 5.26 19.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -125.91 17.45 7.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.458 0.572 . . . . 0.0 111.893 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.05 113.94 5.43 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.083 0.153 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 66' ' ' PHE . 3.3 tp -61.38 123.05 16.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.557 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.9 m-85 -111.11 130.39 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.393 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -137.63 141.24 41.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.325 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 83' ' ' LEU . 69.2 t -123.83 131.3 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.73 146.88 18.75 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.34 152.85 16.74 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.9 165.15 25.07 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -33.06 67.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.398 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -81.54 -5.82 58.37 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.6 t -89.77 131.56 39.27 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.95 155.47 53.02 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.337 1.358 . . . . 0.0 110.403 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.2 t80 -65.11 -34.24 77.93 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.493 -0.754 . . . . 0.0 110.577 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.74 -37.1 70.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.72 0.295 . . . . 0.0 110.254 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -36.08 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.847 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.26 -39.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.573 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.7 mm -60.39 -46.96 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.503 0.668 . . . . 0.0 109.436 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.63 -45.5 70.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.312 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.12 78.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.346 0.593 . . . . 0.0 111.19 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' B' ' 83' ' ' LEU . 7.7 mt -61.57 -36.78 81.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.6 0.714 . . . . 0.0 109.505 177.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -60.84 -42.95 98.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.904 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.37 -38.95 91.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.059 0.457 . . . . 0.0 110.58 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.517 HD13 HD13 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.38 -41.89 98.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.159 179.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -63.17 -43.68 97.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.9 -38.5 72.9 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.76 12.08 20.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.2 44.71 97.14 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.0 mt . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo . . . . . 0 N--CA 1.477 0.533 0 N-CA-C 114.668 0.988 . . . . 0.0 114.668 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.83 117.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.78 128.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.788 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -114.6 121.45 43.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 9.4 tm-20 -110.42 127.09 54.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.437 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 123.11 38.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.484 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.29 -22.46 13.7 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.85 -124.37 0.89 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.712 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -107.66 95.99 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 114.916 -0.642 . . . . 0.0 110.202 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -3.25 86.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.133 -0.556 . . . . 0.0 114.375 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 132.31 52.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.547 0.674 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -139.69 158.12 44.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.2 1.0 . . . . 0.0 113.042 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.07 141.77 51.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.682 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 45' ' ' LEU . 4.9 pt -134.33 136.51 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.536 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 115.23 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.565 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.76 108.7 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.381 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.41 47.98 16.53 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.037 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.45 20.14 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -92.34 129.61 38.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.456 1.128 . . . . 0.0 110.498 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.01 136.01 47.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.87 127.33 53.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -117.89 156.36 28.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 112.418 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.76 26.83 48.77 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.428 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' B' ' 42' ' ' GLN . 11.9 mt -88.44 150.23 23.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.465 0.65 . . . . 0.0 112.206 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 16.9 p -91.72 170.03 10.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.529 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.562 ' O ' HG12 ' B' ' 50' ' ' VAL . 13.7 pt-20 -64.68 -47.25 79.07 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.273 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.96 -38.8 92.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.1 ttp -71.6 -39.08 70.76 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.614 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.562 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -62.61 -33.19 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 m -63.59 -49.89 71.57 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.638 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.67 -51.66 47.19 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.823 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.26 -48.09 74.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -58.4 -43.16 88.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.705 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.401 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 9.3 mmm180 -66.19 -44.16 84.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.296 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.03 -40.8 97.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -68.57 -38.81 81.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.356 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.54 -31.09 68.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -77.07 -27.8 54.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.833 0.288 . . . . 0.0 111.528 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -84.05 -33.68 24.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -129.81 108.85 10.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -81.69 5.18 19.17 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.17 17.98 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.248 0.476 . . . . 0.0 111.939 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.42 113.64 5.46 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.135 0.174 . . . . 0.0 111.221 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.54 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.3 tp -61.12 122.8 15.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.54 ' N ' HD12 ' B' ' 65' ' ' LEU . 32.5 m-85 -110.9 130.89 55.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.237 0.542 . . . . 0.0 111.47 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.918 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -138.16 141.26 40.09 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.098 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.416 HG11 HD23 ' B' ' 83' ' ' LEU . 71.4 t -123.92 131.71 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.84 18.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.91 153.06 16.68 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.636 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.3 165.3 24.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -33.3 67.29 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -81.18 -6.17 58.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -89.44 131.51 40.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.22 155.33 51.78 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.276 1.317 . . . . 0.0 110.451 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.82 -34.33 78.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.514 -0.741 . . . . 0.0 110.656 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.92 -36.71 70.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.758 0.314 . . . . 0.0 110.239 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 -35.69 72.43 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.606 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.8 -38.77 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.439 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.764 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.3 mm -60.58 -47.15 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.546 0.689 . . . . 0.0 109.372 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.38 -45.73 69.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.05 79.01 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.296 0.57 . . . . 0.0 111.181 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -61.95 -35.95 79.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.356 0.598 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.68 -42.79 99.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.633 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.2 -38.96 92.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.68 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.494 HD13 HD13 ' B' ' 91' ' ' ILE . 0.6 OUTLIER -63.72 -42.01 98.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.965 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -62.94 -43.91 97.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.44 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.79 -38.22 72.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.615 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.95 11.94 21.2 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.95 96.98 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.1 mt -101.66 -35.09 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.935 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 114.186 0.802 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG11 ' CE1' ' A' ' 66' ' ' PHE . 18.5 t -103.67 110.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -110.33 127.78 67.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD21 ' A' ' 86' ' ' LEU . 7.7 tt -115.69 120.67 40.13 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 14.3 tt0 -110.1 127.19 54.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.577 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.39 114.89 25.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.269 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.13 -22.63 17.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -120.35 0.65 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.436 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -114.35 96.79 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 122.892 0.477 . . . . 0.0 109.767 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 -4.5 85.89 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.713 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 129.67 51.74 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -137.61 156.12 48.42 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.15 0.976 . . . . 0.0 112.805 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -126.1 141.88 51.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.296 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 HD12 ' A' ' 45' ' ' LEU . 4.7 pt -131.16 134.61 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.322 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.1 114.74 27.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.675 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' CD1' ' A' ' 35' ' ' ILE . 80.9 mt -112.18 108.78 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.951 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 48.02 20.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.892 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.01 20.55 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.137 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -92.41 130.03 38.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.505 1.152 . . . . 0.0 110.482 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -108.44 136.95 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.157 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -118.79 127.74 53.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -117.48 156.03 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.104 0.478 . . . . 0.0 112.217 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 25.91 53.11 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.552 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 42' ' ' GLN . 17.1 mt -86.93 149.21 24.95 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.542 0.687 . . . . 0.0 112.208 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 p -91.88 171.44 9.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.419 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' VAL . 11.6 pt-20 -66.62 -44.29 82.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.244 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.79 -39.26 93.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.498 ' HE2' HD22 ' A' ' 45' ' ' LEU . 5.8 ttp -71.17 -41.45 70.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.973 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.2 p -61.66 -34.43 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.55 -50.23 70.32 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.857 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.57 -52.03 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.759 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.84 -47.96 76.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.6 -43.6 84.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.218 0.532 . . . . 0.0 111.672 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.48 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -66.35 -44.46 83.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.281 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.93 -40.13 95.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.178 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' OE2' HG22 ' A' ' 23' ' ' VAL . 4.4 tt0 -69.58 -38.83 77.51 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.401 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.28 -30.38 67.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.65 -27.43 45.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 117.885 0.311 . . . . 0.0 111.249 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -84.77 -35.64 22.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.916 0.388 . . . . 0.0 110.029 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -130.94 101.28 5.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.12 1.12 16.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -116.78 18.34 14.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.614 0.643 . . . . 0.0 111.955 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.68 115.21 7.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.47 126.44 27.84 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE1' HG11 ' A' ' 23' ' ' VAL . 58.9 m-85 -113.61 129.67 56.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.171 0.51 . . . . 0.0 111.592 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -135.24 140.84 45.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG11 HD23 ' A' ' 83' ' ' LEU . 81.3 t -122.54 127.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.97 145.8 17.66 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 155.35 16.73 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.084 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.68 166.86 22.91 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.086 0.469 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -57.88 -34.16 69.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.323 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -80.95 -5.11 57.08 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.9 133.45 41.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.81 152.86 32.94 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.495 1.463 . . . . 0.0 110.34 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -63.41 -37.4 87.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.73 0.696 . . . . 0.0 110.722 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.82 -35.74 66.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.49 -34.82 67.92 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.705 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.0 -38.63 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.76 -47.52 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.329 0.585 . . . . 0.0 109.564 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -54.46 -44.27 72.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.22 78.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.342 0.592 . . . . 0.0 111.242 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 5.9 mt -60.87 -36.97 80.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.79 -41.85 96.38 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.825 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.3 -39.17 92.17 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.514 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.34 -42.27 98.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.074 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -63.72 -41.81 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -38.64 77.34 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.08 11.41 23.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.89 44.62 97.87 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.7 mt . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo . . . . . 0 N--CA 1.481 0.749 0 N-CA-C 114.436 0.898 . . . . 0.0 114.436 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.528 HG11 ' CE1' ' B' ' 66' ' ' PHE . 16.2 t -103.64 109.79 28.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.02 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -110.04 127.3 67.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.192 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.49 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.7 tt -115.06 120.59 40.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 14.4 tt0 -110.04 127.31 54.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.435 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.67 114.79 25.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.038 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 -22.89 17.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.86 -124.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.299 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -109.7 97.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.04 -0.58 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -4.17 86.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.916 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 129.92 52.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.75 155.98 48.47 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.115 0.96 . . . . 0.0 112.795 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.06 141.66 51.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.322 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.593 HG23 HD12 ' B' ' 45' ' ' LEU . 4.5 pt -130.84 134.8 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.301 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.36 114.89 27.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.439 0.638 . . . . 0.0 109.624 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.541 HD11 ' CD1' ' B' ' 35' ' ' ILE . 78.1 mt -112.27 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.775 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.82 48.56 18.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.944 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.46 -25.68 21.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.225 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.449 1.124 . . . . 0.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -108.08 136.94 46.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.295 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.01 127.63 53.62 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.062 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -117.19 156.36 27.81 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.87 26.49 53.34 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.413 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.593 HD12 HG23 ' B' ' 35' ' ' ILE . 16.5 mt -87.4 149.12 24.68 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.485 0.659 . . . . 0.0 112.076 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.1 p -91.62 171.07 9.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.373 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 11.4 pt-20 -66.42 -44.25 83.45 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.269 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.83 -39.29 93.88 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.044 -0.41 . . . . 0.0 111.185 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.447 ' HE2' HD22 ' B' ' 45' ' ' LEU . 6.3 ttp -71.5 -40.98 69.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.953 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -61.85 -34.27 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.78 -49.96 70.9 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.846 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.74 -51.9 45.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.789 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.05 -47.67 76.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -57.64 -43.78 85.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.207 0.527 . . . . 0.0 111.764 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.84 -44.66 84.85 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.314 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.82 -39.87 95.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.165 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.297 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.4 -30.75 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.57 -27.5 45.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.83 0.286 . . . . 0.0 111.268 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -84.72 -35.87 22.21 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.073 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -130.64 101.6 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.42 1.71 15.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -117.28 18.32 14.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.705 0.684 . . . . 0.0 111.91 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 115.41 7.91 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.7 126.27 27.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.528 ' CE1' HG11 ' B' ' 23' ' ' VAL . 60.9 m-85 -113.4 129.49 56.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.244 0.545 . . . . 0.0 111.748 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.02 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.3 140.97 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.953 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.599 HG11 HD23 ' B' ' 83' ' ' LEU . 78.1 t -122.62 127.42 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.79 145.89 17.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.29 155.68 16.91 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.915 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.75 167.63 21.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -58.43 -34.74 71.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.036 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -80.35 -6.04 57.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.89 133.43 43.44 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.1 152.97 31.78 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.561 1.507 . . . . 0.0 110.251 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.729 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.55 -37.25 86.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.739 0.7 . . . . 0.0 110.572 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -55.78 -35.83 66.71 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.32 -35.07 68.53 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.844 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.75 -38.91 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.729 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.7 mm -60.37 -47.53 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.435 0.636 . . . . 0.0 109.784 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.2 mttm -54.4 -44.35 72.25 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.984 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -49.23 78.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.275 0.559 . . . . 0.0 111.146 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 5.8 mt -60.63 -36.96 79.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 109.448 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.05 -41.67 97.04 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.832 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 8.5 mt -65.22 -39.29 92.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.521 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.524 HD13 HD13 ' B' ' 91' ' ' ILE . 1.4 mm? -63.17 -42.63 99.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.93 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -63.64 -41.73 98.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -38.57 77.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.518 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.11 11.04 24.45 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.32 44.6 97.86 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 114.752 0.661 . . . . 0.0 114.752 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.6 mt -102.65 -36.03 4.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.776 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -65.91 -40.78 91.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 46.7 t -115.78 118.48 38.74 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.837 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.95 175.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.871 2.38 . . . . 0.0 115.404 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.23 121.28 65.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.003 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -111.94 127.28 69.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.406 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 25' ' ' LEU . 9.4 tt -114.88 120.68 40.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -109.59 127.72 54.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.418 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 t -85.0 119.93 34.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.207 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.1 -23.07 14.55 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.48 -119.34 0.6 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.953 -1.118 . . . . 0.0 113.861 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 78' ' ' GLU . 29.5 mm -113.56 99.46 8.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.79 -2.21 86.71 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.808 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.98 129.08 53.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -138.72 156.49 47.34 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.152 0.977 . . . . 0.0 112.951 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.62 142.06 51.7 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.31 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.642 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.2 pt -132.47 134.81 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.52 115.11 28.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.369 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.642 HD11 ' CD1' ' A' ' 35' ' ' ILE . 68.1 mt -114.67 109.6 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.219 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.82 44.86 24.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.917 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.81 21.52 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.855 -0.688 . . . . 0.0 114.031 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.53 126.77 35.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.276 1.038 . . . . 0.0 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -105.41 133.15 50.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.948 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.98 126.65 52.72 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.41 158.38 24.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.101 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 26.83 56.35 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.903 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 35' ' ' ILE . 9.6 mt -88.13 149.14 24.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.281 0.562 . . . . 0.0 112.074 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -90.51 169.02 11.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.21 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.4 pt-20 -65.34 -43.62 90.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.61 -40.56 95.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.418 ' CE ' HD22 ' A' ' 45' ' ' LEU . 7.6 ttp -70.77 -38.18 73.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -64.44 -32.8 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.3 m -63.94 -49.26 73.28 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.35 -51.83 42.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.77 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.04 -47.83 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.665 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 m -59.29 -42.88 92.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.611 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -66.97 -43.94 81.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.391 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.41 -40.97 98.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.997 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -38.09 77.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -71.14 -29.45 65.25 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.66 -28.44 45.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.761 0.255 . . . . 0.0 111.433 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.79 -33.78 24.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.212 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -132.47 104.5 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -80.61 5.52 15.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -123.64 17.87 9.56 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.509 0.595 . . . . 0.0 111.688 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 121.7 18.04 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.499 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.12 125.17 25.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -113.14 134.39 54.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.985 0.421 . . . . 0.0 111.264 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.91 142.01 42.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 83' ' ' LEU . 69.3 t -123.51 126.81 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.4 146.34 18.36 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.53 154.46 16.94 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.846 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.88 165.74 23.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 110.911 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.88 -32.77 68.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.27 -6.49 57.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.61 133.54 35.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 156.42 32.44 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.274 1.316 . . . . 0.0 110.306 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.743 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -64.26 -33.9 76.89 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.762 -0.586 . . . . 0.0 110.266 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -57.18 -37.33 71.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -71.09 -35.24 71.76 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.846 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.12 -38.41 80.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.393 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.0 mm -59.93 -48.39 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.444 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -54.15 -45.38 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.469 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.05 -49.18 78.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' B' ' 83' ' ' LEU . 10.8 mt -61.58 -36.17 79.89 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.444 0.64 . . . . 0.0 109.46 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.95 -41.96 98.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.74 -38.86 92.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 110.614 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 91' ' ' ILE . 1.1 mm? -63.57 -41.85 98.35 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.952 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -63.58 -41.0 98.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.51 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -38.92 78.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.449 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.05 11.82 21.81 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.87 44.32 97.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.638 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt -100.34 -39.35 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.716 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.569 -0.213 . . . . 0.0 112.569 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -65.83 -40.99 92.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.963 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 45.8 t -115.95 118.44 38.42 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.803 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.77 175.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.86 2.373 . . . . 0.0 115.43 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.25 121.38 65.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.979 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.81 127.24 69.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.515 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.453 ' C ' HD23 ' B' ' 25' ' ' LEU . 9.4 tt -114.86 120.47 40.08 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.07 128.25 54.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.457 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.45 119.79 34.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.147 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.87 -23.2 14.61 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.47 -123.51 0.83 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.145 -1.026 . . . . 0.0 113.565 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.467 HD13 ' HG2' ' B' ' 78' ' ' GLU . 27.1 mm -108.45 99.76 9.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.011 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.87 85.75 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.968 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.61 129.44 52.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.0 156.55 47.13 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.156 0.979 . . . . 0.0 113.034 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.96 51.76 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.261 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.645 ' CD1' HD11 ' B' ' 37' ' ' ILE . 5.8 pt -132.56 134.94 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 118.527 0.603 . . . . 0.0 112.599 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.73 115.01 28.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.355 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 68.4 mt -114.74 109.54 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.192 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.71 45.05 24.18 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.976 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -26.34 18.99 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.931 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -88.15 126.86 35.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.211 1.005 . . . . 0.0 110.391 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -105.63 132.35 51.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.074 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.545 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -117.24 126.84 53.4 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.7 158.8 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 112.092 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 26.49 57.43 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.932 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 35' ' ' ILE . 9.5 mt -87.92 149.15 24.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.36 0.6 . . . . 0.0 112.325 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.39 169.21 11.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.446 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 16.8 pt-20 -65.63 -43.27 90.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.878 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.72 -40.05 94.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.99 -0.444 . . . . 0.0 111.233 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.431 ' CE ' HD22 ' B' ' 45' ' ' LEU . 7.1 ttp -71.35 -38.17 71.64 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -64.43 -32.86 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -63.96 -48.85 74.85 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -50.84 -51.92 46.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.7 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 mt -64.76 -47.95 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.669 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -59.21 -42.95 92.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.151 0.501 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.411 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -66.91 -43.89 82.2 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.36 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.33 -40.97 98.77 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -37.9 76.75 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -71.18 -29.53 65.3 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.77 -28.42 44.73 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.856 0.298 . . . . 0.0 111.432 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.89 -33.56 24.74 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -132.43 104.42 6.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.84 5.54 15.72 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -123.6 17.53 9.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.517 0.598 . . . . 0.0 111.772 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 122.06 18.44 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.22 125.38 25.87 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.979 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -137.32 141.75 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' B' ' 83' ' ' LEU . 70.4 t -123.46 127.27 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.75 146.3 18.3 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.55 154.57 16.95 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.866 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.81 165.83 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -32.73 68.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.418 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.16 -6.85 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 76.0 t -88.4 133.38 36.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 156.49 33.33 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.409 1.406 . . . . 0.0 110.336 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.745 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -64.64 -33.66 76.46 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.832 -0.543 . . . . 0.0 110.264 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -57.29 -37.44 72.44 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.467 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.93 -35.46 72.23 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.786 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.68 -38.65 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.395 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.745 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.02 -48.01 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.524 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.6 mttm -54.38 -45.13 72.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.398 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.425 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.43 -48.78 80.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.269 0.557 . . . . 0.0 111.283 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.859 HD11 HD11 ' A' ' 83' ' ' LEU . 10.7 mt -62.05 -36.04 80.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.457 0.646 . . . . 0.0 109.419 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.88 -42.0 98.54 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.793 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.5 mt -64.74 -39.01 92.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 110.576 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.625 HD13 HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -63.5 -41.92 98.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.978 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -63.52 -41.01 98.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.458 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -38.73 77.79 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.444 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.12 11.86 21.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 44.02 98.14 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.625 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -100.07 -39.53 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.759 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -52.22 19.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.672 0.273 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.09 128.55 17.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.434 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.2 -173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.158 2.572 . . . . 0.0 114.454 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 64' ' ' THR . 41.3 t -106.7 115.02 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.894 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.9 127.45 69.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.2 tt -115.39 121.52 43.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' N ' HD23 ' A' ' 25' ' ' LEU . 30.1 mt-10 -110.59 127.14 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -85.59 111.41 20.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.96 20.96 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.17 -119.38 0.64 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.68 -1.248 . . . . 0.0 114.16 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.38 99.91 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.069 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.92 -3.31 84.42 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.956 -0.566 . . . . 0.0 114.175 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 131.26 54.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.581 0.69 . . . . 0.0 109.766 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.9 m-85 -137.89 157.48 46.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 122.096 0.95 . . . . 0.0 112.746 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.84 142.2 51.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.878 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.4 pt -132.95 134.37 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.396 0.543 . . . . 0.0 112.341 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 115.05 28.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.247 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 35' ' ' ILE . 33.2 mt -111.59 108.83 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.715 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.99 46.16 26.22 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.664 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.53 24.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.658 -0.782 . . . . 0.0 114.221 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -91.74 128.96 37.78 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.57 1.185 . . . . 0.0 110.201 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.52 135.01 47.69 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.537 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.84 127.71 53.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -117.47 156.1 28.56 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.156 0.503 . . . . 0.0 112.245 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.47 45.01 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.428 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.55 HD12 HG23 ' A' ' 35' ' ' ILE . 35.9 mt -88.75 151.17 22.57 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.278 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -93.14 173.32 7.79 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.586 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.7 mt-10 -67.92 -43.83 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.86 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.6 -38.7 92.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.809 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.4 mtm -70.35 -44.91 67.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.2 p -58.57 -35.27 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.744 0.307 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.2 m -63.55 -51.77 64.01 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.882 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -50.86 -51.18 53.93 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.683 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.31 -48.0 74.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.806 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -58.35 -42.86 87.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.082 0.467 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -66.48 -43.87 84.26 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.152 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -64.44 -39.23 93.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.015 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -38.2 70.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -70.57 -30.83 67.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.587 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.07 -28.75 54.79 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.916 0.325 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -37.45 27.39 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -127.38 105.4 8.5 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.88 1.04 24.88 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.27 20.01 8.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.242 0.474 . . . . 0.0 111.928 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.639 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.76 115.61 8.31 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.431 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.9 123.13 16.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -110.78 129.18 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.237 0.541 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.91 140.53 42.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.586 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.1 p -126.96 134.63 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.42 146.53 18.43 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 154.76 16.64 Favored Glycine 0 C--N 1.33 0.238 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.66 166.25 23.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.826 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -58.93 -31.8 68.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.261 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -81.12 -5.23 57.43 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.2 t -86.48 132.27 43.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.465 ' O ' HG23 ' A' ' 79' ' ' VAL . 71.8 Cg_endo -77.36 154.4 31.87 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.55 1.5 . . . . 0.0 110.495 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.7 t80 -64.2 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.887 -0.508 . . . . 0.0 111.04 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.93 -37.64 69.23 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.536 0.208 . . . . 0.0 110.744 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -71.54 -34.22 69.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.188 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 75' ' ' PRO . 11.1 t -63.43 -38.32 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.372 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.9 mm -60.69 -47.61 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.45 0.643 . . . . 0.0 109.621 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -55.14 -44.35 75.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.929 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.99 87.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -61.47 -37.69 84.51 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.532 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -59.66 -41.49 90.72 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.825 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.76 -39.34 90.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.051 0.453 . . . . 0.0 110.764 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.699 HD13 HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -63.24 -42.95 99.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.909 179.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -63.1 -42.54 99.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.44 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.22 -37.78 72.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.598 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.22 10.59 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.24 44.59 96.8 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.699 HD13 HD13 ' A' ' 86' ' ' LEU . 4.7 mt -99.02 -36.57 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.71 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -71.59 -52.28 18.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.14 128.66 17.6 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.29 -173.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 123.119 2.546 . . . . 0.0 114.431 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.625 HG23 HG22 ' B' ' 64' ' ' THR . 41.3 t -106.37 114.79 46.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.886 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.86 127.79 68.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.522 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt -115.43 121.78 43.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.447 ' N ' HD23 ' B' ' 25' ' ' LEU . 27.9 mt-10 -110.81 126.89 55.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.397 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.34 111.28 20.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.97 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.52 -122.8 0.83 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 119.964 -1.113 . . . . 0.0 114.064 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.72 100.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.15 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.74 -3.57 82.67 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.446 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 131.62 53.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.552 0.676 . . . . 0.0 109.764 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -137.94 157.16 46.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.253 1.025 . . . . 0.0 112.721 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.57 142.63 51.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 113.769 -1.56 . . . . 0.0 109.046 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.6 pt -133.44 134.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.317 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 115.49 29.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.262 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.3 mt -112.07 109.03 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.769 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.44 46.45 22.78 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.621 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 -25.59 24.38 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.914 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -91.75 128.78 37.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.516 1.158 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.44 135.06 47.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.75 127.84 53.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.46 156.49 27.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 112.169 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.54 46.01 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.43 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' B' ' 42' ' ' GLN . 34.2 mt -89.0 150.95 22.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 112.151 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -92.68 173.13 7.93 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.749 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.0 mt-10 -67.57 -44.28 78.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.844 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.2 -38.96 93.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mtm -70.22 -44.47 68.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.2 p -59.01 -35.09 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -63.82 -51.13 66.11 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.869 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.35 -51.3 55.76 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.67 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.17 -48.12 74.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.718 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m -58.14 -43.07 87.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.478 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -66.22 -44.02 85.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.297 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -64.22 -39.36 93.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.018 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -38.34 71.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -70.47 -30.59 67.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.593 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.37 -28.52 52.9 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.932 0.333 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.83 -37.09 27.56 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -127.93 105.27 8.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -78.87 1.0 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -124.99 19.81 8.36 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.276 0.489 . . . . 0.0 111.906 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.625 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.7 115.94 8.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.405 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 22.2 tp -60.18 122.74 15.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.78 129.13 55.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.59 140.21 42.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.747 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.795 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.6 p -126.55 134.46 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.02 146.55 18.49 Favored Glycine 0 C--O 1.226 -0.346 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.99 154.78 16.75 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.11 166.53 23.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.944 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -59.19 -31.63 69.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.281 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -81.1 -5.46 57.69 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.25 132.12 44.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.471 ' O ' HG23 ' B' ' 79' ' ' VAL . 75.1 Cg_endo -77.35 154.06 31.69 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.583 1.522 . . . . 0.0 110.669 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -64.06 -37.83 88.84 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.911 -0.493 . . . . 0.0 111.046 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.47 -37.63 70.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.514 0.197 . . . . 0.0 110.629 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' B' ' 75' ' ' PRO . 1.4 tp10 -71.44 -34.42 70.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.285 0.564 . . . . 0.0 110.199 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 75' ' ' PRO . 11.4 t -63.25 -38.3 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.425 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.94 -47.29 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.453 0.644 . . . . 0.0 109.625 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' B' ' 85' ' ' LEU . 12.1 mmmt -55.33 -43.99 75.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.957 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.79 -47.31 86.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.346 0.594 . . . . 0.0 110.833 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 83' ' ' LEU . 6.3 mt -60.87 -38.05 84.25 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.588 0.708 . . . . 0.0 109.544 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.38 -41.51 89.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.903 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' B' ' 81' ' ' LYS . 1.6 mt -65.85 -39.23 90.58 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.481 . . . . 0.0 110.707 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 91' ' ' ILE . 0.5 OUTLIER -63.4 -42.58 98.79 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.939 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -63.22 -42.77 99.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -37.58 72.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.683 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.48 10.81 23.81 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.12 44.5 97.12 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 115.234 0.853 . . . . 0.0 115.234 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.719 HD13 HD13 ' B' ' 86' ' ' LEU . 4.5 mt -99.25 -36.69 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.033 0 N-CA-C 112.361 -0.296 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 t -65.9 -43.47 88.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.76 131.39 13.56 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.801 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.89 -169.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.224 2.616 . . . . 0.0 114.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 64' ' ' THR . 38.3 t -106.36 110.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.881 HG23 HD11 ' A' ' 67' ' ' LEU . 3.1 mp -108.62 126.38 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.287 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.0 tt -115.54 123.48 48.61 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' HD23 ' A' ' 25' ' ' LEU . 11.3 mt-10 -111.95 127.16 55.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.306 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 74' ' ' VAL . 34.7 t -84.86 108.25 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.537 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -22.71 24.68 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.6 -119.24 0.61 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.939 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.81 98.84 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.63 -3.5 86.54 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.944 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.49 130.58 54.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.544 0.672 . . . . 0.0 109.447 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -139.12 157.25 46.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 122.277 1.037 . . . . 0.0 113.115 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.77 51.06 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.954 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.694 HG23 HD12 ' A' ' 45' ' ' LEU . 3.7 pt -132.3 134.13 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.368 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.64 114.01 26.78 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.389 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 35' ' ' ILE . 63.0 mt -110.71 108.68 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.89 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 47.37 21.18 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.735 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.19 -25.64 23.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.267 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -92.14 128.3 37.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.478 1.139 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.17 135.49 47.55 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.41 127.47 53.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -116.53 155.76 28.09 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.7 46.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.396 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 35' ' ' ILE . 17.5 mt -87.76 149.01 24.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 112.361 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -91.89 173.06 8.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.554 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.1 mt-10 -67.53 -45.01 76.99 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.948 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -37.98 89.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.234 0.47 . . . . 0.0 110.845 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.5 mtp -70.26 -44.87 67.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -58.53 -35.46 54.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.742 0.306 . . . . 0.0 110.504 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.14 -51.76 62.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -50.2 -51.79 41.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.762 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.74 -48.12 75.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.021 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.638 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -66.83 -43.46 83.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.209 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -39.41 92.91 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.043 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -71.13 -37.57 72.31 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.695 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.77 -30.99 67.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.442 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.23 -27.97 53.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.913 0.324 . . . . 0.0 111.148 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.05 -38.81 24.4 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.86 119.18 25.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -91.26 -19.88 22.52 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.37 20.53 11.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.202 0.456 . . . . 0.0 111.579 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.96 115.64 9.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.724 -178.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.06 125.92 26.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -110.0 126.78 54.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.211 0.529 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -134.12 139.85 46.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.491 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.3 p -127.39 135.71 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.37 144.74 16.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.647 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.47 152.79 17.06 Favored Glycine 0 C--N 1.33 0.204 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.1 164.71 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.085 0.469 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 -32.58 68.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.502 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -81.96 -6.84 59.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG11 HG11 ' A' ' 27' ' ' VAL . 79.2 t -85.81 127.79 61.08 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.08 154.41 62.42 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 110.394 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.9 t80 -63.12 -36.66 84.33 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.816 -0.552 . . . . 0.0 110.73 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 110.422 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -36.89 74.89 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 109.781 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.62 -39.55 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.687 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.1 mm -59.85 -48.11 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.409 0.623 . . . . 0.0 109.806 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 4.3 mmmt -54.96 -44.06 74.01 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.96 83.68 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.599 . . . . 0.0 110.873 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' B' ' 83' ' ' LEU . 7.1 mt -60.32 -37.3 80.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.572 0.701 . . . . 0.0 109.541 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.2 -40.88 95.62 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.985 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.3 mt -65.01 -40.19 94.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.673 HD13 HD13 ' A' ' 91' ' ' ILE . 2.5 mm? -63.45 -42.47 98.65 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 t60 -63.24 -41.44 99.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -38.99 76.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.35 10.33 25.4 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.45 44.1 98.46 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.673 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt -99.09 -31.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.053 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -66.08 -43.75 86.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.581 0.229 . . . . 0.0 110.866 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -140.35 131.62 14.12 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.652 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -49.11 -169.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.178 2.585 . . . . 0.0 114.48 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.493 HG23 HG22 ' B' ' 64' ' ' THR . 38.3 t -106.36 110.72 32.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.893 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.83 126.76 65.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.371 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.0 tt -116.05 123.68 48.54 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.502 ' N ' HD23 ' B' ' 25' ' ' LEU . 11.8 mt-10 -112.35 127.23 55.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.225 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 37.5 t -85.06 108.21 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.591 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.6 -22.47 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.57 -123.54 0.85 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.459 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 28.9 mm -108.12 99.08 7.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.191 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -3.43 86.6 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.032 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 130.79 54.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.623 0.712 . . . . 0.0 109.6 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -139.13 157.89 45.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.515 1.15 . . . . 0.0 113.134 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 142.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.835 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.71 HG23 HD12 ' B' ' 45' ' ' LEU . 3.5 pt -132.24 134.1 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.25 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -111.14 114.1 27.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.417 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' B' ' 35' ' ' ILE . 59.7 mt -111.36 108.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.751 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.44 20.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.883 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.16 -25.82 22.24 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.71 -0.757 . . . . 0.0 114.04 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -91.77 128.76 37.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.656 1.228 . . . . 0.0 110.329 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -106.85 135.39 48.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.107 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.36 128.15 53.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -117.28 155.8 28.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.141 0.496 . . . . 0.0 112.325 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.48 27.73 46.59 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.198 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.71 HD12 HG23 ' B' ' 35' ' ' ILE . 17.6 mt -87.68 148.87 24.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.387 0.613 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -92.05 173.18 7.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.405 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.7 mt-10 -67.75 -44.8 76.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.025 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.49 91.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.161 0.505 . . . . 0.0 110.974 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.9 mtp -69.96 -44.87 68.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.369 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -58.57 -35.31 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.728 0.299 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -64.26 -51.53 63.11 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.888 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.39 -51.56 45.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.7 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.12 -48.17 74.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.732 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 18.1 m -57.52 -43.45 84.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 111.753 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -66.65 -43.7 83.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.139 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -39.95 94.52 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.76 -37.3 73.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -70.94 -31.17 67.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.299 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.91 -28.1 55.17 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.11 -0.369 . . . . 0.0 111.131 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -82.13 -38.52 24.63 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -128.15 119.44 25.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -91.28 -20.0 22.38 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 20.58 11.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.067 0.394 . . . . 0.0 111.543 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.493 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.72 115.91 9.51 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.51 125.98 27.42 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.76 127.0 54.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.213 0.53 . . . . 0.0 111.694 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.26 139.77 45.97 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.518 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.788 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.9 p -127.39 135.89 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.34 145.18 17.25 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.649 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.71 152.32 17.16 Favored Glycine 0 N--CA 1.454 -0.161 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.34 165.14 24.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -59.14 -32.27 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.216 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -81.71 -7.13 59.56 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 75.3 t -85.43 127.8 61.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.2 154.18 61.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.222 1.282 . . . . 0.0 110.264 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.687 ' CE1' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -62.96 -36.48 83.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.747 -0.596 . . . . 0.0 110.69 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.48 -36.27 68.92 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -36.9 74.58 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.306 0.574 . . . . 0.0 109.662 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.9 -39.24 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.642 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.687 HD11 ' CE1' ' B' ' 76' ' ' TYR . 46.0 mm -59.99 -48.03 89.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-O 121.476 0.655 . . . . 0.0 109.713 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.4 mmmt -55.12 -44.12 74.72 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.014 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.99 83.48 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.292 0.568 . . . . 0.0 110.9 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 7.4 mt -60.46 -37.2 80.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.611 0.72 . . . . 0.0 109.591 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.25 -40.83 95.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.883 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.4 mt -65.2 -39.9 93.46 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.855 0.36 . . . . 0.0 110.829 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.679 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -63.41 -42.6 98.76 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -63.26 -41.27 99.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.424 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -39.08 76.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.598 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.551 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.3 10.19 25.82 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.78 43.89 98.62 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.679 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -99.15 -31.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 t -88.11 -43.06 11.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 0.0 110.922 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 62.0 t -118.01 120.46 32.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.48 177.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.283 2.655 . . . . 0.0 115.676 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.49 120.13 61.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -112.47 127.71 69.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -117.07 127.25 53.96 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.4 mt-10 -115.84 127.68 55.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.299 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 74' ' ' VAL . 26.4 t -87.52 99.53 8.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.941 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.82 -21.64 51.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.974 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -113.93 92.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 -5.53 79.24 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.705 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.59 128.94 52.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.576 0.688 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.69 156.9 47.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.376 1.084 . . . . 0.0 113.133 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.98 142.29 51.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.842 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -132.83 135.14 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.133 -0.627 . . . . 0.0 112.18 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.69 116.11 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.938 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.05 108.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.183 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 46.85 48.52 18.35 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.523 -0.846 . . . . 0.0 114.39 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.99 -27.11 15.74 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.373 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.81 130.0 37.67 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.412 1.106 . . . . 0.0 110.197 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.29 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.13 125.57 51.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.52 157.02 25.9 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.25 50.99 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.042 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 HG23 ' A' ' 35' ' ' ILE . 13.6 mt -87.44 149.15 24.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.222 0.534 . . . . 0.0 111.971 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 p -92.09 173.16 7.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.2 mt-10 -67.47 -43.79 80.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.948 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.22 -38.25 90.38 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 122.043 -0.411 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mtp -70.93 -43.6 67.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.625 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.32 -35.8 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -63.24 -51.2 67.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.681 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.32 -52.5 36.27 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.93 -47.57 77.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.728 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -58.07 -43.15 86.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.099 0.476 . . . . 0.0 111.424 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -44.66 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.046 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.91 -40.42 96.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.161 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -70.31 -39.23 74.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.236 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.55 -27.73 64.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.41 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -79.86 -26.95 40.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.928 0.331 . . . . 0.0 111.385 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -33.96 25.05 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.741 ' HB3' HG23 ' A' ' 64' ' ' THR . 4.4 t70 -134.52 97.45 3.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -70.86 -6.21 36.4 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -109.04 17.65 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.586 0.63 . . . . 0.0 111.826 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -68.61 115.61 8.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.519 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 66' ' ' PHE . 6.2 tp -65.11 124.69 22.79 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.449 ' N ' HD12 ' A' ' 65' ' ' LEU . 11.8 m-85 -109.09 127.79 54.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.359 0.599 . . . . 0.0 111.514 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -133.95 139.24 45.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.505 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -126.78 137.34 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.96 145.49 17.32 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.88 153.68 16.69 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.17 163.63 24.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.154 0.502 . . . . 0.0 111.285 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -31.76 68.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.415 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -81.73 -5.96 58.61 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 27' ' ' VAL . 74.5 t -89.48 127.05 56.22 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.93 156.17 63.56 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.094 1.196 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.4 t80 -64.46 -34.7 78.8 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.768 -0.583 . . . . 0.0 110.46 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.23 -36.42 70.89 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -36.85 75.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.334 0.587 . . . . 0.0 109.688 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.61 -39.01 81.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.788 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.9 mm -60.39 -48.52 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.359 0.6 . . . . 0.0 109.726 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -54.15 -44.8 71.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.36 -47.47 85.3 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.509 0.671 . . . . 0.0 110.827 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.0 mt -61.0 -36.8 80.46 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 109.378 178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.73 -42.38 97.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.851 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.12 -39.92 95.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.065 0.459 . . . . 0.0 110.837 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 91' ' ' ILE . 2.1 mm? -64.03 -42.38 97.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.063 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.7 -42.32 99.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.511 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.5 -38.66 74.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.83 11.41 20.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.49 44.23 98.27 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 86' ' ' LEU . 4.1 mt -98.06 -30.95 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 N-CA-C 112.895 -0.082 . . . . 0.0 112.895 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -88.27 -43.21 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.757 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.478 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 62.8 t -118.03 120.5 32.44 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.59 177.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.176 2.584 . . . . 0.0 115.745 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.1 t -111.52 120.49 62.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 127.65 69.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.74 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.521 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -117.1 127.09 53.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.492 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.0 mt-10 -115.72 127.68 55.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.165 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.425 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.4 t -87.58 98.99 7.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.033 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.27 -21.86 52.98 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.09 -124.55 0.88 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.055 -1.069 . . . . 0.0 113.704 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.12 93.04 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.079 -0.56 . . . . 0.0 110.105 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.33 79.35 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.814 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 129.13 53.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -138.16 156.65 47.53 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.337 1.065 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.03 142.06 51.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.95 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.621 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -132.64 135.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.357 -0.537 . . . . 0.0 112.406 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.89 115.89 29.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.892 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.0 108.73 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.149 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.478 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 46.31 48.99 15.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.462 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.74 -26.85 16.33 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.176 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.85 129.95 37.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.487 1.144 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.88 136.03 48.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.269 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.55 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -116.83 126.06 52.49 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.79 157.08 26.14 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.89 26.57 53.11 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.057 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.621 HD12 HG23 ' B' ' 35' ' ' ILE . 13.8 mt -86.89 148.94 25.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.388 0.613 . . . . 0.0 112.109 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -91.74 172.97 8.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.45 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.7 -43.62 79.66 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -63.94 -38.61 91.72 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 110.996 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.53 -43.91 68.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.425 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.45 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.13 -35.77 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.948 0.404 . . . . 0.0 110.228 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 19.6 m -63.27 -51.3 66.71 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.745 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.26 -52.49 35.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.79 -47.35 78.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.796 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -58.4 -42.9 88.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.488 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.39 83.29 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.196 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.07 -40.58 96.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.992 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.609 ' OE2' HG21 ' B' ' 64' ' ' THR . 0.0 OUTLIER -70.23 -39.34 75.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.225 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.35 -27.8 64.63 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.524 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -79.63 -27.43 40.96 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.84 0.291 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -83.25 -33.75 25.98 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.732 ' HB3' HG23 ' B' ' 64' ' ' THR . 4.4 t70 -134.96 97.72 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -71.02 -6.15 36.75 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.86 17.4 21.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.7 0.682 . . . . 0.0 111.754 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.732 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -68.3 115.9 8.27 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.471 HD12 ' N ' ' B' ' 66' ' ' PHE . 5.6 tp -65.32 125.13 24.12 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.471 ' N ' HD12 ' B' ' 65' ' ' LEU . 11.6 m-85 -109.44 127.38 54.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 0.0 111.556 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.95 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.785 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.52 137.5 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.12 145.43 17.21 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.522 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.76 153.29 16.83 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.84 164.21 24.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -31.51 69.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.176 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.67 -6.59 59.16 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.425 HG21 ' O ' ' B' ' 27' ' ' VAL . 73.9 t -88.98 127.0 57.41 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.99 156.33 63.0 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.962 1.108 . . . . 0.0 110.298 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.51 -34.9 79.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.996 -0.44 . . . . 0.0 110.419 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.66 -36.02 71.33 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 120.672 0.273 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -36.96 75.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.502 0.668 . . . . 0.0 109.539 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 t -61.56 -39.04 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.687 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.6 mm -60.31 -48.24 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.429 0.633 . . . . 0.0 109.702 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -54.59 -44.68 73.24 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.219 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.34 85.8 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 110.846 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -61.31 -36.56 80.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.666 0.746 . . . . 0.0 109.377 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.99 -41.83 97.25 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.949 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.97 -39.41 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.754 HD13 HD13 ' B' ' 91' ' ' ILE . 2.2 mm? -64.31 -41.96 96.59 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.85 -42.23 99.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.556 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.47 -38.9 75.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.618 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.58 11.67 18.94 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.13 44.27 98.36 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -98.07 -30.53 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.939 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 t -98.19 -58.21 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.448 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 28.9 t -125.85 126.24 24.87 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.114 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -54.11 174.09 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.892 2.395 . . . . 0.0 115.296 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 64' ' ' THR . 46.9 t -112.27 117.23 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.868 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -109.51 127.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.409 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.4 tt -116.02 121.72 43.06 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 tt0 -106.97 125.59 51.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.9 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.32 116.26 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.657 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.31 -23.79 15.49 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -122.89 0.76 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.105 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.1 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 122.666 0.387 . . . . 0.0 110.112 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.26 -3.41 87.24 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.964 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.89 53.47 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -137.48 157.09 47.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.202 1.001 . . . . 0.0 113.335 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 141.99 51.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.708 -1.587 . . . . 0.0 108.638 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 37' ' ' ILE . 5.8 pt -131.73 134.81 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -112.3 114.41 27.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.54 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 35' ' ' ILE . 47.7 mt -114.45 109.99 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.221 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.32 45.45 21.72 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.962 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.98 -26.89 14.55 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.827 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -85.32 125.14 32.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.927 0.863 . . . . 0.0 110.517 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.87 133.27 50.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.94 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.78 127.36 52.73 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.71 155.66 28.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 112.058 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 26.27 51.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.339 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 42' ' ' GLN . 40.7 mt -86.62 148.92 25.26 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.513 0.673 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.8 p -90.77 172.69 8.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.535 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 50' ' ' VAL . 6.2 mt-10 -67.9 -44.29 77.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.675 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.88 -38.79 92.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.099 0.476 . . . . 0.0 110.951 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mtp -69.39 -46.15 67.56 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -59.03 -34.42 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -63.31 -50.42 70.1 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.789 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.42 -52.46 37.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.714 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.64 -47.7 77.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.693 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.6 -43.55 89.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.214 0.531 . . . . 0.0 111.701 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.58 -43.34 85.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.374 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.27 -40.63 96.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.76 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.56 -37.33 76.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.099 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -70.88 -30.91 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.63 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.19 -27.75 57.01 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.247 -0.283 . . . . 0.0 111.038 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.35 -36.48 26.81 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.19 107.59 8.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.81 4.38 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.8 19.24 9.4 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.381 0.537 . . . . 0.0 111.864 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.475 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.1 116.14 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.08 123.78 19.05 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.48 127.93 55.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.097 0.475 . . . . 0.0 111.441 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -133.46 140.27 47.18 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.818 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.7 p -127.33 136.34 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 147.13 19.02 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.15 155.76 17.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.911 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.1 23.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.068 0.461 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -57.63 -33.38 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -79.89 -5.63 55.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.9 t -82.79 132.98 49.83 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 87.3 Cg_endo -79.6 153.19 23.26 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.541 1.494 . . . . 0.0 110.573 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.8 t80 -63.53 -38.45 91.18 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.658 -0.651 . . . . 0.0 110.987 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -56.28 -37.33 69.69 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.599 0.238 . . . . 0.0 110.641 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -71.34 -35.62 71.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.857 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' PRO . 12.7 t -62.24 -38.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.715 HD11 ' CE1' ' A' ' 76' ' ' TYR . 50.5 mm -60.05 -47.92 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.42 0.629 . . . . 0.0 109.612 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -53.79 -44.37 70.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.154 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.69 80.69 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.693 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' B' ' 83' ' ' LEU . 7.4 mt -60.3 -36.35 77.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -61.92 -42.58 99.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.149 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.0 mt -64.43 -39.04 93.07 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 110.985 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 91' ' ' ILE . 2.1 mm? -64.24 -41.84 96.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.139 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -63.47 -40.13 96.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.373 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -38.14 76.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.483 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.29 9.77 27.4 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.42 44.15 95.72 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.709 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp -97.9 -36.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.627 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 33.3 t -98.72 -58.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 26.2 t -125.7 126.16 24.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.129 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -54.3 174.21 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.79 2.327 . . . . 0.0 115.407 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.433 HG23 HG22 ' B' ' 64' ' ' THR . 45.9 t -112.17 117.57 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.92 127.27 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.398 -178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.491 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.5 tt -115.59 121.85 43.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.491 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.5 tt0 -106.8 125.9 51.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.921 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -84.59 116.06 27.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.587 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.9 -24.34 15.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.39 -126.35 0.97 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.964 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.1 mm -108.03 100.88 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.421 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.16 -2.97 87.95 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.144 -0.55 . . . . 0.0 114.0 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 127.85 53.54 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -137.34 157.22 47.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.237 1.018 . . . . 0.0 113.379 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.44 141.72 51.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.754 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.703 HD12 HD11 ' B' ' 37' ' ' ILE . 6.1 pt -131.49 134.57 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.736 0.698 . . . . 0.0 112.816 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.98 114.25 27.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.517 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.703 HD11 HD12 ' B' ' 35' ' ' ILE . 45.1 mt -114.29 109.77 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.36 45.7 22.1 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.831 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.88 -27.31 13.08 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.849 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -84.96 125.43 32.68 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.061 0.931 . . . . 0.0 110.522 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.34 133.09 51.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.823 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.3 127.57 53.33 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -117.18 155.59 29.13 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.51 50.87 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.137 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' B' ' 42' ' ' GLN . 41.4 mt -87.05 149.23 24.87 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.528 0.68 . . . . 0.0 111.998 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -90.98 172.84 8.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.759 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.431 ' O ' HG12 ' B' ' 50' ' ' VAL . 6.1 mt-10 -67.92 -44.11 77.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.8 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -64.41 -38.38 90.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.043 0.449 . . . . 0.0 110.809 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 36.2 mtp -69.23 -46.71 66.68 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.66 -34.37 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -63.47 -50.23 70.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.719 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.8 -52.07 44.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.733 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 6.5 mt -64.61 -48.22 75.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.621 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -43.84 88.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 111.739 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -66.52 -42.98 86.45 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.486 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.61 -40.65 95.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.745 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -69.55 -37.35 77.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.996 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.98 -30.81 67.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.18 -27.65 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.947 0.34 . . . . 0.0 111.039 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -82.33 -36.54 26.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -132.38 107.34 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -80.58 4.54 18.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -123.75 19.18 9.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.465 0.575 . . . . 0.0 111.845 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.433 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.23 116.49 8.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.4 123.83 19.31 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.38 127.66 55.73 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.45 139.96 47.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.609 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.774 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.2 p -127.05 136.5 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.51 147.05 18.96 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.03 155.83 17.32 Favored Glycine 0 N--CA 1.46 0.29 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.989 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 166.55 23.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -58.42 -33.14 69.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.461 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.99 -5.97 56.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -82.41 132.69 51.88 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.464 ' O ' HG23 ' B' ' 79' ' ' VAL . 93.0 Cg_endo -79.55 153.1 23.36 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.683 1.589 . . . . 0.0 110.316 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.717 ' CE1' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -63.38 -38.8 92.55 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.767 -0.583 . . . . 0.0 110.921 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.96 -37.37 68.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.492 0.187 . . . . 0.0 110.679 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -71.3 -35.85 71.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 75' ' ' PRO . 12.5 t -62.18 -38.26 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.717 HD11 ' CE1' ' B' ' 76' ' ' TYR . 50.4 mm -59.92 -47.63 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.51 0.671 . . . . 0.0 109.719 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 tttp -54.28 -44.29 71.77 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.46 81.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.148 0.499 . . . . 0.0 110.716 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.923 HD11 HD11 ' A' ' 83' ' ' LEU . 7.2 mt -60.68 -36.2 78.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.604 0.716 . . . . 0.0 109.238 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -61.93 -42.24 98.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.0 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 1.8 mt -64.86 -38.92 92.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.96 0.41 . . . . 0.0 110.948 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.435 HD12 HG21 ' B' ' 91' ' ' ILE . 2.0 mm? -64.19 -42.05 96.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.288 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.36 -40.34 97.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -38.14 76.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.389 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.727 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.21 9.6 27.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.39 44.3 95.54 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 115.704 1.041 . . . . 0.0 115.704 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.727 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.3 mp -97.65 -37.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.67 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 p -169.42 -64.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 44.4 t -127.94 121.29 21.82 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.952 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.51 176.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.842 2.361 . . . . 0.0 115.692 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.58 116.62 53.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.883 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -108.55 127.16 65.19 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.604 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -115.14 122.04 44.86 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.544 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.2 tm-20 -111.24 128.07 55.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.131 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.31 116.62 29.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.508 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -97.16 -22.15 16.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.8 -122.08 0.72 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.741 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mm -115.59 87.52 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.32 27.72 19.57 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.388 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -139.13 93.08 2.65 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.517 0.675 . . . . 0.0 109.487 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.26 157.39 17.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.263 1.03 . . . . 0.0 113.231 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 142.0 51.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.867 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.709 HG23 HD12 ' A' ' 45' ' ' LEU . 4.8 pt -131.54 133.49 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 118.529 0.604 . . . . 0.0 112.422 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.51 114.33 27.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.473 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 35' ' ' ILE . 67.0 mt -114.27 110.08 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.208 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.42 45.03 22.26 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.93 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 -26.86 17.04 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.086 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.88 126.25 34.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.225 1.013 . . . . 0.0 110.525 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.36 131.94 52.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.921 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -118.75 127.2 53.32 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -117.56 158.67 24.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.49 27.39 54.87 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.949 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.709 HD12 HG23 ' A' ' 35' ' ' ILE . 10.0 mt -87.38 149.15 24.67 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.697 0.76 . . . . 0.0 112.191 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 p -91.36 171.53 9.15 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.419 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.42 -43.61 80.8 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.886 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.0 -38.8 92.42 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.027 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mtp -70.35 -44.11 68.82 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.48 -34.91 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -63.55 -50.46 69.43 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.855 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -50.67 -51.47 48.97 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.807 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.08 -48.09 74.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.279 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -43.84 83.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 111.622 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -66.76 -44.5 81.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.193 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.92 -40.58 96.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -69.41 -38.48 77.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.24 -31.27 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.23 -27.3 53.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.26 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -84.87 -36.62 21.42 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.994 0.426 . . . . 0.0 109.953 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.646 ' HB3' HG23 ' A' ' 64' ' ' THR . 10.4 m-20 -128.84 97.38 4.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.28 -6.11 37.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -114.16 19.19 16.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.573 0.624 . . . . 0.0 111.955 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -67.95 113.38 5.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.446 -179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.45 125.07 23.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -111.19 128.99 56.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.795 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.898 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.89 139.36 46.14 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.51 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.761 HG11 ' CD2' ' A' ' 83' ' ' LEU . 11.9 p -125.72 135.91 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.78 145.38 16.98 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.14 153.13 16.67 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.771 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.75 24.25 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -32.26 65.98 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.75 -5.71 59.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.38 133.25 53.67 Favored Pre-proline 0 CA--C 1.537 0.462 0 O-C-N 122.221 -0.299 . . . . 0.0 110.442 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 Cg_endo -77.34 148.96 27.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.729 1.619 . . . . 0.0 110.729 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 80' ' ' ILE . 4.7 t80 -63.04 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.748 -0.595 . . . . 0.0 111.251 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.56 -37.0 67.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.605 0.24 . . . . 0.0 110.832 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.6 -34.75 67.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.913 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 75' ' ' PRO . 13.2 t -62.67 -38.83 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.381 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CE1' ' A' ' 76' ' ' TYR . 43.3 mm -60.24 -47.48 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.474 0.654 . . . . 0.0 109.407 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -54.12 -43.99 70.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.2 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -49.05 79.28 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.123 0.487 . . . . 0.0 110.792 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.33 -37.9 82.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.381 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.09 -42.0 97.7 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.696 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.22 -39.61 92.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 110.98 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -63.51 -42.26 98.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.65 -42.05 98.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.394 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -38.84 74.26 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.392 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.99 10.83 20.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.65 97.73 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.595 HD13 HD13 ' A' ' 86' ' ' LEU . 4.4 mt -101.15 -34.92 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.666 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 8.9 p -169.69 -64.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.494 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 44.4 t -127.55 121.34 22.26 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -51.8 176.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.851 2.367 . . . . 0.0 115.663 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -111.5 116.81 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.902 HG23 HD11 ' B' ' 67' ' ' LEU . 3.2 mp -108.74 127.11 65.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.632 -177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.524 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.04 122.16 45.32 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.524 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.3 tm-20 -111.21 127.58 55.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.254 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.71 116.89 30.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.323 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -97.4 -22.61 16.51 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.34 -125.71 0.94 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.649 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -111.06 87.84 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.192 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.62 27.93 20.68 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.485 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -138.86 93.3 2.69 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.514 0.673 . . . . 0.0 109.281 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -105.56 157.03 17.67 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.356 1.074 . . . . 0.0 113.336 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.78 141.99 51.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.992 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.724 HG23 HD12 ' B' ' 45' ' ' LEU . 4.8 pt -131.48 133.94 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.527 0.603 . . . . 0.0 112.271 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.05 114.45 27.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.396 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.652 HD11 HD12 ' B' ' 35' ' ' ILE . 72.3 mt -114.46 110.1 30.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.192 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.494 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.17 45.38 20.74 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.044 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.84 -26.8 16.8 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.701 -0.761 . . . . 0.0 114.102 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -86.94 126.3 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.322 1.061 . . . . 0.0 110.436 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.52 131.93 52.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.962 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.04 127.19 53.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -117.33 158.58 24.15 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.242 0.544 . . . . 0.0 112.445 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.21 27.74 54.96 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.724 HD12 HG23 ' B' ' 35' ' ' ILE . 10.4 mt -87.2 149.1 24.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.57 0.7 . . . . 0.0 112.193 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.8 p -91.49 171.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.428 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.9 mt-10 -67.21 -44.08 80.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.748 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.78 -38.69 92.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mtp -70.3 -44.36 68.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.304 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -34.47 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.3 m -64.29 -50.24 68.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.873 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -50.73 -51.55 48.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.604 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.95 -48.32 74.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.11 -43.92 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.058 0.456 . . . . 0.0 111.781 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.458 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -66.81 -44.24 81.72 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.195 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -64.16 -40.09 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.904 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -69.68 -39.01 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.188 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -69.81 -31.2 68.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.09 -27.84 54.3 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.894 0.315 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -84.31 -36.15 22.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.11 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.662 ' HB3' HG23 ' B' ' 64' ' ' THR . 10.4 m-20 -129.27 97.13 4.49 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -70.93 -5.96 34.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -114.15 18.51 17.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.616 0.644 . . . . 0.0 112.053 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.662 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -67.27 113.71 5.4 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.79 124.39 21.36 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -110.62 128.78 55.83 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.372 0.606 . . . . 0.0 112.09 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.902 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -133.61 139.26 46.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.558 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.745 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.4 p -125.94 135.68 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.55 145.27 16.91 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.13 153.2 16.66 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.96 165.92 24.02 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.045 0.45 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -32.35 66.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.78 -5.51 58.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -81.49 133.39 53.11 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.481 ' O ' HG23 ' B' ' 79' ' ' VAL . 95.7 Cg_endo -77.59 149.12 26.7 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.725 1.617 . . . . 0.0 110.708 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.7 t80 -63.27 -39.08 93.58 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.709 -0.619 . . . . 0.0 111.157 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -55.51 -37.12 67.47 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.694 0.283 . . . . 0.0 110.728 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.4 -34.81 68.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.873 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.481 HG23 ' O ' ' B' ' 75' ' ' PRO . 13.9 t -62.67 -38.82 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.7 mm -60.58 -46.7 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.437 0.636 . . . . 0.0 109.447 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 2.4 mttp -54.84 -43.77 73.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.073 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.39 78.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.345 0.593 . . . . 0.0 110.792 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 83' ' ' LEU . 7.6 mt -60.08 -38.12 81.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 109.484 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.81 -42.27 97.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.817 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 9.4 mt -64.76 -39.86 94.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.938 0.399 . . . . 0.0 111.079 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.598 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.42 -42.39 98.74 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.258 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.56 -41.88 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.473 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -38.32 74.41 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.497 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.492 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.35 11.01 20.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 44.67 97.56 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.598 HD13 HD13 ' B' ' 86' ' ' LEU . 4.2 mt -101.05 -35.15 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 112.724 -0.15 . . . . 0.0 112.724 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -108.5 -63.57 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 34.3 t -124.36 123.58 25.87 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.67 174.52 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.903 2.402 . . . . 0.0 115.414 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.0 t -114.52 119.19 60.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.834 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.58 127.57 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.305 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.7 tt -113.88 119.99 39.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 3.1 tt0 -109.31 128.32 54.99 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.113 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -87.2 116.38 29.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.391 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -96.95 -22.75 16.67 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.17 -119.26 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.348 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.66 101.46 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.221 -0.489 . . . . 0.0 109.708 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.72 1.65 72.88 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.884 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.6 mttt -107.12 92.73 4.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.423 0.612 . . . . 0.0 109.831 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -104.14 156.22 18.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.174 0.988 . . . . 0.0 112.926 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.22 141.41 52.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.981 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CD1' HD13 ' A' ' 53' ' ' LEU . 6.5 pt -131.73 134.69 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.654 0.661 . . . . 0.0 112.702 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -112.1 115.77 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.884 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 35' ' ' ILE . 79.0 mt -115.94 110.56 32.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.084 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.3 44.58 27.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.992 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -26.25 18.77 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.744 -0.741 . . . . 0.0 114.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -88.71 127.95 35.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.58 1.19 . . . . 0.0 110.46 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -106.48 134.35 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.0 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.74 126.64 52.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -116.7 157.7 25.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.241 0.543 . . . . 0.0 112.366 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.05 27.76 51.9 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.052 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' A' ' 42' ' ' GLN . 16.7 mt -88.12 150.14 23.52 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 112.293 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.5 p -91.11 171.33 9.33 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.228 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' VAL . 14.6 mt-10 -67.14 -43.89 81.21 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.826 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.78 -38.57 91.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.171 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 mtp -69.87 -44.94 68.8 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.03 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.8 -34.14 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.8 m -64.11 -49.91 70.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.587 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.37 -52.68 35.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.696 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 35' ' ' ILE . 18.6 mt -64.42 -48.01 76.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.713 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.3 t -58.01 -43.88 86.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.074 0.464 . . . . 0.0 111.738 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -44.62 83.61 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.249 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.99 95.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.096 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -69.92 -38.56 76.27 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.634 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.83 -29.41 65.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -78.85 -26.87 44.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.822 0.283 . . . . 0.0 111.393 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -85.63 -34.18 21.44 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.61 95.78 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.74 -13.36 62.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -106.0 19.28 20.79 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.604 0.638 . . . . 0.0 111.897 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' A' ' 23' ' ' VAL . 27.1 m -68.28 111.41 4.56 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.0 tp -66.42 127.21 31.39 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 65' ' ' LEU . 61.2 m-85 -114.3 131.25 56.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.021 0.439 . . . . 0.0 111.486 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' B' ' 67' ' ' LEU . 3.3 pp -134.85 140.94 46.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 83' ' ' LEU . 14.5 p -127.07 136.72 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.15 146.03 17.51 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.81 154.81 16.68 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.093 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 165.13 24.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.134 0.467 . . . . 0.0 111.14 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.29 -32.35 66.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.59 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -81.28 -5.74 58.12 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.29 132.21 48.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.03 151.72 35.32 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.57 1.513 . . . . 0.0 110.193 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.2 t80 -63.38 -36.6 84.24 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.719 -0.613 . . . . 0.0 110.753 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.6 -36.44 69.4 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.81 -34.89 69.73 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.91 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.88 -38.42 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.299 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 49.7 mm -61.2 -47.34 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.426 0.631 . . . . 0.0 109.482 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 3.1 mmtp -54.9 -44.35 74.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.931 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -48.17 82.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.257 0.551 . . . . 0.0 111.055 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.63 -37.15 80.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.384 0.611 . . . . 0.0 109.659 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.92 -41.26 95.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.818 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.6 mt -65.5 -39.68 92.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.578 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 91' ' ' ILE . 2.2 mm? -62.86 -42.29 99.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.119 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -63.79 -42.09 97.79 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.369 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -37.86 75.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.478 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.66 10.51 25.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.65 97.16 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.5 mt -103.39 -37.02 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.017 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -109.07 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.784 0.326 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 34.2 t -124.4 123.67 25.84 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.155 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.41 174.06 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.963 2.442 . . . . 0.0 115.53 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.55 HG23 ' CG2' ' B' ' 64' ' ' THR . 58.8 t -114.34 119.07 60.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.831 HG23 HD11 ' B' ' 67' ' ' LEU . 3.3 mp -110.48 127.81 67.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.302 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.7 tt -114.23 119.83 38.38 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 2.9 tt0 -109.06 128.14 54.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.262 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -87.02 116.0 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.364 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.98 -22.48 16.81 Favored 'General case' 0 CA--C 1.522 -0.112 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.12 -123.53 0.82 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.117 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.51 101.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.894 -0.653 . . . . 0.0 110.279 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.48 1.78 72.03 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.047 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -107.05 92.79 4.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 117.473 0.637 . . . . 0.0 109.747 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -103.89 155.89 18.27 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.26 1.029 . . . . 0.0 113.031 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -123.89 142.12 51.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.772 -1.558 . . . . 0.0 108.928 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.596 HD11 HD13 ' B' ' 53' ' ' LEU . 6.6 pt -132.24 134.8 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 118.671 0.669 . . . . 0.0 112.41 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -112.4 115.89 29.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.543 HD11 HD12 ' B' ' 35' ' ' ILE . 78.2 mt -115.93 110.64 32.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.018 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.31 44.27 27.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.219 -0.991 . . . . 0.0 114.19 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.7 -25.78 21.55 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.061 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -89.01 127.97 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.256 1.028 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.75 134.46 49.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.8 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.62 127.0 53.17 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -117.45 157.94 25.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 112.08 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.79 27.77 52.8 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.896 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 42' ' ' GLN . 16.3 mt -88.35 149.87 23.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.749 0.785 . . . . 0.0 112.35 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.0 p -90.88 171.18 9.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.443 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 14.8 mt-10 -67.11 -43.92 81.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.804 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.95 -38.83 92.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.021 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.7 mtp -69.55 -44.78 70.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.114 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.81 -34.36 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -63.83 -49.92 70.95 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.708 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.18 -52.69 33.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.82 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.596 HD13 HD11 ' B' ' 35' ' ' ILE . 18.4 mt -64.45 -48.38 75.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.723 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -57.9 -43.3 86.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.052 0.453 . . . . 0.0 111.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.86 81.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.305 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -40.37 96.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.62 -38.63 77.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -70.46 -29.72 66.36 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -78.85 -27.08 44.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.876 0.307 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -85.59 -33.71 21.61 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.718 0.294 . . . . 0.0 110.544 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -131.01 95.99 3.94 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.1 -13.42 62.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -105.91 19.48 20.47 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.722 0.692 . . . . 0.0 111.809 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.55 ' CG2' HG23 ' B' ' 23' ' ' VAL . 27.9 m -68.13 111.25 4.38 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.687 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.1 tp -66.41 126.94 30.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.687 ' N ' HD12 ' B' ' 65' ' ' LEU . 61.8 m-85 -113.99 131.26 56.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 111.567 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -134.98 141.14 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.623 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.732 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.8 p -127.47 137.21 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.47 146.14 17.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.69 155.11 16.62 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.765 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.93 165.43 24.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.893 0.378 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.66 -32.75 67.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.294 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -80.99 -5.83 58.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.24 132.04 48.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.81 151.82 36.41 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.557 1.505 . . . . 0.0 110.241 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.724 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -63.51 -36.66 84.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.752 -0.592 . . . . 0.0 110.692 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.65 -36.57 69.69 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -71.49 -34.64 70.32 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.26 -38.17 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.461 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.724 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 49.1 mm -61.27 -47.13 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 3.2 mmtp -55.0 -44.62 74.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.971 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.37 -47.96 83.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 111.086 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.78 -37.31 81.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.698 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.59 -41.56 94.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.751 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.1 mt -65.37 -39.41 92.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.031 0.444 . . . . 0.0 110.565 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.49 HD13 HD13 ' B' ' 91' ' ' ILE . 2.4 mm? -62.96 -42.59 99.87 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -63.26 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.515 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -38.13 75.93 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.509 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.607 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.28 10.17 25.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.25 44.87 97.02 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.7 mt -103.36 -37.15 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 0.0 109.768 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 t -96.52 -47.94 5.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.331 . . . . 0.0 110.984 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 36.3 t -125.49 127.09 24.99 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.49 173.9 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.664 2.243 . . . . 0.0 115.575 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 64' ' ' THR . 49.2 t -112.77 119.24 59.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -110.14 127.27 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.309 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.5 tt -115.66 122.12 44.61 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.0 tt0 -111.0 127.15 55.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.411 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -84.73 112.06 21.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.69 -22.52 20.18 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -119.87 0.65 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.775 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' OE2' ' A' ' 78' ' ' GLU . 27.0 mm -111.87 99.4 8.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 122.905 0.482 . . . . 0.0 109.899 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.08 -2.47 87.62 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.228 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 131.29 54.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.866 0.833 . . . . 0.0 109.431 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -139.29 158.26 44.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.11 0.957 . . . . 0.0 112.942 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 142.64 51.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.192 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.856 HG23 HD12 ' A' ' 45' ' ' LEU . 5.4 pt -130.09 132.9 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.146 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.02 114.63 27.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 35' ' ' ILE . 81.1 mt -114.99 110.39 31.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.473 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.39 46.0 28.78 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.21 -0.995 . . . . 0.0 114.141 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.13 -24.53 24.45 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.68 -0.771 . . . . 0.0 114.308 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 127.76 36.0 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.512 1.156 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.77 133.13 50.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.956 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.86 127.22 53.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -117.45 157.65 25.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.917 0.389 . . . . 0.0 111.919 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.64 26.43 56.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.918 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 35' ' ' ILE . 9.2 mt -85.38 147.58 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.276 0.538 . . . . 0.0 111.941 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -92.03 172.06 8.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.547 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.2 mt-10 -66.14 -45.45 80.94 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.13 -39.42 93.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.14 -0.35 . . . . 0.0 111.059 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.413 ' CE ' HD22 ' A' ' 45' ' ' LEU . 10.3 ttp -70.61 -40.94 72.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -62.82 -34.8 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 m -63.61 -49.95 71.29 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.881 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.47 -52.58 36.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.642 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 35' ' ' ILE . 27.2 mt -64.95 -47.69 76.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.51 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -43.47 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 111.54 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -66.25 -44.24 84.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -41.75 99.17 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.106 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.63 -39.66 73.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -69.89 -28.05 65.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.682 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.41 -27.03 38.15 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.223 -0.298 . . . . 0.0 111.301 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -85.73 -35.41 20.82 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -130.88 105.33 7.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.86 9.23 10.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -126.52 16.25 7.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.486 0.585 . . . . 0.0 111.901 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.497 HG22 HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -68.01 113.77 5.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.46 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 66' ' ' PHE . 8.1 tp -58.44 124.3 19.11 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.5 m-85 -113.1 131.56 55.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.819 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.4 pp -135.22 140.17 45.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.591 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.744 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.65 136.94 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -140.38 147.9 19.55 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.623 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.32 154.55 16.52 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.08 23.38 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.934 0.367 . . . . 0.0 111.437 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -57.54 -32.73 67.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.42 -7.0 58.95 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.7 t -87.71 128.1 55.72 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.47 156.54 54.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.075 1.183 . . . . 0.0 110.08 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.8 t80 -63.65 -36.23 83.13 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.925 -0.485 . . . . 0.0 110.514 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -56.58 -36.33 69.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' OE2' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -70.24 -37.16 74.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.509 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 t -61.36 -39.34 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.897 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 48.2 mm -60.76 -46.93 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.327 0.584 . . . . 0.0 109.577 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -44.84 75.38 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.164 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.07 86.97 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.288 0.566 . . . . 0.0 111.049 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -61.13 -36.77 80.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.586 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.52 -41.15 96.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -39.99 94.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.865 0.365 . . . . 0.0 110.729 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' A' ' 91' ' ' ILE . 1.5 mm? -63.49 -42.4 98.54 Favored 'General case' 0 C--N 1.335 -0.037 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -63.31 -42.14 99.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.421 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.66 -38.73 78.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.384 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.6 10.71 24.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' A' ' 86' ' ' LEU . 5.3 mt -102.18 -37.68 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.812 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.694 -0.163 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.3 t -96.85 -47.93 5.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.452 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 33.5 t -125.53 127.28 24.93 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.38 173.59 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.755 2.303 . . . . 0.0 115.533 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.48 HG23 HG22 ' B' ' 64' ' ' THR . 47.1 t -112.55 119.15 59.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.961 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -110.36 127.49 67.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.263 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.513 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.4 tt -115.98 122.43 45.22 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.513 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.2 tt0 -110.95 127.77 55.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.486 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.04 112.1 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.59 -22.63 20.21 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.65 -123.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.522 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.432 HD12 ' OE2' ' B' ' 78' ' ' GLU . 27.3 mm -107.64 99.56 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.842 -0.679 . . . . 0.0 110.121 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.05 -2.54 87.52 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 114.407 0.523 . . . . 0.0 114.407 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 131.22 54.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.644 0.722 . . . . 0.0 109.556 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -139.17 158.12 44.74 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.143 0.973 . . . . 0.0 112.954 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 142.73 51.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 113.94 -1.482 . . . . 0.0 109.069 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.845 HG23 HD12 ' B' ' 45' ' ' LEU . 5.5 pt -130.33 133.11 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.974 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.98 114.93 28.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.463 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.567 HD11 HD12 ' B' ' 35' ' ' ILE . 81.7 mt -115.27 110.1 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.391 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.39 45.67 28.74 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.256 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.81 -24.94 23.93 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.025 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.82 127.31 35.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.683 1.241 . . . . 0.0 110.393 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -105.2 133.2 50.37 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.115 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.74 127.14 53.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -117.43 157.39 26.3 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.969 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.83 26.37 56.23 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.845 HD12 HG23 ' B' ' 35' ' ' ILE . 9.0 mt -85.18 147.3 26.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.238 0.519 . . . . 0.0 111.778 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -91.83 172.14 8.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.441 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.441 ' O ' HG12 ' B' ' 50' ' ' VAL . 3.2 mt-10 -66.57 -45.08 80.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.18 -39.23 93.57 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.002 -0.436 . . . . 0.0 111.053 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.406 ' CE ' HD22 ' B' ' 45' ' ' LEU . 9.6 ttp -70.71 -40.91 72.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.441 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -62.81 -35.07 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -63.3 -50.23 70.87 Favored 'General case' 0 CA--C 1.523 -0.066 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.926 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.23 -52.83 32.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.624 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.451 HD13 HD11 ' B' ' 35' ' ' ILE . 30.4 mt -64.75 -47.72 77.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.601 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -58.85 -43.33 90.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.279 0.561 . . . . 0.0 111.661 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -66.23 -44.06 84.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.284 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -42.0 99.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.59 -39.41 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.987 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.06 -28.47 65.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.716 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.78 -27.48 40.4 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.948 0.34 . . . . 0.0 111.43 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.72 -34.85 21.14 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.949 0.404 . . . . 0.0 110.337 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -131.16 105.74 7.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.33 9.48 10.8 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -126.58 16.15 7.58 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 111.854 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.48 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -68.06 114.27 6.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.375 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.439 HD12 ' N ' ' B' ' 66' ' ' PHE . 7.8 tp -58.85 124.48 19.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.608 0.242 . . . . 0.0 110.534 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.439 ' N ' HD12 ' B' ' 65' ' ' LEU . 31.8 m-85 -113.51 131.36 56.09 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.799 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.34 140.18 44.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.881 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.762 HG11 ' CD2' ' B' ' 83' ' ' LEU . 14.3 p -126.76 136.03 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.42 147.68 19.39 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.806 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.98 154.3 16.46 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.95 165.67 23.22 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.956 0.408 . . . . 0.0 111.286 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -58.42 -32.72 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.324 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.21 -7.5 59.0 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -86.98 128.03 57.4 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.42 156.4 54.48 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.139 1.226 . . . . 0.0 110.165 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.39 -36.44 83.74 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.866 -0.521 . . . . 0.0 110.683 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.18 -36.39 68.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.432 ' OE2' HD12 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -70.38 -37.15 74.5 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.674 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.19 -39.59 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.674 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 47.9 mm -60.59 -47.3 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 109.64 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.06 74.36 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.216 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.63 84.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.382 0.61 . . . . 0.0 110.907 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.53 -36.72 79.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.78 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -61.72 -41.32 97.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.837 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -39.94 94.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.002 0.429 . . . . 0.0 110.684 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.586 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -63.59 -42.54 98.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.304 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.73 76.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.74 10.84 24.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 44.41 98.11 Favored Glycine 0 C--N 1.33 0.25 0 N-CA-C 115.059 0.784 . . . . 0.0 115.059 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.586 HD13 HD13 ' B' ' 86' ' ' LEU . 5.0 mt -101.9 -37.05 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.75 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 m -163.03 -61.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 42.9 t -127.02 123.19 23.46 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.269 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -52.37 175.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.017 2.478 . . . . 0.0 115.775 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 58.5 t -112.82 118.82 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.22 127.87 68.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 26' ' ' GLU . 4.9 tt -116.01 123.27 47.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.9 tm-20 -112.01 128.98 56.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.156 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 74' ' ' VAL . 29.3 t -88.68 96.67 6.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.181 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB3' ' HG3' ' A' ' 32' ' ' LYS . . . -76.61 -22.06 54.69 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.52 -120.65 0.65 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -112.57 101.12 12.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.019 0.527 . . . . 0.0 109.706 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.59 0.48 73.5 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.806 -0.633 . . . . 0.0 113.93 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -109.66 95.95 5.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.732 0.777 . . . . 0.0 110.285 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -104.83 156.65 17.82 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.294 1.045 . . . . 0.0 113.025 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -124.09 142.25 51.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.666 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 37' ' ' ILE . 5.3 pt -132.77 134.24 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.15 115.15 28.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.679 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 35' ' ' ILE . 48.8 mt -114.56 109.51 28.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.252 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.22 45.38 27.61 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.13 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.11 -25.73 22.61 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.071 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.47 128.07 36.41 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.327 1.064 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.89 136.05 47.4 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.023 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 127.48 53.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.35 157.7 25.69 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 112.228 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.53 52.55 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.12 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.614 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -87.94 147.7 24.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 112.221 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -89.71 169.88 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.629 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -65.55 -45.36 83.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.861 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -64.39 -38.77 92.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.101 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.562 ' CE ' HD22 ' A' ' 45' ' ' LEU . 11.1 ttp -72.11 -37.76 69.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.977 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.6 p -64.97 -33.36 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.2 m -62.94 -50.3 71.35 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.448 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.13 -52.49 34.73 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.866 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -65.21 -47.36 77.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.773 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -58.7 -43.11 89.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.482 . . . . 0.0 111.592 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -65.95 -44.34 85.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.284 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.37 -41.58 98.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.122 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -69.57 -38.97 77.61 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.95 -29.75 66.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.575 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -76.91 -27.71 55.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.94 0.336 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -83.44 -35.94 24.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.846 0.355 . . . . 0.0 110.065 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.68 105.25 7.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -78.17 -15.61 58.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -105.13 19.06 21.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.359 0.527 . . . . 0.0 111.858 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 1.9 m -68.79 116.18 8.99 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -63.83 125.27 23.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 178.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.664 ' N ' HD12 ' A' ' 65' ' ' LEU . 55.6 m-85 -111.63 130.04 55.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.198 0.523 . . . . 0.0 111.627 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -135.52 139.93 44.35 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.723 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.67 138.65 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.32 142.81 14.08 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.5 154.0 16.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.722 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.0 23.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -31.43 69.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.515 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.12 -7.07 59.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 27' ' ' VAL . 59.8 t -89.66 131.8 38.74 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.34 155.91 55.31 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.013 1.142 . . . . 0.0 110.246 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.71 -35.46 80.63 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.842 -0.536 . . . . 0.0 110.437 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -56.6 -36.94 69.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.649 0.261 . . . . 0.0 110.402 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -36.58 75.22 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.734 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.03 -39.26 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.483 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.6 mm -60.6 -46.56 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.41 0.624 . . . . 0.0 109.404 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.65 -45.11 73.77 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.182 178.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.386 0.613 . . . . 0.0 110.657 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' B' ' 83' ' ' LEU . 6.6 mt -60.65 -37.11 80.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.486 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -61.32 -41.77 97.56 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.787 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.73 -39.19 90.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.619 -178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.55 -42.89 98.35 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -62.45 -43.13 99.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.567 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.7 -37.57 79.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.422 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.53 10.48 25.25 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.24 98.22 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.3 mt -101.55 -33.78 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.975 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -162.48 -61.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 44.8 t -126.93 123.44 23.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.197 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -52.42 175.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.987 2.458 . . . . 0.0 115.829 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.564 HG23 ' CG2' ' B' ' 64' ' ' THR . 60.3 t -113.08 118.43 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.813 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -111.2 127.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.316 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' B' ' 26' ' ' GLU . 4.9 tt -115.97 123.44 48.02 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.55 ' N ' HD23 ' B' ' 25' ' ' LEU . 3.9 tm-20 -112.03 129.34 56.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.215 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 74' ' ' VAL . 28.4 t -88.91 96.48 6.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.185 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.409 ' HB3' ' HG3' ' B' ' 32' ' ' LYS . . . -76.92 -21.38 54.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.22 -125.3 0.91 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.651 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -107.65 101.9 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.016 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.45 70.55 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.006 -0.543 . . . . 0.0 114.099 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -109.58 95.57 5.7 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.823 0.821 . . . . 0.0 110.361 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -104.24 156.49 17.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.279 1.037 . . . . 0.0 113.093 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -124.0 142.14 51.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.479 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.668 HD12 HD11 ' B' ' 37' ' ' ILE . 5.6 pt -132.76 134.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.452 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -111.3 115.1 28.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.595 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.668 HD11 HD12 ' B' ' 35' ' ' ILE . 45.6 mt -114.51 109.71 29.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.301 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.497 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.89 45.76 25.51 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.408 -0.901 . . . . 0.0 114.179 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -25.77 21.71 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.144 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.39 128.09 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.33 1.065 . . . . 0.0 110.396 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.82 136.02 47.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.899 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.555 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.4 127.52 53.19 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.43 157.02 26.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 27.97 49.01 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 113.119 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.616 HD12 HG23 ' B' ' 35' ' ' ILE . 9.2 mt -87.93 148.23 24.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.653 0.74 . . . . 0.0 112.305 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -90.53 169.59 10.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.411 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.469 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.7 mt-10 -65.27 -45.36 84.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -64.37 -38.81 92.33 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.948 -0.47 . . . . 0.0 111.069 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.566 ' CE ' HD22 ' B' ' 45' ' ' LEU . 10.2 ttp -71.75 -37.98 70.46 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.5 p -64.75 -33.42 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.1 m -62.99 -50.29 71.33 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.506 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.09 -52.39 35.08 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.797 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.416 HD13 HD11 ' B' ' 35' ' ' ILE . 38.6 mt -65.25 -47.73 75.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.683 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -58.38 -43.37 88.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.077 0.465 . . . . 0.0 111.527 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -65.84 -44.4 85.62 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.28 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.27 -41.58 99.04 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.184 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.56 -38.84 77.59 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -69.93 -29.71 66.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.692 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -77.0 -27.78 54.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.851 0.296 . . . . 0.0 111.26 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -83.29 -35.52 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.838 0.351 . . . . 0.0 110.102 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -130.15 105.0 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.84 -15.54 58.98 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -105.38 19.57 20.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.362 0.528 . . . . 0.0 111.899 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.564 ' CG2' HG23 ' B' ' 23' ' ' VAL . 1.8 m -69.26 116.05 9.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.647 HD12 ' N ' ' B' ' 66' ' ' PHE . 0.8 OUTLIER -63.6 125.35 23.99 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.647 ' N ' HD12 ' B' ' 65' ' ' LEU . 55.4 m-85 -111.74 130.58 55.75 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.559 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -135.91 140.06 43.78 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.915 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.722 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -126.85 138.77 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 142.86 14.09 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.25 153.94 16.82 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.09 163.28 24.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.057 0.455 . . . . 0.0 111.322 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -31.44 69.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.307 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.8 -7.15 59.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.4 HG11 HG11 ' B' ' 27' ' ' VAL . 66.9 t -89.55 132.1 38.05 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.5 155.78 54.72 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.052 1.168 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.754 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.74 -35.38 80.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.863 -0.523 . . . . 0.0 110.363 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -56.73 -36.78 70.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.565 0.221 . . . . 0.0 110.423 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.0 -36.5 75.19 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.713 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.19 -39.2 83.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.579 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.754 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.8 mm -60.53 -46.61 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.364 0.602 . . . . 0.0 109.435 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -44.88 73.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.085 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.64 80.86 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.278 0.561 . . . . 0.0 110.767 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.983 HD11 HD11 ' A' ' 83' ' ' LEU . 6.8 mt -60.21 -37.03 79.05 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.566 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -61.13 -41.93 97.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.981 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.41 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.9 OUTLIER -65.69 -39.36 91.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.592 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.567 HD13 HD13 ' B' ' 91' ' ' ILE . 1.5 mm? -63.42 -42.55 98.73 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -62.75 -43.23 99.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.589 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.77 79.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.491 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.19 10.54 24.17 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.42 44.63 97.43 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.071 0.788 . . . . 0.0 115.071 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -101.84 -34.21 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.873 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -68.43 -42.45 78.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.814 0.34 . . . . 0.0 110.997 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 48.0 t -114.57 119.11 40.38 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.712 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.27 174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.0 2.467 . . . . 0.0 115.663 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.8 118.89 58.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 67' ' ' LEU . 3.5 mp -111.2 127.61 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.652 0.263 . . . . 0.0 111.607 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -115.88 122.65 45.99 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -110.59 127.29 55.16 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.207 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.7 105.27 14.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.723 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.63 -22.3 28.02 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.99 -121.55 0.72 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.956 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.15 97.97 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 122.869 0.467 . . . . 0.0 109.94 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.05 -5.3 85.02 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.956 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.04 128.55 53.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.562 0.681 . . . . 0.0 109.482 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -134.84 156.03 49.61 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.231 1.015 . . . . 0.0 112.759 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.45 141.53 52.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.796 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 45' ' ' LEU . 5.1 pt -132.48 133.85 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.263 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -111.36 115.52 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.561 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 35' ' ' ILE . 89.9 mt -113.69 108.92 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.281 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.69 46.74 24.46 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.65 -0.786 . . . . 0.0 114.079 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.99 15.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.082 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.3 129.24 36.55 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.527 1.163 . . . . 0.0 110.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -107.96 135.95 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.027 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -117.53 125.58 51.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.84 156.21 26.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.064 0.459 . . . . 0.0 111.885 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.64 26.95 52.81 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.959 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 42' ' ' GLN . 20.5 mt -86.96 148.7 25.22 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.344 0.572 . . . . 0.0 111.743 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.2 p -89.6 171.73 9.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.183 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' O ' HG12 ' A' ' 50' ' ' VAL . 4.1 mt-10 -66.86 -44.92 79.7 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -62.91 -38.09 89.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.234 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 mtp -70.22 -43.43 70.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -59.27 -34.73 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.899 0.38 . . . . 0.0 110.08 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -63.98 -50.48 68.41 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.824 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -50.71 -52.07 43.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.657 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.84 -47.95 76.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.46 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -57.32 -43.88 83.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 111.618 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mmt180 -66.66 -44.33 82.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.243 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -64.53 -40.02 94.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.99 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -69.94 -38.69 76.26 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.43 -31.33 69.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.9 -28.73 55.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.887 0.312 . . . . 0.0 111.239 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -82.24 -36.82 26.78 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -128.59 112.16 13.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -84.58 -10.07 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -112.45 19.67 17.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.376 0.535 . . . . 0.0 111.952 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 113.36 5.55 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.32 125.51 24.15 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -112.54 128.31 56.31 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 111.737 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' B' ' 67' ' ' LEU . 3.1 pp -132.16 139.27 48.34 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.461 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 83' ' ' LEU . 15.0 p -127.24 137.89 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.35 144.62 15.84 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.6 156.61 16.01 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.833 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.51 163.21 24.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.138 0.495 . . . . 0.0 111.276 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -57.47 -31.85 66.36 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.649 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.01 -6.01 58.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.27 129.72 57.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' VAL . 67.9 Cg_endo -73.31 151.81 49.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.22 1.28 . . . . 0.0 110.426 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -62.94 -39.46 94.7 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.493 -0.754 . . . . 0.0 111.271 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.73 -35.58 66.29 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.82 -35.96 70.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.204 0.526 . . . . 0.0 109.744 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' PRO . 6.5 t -62.44 -38.82 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.439 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 76' ' ' TYR . 47.7 mm -61.04 -47.6 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -44.74 68.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.16 78.93 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.454 0.645 . . . . 0.0 110.358 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.35 -37.08 79.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.864 0.84 . . . . 0.0 109.353 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -61.32 -42.92 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 47' ' ' GLU . 7.6 mt -63.6 -39.73 95.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 110.657 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.08 -41.97 99.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -63.85 -41.23 97.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.486 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.7 -38.68 78.81 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.442 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.43 11.02 22.9 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.32 44.13 98.1 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.668 HD13 HD13 ' A' ' 86' ' ' LEU . 3.4 mt -99.11 -36.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.671 -179.525 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 112.731 -0.147 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -67.94 -42.53 80.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 110.775 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 48.3 t -114.29 119.57 40.01 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.11 175.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.932 2.421 . . . . 0.0 115.652 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.63 118.67 58.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -110.98 127.43 68.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 120.698 0.285 . . . . 0.0 111.675 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.8 tt -115.65 122.59 46.03 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -110.6 126.85 54.89 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.314 -178.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.43 105.3 14.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.788 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.36 -22.31 28.5 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.88 -124.71 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.778 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -109.04 97.58 5.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.406 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.33 -5.19 85.05 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.106 -0.569 . . . . 0.0 114.049 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 128.79 54.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -135.15 156.07 49.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.334 1.064 . . . . 0.0 112.804 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.52 141.48 52.06 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.828 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.543 HG23 HD12 ' B' ' 45' ' ' LEU . 5.1 pt -132.31 134.14 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.265 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -111.58 115.72 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.566 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.48 HD11 HD12 ' B' ' 35' ' ' ILE . 93.0 mt -113.98 108.8 26.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.276 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.85 46.47 25.42 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.015 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.91 16.53 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.046 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -90.39 129.27 36.61 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.453 1.127 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -108.37 135.96 48.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.923 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -117.43 126.14 52.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -116.25 156.21 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.175 0.512 . . . . 0.0 111.864 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.52 27.35 51.74 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.065 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' B' ' 42' ' ' GLN . 20.9 mt -87.27 148.89 24.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.281 0.562 . . . . 0.0 111.741 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.5 p -89.51 171.88 9.38 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.183 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.51 ' O ' HG12 ' B' ' 50' ' ' VAL . 4.2 mt-10 -67.05 -44.85 79.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.508 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.19 -37.99 89.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.101 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 23.6 mtp -70.14 -43.68 70.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.51 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.8 OUTLIER -59.13 -34.65 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.2 m -64.27 -50.24 68.7 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.834 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -50.65 -51.94 44.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.658 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.02 -48.02 75.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.377 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.12 -44.05 82.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 111.561 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.425 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 2.4 mmt180 -66.65 -44.27 82.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.147 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.5 -40.25 95.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.929 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -69.91 -38.26 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.195 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -69.91 -31.3 69.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.6 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -76.81 -28.98 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 122.213 -0.305 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -82.06 -36.56 27.54 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -128.71 112.39 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -84.66 -10.43 57.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -112.21 19.63 17.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.322 0.51 . . . . 0.0 111.945 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 113.11 5.17 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.39 125.31 23.46 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -112.3 128.01 56.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 111.672 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 67' ' ' LEU . 3.3 pp -132.21 139.45 48.33 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.344 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.772 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.3 p -127.53 137.91 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.55 145.12 16.42 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.81 156.86 16.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.039 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 163.18 24.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 111.396 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -57.59 -31.82 66.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.485 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.17 -6.37 59.15 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 72.6 t -83.77 129.43 59.42 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.98 151.57 50.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.545 1.496 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -62.86 -39.62 94.96 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.757 -0.589 . . . . 0.0 111.23 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.42 -35.55 65.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.685 0.279 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -72.07 -35.74 69.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -62.65 -38.85 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.7 mm -60.98 -47.45 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -44.63 68.08 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.982 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.407 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.33 -48.85 80.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 110.459 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -60.59 -37.2 80.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.789 0.804 . . . . 0.0 109.221 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.19 -42.77 99.17 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.677 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.411 HD11 ' OE1' ' B' ' 47' ' ' GLU . 8.3 mt -63.96 -39.57 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.239 0.542 . . . . 0.0 110.831 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.67 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.32 -41.72 98.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.894 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -63.9 -41.38 97.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.59 -38.69 78.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.366 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.606 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.35 11.0 22.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.37 44.28 97.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.67 HD13 HD13 ' B' ' 86' ' ' LEU . 3.4 mt -99.16 -36.16 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.893 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -51.45 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.3 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 17.7 t -121.82 125.45 26.71 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.63 173.24 0.19 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.677 2.251 . . . . 0.0 115.094 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 64' ' ' THR . 47.6 t -113.59 118.07 57.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' A' ' 67' ' ' LEU . 3.3 mp -109.44 127.69 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.141 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.6 tt -113.96 120.35 40.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' N ' HD23 ' A' ' 25' ' ' LEU . 8.8 tt0 -111.12 128.77 56.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.177 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 74' ' ' VAL . 38.8 t -85.29 120.84 36.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.743 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.11 -23.12 14.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.37 -121.16 0.65 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.983 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -113.55 100.56 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.98 -0.77 86.64 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.881 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.24 93.93 4.82 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.42 0.61 . . . . 0.0 110.009 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -103.37 156.01 18.06 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.11 0.957 . . . . 0.0 112.717 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -122.92 141.44 51.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.989 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.611 HD11 HD13 ' A' ' 53' ' ' LEU . 8.7 pt -131.06 133.8 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.94 114.24 27.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.645 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 35' ' ' ILE . 98.3 mt -116.09 110.09 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.883 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.61 42.76 28.0 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.717 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.78 -26.39 18.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.996 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.72 124.93 31.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.184 0.992 . . . . 0.0 110.526 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 130.98 52.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.632 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -119.37 127.12 52.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.69 157.87 25.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.021 0.439 . . . . 0.0 111.901 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.91 27.3 50.74 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.07 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 42' ' ' GLN . 15.4 mt -88.48 150.32 23.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.8 0.81 . . . . 0.0 112.698 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -91.32 171.59 9.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.143 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 24.4 mt-10 -66.49 -45.02 80.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.789 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -63.53 -39.28 94.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 mtm -69.92 -44.6 69.32 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.171 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -58.87 -33.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 m -63.89 -50.68 67.79 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.628 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -49.8 -53.23 26.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.659 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 35' ' ' ILE . 27.8 mt -64.78 -48.1 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.477 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 t -58.14 -43.12 87.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 111.701 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -44.1 84.62 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.499 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.66 -39.96 94.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -37.81 76.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.898 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.49 -31.15 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.641 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.01 -28.17 54.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.811 0.278 . . . . 0.0 111.249 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -83.27 -37.77 23.05 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.03 101.79 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -76.9 -1.54 29.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -121.38 19.76 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.164 0.438 . . . . 0.0 111.913 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.589 ' CG2' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.54 118.23 12.15 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.486 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -64.36 127.32 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -114.36 131.53 56.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 111.515 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.921 HD11 HG23 ' A' ' 24' ' ' ILE . 3.0 pp -135.55 141.3 45.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.023 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 83' ' ' LEU . 86.9 t -122.39 127.36 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.4 142.48 13.99 Favored Glycine 0 C--N 1.334 0.46 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.47 155.5 16.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.219 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.2 164.81 23.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.042 0.449 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -58.81 -32.79 69.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.51 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -80.72 -6.23 58.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 27' ' ' VAL . 77.3 t -85.64 136.82 36.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . 98.2 Cg_endo -78.75 152.24 25.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.542 1.495 . . . . 0.0 110.457 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -64.08 -38.51 91.33 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.24 -36.48 66.07 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.664 0.269 . . . . 0.0 110.538 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.09 -34.26 66.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.783 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.2 t -62.28 -39.98 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.709 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.4 mm -59.01 -48.81 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.609 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.002 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.22 70.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -60.62 -36.88 79.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.624 0.726 . . . . 0.0 109.255 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.75 -41.97 96.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.81 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 3.4 mt -65.49 -38.57 90.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.011 0.434 . . . . 0.0 110.487 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.43 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.08 -42.38 99.62 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.009 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.5 -41.54 98.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.593 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.51 -38.3 77.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.536 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -92.29 11.67 25.06 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.18 44.59 97.24 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 114.869 0.708 . . . . 0.0 114.869 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.2 mt -102.67 -35.3 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.421 . . . . 0.0 109.877 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.026 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -51.03 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.632 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 17.4 t -122.06 125.26 26.69 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.422 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.44 172.55 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.871 2.38 . . . . 0.0 115.104 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.576 HG23 HG22 ' B' ' 64' ' ' THR . 47.0 t -113.09 117.88 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.938 HG23 HD11 ' B' ' 67' ' ' LEU . 3.5 mp -109.21 127.97 65.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.47 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.7 tt -114.31 120.58 40.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 8.5 tt0 -111.31 128.93 56.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.137 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 74' ' ' VAL . 35.8 t -85.51 120.91 36.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.679 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 -23.18 13.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.13 -125.19 0.88 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.779 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.76 100.74 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.109 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.76 -0.53 86.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.119 -0.491 . . . . 0.0 114.013 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 94.5 5.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.466 0.633 . . . . 0.0 109.902 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.63 156.01 18.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.219 1.009 . . . . 0.0 112.765 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -122.76 141.91 51.3 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.038 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 53' ' ' LEU . 8.5 pt -131.28 133.8 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 113.9 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.79 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.536 HD11 HD12 ' B' ' 35' ' ' ILE . 99.0 mt -115.63 110.35 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.926 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.28 42.78 25.59 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.06 -1.067 . . . . 0.0 113.769 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -26.17 19.75 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.899 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.58 124.86 31.21 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.302 1.051 . . . . 0.0 110.561 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -104.83 131.01 52.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.644 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -119.36 126.7 52.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.51 158.05 25.22 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.063 0.459 . . . . 0.0 111.9 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 27.23 51.44 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.273 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 42' ' ' GLN . 14.7 mt -88.5 150.59 23.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.822 0.82 . . . . 0.0 112.681 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -91.68 171.5 9.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.1 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.492 ' O ' HG12 ' B' ' 50' ' ' VAL . 24.9 mt-10 -66.19 -45.18 81.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.57 -39.35 94.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.892 0.314 . . . . 0.0 111.325 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 mtm -69.84 -44.65 69.46 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.351 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.492 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -58.67 -33.49 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.8 m -64.21 -50.4 68.2 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.736 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.09 -53.01 30.12 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.523 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.591 HD13 HD11 ' B' ' 35' ' ' ILE . 22.6 mt -64.98 -47.88 75.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.729 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -58.41 -43.43 88.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -43.88 87.04 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.581 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -64.81 -40.07 94.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.75 76.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -70.39 -31.17 68.28 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.652 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -28.38 55.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.971 0.35 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -83.07 -37.74 23.45 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.17 101.22 6.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -76.23 -1.67 27.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -121.48 19.74 11.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.281 0.491 . . . . 0.0 111.824 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.576 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -69.56 118.0 11.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.421 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.8 127.03 29.55 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 40.0 m-85 -114.22 131.51 56.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.938 HD11 HG23 ' B' ' 24' ' ' ILE . 3.0 pp -135.55 141.4 45.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.264 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 87.0 t -122.53 127.07 74.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.13 142.44 13.96 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.42 155.15 16.27 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.117 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.02 165.2 23.68 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.968 0.414 . . . . 0.0 111.229 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -59.42 -32.21 69.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.429 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -80.94 -6.93 59.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.488 HG11 HG11 ' B' ' 27' ' ' VAL . 72.4 t -85.07 136.58 38.17 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.454 ' O ' HG23 ' B' ' 79' ' ' VAL . 96.1 Cg_endo -78.55 151.98 25.88 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.773 1.649 . . . . 0.0 110.385 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.5 t80 -63.88 -38.43 91.07 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.43 -0.794 . . . . 0.0 111.108 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -55.31 -36.5 66.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.68 0.276 . . . . 0.0 110.425 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.01 -34.31 66.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.078 0.466 . . . . 0.0 109.868 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' B' ' 75' ' ' PRO . 20.1 t -62.59 -39.1 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 45.6 mm -60.08 -48.26 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.507 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -53.68 -43.01 68.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.076 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -51.07 71.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 110.884 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 83' ' ' LEU . 8.5 mt -60.55 -37.51 81.48 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.702 0.763 . . . . 0.0 109.116 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.798 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.6 mt -65.49 -38.46 89.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.559 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.436 HD13 HD13 ' B' ' 91' ' ' ILE . 1.2 mm? -63.27 -42.21 99.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.094 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.68 -41.63 98.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.424 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.38 -38.37 77.15 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.429 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -92.07 11.49 25.18 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.37 44.8 97.2 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.2 mt -102.95 -35.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.986 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -136.06 -48.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.994 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 49.0 t -115.5 123.08 31.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.764 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.9 176.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.876 2.384 . . . . 0.0 115.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 HG22 ' A' ' 64' ' ' THR . 48.9 t -113.71 119.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.899 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -111.9 127.65 68.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.291 -178.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.481 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -114.73 121.23 42.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.17 127.18 53.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.286 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.17 118.7 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.69 -23.06 15.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.95 -120.27 0.65 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.01 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.525 HD13 ' HG2' ' A' ' 78' ' ' GLU . 28.4 mm -112.26 99.3 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 123.061 0.544 . . . . 0.0 109.793 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.75 -3.91 85.92 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.239 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 131.22 53.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 117.754 0.777 . . . . 0.0 109.897 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -138.03 157.24 46.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.134 0.969 . . . . 0.0 112.917 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.9 141.95 51.78 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.839 -1.528 . . . . 0.0 109.328 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 53' ' ' LEU . 8.2 pt -132.15 134.86 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.502 0.592 . . . . 0.0 112.406 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.28 115.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.488 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 HD12 ' A' ' 35' ' ' ILE . 80.7 mt -114.29 110.12 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.343 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.66 45.52 24.0 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.446 -0.883 . . . . 0.0 114.076 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -26.5 18.31 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.205 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.59 128.72 36.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.41 1.105 . . . . 0.0 110.356 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.31 135.95 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.007 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.565 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -119.07 126.86 52.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.45 156.81 27.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.103 0.477 . . . . 0.0 112.238 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.25 45.71 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.322 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.6 mt -90.27 151.99 21.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.45 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 p -92.58 171.54 8.95 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.187 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.24 -42.31 84.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.081 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -64.32 -39.46 93.96 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.073 0.463 . . . . 0.0 111.142 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.17 -43.9 69.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.288 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -59.31 -34.41 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -64.09 -49.58 71.7 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.62 -51.93 44.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.746 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 35' ' ' ILE . 31.4 mt -64.49 -48.03 76.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.527 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t -58.23 -43.73 87.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.422 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.4 85.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.314 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.47 -41.58 98.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.154 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.99 -38.06 75.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.018 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.22 -30.21 67.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.95 -27.96 49.43 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.186 -0.321 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -82.68 -36.87 25.55 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -131.55 105.68 7.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.38 -8.03 58.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.69 19.42 18.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.421 0.555 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.532 HG22 HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -68.96 117.84 11.13 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.2 tp -64.29 124.17 21.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.609 ' N ' HD12 ' A' ' 65' ' ' LEU . 56.2 m-85 -112.52 132.81 54.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.958 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.06 140.44 43.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.416 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.3 t -122.99 129.45 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.25 146.82 18.81 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.79 155.04 17.08 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.939 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.8 163.6 25.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.99 0.424 . . . . 0.0 111.248 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.73 -32.53 65.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.567 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -80.77 -5.56 57.33 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.3 t -89.79 131.07 40.66 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.46 155.69 50.37 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.152 1.235 . . . . 0.0 110.339 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.8 t80 -64.21 -34.89 79.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 121.787 -0.57 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -71.48 -35.75 70.91 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.79 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.57 -39.24 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.714 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.1 mm -59.92 -48.88 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.518 0.675 . . . . 0.0 109.415 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.8 ttmm -53.98 -44.6 70.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.51 178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.69 -49.05 79.01 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.353 0.597 . . . . 0.0 111.009 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' B' ' 83' ' ' LEU . 11.4 mt -61.89 -36.0 80.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 108.989 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -61.8 -42.56 99.17 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.039 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.2 mt -63.87 -38.74 92.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.535 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 91' ' ' ILE . 1.8 mm? -63.81 -42.15 97.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.987 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -62.86 -42.39 99.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.668 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.47 -38.45 74.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.616 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -89.49 11.02 20.6 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.52 44.22 98.28 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.649 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt -101.57 -38.72 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.782 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 29.4 t -135.62 -48.14 0.69 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 111.008 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.502 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 49.8 t -115.74 123.09 31.7 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.55 176.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.07 2.513 . . . . 0.0 115.732 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.544 HG23 HG22 ' B' ' 64' ' ' THR . 47.4 t -113.51 119.68 61.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.946 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -111.87 127.93 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.316 -178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.459 HD13 HD21 ' B' ' 86' ' ' LEU . 8.0 tt -115.21 120.93 41.36 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.86 127.4 54.0 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.24 118.96 33.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.14 -22.78 15.05 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.8 -124.18 0.87 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.629 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.531 HD13 ' HG2' ' B' ' 78' ' ' GLU . 29.1 mm -107.8 99.55 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.979 -0.611 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.5 -3.62 86.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 114.391 0.516 . . . . 0.0 114.391 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.53 131.22 53.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.617 0.709 . . . . 0.0 109.698 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -137.86 156.9 47.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.048 0.927 . . . . 0.0 113.007 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 142.24 51.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.253 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.645 HD12 HD11 ' B' ' 37' ' ' ILE . 8.0 pt -132.32 134.65 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 118.499 0.591 . . . . 0.0 112.581 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.82 114.95 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.58 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.645 HD11 HD12 ' B' ' 35' ' ' ILE . 74.6 mt -114.51 109.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.347 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.502 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.11 45.17 26.87 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.996 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.26 19.31 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 119.277 -0.735 . . . . 0.0 114.254 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -89.45 129.02 36.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.46 1.13 . . . . 0.0 110.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.49 135.83 48.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.88 -178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.568 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -119.17 127.07 52.97 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -117.89 156.69 28.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 112.183 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.45 27.8 46.42 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.33 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' B' ' 42' ' ' GLN . 2.7 mt -90.14 151.98 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.557 0.694 . . . . 0.0 112.495 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.1 p -92.42 171.94 8.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.31 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.448 ' O ' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER -67.67 -41.59 83.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.136 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.1 -39.91 93.8 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.06 0.457 . . . . 0.0 110.897 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.5 mtm -69.82 -43.7 71.5 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.448 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.1 p -59.52 -34.6 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -63.75 -50.08 70.49 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.56 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.667 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.632 HD13 HD11 ' B' ' 35' ' ' ILE . 28.9 mt -64.51 -47.96 76.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.658 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -58.44 -42.9 88.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.421 0.629 . . . . 0.0 111.473 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -43.74 82.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.361 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -63.99 -41.5 97.49 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.877 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.09 -37.69 75.48 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -70.6 -30.13 66.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.594 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -78.08 -28.03 48.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.833 0.288 . . . . 0.0 111.214 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -82.63 -36.51 26.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -131.74 105.99 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -79.5 -8.42 59.13 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.41 19.58 18.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.899 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.544 HG22 HG23 ' B' ' 23' ' ' VAL . 0.6 OUTLIER -69.14 117.72 11.13 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.591 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.0 tp -64.34 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.591 ' N ' HD12 ' B' ' 65' ' ' LEU . 56.7 m-85 -112.28 132.97 54.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 111.151 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.946 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.95 140.53 44.06 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.291 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.01 129.46 75.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.34 146.97 18.96 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.16 155.46 17.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.13 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.94 163.66 25.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.989 0.423 . . . . 0.0 111.259 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -56.98 -32.88 66.54 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.388 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.59 -5.62 57.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.54 131.1 41.09 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.36 155.97 50.71 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.197 1.265 . . . . 0.0 110.242 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.9 t80 -64.73 -34.61 78.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.676 -0.64 . . . . 0.0 110.386 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.38 -37.4 70.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.531 ' HG2' HD13 ' B' ' 30' ' ' ILE . 0.2 OUTLIER -71.17 -35.71 71.73 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.803 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 18.4 t -61.87 -39.23 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.509 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.9 mm -59.75 -48.87 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.404 0.621 . . . . 0.0 109.41 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.5 ttmm -53.84 -44.94 70.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.492 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.429 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.64 -49.03 79.01 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.451 0.643 . . . . 0.0 110.929 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.68 -36.0 79.59 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.741 0.782 . . . . 0.0 109.273 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.75 -42.71 99.32 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.073 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.0 mt -64.15 -38.47 91.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.111 0.481 . . . . 0.0 110.499 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.632 HD13 HD13 ' B' ' 91' ' ' ILE . 1.7 mm? -64.06 -42.07 97.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.889 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -62.81 -42.46 99.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.568 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.29 -38.77 74.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.657 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -89.44 11.23 19.9 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.38 44.46 98.01 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 115.129 0.811 . . . . 0.0 115.129 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.632 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.68 -38.07 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.659 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.2 m -75.84 163.0 27.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.568 0.223 . . . . 0.0 110.855 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 22' ' ' PRO . 41.1 t -35.06 140.23 0.31 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.879 0.872 . . . . 0.0 113.161 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 21' ' ' VAL . 26.3 Cg_exo -46.47 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.351 2.701 . . . . 0.0 114.927 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 64' ' ' THR . 45.5 t -106.72 110.09 30.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 67' ' ' LEU . 3.2 mp -107.71 126.64 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.194 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 5.9 tt -114.65 120.69 40.98 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -109.93 126.9 54.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.323 -178.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 74' ' ' VAL . 28.8 t -85.14 109.34 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.894 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.78 -22.51 22.1 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -120.71 0.67 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.547 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.14 100.27 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.66 -4.65 84.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.972 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 131.11 54.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.439 0.62 . . . . 0.0 109.354 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -139.79 157.96 44.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.218 1.009 . . . . 0.0 113.077 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.886 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.842 HG23 HD12 ' A' ' 45' ' ' LEU . 4.3 pt -131.35 133.96 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.354 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -112.12 115.12 28.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.571 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -111.99 108.56 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.573 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.77 47.23 18.82 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.956 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.93 -27.0 18.04 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.69 -0.767 . . . . 0.0 114.002 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -90.38 128.4 36.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.464 1.132 . . . . 0.0 110.749 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 -106.55 133.0 51.9 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -117.25 128.02 54.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.61 157.38 26.49 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 27.61 52.04 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.934 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 35' ' ' ILE . 9.4 mt -86.94 147.86 25.58 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.213 0.506 . . . . 0.0 112.063 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -91.92 171.99 8.75 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.588 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.8 mt-10 -66.08 -46.16 78.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.065 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.902 0.319 . . . . 0.0 111.283 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.426 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -71.53 -39.22 70.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -62.39 -34.93 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.52 -50.77 68.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.773 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -52.84 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.032 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.08 -47.25 77.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.685 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -59.18 -42.83 91.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.705 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -44.03 85.14 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.236 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -40.63 96.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -70.26 -39.96 74.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.43 -28.2 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.673 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.23 -26.44 39.09 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.883 0.31 . . . . 0.0 111.277 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -85.19 -34.93 21.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.777 0.322 . . . . 0.0 110.446 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -132.87 94.78 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.96 -4.01 26.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -114.9 17.25 17.05 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.771 0.714 . . . . 0.0 111.858 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.542 ' CG2' HG23 ' A' ' 23' ' ' VAL . 2.2 m -69.28 126.42 29.73 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.2 tp -69.55 127.08 31.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 23' ' ' VAL . 8.3 m-85 -114.34 131.43 56.54 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.254 0.549 . . . . 0.0 111.464 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.44 140.34 44.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.662 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.759 HG11 ' CD2' ' A' ' 83' ' ' LEU . 14.2 p -126.36 135.35 64.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.22 145.66 17.21 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.45 154.59 16.4 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.986 -0.625 . . . . 0.0 111.831 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.15 164.07 25.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.113 0.482 . . . . 0.0 111.234 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -31.84 68.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.343 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -80.9 -6.09 58.21 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.424 HG11 HG11 ' A' ' 27' ' ' VAL . 69.9 t -86.15 132.06 44.6 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.9 152.81 41.77 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.554 1.502 . . . . 0.0 110.172 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.1 t80 -63.48 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.541 0.61 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -56.21 -35.71 67.62 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.02 -36.56 72.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.03 -39.11 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.813 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 46.5 mm -61.89 -45.41 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 109.508 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -44.92 80.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.858 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.28 -46.71 87.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.517 0.675 . . . . 0.0 110.737 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' B' ' 83' ' ' LEU . 4.8 mt -61.37 -37.63 84.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.716 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.52 -41.55 94.64 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.838 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -39.2 91.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.432 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.529 HD13 HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.41 -42.94 98.77 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.015 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -63.17 -41.94 99.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -37.94 76.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.351 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.99 10.08 28.05 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.21 45.11 97.19 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 115.266 0.866 . . . . 0.0 115.266 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.6 mt -102.68 -38.14 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.775 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -75.6 162.79 27.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.59 0.233 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' B' ' 22' ' ' PRO . 40.8 t -34.93 140.47 0.29 Allowed Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.0 0.92 . . . . 0.0 113.174 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.434 ' HD2' HG13 ' B' ' 21' ' ' VAL . 25.8 Cg_exo -46.25 -171.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.507 2.805 . . . . 0.0 114.935 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' B' ' 64' ' ' THR . 47.5 t -106.82 110.2 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -108.0 126.86 64.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 5.9 tt -114.5 120.74 41.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.456 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -110.01 127.1 54.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.189 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 74' ' ' VAL . 31.7 t -85.3 108.85 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.37 -22.55 22.54 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.41 -124.67 0.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.253 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.73 100.99 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.16 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.69 82.64 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.208 -0.52 . . . . 0.0 114.055 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.3 130.83 54.07 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.576 0.688 . . . . 0.0 109.488 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -139.2 158.07 44.82 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.336 1.065 . . . . 0.0 113.219 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.17 142.21 51.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.803 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.862 HG23 HD12 ' B' ' 45' ' ' LEU . 4.2 pt -131.54 133.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.491 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.8 114.7 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.826 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.77 109.0 26.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.517 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.44 47.79 16.8 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.962 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -26.88 17.57 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.272 -0.738 . . . . 0.0 114.197 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -90.5 128.79 36.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.603 1.202 . . . . 0.0 110.473 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -107.04 133.3 51.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.205 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.461 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -117.53 127.94 54.48 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -117.45 157.81 25.59 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.76 52.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.553 -0.748 . . . . 0.0 113.052 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.862 HD12 HG23 ' B' ' 35' ' ' ILE . 9.3 mt -87.07 148.1 25.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 112.029 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.9 p -92.19 171.76 8.87 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.499 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.502 ' O ' HG12 ' B' ' 50' ' ' VAL . 29.7 mt-10 -66.01 -46.22 78.71 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.023 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.23 -39.13 93.75 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.991 -0.443 . . . . 0.0 111.134 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.421 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -71.37 -39.66 71.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.852 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.502 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -62.31 -34.83 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -63.53 -50.83 68.02 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.94 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.16 -52.97 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.808 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.95 -47.37 77.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.796 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.64 -43.26 89.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.097 0.475 . . . . 0.0 111.638 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -44.03 85.28 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.312 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -40.45 95.98 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -70.42 -40.06 74.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.084 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -69.23 -28.12 66.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.25 -26.8 38.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.956 0.344 . . . . 0.0 111.314 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.05 -34.56 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 110.527 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -132.95 94.73 3.42 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -72.11 -3.85 25.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -114.93 16.79 17.16 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.71 0.686 . . . . 0.0 111.828 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.553 ' CG2' HG23 ' B' ' 23' ' ' VAL . 2.0 m -68.87 126.45 29.81 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.852 -0.158 . . . . 0.0 111.386 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 66' ' ' PHE . 11.6 tp -70.28 126.91 31.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.495 ' CE2' HG11 ' B' ' 23' ' ' VAL . 8.4 m-85 -113.68 131.1 56.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 67' ' ' LEU . 3.4 pp -135.08 140.22 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.776 HG11 HD21 ' B' ' 83' ' ' LEU . 14.8 p -126.25 135.64 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.41 145.57 17.05 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.22 154.36 16.46 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.825 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.95 164.51 25.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -31.33 69.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.37 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -81.32 -6.25 58.7 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' B' ' 27' ' ' VAL . 70.7 t -85.82 132.06 45.26 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.17 153.0 40.68 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.416 1.411 . . . . 0.0 110.159 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.71 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -63.53 -38.28 90.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.652 0.66 . . . . 0.0 111.084 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.78 -36.14 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.85 -36.58 72.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -61.92 -39.2 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.681 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.71 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 46.2 mm -61.8 -45.75 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.466 0.65 . . . . 0.0 109.604 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -45.05 78.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.978 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.2 -46.84 87.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.518 0.675 . . . . 0.0 110.682 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.863 HD11 HD11 ' A' ' 83' ' ' LEU . 4.9 mt -61.19 -37.97 84.86 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.758 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.23 -41.56 93.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.808 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -39.17 91.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.53 HD13 HD13 ' B' ' 91' ' ' ILE . 0.9 OUTLIER -63.3 -42.94 99.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.059 179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -63.42 -41.82 98.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.99 76.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.34 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.06 10.47 26.63 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.29 45.12 97.12 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.6 mt -103.1 -38.31 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.931 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -65.69 -53.34 42.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 0.0 111.075 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 61.9 t -94.32 112.45 57.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -47.85 -176.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.283 2.655 . . . . 0.0 114.945 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.594 HG23 ' CG2' ' A' ' 64' ' ' THR . 66.3 t -116.3 124.89 73.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -116.15 127.98 73.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.606 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HD21 ' A' ' 86' ' ' LEU . 9.2 tt -115.5 125.72 53.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.03 128.84 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.811 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 74' ' ' VAL . 25.9 t -83.01 122.91 38.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.707 -1.133 . . . . 0.0 107.999 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.87 -22.78 14.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.91 -118.84 0.6 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.018 -1.086 . . . . 0.0 113.843 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mm -113.38 95.76 4.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 122.961 0.504 . . . . 0.0 109.722 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.25 -3.25 86.79 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.157 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.01 51.15 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.648 0.724 . . . . 0.0 109.443 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.44 157.92 44.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.155 0.978 . . . . 0.0 112.934 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.87 142.06 51.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.315 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.68 ' CD1' HD11 ' A' ' 37' ' ' ILE . 6.1 pt -132.64 135.46 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.04 113.88 26.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 35' ' ' ILE . 55.2 mt -109.93 106.85 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.151 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 46.68 49.31 16.62 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.082 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.35 -26.68 18.36 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.982 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.72 127.84 37.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.439 1.12 . . . . 0.0 110.315 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -105.52 136.04 45.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.157 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.14 127.83 53.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -117.84 156.97 27.47 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.14 26.93 54.24 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.087 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD22 ' CE ' ' A' ' 49' ' ' MET . 7.5 mt -87.87 149.95 23.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 112.412 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -92.0 169.52 10.59 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.09 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.6 pt-20 -65.37 -44.89 86.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.256 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -64.08 -39.1 93.32 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.119 -0.363 . . . . 0.0 111.279 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.639 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.69 -37.75 70.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.936 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -64.57 -34.05 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -63.27 -49.73 72.95 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.703 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.96 -51.63 50.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.769 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.17 -46.8 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.703 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.4 m -59.11 -43.63 91.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.271 0.558 . . . . 0.0 111.532 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -65.61 -44.18 87.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.349 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -63.45 -41.65 98.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.198 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.71 -38.17 76.82 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.26 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.805 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -77.44 -27.66 52.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 117.959 0.345 . . . . 0.0 111.345 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -35.0 25.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 110.179 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -130.94 99.32 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -72.89 -20.78 61.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.3 20.0 13.33 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.215 0.461 . . . . 0.0 111.775 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.594 ' CG2' HG23 ' A' ' 23' ' ' VAL . 19.4 m -70.34 119.11 14.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.91 126.72 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.37 135.64 53.86 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 24' ' ' ILE . 3.8 pp -138.67 141.28 39.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 83' ' ' LEU . 54.5 t -123.54 128.53 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.02 -178.89 15.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.52 156.54 27.86 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.528 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.73 164.39 23.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.051 0.453 . . . . 0.0 111.38 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -58.45 -32.49 68.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.48 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.05 -7.13 59.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 27' ' ' VAL . 69.9 t -85.81 130.15 51.76 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.89 155.81 43.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.129 1.219 . . . . 0.0 110.516 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.4 t80 -65.03 -34.46 78.49 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.594 -0.691 . . . . 0.0 110.27 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.43 -36.85 69.45 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -36.92 73.91 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.299 0.571 . . . . 0.0 109.716 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.17 -39.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.758 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.3 mm -59.5 -49.52 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.452 0.644 . . . . 0.0 109.711 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -55.02 -43.6 73.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.378 178.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.44 77.75 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.753 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 7.9 mt -61.12 -35.91 78.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.642 0.734 . . . . 0.0 109.095 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.28 -43.77 98.33 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.887 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.6 mt -64.67 -37.65 88.3 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.903 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD13 HD13 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.3 -41.85 96.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.374 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -63.87 -39.59 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.82 -38.95 79.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.51 11.4 24.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.62 44.68 97.63 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.821 0.688 . . . . 0.0 114.821 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.63 HD13 HD13 ' A' ' 86' ' ' LEU . 4.0 mt -100.0 -34.35 4.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.957 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -65.6 -53.48 41.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.291 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 61.5 t -94.45 112.34 57.29 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.135 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -47.52 -176.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.352 2.701 . . . . 0.0 115.03 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' B' ' 64' ' ' THR . 65.9 t -116.4 124.52 72.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -115.76 128.11 73.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.735 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.503 HD13 HD21 ' B' ' 86' ' ' LEU . 9.4 tt -115.57 125.54 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.88 128.46 55.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.816 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.482 ' O ' HG21 ' B' ' 74' ' ' VAL . 24.1 t -82.74 122.67 37.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.6 -23.08 14.33 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.32 -122.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.45 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.0 mm -108.75 96.11 4.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.273 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 -3.14 87.08 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.187 -0.53 . . . . 0.0 114.116 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 134.34 50.67 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.708 0.754 . . . . 0.0 109.494 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.62 157.96 44.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.03 0.919 . . . . 0.0 112.944 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.96 141.66 51.87 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.383 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.678 ' CD1' HD11 ' B' ' 37' ' ' ILE . 6.1 pt -132.45 135.33 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.449 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.95 113.74 26.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD1' ' B' ' 35' ' ' ILE . 55.8 mt -109.94 106.93 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.182 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 47.18 49.31 19.1 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.96 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.75 -26.57 17.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.667 -0.778 . . . . 0.0 114.01 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -91.36 127.63 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.489 1.144 . . . . 0.0 110.34 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -105.51 135.71 46.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.86 127.47 53.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -117.45 157.02 26.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.84 27.16 54.43 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.744 -0.662 . . . . 0.0 113.178 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' CE ' ' B' ' 49' ' ' MET . 7.5 mt -87.72 150.12 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -92.49 169.92 10.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.128 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.505 ' O ' HG12 ' B' ' 50' ' ' VAL . 5.6 pt-20 -65.46 -44.98 85.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.18 -39.0 93.08 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.916 -0.49 . . . . 0.0 111.283 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.629 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.71 -37.95 70.57 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.913 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.4 p -64.37 -34.1 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 45.9 m -63.12 -49.65 73.59 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.815 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -50.89 -52.11 45.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.62 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -64.61 -46.95 80.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.789 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 42.4 m -58.9 -43.58 91.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -65.85 -43.78 87.44 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.359 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -63.86 -41.86 97.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.081 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -69.56 -38.31 77.36 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.019 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.34 -30.08 66.94 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.27 -27.82 53.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.881 0.31 . . . . 0.0 111.316 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -34.67 25.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -131.32 98.98 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -72.56 -20.77 61.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.2 19.97 13.26 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.324 0.511 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.588 ' CG2' HG23 ' B' ' 23' ' ' VAL . 21.5 m -70.43 118.54 13.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.26 126.71 29.59 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.68 135.65 53.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.143 0.497 . . . . 0.0 111.634 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.934 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -138.73 141.65 38.9 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 83' ' ' LEU . 56.0 t -123.73 128.17 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.61 -178.86 15.57 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.04 27.28 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.644 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.63 164.57 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.01 0.433 . . . . 0.0 111.464 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -58.67 -32.49 69.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.419 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.89 -7.57 59.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 27' ' ' VAL . 77.3 t -85.38 129.88 53.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.72 155.68 44.31 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.257 1.305 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.2 t80 -64.88 -34.32 78.12 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.578 -0.701 . . . . 0.0 110.238 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.6 -36.87 69.9 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -36.48 73.19 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.247 0.546 . . . . 0.0 109.595 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.63 -39.38 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.6 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.9 mm -59.58 -49.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.425 0.631 . . . . 0.0 109.685 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 1.1 ttmm -55.33 -43.52 75.04 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.324 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.4 77.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.308 0.575 . . . . 0.0 110.757 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 8.6 mt -61.22 -35.82 78.24 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.687 0.755 . . . . 0.0 109.196 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -61.29 -43.66 98.51 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.966 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 3.1 mt -64.76 -38.04 89.66 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.061 0.457 . . . . 0.0 110.776 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.613 HD13 HD13 ' B' ' 91' ' ' ILE . 0.7 OUTLIER -63.76 -41.71 97.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.489 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -64.22 -39.19 93.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.499 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.25 -38.7 80.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.195 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.572 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.58 44.37 98.05 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 114.708 0.643 . . . . 0.0 114.708 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.613 HD13 HD13 ' B' ' 86' ' ' LEU . 4.1 mt -99.64 -35.01 4.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.913 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -63.43 -33.46 75.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.599 0.237 . . . . 0.0 110.876 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 21.0 t -118.91 120.99 30.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.931 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -51.64 173.3 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.72 2.28 . . . . 0.0 115.428 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.647 HG23 HG22 ' A' ' 64' ' ' THR . 55.7 t -115.32 120.54 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.075 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -111.43 127.9 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.344 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.48 121.13 41.77 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.3 mt-10 -110.15 127.35 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.403 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -84.55 119.67 33.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.126 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.92 -23.26 14.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.67 -122.07 0.72 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.554 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.88 98.78 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 122.812 0.445 . . . . 0.0 109.937 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -3.36 87.13 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.05 -0.595 . . . . 0.0 114.041 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.31 54.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.54 0.67 . . . . 0.0 109.313 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -138.83 156.79 47.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.228 1.013 . . . . 0.0 113.08 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.72 141.87 51.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.895 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 45' ' ' LEU . 6.0 pt -133.71 135.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.514 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.45 117.21 31.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.959 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' OE2' ' A' ' 57' ' ' GLU . 89.9 mt -115.83 110.42 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.284 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.93 44.34 31.75 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.133 -1.032 . . . . 0.0 114.087 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.08 -24.88 24.76 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.982 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.5 128.48 36.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.371 1.085 . . . . 0.0 109.959 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -106.81 135.05 49.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.04 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -117.16 126.08 52.23 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -117.03 156.65 27.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.11 0.481 . . . . 0.0 111.925 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 26.91 53.37 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.952 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.4 mt -87.42 149.21 24.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.278 0.561 . . . . 0.0 112.077 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.7 p -90.52 171.53 9.34 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.12 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.9 pt-20 -66.58 -44.26 82.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -63.6 -38.87 92.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.5 mtp -69.89 -43.66 71.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.315 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.58 -34.73 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -63.81 -50.23 69.74 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.685 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -50.31 -52.49 36.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.747 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.7 mt -64.78 -48.33 74.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.604 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -59.27 -42.68 91.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.209 0.528 . . . . 0.0 111.605 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.74 -44.15 82.26 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.165 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.34 -39.66 94.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.884 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' A' ' 37' ' ' ILE . 8.3 mm-40 -70.82 -38.34 73.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.241 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -69.91 -31.84 69.83 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.32 -27.81 47.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.817 0.281 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -85.1 -35.16 21.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.237 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -130.95 96.98 4.19 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -75.51 -0.8 21.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.91 16.86 13.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.66 0.664 . . . . 0.0 111.841 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.647 HG22 HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -69.55 119.18 13.41 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.235 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.42 125.51 24.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -114.19 133.17 55.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.075 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.74 142.29 44.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.429 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG11 ' CD2' ' A' ' 83' ' ' LEU . 73.1 t -123.43 126.12 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -135.85 145.7 17.69 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.44 154.53 16.91 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 165.1 25.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.0 110.871 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.01 -32.58 64.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -81.2 -5.63 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.8 t -84.74 131.24 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 79' ' ' VAL . 72.7 Cg_endo -75.23 152.78 40.12 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.503 1.469 . . . . 0.0 109.99 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.4 t80 -64.15 -36.94 85.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.855 0.752 . . . . 0.0 110.981 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -56.3 -36.65 68.9 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.79 -36.25 70.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 75' ' ' PRO . 16.5 t -61.55 -39.0 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.402 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.713 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.2 mm -59.53 -50.69 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.386 0.613 . . . . 0.0 109.452 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -44.18 70.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.442 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.37 -48.49 80.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.387 0.613 . . . . 0.0 110.659 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' B' ' 83' ' ' LEU . 10.2 mt -62.23 -36.08 80.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.69 0.757 . . . . 0.0 109.189 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -61.78 -41.9 98.32 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.812 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.34 -38.71 92.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 HD13 ' A' ' 91' ' ' ILE . 2.7 mm? -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.028 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -63.56 -43.09 98.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.575 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.1 -39.12 74.44 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.57 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.555 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.25 12.79 19.11 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.6 44.86 95.32 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.583 0.593 . . . . 0.0 114.583 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 89' ' ' ALA . 5.1 mt -106.1 -43.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.306 0.574 . . . . 0.0 109.969 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.65 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 71.1 m -63.16 -33.89 76.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.016 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.431 ' CG1' ' HA2' ' B' ' 38' ' ' GLY . 21.5 t -118.79 121.08 30.95 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -51.79 173.49 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.777 2.318 . . . . 0.0 115.544 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.622 HG23 HG22 ' B' ' 64' ' ' THR . 56.3 t -115.43 120.47 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.049 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -111.39 127.72 68.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.467 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.15 121.12 42.04 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 3.1 mt-10 -109.94 127.14 54.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.303 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.3 119.67 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.387 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.88 -23.61 14.53 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.15 -125.75 0.94 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.399 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -108.37 98.87 7.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.117 -0.542 . . . . 0.0 110.236 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.37 -3.51 86.99 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 121.123 -0.561 . . . . 0.0 114.088 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 130.52 54.15 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.552 0.676 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -138.99 157.11 46.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.282 1.039 . . . . 0.0 113.166 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.94 141.96 51.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.863 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.531 HG23 HD12 ' B' ' 45' ' ' LEU . 5.8 pt -133.85 135.14 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.422 0.555 . . . . 0.0 112.438 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.9 m -112.19 117.36 32.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.474 HG21 ' OE2' ' B' ' 57' ' ' GLU . 91.4 mt -116.27 110.54 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.086 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.431 ' HA2' ' CG1' ' B' ' 21' ' ' VAL . . . 48.62 44.59 29.88 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.213 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.99 -24.97 24.17 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.732 -0.747 . . . . 0.0 114.026 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.34 128.41 36.44 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.414 1.107 . . . . 0.0 110.108 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -106.73 134.56 49.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.022 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -116.73 125.77 52.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -116.55 156.8 26.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.097 0.475 . . . . 0.0 112.127 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.22 26.79 54.32 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.042 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' B' ' 42' ' ' GLN . 10.9 mt -87.4 149.61 24.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.261 0.553 . . . . 0.0 111.997 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -90.69 171.61 9.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.064 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.0 pt-20 -67.0 -44.13 81.13 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.52 -39.06 93.45 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.145 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.7 mtp -69.95 -43.46 71.52 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.68 -34.58 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 -50.18 69.54 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.532 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -50.19 -52.59 34.43 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.732 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.69 -48.73 73.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.573 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -58.95 -42.43 89.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.077 0.465 . . . . 0.0 111.71 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -67.1 -44.09 80.86 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.072 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -64.24 -39.87 94.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.474 ' OE2' HG21 ' B' ' 37' ' ' ILE . 8.3 mm-40 -70.61 -38.64 73.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.67 -31.7 69.9 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.56 -27.61 45.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.9 0.318 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -85.16 -35.14 21.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.24 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -130.88 97.24 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -75.73 -0.79 22.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -118.83 16.39 13.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.703 0.683 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.622 HG22 HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -69.15 119.26 13.16 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.56 125.12 23.2 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -113.76 133.49 55.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 111.416 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.049 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -136.02 142.45 44.46 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' B' ' 83' ' ' LEU . 73.8 t -123.41 126.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.02 145.55 17.51 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.51 154.58 16.94 Favored Glycine 0 CA--C 1.511 -0.208 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.634 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 165.58 24.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -56.65 -32.39 65.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.524 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -81.06 -6.12 58.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.41 130.9 52.05 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.417 ' O ' HG23 ' B' ' 79' ' ' VAL . 71.8 Cg_endo -75.13 152.54 40.29 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.571 1.514 . . . . 0.0 110.003 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.1 t80 -63.92 -37.05 85.98 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.649 -0.657 . . . . 0.0 110.983 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -56.41 -36.27 68.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.0 -36.06 69.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.184 0.516 . . . . 0.0 109.637 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 75' ' ' PRO . 16.9 t -61.71 -39.18 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.488 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -59.42 -50.56 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.319 0.58 . . . . 0.0 109.469 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.19 -43.89 71.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.439 178.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.57 -48.85 79.53 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.456 0.646 . . . . 0.0 110.494 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 83' ' ' LEU . 10.8 mt -61.74 -36.16 80.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.191 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.83 -41.7 98.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.938 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -64.51 -38.56 91.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 110.439 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.428 HD13 HD13 ' B' ' 91' ' ' ILE . 2.6 mm? -64.1 -41.72 97.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -63.48 -42.98 98.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -57.37 -38.72 74.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.514 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.537 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.48 12.55 20.37 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.93 44.81 95.88 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 5.2 mt -106.26 -44.92 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.303 0.573 . . . . 0.0 109.682 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.963 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 m -97.38 -31.26 12.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 32.4 t -124.25 125.66 25.67 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.067 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -54.86 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.888 2.392 . . . . 0.0 115.235 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 66' ' ' PHE . 39.7 t -113.33 120.23 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.068 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -112.84 129.01 69.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.491 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.9 tt -117.58 124.9 49.79 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HD23 ' A' ' 25' ' ' LEU . 9.2 tt0 -112.91 129.62 56.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.521 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.94 109.62 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.729 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -89.38 -23.3 22.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.34 -119.39 0.62 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.45 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 mm -112.28 95.22 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.6 89.5 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.202 -0.523 . . . . 0.0 114.158 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -106.89 91.95 3.88 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.698 0.749 . . . . 0.0 110.061 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.34 154.32 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.184 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.36 143.61 50.89 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.417 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 37' ' ' ILE . 7.4 pt -133.86 135.85 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -112.85 115.97 29.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.312 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.811 HD11 HD12 ' A' ' 35' ' ' ILE . 59.6 mt -116.49 111.68 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.891 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 49.02 44.63 32.65 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.142 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.11 -23.87 27.45 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.859 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.57 126.54 35.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.348 1.074 . . . . 0.0 109.869 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 133.43 49.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.588 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.99 123.85 49.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.84 149.49 30.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.54 78.54 0.65 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mt -137.78 148.06 45.2 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.282 0.563 . . . . 0.0 111.629 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 p -89.64 169.33 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.513 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.3 pt-20 -67.98 -41.12 82.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.945 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.86 -38.72 91.91 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.143 -0.348 . . . . 0.0 110.95 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mtp -69.81 -45.06 68.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.75 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -57.46 -35.76 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.889 0.376 . . . . 0.0 110.233 179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -63.77 -49.99 70.8 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.853 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -53.08 27.98 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 35' ' ' ILE . 3.7 mt -65.21 -48.38 73.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.558 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 m -58.63 -43.03 89.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.577 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.68 -43.82 83.45 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.229 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -63.51 -41.42 98.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.877 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -37.73 76.54 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -70.83 -29.94 66.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.477 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -76.88 -27.62 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.844 0.293 . . . . 0.0 110.867 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -82.12 -38.25 25.07 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -129.2 110.46 12.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -82.51 7.29 14.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -127.09 20.32 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.145 0.43 . . . . 0.0 111.88 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.86 113.23 5.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -61.36 123.54 18.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 23' ' ' VAL . 43.6 m-85 -114.26 133.09 55.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.068 HD11 HG23 ' A' ' 24' ' ' ILE . 2.1 pp -132.96 141.42 48.32 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.258 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 83' ' ' LEU . 53.4 t -123.55 124.79 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.42 142.3 13.57 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.9 154.99 16.23 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.687 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.88 163.38 24.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.357 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -31.44 69.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.98 -6.61 58.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.1 t -89.93 135.34 30.39 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.42 154.99 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.021 1.147 . . . . 0.0 110.373 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.767 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -63.79 -35.5 80.81 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.399 -0.813 . . . . 0.0 110.48 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.36 -36.75 66.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.415 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -34.53 67.27 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.835 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.41 -38.98 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.767 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 50.3 mm -59.19 -49.48 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.0 mttp -53.31 -44.35 68.29 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.283 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -51.95 67.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' B' ' 83' ' ' LEU . 9.9 mt -60.24 -36.73 78.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -62.24 -41.53 98.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.541 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 6.9 mt -64.13 -39.25 93.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.115 0.483 . . . . 0.0 110.675 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 HD13 ' A' ' 91' ' ' ILE . 1.2 mm? -63.87 -41.8 97.68 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.12 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.35 -41.18 98.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.359 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.26 -38.37 76.8 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.31 10.61 24.19 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.22 44.69 97.79 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.587 HD13 HD13 ' A' ' 86' ' ' LEU . 3.5 mt -101.13 -34.78 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.116 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.873 -0.091 . . . . 0.0 112.873 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 5.7 m -96.91 -32.23 12.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.318 . . . . 0.0 111.094 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.466 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 36.0 t -123.63 125.85 25.9 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -54.83 173.29 0.27 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.804 2.336 . . . . 0.0 115.258 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' B' ' 66' ' ' PHE . 40.0 t -113.5 120.09 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -112.7 129.3 68.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.392 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.451 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -117.64 124.97 49.87 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.43 ' N ' HD23 ' B' ' 25' ' ' LEU . 9.8 tt0 -113.09 129.36 56.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.63 109.38 18.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.664 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 32' ' ' LYS . . . -89.14 -23.52 22.44 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.72 -123.53 0.84 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.24 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.25 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.17 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.97 0.46 89.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.085 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 0.0 OUTLIER -106.79 92.12 3.96 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.705 0.752 . . . . 0.0 110.156 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.13 154.26 18.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.265 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.18 143.86 50.73 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 37' ' ' ILE . 7.3 pt -133.8 135.86 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.3 t -112.93 116.11 29.47 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.291 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.808 HD11 HD12 ' B' ' 35' ' ' ILE . 61.1 mt -116.71 111.42 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.957 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 49.23 44.49 34.45 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.12 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.15 -23.71 28.29 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.781 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.64 126.61 35.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.334 1.067 . . . . 0.0 109.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.68 133.69 49.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.483 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.23 123.97 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -110.94 149.41 30.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.51 78.97 0.63 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.11 148.33 44.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.453 0.644 . . . . 0.0 111.475 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.6 p -89.9 169.39 11.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.499 ' O ' HG12 ' B' ' 50' ' ' VAL . 8.4 pt-20 -68.0 -41.39 82.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.39 -38.83 92.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 33.7 mtp -69.88 -44.97 68.68 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.831 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 47' ' ' GLU . 0.5 OUTLIER -57.62 -35.43 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.916 0.388 . . . . 0.0 110.143 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 26.6 m -64.1 -49.69 71.23 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.045 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -53.32 27.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.646 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.487 HD13 ' CD1' ' B' ' 35' ' ' ILE . 4.3 mt -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.439 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -58.48 -43.59 89.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.11 0.481 . . . . 0.0 111.53 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -66.38 -43.52 85.69 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.238 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.02 -40.71 96.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.09 -37.91 75.53 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.66 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -70.55 -29.93 66.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.747 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -77.03 -27.98 54.74 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.234 -0.291 . . . . 0.0 110.868 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.99 -37.93 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -129.61 110.19 11.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.07 6.98 14.58 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -127.07 20.45 6.92 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.22 0.464 . . . . 0.0 111.895 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.89 113.66 5.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.461 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.66 123.48 18.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.403 ' CD1' ' HB ' ' B' ' 23' ' ' VAL . 44.9 m-85 -114.05 133.09 55.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.546 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 2.1 pp -133.02 141.33 48.21 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.144 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.611 HG11 HD23 ' B' ' 83' ' ' LEU . 54.8 t -123.46 124.61 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.44 141.95 13.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.33 155.51 16.06 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 163.87 23.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 111.259 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -31.25 69.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.335 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -81.17 -6.81 59.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.79 135.01 31.01 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.27 155.27 41.69 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.071 1.181 . . . . 0.0 110.153 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.5 t80 -64.02 -35.52 80.99 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.467 -0.771 . . . . 0.0 110.377 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -55.42 -37.12 67.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.94 -35.18 69.54 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.067 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -61.84 -39.22 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.349 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 50.3 mm -59.04 -48.91 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.485 0.659 . . . . 0.0 109.42 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 13.1 mttp -53.85 -44.2 70.13 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.401 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.11 -51.68 68.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.292 0.568 . . . . 0.0 110.96 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 83' ' ' LEU . 9.9 mt -60.56 -36.55 78.73 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.781 0.801 . . . . 0.0 109.196 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -62.37 -41.6 98.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.62 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 6.7 mt -64.02 -38.92 92.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.666 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.6 HD13 HD13 ' B' ' 91' ' ' ILE . 1.3 mm? -63.93 -41.99 97.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -63.48 -40.95 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.581 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.36 -38.67 77.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.32 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.574 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.22 10.64 23.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.4 44.75 97.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.6 HD13 HD13 ' B' ' 86' ' ' LEU . 3.5 mt -101.23 -35.25 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -70.98 -56.56 5.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.981 0.419 . . . . 0.0 110.602 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 43.4 t -128.37 124.64 22.97 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.14 174.89 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.876 2.384 . . . . 0.0 115.725 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.568 HG23 ' CG2' ' A' ' 64' ' ' THR . 61.8 t -113.75 122.18 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -112.48 127.95 69.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.439 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.7 tt -115.08 121.85 44.32 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 8.4 mt-10 -110.11 126.46 54.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.323 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.7 119.71 34.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.56 -22.75 15.33 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.54 -117.84 0.56 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.842 -1.171 . . . . 0.0 114.009 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mm -113.36 101.11 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 109.788 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.14 82.46 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.702 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 129.52 53.99 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.553 0.676 . . . . 0.0 109.384 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -138.13 156.11 48.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.79 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -125.77 144.12 50.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.195 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 53' ' ' LEU . 8.4 pt -133.72 135.72 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.853 0.752 . . . . 0.0 113.027 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -113.19 116.87 30.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 35' ' ' ILE . 89.4 mt -116.35 111.64 36.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.814 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 48.7 46.18 30.78 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.357 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.73 -25.24 19.98 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.662 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.6 127.34 35.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.126 0.963 . . . . 0.0 110.109 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 134.57 48.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.472 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -114.87 123.35 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -110.4 148.48 31.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.976 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 78.81 0.69 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mt -136.96 148.66 47.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.139 0.495 . . . . 0.0 111.127 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 p -91.26 171.3 9.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.638 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.06 -42.13 80.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.44 -38.8 92.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.004 0.431 . . . . 0.0 110.711 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mtm -70.04 -46.61 64.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.349 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.1 p -58.09 -35.63 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.775 0.321 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -64.12 -49.34 72.55 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.76 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -50.51 -52.49 38.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.706 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 35' ' ' ILE . 15.6 mt -64.94 -47.69 76.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.624 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -58.93 -43.31 91.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.117 0.484 . . . . 0.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -66.49 -44.09 83.59 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.363 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -63.46 -40.58 97.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.913 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.75 -38.88 76.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.196 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -69.66 -30.65 68.38 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -78.14 -28.08 48.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.859 0.299 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -84.36 -34.94 23.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.92 0.391 . . . . 0.0 110.018 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -130.19 95.68 3.98 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -68.9 -7.87 38.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -113.78 19.46 16.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.547 0.612 . . . . 0.0 112.096 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.568 ' CG2' HG23 ' A' ' 23' ' ' VAL . 4.0 m -69.04 117.0 10.14 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 125.24 23.59 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -114.37 133.88 55.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 0.0 111.471 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -136.27 141.99 43.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 83' ' ' LEU . 79.6 t -123.57 129.13 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.23 146.57 18.38 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.47 16.76 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.925 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.09 165.18 24.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.469 . . . . 0.0 110.999 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -57.11 -32.64 66.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.341 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.23 -5.84 58.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.81 135.21 30.73 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.39 156.92 29.17 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.131 1.221 . . . . 0.0 110.631 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.759 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.9 t80 -65.15 -33.88 77.05 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.614 -0.679 . . . . 0.0 110.506 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -57.07 -37.55 72.02 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.256 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.52 70.77 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.85 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -62.66 -39.02 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.323 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.4 mm -59.32 -48.91 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.368 0.604 . . . . 0.0 109.591 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -53.67 -44.8 69.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.385 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -58.05 -49.64 76.2 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.327 0.584 . . . . 0.0 110.99 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' B' ' 83' ' ' LEU . 8.0 mt -62.38 -36.58 82.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.545 0.688 . . . . 0.0 109.234 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.7 -43.28 97.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.814 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 8.8 mt -65.29 -38.06 89.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 110.706 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -63.77 -42.04 97.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.149 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -62.93 -41.98 99.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.47 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.66 -38.58 78.47 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.68 10.97 23.67 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.77 97.62 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 89' ' ' ALA . 3.8 mt -101.67 -36.61 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.851 -179.616 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 53.0 p -70.25 -56.49 6.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.49 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 43.8 t -128.44 124.68 22.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.184 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.14 174.72 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 115.736 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.546 HG23 ' CG2' ' B' ' 64' ' ' THR . 56.8 t -113.65 122.31 67.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.006 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -112.83 127.99 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.312 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.492 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -115.2 121.83 44.16 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' B' ' 34' ' ' ALA . 8.7 mt-10 -109.96 126.44 53.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.362 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -84.54 119.7 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.76 -22.32 15.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.33 -122.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.717 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -108.12 101.65 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.04 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.26 80.29 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.897 -0.592 . . . . 0.0 114.017 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 129.57 53.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 117.426 0.613 . . . . 0.0 109.429 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.16 156.09 48.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.599 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -125.62 144.18 50.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.164 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.561 HD11 HD13 ' B' ' 53' ' ' LEU . 8.4 pt -133.69 135.8 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -113.46 116.93 30.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.052 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.538 HD11 HD12 ' B' ' 35' ' ' ILE . 91.3 mt -116.43 111.53 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.99 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.68 46.08 30.69 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.251 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.82 -25.17 20.6 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.669 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.54 126.97 35.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.242 1.021 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 134.73 48.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.457 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.417 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.96 123.11 48.28 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.14 148.47 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 78.71 0.71 Allowed Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' B' ' 42' ' ' GLN . 4.1 mt -137.03 148.32 46.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.081 0.467 . . . . 0.0 111.149 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -90.99 171.43 9.28 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.65 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.427 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.1 pt-20 -67.86 -42.17 81.74 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.874 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.55 -39.01 92.96 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.078 -0.389 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mtm -69.99 -46.55 64.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.199 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.0 OUTLIER -58.09 -36.08 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 51.6 m -63.72 -49.42 73.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.764 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -50.58 -52.03 42.94 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.738 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.561 HD13 HD11 ' B' ' 35' ' ' ILE . 15.2 mt -65.28 -47.67 75.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.631 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -59.13 -43.04 91.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.058 0.456 . . . . 0.0 111.518 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -66.65 -43.96 83.19 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.343 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.56 -40.52 97.19 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.76 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -38.66 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -69.79 -30.93 68.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -78.27 -28.05 47.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.852 0.296 . . . . 0.0 111.459 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -84.42 -34.94 23.41 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -130.12 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -69.18 -7.6 37.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -113.96 19.28 16.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.565 0.62 . . . . 0.0 111.958 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.546 ' CG2' HG23 ' B' ' 23' ' ' VAL . 3.9 m -68.87 116.86 9.84 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.58 125.16 23.34 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -114.39 134.04 55.27 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.974 0.416 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.006 HD11 HG23 ' B' ' 24' ' ' ILE . 3.3 pp -136.57 141.73 43.33 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.409 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.518 HG11 ' CD2' ' B' ' 83' ' ' LEU . 78.8 t -123.31 129.62 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.49 18.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.05 154.47 16.78 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.03 165.37 24.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.066 0.46 . . . . 0.0 111.061 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -57.25 -32.76 66.9 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.361 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.0 -6.38 58.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 77.7 t -89.18 135.49 31.39 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.9 156.82 27.19 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.227 1.285 . . . . 0.0 110.558 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.757 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.9 t80 -65.06 -33.89 77.13 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.792 -0.567 . . . . 0.0 110.423 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.27 -37.59 72.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -34.53 70.78 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.882 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 19.4 t -62.66 -38.93 82.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.315 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.757 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -59.52 -48.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.334 0.588 . . . . 0.0 109.602 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -44.76 71.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.277 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.403 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -58.15 -49.38 77.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.321 0.581 . . . . 0.0 111.039 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -62.66 -36.29 82.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.58 0.705 . . . . 0.0 109.34 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -60.83 -43.55 98.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.871 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.02 -38.14 89.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 110.598 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -63.65 -41.91 98.18 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.195 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -63.08 -41.97 99.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.553 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -58.62 -38.46 78.07 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.399 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.558 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.57 10.75 24.25 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.23 44.71 97.75 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' B' ' 89' ' ' ALA . 3.9 mt -101.34 -36.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.854 -179.651 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.989 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -153.5 -57.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 40.1 t -135.35 129.04 18.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.501 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -55.45 176.64 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.106 2.537 . . . . 0.0 115.405 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 66' ' ' PHE . 22.1 t -110.67 120.7 62.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -114.3 128.97 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 86' ' ' LEU . 7.8 tt -115.75 122.48 45.62 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.39 128.28 56.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -85.13 119.16 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.2 -22.16 15.77 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -119.85 0.64 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.945 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -112.84 100.64 11.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -2.84 83.39 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.755 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.14 53.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.539 0.669 . . . . 0.0 109.301 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -137.15 156.37 48.43 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.068 0.937 . . . . 0.0 112.576 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.23 142.34 51.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.138 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.558 HG23 HD12 ' A' ' 45' ' ' LEU . 5.8 pt -131.6 134.89 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.459 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.97 113.89 26.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.545 0.688 . . . . 0.0 110.263 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.15 110.07 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.422 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 42.94 49.37 6.23 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.298 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.12 -37.35 3.44 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.799 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.4 119.12 14.1 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.846 0.323 . . . . 0.0 111.113 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -105.37 128.39 53.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.85 126.57 52.64 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.86 157.25 26.99 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.47 25.58 56.49 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.176 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 42' ' ' GLN . 12.7 mt -86.98 149.97 24.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.307 0.575 . . . . 0.0 111.929 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.75 171.7 8.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.269 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.1 pt-20 -67.68 -42.91 81.34 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.143 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.09 -39.22 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -69.76 -45.9 67.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.395 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 35' ' ' ILE . 2.0 p -58.51 -34.85 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 m -62.95 -50.22 71.64 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.27 -52.76 33.64 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.828 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.94 -47.84 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.7 m -59.52 -42.67 92.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 111.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -66.2 -44.78 82.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.32 99.25 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.47 -39.8 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -69.91 -29.8 67.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.65 -28.44 45.42 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 117.723 0.238 . . . . 0.0 111.515 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -83.57 -35.76 24.49 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.08 106.21 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.7 6.21 13.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -125.53 17.97 8.15 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.613 0.642 . . . . 0.0 111.908 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.08 114.57 5.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.863 -0.153 . . . . 0.0 111.212 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.45 122.67 14.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 23' ' ' VAL . 12.9 m-85 -113.34 134.39 54.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.072 0.463 . . . . 0.0 111.294 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -138.15 141.34 40.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.405 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 96.7 t -122.99 127.67 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.12 146.79 18.78 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.5 155.0 16.96 Favored Glycine 0 N--CA 1.462 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.021 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.51 164.5 24.66 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 120.922 0.391 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -56.97 -33.24 66.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.512 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.25 -5.64 56.54 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.69 134.58 31.99 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' O ' HG23 ' A' ' 79' ' ' VAL . 73.8 Cg_endo -77.26 156.72 33.33 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.28 1.32 . . . . 0.0 110.006 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.705 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.4 t80 -64.86 -35.62 81.73 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.666 -0.646 . . . . 0.0 110.683 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -56.57 -37.36 70.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.712 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 75' ' ' PRO . 19.9 t -62.54 -39.28 83.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.442 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.705 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 45.7 mm -60.17 -47.4 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.26 178.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -59.2 -48.92 79.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.336 0.589 . . . . 0.0 110.863 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' B' ' 83' ' ' LEU . 10.0 mt -60.56 -37.1 80.18 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.527 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -61.23 -41.67 97.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.975 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 2.8 mt -66.12 -38.31 87.87 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 110.553 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 25' ' ' LEU . 1.2 mm? -63.89 -42.12 97.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -63.15 -43.3 98.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.12 -38.77 73.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.3 12.16 19.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.42 44.87 96.31 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 89' ' ' ALA . 4.4 mt -103.0 -36.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.023 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -153.1 -57.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 40.6 t -135.55 128.88 18.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.664 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.18 176.52 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.91 2.406 . . . . 0.0 115.486 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' B' ' 66' ' ' PHE . 21.9 t -110.54 120.72 61.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.999 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -114.25 128.58 71.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.573 HD13 HD21 ' B' ' 86' ' ' LEU . 7.9 tt -115.5 122.64 46.32 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -112.45 128.07 56.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.709 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.72 119.22 33.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.64 -21.88 15.66 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.75 -124.17 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.565 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mm -107.78 100.97 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.27 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -2.8 82.28 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.01 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.18 53.76 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.18 156.59 48.14 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.128 0.966 . . . . 0.0 112.592 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.46 142.4 51.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.117 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.571 HG23 HD12 ' B' ' 45' ' ' LEU . 6.0 pt -131.95 134.91 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.345 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.2 114.21 26.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.601 0.715 . . . . 0.0 110.119 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.32 110.17 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.458 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 42.71 49.71 5.96 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 120.787 -0.72 . . . . 0.0 114.24 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.76 -37.37 3.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.863 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -70.13 118.58 13.14 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.855 0.328 . . . . 0.0 111.158 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -104.72 128.84 52.95 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.573 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.41 126.58 52.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -117.9 157.45 26.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 25.38 57.1 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.118 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 42' ' ' GLN . 13.0 mt -86.84 149.92 24.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.382 0.591 . . . . 0.0 112.078 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -91.68 171.53 9.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.504 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.423 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 pt-20 -67.52 -42.82 82.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.34 -39.47 92.43 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 34.5 mtp -69.42 -45.83 68.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.472 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.447 HG23 HG21 ' B' ' 35' ' ' ILE . 2.0 p -58.74 -34.39 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 110.166 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -63.23 -50.12 71.47 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.922 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.55 -52.78 35.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -64.86 -47.5 77.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.331 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 20.9 m -60.01 -42.42 94.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.145 0.498 . . . . 0.0 111.614 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -66.26 -44.72 82.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.243 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -63.15 -41.03 99.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.908 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -70.03 -39.51 75.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.102 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -70.0 -29.75 66.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.665 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.69 -28.79 45.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.754 0.252 . . . . 0.0 111.535 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.16 -35.73 25.29 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.04 106.06 8.38 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.46 6.06 13.39 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -125.37 17.85 8.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.622 0.646 . . . . 0.0 111.918 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.402 HG22 HG23 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -67.09 114.84 6.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.893 -0.14 . . . . 0.0 111.22 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tp -59.64 122.89 15.24 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.426 ' CE1' HG11 ' B' ' 23' ' ' VAL . 13.3 m-85 -113.58 133.94 54.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.173 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.999 HD11 HG23 ' B' ' 24' ' ' ILE . 3.6 pp -137.9 141.34 40.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.417 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.498 ' HB ' HD21 ' B' ' 83' ' ' LEU . 98.6 t -123.2 127.91 74.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.05 146.71 18.7 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.13 154.97 16.8 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 121.127 -0.558 . . . . 0.0 111.959 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.44 165.25 23.99 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -57.95 -32.88 68.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.513 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.2 -6.18 57.36 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -89.35 134.53 32.64 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.402 ' O ' HG23 ' B' ' 79' ' ' VAL . 70.0 Cg_endo -77.47 156.83 32.6 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.201 1.268 . . . . 0.0 110.256 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.711 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.3 t80 -64.85 -35.92 82.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.713 -0.617 . . . . 0.0 110.592 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -56.46 -37.36 70.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -35.61 73.34 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.772 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 75' ' ' PRO . 18.6 t -62.31 -39.26 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.596 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.711 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.7 mm -60.21 -47.08 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.408 0.623 . . . . 0.0 109.469 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.2 OUTLIER -54.59 -44.93 73.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.276 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.451 ' O ' HD23 ' B' ' 86' ' ' LEU . . . -59.48 -48.79 80.31 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.322 0.582 . . . . 0.0 110.809 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 83' ' ' LEU . 10.0 mt -60.8 -36.76 79.86 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.392 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -61.33 -41.92 97.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.039 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 2.7 mt -65.77 -38.58 89.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.123 0.487 . . . . 0.0 110.555 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.573 HD21 HD13 ' B' ' 25' ' ' LEU . 1.2 mm? -63.69 -42.15 98.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.2 -43.35 98.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.437 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -39.1 74.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.707 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 12.02 18.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.65 44.75 96.6 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' B' ' 89' ' ' ALA . 4.3 mt -103.03 -35.77 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.147 0.499 . . . . 0.0 109.943 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.051 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 m -82.21 -40.33 21.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.631 0.253 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -135.14 125.94 17.28 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.972 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.39 -171.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.022 2.482 . . . . 0.0 114.542 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.0 118.11 52.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.8 128.27 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.71 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -114.3 121.42 43.61 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 9.4 tm-20 -110.46 127.14 55.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.29 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.85 123.43 39.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.457 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.52 -22.49 13.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.3 -120.75 0.68 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.64 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.44 95.97 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.762 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.87 -3.52 85.94 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.949 -0.569 . . . . 0.0 114.406 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.82 132.28 52.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.488 0.644 . . . . 0.0 109.375 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -139.93 158.03 44.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.172 0.986 . . . . 0.0 112.985 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -125.64 141.85 51.81 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.748 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 45' ' ' LEU . 4.5 pt -134.19 135.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.704 0.684 . . . . 0.0 112.706 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.35 115.52 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.694 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.89 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.245 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.45 48.31 16.58 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.848 -0.691 . . . . 0.0 114.215 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.29 -25.83 22.41 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.814 -0.708 . . . . 0.0 114.135 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.72 129.63 38.58 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.501 1.15 . . . . 0.0 110.501 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.1 135.69 48.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.11 127.96 54.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -118.13 156.09 29.3 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.94 26.88 47.79 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.304 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' GLN . 11.7 mt -88.46 150.15 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.344 0.572 . . . . 0.0 112.303 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.3 p -91.72 170.6 9.77 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.545 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' O ' HG12 ' A' ' 50' ' ' VAL . 13.7 pt-20 -65.02 -47.25 78.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.9 -38.75 92.17 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.133 -0.355 . . . . 0.0 111.38 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.3 ttp -71.57 -39.04 70.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.668 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -62.78 -32.8 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 m -63.79 -50.21 69.88 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.539 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.11 -52.3 36.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.88 -48.08 75.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.462 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.6 m -58.65 -42.56 88.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.086 0.469 . . . . 0.0 111.548 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 9.2 mmm180 -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.284 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.72 -40.98 98.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.912 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.64 -38.4 80.46 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.598 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -70.82 -30.89 67.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.849 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.15 -28.09 54.05 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -83.65 -33.82 25.17 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.296 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -129.65 109.12 10.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.97 5.26 19.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -125.91 17.45 7.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.458 0.572 . . . . 0.0 111.893 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.05 113.94 5.43 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.083 0.153 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 66' ' ' PHE . 3.3 tp -61.38 123.05 16.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.557 ' N ' HD12 ' A' ' 65' ' ' LEU . 31.9 m-85 -111.11 130.39 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.393 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -137.63 141.24 41.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.325 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 83' ' ' LEU . 69.2 t -123.83 131.3 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.73 146.88 18.75 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.34 152.85 16.74 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.9 165.15 25.07 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -33.06 67.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.398 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -81.54 -5.82 58.37 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.6 t -89.77 131.56 39.27 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.95 155.47 53.02 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.337 1.358 . . . . 0.0 110.403 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.2 t80 -65.11 -34.24 77.93 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.493 -0.754 . . . . 0.0 110.577 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.74 -37.1 70.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.72 0.295 . . . . 0.0 110.254 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -36.08 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.847 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.26 -39.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.573 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.77 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.7 mm -60.39 -46.96 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.503 0.668 . . . . 0.0 109.436 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.63 -45.5 70.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.312 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.12 78.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.346 0.593 . . . . 0.0 111.19 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' B' ' 83' ' ' LEU . 7.7 mt -61.57 -36.78 81.62 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.6 0.714 . . . . 0.0 109.505 177.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -60.84 -42.95 98.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.904 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.37 -38.95 91.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.059 0.457 . . . . 0.0 110.58 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.517 HD13 HD13 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.38 -41.89 98.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.159 179.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -63.17 -43.68 97.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.9 -38.5 72.9 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -90.76 12.08 20.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.2 44.71 97.14 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.0 mt -101.33 -35.07 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.838 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 112.957 -0.057 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -82.38 -40.21 21.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.617 0.246 . . . . 0.0 110.97 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.03 125.38 17.09 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -48.28 -171.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.992 2.461 . . . . 0.0 114.668 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.83 117.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.918 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.78 128.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.788 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.457 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.8 tt -114.6 121.45 43.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 9.4 tm-20 -110.42 127.09 54.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.437 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 123.11 38.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.484 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.29 -22.46 13.7 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.85 -124.37 0.89 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.712 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.9 mm -107.66 95.99 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 114.916 -0.642 . . . . 0.0 110.202 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -3.25 86.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.133 -0.556 . . . . 0.0 114.375 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 132.31 52.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.547 0.674 . . . . 0.0 109.304 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -139.69 158.12 44.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.2 1.0 . . . . 0.0 113.042 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.07 141.77 51.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.682 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 45' ' ' LEU . 4.9 pt -134.33 136.51 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.536 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 115.23 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.565 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 94.0 mt -110.76 108.7 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.381 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.41 47.98 16.53 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.037 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.45 20.14 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.795 -0.717 . . . . 0.0 114.097 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -92.34 129.61 38.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.456 1.128 . . . . 0.0 110.498 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.01 136.01 47.59 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.87 127.33 53.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -117.89 156.36 28.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 112.418 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.76 26.83 48.77 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.428 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' B' ' 42' ' ' GLN . 11.9 mt -88.44 150.23 23.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.465 0.65 . . . . 0.0 112.206 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 16.9 p -91.72 170.03 10.24 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.529 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.562 ' O ' HG12 ' B' ' 50' ' ' VAL . 13.7 pt-20 -64.68 -47.25 79.07 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.273 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.96 -38.8 92.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.929 0.395 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.1 ttp -71.6 -39.08 70.76 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.614 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.562 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -62.61 -33.19 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 m -63.59 -49.89 71.57 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.638 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.67 -51.66 47.19 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.823 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.26 -48.09 74.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -58.4 -43.16 88.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.705 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.401 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 9.3 mmm180 -66.19 -44.16 84.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.296 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.03 -40.8 97.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.071 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -68.57 -38.81 81.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.356 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.54 -31.09 68.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -77.07 -27.8 54.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.833 0.288 . . . . 0.0 111.528 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -84.05 -33.68 24.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -129.81 108.85 10.47 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -81.69 5.18 19.17 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.17 17.98 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.248 0.476 . . . . 0.0 111.939 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.42 113.64 5.46 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.135 0.174 . . . . 0.0 111.221 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.54 HD12 ' N ' ' B' ' 66' ' ' PHE . 3.3 tp -61.12 122.8 15.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.54 ' N ' HD12 ' B' ' 65' ' ' LEU . 32.5 m-85 -110.9 130.89 55.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.237 0.542 . . . . 0.0 111.47 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.918 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -138.16 141.26 40.09 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.098 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.416 HG11 HD23 ' B' ' 83' ' ' LEU . 71.4 t -123.92 131.71 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.84 18.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.91 153.06 16.68 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.636 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.3 165.3 24.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.762 0.315 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -33.3 67.29 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -81.18 -6.17 58.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 68.2 t -89.44 131.51 40.08 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.22 155.33 51.78 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.276 1.317 . . . . 0.0 110.451 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.0 t80 -64.82 -34.33 78.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.514 -0.741 . . . . 0.0 110.656 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.92 -36.71 70.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.758 0.314 . . . . 0.0 110.239 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 -35.69 72.43 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.606 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 t -61.8 -38.77 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.439 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.764 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 44.3 mm -60.58 -47.15 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.546 0.689 . . . . 0.0 109.372 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -53.38 -45.73 69.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.68 -49.05 79.01 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.296 0.57 . . . . 0.0 111.181 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 83' ' ' LEU . 8.0 mt -61.95 -35.95 79.98 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.356 0.598 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.68 -42.79 99.4 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.633 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.2 -38.96 92.1 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.68 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.494 HD13 HD13 ' B' ' 91' ' ' ILE . 0.6 OUTLIER -63.72 -42.01 98.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.965 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -62.94 -43.91 97.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.44 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.79 -38.22 72.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.615 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -90.95 11.94 21.2 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.95 96.98 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.1 mt -101.66 -35.09 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.935 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.455 0 N-CA-C 112.763 -0.135 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 t -69.33 -54.27 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.68 126.59 27.05 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.97 -164.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.052 2.501 . . . . 0.0 114.186 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG11 ' CE1' ' A' ' 66' ' ' PHE . 18.5 t -103.67 110.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 67' ' ' LEU . 3.4 mp -110.33 127.78 67.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD21 ' A' ' 86' ' ' LEU . 7.7 tt -115.69 120.67 40.13 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 14.3 tt0 -110.1 127.19 54.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.577 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.39 114.89 25.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.269 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.13 -22.63 17.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -120.35 0.65 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.436 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -114.35 96.79 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 122.892 0.477 . . . . 0.0 109.767 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 -4.5 85.89 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.713 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 129.67 51.74 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -137.61 156.12 48.42 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.15 0.976 . . . . 0.0 112.805 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . . . -126.1 141.88 51.76 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.296 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 HD12 ' A' ' 45' ' ' LEU . 4.7 pt -131.16 134.61 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.322 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.1 114.74 27.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.675 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' CD1' ' A' ' 35' ' ' ILE . 80.9 mt -112.18 108.78 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.951 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.2 48.02 20.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.892 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.77 -26.01 20.55 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.137 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -92.41 130.03 38.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.505 1.152 . . . . 0.0 110.482 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -108.44 136.95 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.157 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -118.79 127.74 53.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -117.48 156.03 28.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.104 0.478 . . . . 0.0 112.217 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 25.91 53.11 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.552 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 42' ' ' GLN . 17.1 mt -86.93 149.21 24.95 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.542 0.687 . . . . 0.0 112.208 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 p -91.88 171.44 9.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.419 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' VAL . 11.6 pt-20 -66.62 -44.29 82.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.244 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.79 -39.26 93.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.498 ' HE2' HD22 ' A' ' 45' ' ' LEU . 5.8 ttp -71.17 -41.45 70.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.973 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.2 p -61.66 -34.43 62.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.55 -50.23 70.32 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.857 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.57 -52.03 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.759 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -64.84 -47.96 76.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -57.6 -43.6 84.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.218 0.532 . . . . 0.0 111.672 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -66.35 -44.46 83.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.281 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.93 -40.13 95.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.178 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' OE2' HG22 ' A' ' 23' ' ' VAL . 4.4 tt0 -69.58 -38.83 77.51 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.401 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.28 -30.38 67.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.65 -27.43 45.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 117.885 0.311 . . . . 0.0 111.249 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -84.77 -35.64 22.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.916 0.388 . . . . 0.0 110.029 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -130.94 101.28 5.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.12 1.12 16.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -116.78 18.34 14.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.614 0.643 . . . . 0.0 111.955 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.68 115.21 7.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.47 126.44 27.84 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CE1' HG11 ' A' ' 23' ' ' VAL . 58.9 m-85 -113.61 129.67 56.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.171 0.51 . . . . 0.0 111.592 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 24' ' ' ILE . 3.5 pp -135.24 140.84 45.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG11 HD23 ' A' ' 83' ' ' LEU . 81.3 t -122.54 127.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.97 145.8 17.66 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 155.35 16.73 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.084 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.68 166.86 22.91 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.086 0.469 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -57.88 -34.16 69.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.323 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -80.95 -5.11 57.08 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.9 133.45 41.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.81 152.86 32.94 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.495 1.463 . . . . 0.0 110.34 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.9 t80 -63.41 -37.4 87.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.73 0.696 . . . . 0.0 110.722 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -55.82 -35.74 66.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.49 -34.82 67.92 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.705 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.0 -38.63 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.76 -47.52 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.329 0.585 . . . . 0.0 109.564 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -54.46 -44.27 72.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.22 78.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.342 0.592 . . . . 0.0 111.242 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 5.9 mt -60.87 -36.97 80.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.79 -41.85 96.38 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.825 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.3 -39.17 92.17 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.514 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD13 HD13 ' A' ' 91' ' ' ILE . 1.4 mm? -63.34 -42.27 98.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.074 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -63.72 -41.81 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -38.64 77.34 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -91.08 11.41 23.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.89 44.62 97.87 Favored Glycine 0 C--N 1.332 0.314 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 89' ' ' ALA . 4.7 mt -102.61 -36.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.705 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -69.74 -54.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 111.087 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 22.2 t -118.92 126.53 27.05 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.672 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -50.64 -164.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.132 2.555 . . . . 0.0 114.436 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.528 HG11 ' CE1' ' B' ' 66' ' ' PHE . 16.2 t -103.64 109.79 28.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.02 HG23 HD11 ' B' ' 67' ' ' LEU . 3.4 mp -110.04 127.3 67.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.192 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.49 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.7 tt -115.06 120.59 40.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 34' ' ' ALA . 14.4 tt0 -110.04 127.31 54.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.435 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.67 114.79 25.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.038 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 -22.89 17.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.86 -124.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.299 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -109.7 97.14 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.04 -0.58 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -4.17 86.21 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.916 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.42 129.92 52.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.75 155.98 48.47 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.115 0.96 . . . . 0.0 112.795 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' B' ' 26' ' ' GLU . . . -126.06 141.66 51.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.322 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.593 HG23 HD12 ' B' ' 45' ' ' LEU . 4.5 pt -130.84 134.8 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.301 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.36 114.89 27.87 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.439 0.638 . . . . 0.0 109.624 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.541 HD11 ' CD1' ' B' ' 35' ' ' ILE . 78.1 mt -112.27 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.775 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.82 48.56 18.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.944 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.46 -25.68 21.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.225 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.449 1.124 . . . . 0.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -108.08 136.94 46.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.295 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.577 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -119.01 127.63 53.62 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.062 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -117.19 156.36 27.81 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.87 26.49 53.34 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.413 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.593 HD12 HG23 ' B' ' 35' ' ' ILE . 16.5 mt -87.4 149.12 24.68 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.485 0.659 . . . . 0.0 112.076 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.1 p -91.62 171.07 9.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.373 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.473 ' O ' HG12 ' B' ' 50' ' ' VAL . 11.4 pt-20 -66.42 -44.25 83.45 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.269 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.83 -39.29 93.88 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.044 -0.41 . . . . 0.0 111.185 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.447 ' HE2' HD22 ' B' ' 45' ' ' LEU . 6.3 ttp -71.5 -40.98 69.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.953 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.473 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -61.85 -34.27 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 18.1 m -63.78 -49.96 70.9 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.846 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -50.74 -51.9 45.69 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.789 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.05 -47.67 76.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -57.64 -43.78 85.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.207 0.527 . . . . 0.0 111.764 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.84 -44.66 84.85 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.314 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.82 -39.87 95.27 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.165 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.4 -38.18 74.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.297 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -70.4 -30.75 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.57 -27.5 45.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.83 0.286 . . . . 0.0 111.268 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -84.72 -35.87 22.21 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.904 0.383 . . . . 0.0 110.073 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -130.64 101.6 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -76.42 1.71 15.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -117.28 18.32 14.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.705 0.684 . . . . 0.0 111.91 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 115.41 7.91 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.7 126.27 27.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.528 ' CE1' HG11 ' B' ' 23' ' ' VAL . 60.9 m-85 -113.4 129.49 56.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.244 0.545 . . . . 0.0 111.748 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.02 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.3 140.97 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.953 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.599 HG11 HD23 ' B' ' 83' ' ' LEU . 78.1 t -122.62 127.42 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.79 145.89 17.78 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.29 155.68 16.91 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.915 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.75 167.63 21.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -58.43 -34.74 71.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.036 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -80.35 -6.04 57.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.89 133.43 43.44 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.1 152.97 31.78 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.561 1.507 . . . . 0.0 110.251 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.729 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.0 t80 -63.55 -37.25 86.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.739 0.7 . . . . 0.0 110.572 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -55.78 -35.83 66.71 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.32 -35.07 68.53 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.844 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.75 -38.91 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.729 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.7 mm -60.37 -47.53 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.435 0.636 . . . . 0.0 109.784 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 4.2 mttm -54.4 -44.35 72.25 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.984 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.11 -49.23 78.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.275 0.559 . . . . 0.0 111.146 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 5.8 mt -60.63 -36.96 79.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.449 0.642 . . . . 0.0 109.448 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.05 -41.67 97.04 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.832 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 8.5 mt -65.22 -39.29 92.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.521 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.524 HD13 HD13 ' B' ' 91' ' ' ILE . 1.4 mm? -63.17 -42.63 99.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.93 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -63.64 -41.73 98.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -38.57 77.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.518 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' B' ' 91' ' ' ILE . . . -91.11 11.04 24.45 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.32 44.6 97.86 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 114.752 0.661 . . . . 0.0 114.752 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' B' ' 89' ' ' ALA . 4.6 mt -102.65 -36.03 4.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.776 -179.653 . . . . . . . . 1 1 . 1 stop_ save_